"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,US,A1,US 2022/0124345 A1,146-106-138-646-059,2022-04-21,2022,US 202117486472 A,2021-09-27,US 202117486472 A;;US 201916265804 A,2019-02-01,METHODS AND SYSTEMS FOR PROVIDING VARIABLE BITRATE CONTENT,"Provided are methods and systems for providing variable bitrate content (e.g., video content, audio content, multimedia content, etc.). The content may comprise a plurality of portions (e.g., frames, segments, fragments, etc.). Each portion of the content may be tagged and/or associated with a content element. A content element may be associated with and/or indicate one or more of an encoding parameter associated with a respective portion of the content, attributes of the content (e.g., a scene transition, scene change, etc.) associated with the respective portion of the content, or additional content related items (e.g., one or more advertisements, etc.) associated with the respective portion of the content. The content element may be used to determine a bitrate to associate with the respective portion of the content. The content may be received/retrieved according to the determined bitrates.",COMCAST CABLE COMM LLC,ENG ADAM;;ENG DAVID,COMCAST CABLE COMMUNICATIONS LLC (2020-08-29),https://lens.org/146-106-138-646-059,Patent Application,yes,16,0,6,6,0,H04N21/233;;H04N21/23418;;H04N21/23439;;H04N21/2662;;H04N21/2402;;H04N21/239;;H04N21/26216;;H04N21/26258;;H04N21/8456;;H04N21/812;;H04N21/84;;H04N21/2353;;H04N19/115;;H04N19/14,H04N19/14;;H04N19/115,,0,0,,,,PENDING
2,EP,A1,EP 3691278 A1,002-147-187-713-587,2020-08-05,2020,EP 20154877 A,2020-01-31,US 201916265804 A,2019-02-01,METHODS AND SYSTEMS FOR PROVIDING VARIABLE BITRATE CONTENT,"Provided are methods and systems for providing variable bitrate content (e.g., video content, audio content, multimedia content, etc.). The content may comprise a plurality of portions (e.g., frames, segments, fragments, etc.). Each portion of the content may be tagged and/or associated with a content element. A content element may be associated with and/or indicate one or more of an encoding parameter associated with a respective portion of the content, attributes of the content (e.g., a scene transition, scene change, etc.) associated with the respective portion of the content, or additional content related items (e.g., one or more advertisements, etc.) associated with the respective portion of the content. The content element may be used to determine a bitrate to associate with the respective portion of the content. The content may be received/retrieved according to the determined bitrates.
",COMCAST CABLE COMM LLC,ENG ADAM;;ENG DAVID,,https://lens.org/002-147-187-713-587,Patent Application,yes,2,0,6,6,0,H04N21/233;;H04N21/23418;;H04N21/23439;;H04N21/2662;;H04N21/2402;;H04N21/239;;H04N21/26216;;H04N21/26258;;H04N21/8456;;H04N21/812;;H04N21/84;;H04N21/2353;;H04N19/115;;H04N19/14,H04N21/233;;H04N21/234;;H04N21/2343;;H04N21/235;;H04N21/239;;H04N21/24;;H04N21/262;;H04N21/2662;;H04N21/81;;H04N21/84;;H04N21/845,,0,0,,,,ACTIVE
3,CA,A1,CA 3070642 A1,091-043-902-671-833,2020-08-01,2020,CA 3070642 A,2020-01-31,US 201916265804 A,2019-02-01,METHODS AND SYSTEMS FOR PROVIDING VARIABLE BITRATE CONTENT,"Provided are methods and systems for providing variable bitrate content (e.g., video content, audio content, multimedia content, etc.). The content may comprise a plurality of portions (e.g., frames, segments, fragments, etc.). Each portion of the content may be tagged and/or associated with a content element. A content element may be associated with and/or indicate one or more of an encoding parameter associated with a respective portion of the content, attributes of the content (e.g., a scene transition, scene change, etc.) associated with the respective portion of the content, or additional content related items (e.g., one or more advertisements, etc.) associated with the respective portion of the content. The content element may be used to determine a bitrate to associate with the respective portion of the content. The content may be received/retrieved according to the determined bitrates.",COMCAST CABLE COMM LLC,ENG ADAM;;ENG DAVID,,https://lens.org/091-043-902-671-833,Patent Application,no,0,0,6,6,0,H04N21/233;;H04N21/23418;;H04N21/23439;;H04N21/2662;;H04N21/2402;;H04N21/239;;H04N21/26216;;H04N21/26258;;H04N21/8456;;H04N21/812;;H04N21/84;;H04N21/2353;;H04N19/115;;H04N19/14,H04N19/34;;H04N19/115;;H04N19/134;;H04N19/159;;H04N19/52,,0,0,,,,PENDING
4,US,B2,US 11166028 B2,184-332-556-343-708,2021-11-02,2021,US 201916265804 A,2019-02-01,US 201916265804 A,2019-02-01,Methods and systems for providing variable bitrate content,"Provided are methods and systems for providing variable bitrate content (e.g., video content, audio content, multimedia content, etc.). The content may comprise a plurality of portions (e.g., frames, segments, fragments, etc.). Each portion of the content may be tagged and/or associated with a content element. A content element may be associated with and/or indicate one or more of an encoding parameter associated with a respective portion of the content, attributes of the content (e.g., a scene transition, scene change, etc.) associated with the respective portion of the content, or additional content related items (e.g., one or more advertisements, etc.) associated with the respective portion of the content. The content element may be used to determine a bitrate to associate with the respective portion of the content. The content may be received/retrieved according to the determined bitrates.",COMCAST CABLE COMM LLC,ENG ADAM;;ENG DAVID,COMCAST CABLE COMMUNICATIONS LLC (2020-08-29),https://lens.org/184-332-556-343-708,Granted Patent,yes,15,0,6,6,0,H04N21/233;;H04N21/23418;;H04N21/23439;;H04N21/2662;;H04N21/2402;;H04N21/239;;H04N21/26216;;H04N21/26258;;H04N21/8456;;H04N21/812;;H04N21/84;;H04N21/2353;;H04N19/115;;H04N19/14,H04N19/00;;H04N19/115;;H04N19/14,,3,0,,,"Extended European Search Report dated Apr. 28, 2020 by the European Patent Office for EP Application No. 20154877.3, filed on Feb. 1, 2019 (12 pages).;;EP, 201548773.3, Jan. 31, 2020, Adam Eng.;;European Search Report issued in related application No. EP20154877.3 dated Apr. 28, 2020.",ACTIVE
5,US,A1,US 2020/0252618 A1,040-338-692-865-047,2020-08-06,2020,US 201916265804 A,2019-02-01,US 201916265804 A,2019-02-01,METHODS AND SYSTEMS FOR PROVIDING VARIABLE BITRATE CONTENT,"Provided are methods and systems for providing variable bitrate content (e.g., video content, audio content, multimedia content, etc.). The content may comprise a plurality of portions (e.g., frames, segments, fragments, etc.). Each portion of the content may be tagged and/or associated with a content element. A content element may be associated with and/or indicate one or more of an encoding parameter associated with a respective portion of the content, attributes of the content (e.g., a scene transition, scene change, etc.) associated with the respective portion of the content, or additional content related items (e.g., one or more advertisements, etc.) associated with the respective portion of the content. The content element may be used to determine a bitrate to associate with the respective portion of the content. The content may be received/retrieved according to the determined bitrates.",COMCAST CABLE COMM LLC,ENG ADAM;;ENG DAVID,COMCAST CABLE COMMUNICATIONS LLC (2020-08-29),https://lens.org/040-338-692-865-047,Patent Application,yes,22,4,6,6,0,H04N21/233;;H04N21/23418;;H04N21/23439;;H04N21/2662;;H04N21/2402;;H04N21/239;;H04N21/26216;;H04N21/26258;;H04N21/8456;;H04N21/812;;H04N21/84;;H04N21/2353;;H04N19/115;;H04N19/14,H04N19/14;;H04N19/115,,0,0,,,,ACTIVE
6,EP,B1,EP 3691278 B1,038-932-633-365-499,2023-04-19,2023,EP 20154877 A,2020-01-31,US 201916265804 A,2019-02-01,METHODS AND SYSTEMS FOR PROVIDING VARIABLE BITRATE CONTENT,,COMCAST CABLE COMM LLC,ENG ADAM;;ENG DAVID,,https://lens.org/038-932-633-365-499,Granted Patent,yes,2,0,6,6,0,H04N21/233;;H04N21/23418;;H04N21/23439;;H04N21/2662;;H04N21/2402;;H04N21/239;;H04N21/26216;;H04N21/26258;;H04N21/8456;;H04N21/812;;H04N21/84;;H04N21/2353;;H04N19/115;;H04N19/14,H04N21/233;;H04N21/234;;H04N21/2343;;H04N21/235;;H04N21/239;;H04N21/24;;H04N21/262;;H04N21/2662;;H04N21/81;;H04N21/84;;H04N21/845,,0,0,,,,ACTIVE
7,US,B1,US 8743019 B1,152-487-957-002-117,2014-06-03,2014,US 13205105 A,2005-05-17,US 13205105 A,2005-05-17,System and method for abstracting computer displays across a host-client network,Embodiments of the present invention include a host computer system implemented method comprising receiving an indication of total requested display size of a remotely coupled client computer system. The method further includes automatically determining a number of display screens and a predetermined average display screen size. The method further includes an operating system of the host computer system allocating therein a display area to accommodate the total requested display size and dividing the display area into a number of separate portions equal to the number of display screens usable by the client computer system. The method further includes allocating each separate portion of the display area of the host computer system to a respective display screen of the client computer wherein each separate portion so allocated functions as a separate and independent display screen.,ENG DAVID;;NVIDIA CORP,ENG DAVID,NVIDIA CORPORATION (2005-05-17),https://lens.org/152-487-957-002-117,Granted Patent,yes,104,11,1,1,0,G06F3/1454;;G06F3/1454;;G06F3/1423;;G06F3/1423;;G09G5/14;;G09G5/14;;G09G2340/0407;;G09G2340/0407;;G09G2340/0464;;G09G2340/0464,G09G5/00,345/1.1;;345/1.2;;345/3.4,16,0,,,"McFedries, ebook titled ""Complete Idiot's Guide to Windows XP"", published Oct. 3, 2001, pp. 1-7.;;""System Management Bus (SMBus) Specification,"" Version 2.0, Aug. 3, 2000; pp. 1-59.;;Handtops.com, ""FlipStart PC in Detail"" pp. 1-4, downloaded from the Internet o Sep. 20, 2005 from http://www.handtops.com/show/news/5.;;Microsoft Corporation, ""Microsoft Windows Hardware Showcase"", dated Apr. 28, 2005; pp. 1-5; downloaded from the Internet on Sep. 15, 2005, from http://www.microsoft.com/whdc/winhec/hwshowcase05.mspx.;;Paul Thurrot's SuperSite for Windows, ""WinHEC 2004 Longhorn Prototypes Gallery"", dated May 10, 2004, pp. 1-4, downloaded from the Internet on Sep. 15, 2005 from http://www.sinwupersite.com/showcase.loghom-winhc-proto.asp.;;PCWorld.com, ""Microsoft Pitches Display for Laptop Lids"" dated Feb. 10, 2005, pp. 1-2, downloaded from the Internet on Mar. 8, 2006 from http://www.pcworld.com/resources/article/aid/119644.asp.;;Vulcan Inc., ""Connectivity FAQ"", p. 1, downloaded from the internet on Sep. 20, 2005 from http://www.flipstartpc.com/faq-connectivity.asp.;;Vulcan, Inc., ""Product Features: LID Module"", p. 1, downloaded from the Internet on Sep. 19, 2005 from http://www.flipstartpc.com/aboutproduct-features-lidmodule.asp.;;Vulcan, Inc., ""Product Features: Size and performanc"", p. 1; downloaded from the Internet on Sep. 20, 2005 from http://www.flipstartpc.com/aboutproduct-features-sizeandpower.asp.;;Vulcan, Inc., ""Software FAQ"", p. 1, downloaded from the Internet on Sep. 20, 2005 from http://www.flipstartpc.com/faq-software.asp.;;Andrew Fuller; ""Auxiliary Display Platform in Longhorn""; Microsoft Corporation; The Microsoft Hardware Engineering Conference Apr. 25-27, 2005; Slides 1-29.;;""Epson: EMP Monitor V4.10 Operation Guide"", by Seiko Epson Corp., 2006 http://support.epsonsu/products/manuals/100396/Manual/EMPMonitor.pdf.;;""Graphics: Intel ® 82852/82855 Graphics Controller Family"", Intel, Archived Nov. 2, 2006 by archive.org. Dowloaded Jun. 30, 2011, http://web.archive.org/20061103045644/http://www.intel.com/support/graphics/inte1852gm/sb/CS-009064.html.;;""The Java Tutorial: How to Use Combo Boxes"", Archived Mar. 5, 2006 by archive.org, Downloaded Jun. 30, 2011, http://web.archive.org/web/20050305000852/http://www.mips.unice.fr/Doc/Java/Tutorial/uiswing/components/combobox.html.;;Usage: NVIDIA GeForce 6800-PCIe x16, Dell, archived Jan. 15, 2006 by archive.org, Downloaded Jun. 29, 2011, http://web.archive.org/web/20060115050119/http://support.dell.com/support/edocs/video/P82192/en/usage.html.;;""Virtual Network Computing"", http://en.wikipedia.org/wiki/Vnc, Downloaded Circa: Dec. 18, 2008, pp. 1-4.",ACTIVE
8,US,B1,US 7649536 B1,069-515-973-484-897,2010-01-19,2010,US 45454706 A,2006-06-16,US 45454706 A,2006-06-16,"System, method, and computer program product for utilizing natural motions of a user to display intuitively correlated reactions","A system, method, and computer program product are provided for utilizing natural motions of a user to display intuitively correlated reactions. In use, an application-independent command is received from an input device utilizing at least one natural motion of a user with an associated degree. In response to the application-independent command, a reaction is displayed on a display in a manner that is intuitively correlated with the at least one natural motion. Further, a degree of the reaction is a function of the degree of the at least one natural motion.",NVIDIA CORP,ENG DAVID LEE,NVIDIA CORPORATION (2006-06-07),https://lens.org/069-515-973-484-897,Granted Patent,yes,24,6,1,1,0,G06F3/038;;G09G2370/24;;G06F3/038;;G09G2370/24,G06T13/00;;G06T15/70,345/474,9,4,068-741-319-660-090;;006-892-596-345-645;;122-349-077-545-742;;004-411-729-645-228,10.1145/968363.968386;;10.1145/985692.985743;;10.1145/958432.958473;;10.1145/371578.371593,"Jason S. Babcock, Jeff B. Pelz; Building a lightweight eyetracking headgear ETRA '04: Proceedings of the 2004 symposium on Eye tracking research & applications; Mar. 2004, ACM.;;Papier-Mache: toolkit support for tangible input Scott R. Klemmer, Jack Li, James Lin, James A. Landay Apr. 2004 CHI '04: Proceedings of the SIGCHI conference on Human factors in computing systems Publisher: ACM.;;GWindows: robust stereo vision for gesture-based control of windows Andrew Wilson, Nuria Oliver Nov. 2003.;;Phillips, JG et al., ""A Kinematic Analysis of Computer Mouse Movements"", Psychology Department, Monash University, Clayton VIC 3168, Australia.;;Opera Software, http://www.opera.com.;;Avid Solutions, http://www.avid.com.;;Softimage, http://www.softimage.com.;;NVIDIA ForceWare 55 Hands-On, HotHardware.com.;;Hilbert et al., ""Extracting Usability Information from User Interface Events,"" ACM Computing Surveys, vol. 32, No. 4, Dec. 2000, pp. 384-421.",INACTIVE
9,US,B2,US 11810551 B2,068-187-971-950-624,2023-11-07,2023,US 202117523012 A,2021-11-10,US 202117523012 A;;US 202016986945 A;;US 201816146619 A,2018-09-28,Monitoring of one or more audio/video collection devices,"Methods, systems, and apparatuses are described for monitoring of one or more A/V collection devices within a premises. Based on the monitoring, one or more computing devices may determine whether to route or block a data transmission outside a premises. The data transmission may be routed or blocked based on, for example, one or more of the following: whether a transmission window associated with an A/V collection device is open or closed; whether the data transmission is being sent to an authorized destination device; whether the data transmission is encrypted, and the like.",COMCAST CABLE COMM LLC,PATEL MEHUL;;ENG DAVID,COMCAST CABLE COMMUNICATIONS LLC (2018-09-28),https://lens.org/068-187-971-950-624,Granted Patent,yes,60,0,8,8,0,G06F3/167;;G10L2015/088;;G10L15/07;;G10L15/08;;G10L17/22;;G10L2015/088;;H04W12/06;;H04W12/08,G10L15/08;;G10L15/07;;G10L17/22;;H04W12/06;;H04W12/08,,7,0,,,"Feb. 27, 2023—European Office Action—EP 19200214.5.;;Baig Edward C.: “Alexa will turn off wi-fi when it's homework time”, USA today, Nov. 17, 2016 (Nov. 17, 2016), pp. 1-6, XP93026026, Retrieved from the Internet on Feb. 22, 2023: URL:https://eu.usatoday.com/story/tech/columnisVbaig/2016/11/17/alexa-turn-off-wi-fi-when-s-homework-time/94013704/.;;Jason Fitzpatrick, “How to Stop your Amazon Echo from Listening In” as shown on HowtoGeek.com on Jan. 2, 2016. Retrieved from: https://www.howtogeek.com/237397/how-to-stop-your-amazon-echo-from-listening-in/.;;Sharon Profis, “Amazon Echo saves all your voice data. Here's how to delete it” as shown on Cnet.com on Feb. 14, 2015. Retrieved from: https://www.cnet.com/how-to/amazon-echo-saves-all-your-voice-data-heres-how-to-delete-them/.;;Dec. 18, 2019—European Extended Search Report—EP 19200214.5.;;Sunny, “Project Alias—Enjoy Alexa without the constant voice monitoring” Feb. 16, 2018. Retrieved from: https://blog.banggood.com/project-alias-for-offline-alexa-privacy-63151.html.;;Sep. 22, 2021—European Office Action—EP 19200214.5.",ACTIVE
10,US,B2,US 11924662 B2,082-088-179-481-338,2024-03-05,2024,US 17097879,2020-11-13,,,Remote user plane deployment and configuration,"Aspects of the subject disclosure may include, for example, a method that includes providing, by a processing system including a processor, a controller function for a user plane function (UPF) of a communication network; the controller function facilitates automated procedures for authentication, deployment, configuration, testing, and/or controlling availability of the UPF, independent of a source of the UPF. The method also includes providing, by the processing system, an interface to facilitate communication between the controller function and the UPF; the controller function uses the interface to facilitate the procedures. Other embodiments are disclosed.","AT&T Intellectual Property I, L.P.",David Midkiff;;Douglas Eng,AT&T INTELLECTUAL PROPERTY I L.P (2020-11-11),https://lens.org/082-088-179-481-338,Granted Patent,yes,41,0,1,1,0,H04W24/10;;H04W8/04;;H04W8/06;;H04W12/033;;H04W88/10,H04W24/10;;H04W8/04;;H04W8/06;;H04W12/033;;H04W88/10,,1,0,,,"Kim et al., “Design of Unifeed Authentication for Multi-mode Terminal between Service and Access network in NGN”, in Advanced Communication Technology, 2008. ICACT 2008. 10th International Conference on, vol. 2, Feb. 2008, pp. 1288-1292 (Year: 2008).",UNKNOWN
11,US,A1,US 2005/0240742 A1,188-342-049-962-330,2005-10-27,2005,US 83138204 A,2004-04-22,US 83138204 A,2004-04-22,Method and apparatus for improving performance of data storage systems,"Techniques for improving access time in data storage systems are disclosed. These techniques can be used to prevent undesirable access delays that are often experienced in conventional storage systems. “Slow-access” can be defined as an access operation that does not successfully complete within a predetermined amount of time. The “slow-access” time can, for example, be defined based on a system requirement, specification, or a particular need of a specific application. As such, when detected “slow-access” indicates a potential performance problem that can manifest in undesirable effects. A data storage system is evaluated for potential performance problems by scanning it for “slow-access.” In addition, preventative measures are taken to prevent occurrence of a “slow-access” once it has been identified. These measures can prevent the undesirable effects experienced in conventional storage systems. This also means that specific system or application requirements can be certified and met.",APPLE COMPUTER,ENG MICHAEL;;WONG DAVID,APPLE INC (2004-04-20),https://lens.org/188-342-049-962-330,Patent Application,yes,16,25,4,4,0,G06F11/3419;;G06F2201/81;;G06F2201/88;;G06F11/3419;;G06F2201/81;;G06F2201/88,G06F12/00,711/167;;711/170,0,0,,,,ACTIVE
12,US,A1,US 2020/0105250 A1,117-206-932-509-066,2020-04-02,2020,US 201816146619 A,2018-09-28,US 201816146619 A,2018-09-28,Monitoring of One or More Audio/Video Collection Devices,"Methods, systems and apparatuses are described for monitoring of one or more A/V collection devices within a premises. Based on the monitoring, one or more computing devices may determine whether to route or block a data transmission outside a premises. The data transmission may be routed or blocked based on, for example, one or more of the following: whether a transmission window associated with an A/V collection device is open or closed; whether the data transmission is being sent to an authorized destination device; whether the data transmission is encrypted, and the like.",COMCAST CABLE COMM LLC,PATEL MEHUL;;ENG DAVID,COMCAST CABLE COMMUNICATIONS LLC (2018-09-28),https://lens.org/117-206-932-509-066,Patent Application,yes,0,2,8,8,0,G06F3/167;;G10L2015/088;;G10L15/07;;G10L15/08;;G10L17/22;;G10L2015/088;;H04W12/06;;H04W12/08,G10L15/08;;G10L15/07;;G10L17/22;;H04W12/06;;H04W12/08,,0,0,,,,ACTIVE
13,US,A1,US 2008/0263276 A1,124-951-451-805-984,2008-10-23,2008,US 11861108 A,2008-05-09,US 11861108 A;;US 83138204 A,2004-04-22,METHOD AND APPARATUS FOR EVALUATING AND IMPROVING DISK ACCESS TIME IN A RAID SYSTEM,"Techniques for improving access time in data storage systems are disclosed. These techniques can be used to prevent undesirable access delays that are often experienced in conventional storage systems. “Slow-access” can be defined as an access operation that does not successfully complete within a predetermined amount of time. The “slow-access” time can, for example, be defined based on a system requirement, specification, or a particular need of a specific application. As such, when detected “slow-access” indicates a potential performance problem that can manifest in undesirable effects. A data storage system is evaluated for potential performance problems by scanning it for “slow-access.” In addition, preventative measures are taken to prevent occurrence of a “slow-access” once it has been identified. These measures can prevent the undesirable effects experienced in conventional storage systems. This also means that specific system or application requirements can be certified and met.",APPLE INC,ENG MICHAEL;;WONG DAVID,,https://lens.org/124-951-451-805-984,Patent Application,yes,20,3,4,4,0,G06F11/3419;;G06F2201/81;;G06F2201/88;;G06F11/3419;;G06F2201/81;;G06F2201/88,G06F12/00,711/114;;711/167;;X711E12001,0,0,,,,ACTIVE
14,US,A1,US 2022/0159496 A1,151-796-608-797-284,2022-05-19,2022,US 202017097879 A,2020-11-13,US 202017097879 A,2020-11-13,REMOTE USER PLANE DEPLOYMENT AND CONFIGURATION,"Aspects of the subject disclosure may include, for example, a method that includes providing, by a processing system including a processor, a controller function for a user plane function (UPF) of a communication network; the controller function facilitates automated procedures for authentication, deployment, configuration, testing, and/or controlling availability of the UPF, independent of a source of the UPF. The method also includes providing, by the processing system, an interface to facilitate communication between the controller function and the UPF; the controller function uses the interface to facilitate the procedures. Other embodiments are disclosed.",AT & T IP I LP,MIDKIFF DAVID;;ENG DOUGLAS,AT&T INTELLECTUAL PROPERTY I L.P (2020-11-11),https://lens.org/151-796-608-797-284,Patent Application,yes,24,1,1,1,0,H04W88/14;;H04W12/033;;H04W12/06;;H04W24/10;;H04W8/04;;H04W8/06;;H04W88/10;;H04W12/033,H04W24/10;;H04W8/04;;H04W8/06;;H04W12/00;;H04W88/10,,0,0,,,,ACTIVE
15,US,B2,US 7879600 B2,037-302-820-288-836,2011-02-01,2011,US 91344906 A,2006-05-05,AU 2005/902290 A;;IB 2006001493 W,2005-05-06,Waste converter,A waste converter ( 10 ) for domestic use includes two waste conversion regions. Household waste is placed in a primary waste conversion region ( 40 ) which includes flies and maggots. When waste has sufficiently decomposed it falls through to a secondary waste conversion region which includes composting worms and woodlice.,CHEE ENG LOCK DAVID,CHEE ENG LOCK DAVID,,https://lens.org/037-302-820-288-836,Granted Patent,yes,12,2,7,9,0,A01K67/033;;A01K67/033;;A01K67/0332;;A01K67/0332;;B09B3/00;;B09B3/00;;C05F9/02;;C05F17/90;;C05F17/05;;C05F17/05;;Y02P20/145;;Y02P20/145;;Y02W30/40;;Y02W30/40,C12M1/02;;C05F9/02,435/290.2;;435/290.4,1,0,,,"Derwent Abstract Accession No. 94-015435/02, TW 215070 A, Mitsui Kinzoku Staff Service KK, Oct. 21, 1993.",INACTIVE
16,EP,A1,EP 2400056 A1,086-658-444-356-333,2011-12-28,2011,EP 10167546 A,2010-06-28,EP 10167546 A,2010-06-28,Device for processing bearing surfaces of rails using peripheral grinding with adjustable grinding profile,"Die Erfindung betrifft eine Vorrichtung zum Bearbeiten der Laufflächen von Schienen (3) durch Umfangsschleifen mit einem Schienenlaufräder zum Befahren der Schiene (3) aufweisenden Fahrgestell und wenigstens einem an dem Fahrgestell festgelegten, mit darin angeordneten Schleifkörpern (6) an die Lauffläche der Schiene (3) zustellbaren Schleifgestell (4), welches individuell auf je einer zur Schienlängsrichtung einen spitzen Winkel einschließenden Rotationsachse frei drehbar gelagert die Schleifkörper (6) zum Umfangsschleifen aufweist. Um eine solche Vorrichtung dahingehend weiterzubilden, dass mit ihr ein variableres und den Anforderungen angepasstes Bearbeiten der Laufflächen von Schienen (3) möglich ist, wird vorgeschlagen, dass das Schleifgestell (4) derart in einer Richtung quer zur Längsrichtung der Schiene (3) und quer zur Vertikalen verlagerbar an dem Fahrgestell (4) angeordnet ist, dass durch ein solches Verlagern des Schleifgestells (4) die Position, an der die Schleifkörper (3) mit ihrer Umfangsfläche (7) an der Lauffläche der Schiene (3) angreifen, in einer Richtung quer zur Schienenlängsrichtung verändert wird, und weiter dadurch gekennzeichnet, dass Mittel (12) zum Verlagern des Schleifgestells (4) vorgesehen sind.
",VOSSLOH HIGH SPEED GRINDING GMBH,KRUEGER DAVID B ENG,,https://lens.org/086-658-444-356-333,Patent Application,yes,7,5,1,1,0,E01B31/17,E01B31/17,,0,0,,,,DISCONTINUED
17,WO,A2,WO 2006/120569 A2,088-134-396-338-397,2006-11-16,2006,IB 2006001493 W,2006-05-05,AU 2005/902290 A,2005-05-06,WASTE CONVERTER,A waste converter (10) for domestic use includes two waste conversion regions. Household waste is placed in a primary waste conversion region (40) which includes flies and maggots. When waste has sufficiently decomposed it falls through to a secondary waste conversion region which includes composting worms and woodlice.,CHEE ENG LOCK DAVID,CHEE ENG LOCK DAVID,,https://lens.org/088-134-396-338-397,Patent Application,yes,0,1,7,9,0,A01K67/033;;A01K67/033;;A01K67/0332;;A01K67/0332;;B09B3/00;;B09B3/00;;C05F9/02;;C05F17/90;;C05F17/05;;C05F17/05;;Y02P20/145;;Y02P20/145;;Y02W30/40;;Y02W30/40,C05F17/02;;C05F9/02,,0,0,,,,PENDING
18,WO,A3,WO 2006/120569 A3,083-724-754-604-308,2007-04-19,2007,IB 2006001493 W,2006-05-05,AU 2005/902290 A,2005-05-06,WASTE CONVERTER,A waste converter (10) for domestic use includes two waste conversion regions. Household waste is placed in a primary waste conversion region (40) which includes flies and maggots. When waste has sufficiently decomposed it falls through to a secondary waste conversion region which includes composting worms and woodlice.,CHEE ENG LOCK DAVID,CHEE ENG LOCK DAVID,,https://lens.org/083-724-754-604-308,Search Report,yes,2,0,7,9,0,A01K67/033;;A01K67/033;;A01K67/0332;;A01K67/0332;;B09B3/00;;B09B3/00;;C05F9/02;;C05F17/90;;C05F17/05;;C05F17/05;;Y02P20/145;;Y02P20/145;;Y02W30/40;;Y02W30/40,C05F17/02;;C05F9/02,,1,0,,,"DATABASE WPI Week 199402, Derwent World Patents Index; Class Q35, AN 1994-015435, XP003010609",PENDING
19,US,B2,US 7383400 B2,194-006-807-274-145,2008-06-03,2008,US 83138204 A,2004-04-22,US 83138204 A,2004-04-22,Method and apparatus for evaluating and improving disk access time in a RAID system,"Techniques for improving access time in data storage systems are disclosed. These techniques can be used to prevent undesirable access delays that are often experienced in conventional storage systems. “Slow-access” can be defined as an access operation that does not successfully complete within a predetermined amount of time. The “slow-access” time can, for example, be defined based on a system requirement, specification, or a particular need of a specific application. As such, when detected “slow-access” indicates a potential performance problem that can manifest in undesirable effects. A data storage system is evaluated for potential performance problems by scanning it for “slow-access.” In addition, preventative measures are taken to prevent occurrence of a “slow-access” once it has been identified. These measures can prevent the undesirable effects experienced in conventional storage systems. This also means that specific system or application requirements can be certified and met.",APPLE INC,ENG MICHAEL;;WONG DAVID,APPLE INC (2004-04-20),https://lens.org/194-006-807-274-145,Granted Patent,yes,17,8,4,4,0,G06F11/3419;;G06F2201/81;;G06F2201/88;;G06F11/3419;;G06F2201/81;;G06F2201/88,G06F11/30;;G06F12/00,711/154;;711/114;;714/47,10,1,071-984-908-937-080,10.1145/166266.168435,"Tobagi et al. ""Streaming RAID-A Disk Array Management System for Video Files."" No date available, Starlight Networks, Inc.;;Computer dictionary, 1997, Microsoft Press, Third Edition, p. 121.;;Office Action of Nov. 10, 2005 from U.S. Appl. No. 10/303,121.;;U.S. Appl. No. 10/303,121, filed Nov. 22, 2002.;;U.S. Appl. No. 10/831,417, filed Apr. 22, 2004.;;Office Action from U.S. Appl. No. 10/303,121, filed Mar. 2, 2006, 10 pages.;;Final Office Action from U.S. Appl. No. 10/303,121, filed May 30, 2006, 5 pages.;;Office Action from U.S. Appl. No. 10/831,417, filed May 12, 2006, 14 pages.;;Final Office Action from U.S. Appl. No. 10/831,417, filed Aug. 29, 2006, 18 pages.;;Office Action from U.S. Appl. No. 11/542,389, filed Mar. 7, 2007, 17 pages.",ACTIVE
20,GB,B,GB 2442887 B,195-476-283-356-125,2009-04-15,2009,GB 0723923 A,2006-05-05,IB 2006001493 W;;AU 2005/902290 A,2005-05-06,Waste converter,,CHEE ENG LOCK DAVID,CHEE ENG LOCK DAVID,,https://lens.org/195-476-283-356-125,Granted Patent,no,3,0,7,9,0,A01K67/033;;A01K67/033;;A01K67/0332;;A01K67/0332;;B09B3/00;;B09B3/00;;C05F9/02;;C05F17/90;;C05F17/05;;C05F17/05;;Y02P20/145;;Y02P20/145;;Y02W30/40;;Y02W30/40,C05F17/02;;C05F9/02,,0,0,,,,INACTIVE
21,US,A1,US 2021/0193122 A1,027-350-510-484-341,2021-06-24,2021,US 202016986945 A,2020-08-06,US 202016986945 A;;US 201816146619 A,2018-09-28,Monitoring of One or More Audio/Video Collection Devices,"Methods, systems and apparatuses are described for monitoring of one or more A/V collection devices within a premises. Based on the monitoring, one or more computing devices may determine whether to route or block a data transmission outside a premises. The data transmission may be routed or blocked based on, for example, one or more of the following: whether a transmission window associated with an A/V collection device is open or closed; whether the data transmission is being sent to an authorized destination device; whether the data transmission is encrypted, and the like.",COMCAST CABLE COMM LLC,PATEL MEHUL;;ENG DAVID,COMCAST CABLE COMMUNICATIONS LLC (2018-09-28),https://lens.org/027-350-510-484-341,Patent Application,yes,0,0,8,8,0,G06F3/167;;G10L2015/088;;G10L15/07;;G10L15/08;;G10L17/22;;G10L2015/088;;H04W12/06;;H04W12/08,G10L15/08;;G10L15/07;;G10L17/22;;H04W12/06;;H04W12/08,,0,0,,,,ACTIVE
22,US,A1,US 2022/0180860 A1,035-574-449-276-377,2022-06-09,2022,US 202117523012 A,2021-11-10,US 202117523012 A;;US 202016986945 A;;US 201816146619 A,2018-09-28,Monitoring of One or More Audio/Video Collection Devices,"Methods, systems, and apparatuses are described for monitoring of one or more A/V collection devices within a premises. Based on the monitoring, one or more computing devices may determine whether to route or block a data transmission outside a premises. The data transmission may be routed or blocked based on, for example, one or more of the following: whether a transmission window associated with an A/V collection device is open or closed; whether the data transmission is being sent to an authorized destination device; whether the data transmission is encrypted, and the like.",COMCAST CABLE COMM LLC,PATEL MEHUL;;ENG DAVID,COMCAST CABLE COMMUNICATIONS LLC (2018-09-28),https://lens.org/035-574-449-276-377,Patent Application,yes,0,0,8,8,0,G06F3/167;;G10L2015/088;;G10L15/07;;G10L15/08;;G10L17/22;;G10L2015/088;;H04W12/06;;H04W12/08,G10L15/07;;G10L15/08;;G10L17/22;;H04W12/06;;H04W12/08,,0,0,,,,ACTIVE
23,US,B2,US 7873784 B2,081-123-933-207-408,2011-01-18,2011,US 11861108 A,2008-05-09,US 11861108 A;;US 83138204 A,2004-04-22,Method and apparatus for evaluating and improving disk access time in a raid system,"Techniques for improving access time in data storage systems are disclosed. These techniques can be used to prevent undesirable access delays that are often experienced in conventional storage systems. “Slow-access” can be defined as an access operation that does not successfully complete within a predetermined amount of time. The “slow-access” time can, for example, be defined based on a system requirement, specification, or a particular need of a specific application. As such, when detected “slow-access” indicates a potential performance problem that can manifest in undesirable effects. A data storage system is evaluated for potential performance problems by scanning it for “slow-access.” In addition, preventative measures are taken to prevent occurrence of a “slow-access” once it has been identified. These measures can prevent the undesirable effects experienced in conventional storage systems. This also means that specific system or application requirements can be certified and met.",APPLE INC,ENG MICHAEL;;WONG DAVID,,https://lens.org/081-123-933-207-408,Granted Patent,yes,21,2,4,4,0,G06F11/3419;;G06F2201/81;;G06F2201/88;;G06F11/3419;;G06F2201/81;;G06F2201/88,G06F12/00,711/114;;711/154;;714/47,18,1,071-984-908-937-080,10.1145/166266.168435,"Tobagi et al. ""Streaming RAID-A Disk Array Management System for Video Files."" No date available, Starlight Networks, Inc.;;Computer dictionary, 1997, Microsoft Press, Third Edition, p. 121.;;Final Office Action from U.S. Appl. No. 10/303,121, May 30, 2006, 5 pages.;;Final Office Action from U.S. Appl. No. 10/831,382, Nov. 2, 2006, 27 pages.;;Office Action from U.S. Appl. No. 10/831,417, May 12, 2006, 14 pages.;;Final Office Action from U.S. Appl. No. 10/831,417, Aug. 29, 2006, 18 pages.;;Final Office Action from U.S. Appl. No. 11/542,389, Jul. 12, 2007, 16 pages.;;Office Action from U.S. Appl. No. 10/303,121, Mar. 2, 2006, 10 pages.;;Office Action from U.S. Appl. No. 10/831,382, Apr. 20, 2007, 28 pages.;;Office Action from U.S. Appl. No. 10/831,382, May 22, 2006, 24 pages.;;Office Action from U.S. Appl. No. 11/542,389, Mar. 7, 2007, 17 pages.;;Office Action from U.S. Appl. No. 10/303,121, Nov. 10, 2005, 17 pages.;;Office Action from U.S. Appl. No. 11/542,389, dated Nov. 14, 2007.;;Notice of Allowance and Allowed Claims dated Jan. 31, 2008 for U.S. Appl. No. 10/831,382.;;Notice of Allowance dated Mar. 27, 2008 for U.S. Appl. No. 11/542,389.;;Notice of Allowance dated Jul. 8, 2010 in U.S. Appl. No. 11/682,113.;;Office Action dated Jul. 13, 2009 in U.S. Appl. No. 11/682,113.;;Office Action dated Dec. 1, 2009 in U.S. Appl. No. 11/682,113.",ACTIVE
24,CA,A1,CA 3056958 A1,128-871-761-704-084,2020-03-28,2020,CA 3056958 A,2019-09-27,US 201816146619 A,2018-09-28,MONITORING OF ONE OR MORE AUDIO/VIDEO COLLECTION DEVICES,"Methods, systems and apparatuses are described for monitoring of one or more A/V collection devices within a premises. Based on the monitoring, one or more computing devices may determine whether to route or block a data transmission outside a premises. The data transmission may be routed or blocked based on, for example, one or more of the following: whether a transmission window associated with an A/V collection device is open or closed; whether the data transmission is being sent to an authorized destination device; whether the data transmission is encrypted, and the like.",COMCAST CABLE COMM LLC,PATEL MEHUL;;ENG DAVID,,https://lens.org/128-871-761-704-084,Patent Application,no,0,0,8,8,0,G06F3/167;;G10L2015/088;;G10L15/07;;G10L15/08;;G10L17/22;;G10L2015/088;;H04W12/06;;H04W12/08,H04L29/12;;G10L15/22;;H04L12/701;;H04L29/06;;H04N21/233,,0,0,,,,PENDING
25,US,B2,US 10762893 B2,076-676-407-908-086,2020-09-01,2020,US 201816146619 A,2018-09-28,US 201816146619 A,2018-09-28,Monitoring of one or more audio/video collection devices,"Methods, systems and apparatuses are described for monitoring of one or more A/V collection devices within a premises. Based on the monitoring, one or more computing devices may determine whether to route or block a data transmission outside a premises. The data transmission may be routed or blocked based on, for example, one or more of the following: whether a transmission window associated with an A/V collection device is open or closed; whether the data transmission is being sent to an authorized destination device; whether the data transmission is encrypted, and the like.",COMCAST CABLE COMM LLC,PATEL MEHUL;;ENG DAVID,COMCAST CABLE COMMUNICATIONS LLC (2018-09-28),https://lens.org/076-676-407-908-086,Granted Patent,yes,46,0,8,8,0,G06F3/167;;G10L2015/088;;G10L15/07;;G10L15/08;;G10L17/22;;G10L2015/088;;H04W12/06;;H04W12/08,G10L15/08;;G10L15/07;;G10L17/22;;H04W12/06;;H04W12/08,,4,0,,,"Jason Fitzpatrick, “How to Stop your Amazon Echo from Listening in” as shown on HowtoGeek.com on Jan. 2, 2016. Retrieved from: https://www.howtogeek.com/237397/how-to-stop-your-amazon-echo-from-listening-in/.;;Sharon Profis, “Amazon Echo saves all your voice data. Here's how to delete it” as shown on Cnet.com on Feb. 14, 2015. Retrieved from: https://www.cnet.com/how-to/amazon-echo-saves-all-your-voice-data-heres-how-to-delete-them/.;;Dec. 18, 2019—European Extended Search Report—EP 19200214.5.;;Sunny, “Project Alias—Enjoy Alexa without the constant voice monitoring” Feb. 16, 2018. Retrieved from: https://blog.banggood.com/project-alias-for-offline-alexa-privacy-63151.html.",ACTIVE
26,AU,B2,AU 2006/245433 B2,196-650-659-930-381,2012-02-09,2012,AU 2006/245433 A,2006-05-05,AU 2005/902290 A;;IB 2006001493 W;;AU 2006/245433 A,2005-05-06,Waste converter,A waste converter (10) for domestic use includes two waste conversion regions. Household waste is placed in a primary waste conversion region (40) which includes flies and maggots. When waste has sufficiently decomposed it falls through to a secondary waste conversion region which includes composting worms and woodlice.,CHEE ENG LOCK DAVID,CHEE ENG LOCK DAVID,,https://lens.org/196-650-659-930-381,Granted Patent,no,0,0,2,9,0,Y02P20/145;;C05F17/907;;Y02W30/40,C05F17/02;;C05F9/02,,0,0,,,,INACTIVE
27,US,B2,US 11211054 B2,120-107-457-766-956,2021-12-28,2021,US 202016986945 A,2020-08-06,US 202016986945 A;;US 201816146619 A,2018-09-28,Monitoring of one or more audio/video collection devices,"Methods, systems and apparatuses are described for monitoring of one or more A/V collection devices within a premises. Based on the monitoring, one or more computing devices may determine whether to route or block a data transmission outside a premises. The data transmission may be routed or blocked based on, for example, one or more of the following: whether a transmission window associated with an A/V collection device is open or closed; whether the data transmission is being sent to an authorized destination device; whether the data transmission is encrypted, and the like.",COMCAST CABLE COMM LLC,PATEL MEHUL;;ENG DAVID,COMCAST CABLE COMMUNICATIONS LLC (2018-09-28),https://lens.org/120-107-457-766-956,Granted Patent,yes,61,0,8,8,0,G06F3/167;;G10L2015/088;;G10L15/07;;G10L15/08;;G10L17/22;;G10L2015/088;;H04W12/06;;H04W12/08,G10L15/08;;G10L15/07;;G10L17/22;;H04W12/06;;H04W12/08,,5,0,,,"Jason Fitzpatrick, “How to Stop your Amazon Echo from Listening In” as shown on HowtoGeek.com on Jan. 2, 2016. Retrieved from: https://www.howtogeek.com/237397/how-to-stop-your-amazon-echo-from-listening-in/.;;Sharon Profis, “Amazon Echo saves all your voice data. Here's how to delete it” as shown on Cnet.com on Feb. 14, 2015. Retrieved from: https://www.cnet.com/how-to/amazon-echo-saves-all-your-voice-data-heres-how-to-delete-them/.;;Dec. 18, 2019—European Extended Search Report—EP 19200214.5.;;Sunny, “Project Alias—Enjoy Alexa without the constant voice monitoring” Feb. 16, 2018. Retrieved from: https://blog.banggood.com/project-alias-for-offline-alexa-privacy-63151.html.;;Sep. 22, 2021—European Office Action—EP 19200214.5.",ACTIVE
28,GB,A,GB 2442887 A,138-711-493-312-534,2008-04-16,2008,GB 0723923 A,2006-05-05,IB 2006001493 W;;AU 2005/902290 A,2005-05-06,Waste converter,A waste converter (10) for domestic use includes two waste conversion regions. Household waste is placed in a primary waste conversion region (40) which includes flies and maggots. When waste has sufficiently decomposed it falls through to a secondary waste conversion region which includes composting worms and woodlice.,CHEE ENG LOCK DAVID,CHEE ENG LOCK DAVID,,https://lens.org/138-711-493-312-534,Patent Application,no,3,0,7,9,0,A01K67/033;;A01K67/033;;A01K67/0332;;A01K67/0332;;B09B3/00;;B09B3/00;;C05F9/02;;C05F17/90;;C05F17/05;;C05F17/05;;Y02P20/145;;Y02P20/145;;Y02W30/40;;Y02W30/40,C05F17/02;;C05F9/02,,0,0,,,,INACTIVE
29,US,A1,US 2008/0206856 A1,184-112-512-649-92X,2008-08-28,2008,US 91344906 A,2006-05-05,AU 2005/902290 A;;IB 2006001493 W,2005-05-06,Waste Converter,A waste converter ( 10 ) for domestic use includes two waste conversion regions. Household waste is placed in a primary waste conversion region ( 40 ) which includes flies and maggots. When waste has sufficiently decomposed it falls through to a secondary waste conversion region which includes composting worms and woodlice.,CHEE ENG LOCK DAVID,CHEE ENG LOCK DAVID,,https://lens.org/184-112-512-649-92X,Patent Application,yes,8,2,7,9,0,A01K67/033;;A01K67/033;;A01K67/0332;;A01K67/0332;;B09B3/00;;B09B3/00;;C05F9/02;;C05F17/90;;C05F17/05;;C05F17/05;;Y02P20/145;;Y02P20/145;;Y02W30/40;;Y02W30/40,C12M1/00,435/290.3,0,0,,,,INACTIVE
30,EP,A1,EP 3629146 A1,069-273-329-842-316,2020-04-01,2020,EP 19200214 A,2019-09-27,US 201816146619 A,2018-09-28,MONITORING OF ONE OR MORE AUDIO/VIDEO COLLECTION DEVICES,"Methods, systems and apparatuses are described for monitoring of one or more A/V collection devices within a premises. Based on the monitoring, one or more computing devices may determine whether to route or block a data transmission outside a premises. The data transmission may be routed or blocked based on, for example, one or more of the following: whether a transmission window associated with an A/V collection device is open or closed; whether the data transmission is being sent to an authorized destination device; whether the data transmission is encrypted, and the like.
",COMCAST CABLE COMM LLC,PATEL MEHUL;;ENG DAVID,,https://lens.org/069-273-329-842-316,Patent Application,yes,4,0,8,8,0,G06F3/167;;G10L2015/088;;G10L15/07;;G10L15/08;;G10L17/22;;G10L2015/088;;H04W12/06;;H04W12/08,G06F3/16;;G10L15/22,,1,0,,,"SUNNY: ""Project Alias - Enjoy Alexa without the constant voice monitoring - Banggood.com Gadget News Blog"", BANGGOOD, 16 February 2018 (2018-02-16), XP055651759, Retrieved from the Internet <URL:https://blog.banggood.com/project-alias-for-offline-alexa-privacy-63151.html> [retrieved on 20191211]",PENDING
31,AU,A1,AU 2006/245433 A1,177-478-264-827-530,2006-11-16,2006,AU 2006/245433 A,2006-05-05,AU 2005/902290 A;;IB 2006001493 W;;AU 2006/245433 A,2005-05-06,Waste converter,,CHEE ENG,CHEE ENG LOCK DAVID,,https://lens.org/177-478-264-827-530,Patent Application,no,0,0,2,9,0,C05F17/907;;Y02P20/145;;Y02W30/40,C05F17/02;;C05F9/02,,0,0,,,,INACTIVE
32,US,A1,US 2020/0145824 A1,040-670-473-454-680,2020-05-07,2020,US 201816181099 A,2018-11-05,US 201816181099 A,2018-11-05,Localized Multi-Factor Network Authentication,"Systems, apparatuses, and methods are described for localized multi-factor network authentication are disclosed. A computing device associated with a network may provide an access code via a power line network of a premises and may request that devices attempting to gain access to a wireless network provide the access code. Access of devices to the wireless network may be blocked or limited based on monitored behavior.",COMCAST CABLE COMM LLC,JONES JR DONALD J;;ENG ADAM;;ENG DAVID,COMCAST CABLE COMMUNICATIONS LLC (2018-11-05),https://lens.org/040-670-473-454-680,Patent Application,yes,44,4,1,1,0,H04L63/0876;;H04W12/06;;H04W48/02;;H04B3/54;;H04W12/06;;H04L63/0876;;H04W48/02,H04W12/06;;H04L29/06;;H04W48/02,,0,0,,,,PENDING
33,US,A1,US 2018/0059994 A1,154-887-819-325-802,2018-03-01,2018,US 201615251276 A,2016-08-30,US 201615251276 A,2016-08-30,PROCESSING PRINT JOBS WITH A SINGLE SHEET JOB MODEL,"System and methods for processing and printing print jobs with a single sheet job model job model. In one embodiment, a print controller includes an interface that receives a print job, and a processing unit that initiates a processing task for a group of pages in the print job. The print controller also includes a sheet controller that establishes a single sheet job model in memory for the processing task, and that iteratively inserts sheet properties of a set of pages of the group into the single sheet job model, provides the single sheet job model with the sheet properties to the processing task, and erases the sheet properties from the single sheet job model.",ENG KATIE ASHLEY;;WARD DAVID;;RICOH CO LTD,ENG KATIE ASHLEY;;WARD DAVID,RICOH COMPANY LTD (2016-08-29),https://lens.org/154-887-819-325-802,Patent Application,yes,12,0,2,2,0,G06F3/122;;G06F3/122;;G06F3/1206;;G06F3/1206;;G06F3/1247;;G06F3/1247;;G06F3/1282;;G06F3/1282;;G06K15/1827;;G06K15/1827;;G06K15/1836;;G06K15/1836;;G06K15/1851;;G06K15/1851;;G06K15/1861;;G06K15/1861;;G06K15/1868;;G06K15/1868,G06F3/12;;G06K15/02,,0,0,,,,ACTIVE
34,US,B2,US 10241732 B2,038-128-513-987-659,2019-03-26,2019,US 201615251276 A,2016-08-30,US 201615251276 A,2016-08-30,Processing print jobs with a single sheet job model,"System and methods for processing and printing print jobs with a single sheet job model job model. In one embodiment, a print controller includes an interface that receives a print job, and a processing unit that initiates a processing task for a group of pages in the print job. The print controller also includes a sheet controller that establishes a single sheet job model in memory for the processing task, and that iteratively inserts sheet properties of a set of pages of the group into the single sheet job model, provides the single sheet job model with the sheet properties to the processing task, and erases the sheet properties from the single sheet job model.",ENG KATIE ASHLEY;;WARD DAVID;;RICOH CO LTD,ENG KATIE ASHLEY;;WARD DAVID,RICOH COMPANY LTD (2016-08-29),https://lens.org/038-128-513-987-659,Granted Patent,yes,16,1,2,2,0,G06F3/122;;G06F3/122;;G06F3/1206;;G06F3/1206;;G06F3/1247;;G06F3/1247;;G06F3/1282;;G06F3/1282;;G06K15/1827;;G06K15/1827;;G06K15/1836;;G06K15/1836;;G06K15/1851;;G06K15/1851;;G06K15/1861;;G06K15/1861;;G06K15/1868;;G06K15/1868,G06F3/12;;G06K15/02,,1,1,011-138-644-925-852,10.1145/1600193.1600218,"Nunes, T. et al; Job Profiling in High Performance Printing; DocEng '09, Sep. 16-18, 2009 Munich, Germany; Copyright 2009.",ACTIVE
35,WO,A1,WO 2020/167586 A1,036-636-508-384-931,2020-08-20,2020,US 2020/0017064 W,2020-02-06,US 201962804083 P,2019-02-11,AUTOMATED DATA DISCOVERY FOR CYBERSECURITY,"Automated data discovery for cybersecurity. In an embodiment, a plurality of semantic objects, representing in-context textual components of statement(s) in a data-access language, captured from network traffic, are received. The textual components are parsed into group(s) of word(s). The group(s) are then matched to lemmas in a semantic dictionary to produce matched lemma(s), and the matched lemma(s) are matched to lexical entry(ies) in the semantic dictionary to produce matched lexical entry(ies). The matched lexical entry(ies) are matched to classifier(s) in a classifier database to produce classification(s). Each classification represents a possibility that the statement(s) access data within that classification. The classification(s) may be stored in association with their context for quantitative and/or qualitative analysis of the types and locations of data within a network.",DB CYBERTECH INC,ROSENBERG DAVID A;;ENG VINCENT,,https://lens.org/036-636-508-384-931,Patent Application,yes,7,0,1,1,0,G06F40/237;;G06F40/284;;G06F40/30;;G06F40/211,G06F40/221;;G06F40/237;;G06F40/284;;G06F40/30,,0,0,,,,PENDING
36,US,A1,US 2020/0297444 A1,141-262-105-948-184,2020-09-24,2020,US 202016826114 A,2020-03-20,US 202016826114 A;;US 201962821993 P,2019-03-21,SYSTEMS AND METHODS FOR LOCALIZATION BASED ON MACHINE LEARNING,"Certain aspects relate to systems and techniques for localizing and/or navigating a medical instrument within a luminal network. A medical system can include an elongate body configured to be inserted into the luminal network, as well as an imaging device positioned on a distal portion of the elongate body. The system may include memory and processors configured to receive from the imaging device image data that includes an image captured when the elongate body is within the luminal network. The image can depict one or more branchings of the luminal network. The processor can be configured to access a machine learning model of one or more luminal networks and determine, based on the machine learning model and information regarding the one or more branchings, a location of the distal portion of the elongate body within the luminal network.",UNIV LELAND STANFORD JUNIOR,CAMARILLO DAVID B;;ENG DAVID;;SGANGA JAKE,,https://lens.org/141-262-105-948-184,Patent Application,yes,5,76,1,1,0,A61B2034/2051;;A61B2090/376;;A61B2090/3614;;A61B2090/306;;A61B2034/2059;;A61B2090/309;;A61B2017/00809;;A61B2017/00477;;A61B2034/105;;A61B2034/2065;;A61B2034/2061;;A61B34/20;;A61B2090/367;;A61G13/04;;A61G13/06;;A61G13/1235;;A61G13/101;;A61B1/2676;;A61B1/00149;;G16H50/20;;G16H20/40;;G16H30/40;;A61B34/37;;A61B2034/301;;A61B34/70;;G06N20/00;;G06N3/08;;G06N3/045;;A61B34/70;;A61B34/37;;A61B34/20;;A61B34/10;;A61B2034/301;;A61B1/2676;;G16H50/00;;G16H30/00;;A61B2034/102;;G06N3/02,A61B34/00;;A61B1/267;;A61B34/10;;A61B34/20;;A61B34/37;;G06N3/02;;G16H30/00;;G16H50/00,,1,0,,,"Karkus et al., ""Particle Filter Networks with Application to Visual Localization"", 2018 (Year: 2018)",PENDING
37,US,S,US D0784611 S,051-723-553-018-905,2017-04-18,2017,US 201529514974 F,2015-01-19,US 201529514974 F,2015-01-19,Electronic hookah apparatus,,ENG RYAN;;LAM DAVID;;WONG ERIC,ENG RYAN;;LAM DAVID;;WONG ERIC,NGEN SMOKE LLC (2015-03-31),https://lens.org/051-723-553-018-905,Design Right,no,0,3,2,2,0,,,2702;;D27/162,0,0,,,,ACTIVE
38,US,B1,US 10248371 B1,121-932-609-628-939,2019-04-02,2019,US 201816003193 A,2018-06-08,US 201816003193 A,2018-06-08,Print job order optimization mechanism,"A printing system is disclosed. The printing system includes at least one memory device to store optimization logic and one or more processors, coupled to the at least one memory device, to execute the optimization logic to receive a print job batch including a plurality of print jobs each having starting and ending media length pair values and generate a revised print job order list having a sequence for printing the plurality of print jobs to reduce a number of media length transitions based on a matching of the starting and ending media length pair values of the plurality of print jobs.",ENG KATIE;;MANDRY STEPHEN;;WARD DAVID;;RICOH CO LTD,ENG KATIE;;MANDRY STEPHEN;;WARD DAVID,RICOH COMPANY LTD (2018-06-07),https://lens.org/121-932-609-628-939,Granted Patent,yes,13,0,1,1,0,G06F3/1263;;G06F3/1282;;G06F3/1262;;G06F3/1211;;G06F3/1263;;G06F3/1259;;G06F3/1207;;G06F3/1211;;G06F3/1282;;G06F3/1262,G06F3/12,,1,1,036-409-524-014-877,10.1016/j.simpat.2015.05.003,"Kothari, S., Peck, T., Zeng. J. et al. (2015). Simulation as a cloud service for short-run high throughput industrial print production using a service broker architecture. Simulation modelling practice and theory, 58, pp. 115-139.",ACTIVE
39,US,S,US D0787847 S,184-449-159-343-404,2017-05-30,2017,US 201629568679 F,2016-06-20,US 201629568679 F,2016-06-20,Adjustable stool for use with a toilet,,NADIALABS INC,NAIK TIKESWAR;;GONZALES DAVID;;ENG BRUCE,NADIALABS INC (2017-04-13),https://lens.org/184-449-159-343-404,Design Right,no,0,5,1,1,0,,,0601;;D 6353,0,0,,,,ACTIVE
40,US,A1,US 2007/0150686 A1,046-120-977-060-767,2007-06-28,2007,US 68211307 A,2007-03-05,US 68211307 A;;US 83141704 A,2004-04-22,ACCESSING DATA STORAGE SYSTEMS WITHOUT WAITING FOR READ ERRORS,"Improved techniques for accessing data storage systems are disclosed. These techniques detect, correct and prevent undesirable access delays experienced in storage systems. “Slow-access” refers to an access operation that does not successfully complete within a predetermined amount of time. When slow-access is detected, an attempt is made to provide data by other means rather than waiting for the access operation to eventually complete. By way of example, parity information is used to generate data rather than waiting beyond a predetermined amount of time for a “slow-read” operation to complete. In addition, preventative measures can be taken to avoid reoccurrence of a “slow-access” operating once it has been identified. These preventative measures, for example, include rewriting the same data to the same data section that caused the slow-access problem or remapping the section to another section in order to avoid the same section of data to cause another slow access problem.",APPLE INC,ENG MICHAEL;;WONG DAVID;;BENARESH LAMONT,APPLE INC (2007-01-09),https://lens.org/046-120-977-060-767,Patent Application,yes,58,4,4,4,0,G06F11/1088;;G06F11/1088;;G06F3/0611;;G06F3/0611;;G06F3/0616;;G06F3/0616;;G06F3/065;;G06F3/065;;G06F3/0689;;G06F3/0689;;G06F11/1076;;G06F11/1076,G06F13/00;;G06F3/06;;G06F11/10;;G06F12/00,711/167;;711/170,0,0,,,,INACTIVE
41,US,S,US D0814105 S,101-383-627-624-523,2018-03-27,2018,US 201729594363 F,2017-02-17,US 201729594363 F;;US 201529514974 F,2015-01-19,Electronic hookah,,NGEN SMOKE LLC,ENG RYAN;;WONG ERIC;;LAM DAVID,NGEN SMOKE LLC (2015-03-31),https://lens.org/101-383-627-624-523,Design Right,no,0,16,2,2,0,,,2702;;D27/167,0,0,,,,ACTIVE
42,DE,D1,DE 69426979 D1,143-871-257-594-764,2001-05-03,2001,DE 69426979 T,1994-07-11,US 9322593 A;;US 18766494 A;;US 9407706 W,1993-07-16,VERFAHREN ZUR HERSTELLUNG VON HIV-PROTEASEHEMMERN,,MERCK & CO INC,ASKIN DAVID;;VOLANTE P;;ENG K,"MERCK SHARP & DOHME CORP., NEW JERSEY, N.J., US (2010-09-23)",https://lens.org/143-871-257-594-764,Granted Patent,no,0,0,41,47,0,C07D263/52;;C07D413/06;;C07D263/52;;C07D413/06,C07D241/04;;C07D241/14;;C07D263/52;;C07D413/06,,0,0,,,,EXPIRED
43,US,B2,US 7213103 B2,019-143-591-840-683,2007-05-01,2007,US 83141704 A,2004-04-22,US 83141704 A,2004-04-22,Accessing data storage systems without waiting for read errors,"Improved techniques for accessing data storage systems are disclosed. These techniques detect, correct and prevent undesirable access delays experienced in storage systems. “Slow-access” refers to an access operation that does not successfully complete within a predetermined amount of time. When slow-access is detected, an attempt is made to provide data by other means rather than waiting for the access operation to eventually complete. By way of example, parity information is used to generate data rather than waiting beyond a predetermined amount of time for a “slow-read” operation to complete. In addition, preventative measures can be taken to avoid reoccurrence of a “slow-access” operating once it has been identified. These preventative measures, for example, include rewriting the same data to the same data section that caused the slow-access problem or remapping the section to another section in order to avoid the same section of data to cause another slow access problem.",APPLE INC,ENG MICHAEL;;WONG DAVID;;BENARESH LAMONT,APPLE INC (2004-04-15),https://lens.org/019-143-591-840-683,Granted Patent,yes,17,26,4,4,0,G06F11/1088;;G06F11/1088;;G06F3/0611;;G06F3/0611;;G06F3/0616;;G06F3/0616;;G06F3/065;;G06F3/065;;G06F3/0689;;G06F3/0689;;G06F11/1076;;G06F11/1076,G06F13/00;;G06F3/06;;G06F11/10;;G06F12/00,711/114;;711/154;;714/6,9,1,071-984-908-937-080,10.1145/166266.168435,"Tobagi et al. ""Streaming RAID-A Disk Array Management System for Video Files."" No date available, Starlight Networks, Inc.;;Computer dictionary, 1997, Microsoft Press, Third Edition, p. 121.;;Office Action of Nov. 10, 2005 from U.S. Appl. No. 10,303,121.;;U.S. Appl. No. 10,303,121, filed on Nov. 22, 2002.;;U.S. Appl. No. 10,831,382, filed on Apr. 22, 2004.;;Office Action from U.S. Appl. No. 10/303,121, Mar. 2, 2006, 10 pages.;;Final Office Action from U.S. Appl. No. 10/303,121, May 30, 2006, 5 pages.;;Office Action from U.S. Appl. No. 10/831,382, May 22, 2006, 24 pages.;;Final Office Action from U.S. Appl. No. 10/831,382, Nov. 2, 2006, 27 pages.",INACTIVE
44,US,A1,US 2005/0240743 A1,149-092-449-811-319,2005-10-27,2005,US 83141704 A,2004-04-22,US 83141704 A,2004-04-22,Method and apparatus for accessing data storage systems,"Improved techniques for accessing data storage systems are disclosed. These techniques detect, correct and prevent undesirable access delays experienced in storage systems. “Slow-access” refers to an access operation that does not successfully complete within a predetermined amount of time. When slow-access is detected, an attempt is made to provide data by other means rather than waiting for the access operation to eventually complete. By way of example, parity information is used to generate data rather than waiting beyond a predetermined amount of time for a “slow-read” operation to complete. In addition, preventative measures can be taken to avoid reoccurrence of a “slow-access” operating once it has been identified. These preventative measures, for example, include rewriting the same data to the same data section that caused the slow-access problem or remapping the section to another section in order to avoid the same section of data to cause another slow access problem.",APPLE COMPUTER,ENG MICHAEL;;WONG DAVID;;BENARESH LAMONT,APPLE INC (2004-04-15),https://lens.org/149-092-449-811-319,Patent Application,yes,16,27,4,4,0,G06F11/1088;;G06F11/1088;;G06F3/0611;;G06F3/0611;;G06F3/0616;;G06F3/0616;;G06F3/065;;G06F3/065;;G06F3/0689;;G06F3/0689;;G06F11/1076;;G06F11/1076,G06F3/06;;G06F11/10;;G06F12/00,711/167;;711/170,0,0,,,,INACTIVE
45,DE,T2,DE 69426979 T2,136-117-776-831-735,2001-09-20,2001,DE 69426979 T,1994-07-11,US 9322593 A;;US 18766494 A;;US 9407706 W,1993-07-16,VERFAHREN ZUR HERSTELLUNG VON HIV-PROTEASEHEMMERN,,MERCK & CO INC,ASKIN DAVID;;VOLANTE P;;ENG K,"MERCK SHARP & DOHME CORP., NEW JERSEY, N.J., US (2010-09-23)",https://lens.org/136-117-776-831-735,Granted Patent,no,0,0,41,47,0,C07D263/52;;C07D413/06;;C07D263/52;;C07D413/06,C07D241/04;;C07D241/14;;C07D263/52;;C07D413/06,,0,0,,,,EXPIRED
46,US,B2,US 7822922 B2,148-068-294-225-262,2010-10-26,2010,US 68211307 A,2007-03-05,US 68211307 A;;US 83141704 A,2004-04-22,Accessing data storage systems without waiting for read errors,"Improved techniques for accessing data storage systems are disclosed. These techniques detect, correct and prevent undesirable access delays experienced in storage systems. “Slow-access” refers to an access operation that does not successfully complete within a predetermined amount of time. When slow-access is detected, an attempt is made to provide data by other means rather than waiting for the access operation to eventually complete. By way of example, parity information is used to generate data rather than waiting beyond a predetermined amount of time for a “slow-read” operation to complete. In addition, preventative measures can be taken to avoid reoccurrence of a “slow-access” operating once it has been identified. These preventative measures, for example, include rewriting the same data to the same data section that caused the slow-access problem or remapping the section to another section in order to avoid the same section of data to cause another slow access problem.",APPLE INC,ENG MICHAEL;;WONG DAVID;;BENARESH LAMONT,APPLE INC (2007-01-09),https://lens.org/148-068-294-225-262,Granted Patent,yes,90,4,4,4,0,G06F11/1088;;G06F11/1088;;G06F3/0611;;G06F3/0611;;G06F3/0616;;G06F3/0616;;G06F3/065;;G06F3/065;;G06F3/0689;;G06F3/0689;;G06F11/1076;;G06F11/1076,G06F13/00;;G06F3/06;;G06F11/10;;G06F12/00,711/114;;711/154;;714/6,39,24,111-951-400-972-043;;060-528-640-212-848;;104-225-503-403-10X;;021-020-417-155-260;;014-020-764-588-729;;025-590-502-935-19X;;020-821-751-831-299;;167-601-673-424-132;;083-090-704-864-45X;;001-541-636-607-026;;178-018-822-092-428;;157-244-994-854-867;;003-516-231-935-37X;;144-984-520-862-39X;;050-960-209-209-625;;015-046-075-025-252;;029-675-300-822-726;;001-284-458-688-091;;131-000-538-196-181;;038-876-909-615-37X;;004-226-307-434-282;;036-476-368-613-762;;032-901-035-763-470;;071-984-908-937-080,10.1109/dcs.1988.12560;;10.1109/tse.1981.230839;;10.1109/12.543706;;10.1109/iwooos.1992.252980;;10.1109/hpdc.1999.805311;;10.1109/parbse.1990.77156;;10.1109/32.67594;;10.1109/pccc.1990.101609;;10.1109/ride.1992.227395;;10.1109/icpads.2002.1183417;;10.1109/icde.1999.754902;;10.1109/71.980025;;10.1109/hcw.2000.843742;;10.1109/tse.1977.231175;;10.1109/icde.1993.344067;;10.1109/mrd.1990.138246;;10.1109/pdis.1994.331736;;10.1145/369028.369125;;10.1109/71.159043;;10.1109/hotos.1999.798369;;10.1109/icdcs.1992.234995;;10.1109/icdcs.1989.37930;;10.1109/iwooos.1991.183026;;10.1145/166266.168435,"Computer dictionary, 1997, Microsoft Press, Third Edition, p. 121.;;Benford, ""Dynamic Definition of Entries and Attributes in the Directory Service,"" 8th International Conference on Distributed Computing Systems, Jun. 13-17, 1988, pp. 563-568.;;Chang et al., ""Extended K-d Tree Database Organization"" A Dynamic Multiattribute Clustering Method, IEEE Transactions on Software Engineering, vol. SE-7, No. 3, May 1981, pp. 284-290.;;Chen et al., ""A Performance Evaluation of Raid Architectures,"" IEEE Transactions on Computers, vol. 45, No. 10, Oct. 1996, pp. 1116-1130.;;Chen et al., ""Schemes for Snapshot Advancement for Multiversion Concurrency Control,"" IBM Technical Disclosure Bulletin, vol. 34, No. 12, May 1992, pp. 135-137.;;Coley, ""Support of a Dynamically Managed Device Switch Table on a UNIX Operating System,"" IBM Technical Disclosure Bulletin, vol. 34, No. 10A, Mar. 1992, pp. 130-132.;;Condry et al., ""The Object-Oriented Advantage in Prototyping a Remote File System,"" Proceedings of the Second International Workshop on Object Orientation in Operating Systems, Sep. 24-25, 1992, pp. 190-199.;;Corn et al., ""Dynamic Memory Estimation for Database Monitor Snapshot,"" IBM Technical Disclosure Bulletin, vol. , No. , May 1992, pp. 135-137.;;Cruz et al., ""Dunes: A Performance-Oriented System Support Environment for Dependency Maintenance in Workstation Networks,"" Proceedings of the Eighth International Symposium on High Performance Distributed Computing, 1999, pp. 309-318.;;de Jonge et al., ""Concurrent Access to B-trees,"" International Conference on Databases, Parallel Architectures and their Applications, PARBASE-90, Mar. 7-9, 1990, pp. 312-320.;;Duvall et al., ""Database Server Journal Backup Automation Technique,"" IBM Technical Disclosure Bulletin, vol. 36, No. 2, Feb. 1993, p. 463.;;Emma et al., ""Exclusive Use Directory and Inode Caching,"" IBM Technical Disclosure Bulletin, vol. 32, No. 7, Dec. 1989, pp. 279-280.;;Gait, ""Stability, Availability, and Response in Network File Service,"" IEEE Transactions on Software Engineering, vol. 17, No. 2, Feb. 1991, pp. 133-140.;;Greene, ""Indicating the ""File Types"" in the Files Window of a User-Interactive Display System,"" IBM Technical Disclosure Bulletin, vol. 29, No. 6, Nov. 1986, p. 2684.;;Helary et al., ""Computing Particular Snapshots in Distributed Systems,"" Ninth Annaul International Phoenix Conference on Computers and Communications, Mar. 21-23, 1990, pp. 116-123.;;Henson, ""Managing Executing Files in a Virtual File System,"" IBM Technical Disclosure Bulletin, vol. 30, No. 10, Mar. 1988, pp. 68-69.;;Heyrman et al., ""Storage Management Mechanism for Managing Snapshot Pages, "" IBM Technical Disclosure Bulletin, vol. 35, No. 4B, Sep. 1992, pp. 26-29.;;Honishi et al., ""An Index Structure for Parallel Database Processing,"" Second International Workshop on Research Issues on Data Engineering, Transaction and Query Processing, Feb. 2-3, 1992, pp. 224-225.;;Hsieh et al., ""Performance Evaluation of Software Raid vs. Hardware RAID for Parallel Virtual File System,"" Proceedings of the Ninth International Conference on Parallel and Distributed Systems, 2002, pp. 1-7.;;Hua et al., ""Improving RAID Performance Using a Multibuffer Technique,"" Proceedings of the 15th International Conference on Data Engineering, Mar. 23-26, 1999, pp. 79-86.;;Hwang et al., ""Orthogonal Striping and Minoring in Distributed RAID for I/O-Centric Cluster Computing,"" IEEE Transactions on Parallel and Distributed Systems, vol. 13, No. 1, Jan. 2002, pp. 26-44.;;Hwang et al., ""Reliable Cluster Computing with a New Checkpointing RAID-x Architecture,"" Proceedings of the 9th International Heterogeneous Computing Workshop, 2000, pp. 171-184.;;Jin et al., ""Improving Partial Stripe Write Performance in RAID Level 5,"" Proceeding of the Second IEEE International Caracas Conference on Devices, Circuits and Systems, 1998, pp. 396-400.;;Kashyap et al., ""Analysis of the Multiple-Attribute-Tree Data-Base Organization,"" IEEE Transactions on Software Engineering, vol. SE-3, No. 6, Nov. 1977, pp. 451-467.;;Kemper et al., ""Adaptable Pointer Swizzling Strategies in Object Bases,"" Ninth International Conference on Data Engineering, Apr. 19-23, 1993, pp. 155-162.;;Kumar, ""Coping with Conflicts in an Optimistically Replicated File System,"" IEEE Workshop on the Management of Replicated Data, Nov. 8-9, 1990, pp. 60-64.;;Mogi et al., ""Dynamic Parity Stripe Reorganizations for RAID5 Disk Arrays,"" Proceedings of the Third International Conference on Parallel and Distributed Information Systems, Sep. 28-30, 1994, pp. 17-26.;;Park et al., ""Striping in Disk Array RM2 Enabling the Tolerance of Double Disk Failures,"" Proceedings of the 1996 ACM/IEEE Conference on Supercomputing (SC'96).;;Pilarski et al., ""Checkpointing for Distributed Databases: Starting from the Basics,"" IEEE Transactions on Parallel and Distributed Systems, vol. 3, No. 5, Sep. 1992, pp. 602-610.;;Santry, ""Elephant: The File System that Never Forgets,"" Proceedings of the Seventh Workshop on Hot Topics in Operating Systems, 1999, pp. 2-7.;;Sechrest et al., ""Blending Hierarchical and Attribute-Based File Naming,"" Proceedings of the 12th International Conference on Distributed Computing Systems, Jun. 9-12, 1992, pp. 572-580.;;Venkatesan, ""Message-Optimal Incremental Snapshots,"" 9th International Conference on Distributed Computing Systems, Jun. 5-9, 1989, pp. 53-60.;;Watanabe et al., ""Eliminate Information Inconsistency for X.500 Directory,"" Singapore ICCS '94 Conference Proceedings, Nov. 14-18, 1994, pp. 1180-1184.;;Wilson, ""Operating System Support for Small Objects,"" Workshop on Object Orientation in Operating Systems, Oct. 17-18, 1991, pp. 80-86.;;Yang et al., ""Global Snapshots for Distributed Debugging,"" Proceedings of the Fourth International Conference on Computing and Information, ICCI '92, May 28-30 1992, pp. 436-440.;;Tobagi et al. ""Streaming RAID-A Disk Array Management System for Video Files."" No date available, Starlight Networks, Inc.;;U.S. Appl. No. 10,303,121 filed on Nov. 22, 2002.;;U.S. Appl. No. 10,831,382 filed on Apr. 22, 2004.;;U.S. Appl. No. 10,831,417 filed on Apr. 22, 2004.",INACTIVE
47,PA,A1,PA 8619601 A1,132-492-932-811-031,2006-03-24,2006,PA 8619601 A,2004-12-07,US 52792803 P;;US 58482304 P,2003-12-08,DERIVADOS OXAZOL DE TETRACICLINAS,"ESTA INVENCION PROPORCIONA COMPUESTOS DE LA FORMULA: I EN LA CUAL A"", X E Y SON DEFINIDOS EN LA MEMORIA DESCRIPTIVA. ESTOS COMPUESTOS SON UTILES COMO AGENTES ANTIBACTERIANOS.",WYETH CORP,SUM PHAIK-ENG;;HOW DAVID BRIAN,,https://lens.org/132-492-932-811-031,Patent Application,no,0,0,43,44,0,A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04;;C07C2603/46;;A61P31/04;;C07D263/62;;C07D263/54;;C07D263/52;;C07C237/26;;C07D413/04;;A61K31/65;;C07D417/04;;C07D413/06;;C07D263/52;;C07C2603/46,A61K31/423;;A61K31/65;;A61P31/04;;C07C237/26;;C07D263/52;;C07D313/04;;C07D413/04;;C07D413/06;;C07D417/04,,0,0,,,,PENDING
48,CN,A,CN 1940573 A,022-024-039-089-984,2007-04-04,2007,CN 200610066591 A,2006-04-03,US 23951205 A,2005-09-29,Test fixture,,AGILENT TECHNOLOGIES INC,ENG-HOOI AMBLER DAVID R KUSLUS,,https://lens.org/022-024-039-089-984,Patent Application,no,0,5,2,2,0,G01R31/002;;G01R31/002,G01R1/02;;G01R1/18;;G01R31/00,,0,0,,,,DISCONTINUED
49,US,B1,US 11308372 B1,099-401-756-508-621,2022-04-19,2022,US 202117220911 A,2021-04-01,US 202117220911 A,2021-04-01,Efficient sheet map loading for print jobs,"System and methods for efficient sheet map loading for print jobs. In one embodiment, a preflight system processes a print job to build a first sheet mapping for rasterizing and printing the print job, and stores the first sheet mapping. A job controller determines an estimate time to load the first sheet mapping from the memory using job properties as input to estimator logic. In response to determining that the estimate time for loading the first sheet mapping from the memory is shorter than a time threshold, the first sheet mapping is loaded from memory, and provided for rasterizing and printing. Otherwise, if the estimate time is longer than the time threshold, the job controller builds a second sheet mapping, and provides the second sheet mapping in increments for the rasterizing and the printing of the print job as the building of the second sheet mapping is in progress.",PECK DAKOTA;;ENG KATIE ASHLEY;;WARD DAVID;;RICOH CO LTD,PECK DAKOTA;;ENG KATIE ASHLEY;;WARD DAVID,RICOH COMPANY LTD (2021-03-04),https://lens.org/099-401-756-508-621,Granted Patent,yes,6,0,1,1,0,G06K15/1807;;G06K15/1823;;G06K15/1836;;G06F3/1252;;G06F3/1257;;G06F3/1205;;G06F3/1282;;G06K15/1806;;G06F3/1252;;G06F3/1257;;G06K15/1823;;G06K15/1836;;G06N20/00;;G06F3/1205,G06K15/02;;G06F3/12;;G06N20/00,,1,0,,,"Kerry Stevenson; Dialing in 3D Printing Parameters With Machine Learning; https://www.fabbaloo.com; Nov. 26, 2020.",ACTIVE
50,EP,B1,EP 0129392 B1,093-897-774-944-930,1988-05-18,1988,EP 84303946 A,1984-06-12,GB 8316592 A,1983-06-17,CONTAINER HANDLING APPARATUS,"Container handling apparatus is for enabling a variety of containers, primarily for refuse, to be unloaded into a vehicle or other large receiving container. The apparatus includes a tipping frame 9 which is pivotable about a horizontal axis 8 to tip the containers 6. A lift carriage 14 is mounted on the tipping frame 9 for movement relative to the tipping frame and pick up means 29, 33 picks up the containers during movement of the lift carriage. The lift carriage 14 effects a sliding movement relative to the tipping frame 9, preferably by means of a scissors linkage 24 to amplify the movement of a drive cylinder 19.",DAVID MACKRILL ENGINEERING LTD.,"HOWARD, MICHAEL JOHN DAVID MACKRILL ENG. LTD.",,https://lens.org/093-897-774-944-930,Granted Patent,yes,7,2,6,6,0,B65F3/043;;B65F2003/0286,B65F3/02;;B65F3/04,,0,0,,,,EXPIRED
51,US,A1,US 2016/0247048 A1,105-576-399-478-224,2016-08-25,2016,US 201514629846 A,2015-02-24,US 201514629846 A,2015-02-24,PRINT JOB RE-PREFLIGHT MECHANISM,"A method is disclosed. The method includes receiving print job data at a printing system, performing a first preflight of the print job data to collect job attribute data, detecting that one or more changes have been made to the print job data and performing a second preflight of the print job data using the job attribute data collected during the first preflight based on the one or more changes.",WARD DAVID;;ENG KATIE ASHLEY;;BANDYOPADHYAY ARITRA;;RICOH CO LTD,WARD DAVID;;ENG KATIE ASHLEY;;BANDYOPADHYAY ARITRA,RICOH COMPANY LTD (2015-02-12),https://lens.org/105-576-399-478-224,Patent Application,yes,0,0,1,1,0,G06K15/1822;;G06K15/1806;;G06K15/1806;;G06K15/1822,G06K15/02,,0,0,,,,DISCONTINUED
52,US,A1,US 2016/0110144 A1,173-940-834-823-825,2016-04-21,2016,US 201414518080 A,2014-10-20,US 201414518080 A,2014-10-20,RECONSTRUCTION OF SUSPENDED PRINT JOBS,"System and methods for reconstructing a suspended print job. In one embodiment, a print controller receives a print job, and initiates construction of a sheet based on logical pages of the print job. Print controller determines a sheet number for the sheet that identifies a page number of one or more logical pages related to the construction of the sheet, an offset for the sheet that identifies an order of the sheet with respect to other sheets that share the sheet number. Print controller also assigns a sheet identifier to the sheet that includes the sheet number and the offset, and receives the sheet identifier in response to a determination to resume the print job from a suspended state. Print controller initiates processing for resuming the print job from the sheet based on the sheet number and the offset in the sheet identifier.",BANDYOPADHYAY ARITRA;;WARD DAVID;;ENG KATIE ASHLEY;;RICOH CO LTD,BANDYOPADHYAY ARITRA;;WARD DAVID;;ENG KATIE ASHLEY,RICOH COMPANY LTD (2014-10-17),https://lens.org/173-940-834-823-825,Patent Application,yes,2,4,2,2,0,G03G15/5012;;G06F3/1285;;G06F3/1252;;G06F3/1234;;G06F3/1252;;G06F3/1242;;G06F3/1293;;G06F3/1234;;G06F3/1241;;G03G15/655;;G06F3/1285;;G03G15/5012,G06F3/12,,0,0,,,,INACTIVE
53,US,B2,US 9626138 B2,170-517-857-380-10X,2017-04-18,2017,US 201414518080 A,2014-10-20,US 201414518080 A,2014-10-20,Reconstruction of suspended print jobs,"System and methods for reconstructing a suspended print job. In one embodiment, a print controller receives a print job, and initiates construction of a sheet based on logical pages of the print job. Print controller determines a sheet number for the sheet that identifies a page number of one or more logical pages related to the construction of the sheet, an offset for the sheet that identifies an order of the sheet with respect to other sheets that share the sheet number. Print controller also assigns a sheet identifier to the sheet that includes the sheet number and the offset, and receives the sheet identifier in response to a determination to resume the print job from a suspended state. Print controller initiates processing for resuming the print job from the sheet based on the sheet number and the offset in the sheet identifier.",BANDYOPADHYAY ARITRA;;WARD DAVID;;ENG KATIE ASHLEY;;RICOH CO LTD,BANDYOPADHYAY ARITRA;;WARD DAVID;;ENG KATIE ASHLEY,RICOH COMPANY LTD (2014-10-17),https://lens.org/170-517-857-380-10X,Granted Patent,yes,38,1,2,2,0,G03G15/5012;;G06F3/1285;;G06F3/1252;;G06F3/1234;;G06F3/1252;;G06F3/1242;;G06F3/1293;;G06F3/1234;;G06F3/1241;;G03G15/655;;G06F3/1285;;G03G15/5012,G06F3/12;;G03G15/00,,0,0,,,,INACTIVE
54,US,A1,US 2012/0121310 A1,090-503-358-968-69X,2012-05-17,2012,US 94699110 A,2010-11-16,US 94699110 A,2010-11-16,COSMETIC BRUSH APPLICATOR SYSTEM,An integrated cosmetic brush applicator system having both a brush section and reservoir section in which the brush can be pushed to an extended applicator position moveable out from the brush section an automatically pushed back into a retracted storage position when the brush section is tightly connected to the reservoir section. A push button assembly enables the brush to manually be pushed out from its retracted to an extended position permitting the brush to be used to apply cosmetic material. The brush is in contact with the reservoir section to allow cosmetic material to coat the brush when the system is in the closed position.,ENG SERENA;;COWAN DAVID M;;GELARDL PEPIN,ENG SERENA;;COWAN DAVID M;;GELARDL PEPIN,TOPLINE PRODUCTS COMPANY INC (2010-11-07),https://lens.org/090-503-358-968-69X,Patent Application,yes,3,0,1,1,0,A45D33/006;;A45D33/025;;A45D33/26;;A45D33/36;;A45D40/24;;A45D33/006;;A45D33/26;;A45D33/36;;A45D40/24;;A45D33/025,A45D40/26,401/129,0,0,,,,DISCONTINUED
55,CN,A,CN 1890226 A,151-663-606-514-528,2007-01-03,2007,CN 200480036493 A,2004-12-07,US 52792803 P;;US 58482304 P,2003-12-08,Oxazole derivatives of tetracyclines,,WYETH CORP,SUM PHAIK-ENG HOW DAVID B HOPP,,https://lens.org/151-663-606-514-528,Patent Application,no,0,0,43,44,0,A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04;;C07C2603/46;;A61P31/04;;C07D263/62;;C07D263/54;;C07D263/52;;C07C237/26;;C07D413/04;;A61K31/65;;C07D417/04;;C07D413/06;;C07D263/52;;C07C2603/46,C07D263/52;;A61K31/423;;A61K31/65;;A61P31/04;;C07C237/26;;C07D413/04;;C07D413/06;;C07D417/04,,0,0,,,,INACTIVE
56,CA,C,CA 2167183 C,012-475-229-661-697,2005-11-15,2005,CA 2167183 A,1994-07-11,US 9322593 A;;US 18766494 A;;US 9407706 W,1993-07-16,PROCESS FOR MAKING HIV PROTEASE INHIBITORS,"A process for making a compound of formula I comprises reacting an epoxide of formula IV with an amine of formula V, wherein R1, R2, R3, R4, r and a are defined herein. Compounds of formula I are useful as HIV protease inhibitors. <IMG>",MERCK & CO INC,ASKIN DAVID;;VOLANTE RALPH P;;ENG KAN K,,https://lens.org/012-475-229-661-697,Granted Patent,no,0,0,2,47,0,,C07D263/52;;C07D413/06;;C07D453/02;;C07D471/04;;C07F9/653,,0,0,,,,EXPIRED
57,EP,B1,EP 1825593 B1,126-416-659-322-162,2019-01-09,2019,EP 05844892 A,2005-11-04,US 2005/0039968 W;;US 90511904 A,2004-12-16,BROADBAND HIGH EFFICIENCY TRAVELING WAVE TUBE AMPLIFIER SYSTEM,,BOEING CO,GOLDBERG DAVID R;;ENG JOHN E;;NICOL ERIC,,https://lens.org/126-416-659-322-162,Granted Patent,yes,5,0,5,5,0,H03F1/02;;H03F1/3241;;H03F1/3294;;H03F3/58;;H03F2200/102;;H03F3/58;;H03F2200/102;;H03F1/02;;H03F1/3294;;H03F1/3241,H03F3/58;;H03F1/02;;H03F1/32,,1,0,,,"KUIPERS M ET AL: ""PRE-DISTORTED AMPLIFIERS FOR OFDM IN WIRELESS INDOOR MULTIMEDIA COMMUNICATIONS"" VTC 2000-SPRING. 2000 IEEE 51ST. VEHICULAR TECHNOLOGY CONFERENCE PROCEEDINGS. TOKYO, JAPAN, MAY 15-18, 2000, IEEE VEHICULAR TECHNOLGY CONFERENCE, NEW YORK, NY : IEEE, US, vol. VOL. 1 OF 3. CONF. 51, 15 May 2000 (2000-05-15), pages 395-399, XP000970648 ISBN: 0-7803-5719-1",ACTIVE
58,US,A1,US 2020/0084266 A1,160-931-505-687-598,2020-03-12,2020,US 201916680702 A,2019-11-12,US 201916680702 A;;US 201514844907 A,2015-09-03,DYNAMICALLY PROVIDING HOST INPUT CONTROL FOR STREAMING APPLICATIONS,"A computer streaming system includes a remote user device and a host streaming unit. The host streaming unit determines input methods suitable for the remote user device to interact with content streamed to the remote user using a selected application. The host streaming unit detects whether a user interface of the selected application is supported by the remote user device and dynamically institutes emulated native input support for the remote user device when the host streaming unit detects the user interface of the selected application is not supported by the remote user device. Additionally, the host streaming unit dynamically dismisses emulated native input support for the remote user device when the host streaming unit detects the user interface of the selected application is supported by the remote user device, causing the remote user device to return to native input control. Also provided is a method of streaming a computer application.",NVIDIA CORP,ENG DAVID;;MEDISETTY RAJESH;;CHAUDHARY AMIT;;DHRU RAHIL,NVIDIA CORPORATION (2015-08-20),https://lens.org/160-931-505-687-598,Patent Application,yes,0,0,4,4,0,H04N21/2387;;H04N21/4402;;H04N21/4788;;H04N21/8456;;G06F3/04886;;H04L67/10;;H04L67/141;;G06F3/04886;;H04N21/4788;;H04N21/8456;;H04N21/4402;;H04N21/2387,H04L29/08;;G06F3/0488;;H04N21/2387;;H04N21/4402;;H04N21/4788;;H04N21/845,,0,0,,,,ACTIVE
59,US,B2,US 10484459 B2,159-803-374-712-80X,2019-11-19,2019,US 201514844907 A,2015-09-03,US 201514844907 A,2015-09-03,Dynamically providing host input control for streaming applications,"A computer streaming system includes an application hints unit that provides an advisory hint for a remote user device corresponding to a selected streaming application, and a sending unit that manages streaming of the advisory hint and the selected streaming application over a network connected to the remote user device. Additionally, the computer streaming system includes a receiving unit that recovers the advisory hint for the remote user device, and a hints processing unit that applies the advisory hint to the remote user device when employing the selected computer application. Also, the computer streaming system includes a feedback unit that provides remote user feedback information over the network directed to responding to the advisory hint, and an update unit that provides the remote user feedback information. Also provided is a method of streaming a computer application.",NVIDIA CORP,ENG DAVID;;MEDISETTY RAJESH;;CHAUDHARY AMIT;;DHRU RAHIL,NVIDIA CORPORATION (2015-08-20),https://lens.org/159-803-374-712-80X,Granted Patent,yes,64,0,4,4,0,H04N21/2387;;H04N21/4402;;H04N21/4788;;H04N21/8456;;G06F3/04886;;H04L67/10;;H04L67/141;;G06F3/04886;;H04N21/4788;;H04N21/8456;;H04N21/4402;;H04N21/2387,H04L29/08;;G06F3/0488;;H04N21/2387;;H04N21/4402;;H04N21/4788;;H04N21/845,,0,0,,,,ACTIVE
60,AU,A,AU 1995/027099 A,004-620-232-747-123,1996-01-25,1996,AU 1995/027099 A,1995-06-27,CA 2126952 A;;CA 9500369 W,1994-06-28,Method of amplification for increasing the sensitivity of detecting nucleic acid-probe target hybrids,"The present invention provides a method for simplifying and significantly enhancing the sensitivity of nucleic acid hybridization assays. A method is described whereby a single-stranded primary nucleic acid sequence that includes a region of sequences complementary to a single-stranded target nucleic acid sequence is hybridized to the target molecule. Stability of the double-stranded complex thereby formed can be enhanced by using RNA as the probe if DNA is the target or DNA as the probe if RNA is the target. The probe-target complex is subsequently immunocaptured for detection. After washing away extraneous material, a secondary nucleic acid sequence containing many repeating sequence units is hybridized to the probe component of the immobilized probe-target complex. Detection occurs following hybridization of many labelled nucleic acid sequence probes to each of the repeating sequence units of a nucleic acid amplification probe. Thus, attachment of multiple labelling probes to an amplification probe that is hybridized to an immobilized probe-target complex, provides a simplified method for amplifying the detection signal and therefore the sensitivity of nucleic acid hybridization assays.",KALYX BIOSCIENCES INC,PANDIAN SITHIAN;;AW ENG JOM;;SMITH DAVID I,,https://lens.org/004-620-232-747-123,Patent Application,no,0,0,11,13,0,C12Q1/682;;Y02A50/30;;C12Q1/682;;Y02A50/30,G01N33/58;;C12N15/09;;C12Q1/68,,0,0,,,,PENDING
61,GR,T3,GR 3035645 T3,036-794-544-056-357,2001-06-29,2001,GR 20010400119 T,2001-03-29,US 9322593 A;;US 18766494 A;;US 9407706 W,1993-07-16,PROCESS FOR MAKING HIV PROTEASE INHIBITORS,,MERCK & CO INC,ASKIN DAVID;;VOLANTE RALPH P;;ENG KAN K,,https://lens.org/036-794-544-056-357,Granted Patent,no,0,0,41,47,0,C07D263/52;;C07D413/06;;C07D263/52;;C07D413/06,C07D241/04;;C07D241/14;;C07D263/52;;C07D413/06,,0,0,,,,EXPIRED
62,AT,T1,AT E188744 T1,044-764-167-747-779,2000-01-15,2000,AT 95922381 T,1995-06-27,CA 2126952 A;;CA 9500369 W,1994-06-28,VERFAHREN ZUR ERHÖHUNG DER NACHWEISEMPFINDLICHKEIT VON NUKLEINSÄURE-HYBRIDEN (TARGET/PROBE),"The present invention provides a method for simplifying and significantly enhancing the sensitivity of nucleic acid hybridization assays. A method is described whereby a single-stranded primary nucleic acid sequence that includes a region of sequences complementary to a single-stranded target nucleic acid sequence is hybridized to the target molecule. Stability of the double-stranded complex thereby formed can be enhanced by using RNA as the probe if DNA is the target or DNA as the probe if RNA is the target. The probe-target complex is subsequently immunocaptured for detection. After washing away extraneous material, a secondary nucleic acid sequence containing many repeating sequence units is hybridized to the probe component of the immobilized probe-target complex. Detection occurs following hybridization of many labelled nucleic acid sequence probes to each of the repeating sequence units of a nucleic acid amplification probe. Thus, attachment of multiple labelling probes to an amplification probe that is hybridized to an immobilized probe-target complex, provides a simplified method for amplifying the detection signal and therefore the sensitivity of nucleic acid hybridization assays.",KALYX BIOSCIENCES INC,PANDIAN SITHIAN;;AW ENG JOM;;SMITH DAVID I,,https://lens.org/044-764-167-747-779,Granted Patent,no,0,0,11,13,0,C12Q1/682;;Y02A50/30;;C12Q1/682;;Y02A50/30,G01N33/58;;C12N15/09;;C12Q1/68,,0,0,,,,DISCONTINUED
63,NO,L,NO 960168 L,067-941-101-428-627,1996-03-15,1996,NO 960168 A,1996-01-15,US 9322593 A;;US 18766494 A;;US 9407706 W,1993-07-16,Fremgangsmåte for fremstilling av HIV-proteaseinhibitorer,,MERCK & CO INC,ASKIN DAVID;;VOLANTE RALPH P;;ENG KAN K,,https://lens.org/067-941-101-428-627,Abstract,no,0,0,41,47,0,C07D263/52;;C07D413/06;;C07D263/52;;C07D413/06,C07D241/14;;C07D241/04;;C07D263/52;;C07D413/06,,0,0,,,,EXPIRED
64,US,A,US 5948401 A,080-093-729-137-632,1999-09-07,1999,US 77265196 A,1996-12-23,US 77265196 A;;US 910195 P,1995-12-22,Cationic therapeutic systems,"The present invention relates to delivery systems comprising a cationic polymer, optionally in conjunction with an anionic polymer, to deliver cationic therapeutic agents and their application to a mucosal surface. In particular, these delivery systems are well suited for the treatment of intraocular pressure and glaucoma by way of a sustained delivery system.",UNION CARBIDE CHEM PLASTIC,DONABEDIAN DAVID HAGOP;;ENG DONNA JEAN;;MARLIN LAWRENCE,UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (1996-12-18),https://lens.org/080-093-729-137-632,Granted Patent,yes,15,16,3,3,0,A61K9/0048;;A61K31/137;;A61K31/138;;A61K31/165;;A61K31/166;;A61K31/167;;A61K31/216;;A61K31/27;;A61K31/343;;A61K31/404;;A61K31/4168;;A61K31/4178;;A61K31/42;;A61K31/427;;A61K31/4704;;A61K31/5377;;A61K47/36;;A61K9/0048;;A61K31/4704;;A61K31/343;;A61K31/138;;A61K31/216;;A61K31/404;;A61K31/4168;;A61K31/165;;A61K31/427;;A61K31/166;;A61K47/36;;A61K31/5377;;A61K31/137;;A61K31/42;;A61K31/4178;;A61K31/167;;A61K31/27,A61K9/00;;A61K31/137;;A61K31/138;;A61K31/165;;A61K31/166;;A61K31/167;;A61K31/216;;A61K31/27;;A61K31/343;;A61K31/404;;A61K31/4168;;A61K31/4178;;A61K31/42;;A61K31/427;;A61K31/4704;;A61K45/00;;A61K47/36,424/78.04,0,0,,,,EXPIRED
65,US,A1,US 2019/0037084 A1,090-526-425-464-048,2019-01-31,2019,US 201816151582 A,2018-10-04,US 201816151582 A;;US 201615256123 A,2016-09-02,AUTOMATED TEST SUITE MECHANISM,"A method is disclosed. The method includes generating a set of test case tags that describe attributes included in a test case and store the set of test case tags and the test case, receiving input information, and dynamically generating a test suite of one or more test cases based on input attributes data included in the input information, wherein the input information comprises code change information.",RICOH CO LTD,MANDRY STEPHEN JARED;;ENG KATIE ASHELY;;WARD DAVID,,https://lens.org/090-526-425-464-048,Patent Application,yes,7,2,4,4,0,G06F3/1204;;G06F3/1204;;G06F3/1211;;G06F3/1215;;G06F3/1215;;G06F3/123;;G06F3/123;;G06F3/1244;;G06F3/1244;;G06F3/1248;;G06F3/1254;;G06F3/1254;;G06F3/1256;;G06F3/1256;;G06F3/1263;;G06F3/1263;;G06F3/1282;;G06F3/1282;;H04N1/00031;;H04N1/00063;;H04N2201/0094,H04N1/00;;G06F3/12,,0,0,,,,ACTIVE
66,CA,A1,CA 2157416 A1,112-581-101-660-606,1997-03-02,1997,CA 2157416 A,1995-09-01,CA 2157416 A,1995-09-01,METHOD FOR ENHANCING DETECTION ABILITY OF NUCLEIC ACID ASSAYS EMPLOYING NUCLEIC ACID SEQUENCE BASED AMPLIFICATION,"This invention relates to a new and novel method for significantly enhancing the sensitivity of assays aimed at detecting the presence of target deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequences in a sample. Specifically, this method applies to techniques that employ nucleic acid sequence based amplications (NASBA?) or other nucleic amplification techniques to amplify copies of the target RNA or DNA (Sooknanan et al., Bio""Techniques, 17: 1077-1085, 1994) to allow for detection. The method of the present invention combines the following three steps for the first time: RNA amplification using NASBA; RNA:DNA hybrid formation; and immunochemical detection of heteroduplex nucleic acid sequences. This method extends the standard NASBA techniques to accommodate amplification of copies of the NASBA product, which, following binding to DNA sequences facilitates immunochemical detection of the RNA:DNA hybrids thereby formed. This combination of steps results in a new assay with increased simplicity, speed and sensitivity, including a greatly improved signal-to-noise ratio, over standard nucleic acid detection methods. This improved method will be extremely useful for performing analyses in the forensic, clinical, agricultural and biological fields.",PANDIAN SITHIAN;;AW ENG JOM;;SMITH DAVID I,PANDIAN SITHIAN;;AW ENG JOM;;SMITH DAVID I,,https://lens.org/112-581-101-660-606,Patent Application,no,0,2,1,1,0,C12Q1/68;;C12Q1/70;;G01N33/53,C12Q1/68;;C12Q1/70;;G01N33/53,,0,0,,,,DISCONTINUED
67,CA,A1,CA 2168803 A1,121-229-615-238-342,1996-11-23,1996,CA 2168803 A,1996-02-05,US 44548195 A,1995-05-22,NUCLEIC ACIDS BOUND TO A MACROPOROUS HYDROPHOBIC SYNTHETIC POLYMER CLOTH FOR HYBRIDIZATION TECHNIQUES,"This invention relates to the detection of nucleic acids, either DNA or RNA, based on their hybridization techniques. This invention also relates to a hydrophobic cloth useful as an adsorbent of nucleic acids for conducting hybridization reactions. This invention also relates to a cloth-based nucleic acid hybridization assay for obtaining significant and specific signals arising from the formation of the nucleic acid probe-target hybrids. This invention also relates to a cloth-based nucleic acid hybridization assay for the rapid detection of nucleic acids of any organism, such as eukaryotes, prokaryotes and viruses. This invention also relates to the method of lysis of cells derived from any of the above organisms, in a manner suitable for releasing the nucleic acids and simultaneousdenaturation and suitable for application in the cloth-based hybridization assay.",PANDIAN SITHIAN;;AW ENG JOM;;SMITH DAVID I,PANDIAN SITHIAN;;AW ENG JOM;;SMITH DAVID I,,https://lens.org/121-229-615-238-342,Patent Application,no,0,0,1,1,0,,C12Q1/68,,0,0,,,,DISCONTINUED
68,WO,A1,WO 2006/065388 A1,140-212-110-618-241,2006-06-22,2006,US 2005/0039968 W,2005-11-04,US 90511904 A,2004-12-16,BROADBAND HIGH EFFICIENCY TRAVELING WAVE TUBE AMPLIFIER SYSTEM,"A power control system for a satellite receiving radio-frequency signals includes a traveling wave tube amplifier system and corresponding traveling wave tube. An anode voltage of the traveling wave tube amplifier system is used to modulate or saturate the current of the electron beam of the traveling wave tube so that the output power of the traveling wave tube amplifier system, from the saturated electron beam, is proportional to a waveform envelope of the radio-frequency signals.",BOEING CO;;GOLDBERG DAVID R;;ENG JOHN E;;NICOL ERIC,GOLDBERG DAVID R;;ENG JOHN E;;NICOL ERIC,,https://lens.org/140-212-110-618-241,Patent Application,yes,5,9,5,5,0,H03F1/02;;H03F1/3241;;H03F1/3294;;H03F3/58;;H03F2200/102;;H03F3/58;;H03F2200/102;;H03F1/02;;H03F1/3294;;H03F1/3241,H03F3/58;;H03F1/02;;H03F1/32,,1,1,002-076-535-393-335,10.1109/vetecs.2000.851486,"KUIPERS M ET AL: ""PRE-DISTORTED AMPLIFIERS FOR OFDM IN WIRELESS INDOOR MULTIMEDIA COMMUNICATIONS"", VTC 2000-SPRING. 2000 IEEE 51ST. VEHICULAR TECHNOLOGY CONFERENCE PROCEEDINGS. TOKYO, JAPAN, MAY 15-18, 2000, IEEE VEHICULAR TECHNOLGY CONFERENCE, NEW YORK, NY : IEEE, US, vol. VOL. 1 OF 3. CONF. 51, 15 May 2000 (2000-05-15), pages 395 - 399, XP000970648, ISBN: 0-7803-5719-1",PENDING
69,CZ,B6,CZ 293953 B6,030-206-601-662-256,2004-08-18,2004,CZ 13196 A,1994-07-11,US 9322593 A;;US 18766494 A,1993-07-16,Process for preparing intermediates useful in the preparation of HIV-protease inhibitors and corresponding intermediates,"The present invention relates to the preparation process of intermediates of the general formula I, which are valuable compounds for the preparation of HIV protease inhibitor compounds. The intermediates can be made by reacting compounds of the general formula IV with amines of the general formula V. The invention also relates to intermediates of the general formula IV.",MERCK & CO INC,ASKIN DAVID;;VOLANTE RALPH P;;ENG KAN K,,https://lens.org/030-206-601-662-256,Granted Patent,no,0,0,41,47,0,C07D263/52;;C07D413/06;;C07D263/52;;C07D413/06,C07D241/04;;C07D241/14;;C07D263/52;;C07D413/06,,0,0,,,,EXPIRED
70,LV,A,LV 12825 A,041-836-489-528-115,2002-05-20,2002,LV 020039 A,2002-03-15,US 9322593 A;;US 18766494 A,1993-07-16,Process for making hiv protease inhibitors,"The present invention is concerned with a novel intermediate and process for synthesizing compounds which inhibit the protease of HIV. The instant process involves the reaction of an amide enolate derived from an amide with an activated nonracemic glycidol derivative, such as 2(S)-glycidyl tpsylate, to afford an epoxide intermediate which is a key intermediate useful in the preparation of HIV protease inhibitor compounds.",MERCK & CO INC,ASIKN DAVID;;VOLANTE RALPH P;;ENG KAN K,,https://lens.org/041-836-489-528-115,Patent Application,no,0,0,41,47,0,C07D263/52;;C07D413/06;;C07D263/52;;C07D413/06,C07D241/14;;C07D241/04;;C07D263/52;;C07D413/06,,0,0,,,,EXPIRED
71,CA,A1,CA 2163687 A1,073-534-539-704-103,1997-05-25,1997,CA 2163687 A,1995-11-24,CA 2163687 A;;US 75324596 A,1995-11-24,DEVICE AND METHOD OF USE FOR DETECTION OF BACTERIAL LIPOPOLYSACCHARIDES,This invention relates to a device comprising a hydrophobic solid support coated with a chemical that can capture bacterial lipopolysaccharides (LPS). This invention al so relates to the use of such a device in an immunoassay for the detection of microorganisms. This invention also relates to the incorporation of such a device into a diagnostic k it.,PANDIAN SITHIAN;;AW ENG JOM;;SMITH DAVID I,PANDIAN SITHIAN;;AW ENG JOM;;SMITH DAVID I,,https://lens.org/073-534-539-704-103,Patent Application,no,0,0,2,2,0,G01N33/56916;;G01N2333/245;;G01N2333/255;;Y10S436/81;;G01N33/56916;;G01N2333/255;;G01N2333/245;;Y10S436/81,G01N33/569,,0,0,,,,DISCONTINUED
72,AT,B1,AT 525060 B1,078-203-958-249-198,2022-12-15,2022,AT 506562021 A,2021-08-12,AT 506562021 A,2021-08-12,Kontrollverfahren für eine Kontrolle eines Brennstoffzellennetzwerks,"Die vorliegende Erfindung betrifft ein Kontrollverfahren für eine Kontrolle eines Brennstoffzellennetzwerks (200) mit wenigstens zwei separaten Brennstoffzellensystemen (100) mit jeweils wenigstens einem Brennstoffzellenstapel (110) zum Erzeugen elektrischer Energie für einen Antrieb eines Hochleistungsfahrzeugs (300), gekennzeichnet durch die folgenden Schritte: ‐ Erfassen einer Leistungsanforderung (LAF) für den Antrieb des Hochleistungsfahrzeugs (300), ‐ Aufteilen der Leistungsanforderung (LAF) auf die wenigstens zwei Brennstoffzellensysteme (100), ‐ Betreiben der wenigstens zwei Brennstoffzellensysteme (100) mit Betriebsleistungen (BL) für ein kombiniertes Erfüllen der Leistungsanforderung (LAF), ‐ Erfassen wenigstens einer reversiblen Schädigung der wenigstens zwei Brennstoffzellensysteme (100), ‐ Temporäres Betreiben wenigstens eines Brennstoffzellensystems (100) in einem Regenerationsbetrieb (RB) zum wenigstens teilweisen Beheben der reversiblen Schädigung, wobei wenigstens ein weiteres Brennstoffzellensystem (100) in einem Ausgleichsbetrieb (AB) betrieben wird zum Ausgleich der fehlenden Betriebsleistung (BL) des Brennstoffzellensystems (100) beim Erfüllen der Leistungsanforderung (LAF).",AVL LIST GMBH,DAVID ALDRIAN DIPL -ING;;KATHARINA WEINGRILL B ENG,,https://lens.org/078-203-958-249-198,Granted Patent,no,4,0,3,3,0,H01M8/0494;;H01M8/04955;;H01M8/249;;H01M2250/20;;Y02E60/50;;Y02T90/40;;H01M8/0494;;H01M8/04955;;H01M8/249;;H01M2250/20,H01M8/04858;;H01M8/04955;;H01M8/249,,0,0,,,,ACTIVE
73,US,A,US 5496948 A,129-429-991-975-458,1996-03-05,1996,US 45906995 A,1995-06-21,US 45906995 A;;US 18766494 A;;US 9322593 A,1993-07-16,Process for making HIV protease inhibitors,Intermediates of structural formula ##STR1## can be made by reacting glycidol or an activated derivative thereof with an amide. The process and intermediates are useful for synthesizing HIV protease inhibitor compounds.,MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;VOLANTE RALPH P,MERCK SHARP & DOHME CORP (2009-11-02),https://lens.org/129-429-991-975-458,Granted Patent,yes,0,3,41,47,0,C07D263/52;;C07D413/06;;C07D263/52;;C07D413/06,C07D241/14;;C07D241/04;;C07D263/52;;C07D413/06,544/368;;544/349;;544/360;;544/365;;544/117;;544/119;;544/120;;544/121;;544/124;;544/128;;544/131;;544/137;;546/146;;546/270;;548/217,2,0,,,"CA 116:256007a Highly . . . HIV 1 protease, Askin et al., pp. 835 836, 1992.;;CA 119:9166s Stereo selective . . . epoxides. Askin et al., p. 947, 1993.",EXPIRED
74,SK,A3,SK 5596 A3,182-116-355-733-727,1997-01-08,1997,SK 5596 A,1994-07-11,US 9322593 A;;US 18766494 A;;US 9407706 W,1993-07-16,METHOD OF PRODUCING INTERMEDIATES FOR MAKING HIV-PROTEASE INHIBITORS AND BELONGING INTERMEDIATE PRODUCTS,"Disclosed is a production method of intermediates of general formula (I), which are precious substances for production of HIV -protease inhibitors by the reaction between the compounds of gen eral formula (IV) and amines of general formula (V). In the said substances the individual general symbols have the meaning stated in the main claim. The invention relates also to intermediates o f general formula (IV), in which the general symbols have the mea ning stated in the claim 8.",MERCK & CO INC,ASKIN DAVID;;VOLANTE RALPH P;;ENG KAN K,"MERCK SHARP & DOHME CORP., RAHWAY, NJ, US (2010-04-29)",https://lens.org/182-116-355-733-727,Patent Application,no,0,0,41,47,0,C07D263/52;;C07D413/06;;C07D263/52;;C07D413/06,C07D241/14;;C07D263/52;;C07D241/04;;C07D413/06,,0,0,,,,EXPIRED
75,US,A1,US 2017/0070560 A1,072-629-471-403-616,2017-03-09,2017,US 201514844907 A,2015-09-03,US 201514844907 A,2015-09-03,DYNAMICALLY PROVIDING HOST INPUT CONTROL FOR STREAMING APPLICATIONS,"A computer streaming system includes an application hints unit that provides an advisory hint for a remote user device corresponding to a selected streaming application, and a sending unit that manages streaming of the advisory hint and the selected streaming application over a network connected to the remote user device. Additionally, the computer streaming system includes a receiving unit that recovers the advisory hint for the remote user device, and a hints processing unit that applies the advisory hint to the remote user device when employing the selected computer application. Also, the computer streaming system includes a feedback unit that provides remote user feedback information over the network directed to responding to the advisory hint, and an update unit that provides the remote user feedback information. Also provided is a method of streaming a computer application.",NVIDIA CORP,ENG DAVID;;MEDISETTY RAJESH;;CHAUDHARY AMIT;;DHRU RAHIL,NVIDIA CORPORATION (2015-08-20),https://lens.org/072-629-471-403-616,Patent Application,yes,25,3,4,4,0,H04N21/2387;;H04N21/4402;;H04N21/4788;;H04N21/8456;;G06F3/04886;;H04L67/10;;H04L67/141;;G06F3/04886;;H04N21/4788;;H04N21/8456;;H04N21/4402;;H04N21/2387,H04L29/08;;G06F3/0488,,0,0,,,,ACTIVE
76,WO,A2,WO 1996/000795 A2,130-399-506-972-247,1996-01-11,1996,CA 9500369 W,1995-06-27,CA 2126952 A,1994-06-28,METHOD OF AMPLIFICATION FOR INCREASING THE SENSITIVITY OF DETECTING NUCLEIC ACID-PROBE TARGET HYBRIDS,"The present invention provides a method for simplifying and significantly enhancing the sensitivity of nucleic acid hybridization assays. A method is described whereby a single-stranded primary nucleic acid sequence that includes a region of sequences complementary to a single-stranded target nucleic acid sequence is hybridized to the target molecule. Stability of the double-stranded complex thereby formed can be enhanced by using RNA as the probe if DNA is the target or DNA as the probe if RNA is the target. The probe-target complex is subsequently immunocaptured for detection. After washing away extraneous material, a secondary nucleic acid sequence containing many repeating sequence units is hybridized to the probe component of the immobilized probe-target complex. Detection occurs following hybridization of many labelled nucleic acid sequence probes to each of the repeating sequence units of a nucleic acid amplification probe. Thus, attachment of multiple labelling probes to an amplification probe that is hybridized to an immobilized probe-target complex, provides a simplified method for amplifying the detection signal and therefore the sensitivity of nucleic acid hybridization assays.",KALYX BIOSCIENCES INC;;PANDIAN SITHIAN;;AW ENG JOM;;SMITH DAVID I,PANDIAN SITHIAN;;AW ENG JOM;;SMITH DAVID I,,https://lens.org/130-399-506-972-247,Patent Application,no,0,17,11,13,0,C12Q1/682;;Y02A50/30;;C12Q1/682;;Y02A50/30,C12N15/09;;C12Q1/68;;G01N33/58,,0,0,,,,PATENTED
77,WO,A3,WO 1995/002584 A3,041-108-547-250-751,1995-03-09,1995,US 9407706 W,1994-07-11,US 9322593 A;;US 18766494 A,1993-07-16,PROCESS FOR MAKING HIV PROTEASE INHIBITORS,Intermediates of structural formula (IV) can be made by reacting glycidol or an activated derivative thereof with an amide. The process and intermediates are useful for synthesizing HIV protease inhibitor compounds.,MERCK & CO INC,ASKIN DAVID;;VOLANTE RALPH P;;ENG KAN K,,https://lens.org/041-108-547-250-751,Search Report,yes,3,0,41,47,0,C07D263/52;;C07D413/06;;C07D263/52;;C07D413/06,C07D241/14;;C07D241/04;;C07D263/52;;C07D413/06,,2,2,077-587-887-297-860;;084-329-244-217-996,10.1021/jo00036a004;;10.1016/s0040-4039(00)91945-2,"D. ASKIN ET AL.: ""Highly Diastereoselective Alkylations of Chiral Amide Enolates: New Routes to Hydroxyethylene Dipeptide Isostere Inhibitors of HIV-1 Protease"", J. ORG. CHEM., vol. 57, no. 10, 1992, pages 2771 - 2773;;B.D. DORSEY ET AL.: ""A Concise and Enantioselective Synthesis of Novel HIV-1 Protease Transition state Mimics"", TETRAHEDRON LETTERS, vol. 34, no. 12, 1993, pages 1851 - 1854",PATENTED
78,HU,A,HU T74583 A,111-569-351-717-830,1997-01-28,1997,HU 9600077 A,1994-07-11,US 9322593 A;;US 18766494 A,1993-07-16,"PROCESS FOR MAKING INDENO[1,2-D]OXAZOLE HIV PROTEASE INHIBITORS",,MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;VOLANTE RALPH P,"MERCK SHARP & DOHME CORP., US (2010-05-28)",https://lens.org/111-569-351-717-830,Unknown,no,0,0,41,47,0,C07D263/52;;C07D413/06;;C07D263/52;;C07D413/06,C07D241/04;;C07D241/14;;C07D263/52;;C07D413/06,,0,0,,,,DISCONTINUED
79,NO,B1,NO 306297 B1,124-708-658-855-532,1999-10-18,1999,NO 960168 A,1996-01-15,US 9322593 A;;US 18766494 A;;US 9407706 W,1993-07-16,FremgangsmÕte for fremstilling av HIV-proteaseinhibitorer,,MERCK & CO INC,ASKIN DAVID;;VOLANTE RALPH P;;ENG KAN K,,https://lens.org/124-708-658-855-532,Granted Patent,no,0,0,41,47,0,C07D263/52;;C07D413/06;;C07D263/52;;C07D413/06,C07D241/14;;C07D241/04;;C07D263/52;;C07D413/06,,0,0,,,,EXPIRED
80,EP,B1,EP 0708762 B1,150-586-331-543-051,2001-03-28,2001,EP 94922511 A,1994-07-11,US 9322593 A;;US 18766494 A;;US 9407706 W,1993-07-16,PROCESS FOR MAKING HIV PROTEASE INHIBITORS,,MERCK & CO INC,ASKIN DAVID;;VOLANTE RALPH P;;ENG KAN K,"MERCK  SHARP & DOHME CORP. (2011-09-29);;MERCK & CO., INC. (2007-10-15)",https://lens.org/150-586-331-543-051,Granted Patent,yes,3,0,41,47,0,C07D263/52;;C07D413/06;;C07D263/52;;C07D413/06,C07D241/04;;C07D241/14;;C07D263/52;;C07D413/06,,2,0,,,"J. ORG. CHEM., vol.57, no.10, 1992 pages 2771 - 2773 D. ASKIN ET AL. 'Highly Diastereoselective Alkylations of Chiral Amide Enolates: New Routes to Hydroxyethylene Dipeptide Isostere Inhibitors of HIV-1 Protease';;TETRAHEDRON LETTERS, vol.34, no.12, 1993 pages 1851 - 1854 B.D. DORSEY ET AL. 'A Concise and Enantioselective Synthesis of Novel HIV-1 Protease Transition state Mimics'",EXPIRED
81,AT,A1,AT 524627 A1,155-084-316-071-158,2022-07-15,2022,AT 500092021 A,2021-01-13,AT 500092021 A,2021-01-13,Prüfverfahren zum Prüfen einer Trennfunktionalität einer Hauptschaltvorrichtung einer elektrischen Verbindungsvorrichtung eines Brennstoffzellensystems,"Die vorliegende Erfindung betrifft ein Prüfverfahren zum Prüfen der Trennfunktionalität einer Hauptschaltvorrichtung (110) einer elektrischen Verbindungsvorrichtung (100) eines Brennstoffzellensystems (200), aufweisend die folgenden Schritte:  Erzeugung einer Spannungsvariation (VV) auf der Niederspannungs-Seite (LVS) einer Transformatorvorrichtung (120),  Schalten eines negativen Hauptschalters (112) der Hauptschaltervorrichtung (110),  Erfassen einer Spannungsdifferenz (VD) zwischen einer Niederspannung (LV) der Niederspannungs-Seite (LVS) der Transformatorvorrichtung (120) und einer Systemspannung (SV) des Brennstoffzellensystems (200),  Vergleich der erfassten Spannungsdifferenz (VD) mit einem Nullwert (NW).",AVL LIST GMBH,KATHARINA WEINGRILL B ENG;;DAVID ALDRIAN DIPL ING,,https://lens.org/155-084-316-071-158,Patent Application,no,2,0,6,6,0,G01R31/3277;;H02H3/207;;G01R31/327;;Y02E60/50,G01R31/327;;H02H3/20,,0,0,,,,ACTIVE
82,AT,T1,AT E200079 T1,119-365-853-317-34X,2001-04-15,2001,AT 94922511 T,1994-07-11,US 9322593 A;;US 18766494 A;;US 9407706 W,1993-07-16,VERFAHREN ZUR HERSTELLUNG VON HIV-PROTEASEHEMMERN,,MERCK & CO INC,ASKIN DAVID;;VOLANTE RALPH P;;ENG KAN K,,https://lens.org/119-365-853-317-34X,Granted Patent,no,0,0,41,47,0,C07D263/52;;C07D413/06;;C07D263/52;;C07D413/06,C07D241/04;;C07D241/14;;C07D263/52;;C07D413/06,,0,0,,,,DISCONTINUED
83,US,A,US 5491238 A,147-144-275-174-565,1996-02-13,1996,US 45837995 A,1995-06-02,US 45837995 A;;US 18766494 A;;US 9322593 A,1993-07-16,Process for making HIV protease inhibitors,Intermediates of structural formula ##STR1## can be made by reacting glycidol or an activated derivative thereof with an amide. The process and intermediates are useful for synthesizing HIV protease inhibitor compounds.,MERCK & CO INC,ASKIN DAVID;;VOLANTE RALPH P;;ENG KAN K,MERCK SHARP & DOHME CORP (2009-11-02),https://lens.org/147-144-275-174-565,Granted Patent,yes,0,5,41,47,0,C07D263/52;;C07D413/06;;C07D263/52;;C07D413/06,C07D241/14;;C07D263/52;;C07D241/04;;C07D413/06,546/270;;546/174;;548/113;;548/236;;548/455;;549/398,1,0,,,"CA 121:256269 Highly . . . inhibitor L 735,524. Askin et al., 1994.",EXPIRED
84,DE,D1,DE 69603163 D1,158-311-772-386-256,1999-08-12,1999,DE 69603163 T,1996-03-11,US 40479895 A;;US 9602556 W,1995-03-15,VERFAHREN ZUR HERSTELLUNG VON HIV PROTEASE INHIBITOR AUSGEHEND VON (2S)-4-PICOLYL-2-PIPERAZIN-t-BUTYLCARBOXAMID,,MERCK & CO INC,ASKIN DAVID;;ENG KAN;;REIDER PAUL;;VOLANTE RALPH,,https://lens.org/158-311-772-386-256,Granted Patent,no,0,0,22,22,0,C07D401/06;;Y02P20/55;;A61P31/18;;C07D401/06;;Y02P20/55,C07D401/06,,0,0,,,,EXPIRED
85,FI,A0,FI 960184 A0,170-693-320-056-564,1996-01-15,1996,FI 960184 A,1996-01-15,US 9322593 A;;US 18766494 A;;US 9407706 W,1993-07-16,Menetelmä HIV-proteaasi-inhibiittoreiden valmistamiseksi,,MERCK & CO INC,ASKIN DAVID;;VOLANTE RALPH P;;ENG KAN K,MERCK SHARP & DOHME CORP. (2010-03-16),https://lens.org/170-693-320-056-564,Patent Application,no,0,0,41,47,0,C07D263/52;;C07D413/06;;C07D263/52;;C07D413/06,C07D241/04;;C07D241/14;;C07D263/52;;C07D413/06,,0,0,,,,EXPIRED
86,EP,A1,EP 0888770 A1,187-561-178-775-519,1999-01-07,1999,EP 97304914 A,1997-07-04,EP 97304914 A,1997-07-04,Compositions comprising cationic polysaccharides and cationic drugs,"The present invention relates to delivery systems comprising a cationic polymer, optionally in conjunction with an anionic polymer, to deliver cationic therapeutic agents and their application to a mucosal surface. In particular, these delivery systems are well suited for the treatment of intraocular pressure and glaucoma by way of a sustained delivery system.",UNION CARBIDE CHEM PLASTIC,DONABEDIAN DAVID HAGOP;;MARLIN LAWRENCE;;ENG DONNA JEAN,,https://lens.org/187-561-178-775-519,Patent Application,yes,1,2,1,1,0,A61K47/36;;A61K9/0014;;A61K9/0048;;A61K47/38,A61K9/00;;A61K47/36;;A61K47/38,,1,0,,,"DATABASE WPI Week 9745, Derwent World Patents Index; AN 97-480847 [45], XP002049250",DISCONTINUED
87,ZA,B,ZA 945234 B,035-634-391-959-432,1995-02-28,1995,ZA 945234 A,1994-07-18,US 9322593 A,1993-07-16,Process for making HIV protease inhibitors,,MERCK & CO INC,ASKIN DAVID;;VOLANTE RALPH P;;ENG KAN K,,https://lens.org/035-634-391-959-432,Granted Patent,no,0,0,4,47,0,C07D263/52;;C07D413/06;;C07D263/52;;C07D263/52;;C07D413/06,C07D263/52;;C07D413/06,,0,0,,,,EXPIRED
88,PL,B1,PL 179039 B1,090-733-159-650-383,2000-07-31,2000,PL 31261394 A,1994-07-11,US 9322593 A;;US 18766494 A;;US 9407706 W,1993-07-16,METHOD OF MANUFACTURING HIV PROTEASE INHIBITORS,,MERCK & CO INC,ASKIN DAVID;;VOLANTE RALPH P;;ENG KAN K,,https://lens.org/090-733-159-650-383,Granted Patent,no,0,0,41,47,0,C07D263/52;;C07D413/06;;C07D263/52;;C07D413/06,C07D241/14;;C07D241/04;;C07D263/52;;C07D413/06,,0,0,,,,EXPIRED
89,NZ,A,NZ 269904 A,093-539-125-840-998,1997-11-24,1997,NZ 26990494 A,1994-07-11,US 9322593 A;;US 18766494 A;;US 9407706 W,1993-07-16,"1,3-OXAZOLE DERIVATIVES; PREPARATIVE PROCESS; INTERMEDIATE COMPOUNDS",,MERCK & CO INC,ASKIN DAVID;;VOLANTE RALPH P;;ENG KAN K,,https://lens.org/093-539-125-840-998,Patent Application,no,0,0,41,47,0,C07D263/52;;C07D413/06;;C07D263/52;;C07D413/06,C07D241/14;;C07D263/52;;C07D241/04;;C07D413/06,,0,0,,,,DISCONTINUED
90,US,A,US 5888754 A,124-615-842-139-779,1999-03-30,1999,US 75324596 A,1996-11-25,US 75324596 A;;CA 2163687 A,1995-11-24,Device and method of use for detection of bacterial lipopolysaccharides,This invention relates to a device comprising a hydrophobic solid support coated with a chemical that can capture bacterial lipopolysaccharides (LPS). This invention also relates to the use of such a device in an immunoassay for the detection of microorganisms. This invention also relates to the incorporation of such a device into a diagnostic kit.,KALYX BIOSCIENCES INC,PANDIAN SITHIAN;;AW ENG JOM;;SMITH DAVID I,KALYX BIOSCIENCES INC (1997-06-06),https://lens.org/124-615-842-139-779,Granted Patent,yes,2,3,2,2,0,G01N33/56916;;G01N2333/245;;G01N2333/255;;Y10S436/81;;G01N33/56916;;G01N2333/255;;G01N2333/245;;Y10S436/81,G01N33/569,435/7.92;;435/4;;435/71;;435/7.2;;435/7.32;;435/7.72;;435/287.1;;435/287.2;;436/518;;436/527;;436/531;;436/543;;436/810;;422/56;;422/61,4,3,078-085-396-820-270;;001-639-324-090-22X;;021-075-147-586-527,9157052;;10.3109/08820139609059300;;10.1016/0168-1605(91)90035-n;;1742171;;10.1016/0168-1605(94)00045-8;;7710916,Goni et al. Immunolog. Invest. 1996. 25(3):177 183.;;Frobisher. Fundamentals of Microbiol. 8th Ed. 1968. p. 301.;;Blais et al. Int. J. Food Microbiol. 1991. 14:43 50.;;Wang et al. Int. J. Food Microbiol. 1995. 24: 397 406.,EXPIRED
91,EP,A2,EP 0770142 A2,134-901-152-247-289,1997-05-02,1997,EP 95922381 A,1995-06-27,CA 9500369 W;;CA 2126952 A,1994-06-28,METHOD OF AMPLIFICATION FOR INCREASING THE SENSITIVITY OF DETECTING NUCLEIC ACID-PROBE TARGET HYBRIDS,"The present invention provides a method for simplifying and significantly enhancing the sensitivity of nucleic acid hybridization assays. A method is described whereby a single-stranded primary nucleic acid sequence that includes a region of sequences complementary to a single-stranded target nucleic acid sequence is hybridized to the target molecule. Stability of the double-stranded complex thereby formed can be enhanced by using RNA as the probe if DNA is the target or DNA as the probe if RNA is the target. The probe-target complex is subsequently immunocaptured for detection. After washing away extraneous material, a secondary nucleic acid sequence containing many repeating sequence units is hybridized to the probe component of the immobilized probe-target complex. Detection occurs following hybridization of many labelled nucleic acid sequence probes to each of the repeating sequence units of a nucleic acid amplification probe. Thus, attachment of multiple labelling probes to an amplification probe that is hybridized to an immobilized probe-target complex, provides a simplified method for amplifying the detection signal and therefore the sensitivity of nucleic acid hybridization assays.",KALYX BIOSCIENCES INC,PANDIAN SITHIAN;;AW ENG JOM;;SMITH DAVID I,KALYX BIOSCIENCES INC. TRANSFER- 567782 B.C. LTD. (2002-10-31),https://lens.org/134-901-152-247-289,Patent Application,yes,0,0,11,13,0,C12Q1/682;;Y02A50/30;;C12Q1/682;;Y02A50/30,G01N33/58;;C12N15/09;;C12Q1/68,,0,0,,,,EXPIRED
92,US,A,US 5463067 A,159-592-207-238-226,1995-10-31,1995,US 18766494 A,1994-01-26,US 18766494 A;;US 9322593 A,1993-07-16,Process for making HIV protease inhibitors,Intermediates of structural formula ##STR1## can be made by reacting glycidol or an activated derivative thereof with an amide. The process and intermediates are useful for synthesizing HIV protease inhibitor compounds.,MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;VOLANTE RALPH P,MERCK SHARP & DOHME CORP (2012-04-26),https://lens.org/159-592-207-238-226,Granted Patent,yes,5,11,4,47,0,C07D263/52;;C07D413/06;;C07D263/52;;C07D263/52;;C07D413/06,C07D263/52;;C07D413/06,548/113;;548/217;;546/146;;546/173;;546/176;;546/252;;546/270;;546/337;;544/349;;544/360;;544/364;;544/368;;544/390,6,3,068-570-941-862-916;;100-973-919-380-464;;084-329-244-217-996,10.1021/jo00048a028;;10.1021/cr00004a001;;10.1016/s0040-4039(00)91945-2,"J. Org. Chem., 57, 5931 5936, Asymemetric . . . 2,3 Methanomethionine, Burgess et al, 1992.;;J. Chem. Soc., Chem. Commun., Asymmetric . . . Hypoglycin A., Baldwin et al., 1992, 1249 1251.;;Chemical Reviews, vol. 91, No. 4, The Synthetic . . . Alcohols., 437 475, Hanson et al., 1991.;;Organic Chemistry, 2nd ed., John McMurry, Conversion of Alcohols into Tosylates, pp. 600 601, 1988.;;Advanced Organic Chemistry, 2nd ed., Jerry March, The Effect of the Leaving Group, pp. 325 327, 1978.;;Dorsy, et al., A Concise and Enantioselective Synthesis of Novel HIV 1 Protease Transition State Mimics , Tet. Lett., vol. 34, No. 12, pp. 1851 1854 (1993).",EXPIRED
93,AT,A4,AT 524946 A4,051-014-065-702-060,2022-11-15,2022,AT 506672021 A,2021-08-17,AT 506672021 A,2021-08-17,Diagnoseverfahren für eine Schädigungsdiagnose bei einem Betrieb eines Brennstoffzellensystems,"Die vorliegende Erfindung betrifft ein Diagnoseverfahren für eine Schädigungsdiagnose bei einem Betrieb eines Brennstoffzellensystems (100) mit einem Brennstoffzellenstapel (110) mit einem Anodenabschnitt (120) und einem Kathodenabschnitt (130), gekennzeichnet durch die folgenden Schritte: ‐ Empfangen eines Betriebsstopp-Signals (BSS) für einen Stopp des Betriebs des Brennstoffzellensystems (100), ‐ Stoppen der Gaszufuhr zum Kathodenabschnitt (130) des Brennstoffzellenstapels (110), ‐ Vorgabe eines Entladestroms (IE) zum Entladen des Brennstoffzellenstapels (110), ‐ Überwachen einer Zellspannung (UZ) am Brennstoffzellenstapel (110), ‐ Beenden der Vorgabe des Entladestroms (IE) bei Erreichen einer Diagnose-Startspannung (UDS) am Brennstoffzellenstapel (110), ‐ Erfassen einer Diagnosezeitspanne (DZ) vom Diagnose-Startzeitpunkt (DZS) bei Erreichen der Diagnose-Startspannung (UDS) bis zum Diagnose-Endzeitpunkt (DZE) bei Erreichen einer Diagnose-Endspannung (UDE).",AVL LIST GMBH,DAVID ALDRIAN DIPL -ING;;KATHARINA WEINGRILL B ENG,,https://lens.org/051-014-065-702-060,Patent Application,no,4,0,3,3,0,H01M8/04303;;H01M8/04544;;H01M8/04671;;H01M8/04679;;H01M2250/20,H01M8/04303;;H01M8/04537;;H01M8/04664,,0,0,,,,ACTIVE
94,US,A1,US 2002/0155456 A1,049-268-813-738-80X,2002-10-24,2002,US 94029601 A,2001-08-27,US 94029601 A;;CA 2126952 A;;US 71947696 A;;US 47405395 A;;US 27584994 A,1994-06-28,Method of amplification for increasing the sensitivity of detecting nucleic acid-probe target hybrids,"
   The present invention provides a method for simplifying and significantly enhancing the sensitivity of nucleic acid hybridization assays. A method is described whereby a single-stranded primary nucleic acid sequence that includes a region of sequences complementary to a single-stranded target nucleic acid sequence is hybridized to the target molecule. Stability of the double-stranded complex thereby formed can be enhanced by using RNA as the probe if DNA is the target or DNA as the probe if RNA is the target. The probe-target complex is subsequently immunocaptured for detention. After washing away extraneous material, a secondary nucleic acid sequence containing many repeating sequence units is hybridized to the probe component of the immobilized probe-target complex. Detection occurs following hybridization of many labelled nucleic acid sequence probes to each of the repeating sequence units of a nucleic acid amplification probe. Thus, attachment of multiple labelling probes to an amplification probe that is hybridized to an immobilized probe-target complex, provides a simplified method for amplifying the detection signal and therefore the sensitivity of nucleic acid hybridization assays. 
",PANDIAN SITHIAN;;AW ENG JOM;;SMITH DAVID I.,PANDIAN SITHIAN;;AW ENG JOM;;SMITH DAVID I,,https://lens.org/049-268-813-738-80X,Patent Application,yes,16,2,2,13,0,C12Q1/682;;Y02A50/30;;C12Q1/682,C12Q1/68,435/6;;435/91.2;;536/24.3,0,0,,,,DISCONTINUED
95,NO,D0,NO 960168 D0,058-405-928-660-250,1996-01-15,1996,NO 960168 A,1996-01-15,US 9322593 A;;US 18766494 A;;US 9407706 W,1993-07-16,Fremgangsmåte for fremstilling av HIV-proteaseinhibitorer,,MERCK & CO INC,ASKIN DAVID;;VOLANTE RALPH P;;ENG KAN K,,https://lens.org/058-405-928-660-250,Patent Application,no,0,0,41,47,0,C07D263/52;;C07D413/06;;C07D263/52;;C07D413/06,C07D241/14;;C07D241/04;;C07D263/52;;C07D413/06,,0,0,,,,EXPIRED
96,CA,A1,CA 2126952 A1,066-060-907-673-318,1995-12-29,1995,CA 2126952 A,1994-06-28,CA 2126952 A,1994-06-28,"PROBE, KIT, AND METHOD OF AMPLIFICATION FOR INCREASING THE SENSITIVITY OF NUCLEIC ACID HYBRIDIZATION ASSAYS","The present invention provides a method for simplifying and significantly enhancing the sensitivity of nucleic acid hybridization assays. A method is described whereby a single-stranded primary nucleic acid sequence that includes a region of sequences complementary to a single-stranded target nucleic acid sequence is hybridized to the target molecule. Stability of the double-stranded complex thereby formed can be enhanced by using RNA as the probe if DNA is the target or DNA as the probe if RNA is the target. The probe-target complex is subsequently immunocaptured for detection. After washing away extraneous material, a secondary nucleic acid sequence containing many repeating sequence units is hybridized to the probe component of the immobilized probe-target complex. Detection occurs following hybridization of many labelled nucleic acid sequence probes to each of the repeating sequence units of a nucleic acid amplification probe. Thus, attachment of multiple labelling probes to an amplification probe that is hybridized to an immobilized probe-target complex, provides a simplified method for amplifying the detection signal and therefore the sensitivity of nucleic acid hybridization assays.",KALYX BIOSCIENCES INC,PANDIAN SITHIAN;;AW ENG J;;SMITH DAVID I,,https://lens.org/066-060-907-673-318,Patent Application,no,0,0,11,13,0,C12Q1/682;;Y02A50/30;;C12Q1/682;;Y02A50/30,G01N33/58;;C12N15/09;;C12Q1/68,,0,0,,,,EXPIRED
97,EP,B1,EP 0770142 B1,137-061-502-532-769,2000-01-12,2000,EP 95922381 A,1995-06-27,CA 9500369 W;;CA 2126952 A,1994-06-28,METHOD FOR INCREASING THE SENSITIVITY OF DETECTING NUCLEIC ACID-PROBE TARGET HYBRIDS,"The present invention provides a method for simplifying and significantly enhancing the sensitivity of nucleic acid hybridization assays. A method is described whereby a single-stranded primary nucleic acid sequence that includes a region of sequences complementary to a single-stranded target nucleic acid sequence is hybridized to the target molecule. Stability of the double-stranded complex thereby formed can be enhanced by using RNA as the probe if DNA is the target or DNA as the probe if RNA is the target. The probe-target complex is subsequently immunocaptured for detection. After washing away extraneous material, a secondary nucleic acid sequence containing many repeating sequence units is hybridized to the probe component of the immobilized probe-target complex. Detection occurs following hybridization of many labelled nucleic acid sequence probes to each of the repeating sequence units of a nucleic acid amplification probe. Thus, attachment of multiple labelling probes to an amplification probe that is hybridized to an immobilized probe-target complex, provides a simplified method for amplifying the detection signal and therefore the sensitivity of nucleic acid hybridization assays.",KALYX BIOSCIENCES INC,PANDIAN SITHIAN;;AW ENG JOM;;SMITH DAVID I,KALYX BIOSCIENCES INC. TRANSFER- 567782 B.C. LTD. (2002-10-31),https://lens.org/137-061-502-532-769,Granted Patent,yes,8,0,11,13,0,C12Q1/682;;Y02A50/30;;C12Q1/682;;Y02A50/30,G01N33/58;;C12N15/09;;C12Q1/68,,0,0,,,,EXPIRED
98,AU,A,AU 1994/073588 A,056-639-513-626-287,1995-02-13,1995,AU 1994/073588 A,1994-07-11,US 9322593 A;;US 18766494 A;;US 9407706 W,1993-07-16,Process for making hiv protease inhibitors,,MERCK & CO INC,ASKIN DAVID;;VOLANTE RALPH P;;ENG KAN K,,https://lens.org/056-639-513-626-287,Patent Application,no,0,0,41,47,0,C07D263/52;;C07D413/06;;C07D263/52;;C07D413/06,C07D241/04;;C07D241/14;;C07D263/52;;C07D413/06,,0,0,,,,EXPIRED
99,DK,T3,DK 0708762 T3,058-640-263-605-344,2001-04-30,2001,DK 94922511 T,1994-07-11,US 9322593 A;;US 18766494 A;;US 9407706 W,1993-07-16,Fremgangsmåde til fremstilling af HIV protease-inhibitorer,,MERCK & CO INC,ASKIN DAVID;;VOLANTE RALPH P;;ENG KAN K,,https://lens.org/058-640-263-605-344,Granted Patent,no,0,0,41,47,0,C07D263/52;;C07D413/06;;C07D263/52;;C07D413/06,C07D241/04;;C07D241/14;;C07D263/52;;C07D413/06,,0,0,,,,EXPIRED
100,US,A,US 5627030 A,137-433-499-265-00X,1997-05-06,1997,US 27584994 A,1994-07-15,CA 2126952 A,1994-06-28,Method of amplification for increasing the sensitivity of detecting nucleic acid-probe target hybrids,"The present invention provides a method for simplifying and significantly enhancing the sensitivity of nucleic acid hybridization assays. A method is described whereby a single-stranded primary nucleic acid sequence that includes a region of sequences complementary to a single-stranded target nucleic acid sequence is hybridized to the target molecule. Stability of the double-stranded complex thereby formed can be enhanced by using RNA as the probe if DNA is the target or DNA as the probe if RNA is the target. The probe-target complex is subsequently immunocaptured for detection. After washing away extraneous material, a secondary nucleic acid sequence containing many repeating sequence units is hybridized to the probe component of the immobilized probe-target complex. Detection occurs following hybridization of many labelled nucleic acid sequence probes to each of the repeating sequence units of a nucleic acid amplification probe. Thus, attachment of multiple labelling probes to an amplification probe that is hybridized to an immobilized probe-target complex, provides a simplified method for amplifying the detection signal and therefore the sensitivity of nucleic acid hybridization assays.",KALYX BIOSCIENCES INC,PANDIAN SITHIAN;;AW ENG J;;SMITH DAVID I,KALYX BIOSCIENCES INC (1994-07-05),https://lens.org/137-433-499-265-00X,Granted Patent,yes,3,74,11,13,0,C12Q1/682;;Y02A50/30;;C12Q1/682;;Y02A50/30,C12N15/09;;C12Q1/68;;G01N33/58,435/6;;435/5;;536/24.3;;935/77;;935/88,1,1,042-030-252-347-299,3285726;;10.1016/0003-2697(88)90251-5,"Matthews, J. et al. Aml. Biochem. 169: 1 25, 1988.",EXPIRED
101,CZ,A3,CZ 13196 A3,149-706-395-027-61X,1996-04-17,1996,CZ 13196 A,1994-07-11,US 9322593 A;;US 18766494 A,1993-07-16,PROCESS FOR PREPARING INTERMEDIATES FOR PREPARING HIV-PROTEASE INHIBITORS AND CORRESPONDING INTERMEDIATES,,MERCK & CO INC,ASKIN DAVID;;VOLANTE RALPH P;;ENG KAN K,,https://lens.org/149-706-395-027-61X,Patent Application,no,0,0,41,47,0,C07D263/52;;C07D413/06;;C07D263/52;;C07D413/06,C07D241/04;;C07D241/14;;C07D263/52;;C07D413/06,,0,0,,,,EXPIRED
102,US,A1,US 2014/0304093 A1,157-884-164-222-102,2014-10-09,2014,US 201314102419 A,2013-12-10,US 201314102419 A;;US 201361809763 P,2013-04-08,METHOD AND SYSTEM TO PROMOTE SALES OR SERVICES WITH SOCIAL SALES POINT,"The present disclosure is directed towards small modules, web plugins, which may be placed on any influential content which simplify and promote sales by operating as a social sales point (SSP). SSP's simplify sales by avoiding buyers engaging in any further searches or product comparisons. The sales process is promoted and supported by the inherent trust and revere placed upon the content owner, with the influential content providing a framework to complete the transaction and close the sale. Additionally, SSP promotes sales by keeping track of the reward of referrers, and provide a fair way of sharing reward with this social middle man. SSP allows simple proliferation, so that any effective promotion will quickly spread to its maximum by the power of social media.",CHENG XUEJIANG;;LEE ENG-KEONG DAVID;;DAS KALYAN,CHENG XUEJIANG;;LEE ENG-KEONG DAVID;;DAS KALYAN,,https://lens.org/157-884-164-222-102,Patent Application,yes,4,4,2,2,0,G06Q30/0207;;G06Q30/06;;G06Q50/01;;G06Q20/20;;G06Q20/12;;G06Q20/384;;G06Q20/202;;G06Q20/20;;G06Q20/12;;G06Q50/01;;G06Q30/06;;G06Q30/0207,G06Q20/12;;G06Q20/20,705/16,0,0,,,,DISCONTINUED
103,US,B2,US 10122866 B2,164-733-106-778-984,2018-11-06,2018,US 201615256123 A,2016-09-02,US 201615256123 A,2016-09-02,Automated test suite mechanism,"A method is disclosed. The method includes generating a set of test case tags that describe attributes included in a test case and store the set of test case tags and the test case, receiving input information, and dynamically generating a test suite of one or more test cases based on input attributes data included in the input information, wherein the input information comprises code change information.",MANDRY STEPHEN JARED;;ENG KATIE ASHLEY;;WARD DAVID;;RICOH CO LTD,MANDRY STEPHEN JARED;;ENG KATIE ASHLEY;;WARD DAVID,RICOH COMPANY LTD (2016-08-24),https://lens.org/164-733-106-778-984,Granted Patent,yes,11,0,4,4,0,G06F3/1204;;G06F3/1204;;G06F3/1211;;G06F3/1215;;G06F3/1215;;G06F3/123;;G06F3/123;;G06F3/1244;;G06F3/1244;;G06F3/1248;;G06F3/1254;;G06F3/1254;;G06F3/1256;;G06F3/1256;;G06F3/1263;;G06F3/1263;;G06F3/1282;;G06F3/1282;;H04N1/00031;;H04N1/00063;;H04N2201/0094,H04N1/00;;G06F3/12,,1,0,,,"Kulkarni, Parikshit, “Exploiting JDF Between Customer and Print-Shop”, Helsinki University of Technology, pp. 1-47, 2006.",INACTIVE
104,AT,A4,AT 525060 A4,187-624-836-640-647,2022-12-15,2022,AT 506562021 A,2021-08-12,AT 506562021 A,2021-08-12,Kontrollverfahren für eine Kontrolle eines Brennstoffzellennetzwerks,"Die vorliegende Erfindung betrifft ein Kontrollverfahren für eine Kontrolle eines Brennstoffzellennetzwerks (200) mit wenigstens zwei separaten Brennstoffzellensystemen (100) mit jeweils wenigstens einem Brennstoffzellenstapel (110) zum Erzeugen elektrischer Energie für einen Antrieb eines Hochleistungsfahrzeugs (300), gekennzeichnet durch die folgenden Schritte: ‐ Erfassen einer Leistungsanforderung (LAF) für den Antrieb des Hochleistungsfahrzeugs (300), ‐ Aufteilen der Leistungsanforderung (LAF) auf die wenigstens zwei Brennstoffzellensysteme (100), ‐ Betreiben der wenigstens zwei Brennstoffzellensysteme (100) mit Betriebsleistungen (BL) für ein kombiniertes Erfüllen der Leistungsanforderung (LAF), ‐ Erfassen wenigstens einer reversiblen Schädigung der wenigstens zwei Brennstoffzellensysteme (100), ‐ Temporäres Betreiben wenigstens eines Brennstoffzellensystems (100) in einem Regenerationsbetrieb (RB) zum wenigstens teilweisen Beheben der reversiblen Schädigung, wobei wenigstens ein weiteres Brennstoffzellensystem (100) in einem Ausgleichsbetrieb (AB) betrieben wird zum Ausgleich der fehlenden Betriebsleistung (BL) des Brennstoffzellensystems (100) beim Erfüllen der Leistungsanforderung (LAF).",AVL LIST GMBH,DAVID ALDRIAN DIPL -ING;;KATHARINA WEINGRILL B ENG,,https://lens.org/187-624-836-640-647,Patent Application,no,4,0,3,3,0,H01M8/0494;;H01M8/04955;;H01M8/249;;H01M2250/20;;Y02E60/50;;Y02T90/40;;H01M8/0494;;H01M8/04955;;H01M8/249;;H01M2250/20,H01M8/04858;;H01M8/04955;;H01M8/249,,0,0,,,,ACTIVE
105,US,A1,US 2018/0069967 A1,020-187-209-918-727,2018-03-08,2018,US 201615256123 A,2016-09-02,US 201615256123 A,2016-09-02,AUTOMATED TEST SUITE MECHANISM,"A method is disclosed. The method includes generating a set of test case tags that describe attributes included in a test case and store the set of test case tags and the test case, receiving input information, and dynamically generating a test suite of one or more test cases based on input attributes data included in the input information, wherein the input information comprises code change information.",MANDRY STEPHEN JARED;;ENG KATIE ASHLEY;;WARD DAVID;;RICOH CO LTD,MANDRY STEPHEN JARED;;ENG KATIE ASHLEY;;WARD DAVID,RICOH COMPANY LTD (2016-08-24),https://lens.org/020-187-209-918-727,Patent Application,yes,3,13,4,4,0,G06F3/1204;;G06F3/1204;;G06F3/1211;;G06F3/1215;;G06F3/1215;;G06F3/123;;G06F3/123;;G06F3/1244;;G06F3/1244;;G06F3/1248;;G06F3/1254;;G06F3/1254;;G06F3/1256;;G06F3/1256;;G06F3/1263;;G06F3/1263;;G06F3/1282;;G06F3/1282;;H04N1/00031;;H04N1/00063;;H04N2201/0094,H04N1/00;;G06F3/12,,0,0,,,,INACTIVE
106,WO,A3,WO 1995/002584 A3,166-808-566-321-981,1995-01-26,1995,US US9407706,1994-07-11,"US 93,225;;US 187,664",1993-07-16,PROCESS FOR MAKING HIV PROTEASE INHIBITORS,Intermediates of structural formula (IV) can be made by reacting glycidol or an activated derivative thereof with an amide. The process and intermediates are useful for synthesizing HIV protease inhibitor compounds.,"MERCK & CO., INC.","ASKIN, David;;VOLANTE, Ralph, P.;;ENG, Kan, K.",,https://lens.org/166-808-566-321-981,Search Report,yes,0,0,1,1,0,,C07D263/52;;C07D413/06,,0,0,,,,UNKNOWN
107,EP,A1,EP 0708762 A1,123-320-734-859-811,1996-05-01,1996,EP 94922511 A,1994-07-11,US 9322593 A;;US 18766494 A;;US 9407706 W,1993-07-16,PROCESS FOR MAKING HIV PROTEASE INHIBITORS,,MERCK & CO INC,ASKIN DAVID;;VOLANTE RALPH P;;ENG KAN K,"MERCK  SHARP & DOHME CORP. (2011-09-29);;MERCK & CO., INC. (2007-10-15)",https://lens.org/123-320-734-859-811,Patent Application,yes,0,0,41,47,0,C07D263/52;;C07D413/06;;C07D263/52;;C07D413/06,C07D241/04;;C07D241/14;;C07D263/52;;C07D413/06,,0,0,,,,EXPIRED
108,US,B1,US 6306657 B1,144-210-799-148-37X,2001-10-23,2001,US 71947696 A,1996-09-25,US 71947696 A;;CA 2126952 A;;US 47405395 A;;US 27584994 A,1994-06-28,Polynucleotide probe and kit for amplifying signal detection in hybridization assays,"The present invention provides a method for simplifying and significantly enhancing the sensitivity of nucleic acid hybridization assays. A method is described whereby a single-stranded primary nucleic acid sequence that includes a region of sequences complementary to a single-stranded target nucleic acid sequence is hybridized to the target molecule. Stability of the double-stranded complex thereby formed can be enhanced by using RNA as the probe if DNA is the target or DNA as the probe if RNA is the target. The probe-target complex is subsequently immunocaptured for detection. After washing away extraneous material, a secondary nucleic acid sequence containing many repeating sequence units is hybridized to the probe component of the immobilized probe-target complex. Detection occurs following hybridization of many labelled nucleic acid sequence probes to each of the repeating sequence units of a nucleic acid amplification probe. Thus, attachment of multiple labelling probes to an amplification probe that is hybridized to an immobilized probe-target complex, provides a simplified method for amplifying the detection signal and therefore the sensitivity of nucleic acid hybridization assays.",KALYX BIOSCIENCES INC,PANDIAN SITHIAN;;AW ENG JOM;;SMITH DAVID I,,https://lens.org/144-210-799-148-37X,Granted Patent,yes,11,3,2,13,0,C12Q1/682;;Y02A50/30;;C12Q1/682,C12Q1/68,436/6;;435/6;;536/24.3;;530/387.1,7,6,003-278-847-001-128;;011-367-868-333-871;;000-522-364-854-014;;022-864-243-735-367;;022-864-243-735-367;;042-030-252-347-299,pmc182341;;7690222;;10.1128/aem.59.8.2698-2705.1993;;10.1128/aem.60.1.348-352.1994;;pmc201312;;7509587;;8215354;;10.1128/aem.59.9.2795-2800.1993;;pmc182368;;10.1016/0003-2697(87)90467-2;;2437829;;10.1016/0003-2697(87)90467-2;;2437829;;3285726;;10.1016/0003-2697(88)90251-5,"Fliss et al., Applied and Environmental Microbiology 59(8) : 2698-2705 (Aug. 1993).*;;Blais B., Applied and Environmental Microbiology 60(1) : 348-352 (Jan. 1994).*;;Blais et al., Applied and Environmental Microbiology 59(9) : 2795-2800 (Sep. 1993).*;;Stollar et al., Analytical Biochemistry 161 : 387-394 (1987).*;;The Stratagene Catalog, p. 39 (1988).*;;Stollar et al. (1987), ""Immunochemical Approaches to Gene Probe Assays,"" Analytical Biochemistry, vol. 161, pp. 387-394.;;Matthews (1988), ""Analytical Strategies for the Use of DNA Probes,"" Analytical Biochemistry, vol. 169, pp. 1-25.",EXPIRED
109,ES,T3,ES 2155091 T3,173-854-890-102-271,2001-05-01,2001,ES 94922511 T,1994-07-11,US 9322593 A;;US 18766494 A,1993-07-16,PROCEDIMIENTO PARA LA PRODUCCION DE INHIBIDORES DE LA PROTEASA DEL VIH.,LOS INTERMEDIOS DE LA FORMULA ESTRUCTURA (IV) SE PUEDEN PRODUCIR HACIENDO REACCIIBAR GLICIDOL O UN DERIVADO ACTIVADO DEL MISMO CON UNA AMIDA. EL PROCESO Y LOS INTERMEDIOS SON UTILES PARA LA SINTETIZACION DE COMPUESTOS INHIBIDORES DE LA PROTEASA DEL VIH.,MERCK & CO INC,ASKIN DAVID;;VOLANTE RALPH P;;ENG KAN K,,https://lens.org/173-854-890-102-271,Granted Patent,no,0,0,41,47,0,C07D263/52;;C07D413/06;;C07D263/52;;C07D413/06,C07D241/04;;C07D241/14;;C07D263/52;;C07D413/06,,0,0,,,,EXPIRED
110,FI,B,FI 119473 B,193-288-573-056-461,2008-11-28,2008,FI 960184 A,1996-01-15,US 9322593 A;;US 18766494 A;;US 9407706 W,1993-07-16,Menetelmä HIV-proteaasi-inhibiittoreiden valmistamiseksi,,MERCK & CO INC,ASKIN DAVID;;VOLANTE RALPH P;;ENG KAN K,MERCK SHARP & DOHME CORP. (2010-03-16),https://lens.org/193-288-573-056-461,Patent Application,no,0,0,41,47,0,C07D263/52;;C07D413/06;;C07D263/52;;C07D413/06,C07D241/04;;C07D263/52;;C07D241/14;;C07D413/06,,0,0,,,,EXPIRED
111,SK,B6,SK 282616 B6,015-715-531-601-918,2002-10-08,2002,SK 5596 A,1994-07-11,US 9322593 A;;US 18766494 A;;US 9407706 W,1993-07-16,PRODUCTION METHOD FOR INTERMEDIATES FOR PRODUCTION OF HIV-PROTEAS E INHIBITORS AND RELEVANT INTERMEDIATES,"Disclosed is a production method of intermediates of general formula (I), which are precious substances for production of HIV-protease inhibitors by the reaction between the compounds of general formula (IV) and amines of general formula (V). In the said substances the individual general symbols have the meaning stated in the main claim. The invention relates also to intermediates of general formula (IV), in which the general symbols have the meaning stated in the claim 8.",MERCK & CO INC,ASKIN DAVID;;VOLANTE RALPH P;;ENG KAN K,"MERCK SHARP & DOHME CORP., RAHWAY, NJ, US (2010-04-29)",https://lens.org/015-715-531-601-918,Granted Patent,no,0,0,41,47,0,C07D263/52;;C07D413/06;;C07D263/52;;C07D413/06,C07D241/14;;C07D241/04;;C07D263/52;;C07D413/06,,0,0,,,,EXPIRED
112,US,B2,US 10588471 B2,032-498-887-497-62X,2020-03-17,2020,US 201816192792 A,2018-11-15,US 201816192792 A;;US 201615177205 A;;US 201562173338 P;;US 201562190260 P;;US 201562222507 P;;US 201562246107 P;;US 201662276816 P;;US 201662297864 P;;US 201662323514 P;;US 201662344811 P,2015-06-09,Stool for use with a toilet,"A stool is provided that provides a raised heel squat position to a user that engages the stool. The raised heel squatting position promotes a healthy and productive experience on a toilet. The stool may be collapsible for easier storage and transportation. The stool may be adjustable to provide custom fittings to different size users. Additionally, the stool may be intelligent and may provide a customized immersive experience to a person on a toilet.",NADIALABS INC,NAIK TIKESWAR;;ENG BRUCE W;;GONZALEZ DAVID E,NADIALABS INC (2018-11-08),https://lens.org/032-498-887-497-62X,Granted Patent,yes,15,1,5,5,0,A47K17/028;;A47K17/028;;A45D34/02;;A45D34/02;;A47C16/02;;A47C16/02;;A47C16/025;;A47C16/025;;A61B5/02055;;A61B5/02055;;A61B5/1036;;A61B5/1036;;A61B5/6891;;A61B5/6891;;A61H15/0078;;A61H15/0078;;A61H23/02;;A61H23/02;;A61H2015/0007;;A61H2015/0007;;A61H2015/0014;;A61H2015/0014;;A61H2015/0028;;A61H2015/0028;;A61H2015/0042;;A61H2015/0042;;A61H2015/0071;;A61H2015/0071;;A61H2201/0107;;A61H2201/0107;;A61H2201/0138;;A61H2201/0138;;A61H2201/0161;;A61H2201/0161;;A61H2201/0188;;A61H2201/0188;;A61H2201/0192;;A61H2201/0192;;A61H2201/0207;;A61H2201/0207;;A61H2201/0214;;A61H2201/0214;;A61H2201/0221;;A61H2201/0221;;A61H2201/164;;A61H2201/164;;A61H2201/1685;;A61H2201/1685;;A61H2201/5007;;A61H2201/5007;;A61H2201/5012;;A61H2201/5012;;A61H2201/503;;A61H2201/503;;A61H2201/5038;;A61H2201/5038;;A61H2201/5043;;A61H2201/5043;;A61H2201/5048;;A61H2201/5048;;A61H2201/5058;;A61H2201/5058;;A61H2201/5097;;A61H2201/5097;;A61H2203/0431;;A61H2203/0431;;A61H2205/12;;A61H2205/12;;A61H2205/125;;A61H2205/125;;A61H2230/00;;A61H2230/00;;A61H2230/06;;A61H2230/06;;A61H2230/202;;A61H2230/202;;A61H2230/25;;A61H2230/25;;A61H2230/30;;A61H2230/30;;A61H2230/50;;A61H2230/50;;A61H2230/70;;A61H2230/70;;A61H2230/80;;A61H2230/80;;A61L9/00;;A61L9/14;;A61L9/14;;A63B21/00047;;A63B21/00047;;A63B23/0458;;A63B23/0458;;A63B71/0622;;A63B71/0622;;A63B2023/0411;;A63B2023/0411;;A63B2071/0625;;A63B2071/0625;;A63B2071/0655;;A63B2071/0655;;A63B2210/50;;A63B2210/50;;A63B2225/093;;A63B2225/093;;A63B2225/50;;A63B2225/50;;A63B2225/64;;A63B2225/64;;A63B2225/66;;A63B2225/66;;A63B2230/01;;A63B2230/01;;A63B2230/08;;A63B2230/08;;A63B2230/202;;A63B2230/202;;A63B2230/30;;A63B2230/30;;A63B2230/50;;A63B2230/50;;G01G19/52;;G08C17/02;;G08C17/02;;G08C2201/93;;G08C2201/93,A47K17/02;;A45D34/02;;A47C16/02;;A61B5/00;;A61B5/0205;;A61B5/103;;A61H15/00;;A61H23/02;;A61L9/00;;A61L9/14;;A63B21/00;;A63B23/04;;A63B71/06;;G01G19/52;;G08C17/02,,0,0,,,,ACTIVE
113,US,B2,US 11140216 B2,080-967-963-820-493,2021-10-05,2021,US 201916680702 A,2019-11-12,US 201916680702 A;;US 201514844907 A,2015-09-03,Dynamically providing host input control for streaming applications,"A computer streaming system includes a remote user device and a host streaming unit. The host streaming unit determines input methods suitable for the remote user device to interact with content streamed to the remote user using a selected application. The host streaming unit detects whether a user interface of the selected application is supported by the remote user device and dynamically institutes emulated native input support for the remote user device when the host streaming unit detects the user interface of the selected application is not supported by the remote user device. Additionally, the host streaming unit dynamically dismisses emulated native input support for the remote user device when the host streaming unit detects the user interface of the selected application is supported by the remote user device, causing the remote user device to return to native input control. Also provided is a method of streaming a computer application.",NVIDIA CORP,ENG DAVID;;MEDISETTY RAJESH;;CHAUDHARY AMIT;;DHRU RAHIL,NVIDIA CORPORATION (2015-08-20),https://lens.org/080-967-963-820-493,Granted Patent,yes,65,0,4,4,0,H04N21/2387;;H04N21/4402;;H04N21/4788;;H04N21/8456;;G06F3/04886;;H04L67/10;;H04L67/141;;G06F3/04886;;H04N21/4788;;H04N21/8456;;H04N21/4402;;H04N21/2387,H04L29/08;;G06F3/0488;;H04N21/2387;;H04N21/4402;;H04N21/4788;;H04N21/845,,0,0,,,,ACTIVE
114,LV,B,LV 12825 B,111-120-124-360-712,2002-09-20,2002,LV 020039 A,2002-03-15,US 9322593 A;;US 18766494 A,1993-07-16,PROCESS FOR MAKING HIV PROTEASE INHIBITORS,"The present invention is concerned with a novel intermediate and process for synthesizing compounds which inhibit the protease of HIV. The instant process involves the reaction of an amide enolate derived from an amide with an activated nonracemic glycidol derivative, such as 2(S)-glycidyl tpsylate, to afford an epoxide intermediate which is a key intermediate useful in the preparation of HIV protease inhibitor compounds.",MERCK & CO INC,ASIKN DAVID;;VOLANTE RALPH P;;ENG KAN K,,https://lens.org/111-120-124-360-712,Granted Patent,no,0,0,41,47,0,C07D263/52;;C07D413/06;;C07D263/52;;C07D413/06,C07D241/14;;C07D241/04;;C07D263/52;;C07D413/06,,0,0,,,,EXPIRED
115,CA,C,CA 2193149 C,109-687-131-006-012,2002-04-23,2002,CA 2193149 A,1996-12-17,US 910195 P,1995-12-22,CATIONIC THERAPUETIC AGENTS AND DELIVERY SYSTEMS,"The present invention relates to delivery systems comprising a cationic polymer, optionally in conjunction with an anionic polymer, to deliver cationic therapeutic agents and their application to a mucosal surface. In particular, these delivery systems are well suited for the treatment of intraocular pressure and glaucoma by way of a sustained delivery system.",UNION CARBIDE CHEM PLASTIC,DONABEDIAN DAVID H;;MARLIN LAWRENCE;;ENG DONNA J,,https://lens.org/109-687-131-006-012,Granted Patent,no,0,0,3,3,0,A61K9/0048;;A61K31/137;;A61K31/138;;A61K31/165;;A61K31/166;;A61K31/167;;A61K31/216;;A61K31/27;;A61K31/343;;A61K31/404;;A61K31/4168;;A61K31/4178;;A61K31/42;;A61K31/427;;A61K31/4704;;A61K31/5377;;A61K47/36;;A61K9/0048;;A61K31/4704;;A61K31/343;;A61K31/138;;A61K31/216;;A61K31/404;;A61K31/4168;;A61K31/165;;A61K31/427;;A61K31/166;;A61K47/36;;A61K31/5377;;A61K31/137;;A61K31/42;;A61K31/4178;;A61K31/167;;A61K31/27,A61K9/00;;A61K31/137;;A61K31/138;;A61K31/165;;A61K31/166;;A61K31/167;;A61K31/216;;A61K31/27;;A61K31/343;;A61K31/404;;A61K31/4168;;A61K31/4178;;A61K31/42;;A61K31/427;;A61K31/4704;;A61K45/00;;A61K47/36,,0,0,,,,EXPIRED
116,US,B2,US 10587762 B2,143-928-672-078-569,2020-03-10,2020,US 201816151582 A,2018-10-04,US 201816151582 A;;US 201615256123 A,2016-09-02,Automated test suite mechanism,"A method is disclosed. The method includes generating a set of test case tags that describe attributes included in a test case and store the set of test case tags and the test case, receiving input information, and dynamically generating a test suite of one or more test cases based on input attributes data included in the input information, wherein the input information comprises code change information.",RICOH CO LTD,MANDRY STEPHEN JARED;;ENG KATIE ASHELY;;WARD DAVID,,https://lens.org/143-928-672-078-569,Granted Patent,yes,15,0,4,4,0,G06F3/1204;;G06F3/1204;;G06F3/1211;;G06F3/1215;;G06F3/1215;;G06F3/123;;G06F3/123;;G06F3/1244;;G06F3/1244;;G06F3/1248;;G06F3/1254;;G06F3/1254;;G06F3/1256;;G06F3/1256;;G06F3/1263;;G06F3/1263;;G06F3/1282;;G06F3/1282;;H04N1/00031;;H04N1/00063;;H04N2201/0094,H04N1/00;;G06F3/12,,1,0,,,"Kulkarni, Parikshit, “Exploiting JDF Between Customer and Print-Shop” Helsinki Univ. of Tech, pp. 1-47, 2006.",ACTIVE
117,EP,A1,EP 1825593 A1,156-258-553-030-37X,2007-08-29,2007,EP 05844892 A,2005-11-04,US 2005/0039968 W;;US 90511904 A,2004-12-16,BROADBAND HIGH EFFICIENCY TRAVELING WAVE TUBE AMPLIFIER SYSTEM,,BOEING CO,GOLDBERG DAVID R;;ENG JOHN E;;NICOL ERIC,,https://lens.org/156-258-553-030-37X,Patent Application,yes,0,0,5,5,0,H03F1/02;;H03F1/3241;;H03F1/3294;;H03F3/58;;H03F2200/102;;H03F3/58;;H03F2200/102;;H03F1/02;;H03F1/3294;;H03F1/3241,H03F1/02;;H03F3/58;;H03F1/32,,0,0,,,,ACTIVE
118,PT,E,PT 708762 E,078-166-277-520-982,2001-07-31,2001,PT 94922511 T,1994-07-11,US 9322593 A;;US 18766494 A,1993-07-16,PROCESSO PARA A PRODUCAO DE INIBIDORES DE PROTEASE DE HIV,,MERCK & CO INC,ASKIN DAVID;;VOLANTE RALPH P;;ENG KAN K,,https://lens.org/078-166-277-520-982,Granted Patent,no,0,0,41,47,0,C07D263/52;;C07D413/06;;C07D263/52;;C07D413/06,C07D241/14;;C07D241/04;;C07D263/52;;C07D413/06,,0,0,,,,EXPIRED
119,HU,D0,HU 9600077 D0,095-710-935-792-350,1996-03-28,1996,HU 9600077 A,1994-07-11,US 9322593 A;;US 18766494 A,1993-07-16,PROCESS FOR MAKING HIV PROTEASE INHIBITORS,,MERCK & CO INC,ASKIN DAVID;;VOLANTE RALPH P;;ENG KAN K,"MERCK SHARP & DOHME CORP., US (2010-05-28)",https://lens.org/095-710-935-792-350,Patent Application,no,0,0,41,47,0,C07D263/52;;C07D413/06;;C07D263/52;;C07D413/06,C07D241/04;;C07D241/14;;C07D263/52;;C07D413/06,,0,0,,,,DISCONTINUED
120,WO,A2,WO 1995/002584 A2,138-144-919-852-063,1995-01-26,1995,US 9407706 W,1994-07-11,US 9322593 A;;US 18766494 A,1993-07-16,PROCESS FOR MAKING HIV PROTEASE INHIBITORS,Intermediates of structural formula (IV) can be made by reacting glycidol or an activated derivative thereof with an amide. The process and intermediates are useful for synthesizing HIV protease inhibitor compounds.,MERCK & CO INC,ASKIN DAVID;;VOLANTE RALPH P;;ENG KAN K,,https://lens.org/138-144-919-852-063,Patent Application,no,0,7,41,47,0,C07D263/52;;C07D413/06;;C07D263/52;;C07D413/06,C07D241/14;;C07D241/04;;C07D263/52;;C07D413/06,,0,0,,,,PATENTED
121,AT,A1,AT 525865 A1,144-605-964-208-177,2023-07-15,2023,AT 508092022 A,2022-10-19,AT 508092022 A,2022-10-19,Verfahren Ermittlung eines Betriebszustandes eines Brennstoffzellensystems,"Die Erfindung betrifft ein Verfahren zur Ermittlung eines Betriebszustandes eines Brennstoffzellensystems (1), das einen Zellenstapel (2) mit zumindest einem Ano- denabschnitt (3) und zumindest einem Kathodenabschnitt (4) aufweist, wobei strom- aufwärts des Anodenabschnitts (3) ein Zuführventil (5) angeordnet ist, aufweisend die Schritte: - variierendes Zuführen eines ersten Fluides zu dem Anodenabschnitt (3) durch das erste Zuführventil (5) mit einem Variationsmuster, wobei dem Fluidstrom das Variationsmuster durch das Zuführventil (5) aufgeprägt wird, - Ermitteln einer anodenspezifischen Spannungsantwort des Zellenstapels (2) während des variierenden Führens des ersten Fluides zum Anodenabschnitt (3), - Ermitteln einer Wasserstoffkonzentration im zumindest einen Anodenabschnitt des Brennstoffzellensystems (1) anhand der anodenspezifischen Spannungsan- twort. Weiter betrifft die Erfindung ein PEM-Brennstoffzellensystem sowie die Verwendung eines solchen PEM-Brennstoffzellensystems.",AVL LIST GMBH,KATHARINA WEINGRILL B ENG;;DAVID WEINGRILL DIPL -ING,,https://lens.org/144-605-964-208-177,Patent Application,no,2,0,1,1,0,H01M8/04447;;H01M8/04544;;H01M8/04753;;H01M2250/20;;H01M2008/1095,H01M8/0444;;H01M8/04537;;H01M8/04746;;H01M8/10,,0,0,,,,DISCONTINUED
122,AT,B1,AT 524946 B1,151-819-690-173-890,2022-11-15,2022,AT 506672021 A,2021-08-17,AT 506672021 A,2021-08-17,Diagnoseverfahren für eine Schädigungsdiagnose bei einem Betrieb eines Brennstoffzellensystems,"Die vorliegende Erfindung betrifft ein Diagnoseverfahren für eine Schädigungsdiagnose bei einem Betrieb eines Brennstoffzellensystems (100) mit einem Brennstoffzellenstapel (110) mit einem Anodenabschnitt (120) und einem Kathodenabschnitt (130), gekennzeichnet durch die folgenden Schritte: ‐ Empfangen eines Betriebsstopp-Signals (BSS) für einen Stopp des Betriebs des Brennstoffzellensystems (100), ‐ Stoppen der Gaszufuhr zum Kathodenabschnitt (130) des Brennstoffzellenstapels (110), ‐ Vorgabe eines Entladestroms (IE) zum Entladen des Brennstoffzellenstapels (110), ‐ Überwachen einer Zellspannung (UZ) am Brennstoffzellenstapel (110), ‐ Beenden der Vorgabe des Entladestroms (IE) bei Erreichen einer Diagnose-Startspannung (UDS) am Brennstoffzellenstapel (110), ‐ Erfassen einer Diagnosezeitspanne (DZ) vom Diagnose-Startzeitpunkt (DZS) bei Erreichen der Diagnose-Startspannung (UDS) bis zum Diagnose-Endzeitpunkt (DZE) bei Erreichen einer Diagnose-Endspannung (UDE).",AVL LIST GMBH,DAVID ALDRIAN DIPL -ING;;KATHARINA WEINGRILL B ENG,,https://lens.org/151-819-690-173-890,Granted Patent,no,4,0,3,3,0,H01M8/04303;;H01M8/04544;;H01M8/04671;;H01M8/04679;;H01M2250/20,H01M8/04303;;H01M8/04537;;H01M8/04664,,0,0,,,,ACTIVE
123,WO,A3,WO 1996/000795 A3,162-325-823-745-645,1996-02-22,1996,CA 9500369 W,1995-06-27,CA 2126952 A,1994-06-28,METHOD OF AMPLIFICATION FOR INCREASING THE SENSITIVITY OF DETECTING NUCLEIC ACID-PROBE TARGET HYBRIDS,"The present invention provides a method for simplifying and significantly enhancing the sensitivity of nucleic acid hybridization assays. A method is described whereby a single-stranded primary nucleic acid sequence that includes a region of sequences complementary to a single-stranded target nucleic acid sequence is hybridized to the target molecule. Stability of the double-stranded complex thereby formed can be enhanced by using RNA as the probe if DNA is the target or DNA as the probe if RNA is the target. The probe-target complex is subsequently immunocaptured for detection. After washing away extraneous material, a secondary nucleic acid sequence containing many repeating sequence units is hybridized to the probe component of the immobilized probe-target complex. Detection occurs following hybridization of many labelled nucleic acid sequence probes to each of the repeating sequence units of a nucleic acid amplification probe. Thus, attachment of multiple labelling probes to an amplification probe that is hybridized to an immobilized probe-target complex, provides a simplified method for amplifying the detection signal and therefore the sensitivity of nucleic acid hybridization assays.",KALYX BIOSCIENCES INC;;PANDIAN SITHIAN;;AW ENG JOM;;SMITH DAVID I,PANDIAN SITHIAN;;AW ENG JOM;;SMITH DAVID I,,https://lens.org/162-325-823-745-645,Search Report,yes,8,0,11,13,0,C12Q1/682;;Y02A50/30;;C12Q1/682;;Y02A50/30,C12N15/09;;C12Q1/68;;G01N33/58,,0,0,,,,PATENTED
124,CA,A1,CA 2167183 A1,087-838-418-223-531,1995-01-26,1995,CA 2167183 A,1994-07-11,US 9322593 A;;US 18766494 A;;US 9407706 W,1993-07-16,PROCESS FOR MAKING HIV PROTEASE INHIBITORS,Intermediates of structural formula (IV) can be made by reacting glycidol or an activated derivative thereof with an amide. The process and intermediates are useful for synthesizing HIV protease inhibitor compounds.,MERCK & CO INC,ASKIN DAVID;;VOLANTE RALPH P;;ENG KAN K,,https://lens.org/087-838-418-223-531,Patent Application,no,0,0,2,47,0,,C07D263/52;;C07D413/06;;C07D453/02;;C07D471/04;;C07F9/653,,0,0,,,,EXPIRED
125,PL,A1,PL 312613 A1,078-120-752-469-490,1996-04-29,1996,PL 31261394 A,1994-07-11,US 9322593 A;;US 18766494 A;;US 9407706 W,1993-07-16,METHOD OF MANUFACTURING HIV PROTEASE INHIBITORS,,MERCK & CO INC,ASKIN DAVID;;VOLANTE RALPH P;;ENG KAN K,,https://lens.org/078-120-752-469-490,Patent Application,no,0,0,41,47,0,C07D263/52;;C07D413/06;;C07D263/52;;C07D413/06,C07D241/14;;C07D241/04;;C07D263/52;;C07D413/06,,0,0,,,,EXPIRED
126,US,A1,US 2019/0082900 A1,074-569-087-646-155,2019-03-21,2019,US 201816192792 A,2018-11-15,US 201816192792 A;;US 201615177205 A;;US 201562173338 P;;US 201562190260 P;;US 201562222507 P;;US 201562246107 P;;US 201662276816 P;;US 201662297864 P;;US 201662323514 P;;US 201662344811 P,2015-06-09,STOOL FOR USE WITH A TOLIET,"A stool is provided that provides a raised heel squat position to a user that engages the stool. The raised heel squatting position promotes a healthy and productive experience on a toilet. The stool may be collapsible for easier storage and transportation. The stool may be adjustable to provide custom fittings to different size users. Additionally, the stool may be intelligent and may provide a customized immersive experience to a person on a toilet.",NADIALABS INC,NAIK TIKESWAR;;ENG BRUCE W;;GONZALEZ DAVID E,NADIALABS INC (2018-11-08),https://lens.org/074-569-087-646-155,Patent Application,yes,14,1,5,5,0,A47K17/028;;A47K17/028;;A45D34/02;;A45D34/02;;A47C16/02;;A47C16/02;;A47C16/025;;A47C16/025;;A61B5/02055;;A61B5/02055;;A61B5/1036;;A61B5/1036;;A61B5/6891;;A61B5/6891;;A61H15/0078;;A61H15/0078;;A61H23/02;;A61H23/02;;A61H2015/0007;;A61H2015/0007;;A61H2015/0014;;A61H2015/0014;;A61H2015/0028;;A61H2015/0028;;A61H2015/0042;;A61H2015/0042;;A61H2015/0071;;A61H2015/0071;;A61H2201/0107;;A61H2201/0107;;A61H2201/0138;;A61H2201/0138;;A61H2201/0161;;A61H2201/0161;;A61H2201/0188;;A61H2201/0188;;A61H2201/0192;;A61H2201/0192;;A61H2201/0207;;A61H2201/0207;;A61H2201/0214;;A61H2201/0214;;A61H2201/0221;;A61H2201/0221;;A61H2201/164;;A61H2201/164;;A61H2201/1685;;A61H2201/1685;;A61H2201/5007;;A61H2201/5007;;A61H2201/5012;;A61H2201/5012;;A61H2201/503;;A61H2201/503;;A61H2201/5038;;A61H2201/5038;;A61H2201/5043;;A61H2201/5043;;A61H2201/5048;;A61H2201/5048;;A61H2201/5058;;A61H2201/5058;;A61H2201/5097;;A61H2201/5097;;A61H2203/0431;;A61H2203/0431;;A61H2205/12;;A61H2205/12;;A61H2205/125;;A61H2205/125;;A61H2230/00;;A61H2230/00;;A61H2230/06;;A61H2230/06;;A61H2230/202;;A61H2230/202;;A61H2230/25;;A61H2230/25;;A61H2230/30;;A61H2230/30;;A61H2230/50;;A61H2230/50;;A61H2230/70;;A61H2230/70;;A61H2230/80;;A61H2230/80;;A61L9/00;;A61L9/14;;A61L9/14;;A63B21/00047;;A63B21/00047;;A63B23/0458;;A63B23/0458;;A63B71/0622;;A63B71/0622;;A63B2023/0411;;A63B2023/0411;;A63B2071/0625;;A63B2071/0625;;A63B2071/0655;;A63B2071/0655;;A63B2210/50;;A63B2210/50;;A63B2225/093;;A63B2225/093;;A63B2225/50;;A63B2225/50;;A63B2225/64;;A63B2225/64;;A63B2225/66;;A63B2225/66;;A63B2230/01;;A63B2230/01;;A63B2230/08;;A63B2230/08;;A63B2230/202;;A63B2230/202;;A63B2230/30;;A63B2230/30;;A63B2230/50;;A63B2230/50;;G01G19/52;;G08C17/02;;G08C17/02;;G08C2201/93;;G08C2201/93,A47K17/02;;A45D34/02;;A47C16/02;;A61B5/00;;A61B5/0205;;A61B5/103;;A61H15/00;;A61H23/02;;A61L9/00;;A61L9/14;;A63B21/00;;A63B23/04;;A63B71/06;;G01G19/52;;G08C17/02,,0,0,,,,ACTIVE
127,FI,A,FI 960184 A,131-962-693-122-358,1996-03-14,1996,FI 960184 A,1996-01-15,US 9322593 A;;US 18766494 A;;US 9407706 W,1993-07-16,Menetelmä HIV-proteaasi-inhibiittoreiden valmistamiseksi,,MERCK & CO INC,ASKIN DAVID;;VOLANTE RALPH P;;ENG KAN K,MERCK SHARP & DOHME CORP. (2010-03-16),https://lens.org/131-962-693-122-358,Patent Application,no,0,0,41,47,0,C07D263/52;;C07D413/06;;C07D263/52;;C07D413/06,C07D241/04;;C07D241/14;;C07D263/52;;C07D413/06,,0,0,,,,EXPIRED
128,DE,D1,DE 69514521 D1,147-058-948-586-310,2000-02-17,2000,DE 69514521 T,1995-06-27,CA 2126952 A;;CA 9500369 W,1994-06-28,VERFAHREN ZUR ERHÖHUNG DER NACHWEISEMPFINDLICHKEIT VON NUKLEINSÄURE-HYBRIDEN (TARGET/PROBE),"The present invention provides a method for simplifying and significantly enhancing the sensitivity of nucleic acid hybridization assays. A method is described whereby a single-stranded primary nucleic acid sequence that includes a region of sequences complementary to a single-stranded target nucleic acid sequence is hybridized to the target molecule. Stability of the double-stranded complex thereby formed can be enhanced by using RNA as the probe if DNA is the target or DNA as the probe if RNA is the target. The probe-target complex is subsequently immunocaptured for detection. After washing away extraneous material, a secondary nucleic acid sequence containing many repeating sequence units is hybridized to the probe component of the immobilized probe-target complex. Detection occurs following hybridization of many labelled nucleic acid sequence probes to each of the repeating sequence units of a nucleic acid amplification probe. Thus, attachment of multiple labelling probes to an amplification probe that is hybridized to an immobilized probe-target complex, provides a simplified method for amplifying the detection signal and therefore the sensitivity of nucleic acid hybridization assays.",KALYX BIOSCIENCES INC,PANDIAN SITHIAN;;AW ENG JOM;;SMITH DAVID I,,https://lens.org/147-058-948-586-310,Granted Patent,no,0,0,11,13,0,C12Q1/682;;Y02A50/30;;C12Q1/682;;Y02A50/30,G01N33/58;;C12N15/09;;C12Q1/68,,0,0,,,,EXPIRED
129,AU,B2,AU 676079 B2,174-857-201-366-141,1997-02-27,1997,AU 1994/073588 A,1994-07-11,US 9322593 A;;US 18766494 A;;US 9407706 W,1993-07-16,Process for making HIV protease inhibitors,,MERCK & CO INC,ASKIN DAVID;;VOLANTE RALPH P;;ENG KAN K,,https://lens.org/174-857-201-366-141,Granted Patent,no,3,0,41,47,0,C07D263/52;;C07D413/06;;C07D263/52;;C07D413/06,C07D241/04;;C07D241/14;;C07D263/52;;C07D413/06,,0,0,,,,EXPIRED
130,CA,C,CA 2126952 C,188-143-510-867-891,2010-12-14,2010,CA 2126952 A,1994-06-28,CA 2126952 A,1994-06-28,"PROBE, KIT, AND METHOD OF AMPLIFICATION FOR INCREASING THE SENSITIVITY OF NUCLEIC ACID HYBRIDIZATION ASSAYS","The present invention provides a method for simplifying and significantly enhancing the sensitivity of nucleic acid hybridization assays. A method is described whereby a single-stranded primary nucleic acid sequence that includes a region of sequences complementary to a single-stranded target nucleic acid sequence is hybridized to the target molecule. Stability of the double-stranded complex thereby formed can be enhanced by using RNA as the probe if DNA is the target or DNA as the probe if RNA is the target. The probe-target complex is subsequently immunocaptured for detection. After washing away- extraneous material, a secondary nucleic acid sequence containing many repeating sequence units is hybridized to the probe component of the immobilized probe-target complex. Detection occurs following hybridization of many labelled nucleic acid sequence probes to each of the repeating sequence units of a nucleic acid amplification probe. Thus, attachment of multiple labelling probes to an amplification probe that is hybridized to an immobilized probe-target complex, provides a simplified method for amplifying the detection signal and therefore the sensitivity of nucleic acid hybridization assays.",KALYX BIOSCIENCES INC,PANDIAN SITHIAN;;AW ENG JOM;;SMITH DAVID I,,https://lens.org/188-143-510-867-891,Granted Patent,no,0,0,11,13,0,C12Q1/682;;Y02A50/30;;C12Q1/682;;Y02A50/30,C12Q1/70;;G01N33/58;;C07H21/00;;C12N15/09;;C12Q1/68,,0,0,,,,EXPIRED
131,CA,A1,CA 2193149 A1,198-644-053-879-325,1997-06-23,1997,CA 2193149 A,1996-12-17,US 910195 P,1995-12-22,CATIONIC THERAPUETIC AGENTS AND DELIVERY SYSTEMS,"The present invention relates to delivery systems comprising a cationic polymer, optionally in conjunction with an anionic polymer, to deliver cationic therapeutic agents and their application to a mucosal surface. In particular, these delivery systems are well suited for the treatment of intraocular pressure and glaucoma by way of a sustained delivery system.",UNION CARBIDE CHEM PLASTIC,DONABEDIAN DAVID H;;MARLIN LAWRENCE;;ENG DONNA J,,https://lens.org/198-644-053-879-325,Patent Application,no,0,0,3,3,0,A61K9/0048;;A61K31/137;;A61K31/138;;A61K31/165;;A61K31/166;;A61K31/167;;A61K31/216;;A61K31/27;;A61K31/343;;A61K31/404;;A61K31/4168;;A61K31/4178;;A61K31/42;;A61K31/427;;A61K31/4704;;A61K31/5377;;A61K47/36;;A61K9/0048;;A61K31/4704;;A61K31/343;;A61K31/138;;A61K31/216;;A61K31/404;;A61K31/4168;;A61K31/165;;A61K31/427;;A61K31/166;;A61K47/36;;A61K31/5377;;A61K31/137;;A61K31/42;;A61K31/4178;;A61K31/167;;A61K31/27,A61K9/00;;A61K31/137;;A61K31/138;;A61K31/165;;A61K31/166;;A61K31/167;;A61K31/216;;A61K31/27;;A61K31/343;;A61K31/404;;A61K31/4168;;A61K31/4178;;A61K31/42;;A61K31/427;;A61K31/4704;;A61K45/00;;A61K47/36,,0,0,,,,EXPIRED
132,AT,B1,AT 524627 B1,198-219-738-730-550,2022-08-15,2022,AT 500092021 A,2021-01-13,AT 500092021 A,2021-01-13,Prüfverfahren zum Prüfen einer Trennfunktionalität einer Hauptschaltvorrichtung einer elektrischen Verbindungsvorrichtung eines Brennstoffzellensystems,"Die vorliegende Erfindung betrifft ein Prüfverfahren zum Prüfen der Trennfunktionalität einer Hauptschaltvorrichtung (110) einer elektrischen Verbindungsvorrichtung (100) eines Brennstoffzellensystems (200), aufweisend die folgenden Schritte:  Erzeugung einer Spannungsvariation (VV) auf der Niederspannungs-Seite (LVS) einer Transformatorvorrichtung (120),  Schalten eines negativen Hauptschalters (112) der Hauptschaltervorrichtung (110),  Erfassen einer Spannungsdifferenz (VD) zwischen einer Niederspannung (LV) der Niederspannungs-Seite (LVS) der Transformatorvorrichtung (120) und einer Systemspannung (SV) des Brennstoffzellensystems (200),  Vergleich der erfassten Spannungsdifferenz (VD) mit einem Nullwert (NW).",AVL LIST GMBH,KATHARINA WEINGRILL B ENG;;DAVID ALDRIAN DIPL ING,,https://lens.org/198-219-738-730-550,Granted Patent,no,2,0,6,6,0,G01R31/3277;;H02H3/207;;G01R31/327;;Y02E60/50,G01R31/327;;H02H3/20,,0,0,,,,ACTIVE
133,US,A1,US 2021/0368415 A1,111-180-135-996-593,2021-11-25,2021,US 202117395943 A,2021-08-06,US 202117395943 A;;US 201514796507 A,2015-07-10,Directional Router Communication and Tracking,"Networking devices may allow for directed wireless communication. Such devices may comprise a movable antenna within a spherical housing having different ports associated with different positions, and may direct wireless communication beams in different directions to provide access to different zones by moving the antenna. A user may configure a system to prioritize or restrict zones or devices based on criteria. This prioritization may facilitate tiered services among users or devices.",COMCAST CABLE COMM LLC,BELLIS WILLIAM;;COMPTON CHRISTINE;;DAVE NIRAV;;ENG ADAM;;ENG DAVID;;LAVERY BRENDAN;;NOWAKOWSKI TAMARA;;VAIDYA ANUPAMA,COMCAST CABLE COMMUNICATIONS LLC (2015-06-29),https://lens.org/111-180-135-996-593,Patent Application,yes,0,0,3,3,0,H04B7/06;;H04W40/023;;H04W40/06;;H04W40/20;;H04B7/0408;;H04B7/0617;;H04W40/16;;H04W16/28;;Y02D30/70;;H04W40/16;;H04W84/12;;H04B7/0408;;H04B7/0617;;H04W40/06;;H04W40/20;;H04W40/023;;H04W16/28;;H04B7/06;;Y02D30/70,H04W40/16;;H04B7/0408;;H04B7/06;;H04W40/02;;H04W40/06;;H04W40/20,,0,0,,,,PENDING
134,US,B2,US 11129077 B2,015-711-019-345-97X,2021-09-21,2021,US 201514796507 A,2015-07-10,US 201514796507 A,2015-07-10,Directional router communication and tracking,"Networking devices may allow for directed wireless communication. Such devices may comprise a movable antenna within a spherical housing having different ports associated with different positions, and may direct wireless communication beams in different directions to provide access to different zones by moving the antenna. A user may configure a system to prioritize or restrict zones or devices based on criteria. This prioritization may facilitate tiered services among users or devices.",COMCAST CABLE COMM LLC,BELLIS WILLIAM;;COMPTON CHRISTINE;;DAVE NIRAV;;ENG ADAM;;ENG DAVID;;LAVERY BRENDAN;;NOWAKOWSKI TAMARA;;VAIDYA ANUPAMA,COMCAST CABLE COMMUNICATIONS LLC (2015-06-29),https://lens.org/015-711-019-345-97X,Granted Patent,yes,25,0,3,3,0,H04B7/06;;H04W40/023;;H04W40/06;;H04W40/20;;H04B7/0408;;H04B7/0617;;H04W40/16;;H04W16/28;;Y02D30/70;;H04W40/16;;H04W84/12;;H04B7/0408;;H04B7/0617;;H04W40/06;;H04W40/20;;H04W40/023;;H04W16/28;;H04B7/06;;Y02D30/70,H04W40/16;;H04B7/0408;;H04B7/06;;H04W16/28;;H04W40/02;;H04W40/06;;H04W40/20;;H04W84/12,,0,0,,,,ACTIVE
135,US,A1,US 2017/0013534 A1,117-720-309-975-833,2017-01-12,2017,US 201514796507 A,2015-07-10,US 201514796507 A,2015-07-10,Directional Router Communication and Tracking,"In accordance with one or more embodiments, networking devices may allow for directed wireless communication. Such devices may direct wireless communication beams in different directions to provide access to different zones. A user may configure a system to prioritize or restrict zones or devices based on criteria. This prioritization may facilitate tiered services among users or devices. A networking device may also direct communication between multiple routers to facilitate a distributed network, allowing for a single device to provide dedicated wireless bridging while separately managing a local wireless network.",COMCAST CABLE COMM LLC,BELLIS WILLIAM;;COMPTON CHRISTINE;;DAVE NIRAV;;ENG ADAM;;ENG DAVID;;LAVERY BRENDAN;;NOWAKOWSKI TAMARA;;VAIDYA ANUPAMA,COMCAST CABLE COMMUNICATIONS LLC (2015-06-29),https://lens.org/117-720-309-975-833,Patent Application,yes,9,13,3,3,0,H04B7/06;;H04W40/023;;H04W40/06;;H04W40/20;;H04B7/0408;;H04B7/0617;;H04W40/16;;H04W16/28;;Y02D30/70;;H04W40/16;;H04W84/12;;H04B7/0408;;H04B7/0617;;H04W40/06;;H04W40/20;;H04W40/023;;H04W16/28;;H04B7/06;;Y02D30/70,H04W40/16,,0,0,,,,ACTIVE
136,CN,A,CN 107073985 A,093-890-869-570-116,2017-08-18,2017,CN 201580059656 A,2015-01-29,US 2015/0013589 W,2015-01-29,Identifying primed printheads,"Priming printheads can, in various examples, include moving a movable member of a printhead from a first position to a second position, measuring a response time of the movable member to move from the first position to the second position, and identifying the printhead as primed.",HEWLETT PACKARD DEVELOPMENT CO,WAGNER JEFFREY A;;WELTER DAVID;;GOH ENG GEE JOHNNY,,https://lens.org/093-890-869-570-116,Patent Application,no,7,0,14,14,0,B41J2/175;;B41J29/38;;B41J2/125;;B41J2/135;;B41J2/14153;;B41J29/38;;B41J29/393;;B41J2/175;;B41J29/38;;B41J2/04508;;B41J2/04586;;B41J2/17596,B41J29/393;;B41J2/175,,0,0,,,,ACTIVE
137,US,A1,US 2006/0234626 A1,124-755-131-730-479,2006-10-19,2006,US 90511904 A,2004-12-16,US 90511904 A,2004-12-16,Broadband High Efficiency Traveling Wave Tube Amplifier System,"A power control system for a satellite receiving radio-frequency signals includes a traveling wave tube amplifier system and corresponding traveling wave tube. An anode voltage of the traveling wave tube amplifier system is used to modulate or saturate the current of the electron beam of the traveling wave tube so that the output power of the traveling wave tube amplifier system, from the saturated electron beam, is proportional to a waveform envelope of the radio-frequency signals.",BOEING CO,GOLDBERG DAVID R;;ENG JOHN E;;NICOL ERIC F,THE BOEING COMPANY (2004-10-28),https://lens.org/124-755-131-730-479,Patent Application,yes,6,7,5,5,0,H03F1/02;;H03F1/3241;;H03F1/3294;;H03F3/58;;H03F2200/102;;H03F3/58;;H03F2200/102;;H03F1/02;;H03F1/3294;;H03F1/3241,H04B7/185,455/13.4,0,0,,,,ACTIVE
138,WO,A1,WO 2016/122543 A1,157-431-541-397-388,2016-08-04,2016,US 2015/0013589 W,2015-01-29,US 2015/0013589 W,2015-01-29,IDENTIFYING PRIMED PRINTHEADS,"Priming printheads can, in various examples, include moving a movable member of a printhead from a first position to a second position, measuring a response time of the movable member to move from the first position to the second position, and identifying the printhead as primed.",HEWLETT PACKARD DEVELOPMENT CO,WAGNER JEFFREY A;;WELTER DAVID;;GOH ENG GEE JOHNNY,,https://lens.org/157-431-541-397-388,Patent Application,yes,5,0,14,14,0,B41J2/175;;B41J29/38;;B41J2/125;;B41J2/135;;B41J2/14153;;B41J29/38;;B41J29/393;;B41J2/175;;B41J29/38;;B41J2/04508;;B41J2/04586;;B41J2/17596,B41J2/175;;B41J29/393,,1,0,,,See also references of EP 3250392A4,PENDING
139,US,A1,US 2017/0305149 A1,076-983-719-753-976,2017-10-26,2017,US 201515521511 A,2015-01-29,US 2015/0013589 W,2015-01-29,IDENTIFYING PRIMED PRINTHEADS,"Priming printheads can, in various examples, include moving a movable member of a printhead from a first position to a second position, measuring a response time of the movable member to move from the first position to the second position, and identifying the printhead as primed.",HEWLETT PACKARD DEVELOPMENT CO LP,WAGNER JEFFREY A;;WELTER DAVID;;GOH ENG GEE JONNY,HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (2015-01-27),https://lens.org/076-983-719-753-976,Patent Application,yes,1,0,14,14,0,B41J2/175;;B41J29/38;;B41J2/125;;B41J2/135;;B41J2/14153;;B41J29/38;;B41J29/393;;B41J2/175;;B41J29/38;;B41J2/04508;;B41J2/04586;;B41J2/17596,B41J2/045,,0,0,,,,ACTIVE
140,US,B1,US 8502844 B1,145-250-347-357-552,2013-08-06,2013,US 64922209 A,2009-12-29,US 64922209 A;;US 22476605 A,2005-09-13,"System, method and computer program product for adjusting a display device viewing experience","A system, method, and computer program product are provided for adjusting a viewing experience associated with a display device. During use, a user interface capable of being used for adjusting the viewing experience associated with the display device is automatically displayed, in response to an event that potentially affects the viewing experience associated with the display device.",FEAR ANDREW C;;RAMOS JENNIFER R;;ENG DAVID LEE;;NVIDIA CORP,FEAR ANDREW C;;RAMOS JENNIFER R;;ENG DAVID LEE,NVIDIA CORPORATION (2005-09-01),https://lens.org/145-250-347-357-552,Granted Patent,yes,13,3,2,2,0,G09G5/003;;G09G5/003;;G09G5/363;;G09G5/363;;G09G2310/0232;;G09G2310/0232;;G09G2320/08;;G09G2320/08;;G09G2330/026;;G09G2330/026;;G09G2340/0407;;G09G2340/0407;;G09G2340/0464;;G09G2340/0464;;G09G2354/00;;G09G2354/00,G09G5/02,345/698;;725/37;;715/718,10,0,,,"Office Action Summary from U.S. Appl. No. 11/224,766 mailed on Mar. 4, 2010.;;Non-Final Office Action from U.S. Appl. No. 11/224,766 dated May 2, 2008.;;Non-Final Office Action from U.S. Appl. No. 11/224,766 dated Jun. 9, 2008.;;Final Office Action from U.S. Appl. No. 11/224,766 dated Nov. 5, 2008.;;Advisory Action from U.S. Appl. No. 11/224,766 dated Jan. 23, 2009.;;Non-Final Office Action from U.S. Appl. No. 11/224,766 dated Mar. 5, 2009.;;Final Office Action from US Application No. 11/224,766 dated Oct. 7, 2009.;;Notice of Allowance from U.S. Appl. No. 11/224,766 dated Aug. 30, 2010.;;nVidia, ""Advanced Timing and CEA/EIA-861B Timings"", Feb. 21, 2008, retrieved from http://www.nvidia.com/object/advanced-timings.html on May 22, 2008, pp. 1-4.;;Vesa, ""Vesa Standard Summaries"", retrieved from http://www.vesa.org/Standards/summaries.htm on May 22, 2008, pp. 1-4.",ACTIVE
141,US,A1,US 2007/0069756 A1,005-001-771-236-772,2007-03-29,2007,US 23951205 A,2005-09-29,US 23951205 A,2005-09-29,Test fixture,A test fixture is adapted to shield a device under test (DUT) from time dependent electromagnetic radiation.,AMBLER DAVID R;;KUSLUSKI GARY J;;TEOH ENG-HOOI,AMBLER DAVID R;;KUSLUSKI GARY J;;TEOH ENG-HOOI,AGILENT TECHNOLOGIES INC (2005-09-26),https://lens.org/005-001-771-236-772,Patent Application,yes,9,12,2,2,0,G01R31/002;;G01R31/002,G01R31/26,324/765,0,0,,,,DISCONTINUED
142,BR,A2,BR 112017008529 A2,107-497-903-197-657,2017-12-19,2017,BR 112017008529 A,2015-01-29,US 2015/0013589 W,2015-01-29,identificação de cabeças de impressão iniciadas,,HEWLETT PACKARD DEVELOPMENT CO,DAVID WELTER;;ENG GEE JOHNNY GOH;;JEFFREY A WAGNER,"HEWLETT-PACKARD DEVELOPMENT COMPANY, LP (US) (2020-06-02)",https://lens.org/107-497-903-197-657,Patent Application,no,0,0,14,14,0,B41J2/175;;B41J29/38;;B41J2/125;;B41J2/135;;B41J2/14153;;B41J29/38;;B41J29/393;;B41J2/175;;B41J29/38;;B41J2/04508;;B41J2/04586;;B41J2/17596,B41J2/175;;B41J29/393,,0,0,,,,INACTIVE
143,US,B1,US 7864203 B1,064-750-906-991-547,2011-01-04,2011,US 22476605 A,2005-09-13,US 22476605 A,2005-09-13,"System, method and computer program product for adjusting a display device viewing experience","A system, method, and computer program product are provided for adjusting a viewing experience associated with a display device. During use, a user interface capable of being used for adjusting the viewing experience associated with the display device is automatically displayed, in response to an event that potentially affects the viewing experience associated with the display device.",NVIDIA CORP,FEAR ANDREW C;;RAMOS JENNIFER R;;ENG DAVID LEE,NVIDIA CORPORATION (2005-09-01),https://lens.org/064-750-906-991-547,Granted Patent,yes,5,19,2,2,0,G09G5/003;;G09G5/003;;G09G5/363;;G09G5/363;;G09G2310/0232;;G09G2310/0232;;G09G2320/08;;G09G2320/08;;G09G2330/026;;G09G2330/026;;G09G2340/0407;;G09G2340/0407;;G09G2340/0464;;G09G2340/0464;;G09G2354/00;;G09G2354/00,G09G5/02;;G06F3/00;;G06T17/00,345/698;;725/37;;715/718;;345/428,3,0,,,"www.computerhope.com definitions of h-sync and v-sync published in 2001 per the web archive (web.archive.org).;;""Vesa Standard Summaries"" http://www.vesa.org/Standards/summaries.htm.;;""Advanced Timing and CEA/EIA-861B Timings"" http://www.nvidia.com/object/advanced-timings.html.",ACTIVE
144,KR,A,KR 20170107957 A,135-785-271-652-843,2017-09-26,2017,KR 20177011536 A,2015-01-29,US 2015/0013589 W,2015-01-29,IDENTIFYING PRIMED PRINTHEADS,"프린트 헤드의 사용준비는 다양한 예에서, 제 1 위치로부터 제 2 위치로 프린트 헤드의 가동 부재를 이동시키는 것, 제 1 위치로부터 제 2 위치로 이동하는 가동 부재의 응답 시간을 측정하는 것, 그리고 프린트 헤드가 사용준비된 것으로 확인하는 것을 포함한다.",HEWLETT PACKARD DEVELOPMENT CO LP,WAGNER JEFFREY A;;WELTER DAVID;;GOH ENG GEE JOHNNY,,https://lens.org/135-785-271-652-843,Patent Application,no,2,0,14,14,0,B41J2/175;;B41J29/38;;B41J2/125;;B41J2/135;;B41J2/14153;;B41J29/38;;B41J29/393;;B41J2/175;;B41J29/38;;B41J2/04508;;B41J2/04586;;B41J2/17596,B41J2/135;;B41J2/125;;B41J2/14;;B41J29/38;;B41J29/393,,0,0,,,,ACTIVE
145,US,A1,US 2022/0350075 A1,169-744-528-676-924,2022-11-03,2022,US 202117244808 A,2021-04-29,US 202117244808 A,2021-04-29,FIBER OPTIC SWITCH EMPLOYING MOVEABLE STRUCTURE INTERACTION WITH THE EVANESCENT FIELD OF A CLADDING-REMOVED FIBER,"Cladding removed from a portion of the optical fiber defines a window exposing the fiber core. A grating having a substantially periodic structure defining a wavelength is moveably positioned in the window, where it can interact with the evanescent field present in the window when optical power is propagating through the fiber. An adjustable positioning fixture holds the grating proximate to the window and operates to change the relative spacing of the fiber core and grating, between: a first position in which the grating is held proximate to the fiber core and substantially interacts with the evanescent field, and a second position in which the grating is held apart from the fiber core and does not substantially interact with the evanescent field.",GENERAL DYNAMICS MISSION SYSTEMS INC,SYLVESTER GARRETT;;ENG DAVID L K;;SWAN M CRAIG,,https://lens.org/169-744-528-676-924,Patent Application,yes,15,0,2,2,0,G02B6/3536;;G02B6/02061;;G02B6/3508;;G02B6/356,G02B6/02;;G02B6/35,,0,0,,,,ACTIVE
146,US,B1,US 6860030 B1,024-755-541-366-969,2005-03-01,2005,US 71343400 A,2000-11-15,US 71343400 A,2000-11-15,Control system for gap measuring,"A control system for measuring a gap in an apparatus for pressing a traveling paper web as the paper web travels through the gap accompanied by at least one belt or felt, the apparatus including a press apparatus and a support surface defining a gap therebetween. A frame is provided for moveably supporting the press apparatus. An actuator is operatively disposed between the frame and press apparatus for selectively moving the press apparatus toward and away from the support to control the gap size. A transducer is mounted in either the press apparatus or support for producing a signal indicative of the pressure on the paper web as the paper web, belt and felt pass through the gap beneath the transducer. A controller is operatively linked with the transducer for receiving the signal, determining the measure of the gap as a function of the pressure, and causing the actuator to selectively move the press apparatus to control the gap size.",VOITH PAPER INC,GRAF EDWIN X;;ENG JAMES A;;ROOT DAVID W,VOITH PAPTER INC (2000-10-16),https://lens.org/024-755-541-366-969,Granted Patent,yes,28,13,3,3,0,D21F3/0209;;D21F3/06;;D21F3/06;;D21F3/0209,D21F3/02;;D21F3/06,33/700;;162/358.3;;73/862.55,0,0,,,,EXPIRED
147,BR,B1,BR 112017008529 B1,050-862-251-800-33X,2022-01-25,2022,BR 112017008529 A,2015-01-29,US 2015/0013589 W,2015-01-29,"Método, mídia legível por computador não transitória e sistema de impressão","identificação de cabeças de impressão iniciadas. iniciar cabeças de impressão pode incluir, em vários exemplos, mover um membro móvel de uma cabeça de impressão de uma primeira posição para uma segunda posição, medir um tempo de resposta do membro móvel para mover da primeira posição para a segunda posição e identificar a cabeça de impressão como iniciada.",HEWLETT PACKARD DEVELOPMENT CO,WELTER DAVID;;ENG GEE JOHNNY GOH;;JEFFREY A WAGNER,"HEWLETT-PACKARD DEVELOPMENT COMPANY, LP (US) (2020-06-02)",https://lens.org/050-862-251-800-33X,Granted Patent,no,0,0,14,14,0,B41J2/175;;B41J29/38;;B41J2/125;;B41J2/135;;B41J2/14153;;B41J29/38;;B41J29/393;;B41J2/175;;B41J29/38;;B41J2/04508;;B41J2/04586;;B41J2/17596,B41J2/175;;B41J29/393,,0,0,,,,INACTIVE
148,US,B1,US 11467336 B1,197-693-519-154-161,2022-10-11,2022,US 202117244808 A,2021-04-29,US 202117244808 A,2021-04-29,Fiber optic switch employing moveable structure interaction with the evanescent field of a cladding-removed fiber,"Cladding removed from a portion of the optical fiber defines a window exposing the fiber core. A grating having a substantially periodic structure defining a wavelength is moveably positioned in the window, where it can interact with the evanescent field present in the window when optical power is propagating through the fiber. An adjustable positioning fixture holds the grating proximate to the window and operates to change the relative spacing of the fiber core and grating, between: a first position in which the grating is held proximate to the fiber core and substantially interacts with the evanescent field, and a second position in which the grating is held apart from the fiber core and does not substantially interact with the evanescent field.",GENERAL DYNAMICS MISSION SYSTEMS INC,SYLVESTER GARRETT;;ENG DAVID L K;;SWAN M CRAIG,GENERAL DYNAMICS MISSION SYSTEMS INC (2021-04-29),https://lens.org/197-693-519-154-161,Granted Patent,yes,16,0,2,2,0,G02B6/3536;;G02B6/02061;;G02B6/3508;;G02B6/356,G02B6/02;;G02B6/35,,1,1,003-370-914-252-093,10.1109/68.544709,"Dong, L., et al., “Novel add/drop filters for wavelength-division-multiplexing optical fiber systems using a Bragg grating assisted mismatched coupler.” IEEE Photonics Technology Letters 8.12 (1996): 1656-1658.",ACTIVE
149,US,B2,US 10308015 B2,010-017-226-051-630,2019-06-04,2019,US 201515521511 A,2015-01-29,US 2015/0013589 W,2015-01-29,Identifying primed printheads,"Priming printheads can, in various examples, include moving a movable member of a printhead from a first position to a second position, measuring a response time of the movable member to move from the first position to the second position, and identifying the printhead as primed.",HEWLETT PACKARD DEVELOPMENT CO,WAGNER JEFFREY A;;WELTER DAVID;;GOH ENG GEE JONNY,HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (2015-01-27),https://lens.org/010-017-226-051-630,Granted Patent,yes,18,1,14,14,0,B41J2/175;;B41J29/38;;B41J2/125;;B41J2/135;;B41J2/14153;;B41J29/38;;B41J29/393;;B41J2/175;;B41J29/38;;B41J2/04508;;B41J2/04586;;B41J2/17596,B41J2/175;;B41J2/045,,0,0,,,,ACTIVE
150,US,B2,US 7358803 B2,110-881-155-986-03X,2008-04-15,2008,US 90511904 A,2004-12-16,US 90511904 A,2004-12-16,Broadband high efficiency traveling wave tube amplifier system,"A power control system for a satellite receiving radio-frequency signals includes a traveling wave tube amplifier system and corresponding traveling wave tube. An anode voltage of the traveling wave tube amplifier system is used to modulate or saturate the current of the electron beam of the traveling wave tube so that the output power of the traveling wave tube amplifier system, from the saturated electron beam, is proportional to a waveform envelope of the radio-frequency signals.",BOEING CO,GOLDBERG DAVID ROSS;;ENG JOHN E;;NICOL ERIC F,THE BOEING COMPANY (2004-10-28),https://lens.org/110-881-155-986-03X,Granted Patent,yes,7,4,5,5,0,H03F1/02;;H03F1/3241;;H03F1/3294;;H03F3/58;;H03F2200/102;;H03F3/58;;H03F2200/102;;H03F1/02;;H03F1/3294;;H03F1/3241,H03F3/58,330/43;;455/13.4;;455/126;;455/127.1;;455/127.2,4,1,002-076-535-393-335,10.1109/vetecs.2000.851486,"Martijn Kuipers, et al., Pre-Distorted Amplifiers for OFDM In Wireless Indoor Multimedia Communications; Vehicular Technology Conference Proceedings; May 15, 2000; vol. 1 of 3.;;Conf. 51, pp. 395-399; Aalborg, Denmark.;;Patent Cooperation Treaty International Search Report.;;Patent Cooperation Treaty Written Opinion of the International Searching Authority.",ACTIVE
151,EP,A1,EP 3250392 A1,177-824-439-939-85X,2017-12-06,2017,EP 15880439 A,2015-01-29,US 2015/0013589 W,2015-01-29,IDENTIFYING PRIMED PRINTHEADS,,HEWLETT PACKARD DEVELOPMENT CO LP,WAGNER JEFFREY A;;WELTER DAVID;;GOH ENG GEE JOHNNY,"HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (2019-05-15)",https://lens.org/177-824-439-939-85X,Patent Application,yes,0,0,14,14,0,B41J2/175;;B41J29/38;;B41J2/125;;B41J2/135;;B41J2/14153;;B41J29/38;;B41J29/393;;B41J2/175;;B41J29/38;;B41J2/04508;;B41J2/04586;;B41J2/17596,B41J2/175;;B41J29/393,,0,0,,,,ACTIVE
152,EP,A4,EP 3250392 A4,014-074-471-078-788,2018-10-17,2018,EP 15880439 A,2015-01-29,US 2015/0013589 W,2015-01-29,IDENTIFYING PRIMED PRINTHEADS,,HEWLETT PACKARD DEVELOPMENT CO,WAGNER JEFFREY A;;WELTER DAVID;;GOH ENG GEE JOHNNY,"HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (2019-05-15)",https://lens.org/014-074-471-078-788,Search Report,no,4,0,14,14,0,B41J2/175;;B41J29/38;;B41J2/125;;B41J2/135;;B41J2/14153;;B41J29/38;;B41J29/393;;B41J2/175;;B41J29/38;;B41J2/04508;;B41J2/04586;;B41J2/17596,B41J2/045;;B41J29/393;;B41J2/175;;B41J29/38,,1,0,,,See also references of WO 2016122543A1,ACTIVE
153,EP,B1,EP 3250392 B1,069-718-436-883-788,2022-03-02,2022,EP 15880439 A,2015-01-29,US 2015/0013589 W,2015-01-29,IDENTIFYING PRIMED PRINTHEADS,,HEWLETT PACKARD DEVELOPMENT CO,WAGNER JEFFREY A;;WELTER DAVID;;GOH ENG GEE JOHNNY,"HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (2019-05-15)",https://lens.org/069-718-436-883-788,Granted Patent,yes,9,0,14,14,0,B41J2/175;;B41J29/38;;B41J2/125;;B41J2/135;;B41J2/14153;;B41J29/38;;B41J29/393;;B41J2/175;;B41J29/38;;B41J2/04508;;B41J2/04586;;B41J2/17596,B41J29/393;;B41J2/045;;B41J2/175;;B41J29/38,,0,0,,,,ACTIVE
154,EP,B1,EP 1400754 B1,133-670-370-216-366,2011-10-26,2011,EP 03077207 A,2003-07-11,US 25220802 A,2002-09-23,Premixed pilot burner for a combustion turbine engine,,SIEMENS ENERGY INC,ENG JESSE;;HARRIS ART;;DEALBA NORTH DAVID;;REID HANK,"SIEMENS POWER GENERATION, INC. (2005-11-23);;SIEMENS ENERGY, INC. (2008-11-26)",https://lens.org/133-670-370-216-366,Granted Patent,yes,2,0,4,4,0,F02C7/222;;F23R3/343;;F02C7/222;;F23R3/343,F23R3/34;;F02C7/22,,0,0,,,,EXPIRED
155,EP,A1,EP 1400754 A1,186-950-202-159-074,2004-03-24,2004,EP 03077207 A,2003-07-11,US 25220802 A,2002-09-23,Premixed pilot burner for a combustion turbine engine,"A combustor (40) for a gas turbine engine is provided with a premix pilot fuel stage (42) in order to reduce the emission of oxides of nitrogen from the engine. An in-service engine may be modified to add the premix pilot fuel stage by delivering premix pilot fuel to a ring manifold (42) for tip-feeding a premix pilot fuel outlet member such as a swirler vane (78) or fuel peg (124). In this manner, complex and expensive components such as the top hat (46), support housing (48) and diffusion pilot burner assembly (44) may be used without modification. Thermal stresses caused by the differential cooling of the ring manifold by the premix pilot fuel (96) are reduced by a heat shield (94) installed within the manifold.",SIEMENS WESTINGHOUSE POWER,ENG JESSE;;HARRIS ART;;DEALBA NORTH DAVID;;REID HANK,"SIEMENS POWER GENERATION, INC. (2005-11-23);;SIEMENS ENERGY, INC. (2008-11-26)",https://lens.org/186-950-202-159-074,Patent Application,yes,9,6,4,4,0,F02C7/222;;F23R3/343;;F02C7/222;;F23R3/343,F23R3/34;;F02C7/22,,0,0,,,,EXPIRED
156,US,B2,US 9251034 B2,105-557-997-421-267,2016-02-02,2016,US 201314089424 A,2013-11-25,US 201314089424 A,2013-11-25,Device performance monitoring,"A computing device performance monitor may be configured to collect performance metric information regarding one or more monitored computing devices, and may assign condition point values to each metric. The performance monitor may generate a total of the condition point values, and use the total to determine an appropriate response.",COMCAST CABLE COMM LLC,LEACH DAVID;;RUSSELL JAMES;;PAROL TIMOTHY;;ENG DAVID;;ANDERSON MARK;;BURKS DANTE,COMCAST CABLE COMMUNICATIONS LLC (2013-10-15),https://lens.org/105-557-997-421-267,Granted Patent,yes,6,0,5,5,0,H04L1/20;;G06F11/3409;;H04L43/08;;H04L43/0817;;H04L43/16;;G06F11/3452;;H04L1/20;;G06F11/3409;;H04L43/08;;H04L43/0817;;H04L43/16;;H04L43/0876,H04L1/18;;G06F11/34;;H04L1/20,,0,0,,,,ACTIVE
157,US,A1,US 2016/0323168 A1,132-229-064-224-700,2016-11-03,2016,US 201514961089 A,2015-12-07,US 201514961089 A;;US 201314089424 A,2013-11-25,Device Performance Monitoring,"A computing device performance monitor may be configured to collect performance metric information regarding one or more monitored computing devices, and may assign condition point values to each metric. The performance monitor may generate a total of the condition point values, and use the total to determine an appropriate response.",COMCAST CABLE COMM LLC,LEACH DAVID;;RUSSELL JAMES;;PAROL TIMOTHY;;ENG DAVID;;ANDERSON MARK;;BURKS DANTE,COMCAST CABLE COMMUNICATIONS LLC (2013-10-15),https://lens.org/132-229-064-224-700,Patent Application,yes,4,2,5,5,0,H04L1/20;;G06F11/3409;;H04L43/08;;H04L43/0817;;H04L43/16;;G06F11/3452;;H04L1/20;;G06F11/3409;;H04L43/08;;H04L43/0817;;H04L43/16;;H04L43/0876,H04L12/26,,0,0,,,,ACTIVE
158,US,B2,US 9960984 B2,017-670-920-151-224,2018-05-01,2018,US 201514961089 A,2015-12-07,US 201514961089 A;;US 201314089424 A,2013-11-25,Device performance monitoring,"A computing device performance monitor may be configured to collect performance metric information regarding one or more monitored computing devices, and may assign condition point values to each metric. The performance monitor may generate a total of the condition point values, and use the total to determine an appropriate response.",COMCAST CABLE COMM LLC,LEACH DAVID;;RUSSELL JAMES;;PAROL TIMOTHY;;ENG DAVID;;ANDERSON MARK;;BURKS DANTE,COMCAST CABLE COMMUNICATIONS LLC (2013-10-15),https://lens.org/017-670-920-151-224,Granted Patent,yes,10,0,5,5,0,H04L1/20;;G06F11/3409;;H04L43/08;;H04L43/0817;;H04L43/16;;G06F11/3452;;H04L1/20;;G06F11/3409;;H04L43/08;;H04L43/0817;;H04L43/16;;H04L43/0876,H04L1/18;;G06F11/34;;H04L1/20;;H04L12/26,,2,0,,,"Motorola Operation Manual: STDC SmartStream Terminal Data Collector v.2.0.2, pp. 1-90. Specific date unknown but believed to be prior to Sep. 2009.;;Cisco OID Parameters, pp. 1-40. Specific date unknown but believed to be prior to Nov. 2007.",ACTIVE
159,US,A1,US 2015/0149850 A1,111-418-264-494-335,2015-05-28,2015,US 201314089424 A,2013-11-25,US 201314089424 A,2013-11-25,Device Performance Monitoring,"A computing device performance monitor may be configured to collect performance metric information regarding one or more monitored computing devices, and may assign condition point values to each metric. The performance monitor may generate a total of the condition point values, and use the total to determine an appropriate response.",COMCAST CABLE COMMUNICATION LLC,LEACH DAVID;;RUSSELL JAMES;;PAROL TIMOTHY;;ENG DAVID;;ANDERSON MARK;;BURKS DANTE,COMCAST CABLE COMMUNICATIONS LLC (2013-10-15),https://lens.org/111-418-264-494-335,Patent Application,yes,6,15,5,5,0,H04L1/20;;G06F11/3409;;H04L43/08;;H04L43/0817;;H04L43/16;;G06F11/3452;;H04L1/20;;G06F11/3409;;H04L43/08;;H04L43/0817;;H04L43/16;;H04L43/0876,G06F11/34;;H04L1/00,714/751,0,0,,,,ACTIVE
160,YU,A,YU 15496 A,113-597-073-996-008,1999-03-04,1999,YU 15496 A,1996-03-15,US 40479895 A,1995-03-15,PROCESS TO MAKE HIV PROTEASE INHIBITOR FROM (2S)-4-PICOLYL-2-PIPERAZINE-T-BUTHYLCARBOXYAMIDE,Postupak za dobijanje klinički efikasnog inhibitora HIV proteaze eliminiše jedan stupanj u njegovoj sintezi. alternativnom konvergentnom sintezom upotrebljavajući 2(S)-4-pikolil-2-piperazin-t-butilkarboksiamid kao intermedijar.,MERCK & CO INC,DAVID ASKIN;;ENG KAN K;;PAUL REIDER;;VOLANTE RALPH P,,https://lens.org/113-597-073-996-008,Patent Application,no,0,0,22,22,0,C07D401/06;;Y02P20/55;;A61P31/18;;C07D401/06;;Y02P20/55,C07D401/06,,0,0,,,,PENDING
161,TW,B,TW 332205 B,162-396-970-155-627,1998-05-21,1998,TW 85102721 A,1996-03-06,US 40479895 A,1995-03-15,"A process for making a clinically efficacious HIV protease inhibitor eliminates one step in its synthesis, by an alternative convergent synthesis using 2(S)-4-picolyl-2-piperazine-t-butyl-carboxamide as an intermediate.","A process for synthesis of a compound of the structure (formula) comprising the steps of: (a) heating for at least one hour a mixture of one equivalent of (formula) with about one equivalent of (formula) at a temperature range between 25 degree C and 150 degree C, the mixture optionally containing suitable solvent; (b) deblocking by treatment with strong acid, and (c) neutralizing the strong acid, to give the desired compound.",MERCK & CO INC,DAVID ASKIN;;KAN K ENG;;PAUL REIDER;;RALPH P VOLANTE,,https://lens.org/162-396-970-155-627,Granted Patent,no,0,0,22,22,0,C07D401/06;;Y02P20/55;;A61P31/18;;C07D401/06;;Y02P20/55,,,0,0,,,,EXPIRED
162,AU,A1,AU 2003/215244 A1,171-347-840-989-522,2003-09-04,2003,AU 2003/215244 A,2003-02-14,US 35691102 P;;US 0304594 W,2002-02-14,COMPLEXES AND METHODS OF USING SAME,,HOFFMANN LA ROCHE;;CURAGEN CORP,JACKSON AMANDA;;OOI CHEAN ENG;;LEWIN DAVID A;;CUTHILL SCOTT,,https://lens.org/171-347-840-989-522,Patent Application,no,0,0,5,5,0,A61K38/00;;C07K14/005;;C07K2319/00;;C12N2710/20022;;G01N33/532;;G01N33/56983;;G01N33/57442;;G01N2333/025;;G01N2500/00;;G01N2500/02;;C07K14/005;;G01N2500/00;;A61K38/00;;G01N2333/025;;G01N33/532;;G01N2500/02;;C07K2319/00;;G01N33/57442;;G01N33/56983;;C12N2710/20022,A61K38/00;;A61K39/00;;C07H21/04;;C07K14/025;;C07K14/47;;C07K16/18;;C12P21/04;;G01N33/532;;G01N33/569;;G01N33/574,,0,0,,,,DISCONTINUED
163,EP,A1,EP 4121799 A1,172-672-929-113-143,2023-01-25,2023,EP 21770904 A,2021-03-19,US 202062991644 P;;US 2021/0023306 W,2020-03-19,LOCALIZED RADIATION SENSING AND REPORTING SURFACES,,UNIV DUKE;;SINGAPORE HEALTH SERV PTE LTD,NG CHEE ENG DAVID;;TORNAI MARTIN;;WONG TERENCE;;TURKINGTON TIMOTHY,,https://lens.org/172-672-929-113-143,Patent Application,yes,0,0,3,3,0,G01T1/17;;G01T7/12;;G01T1/172;;G01T3/06;;G01T7/12,G01T1/20,,0,0,,,,PENDING
164,EA,B1,EA 000178 B1,194-671-595-339-348,1998-12-24,1998,EA 199700235 A,1996-03-11,US 40479895 A;;US 9602556 W,1995-03-15,PROCESS TO MAKE HIV PROTEASE INHIBITOR FROM (2-S)-4 PICOLYL-2PIPERAZINE-t-BUTYLCARBOXAMIDE,"1. A process for making HIV protease inhibitor of the structure comprising the steps of: (a) heating for at least one hour a mixture of one equivalent of (S)-4-(3-picolyl)-2-tert-butylcarboxamide piperazine (1) with about one equivalent of at a temperature range between about 25 degree C and about 150 degree C, said mixture optionally containing suitable solvent; (b) deblocking the compound 3 by treatment with acid (c) neutralizing the acid. 2. The process of Claim 1, wherein the temperature range is between about 50 degree C and about 120 degree C. 3. The process of Claim 1, wherein the temperature range is between about 65 degree C and about 85 degree C. 4. The process of Claim 1, wherein the suitable solvent is either an ester, an alcohol, a hydrocarbon, an ether or a formamide, or mixture thereof. 5. The process of Claim 1, wherein the suitable solvent is an alcohol. 6. The process of Claim 1, wherein the suitable solvent is methanol or isopropanol. 7. The process of Claim 1, wherein the deblocking of step (b) is carried out with gaseous HC1. 8. The process of Claim 1 for synthesis of a compound of the structure comprising the steps of: (a) heating for at least one hour a mixture of one equivalent of (S)-4-(3-picolyl)-2-tert-butylcarboxamide piperazine (1) with about one equivalent of at a temperature range between about 65 degree C and about 85 degree C, said mixture optionally containing as solvent methanol or isopropanol or mixture thereof; (b) cooling the mixture to about 0 degree C; (c) deblocking the compound 3 with gaseous HC1 (d) neutralizing with NaOH. 9. The compound (S)-4-(3-picolyl)-2-tert-butylcarboxamide piperazine (1)",MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;REIDER PAUL;;VOLANTE RALPH P,,https://lens.org/194-671-595-339-348,Granted Patent,no,3,0,22,22,0,C07D401/06;;Y02P20/55;;A61P31/18;;C07D401/06;;Y02P20/55,C07D401/06,,0,0,,,,EXPIRED
165,CZ,A3,CZ 286097 A3,143-091-833-300-780,1998-02-18,1998,CZ 286097 A,1996-03-11,US 40479895 A,1995-03-15,PROCESS FOR PREPARING HIV PROTEASE INHIBITOR,,MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;REIDER PAUL;;VOLANTE RALPH P,,https://lens.org/143-091-833-300-780,Patent Application,no,0,0,22,22,0,C07D401/06;;Y02P20/55;;A61P31/18;;C07D401/06;;Y02P20/55,C07D401/06,,0,0,,,,EXPIRED
166,SK,B6,SK 282021 B6,198-907-123-218-058,2001-10-08,2001,SK 122597 A,1996-03-11,US 40479895 A;;US 9602556 W,1995-03-15,PROCESS TO MAKE HIV PROTEASE INHIBITOR AND INTERMEDIATE FOR ITS PRODUCTION,"Je opísaný spôsob výroby inhibítora HIV proteázy, zlúčeniny J, ktorý spočíva v tom, že sa aspoň hodinu zahrieva zmes jedného ekvivalentu (S)-4-(3-pikolyl)-2-terc.butykarboxamidpiperazínu vzorca (1) s približne jedným ekvivalentom zlúčeniny vzorca (2) pri teplote v rozmedzí 25 až 150 °C, pričom zmes prípadne obsahuje rozpúšťadlo, zo získanej zlúčeniny vzorca (3) sa odštiepi ochranná skupina pôsobením kyseliny a zmes sa neutralizuje, čím vzniká požadovaný produkt.ŕ",MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;REIDER PAUL;;VOLANTE RALPH P,,https://lens.org/198-907-123-218-058,Granted Patent,no,0,0,22,22,0,C07D401/06;;Y02P20/55;;A61P31/18;;C07D401/06;;Y02P20/55,C07D401/06,,0,0,,,,EXPIRED
167,US,B2,US 7515697 B2,071-917-586-372-020,2009-04-07,2009,US 81636504 A,2004-04-01,US 81636504 A;;US 99683701 A;;US 69276900 A;;US 12941398 A;;US 92744397 A;;US 92056797 A;;US 55119000 A;;US 21370398 A,1997-08-29,Method and a system for settlement of trading accounts,"A method of settling accounts of buyers and sellers of telecommunication services by an online exchange system includes storing data representing a financial account of at least one seller and at least one buyer, wherein the financial account includes at least one of accounts receivable and cash receipts. A service node receives an offer to sell the services from the at least one seller and requests to buy the services from the at least one buyer. The service node then matches the offers and requests in accordance with one or more parameters specified in the offers and requests. A route table is generated based on the routes specified in the matched offers and requests and a switch node is configured based on the route table. Fees are computed based on the usage of the matched routes and the financial accounts of the at least one seller and at least one buyer based on the computed fees.",ARBINET THEXCHANGE INC,ENG CHI;;LEMBERG MICHAEL;;MASHINSKY ALEXANDER;;BODNAR GUILLERMO;;SUMKA DAVID,ARBINET-THEXCHANGE INC (2004-05-13);;AIP ACQUISITION LLC (2011-02-11),https://lens.org/071-917-586-372-020,Granted Patent,yes,10,111,2,42,0,G06Q30/04;;G06Q30/04;;G06Q40/04;;G06Q40/04;;G06Q40/12;;G06Q40/12,H04M15/00,379/115.01;;379/114.01;;705/26;;705/34;;705/37,0,0,,,,EXPIRED
168,WO,A2,WO 2003/068940 A2,190-444-638-630-499,2003-08-21,2003,US 0304594 W,2003-02-14,US 35691102 P,2002-02-14,COMPLEXES AND METHODS OF USING SAME,"The invention provides complexes of at least two polypeptides, and methods of using the same. Purified complexes of two polypeptides are provided, including chimeric complexes, and chimeric polypeptides and complexes thereof are also provided, as are nucleic acids encoding chimeric polypeptides and vectors and cells containing the same. Also provided are methods of identifying agents that disrupt polypeptide complexes, methods of identifying complex or polypeptide in a sample, and for removing the same, methods of determining altered expression of a polypeptide in a subject, and methods of treating/preventing disorders involving altered levels of complex or polypeptide.",CURAGEN CORP;;HOFFMANN LA ROCHE;;JACKSON AMANDA;;OOI CHEAN ENG;;LEWIN DAVID A;;CUTHILL SCOTT,JACKSON AMANDA;;OOI CHEAN ENG;;LEWIN DAVID A;;CUTHILL SCOTT,,https://lens.org/190-444-638-630-499,Patent Application,yes,0,0,5,5,0,A61K38/00;;C07K14/005;;C07K2319/00;;C12N2710/20022;;G01N33/532;;G01N33/56983;;G01N33/57442;;G01N2333/025;;G01N2500/00;;G01N2500/02;;C07K14/005;;G01N2500/00;;A61K38/00;;G01N2333/025;;G01N33/532;;G01N2500/02;;C07K2319/00;;G01N33/57442;;G01N33/56983;;C12N2710/20022,A61K38/00;;A61K39/00;;C07H21/04;;C07K14/025;;C07K14/47;;C07K16/18;;C12P21/04;;G01N33/532;;G01N33/569;;G01N33/574,,0,0,,,,PENDING
169,US,A1,US 2004/0243503 A1,014-204-560-692-74X,2004-12-02,2004,US 81636504 A,2004-04-01,US 81636504 A;;US 99683701 A;;US 69276900 A;;US 12941398 A;;US 92744397 A;;US 92056797 A;;US 55119000 A;;US 21370398 A,1997-08-29,Method and a system for settlement of trading accounts,"
   A method of settling accounts of buyers and sellers of telecommunication services by an online exchange system includes storing data representing a financial account of at least one seller and at least one buyer, wherein the financial account includes at least one of accounts receivable and cash receipts. A service node receives an offer to sell the services from the at least one seller and requests to buy the services from the at least one buyer. The service node then matches the offers and requests in accordance with one or more parameters specified in the offers and requests. A route table is generated based on the routes specified in the matched offers and requests and a switch node is configured based on the route table. Fees are computed based on the usage of the matched routes and the financial accounts of the at least one seller and at least one buyer based on the computed fees. 
",ARBINET THEXCHANGE INC,ENG CHI;;LEMBERG MICHAEL;;MASHINSKY ALEXANDER;;BODNAR GUILLERMO;;SUMKA DAVID,ARBINET-THEXCHANGE INC (2004-05-13);;AIP ACQUISITION LLC (2011-02-11),https://lens.org/014-204-560-692-74X,Patent Application,yes,9,78,2,42,0,G06Q30/04;;G06Q30/04;;G06Q40/04;;G06Q40/04;;G06Q40/12;;G06Q40/12,H04M15/00,705/37;;X705 3,0,0,,,,EXPIRED
170,BR,A,BR 9607376 A,001-693-272-322-03X,1997-12-30,1997,BR 9607376 A,1996-03-11,US 40479895 A;;US 9602556 W,1995-03-15,Processos para sintetizar um composto e o respectivo composto,,MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;REIDER PAUL;;VOLANTE RALPH P,,https://lens.org/001-693-272-322-03X,Patent Application,no,0,0,22,22,0,C07D401/06;;Y02P20/55;;A61P31/18;;C07D401/06;;Y02P20/55,C07D401/06,,0,0,,,,DISCONTINUED
171,AU,A1,AU 2003/223236 A1,067-748-765-354-670,2003-11-17,2003,AU 2003/223236 A,2003-02-21,US 13802002 A;;US 0307288 W,2002-05-02,SUBSEA SEPARATOR SYSTEM,,UNION OIL CO,LUSH DAVID;;ENG JONATHAN;;UCOK HIKMET;;HOPGOOD DAVE;;LANDECK CHRIS,,https://lens.org/067-748-765-354-670,Patent Application,no,0,0,6,6,0,E21B43/01;;E21B43/36;;E21B43/36;;E21B43/01,E21B43/01;;E21B43/36,,0,0,,,,DISCONTINUED
172,US,A1,US 2023/0204801 A1,168-025-169-242-405,2023-06-29,2023,US 202117912457 A,2021-03-19,US 202117912457 A;;US 202062991644 P;;US 2021/0023306 W,2020-03-19,LOCALIZED RADIATION SENSING AND REPORTING SURFACES,"The present disclosure describes a radiation sensing and reporting devices, systems, and methods. The devices and systems are a flexible material that detects the presence of radiation over a surface area and reports the specific location and intensity of the radiation. An article is provided that includes a substrate; a plurality of radiation sensors, each radiation sensor of the plurality of radiation sensors being disposed at a corresponding position on the substrate; and alert circuitry coupled to the plurality of radiation sensors, wherein the alert circuitry indicates, in real time, a localized detection of radiation according to corresponding one or more positions on the substrate of a particular one or more radiation sensors of the plurality of radiation sensors.",UNIV DUKE;;SINGAPORE HEALTH SERV PTE LTD,NG CHEE ENG DAVID;;TORNAI MARTIN;;WONG TERENCE;;TURKINGTON TIMOTHY,DUKE UNIVERSITY (2021-05-11);;SINGAPORE GENERAL HOSPITAL (2021-04-08);;SINGAPORE HEALTH SERVICES PTE LTD (2021-04-29),https://lens.org/168-025-169-242-405,Patent Application,yes,0,0,3,3,0,G01T1/17;;G01T7/12;;G01T1/172;;G01T3/06;;G01T7/12,G01T1/172;;G01T3/06;;G01T7/12,,0,0,,,,PENDING
173,US,A1,US 2002/0022176 A1,134-557-150-882-174,2002-02-21,2002,US 83894501 A,2001-04-20,SG 200004432 A,2000-08-11,Battery retainer,"
   The invention provides a battery retainer for retaining a battery comprising a positive electrode and a negative electrode, the battery retainer comprising a positive terminal for contacting the positive electrode of the battery, a negative terminal for contacting the negative electrode of the battery, a receiving chamber designed to be adapted to receive a battery and being open at the top, a pivotable retaining arm located at the top of the receiving chamber and designed and arranged to hold a battery received in the receiving chamber therein, and a spring element located at the bottom of the receiving chamber and designed and arranged to at least partly eject the battery received in the receiving chamber therefrom upon a pivotal movement of the pivotable retaining arm off the battery. 
",AW CHEE SENG;;LEITAO CHRISTOPER;;LIM ENG SENG;;TAN DAVID,AW CHEE SENG;;LEITAO CHRISTOPER;;LIM ENG SENG;;TAN DAVID,HEWLETT-PACKARD COMPANY (2001-04-05);;HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (2003-09-26),https://lens.org/134-557-150-882-174,Patent Application,yes,0,6,2,2,0,Y02E60/10;;H01M50/213;;H01M50/264;;H01M50/216;;H01M50/213;;H01M50/216;;H01M50/264,H01M50/213;;H01M50/216;;H01M50/264,4291;;429/97;;429/123,0,0,,,,EXPIRED
174,US,B2,US 6645665 B2,020-023-071-732-426,2003-11-11,2003,US 83894501 A,2001-04-20,SG 200004432 A,2000-08-11,Battery retainer,"
    The invention provides a battery retainer for retaining a battery comprising a positive electrode and a negative electrode, the battery retainer comprising a positive terminal for contacting the positive electrode of the battery, a negative terminal for contacting the negative electrode of the battery, a receiving chamber designed to be adapted to receive a battery and being open at the top, a pivotable retaining arm located at the top of the receiving chamber and designed and arranged to hold a battery received in the receiving chamber therein, and a spring element located at the bottom of the receiving chamber and designed and arranged to at least partly eject the battery received in the receiving chamber therefrom upon a pivotal movement of the pivotable retaining arm off the battery. 
",HEWLETT PACKARD DEVELOPMENT CO,AW CHEE SENG;;LEITAO CHRISTOPER;;LIM ENG SENG;;TAN DAVID,HEWLETT-PACKARD COMPANY (2001-04-05);;HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (2003-09-26),https://lens.org/020-023-071-732-426,Granted Patent,yes,5,4,2,2,0,Y02E60/10;;H01M50/213;;H01M50/264;;H01M50/216;;H01M50/213;;H01M50/216;;H01M50/264,H01M50/213;;H01M50/216;;H01M50/264,429/100;;429/97;;429/123,0,0,,,,EXPIRED
175,US,A,US 5618937 A,046-104-185-780-213,1997-04-08,1997,US 40479895 A,1995-03-15,US 40479895 A,1995-03-15,Process to make HIV protease inhibitor from (2S)-4-picolyl-2-piperazine-t-butylcarboxamide,"A process for making a clinically efficacious HIV protease inhibitor eliminates one step in its synthesis, by an alternative convergent synthesis using 2(S)-4-picolyl-2-piperazine-t-butylcarboxamide as an intermediate.",MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;REIDER PAUL;;VOLANTE RALPH P,MERCK & CO. INC (1995-03-31),https://lens.org/046-104-185-780-213,Granted Patent,yes,8,5,22,22,0,C07D401/06;;Y02P20/55;;A61P31/18;;C07D401/06;;Y02P20/55,C07D401/06,544/360,5,3,091-845-015-290-107;;101-390-976-999-679;;087-657-262-897-755,10.1016/s0040-4020(01)85962-7;;10.1002/jlcr.2580220803;;10.1246/bcsj.42.3141,"Schlecker et al., The Synthesis of Antihypertensive 3 (1,3,4 oxadiazol 2 yl) Phenoxypropanolamines, Tetrahadron, vol. 44(11), pp. 3289 3294.;;Miyake et al., Synthesis of 14C labelled 2 2 cycolhexylcarbonyloxy 3 4 (2 pyridyl)piperazin 1 yl propyl 3a ,4 ,7 ,7a tetrahydro 4, 7 methano isoindole 1,3(2H) dione dihydrochloride(E 0713), Journal of Labelled Compounds and Radiopharmaceuticals.;;Plenkiewicz et al., Synthetic Utility of 3 (Perfluoro 1,1 dimethylbutyl) 1 propene., Journal of Fluorine Chemistry, vol. 45, pp. 389 400.;;Sundaram, et al., Kinetics of Reactions of Amines with Alkene Oxides , Bull. Chem. Soc. Japan, vol. 42, No. 11, pp. 3141 3147, 1969.;;Trost, Ring Opening of Small Ring Heterocycles by Nucleophiles , Comprehensive Organic Synthesis, vol. VI, pp. 88 89, 1991.",EXPIRED
176,EP,B1,EP 0815101 B1,100-482-557-399-726,1999-07-07,1999,EP 96908523 A,1996-03-11,US 9602556 W;;US 40479895 A,1995-03-15,PROCESS TO MAKE HIV PROTEASE INHIBITOR FROM 2(S)-4-PICOLYL-2-PIPERAZINE-t-BUTYLCARBOXAMIDE,,MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;REIDER PAUL;;VOLANTE RALPH P,,https://lens.org/100-482-557-399-726,Granted Patent,yes,3,0,22,22,0,C07D401/06;;Y02P20/55;;A61P31/18;;C07D401/06;;Y02P20/55,C07D401/06,,0,0,,,,EXPIRED
177,US,A1,US 2004/0055306 A1,149-918-045-338-551,2004-03-25,2004,US 25220802 A,2002-09-23,US 25220802 A,2002-09-23,Premixed pilot burner for a combustion turbine engine,"
    A combustor ( 40 ) for a gas turbine engine is provided with a premix pilot fuel stage ( 42 ) in order to reduce the emission of oxides of nitrogen from the engine. An in-service engine may be modified to add the premix pilot fuel stage by delivering premix pilot fuel to a ring manifold ( 42 ) for tip-feeding a premix pilot fuel outlet member such as a swirler vane ( 78 ) or fuel peg ( 124 ). In this manner, complex and expensive components such as the top hat ( 46 ), support housing ( 48 ) and diffusion pilot burner assembly ( 44 ) may be used without modification. Thermal stresses caused by the differential cooling of the ring manifold by the premix pilot fuel ( 96 ) are reduced by a heat shield ( 94 ) installed within the manifold. 
",SIEMENS WESTINGHOUSE POWER,NORTH DAVID D;;HARRIS ARTHUR J;;REID HANK;;ENG JESSE,SIEMENS ENERGY INC (2002-09-17),https://lens.org/149-918-045-338-551,Patent Application,yes,7,29,4,4,0,F02C7/222;;F02C7/222;;F23R3/343;;F23R3/343,F23R3/34,60/737;;60/746,0,0,,,,EXPIRED
178,SK,A3,SK 122597 A3,077-708-175-010-807,1998-02-04,1998,SK 122597 A,1996-03-11,US 40479895 A;;US 9602556 W,1995-03-15,PROCESS TO MAKE HIV PROTEASE INHIBITOR,"Disclosed is a method for production of HIV protease inhibitor, compound J, consisting in that at least for an hour the mixture of one equivalent 2(S)-4-picolyl-2-piperazine-t- butylcarboxamide of formula (1) is heated with approximately one equivalent of compound of formula (2) under the temperature between 25 to 150 C, whilst the mixture, eventually diluent, from the obtained compound of formula (3) the protective group is removed by the effect of acid and mixture is neutralised therethrough the required product is developed.",MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;REIDER PAUL;;VOLANTE RALPH P,,https://lens.org/077-708-175-010-807,Patent Application,no,0,0,22,22,0,C07D401/06;;Y02P20/55;;A61P31/18;;C07D401/06;;Y02P20/55,C07D401/06,,0,0,,,,EXPIRED
179,HR,B1,HR P960114 B1,037-438-437-347-410,2000-02-29,2000,HR P960114 A,1996-03-11,US 40479895 A,1995-03-15,PROCESS TO MAKE HIV PROTEASE INHIBITOR FROM 2(S)-4-PICOLYL-2-PIPERAZINE-T-BUTYLCARBOXAMIDE,,MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;REIDER PAUL;;VOLANTE RALPH P,,https://lens.org/037-438-437-347-410,Granted Patent,no,0,0,22,22,0,C07D401/06;;Y02P20/55;;A61P31/18;;C07D401/06;;Y02P20/55,C07D401/06,,0,0,,,,EXPIRED
180,CZ,B6,CZ 292549 B6,145-681-879-675-839,2003-10-15,2003,CZ 286097 A,1996-03-11,US 40479895 A,1995-03-15,Process for preparing HIV protease inhibitor,"The invented process for preparing HIV protease inhibitor i.e. the compound J is characterized by the following steps: heating for at least one hour a mixture of one equivalent of (S)-4-(3-picolyl)-2-tert-butyl carboxamide piperazine of the general formula 1 with about one equivalent of the compound of the general formula 2 at a temperature range between about 25 to about 150 degC, whereby said mixture optionally containing suitable solvent; deblocking by treatment with strong acid the protecting group from the obtained compound of the general formula 3 and; neutralizing the mixture, to give the desired product.",MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;REIDER PAUL;;VOLANTE RALPH P,,https://lens.org/145-681-879-675-839,Granted Patent,no,0,0,22,22,0,C07D401/06;;Y02P20/55;;A61P31/18;;C07D401/06;;Y02P20/55,C07D401/06,,0,0,,,,EXPIRED
181,US,A1,US 2019/0075035 A1,000-767-976-718-684,2019-03-07,2019,US 201815937259 A,2018-03-27,US 201815937259 A;;US 201514961089 A;;US 201314089424 A,2013-11-25,Device Performance Monitoring,"A computing device performance monitor may be configured to collect performance metric information regarding one or more monitored computing devices, and may assign condition point values to each metric. The performance monitor may generate a total of the condition point values, and use the total to determine an appropriate response.",COMCAST CABLE COMM LLC,LEACH DAVID B;;RUSSELL JAMES;;PAROL TIMOTHY;;ENG DAVID;;ANDERSON MARK;;BURKS DANTE,COMCAST CABLE COMMUNICATIONS LLC (2013-10-15),https://lens.org/000-767-976-718-684,Patent Application,yes,4,0,5,5,0,H04L1/20;;G06F11/3409;;H04L43/08;;H04L43/0817;;H04L43/16;;G06F11/3452;;H04L1/20;;G06F11/3409;;H04L43/08;;H04L43/0817;;H04L43/16;;H04L43/0876,H04L12/26,,0,0,,,,DISCONTINUED
182,AU,A8,AU 2003/215244 A8,147-839-969-793-118,2003-09-04,2003,AU 2003/215244 A,2003-02-14,US 35691102 P;;US 0304594 W,2002-02-14,Complexes and methods of using same,,CURAGEN CORP;;HOFFMANN LA ROCHE,LEWIN DAVID A;;JACKSON AMANDA;;OOI CHEAN ENG;;CUTHILL SCOTT,,https://lens.org/147-839-969-793-118,Patent Application,no,0,0,5,5,0,A61K38/00;;C07K14/005;;C07K2319/00;;C12N2710/20022;;G01N33/532;;G01N33/56983;;G01N33/57442;;G01N2333/025;;G01N2500/00;;G01N2500/02;;C07K14/005;;G01N2500/00;;A61K38/00;;G01N2333/025;;G01N33/532;;G01N2500/02;;C07K2319/00;;G01N33/57442;;G01N33/56983;;C12N2710/20022,A61K38/00;;A61K39/00;;C07H21/04;;C07K14/025;;C07K14/47;;C07K16/18;;C12P21/04;;G01N33/532;;G01N33/569;;G01N33/574,,0,0,,,,DISCONTINUED
183,US,B1,US 11480737 B1,016-353-322-597-781,2022-10-25,2022,US 202117410948 A,2021-08-24,US 202117410948 A,2021-08-24,Tunable wavelength-selective fiber optic switch employing moveable grating interaction with the evanescent field of a partially-cladding-removed fiber,"In the wavelength selective fiber optic switch, an optical fiber with a portion of cladding removed defines a window facilitating access to the radially evanescent field present when optical power is propagating through the optical fiber, defining a first transmission path. The cladding removed optical fiber, a secondary optical waveguide, and a grating structure form a grating assisted coupler. An adjustable positioning fixture changes the relative spacing of the fiber core, grating, and output waveguide between a decoupled position and a coupled position. The switch operates, in the decoupled position, to allow optical power to propagate unperturbed through the first transmission path, including optical power at said optical wavelength, and in the coupled position, to extract and reroute optical power at the optical wavelength to propagate through the second transmission path, while leaving unperturbed other wavelengths propagating through the first transmission path. A tuning mechanism is implemented that alters the periodic properties of the grating to tune to a desired optical wavelength.",GENERAL DYNAMICS MISSION SYSTEMS INC,SYLVESTER GARRETT SMITH;;ENG DAVID L K;;SWAN M CRAIG,GENERAL DYNAMICS MISSION SYSTEMS INC (2021-08-05),https://lens.org/016-353-322-597-781,Granted Patent,yes,5,0,1,1,0,G02B6/3508;;G02B6/3536;;G02B6/29334;;G02B6/29395;;G02B6/3534;;G02B6/359;;G02B6/3536,G02B6/35,,0,0,,,,ACTIVE
184,AU,A,AU 1996/051738 A,045-379-390-265-516,1996-10-02,1996,AU 1996/051738 A,1996-03-11,US 40479895 A;;US 9602556 W,1995-03-15,Process to make hiv protease inhibitor from 2(s)-4-picolyl-2-piperazine-t-butylcarboxamide,,MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;REIDER PAUL;;VOLANTE RALPH P,,https://lens.org/045-379-390-265-516,Patent Application,no,0,0,22,22,0,C07D401/06;;Y02P20/55;;A61P31/18;;C07D401/06;;Y02P20/55,C07D401/06,,0,0,,,,PENDING
185,US,B1,US 7573925 B1,113-330-755-365-358,2009-08-11,2009,US 74901307 A,2007-05-15,US 74901307 A;;US 74729406 P,2006-05-15,Semiconductor laser having a doped active layer,"Semiconductor lasers having a doped active region. In one example embodiment, a laser includes a substrate and a doped active region positioned above the substrate. The doped active region includes a plurality of quantum wells separated by a plurality of barrier layers. The quantum wells and the barrier layers are doped with a doping material with a concentration between about 1*10^16/cm3 to about 1*10^17/cm3.",FINISAR CORP,YOUNG DAVID BRUCE;;HA YUK LUNG;;VERMA ASHISH;;ENG LARS,FINISAR CORPORATION (2007-07-16);;II-VI DELAWARE INC (2019-09-24),https://lens.org/113-330-755-365-358,Granted Patent,yes,20,3,1,1,0,B82Y20/00;;H01S5/06216;;H01S5/06226;;H01S5/12;;H01S5/2004;;H01S5/3054;;H01S5/3086;;H01S5/3406;;H01S2301/173;;H01S2302/00;;H01S5/12;;H01S5/3086;;B82Y20/00;;H01S5/06226;;H01S2302/00;;H01S5/2004;;H01S5/3054;;H01S2301/173;;H01S5/3406;;H01S5/06216,H01S5/00;;H01S5/12,372/43.01;;372/45.01;;372/46.01,13,1,076-989-478-838-81X,10.1109/iscs.1998.711543,"Sudo, Tsurugi, et al., Semiconductor Laser Having Low Stress Passivation Layer, U.S. Appl. No. 11/749,047, filed May 15, 2007.;;Ha, Yuk Lung, et al., Epitaxial Regrowth in a Distributed Feedback Laser, U.S. Appl. No. 11/749,007, filed May 15, 2007.;;Verma, Ashish K., et al., Thin INP Spacer Layer in High Speed Laser for Reduced Lateral Current Spreading, U.S. Appl. No. 11/749,003, filed May 15, 2007.;;Dimitrov, Roman, et al., Method for Applying Protective Laser Facet Coatings, U.S. Appl. No. 11/749,052, filed May 15, 2007.;;Dimitrov, Roman, et al., High Resistivity Engineered Laser Facet Coatings, U.S. Appl. No. 11/749,057, filed May 15, 2007.;;Dimitrov, Roman et al., Laser Facet Pre-Coating Etch for Controlling Leakage Current, U.S. Appl. No. 11/749,061, filed May 15, 2007.;;Sexl, M., Bohm G., Maier, M., Tranke, G., Weimann, G., & Abstreiter, G. (1997), MBE Growth of Metamorphic In(Ga)A/As Buffers. 1997 IEEE International Symposium on Compound Semiconductors, IEEE, 49-52.;;U.S. Appl. No. 11/749,007, mailed Dec. 9, 2008, Office Action.;;U.S. Appl. No. 11/749,047, mailed Aug. 12, 2008, Office Action.;;U.S. Appl. No. 11/749,047, mailed Feb. 6, 2009, Notice of Allowance.;;U.S. Appl. No. 11/749,033, mailed Jun. 2, 2008, Office Action.;;U.S. Appl. No. 11/749,033, mailed Jan. 13, 2009, Notice of Allowance.;;U.S. Appl. No. 11/749,057, mailed Dec. 11, 2008, Office Action.",ACTIVE
186,WO,A1,WO 1996/028439 A1,141-669-968-273-340,1996-09-19,1996,US 9602556 W,1996-03-11,US 40479895 A,1995-03-15,PROCESS TO MAKE HIV PROTEASE INHIBITOR FROM 2(S)-4-PICOLYL-2-PIPERAZINE-t-BUTYLCARBOXAMIDE,"A process for making a clinically efficacious HIV protease inhibitor eliminates one step in its synthesis, by an alternative convergent synthesis using 2(S)-4-picolyl-2-piperazine-t-butylcarboxamide as an intermediate; as indicated above.",MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;REIDER PAUL;;VOLANTE RALPH P,,https://lens.org/141-669-968-273-340,Patent Application,yes,3,1,22,22,0,C07D401/06;;Y02P20/55;;A61P31/18;;C07D401/06;;Y02P20/55,C07D401/06,,0,0,,,,PATENTED
187,EP,A1,EP 0815101 A1,186-297-433-056-647,1998-01-07,1998,EP 96908523 A,1996-03-11,US 9602556 W;;US 40479895 A,1995-03-15,PROCESS TO MAKE HIV PROTEASE INHIBITOR FROM 2(S)-4-PICOLYL-2-PIPERAZINE-t-BUTYLCARBOXAMIDE,,MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;REIDER PAUL;;VOLANTE RALPH P,,https://lens.org/186-297-433-056-647,Patent Application,yes,0,0,22,22,0,C07D401/06;;Y02P20/55;;A61P31/18;;C07D401/06;;Y02P20/55,C07D401/06,,0,0,,,,EXPIRED
188,HR,A2,HR P960114 A2,191-302-854-738-579,1997-10-31,1997,HR P960114 A,1996-03-11,US 40479895 A,1995-03-15,PROCESS TO MAKE HIV PROTEASE INHIBITOR FROM 2(S)-4-PICOLYL-2-PIPERAZINE-T-BUTYLCARBOXAMIDE,,MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;REIDER PAUL;;VOLANTE RALPH P,,https://lens.org/191-302-854-738-579,Patent Application,no,0,0,22,22,0,C07D401/06;;Y02P20/55;;A61P31/18;;C07D401/06;;Y02P20/55,C07D401/06,,0,0,,,,EXPIRED
189,AT,T1,AT E25815 T1,153-818-382-590-703,1987-03-15,1987,AT 83306705 T,1983-11-03,EP 83306705 A;;GB 8231404 A,1982-11-03,DIAPHANOGRAPHIEGERAET MIT FERNSEHKETTE.,,UNIV ABERDEEN,WATMOUGH DAVID JOHN DEPARTMENT;;AND BIO-ENG UNIVERSITY OF ABER,,https://lens.org/153-818-382-590-703,Granted Patent,no,0,0,5,5,0,A61B5/0091;;A61B5/4312;;A61B5/0091;;A61B5/4312,A61B5/00,,0,0,,,,DISCONTINUED
190,US,B1,US 6931029 B1,139-688-900-790-909,2005-08-16,2005,US 50107400 A,2000-02-09,US 50107400 A,2000-02-09,System and method for synchronizing with data received over an unreliable asynchronous medium,"A system for re-establishing synchrony with data that was synchronous data in a source device but for which synchrony is lost when the data is transmitted over an asynchronous and unreliable medium to a destination device. The system includes buffering of the data received in the destination device from the asynchronous network, readout of the buffers according to a clock, and adjusting the rate of the clock in the destination device according to the rate of transmitting the data from the source device. The clock rate is thus adjusted to re-establish synchrony, and the clock may be used to control synchronous handling of the received data within the destination device.",NORTEL NETWORKS LTD,POTHIER MICHAEL;;LYNCH JOHN;;CAIRNS DAVID;;ENG GLENN;;CYR ANDRE,ROCKSTAR CONSORTIUM US LP (2012-05-09);;RPX CLEARINGHOUSE LLC (2015-01-28);;NORTEL NETWORKS LIMITED (2000-08-30);;ROCKSTAR BIDCO LP (2011-07-29),https://lens.org/139-688-900-790-909,Granted Patent,yes,12,5,1,1,0,H04Q3/62;;H04Q3/62;;H04J3/0632;;H04J3/0632;;H04Q2213/13214;;H04Q2213/13214;;H04Q2213/1322;;H04Q2213/1322;;H04Q2213/1329;;H04Q2213/1329;;H04Q2213/13296;;H04Q2213/13296;;H04Q2213/1336;;H04Q2213/1336,H04J3/06;;H04Q3/62,370/503;;375/354,0,0,,,,EXPIRED
191,WO,A1,WO 2003/093642 A1,166-697-117-664-445,2003-11-13,2003,US 0307288 W,2003-02-21,US 13802002 A,2002-05-02,SUBSEA SEPARATOR SYSTEM,"A preferred embodiment of the inventive fluid delivery system comprises a vertical liquid/vapor separator (6) and riser assembly (8) that comprises a multi-phase separator inlet (12), a vapor outlet (15) and riser, and a liquid outlet port (11) connected to a hydraulically-driven centrifugal pump (9). By controlling the operational speed of the pump, the level of the separated liquid within the separator can be controlled without the need for control valves. The vertical separator is capable of low pressure operation and large variations in controlled liquid levels within the separator, allowing the relatively slow reaction time pump to control the liquid level from low pressure wells penetrating low pressure reservoirs.",UNION OIL CO,LUSH DAVID;;ENG JONATHAN;;UCOK HIKMET;;HOPGOOD DAVE;;LANDECK CHRIS,,https://lens.org/166-697-117-664-445,Patent Application,yes,6,0,6,6,0,E21B43/01;;E21B43/36;;E21B43/36;;E21B43/01,E21B43/01;;E21B43/36,,0,0,,,,PENDING
192,WO,A3,WO 2003/068940 A3,174-024-716-077-502,2003-11-27,2003,US 0304594 W,2003-02-14,US 35691102 P,2002-02-14,COMPLEXES AND METHODS OF USING SAME,"The invention provides complexes of at least two polypeptides, and methods of using the same. Purified complexes of two polypeptides are provided, including chimeric complexes, and chimeric polypeptides and complexes thereof are also provided, as are nucleic acids encoding chimeric polypeptides and vectors and cells containing the same. Also provided are methods of identifying agents that disrupt polypeptide complexes, methods of identifying complex or polypeptide in a sample, and for removing the same, methods of determining altered expression of a polypeptide in a subject, and methods of treating/preventing disorders involving altered levels of complex or polypeptide.",CURAGEN CORP;;HOFFMANN LA ROCHE;;JACKSON AMANDA;;OOI CHEAN ENG;;LEWIN DAVID A;;CUTHILL SCOTT,JACKSON AMANDA;;OOI CHEAN ENG;;LEWIN DAVID A;;CUTHILL SCOTT,,https://lens.org/174-024-716-077-502,Search Report,yes,3,0,5,5,0,A61K38/00;;C07K14/005;;C07K2319/00;;C12N2710/20022;;G01N33/532;;G01N33/56983;;G01N33/57442;;G01N2333/025;;G01N2500/00;;G01N2500/02;;C07K14/005;;G01N2500/00;;A61K38/00;;G01N2333/025;;G01N33/532;;G01N2500/02;;C07K2319/00;;G01N33/57442;;G01N33/56983;;C12N2710/20022,A61K38/00;;A61K39/00;;C07H21/04;;C07K14/025;;C07K14/47;;C07K16/18;;C12P21/04;;G01N33/532;;G01N33/569;;G01N33/574,,1,1,039-688-586-719-032,10.1074/jbc.272.25.15905;;9188490,"ANDERSEN ET AL.: ""Characterization of Skn-1a/i POU domain factors and linkage to papillomavirus gene expression"", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 272, no. 25, 20 June 1997 (1997-06-20), pages 15905 - 15913, XP002953237",PENDING
193,AT,T1,AT E181916 T1,065-218-947-278-946,1999-07-15,1999,AT 96908523 T,1996-03-11,US 40479895 A,1995-03-15,VERFAHREN ZUR HERSTELLUNG VON HIV PROTEASE INHIBITOR AUSGEHEND VON (2S)-4-PICOLYL-2- PIPERAZIN-T-BUTYLCARBOXAMID,,MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;REIDER PAUL;;VOLANTE RALPH P,,https://lens.org/065-218-947-278-946,Granted Patent,no,0,0,22,22,0,C07D401/06;;Y02P20/55;;A61P31/18;;C07D401/06;;Y02P20/55,C07D401/06,,0,0,,,,DISCONTINUED
194,AT,T1,AT E444290 T1,197-447-257-339-911,2009-10-15,2009,AT 04813199 T,2004-12-07,US 52792803 P;;US 58482304 P;;US 2004/0040850 W,2003-12-08,OXAZOLDERIVATE VON TETRACYCLINEN,,WYETH CORP,SUM PHAIK-ENG;;HOW DAVID;;HOPPER DARRIN;;VERA MATTHEW;;SABATINI JOSHUA,,https://lens.org/197-447-257-339-911,Granted Patent,no,0,0,43,44,0,A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04;;C07C2603/46;;A61P31/04;;C07D263/62;;C07D263/54;;C07D263/52;;C07C237/26;;C07D413/04;;A61K31/65;;C07D417/04;;C07D413/06;;C07D263/52;;C07C2603/46,A61K31/423;;A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04,,0,0,,,,INACTIVE
195,US,B1,US 9298413 B1,042-429-909-300-976,2016-03-29,2016,US 201113189421 A,2011-07-22,US 201113189421 A,2011-07-22,"System, method, and computer program product for changing a state of operation of a display system with respect to at least a portion of an image occluded by a non-display surface","A system, method, and computer program product are provided for changing a state of operation of a display system with respect to at least a portion of an image occluded by a non-display surface. In use, a display system is operated in a first state associated with an occlusion of at least a portion of an image resulting from a non-display surface associated with the display system. Additionally, independent of a control panel user interface, a command is received to operate the display system in a second state associated with the occlusion of the at least a portion of the image resulting from the non-display surface associated with the display system. Furthermore, in response to the command, the display system is operated in the second state associated with the occlusion of the at least a portion of the image resulting from the non-display surface associated with the display system.",KARVE ANEESH PADMAKAR;;NAIR RISHI;;TRAY ROBERT ALAN;;ENG DAVID LEE;;NVIDIA CORP,KARVE ANEESH PADMAKAR;;NAIR RISHI;;TRAY ROBERT ALAN;;ENG DAVID LEE,NVIDIA CORPORATION (2011-07-15),https://lens.org/042-429-909-300-976,Granted Patent,yes,13,6,1,1,0,G09G2310/0232;;G09G2340/0471;;G06F3/1446;;G09G2300/026;;G06F3/1446;;G09G2300/026;;G09G2310/0232;;G09G2340/0471,G06F3/048;;G06F3/14,,0,0,,,,ACTIVE
196,US,A1,US 2015/0202533 A1,161-669-594-658-320,2015-07-23,2015,US 201414160339 A,2014-01-21,US 201414160339 A,2014-01-21,MAPPING TOUCHSCREEN GESTURES TO ERGONOMIC CONTROLS ACROSS APPLICATION SCENES,"A technique of implementing on-screen gestures associated with a software application comprises receiving a first control input that relates to a first scene associated with the software application, translating the first control input into a first set of instructions based on a first mapping, and providing the first set of instructions to an operating system that includes the first set of instructions in the software application, receiving a second control input that relates to a second scene associated with the software application, translating the second control input into a second set of instructions based on a second mapping, and providing the second set of instructions to the operating system, wherein the operating system is configured to include the second set of instructions in the software application.",NVIDIA CORP,ENG DAVID LEE;;ZHAO SHICHANG;;SHEN YICHUN;;SU JUN;;MI LIANGCHUAN,NVIDIA CORPORATION (2014-01-14),https://lens.org/161-669-594-658-320,Patent Application,yes,12,6,1,1,0,A63F13/42;;A63F13/426;;A63F13/2145;;A63F13/426;;A63F13/2145;;A63F13/42,A63F13/426;;A63F13/2145;;G06F3/02;;G06F3/038;;G06F3/0481;;G06F3/0488,,0,0,,,,DISCONTINUED
197,US,A1,US 2018/0150729 A1,052-451-666-056-57X,2018-05-31,2018,US 201615361888 A,2016-11-28,US 201615361888 A,2016-11-28,DYNAMIC STORAGE OF RASTER DATA AT A RIP SPOOL FOR MULTIPLE COPY PRINT JOBS,"Embodiments described herein provide for dynamic storage of raster data at a rip spool while printing copies of a multiple copy print job. When printing multiple copies of a print job, some of the print data for the print job is rasterized once, spooled, and de-spooled multiple times for each copy of the print job. The rest of the print data for the print job is rasterized multiple times for each copy of the print job. In the embodiments described herein, additional storage space on the rip spool that becomes available while printing multiple copies of a print job is utilized to store additional raster data for the print job. This reduces the amount of the print data for the print job that is rasterized multiple times.",ENG KATIE ASHLEY;;MANDRY STEPHEN JARED;;USHIJIMA MIKI JUDY;;WARD DAVID;;RICOH CO LTD,ENG KATIE ASHLEY;;MANDRY STEPHEN JARED;;USHIJIMA MIKI JUDY;;WARD DAVID,RICOH COMPANY LTD (2016-11-22),https://lens.org/052-451-666-056-57X,Patent Application,yes,0,0,1,1,0,G06K15/1861;;G06K15/1861;;G06F3/1211;;G06F3/1211;;G06F3/1245;;G06F3/1245;;G06F3/1285;;G06F3/1285;;G06K15/1809;;G06K15/1809;;G06K15/1817;;G06K15/1817;;G06K15/1836;;G06K15/1836;;G06K15/1886;;G06K15/1886,G06K15/02;;G06F3/12,,0,0,,,,DISCONTINUED
198,US,A1,US 2018/0136889 A1,013-649-056-019-754,2018-05-17,2018,US 201615351754 A,2016-11-15,US 201615351754 A,2016-11-15,STORING PREFLIGHT DATA OF A PRINT JOB BASED ON PAGE RANGES,"System and methods for storing preflight data of a print job based on page ranges. In one embodiment, an apparatus includes an interface and a preflight system. The interface receives a print job and a job ticket. The preflight system processes the print job and the job ticket to determine multiple page ranges in the print job that have a similar print attribute throughout their page range. The preflight system also establishes a sheet object in memory for each page range.",WARD DAVID;;ENG KATIE ASHLEY;;MANDRY STEPHEN JARED;;USHIJIMA MIKI JUDY;;RICOH CO LTD,WARD DAVID;;ENG KATIE ASHLEY;;MANDRY STEPHEN JARED;;USHIJIMA MIKI JUDY,RICOH COMPANY LTD (2016-11-08),https://lens.org/013-649-056-019-754,Patent Application,yes,0,5,2,2,0,G06F3/1256;;G06F3/1256;;G06F3/1211;;G06F3/1211;;G06F3/1282;;G06F3/1282;;G06K15/1809;;G06K15/1809;;G06K15/1836;;G06K15/1836;;G06K15/1886;;G06K15/1886,G06F3/12;;G06K15/02,,0,0,,,,INACTIVE
199,US,B2,US 6848260 B2,193-843-863-620-884,2005-02-01,2005,US 25220802 A,2002-09-23,US 25220802 A,2002-09-23,Premixed pilot burner for a combustion turbine engine,"A combustor ( 40 ) for a gas turbine engine is provided with a premix pilot fuel stage ( 42 ) in order to reduce the emission of oxides of nitrogen from the engine. An in-service engine may be modified to add the premix pilot fuel stage by delivering premix pilot fuel to a ring manifold ( 42 ) for tip-feeding a premix pilot fuel outlet member such as a swirler vane ( 78 ) or fuel peg ( 124 ). In this manner, complex and expensive components such as the top hat ( 46 ), support housing ( 48 ) and diffusion pilot burner assembly ( 44 ) may be used without modification. Thermal stresses caused by the differential cooling of the ring manifold by the premix pilot fuel ( 96 ) are reduced by a heat shield ( 94 ) installed within the manifold.",SIEMENS WESTINGHOUSE POWER,NORTH DAVID D;;HARRIS JR ARTHUR J;;REID HANK;;ENG JESSE,SIEMENS ENERGY INC (2002-09-17),https://lens.org/193-843-863-620-884,Granted Patent,yes,31,43,4,4,0,F02C7/222;;F02C7/222;;F23R3/343;;F23R3/343,F23R3/34,60/737;;60/746,0,0,,,,EXPIRED
200,US,B2,US 10289365 B2,063-231-881-028-189,2019-05-14,2019,US 201615351754 A,2016-11-15,US 201615351754 A,2016-11-15,Storing preflight data of a print job based on page ranges,"System and methods for storing preflight data of a print job based on page ranges. In one embodiment, an apparatus includes an interface and a preflight system. The interface receives a print job and a job ticket. The preflight system processes the print job and the job ticket to determine multiple page ranges in the print job that have a similar print attribute throughout their page range. The preflight system also establishes a sheet object in memory for each page range.",WARD DAVID;;ENG KATIE ASHLEY;;MANDRY STEPHEN JARED;;USHIJIMA MIKI JUDY;;RICOH CO LTD,WARD DAVID;;ENG KATIE ASHLEY;;MANDRY STEPHEN JARED;;USHIJIMA MIKI JUDY,RICOH COMPANY LTD (2016-11-08),https://lens.org/063-231-881-028-189,Granted Patent,yes,8,0,2,2,0,G06F3/1256;;G06F3/1256;;G06F3/1211;;G06F3/1211;;G06F3/1282;;G06F3/1282;;G06K15/1809;;G06K15/1809;;G06K15/1836;;G06K15/1836;;G06K15/1886;;G06K15/1886,G06F15/00;;G06F3/12;;G06K15/02,,2,0,,,"Guide for Printing and Scanning; Advanced Output Center; http:///crit.artic.edu/aoc; Feb. 4, 2016.;;Simon Eccles; FESPA Print News; Preflighting customers' PDFs for success in print production; Mar. 1, 2016.",INACTIVE
201,US,A,US 4245222 A,093-333-737-872-321,1981-01-13,1981,US 94285978 A,1978-09-15,US 94285978 A,1978-09-15,Dual function antenna,"A dual function antenna operating at two frequency bands for both the radar uzing function and the telemetry function with a single antenna cavity. A pair of flush-mounted, cavity-backed circumferential slots are located near the base of a missile body and are fed out-of-phase to produce an N=1 mode gain pattern with peaks at nose-on and aft aspects. Each slot is excited by a probe and tee-bar transition. A telemetry band trap circuit is incorporated into the radar band probe and tee-bar to isolate telemetry band energy. A single telemetry probe is inserted into the cavity and spaced apart from the radar probe to excite the antenna at telemetry frequencies.",US NAVY,ENG EDWARD;;GIBBONS GLEN D;;THOMAS DAVID L;;TSE JOHN W,,https://lens.org/093-333-737-872-321,Granted Patent,yes,10,27,1,1,0,H01Q1/286;;H01Q13/18;;H01Q21/205;;H01Q25/005;;H01Q5/40;;H01Q5/50;;H01Q25/005;;H01Q21/205;;H01Q1/286;;H01Q13/18;;H01Q5/40;;H01Q5/50,H01Q1/28;;H01Q5/00;;H01Q5/40;;H01Q5/50;;H01Q13/18,343/708,0,0,,,,EXPIRED
202,AU,A1,AU 2002/364004 A1,023-694-732-962-170,2003-07-24,2003,AU 2002/364004 A,2002-12-12,US 4101301 A;;US 0240167 W,2001-12-28,MULTIPLE MODE POWER THROTTLE MECHANISM,,INTEL CORP,RUSU STEFAN;;TIWARI VIVEK;;BURNS JAMES;;AYERS DAVID;;ENG MARSHA;;GROCHOWSKI EDWARD,,https://lens.org/023-694-732-962-170,Patent Application,no,0,0,9,9,0,G06F1/3203;;G06F1/3243;;G06F9/3017;;G06F9/3836;;G06F9/3869;;G06F9/3873;;G06F9/384;;Y02D10/00;;G06F9/3858;;G06F9/3836;;G06F9/3873;;G06F1/3203;;G06F1/3243;;G06F9/3017;;G06F9/3869;;G06F9/384;;Y02D10/00;;G06F9/3858,G06F1/32;;G06F9/318,,0,0,,,,DISCONTINUED
203,WO,A2,WO 2003/058418 A2,005-687-377-704-821,2003-07-17,2003,US 0240167 W,2002-12-12,US 4101301 A,2001-12-28,MULTIPLE MODE POWER THROTTLE MECHANISM,"A processor (110) includes a digital throttle (130) to monitor the activity of various units (124) of the processor&apos;s instruction execution pipeline (120), and to determine a power state for the processor (110) from the monitored activity. One of two or more power control mechanisms is engaged, responsive to the power state of the processor (110) reaching a threshold.",INTEL CORP,BURNS JAMES;;AYERS DAVID;;ENG MARSHA;;GROCHOWSKI EDWARD;;RUSU STEFAN;;TIWARI VIVEK,,https://lens.org/005-687-377-704-821,Patent Application,yes,0,0,9,9,0,G06F1/3203;;G06F1/3243;;G06F9/3017;;G06F9/3836;;G06F9/3869;;G06F9/3873;;G06F9/384;;Y02D10/00;;G06F9/3858;;G06F9/3836;;G06F9/3873;;G06F1/3203;;G06F1/3243;;G06F9/3017;;G06F9/3869;;G06F9/384;;Y02D10/00;;G06F9/3858,G06F1/32;;G06F9/318,,0,0,,,,PENDING
204,US,B1,US 6651745 B1,068-722-130-787-414,2003-11-25,2003,US 13802002 A,2002-05-02,US 13802002 A,2002-05-02,Subsea riser separator system,"
    A preferred embodiment of the inventive fluid delivery system comprises a vertical liquid/vapor separator and riser assembly that comprises a multi-phase separator inlet, a vapor outlet and riser, and a liquid outlet port connected to a hydraulically-driven centrifugal pump. By controlling the operational speed of the pump, the level of the separated liquid within the separator can be controlled without the need for control valves. The vertical separator is capable of low pressure operation and large variations in controlled liquid levels within the separator, allowing the relatively slow reaction time pump to control the liquid level from low pressure wells penetrating low pressure reservoirs. 
",UNION OIL CO,LUSH DAVID;;ENG JONATHAN;;UCOK HIKMET;;HOPGOOD DAVE;;LANDECK CHRIS;;CARMON KEN,UNION OIL COMPANY OF CALIFORNIA (2002-06-03),https://lens.org/068-722-130-787-414,Granted Patent,yes,20,57,6,6,0,E21B43/01;;E21B43/36;;E21B43/36;;E21B43/01,E21B43/01;;E21B43/36,166/357;;166/267,25,4,141-710-919-905-913;;033-964-079-182-939;;024-875-427-054-757;;007-475-489-508-655,10.4043/12154-ms;;10.4043/14008-ms;;10.4043/6423-ms;;10.4043/13197-ms,"Strand, B. and Bakke, W., ""Subsea Separation on the Troll Field,"" Scandinavian Oil-Gas Magazine, Jul. 8, 1998, pp. 122-124.;;Baggs, C., Kent, I., and Allen, John, ""Troll Pilot Control System: Advanced Control System for a Subsea Separator,"" Offshore Technology Conference (OTC) 12154, May 1-4, 2000, pp 1-10.;;Arnold, K.E. and Ferguson, P.L., ""Tomorrow's Compact Separation Train,"" Hart's E&P, Dec. 1999, pp. 80-82.;;Fjøsne, E., ""Subsea Processing-Maximising Value in Areas With Existing Infrastructure,"" FMC Energy Systems, FMC Kongsberg Subsea, Offshore Technology Conference (OTC) 14008, May 6-9, 2002, pp. 1-5.;;Eriksen, S., ""How Can Subsea Processing Remove Processing Constraints,"" FMC Energy Systems/FMC Kongsberg Subsea, Aug. 30, 2001, 11 pages.;;Davalath, J. ""Economic Benefits of Compact Subsea Separation System,"" FMC Energy Systems, United States, Deep Offshore Technology 1999, 14 pages.;;Songhurst, B.W. and Eyre, G.P., ""Experience Gained From the First U.K. Subsea Separator,"" British Offshore Engineerig Technology, Offshore Technology Conference (OTC) 6423, May 7-10, 1990, pp. 43-50.;;Smith, J.R., ""The Highlander Field: Eight Years On,"" Texaco Norm Sea United Kingdom, Offshore Technology Conference (OTC) 7438, May 2-5, 1994, pp. 177-187.;;Crook, J. ""Seabed Separation First for Troll,"" Petroleum Review, Mar. 1999, p. 31.;;""SUBSIS: Subsea Separation and Injection System,"" ABB Offshore Systems, ABB Oil, Gas & Petrochemicals, (undated), 4 pages.;;""Subsea Separation and Injection by ABB's SUBSIS,"" ABB Offshore Systems , www.abb.com/oilandgas, Aug. 1999, 3 pages.;;Davalath, J., Wessel, J., and Hatlo, A., ""State of the Art in Subsea Pumping Technology,"" FMC Energy Systems, Nov. 7-9, 2000, 11 pages.;;""Helico-Axial Multiphase Pump, Deepwater Technology,"" Multiphase, Guinard Pumps, Textron Fluid Handling Products, May 1989, 12 pages.;;Technical Bulletin, ""Increased Oil Production by Means of Subsea Processing,"" Framo Engineering AS, Bergen, Norway, Jan. 1999, 4 pages.;;Technical Bulletin, ""Boosting-Increased Oil Production and Recovering Utilizing,"" Framo Engineering AS, Bergen, Norway, Nov. 1999, 4 pages.;;Technical Bulletin, ""Subsea Multiphase Pumps for Shell, Draugen,"" Framo Engineering AS, Bergen, Norway, May 1999, 4 pages.;;Technical Bulletin, ""Framo Subsea Multiphase Booster Pumps for BP ETAP,"" Framo Engineering AS, Bergen, Norway, Apr. 1999, 4 pages.;;""Subsea Multiphase Pump,"" Kvaener Eureka a.s., Lier, Norway, (undated), 6 pages.;;Technical Bulletin, ""Increased Oil Production by Means of Subsea Multiphase Boosting,"" Framo Engineering AS, Bergen, Norway, Nov. 1999, 4 pages.;;Rekve, S., ""Fourth-Quarter Seafloor Pump Demo Set,"" Hart's E&P 5<th >Deepwater Technology (undated), p. 31.;;""Multiphase Booster Pumps Provide Efficient Production Tool,"" Hart's E&P 5<th >Deepwater Technology, (undated), p. 32.;;Bradbury, J., ""Pumping Up the Volume,"" Hart's E&P, Oct. 2001, p. 29.;;""Hydraulic Turbine Drive Submersible Centrigual Pumps,"" Weir Pumps, Nov. 2001, pp. 1-2.;;Harden, W.G. and Downie, A.A., ""Field Trial and Subsequent Large-Scale Deployment of a Novel Multiphase Hydraulic Submersible Pump in Texaco's Catain Field,"" Offshore Technology Conference (OTC) 13197, Apr. 30-May 3, 2001, pp. 1-19.;;Arnold, K.E. and Ferguson, P.L., ""Tomorrow's Compact Separation Train,"" Hart's E&P, Dec. 1999, pp. 80-81.",EXPIRED
205,SG,A1,SG 91291 A1,143-102-453-593-113,2002-09-17,2002,SG 2000036293 A,2000-06-28,SG 2000036293 A,2000-06-28,TEMPERATURE CONTROLLED CONTAINER,,FRASER AND NEAVE LTD,LAWRENCE LIM SIM ENG;;DAVID TAY PUAY LENG;;JANSEN TAN CHIN TAT,,https://lens.org/143-102-453-593-113,Patent Application,no,3,0,9,9,0,,B65D/;;B65D81/18;;B65D81/24;;B65D81/38;;B65D88/74;;F25D/;;F25D3/00,,0,0,,,,PENDING
206,US,A1,US 2003/0205384 A1,143-032-986-594-329,2003-11-06,2003,US 13802002 A,2002-05-02,US 13802002 A,2002-05-02,SUBSEA RISER SEPARATOR SYSTEM,"
   A preferred embodiment of the inventive fluid delivery system comprises a vertical liquid/vapor separator and riser assembly that comprises a multi-phase separator inlet, a vapor outlet and riser, and a liquid outlet port connected to a hydraulically-driven centrifugal pump. By controlling the operational speed of the pump, the level of the separated liquid within the separator can be controlled without the need for control valves. The vertical separator is capable of low pressure operation and large variations in controlled liquid levels within the separator, allowing the relatively slow reaction time pump to control the liquid level from low pressure wells penetrating low pressure reservoirs. 
",LUSH DAVID;;ENG JONATHAN;;UCOK HIKMET;;HOPGOOD DAVE;;LANDECK CHRIS;;CARMON KEN,LUSH DAVID;;ENG JONATHAN;;UCOK HIKMET;;HOPGOOD DAVE;;LANDECK CHRIS;;CARMON KEN,UNION OIL COMPANY OF CALIFORNIA (2002-06-03),https://lens.org/143-032-986-594-329,Patent Application,yes,0,15,6,6,0,E21B43/01;;E21B43/36;;E21B43/36;;E21B43/01,E21B43/01;;E21B43/36,166/357;;166/265,0,0,,,,EXPIRED
207,TW,B,TW I224574 B,011-738-509-890-334,2004-12-01,2004,TW 90126411 A,2001-10-25,SG 2000036293 A,2000-06-28,Temperature controlled container structure,"This invention relates to a container structure (1) for transporting goods and in particular fluids. The container structure (1) includes a receptacle (2) for accommodating the fluid, and at least one pipe (3) positioned adjacent the receptacle (2) for receiving a temperature controlling substance. The pipe (3) preferably accommodates chilled glycol whereby the chilled glycol controls the temperature within the receptacle (2). The receptacle (2) and pipe (3) are preferably surrounded by an insulating layer to improve the thermal efficiency of the container. The container has a practical application in relation to the transportation of milk.",FRASER AND NEAVE LTD,LIM SIM ENG LAWRENCE;;TAY PUAY LENG DAVID;;TAN CHIN TAT JANSEN,,https://lens.org/011-738-509-890-334,Granted Patent,no,0,0,9,9,0,,B65D/;;B65D81/18;;B65D81/24;;B65D81/38;;B65D88/74;;F25D/;;F25D3/00,,0,0,,,,EXPIRED
208,CN,A,CN 1608240 A,065-827-628-805-570,2005-04-20,2005,CN 02826267 A,2002-12-12,US 4101301 A,2001-12-28,Multiple mode power throttle mechanism,,INTEL CORP,STEFAN RUSU;;VIVEK TIWARI;;JAMES BURNS;;DAVID AYERS;;MARSHA ENG;;EDWARD GROCHOWSKI,,https://lens.org/065-827-628-805-570,Patent Application,no,0,4,9,9,0,G06F1/3203;;G06F1/3243;;G06F9/3017;;G06F9/3836;;G06F9/3869;;G06F9/3873;;G06F9/384;;Y02D10/00;;G06F9/3858;;G06F9/3836;;G06F9/3873;;G06F1/3203;;G06F1/3243;;G06F9/3017;;G06F9/3869;;G06F9/384;;Y02D10/00;;G06F9/3858,G06F1/32;;G06F9/318,,0,0,,,,EXPIRED
209,HK,A1,HK 1042878 A1,055-397-016-422-974,2002-08-30,2002,HK 02104713 A,2002-06-25,SG 2000036293 A,2000-06-28,Temperature controlled container.,,FRASER AND NEAVE LTD,ENG LAWRENCE LIM SIM;;LENG DAVID TAY PUAY;;TAT JANSEN TAN CHIN,,https://lens.org/055-397-016-422-974,Patent Application,no,0,0,9,9,0,,B65D/;;B65D81/18;;B65D81/24;;B65D81/38;;B65D88/74;;F25D/;;F25D3/00,,0,0,,,,EXPIRED
210,MY,A,MY 123387 A,167-801-770-783-790,2006-05-31,2006,MY PI20004060 A,2000-09-04,SG 2000036293 A,2000-06-28,TEMPERATURE CONTROLLED CONTAINER,"THIS INVENTION RELATES TO A CONTAINER STRUCTURE (1) FOR TRANSPORTING GOODS AND IN PARTICULAR FLUIDS. THE CONTAINER STRUCTURE (1) INCLUDES A RECEPTACLE (2) FOR ACCOMMODATING THE FLUID, AND AT LEAST ONE PIPE (3) POSITIONED ADJACENT THE RECEPTACLE (2) FOR RECEIVING A TEMPERATURE CONTROLLING SUBSTANCE. THE AT LEAST ONE PIPE (3) PREFERABLY ACCOMMODATES CHILLED GLYCOL WHEREBY THE CHILLED GLYCOL CONTROLS THE TEMPERATURE WITHIN THE RECEPTABLE (2). THE RECEPTACLE (2) AND AT LEAST ONE PIPE (3) ARE PREFERABLY SURROUNDED BY AN INSULATING LAYER TO IMPROVE THE THERMAL EFFICIENCY OF THE CONTAINER. THE HAS A PRACTICAL APPLICATION IN RELATION TO THE TRANSPORTATION OF MILK.(FIGURE)",FRASER AND NEAVE LTD,LAWRENCE LIM SIM ENG;;DAVID TAY PUAY LENG;;JANSEN TAN CHIN TAT,,https://lens.org/167-801-770-783-790,Granted Patent,no,0,0,9,9,0,,B65D81/38;;B65D/;;B65D81/18;;B65D81/24;;B65D88/74;;F25D/;;F25D3/00,,0,0,,,,EXPIRED
211,US,A1,US 2009/0100303 A1,075-368-881-497-412,2009-04-16,2009,US 98650807 A,2007-11-21,US 98650807 A;;US 99876307 P,2007-10-12,Adjustable test pattern results latency,"A digital test instrument and a test method provide adjustable results latency. A digital test instrument includes a pattern controller configured to generate a sequence of test patterns, responsive, at least in part, to a pass/fail result, a pattern memory configured to supply the generated sequence of test patterns to a unit under test, a pattern results collection unit configured to receive at least one result value from the unit under test and to determine a pass/fail result for at least one supplied test pattern, and a synchronization unit configured to provide a no-result indication to the pattern controller during a preset number of pattern cycles following the start of a test, the preset number of pattern cycles based on a results latency of the test instrument, and to provide pass/fail results to the pattern controller after the preset number of pattern cycles.",TERADYNE INC,MCGOLDRICK MICHAEL F;;BORROZ WILLIAM T;;ENG STEPHEN K;;MILLEY DAVID A,TERADYNE INC (2008-04-01),https://lens.org/075-368-881-497-412,Patent Application,yes,12,2,12,12,0,G01R31/31726;;G01R31/31813;;G11C29/10;;G11C29/56;;G11C29/10;;G01R31/31813;;G01R31/31726;;G11C29/56,G11C29/00,714/720,0,0,,,,ACTIVE
212,US,A1,US 2021/0097353 A1,127-015-653-296-986,2021-04-01,2021,US 202017119546 A,2020-12-11,US 202017119546 A;;US 201816230788 A;;US 201762609522 P,2017-12-22,FUNCTIONAL IMAGE ARCHIVING,"Some implementations related to archiving of functional images. In some implementations, a method includes accessing images and determining one or more functional labels corresponding to each of the images and one or more confidence scores corresponding to the functional labels. A functional image score is determined for each of the images based on the functional labels having a corresponding confidence score that meets a respective threshold for the functional labels. In response to determining that the functional image score meets a functional image score threshold, a functional image signal is provided that indicates that one or more of the images that meet the functional image score threshold are functional images. The functional images are determined to be archived, and are archived by associating an archive attribute with the functional images such that functional images having the archive attribute are excluded from display in views of the images.",GOOGLE LLC,CHENG SHINKO;;KIM EUNYOUNG;;DAI SHENGYANG;;KHANDELWAL MADHUR;;ENG KRISTINA;;LOXTON DAVID,GOOGLE LLC (2018-12-21),https://lens.org/127-015-653-296-986,Patent Application,yes,8,0,4,4,0,G06F16/51;;G06F18/2433;;G06F16/51;;G06F16/113;;G06F18/2433,G06F16/11;;G06K9/62;;G06F16/51,,0,0,,,,ACTIVE
213,US,A1,US 2002/0046860 A1,034-152-258-931-627,2002-04-25,2002,US 82154901 A,2001-03-29,US 82154901 A;;US 21802900 P,2000-07-12,Reflow encapsulant,"
   A reflow encapsulant is used with substrate and an electronic device. The encapsulant is configured to cure when the assembly is heated so as to reflow solder bumps connecting the substrate and electronic device. The encapsulant includes inorganic filler in an amount of 8% to 20% by weight. The amount of filler provided is sufficiently high to lower the CTE of the encapsulant so as to enhance cured material properties and prevent undue expansion and solder joint damage, but low enough so that the solder joints are not affected by filler particles during reflow. 
",XU ANTAI;;ECHOLS ROBERT MICHAEL;;YEH ENG SIONG DAVID;;PETERSON MICHAEL JOHN,XU ANTAI;;ECHOLS ROBERT MICHAEL;;YEH ENG SIONG DAVID;;PETERSON MICHAEL JOHN,SEAGATE TECHNOLOGY LLC (2001-03-15),https://lens.org/034-152-258-931-627,Patent Application,yes,0,10,2,2,0,H01L21/563;;H01L21/563;;H01L24/29;;H01L24/29;;H01L2224/05568;;H01L2224/05568;;H01L2224/05573;;H01L2224/05573;;H01L2224/16225;;H01L2224/16225;;H01L2224/73203;;H01L2224/73203;;H01L2224/73204;;H01L2224/73204;;H01L2224/83192;;H01L2224/83192;;H01L2924/00014;;H01L2924/00014;;H01L2924/01013;;H01L2924/01013;;H01L2924/01033;;H01L2924/01033;;H01L2924/01082;;H01L2924/01082;;H01L2924/14;;H01L2924/14;;H01L2924/351;;H01L2924/351;;H05K3/284;;H05K3/284;;H05K3/3436;;H05K3/3436;;H05K2201/0209;;H05K2201/0209;;H05K2201/10977;;H05K2201/10977;;Y02P70/50;;Y02P70/50,H01L21/56;;H05K3/28;;H05K3/34,174/52.2,0,0,,,,EXPIRED
214,US,A1,US 2023/0021696 A1,108-204-481-992-291,2023-01-26,2023,US 202117377512 A,2021-07-16,US 202117377512 A,2021-07-16,INTERNAL CORE PROFILE FOR A TURBINE NOZZLE AIRFOIL,"An internal core profile for a turbine nozzle airfoil of a gas turbine is provided. The turbine nozzle may include an airfoil core having an uncoated nominal profile substantially in accordance with Cartesian coordinate values of X, Y, and Z set forth in Table 1, wherein the X, Y, and Z coordinates are distances in inches measured in a Cartesian coordinate system, the corresponding X and Y coordinates, when connected by a smooth continuous arc, define one of a plurality of airfoil core profile sections at each Z distance, and the plurality of airfoil core profile sections, when joined together by smooth continuous arcs, define an airfoil core shape.",DOOSAN ENERBILITY CO LTD,KIM JINUK;;KIM KWANGIL;;BROWN BARRY;;GREENBERG JEFF;;ENG DARRYL;;DAY DAVID,DOOSAN HEAVY INDUSTRIES & CONSTRUCTION CO. LTD (2021-05-18),https://lens.org/108-204-481-992-291,Patent Application,yes,3,0,3,3,0,Y02T50/60;;F05D2250/74;;F05D2240/128;;F05D2220/3212;;F01D9/041;;F01D9/065;;F01D5/288;;F01D9/041;;F01D5/141;;F01D5/187;;F01D5/288;;F05D2240/35;;F05D2220/32;;F01D5/141;;F01D9/041;;F05D2220/3212;;F05D2240/128;;F05D2250/74;;F01D5/18,F01D5/14;;F01D5/18;;F01D9/04,,0,0,,,,ACTIVE
215,US,B1,US 11377961 B1,171-938-073-617-385,2022-07-05,2022,US 202117377502 A,2021-07-16,US 202117377502 A,2021-07-16,Internal core profile for a turbine nozzle airfoil,"An airfoil profile for a second stage turbine nozzle of a gas turbine is provided. The turbine nozzle may include an airfoil portion having an uncoated nominal profile substantially in accordance with Cartesian coordinate values of X, Y, and Z set forth in Table 1, wherein the X, Y, and Z coordinates are distances in inches measured in a Cartesian coordinate system, the corresponding X and Y coordinates, when connected by a smooth continuous arc, define one of a plurality of airfoil profile sections at each Z distance, and the plurality of airfoil profile sections, when joined together by smooth continuous arcs, define an airfoil shape.",DOOSAN HEAVY IND & CONSTRUCTION CO LTD,KIM JINUK;;KIM KWANGIL;;KOPKO JASON;;GREENBERG JEFF;;ENG DARRYL;;DAY DAVID,DOOSAN HEAVY INDUSTRIES & CONSTRUCTION CO. LTD (2021-06-07),https://lens.org/171-938-073-617-385,Granted Patent,yes,27,0,2,2,0,F05D2250/74;;F01D9/041;;F05D2240/128;;F01D5/141;;F05D2230/21;;F05D2230/232;;F05D2230/237;;Y02T50/60;;F01D9/041;;F01D5/141;;F01D5/288;;F05D2240/35;;F05D2220/32;;F01D5/145;;F01D9/041;;F05D2250/74;;F05D2220/3216;;F05D2240/301;;F05D2240/128;;F01D5/141;;F01D5/143,F01D5/14;;F01D9/04,,0,0,,,,ACTIVE
216,EP,B1,EP 2212787 B1,186-035-455-574-381,2017-07-26,2017,EP 08838186 A,2008-10-10,US 2008/0079456 W;;US 99876307 P;;US 98650807 A,2007-10-12,ADJUSTABLE TEST PATTERN RESULTS LATENCY,,TERADYNE INC,MCGOLDRICK MICHAEL F;;BORROZ WILLIAM T;;ENG STEPHEN K;;MILLEY DAVID A,,https://lens.org/186-035-455-574-381,Granted Patent,yes,4,0,12,12,0,G01R31/31726;;G01R31/31813;;G11C29/10;;G11C29/56;;G11C29/10;;G01R31/31813;;G01R31/31726;;G11C29/56,G01R31/3181;;G01R31/317;;G11C29/10;;G11C29/56,,2,0,,,"JONES C ET AL: ""User-centric digital test architecture"", AUTOTESTCON, 2005. IEEE SEPT. 26, 2005, PISCATAWAY, NJ, USA,IEEE, 26 September 2005 (2005-09-26), pages 665-672, XP010910953, DOI: DOI:10.1109/AUTEST.2005.1609214 ISBN: 978-0-7803-9101-7;;JONES C. ET AL.: 'User-centric digital test architecture' IEEE AUTOTESTCON 26 September 2005, XP010910953",ACTIVE
217,TW,A,TW 200928376 A,001-468-204-440-252,2009-07-01,2009,TW 97139125 A,2008-10-13,US 99876307 P;;US 98650807 A,2007-10-12,Adjustable test pattern results latency,"A digital test instrument and a test method provide adjustable results latency. A digital test instrument includes a pattern controller configured to generate a sequence of test patterns, responsive, at least in part, to a pass/fail result, a pattern memory configured to supply the generated sequence of test patterns to a unit under test, a pattern results collection unit configured to receive at least one result value from the unit under test and to determine a pass/fail result for at least one supplied test pattern, and a synchronization unit configured to provide a no-result indication to the pattern controller during a preset number of pattern cycles following the start of a test, the preset number of pattern cycles based on a results latency of the test instrument, and to provide pass/fail results to the pattern controller after the preset number of pattern cycles.",TERADYNE INC,MCGOLDRICK MICHAEL F;;BORROZ WILLIAM T;;ENG STEPHEN K;;MILLEY DAVID A,,https://lens.org/001-468-204-440-252,Patent of Addition,no,0,0,12,12,0,G01R31/31726;;G01R31/31813;;G11C29/10;;G11C29/56;;G11C29/10;;G01R31/31813;;G01R31/31726;;G11C29/56,G01R11/17,,0,0,,,,ACTIVE
218,AU,A,AU 2000/056558 A,055-046-613-543-139,2002-01-03,2002,AU 2000/056558 A,2000-09-07,SG 2000036293 A,2000-06-28,Temperature controlled container,,FRASER AND NEAVE LTD,LIM LAWRENCE SIM ENG;;TAY DAVID PUAY LENG;;TAN JANSEN CHIN TAT,,https://lens.org/055-046-613-543-139,Patent Application,no,0,1,9,9,0,,B65D/;;B65D81/18;;B65D81/24;;B65D81/38;;B65D88/74;;F25D/;;F25D3/00,,0,0,,,,EXPIRED
219,WO,A3,WO 2003/058418 A3,048-119-026-563-945,2004-01-29,2004,US 0240167 W,2002-12-12,US 4101301 A,2001-12-28,MULTIPLE MODE POWER THROTTLE MECHANISM,"A processor (110) includes a digital throttle (130) to monitor the activity of various units (124) of the processor&apos;s instruction execution pipeline (120), and to determine a power state for the processor (110) from the monitored activity. One of two or more power control mechanisms is engaged, responsive to the power state of the processor (110) reaching a threshold.",INTEL CORP,BURNS JAMES;;AYERS DAVID;;ENG MARSHA;;GROCHOWSKI EDWARD;;RUSU STEFAN;;TIWARI VIVEK,,https://lens.org/048-119-026-563-945,Search Report,yes,4,0,9,9,0,G06F1/3203;;G06F1/3243;;G06F9/3017;;G06F9/3836;;G06F9/3869;;G06F9/3873;;G06F9/384;;Y02D10/00;;G06F9/3858;;G06F9/3836;;G06F9/3873;;G06F1/3203;;G06F1/3243;;G06F9/3017;;G06F9/3869;;G06F9/384;;Y02D10/00;;G06F9/3858,G06F1/32;;G06F9/318,,0,0,,,,PENDING
220,AT,A1,AT 526307 A1,078-042-777-703-123,2023-12-15,2023,AT 500232023 A,2023-01-19,AT 500232023 A,2023-01-19,Kühlvorrichtung für ein Kühlen eines Brennstoffzellensystems,"Die vorliegende Erfindung betrifft eine Kühlvorrichtung (10) für ein Kühlen eines Brennstoffzellensystems (100), aufweisend einen Kühlkreislauf (20) für ein Führen von Kühlfluid (KF) mit einem Kühlrücklauf (22) für eine fluidkommunizierende Verbindung mit einem Kühlauslass (122) eines Brennstoffzellenstapels (120) des Brennstoffzellensystems (100) und einem Kühlvorlauf (24) für eine fluidkommunizierende Verbindung mit einem Kühleinlass (124) des Brennstoffzellenstapels (120), wobei der Kühlkreislauf (20) weiter eine Wärmesenke (26) für eine Reduktion der Temperatur des Kühlfluids (KF) zwischen dem Kühlrücklauf (22) und dem Kühlvorlauf (24) und ein Fördermittel (28) zum Fördern des Kühlfluids (KF) vom Kühlrücklauf (22) durch die Wärmesenke (26) zum Kühlvorlauf (24) aufweist, wobei der Kühlvorlauf (24) und/oder der Kühlrücklauf (22) frei von einem elektrischen Erdungsanschluss (200) ausgebildet sind.",AVL LIST GMBH,KATHARINA WEINGRILL B ENG;;ALEXANDER SCHNABEL DIPL -ING;;DAVID WEINGRILL DIPL -ING,,https://lens.org/078-042-777-703-123,Patent Application,no,2,0,1,1,0,H01M8/04029,H01M8/04029,,0,0,,,,PENDING
221,KR,A,KR 20230012957 A,090-839-319-233-18X,2023-01-26,2023,KR 20220005997 A,2022-01-14,US 202117377512 A,2021-07-16,INTERNAL CORE PROFILE FOR A TURBINE NOZZLE AIRFOIL,"An internal core profile for a first stage turbine nozzle airfoil of a gas turbine is provided to improve the aerodynamics and reduce the mechanical stress. A turbine nozzle substantially comprises an airfoil core having an uncoated nominal profile according to the Cartesian values of X, Y, and Z shown in Table 1, wherein the X, Y, and Z coordinates are distances in inches measured in a Cartesian coordinate system, the X and Y coordinates define one of a plurality of airfoil profile sections at each Z distance when connected in a smooth continuous arc, and the plurality of airfoil profile sections define an airfoil shape when joined together in a smooth continuous arc.",DOOSAN ENERBILITY CO LTD,KIM JINUK;;KIM KWANGIL;;BARRY BROWN;;JEFF GREENBERG;;DARRYL ENG;;DAVID DAY,,https://lens.org/090-839-319-233-18X,Patent Application,no,0,0,3,3,0,Y02T50/60;;F05D2250/74;;F05D2240/128;;F05D2220/3212;;F01D9/041;;F01D9/065;;F01D5/288;;F01D9/041;;F01D5/141;;F01D5/187;;F01D5/288;;F05D2240/35;;F05D2220/32;;F01D5/141;;F01D9/041;;F05D2220/3212;;F05D2240/128;;F05D2250/74;;F01D5/18,F01D9/04;;F01D5/14;;F01D5/18;;F01D5/28,,0,0,,,,DISCONTINUED
222,EP,A1,EP 2212787 A1,028-349-854-616-73X,2010-08-04,2010,EP 08838186 A,2008-10-10,US 2008/0079456 W;;US 99876307 P;;US 98650807 A,2007-10-12,ADJUSTABLE TEST PATTERN RESULTS LATENCY,,TERADYNE INC,MCGOLDRICK MICHAEL F;;BORROZ WILLIAM T;;ENG STEPHEN K;;MILLEY DAVID A,,https://lens.org/028-349-854-616-73X,Patent Application,yes,0,0,12,12,0,G01R31/31726;;G01R31/31813;;G11C29/10;;G11C29/56;;G11C29/10;;G01R31/31813;;G01R31/31726;;G11C29/56,G01R31/3181;;G01R31/317;;G11C29/10;;G11C29/56,,0,0,,,,ACTIVE
223,US,B2,US 7210530 B2,041-034-579-288-00X,2007-05-01,2007,US 71704603 A,2003-11-19,US 71704603 A;;US 13802002 A,2002-05-02,Subsea separation system,"A preferred embodiment of the inventive fluid delivery system comprises a vertical liquid/vapor separator and riser assembly that comprises a multi-phase separator inlet, a vapor outlet and riser, and a liquid outlet port connected to a hydraulically-driven centrifugal pump. By controlling the operational speed of the pump, the level of the separated liquid within the separator can be controlled without the need for control valves. The vertical separator is capable of low pressure operation and large variations in controlled liquid levels within the separator, allowing the relatively slow reaction time pump to control the liquid level from low pressure wells penetrating low pressure reservoirs.",CHEVRON USA INC,LUSH DAVID;;ENG JONATHAN;;UCOK HIKMET;;HOPGOOD DAVE;;LANDECK CHRIS;;CARMON KEN,,https://lens.org/041-034-579-288-00X,Granted Patent,yes,25,28,6,6,0,E21B43/01;;E21B43/36;;E21B43/36;;E21B43/01,E21B29/12;;E21B43/01;;E21B43/36,166/357;;166/267,24,5,141-710-919-905-913;;033-964-079-182-939;;024-875-427-054-757;;038-002-248-337-917;;007-475-489-508-655,10.4043/12154-ms;;10.4043/14008-ms;;10.4043/6423-ms;;10.4043/7438-ms;;10.4043/13197-ms,"Strand, B. and Baake, W., ""Subsea Separation on the Troll Field,"" Scandinavian Oil-Gas Magazine, Jul. 8, 1998, pp. 122-124.;;Baggs, C., Kent, I., and Allen, John, ""Troll Pilot Control System: Advanced Control System for a Subsea Separator,"" Offshore Technology Conference (OTC) 12154, May 1-4, 2000, pp. 1-10.;;Arnold, K.E. and Ferguson, P.L., ""Tomorrow's Compact Separation Train,"" Hart's E&P, Dec. 1999, pp. 80-82.;;Fjøsne, E., ""Subsea Processing-Maximising Value in Areas With Existing Infrastructure,"" Offshore Technology Conference (OTC) 14008, May 6-9, 2002, pp. 1-5.;;Eriksen, S., ""How Can Subsea Processing Remove Topside Processing Constraints,"" FMC Energy Systems, FMC Kongsberg Subsea, Aug. 30, 2001, 11 pages.;;Davalath, J. ""Economic Benefits of Compact Subsea Separation System,"" FMC Energy Systems, Deep Offshore Technology 1999, 14 pages.;;Songhurst, B.W. and Eyre, G.P., ""Experience Gained From the First U.K. Subsea Separator,"" Offshore Technology Conference (OTC) 6423, May 7-10, 1990, pp. 43-50.;;Smith, J.R., ""The Highlander Field: Eight Years On,"" Offshore Technology Conference (OTC) 7438, May 2-5, 1994, pp. 177-187.;;Crook, J. ""Seabed Separation First for Troll,"" Petroleum Review, Mar. 1999, pp. 31-32.;;""SUBSIS: Subsea Separation and Injection System,"" ABB Offshore Systems, ABB Oil, Gas & Petrochemicals, (undated), 4 pages.;;""Subsea Separation and Injection by ABB's SUBSIS,"" ABB Offshore Systems, www.abb.com/oilandgas, Aug. 1999, 3 pages.;;Davalath, J., Wessel, J., and Hatlo, A., ""State of the Art In Subsea Pumping Technology,"" FMC Energy Systems, Nov. 7-9, 2000, 11 pages.;;""Helico-Axial Multiphase Pump, Deepwater Technology,"" Multiphase, Guinard Pumps, Textron Fluid Handling Products, May 1989, 12 pages.;;Technical Bulletin, ""Increased Oil Production by Means of Subsea Processing,"" Framo Engineering AS, Bergen, Norway, Jan. 1999, 4 pages.;;Technical Bulletin, ""Boosting-Increased Oil Production and Recovering Utilizing: Multiphase Pumps, Subsea Separator-SWAG,"" Framo Engineering AS, Bergen, Norway, Nov. 1999, 4 pages.;;Technical Bulletin, ""Subsea Multiphase Pumps for Shell, Draugen,"" Framo Engineering AS, Bergen, Norway, May 1999, 4 pages.;;Technical Bulletin, ""Framo Subsea Multiphase Booster Pumps for BP ETAP,"" Framo Engineering AS, Bergen, Norway, Apr. 1999, 4 pages.;;""Subsea Multiphase Pump,"" Kvaener Eureka a.s., Lier, Norway, (undated), 6 pages.;;Technical Bulletin, ""Increased Oil Production by Means of Subsea Multiphase Boosting,"" Framo Engineering AS, Bergen, Norway, Nov. 1999, 4 pages.;;Rekve, S., ""Fourth-Quarter Seafloor Pump Demo Set,"" Hart's E&P 5<SUP>th </SUP>Deepwater Technology (undated), p. 31.;;""Multiphase Booster Pumps Provide Efficient Production Tool,"" Hart's E&P 5<SUP>th </SUP>Deepwater Technology, (undated), p. 32.;;Bradbury, J., ""Pumping Up the Volume,"" Hart's E&P, Oct. 2001, p. 29.;;""Hydraulic Turbine Drive Submersible Centrigual Pumps,"" Weir Pumps, Nov. 2001, pp. 1-2.;;Harden, W.G. and Downie, A.A., ""Field Trial and Subsequent Large-Scale Deployment of a Novel Multiphase Hydraulic Submersible Pump in Texaco's Catain Field,"" Offshore Technology Conference (OTC) 13197, Apr. 30-May 3, 2001, pp. 1-19.",EXPIRED
224,CN,A,CN 115135747 A,054-075-460-188-004,2022-09-30,2022,CN 202080097064 A,2020-12-16,US 201962951022 P;;IB 2020062051 W,2019-12-20,Mycelium material and method for producing same,"Mycelium materials and methods of producing the same are provided herein. In some embodiments, the mycelium material comprises: a cultured mycelium material comprising one or more branched mycelium masses, where the one or more branched mycelium masses may be disrupted and/or an adhesive may be combined with the cultured mycelium material. Methods of producing the mycelium material are also provided.",BOLT THREADS INC,SMITH MATTHEW JAMES;;KITTLESON JOSHUA T;;ENG DAVID JOHN;;BOULET-AUDET MAXIME,,https://lens.org/054-075-460-188-004,Patent Application,no,3,0,7,7,0,C12N1/14;;C12R2001/645;;D06N7/0097;;D04H1/425;;D04H1/4266;;C12R2001/645;;C12N1/145;;C12N1/02;;C12N11/00,C12N1/14;;A61K8/9728;;A61Q19/00;;C12R1/645,,0,0,,,,PENDING
225,ID,A,ID 30583 A,174-263-453-594-249,2002-01-03,2002,ID 20010011 Q,2001-06-08,SG 200036293 A,2000-06-28,WADAH YANG DAPAT DIKENDALIKAN SUHUNYA,,FRASER AND NEAVE LTD,ENG LAWRENCE LIM SIM;;LENG DAVID TAY PUAY;;TAT JANSEN TAN CHIN,,https://lens.org/174-263-453-594-249,Patent Application,no,0,0,1,1,0,,B65D81/24;;B65D81/38;;B65D88/74,,0,0,,,,PENDING
226,WO,A1,WO 2009/049117 A1,020-004-751-118-768,2009-04-16,2009,US 2008/0079456 W,2008-10-10,US 99876307 P;;US 98650807 A,2007-10-12,ADJUSTABLE TEST PATTERN RESULTS LATENCY,"A digital test instrument and a test method provide adjustable results latency. A digital test instrument includes a pattern controller configured to generate a sequence of test patterns, responsive, at least in part, to a pass/fail result, a pattern memory configured to supply the generated sequence of test patterns to a unit under test, a pattern results collection unit configured to receive at least one result value from the unit under test and to determine a pass/fail result for at least one supplied test pattern, and a synchronization unit configured to provide a no-result indication to the pattern controller during a preset number of pattern cycles following the start of a test, the preset number of pattern cycles based on a results latency of the test instrument, and to provide pass/fail results to the pattern controller after the preset number of pattern cycles.",TERADYNE INC;;MCGOLDRICK MICHAEL F;;BORROZ WILLIAM T;;ENG STEPHEN K;;MILLEY DAVID A,MCGOLDRICK MICHAEL F;;BORROZ WILLIAM T;;ENG STEPHEN K;;MILLEY DAVID A,,https://lens.org/020-004-751-118-768,Patent Application,yes,2,0,12,12,0,G01R31/31726;;G01R31/31813;;G11C29/10;;G11C29/56;;G11C29/10;;G01R31/31813;;G01R31/31726;;G11C29/56,G06F11/00;;G01R31/28,,1,1,063-818-200-213-18X,10.1109/autest.2005.1609214,"JONES C. ET AL.: ""User-centric digital test architecture"", IEEE AUTOTESTCON, 26 September 2005 (2005-09-26), XP010910953",PENDING
227,KR,A,KR 20230012956 A,061-496-925-297-139,2023-01-26,2023,KR 20220005996 A,2022-01-14,US 202117377522 A,2021-07-16,INTERNAL CORE PROFILE FOR A TURBINE NOZZLE AIRFOIL,"An internal core profile for a second stage turbine nozzle airfoil of a gas turbine is provided to improve the aerodynamics and reduce the mechanical stress. A turbine nozzle substantially comprises an airfoil core having an uncoated nominal profile according to the Cartesian values of X, Y and Z shown in Table 1, wherein the X, Y, and Z coordinates are distances in inches measured in a Cartesian coordinate system, the X and Y coordinates define one of a plurality of airfoil profile sections at each Z distance when connected in a smooth continuous arc, and the plurality of airfoil profile sections define an airfoil shape when joined together in a smooth continuous arc.",DOOSAN ENERBILITY CO LTD,KIM JINUK;;KIM KWANGIL;;BARRY BROWN;;JEFF GREENBERG;;DARRYL ENG;;DAVID DAY,,https://lens.org/061-496-925-297-139,Patent Application,no,0,0,2,2,0,F01D5/141;;F01D9/065;;F05D2230/90;;F01D5/288;;F05D2250/74;;Y02T50/60;;F01D9/041;;F01D5/141;;F01D5/187;;F01D5/288;;F05D2240/35;;F05D2220/32;;F01D9/02;;F05D2240/12;;F05D2220/32;;F01D9/041;;F01D9/047;;F01D5/148;;F01D9/04;;F01D5/141;;F01D5/187;;F01D5/18;;F01D5/188,F01D9/04;;F01D5/14;;F01D5/18;;F01D5/28,,0,0,,,,DISCONTINUED
228,KR,A,KR 20230012398 A,019-822-804-122-12X,2023-01-26,2023,KR 20220005999 A,2022-01-14,US 202117376497 A,2021-07-15,AIRFOIL PROFILE FOR A TURBINE NOZZLE,"An airfoil profile for a turbine blade of a gas turbine is provided to improve the aerodynamics and reduce the mechanical stress. The turbine nozzle substantially comprises an airfoil portion having an uncoated nominal profile according to the Cartesian values of X, Y and Z shown in Table 1, wherein the X, Y, and Z coordinates are distances in inches measured in a Cartesian coordinate system, the X and Y coordinates define one of a plurality of airfoil profile sections at each Z distance when connected in a smooth continuous arc, and the plurality of airfoil profile sections define an airfoil shape when joined together in a smooth continuous arc.",DOOSAN ENERBILITY CO LTD,KIM JINUK;;KIM KWANGIL;;JASON KOPKO;;JEFF GREENBERG;;DARRYL ENG;;DAVID DAY,,https://lens.org/019-822-804-122-12X,Patent Application,no,0,0,2,2,0,F01D9/041;;F05D2250/74;;Y02T50/60;;F01D9/041;;F01D5/141;;F01D5/288;;F05D2240/35;;F05D2220/32;;F01D9/041;;F05D2240/128;;F05D2220/32;;F05D2240/10;;F01D5/141;;F01D5/143,F01D9/04;;F01D5/14;;F01D5/28,,0,0,,,,DISCONTINUED
229,US,B2,US 11591912 B2,132-531-894-981-783,2023-02-28,2023,US 202117377512 A,2021-07-16,US 202117377512 A,2021-07-16,Internal core profile for a turbine nozzle airfoil,"An internal core profile for a turbine nozzle airfoil of a gas turbine is provided. The turbine nozzle may include an airfoil core having an uncoated nominal profile substantially in accordance with Cartesian coordinate values of X, Y, and Z set forth in Table 1, wherein the X, Y, and Z coordinates are distances in inches measured in a Cartesian coordinate system, the corresponding X and Y coordinates, when connected by a smooth continuous arc, define one of a plurality of airfoil core profile sections at each Z distance, and the plurality of airfoil core profile sections, when joined together by smooth continuous arcs, define an airfoil core shape.",DOOSAN ENERBILITY CO LTD;;DOSAN ENERBILITY CO LTD,KIM JINUK;;KIM KWANGIL;;BROWN BARRY;;GREENBERG JEFF;;ENG DARRYL;;DAY DAVID,DOOSAN HEAVY INDUSTRIES & CONSTRUCTION CO. LTD (2021-05-18),https://lens.org/132-531-894-981-783,Granted Patent,yes,4,0,3,3,0,Y02T50/60;;F05D2250/74;;F05D2240/128;;F05D2220/3212;;F01D9/041;;F01D9/065;;F01D5/288;;F01D9/041;;F01D5/141;;F01D5/187;;F01D5/288;;F05D2240/35;;F05D2220/32;;F01D5/141;;F01D9/041;;F05D2220/3212;;F05D2240/128;;F05D2250/74;;F01D5/18,F01D5/14;;F01D5/18;;F01D9/04,,0,0,,,,ACTIVE
230,KR,A,KR 20230012958 A,134-308-967-386-952,2023-01-26,2023,KR 20220005998 A,2022-01-14,US 202117377502 A,2021-07-16,2 AIRFOIL PROFILE FOR A SECOND STAGE TURBINE NOZZLE,"An internal core profile for a second stage turbine nozzle airfoil of a gas turbine is provided to improve the aerodynamics and reduce the mechanical stress. A turbine nozzle substantially comprises an airfoil core having an uncoated nominal profile according to the Cartesian values of X, Y and Z shown in Table 1, wherein the X, Y, and Z coordinates are distances in inches measured in a Cartesian coordinate system, the X and Y coordinates define one of a plurality of airfoil profile sections at each Z distance when connected in a smooth continuous arc, and the plurality of airfoil profile sections define an airfoil shape when joined together in a smooth continuous arc.",DOOSAN ENERBILITY CO LTD,KIM JINUK;;KIM KWANGIL;;JASON KOPKO;;JEFF GREENBERG;;DARRYL ENG;;DAVID DAY,,https://lens.org/134-308-967-386-952,Patent Application,no,0,0,2,2,0,F05D2250/74;;F01D9/041;;F05D2240/128;;F01D5/141;;F05D2230/21;;F05D2230/232;;F05D2230/237;;Y02T50/60;;F01D9/041;;F01D5/141;;F01D5/288;;F05D2240/35;;F05D2220/32;;F01D5/145;;F01D9/041;;F05D2250/74;;F05D2220/3216;;F05D2240/301;;F05D2240/128;;F01D5/141;;F01D5/143,F01D9/04;;F01D5/14;;F01D5/28,,0,0,,,,DISCONTINUED
231,HK,B,HK 1042878 B,146-551-771-162-24X,2005-04-22,2005,HK 02104713 A,2002-06-25,SG 2000036293 A,2000-06-28,TEMPERATURE CONTROLLED CONTAINER,,FRASER AND NEAVE LTD,LAWRENCE LIM SIM ENG;;DAVID TAY PUAY LENG;;JANSEN TAN CHIN TAT,,https://lens.org/146-551-771-162-24X,Granted Patent,no,0,0,9,9,0,,B65D/;;B65D81/18;;B65D81/24;;B65D81/38;;B65D88/74;;F25D/;;F25D3/00,,0,0,,,,EXPIRED
232,US,A1,US 2003/0154069 A1,001-307-221-581-754,2003-08-14,2003,US 7632602 A,2002-02-14,US 7632602 A,2002-02-14,Computerized system and method for converting selected text between languages,"
   The present invention provides a web-based/computerized system and method for converting selected text between languages. Specifically, under the present invention, a user can designate a source language and a destination language using a computerized device (e.g., personal computer, handheld device, etc.). Once designated, an updatable language dictionary corresponding to the designated languages will be accessed (e.g., downloaded or referenced) at a remote source and used to convert selected text between the languages. 
",IBM,CAREW DAVID;;DINH HUNG;;HU TENG;;LAKHDHIR MANSOOR;;NOETHER ANGELA ENG-LING,INTERNATIONAL BUSINESS MACHINES CORPORATION (2002-02-01),https://lens.org/001-307-221-581-754,Patent Application,yes,15,21,1,1,0,G06F40/58;;G06F40/58,G06F17/28,704/7,0,0,,,,DISCONTINUED
233,US,B2,US 11829404 B2,068-817-644-137-605,2023-11-28,2023,US 202017119546 A,2020-12-11,US 202017119546 A;;US 201816230788 A;;US 201762609522 P,2017-12-22,Functional image archiving,"Some implementations related to archiving of functional images. In some implementations, a method includes accessing images and determining one or more functional labels corresponding to each of the images and one or more confidence scores corresponding to the functional labels. A functional image score is determined for each of the images based on the functional labels having a corresponding confidence score that meets a respective threshold for the functional labels. In response to determining that the functional image score meets a functional image score threshold, a functional image signal is provided that indicates that one or more of the images that meet the functional image score threshold are functional images. The functional images are determined to be archived, and are archived by associating an archive attribute with the functional images such that functional images having the archive attribute are excluded from display in views of the images.",GOOGLE LLC,CHENG SHINKO;;KIM EUNYOUNG;;DAI SHENGYANG;;KHANDELWAL MADHUR;;ENG KRISTINA;;LOXTON DAVID,GOOGLE LLC (2018-12-21),https://lens.org/068-817-644-137-605,Granted Patent,yes,277,0,4,4,0,G06F16/51;;G06F18/2433;;G06F16/51;;G06F16/113;;G06F18/2433,G06F16/51;;G06F16/11;;G06F18/2433,,143,9,050-779-373-968-993;;054-041-864-047-958;;055-642-994-424-491;;001-337-251-310-178;;092-251-043-517-741;;057-091-443-406-427;;006-757-908-435-833;;067-825-083-591-587;;042-458-608-620-40X,10.1007/s10032-006-0020-2;;10.1145/2598153.2598162;;10.1145/2939672;;10.1145/2939672.2939801;;10.1145/240080.240326;;10.1109/issa.2012.6320432;;10.1109/cvpr.2015.7298935;;10.1109/cvpr.2004.1315147;;10.1145/2420950.2420968,"Notice of Acceptance for Australian Patent Application No. 2015214298, dated Apr. 20, 2018, 3 pages.;;Examination Report No. 1 for Australian Patent Application No. 2015214298, dated Apr. 24, 2017, 3 pages.;;Examination Report No. 2 for Australian Patent Application No. 2015214298, dated Nov. 2, 2017, 3 pages.;;WIPO, International Search Report and Written Opinion for International Patent Application No. PCT/US2015/014414, dated May 11, 2015, 8 pages.;;Blippar, “Computer Vision API”, www.web.blippar.com/computer-vision-api, 4 pages.;;Chen, et al., “A Survey of Document Image Classification: problem statement, classifier architecture and performance evaluation”, International Journal of Document Analysis and Recognition (IJDAR), vol. 10, No. 1, Aug. 3, 2006, pp. 1-16.;;Chen, et al., “Bezel Copy: An Efficient Cross-0Application Copy-Paste Technique for Touchscreen Smartphones.”, Advanced Visual Interfaces, ACM, New York, New York, May 27, 2014, pp. 185-192.;;CNIPA, First Office Action (with English translation) for Chinese Patent Application No. 201680082643.2, dated Aug. 5, 2020, 24 pages.;;CNIPA, First Office Action for Chinese Patent Application No. 201580016692.1, dated Nov. 2, 2018, 7 pages.;;CNIPA, First Office Action for Chinese Patent Application No. 201680070359.3, dated Jun. 3, 2020, 9 pages.;;WIPO, International Search Report and Written Opinion for PCT Application No. PCT/US2017/046858, dated Oct. 11, 2017, 10 Pages.;;WIPO, Written Opinion of the International Preliminary Examining Authority for International Patent Application No. PCT/US2018/021028, dated Jun. 14, 2019, 11 pages.;;WIPO, International Search Report and Written Opinion for International Patent Application No. PCT/US2016/068083, dated Mar. 9, 2017, 13 pages.;;WIPO, International Search Report for International Patent Application No. PCT/US2017/052713, dated Dec. 5, 2017, 4 Pages.;;WIPO, International Search Report for International Patent Application No. PCT/US2016/068083, dated Mar. 9, 2017, 4 pages.;;WIPO, International Search Report for International Patent Application No. PCT/US2018/022501, dated May 14, 2018, 4 pages.;;EPO, Communication Pursuant to Article 94(3) EPC for European Patent Application No. 16825663.4, dated Apr. 16, 2019, 5 pages.;;WIPO, International Search Report for International Patent Application No. PCT/US2017/052349, dated Dec. 13, 2017, 5 pages.;;WIPO, International Search Report for International Patent Application No. PCT/US2017/057044, dated Jan. 18, 2018, 5 pages.;;EPO, Communication Pursuant to Article 94(3) EPC for European Patent Application No. 16825663.4, dated May 7, 2020, 5 pages.;;WIPO, Written Opinion for International Patent Application No. PCT/US2017/052713, dated Dec. 5, 2017, 6 Pages.;;EPO, Communication Pursuant to Article 94(3) EPC for European Patent Application No. 16825666.7, dated Apr. 23, 2019, 6 pages.;;WIPO, International Search Report for International Patent Application No. PCT/US2018/022503, dated Aug. 16, 2018, 6 pages.;;WIPO, Written Opinion for International Patent Application No. PCT/US2017/052349, dated Dec. 13, 2017, 6 pages.;;EPO, Communication Pursuant to Article 94(3) EPC for European Patent Application No. 18716399.3, dated Jul. 3, 2020, 6 pages.;;EPO, Communication Pursuant to Article 94(3) EPC for European Patent Application No. 16825666.7, dated Jun. 18, 2020, 6 pages.;;WIPO, Written Opinion for International Patent Application No. PCT/US2018/022501 , dated May 14, 2018, 6 pages.;;WIPO, Written Opinion of the International Preliminary Examining Authority for International Patent Application No. PCT/US2017/052713, dated Oct. 15, 2018, 6 pages.;;EPO, Extended European Search Report for European Patent Application No. 15746410.8, dated Sep. 5, 2017, 7 pages.;;WIPO, Written Opinion for International Patent Application No. PCT/US2018/022503, dated Aug. 16, 2018, 8 pages.;;EPO, Communication Pursuant to Article 94(3) EPC for European Patent Application No. 17794825.4, dated Aug. 4, 2020, 8 pages.;;WIPO, Written Opinion of the International Preliminary Examination Authority for International Patent Application No. PCT/US2017/057044, dated Dec. 20, 2018, 8 pages.;;WIPO, Written Opinion for International Patent Application No. PCT/US2017/057044, dated Jan. 18, 2018, 8 pages.;;WIPO, Written Opinion of the International Preliminary Examining Authority for International Patent Application No. PCT/US2017/052349, dated Aug. 6, 2018, 9 pages.;;WIPO, Written Opinion for International Patent Application No. PCT/US2016/068083, dated Mar. 9, 2017, 9 pages.;;Fuxman, Ariel, “Aw, so cute!”: Allo helps you respond to shared photos, Google Research Blog, https://research.googleblog.com/2016/05/aw-so-cute-allo-helps-you-respond-to.html, May 18, 2016, 6 pages.;;WIPO, International Preliminary Report on Patentability for International Patent Application No. PCT/US2018/021028, dated Nov. 28, 2019, 10 pages.;;WIPO, International Preliminary Report on Patentability for International Patent Application No. PCT/US2018/022501, dated Dec. 17, 2019, 7 pages.;;WIPO, International Preliminary Report on Patentability for International Patent Application No. PCT/US2017/046858, dated Feb. 19, 2019, 7 pages.;;WIPO, International Preliminary Report on Patentability for International Patent Application No. PCT/US2017/052349, dated Mar. 26, 2019, 7 pages.;;WIPO, International Preliminary Report on Patentability for International Patent Application No. PCT/US2018/022503, dated Dec. 17, 2019, 9 pages.;;WIPO, International Preliminary Report on Patentability for International Patent Application No. PCT/US2017/057044, dated Jul. 30, 2019, 9 pages.;;WIPO, International Preliminary Report on Patentability for International Patent Application No. PCT/US2016/068083, dated Jul. 5, 2018, 9 pages.;;IPO, First Examination Report for Indian Patent Application No. 201847014172, dated Jun. 17, 2020, 7 pages.;;JPO, Notice of Allowance (with English translation) for Japanese Patent Application No. 2018-551908, dated Dec. 3, 2019, 2 pages.;;JPO, Notice of Allowance (with English translation) for Japanese Patent Application No. 2019-505058, dated Jan. 21, 2020, 2 pages.;;JPO, Notice of Allowance (including English translation) for Japanese Patent Application No. 2019-547462, dated May 28, 2020, 2 pages.;;JPO, Notice of Allowance (with English translation) for Japanese Patent Application No. 2019-520680, dated Nov. 12, 2019, 2 pages.;;JPO, Notice of Allowance (with English translation) for Japanese Patent Application No. 2018-532399, dated Sep. 23, 2020, 2 pages.;;JPO, Office Action for Japanese Patent Application No. 2018-532399, dated Jun. 16, 2020, 3 pages.;;JPO, Office Action for Japanese Patent Application No. 2018-551908, dated Aug. 20, 2019, 4 pages.;;JPO, Office Action for Japanese Patent Application No. 2018-532399, dated Mar. 10, 2020, 4 pages.;;JPO, Office Action for Japanese Patent Application No. 2019-518995, dated Jul. 28, 2020, 5 pages.;;JPO, Office Action for Japanese Patent Application No. 2019-547462, dated Feb. 18, 2020, 6 pages.;;JPO, Office Action for Japanese Patent Application No. 2018-532399, dated Jul. 23, 2019, 6 pages.;;Kannan, et al., “Smart Reply: Automated Response Suggestions for Email”, Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, KDD '16, ACM Press, New York, New York, Aug. 13, 2016, pp. 955-965.;;Kannan, Anjuli et al., “Smart reply: Automated response suggestion for email”, Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, Aug. 13, 2016, 10 pages.;;Khandelwal, “Hey Allo! Meet Google's AI-powered Smart Messaging App”, The Hacker News, http://web.archive.org/web/20160522155700/https://thehackernews.com/2016/05/google-allo-messenger.html, May 19, 2016, 3 pages.;;KIPO, Notice of Preliminary Rejection for Korean Patent Application No. 10- 2019-7011687, dated May 7, 2019, 3 pages.;;KIPO, Notice of Final Rejection for Korean Patent Application No. 10-2018-7019756, dated Nov. 25, 2019, 3 pages.;;KIPO, Notice of Allowance (with English translation) for Korean Patent Application No. 10-2019-7024479, dated Jan. 17, 2020, 4 pages.;;KIPO, Notice of Final Rejection for Korean Patent Application No. 10-2018-7019756, dated Jan. 17, 2020, 4 pages.;;KIPO, Notice of Final Rejection for Korean Patent Application No. 10-2018-7013953, dated Jun. 13, 2019, 4 pages.;;KIPO, Notice of Final Rejection for Korean Patent Application No. 10-2019-7020465, dated Jun. 29, 2020, 4 pages.;;KIPO, Notice of Final Rejection for Korean Patent Application No. 10-2018-7013953, dated May 8, 2019, 4 pages.;;KIPO, Notice of Allowance for Korean Patent Application No. 10-2019-7011687, dated Sep. 26, 2019, 4 pages.;;KIPO, Notice of Allowance (with English translation) for Korean Patent Application No. 10-2019-7020465, dated Aug. 5, 2020, 5 pages.;;KIPO, Preliminary Rejection for Korean Patent Application No. 10-2018-7013953, dated Oct. 29, 2018, 5 pages.;;KIPO, Notice of Preliminary Rejection (with English translation) for Korean Patent Application No. 10-2019-7020465, dated Jan. 10, 2020, 9 pages.;;KIPO, Notice of Preliminary Rejection for Korean Patent Application No. 10-2018-7019756, dated May 13, 2019, 9 pages.;;KIPO, Notice of Preliminary Rejection for Korean Patent Application No. 10-2019-7024479, dated Sep. 18, 2019, 9 pages.;;Lardinois, F. “Allo brings Google's smarts to messaging”, https://techcrunch.com/2016/09/20/allo-brings-googles-smarts-to-messaging/, Sep. 2016, 14 pages.;;Lee, Jang Ho et al., “Supporting multi-user, multi-applet workspaces in CBE”, Proceedings of the 1996 ACM conference on Computer supported cooperative work, ACM, Nov. 16, 1996, 10 pages.;;Microsoft Corporation, “Windows Messenger for Windows XP”, Retrieved from Internet: http://web.archive.org/web/20030606220012/messenger.msn.com/support/features.asp?client=0 on Sep. 22, 2005, Jun. 6, 2003, 3 pages.;;WIPO, “International Search Report and Written Opinion for International Application No. PCT/US2018/021028”, dated Jun. 15, 2018, 11 Pages.;;Pieterse, et al., “Android botnets on the rise: trends and characteristics”, 2012 Information Security for South Africa, Aug. 15-17, 2012, 5 pages.;;Pinterest,“Pinterest Lens”, www.help.pinterest.com/en/articles/pinterest-lens, 2 pages.;;Russell, “Google Allo is the Hangouts Killer We've Been Waiting For”, Retrieved from the Internet: http://web.archive.org/web/20160519115534/https://www.technobuffalo.com/2016/05/18/google-allo-hangouts-replacement/, May 18, 2016, 3 pages.;;USPTO, Notice of Allowance for U.S. Appl. No. 16/552,902, dated Aug. 27, 2020, 10 pages.;;USPTO, Notice of Allowance for U.S. Appl. No. 16/560,815, dated Aug. 31, 2020, 11 pages.;;USPTO, Notice of Allowance for U.S. Appl. No. 15/709,418, dated Mar. 1, 2018, 11 pages.;;USPTO, Notice of Allowance for U.S. Appl. No. 16/003,661, dated May 1, 2019, 11 pages.;;USPTO, Non-final Office Action for U.S. Appl. No. 15/386,162, dated Nov. 27, 2018, 11 Pages.;;USPTO, Final Office Action for U.S. Appl. No. 15/386,760, dated Jan. 10, 2020, 12 pages.;;USPTO, Non-final Office Action for U.S. Appl. No. 15/386,162, dated Nov. 27, 2018, 12 pages.;;USPTO, Non-final Office Action for U.S. Appl. No. 15/386,760, dated Oct. 11, 2019, 12 pages.;;USPTO, Notice of Allowance for U.S. Appl. No. 15/912,809, dated Sep. 11, 2020, 12 pages.;;USPTO, Final Office Action for U.S. Appl. No. 15/386,162, dated Jun. 5, 2019, 13 pages.;;USPTO, Final Office Action for U.S. Appl. No. 15/386,760, dated May 30, 2019, 13 pages.;;USPTO, Final Office Action for U.S. Appl. No. 15/238,304, dated Nov. 23, 2018, 14 pages.;;USPTO, Notice of Allowance for U.S. Appl. No. 14/618,962, dated Nov. 8, 2016, 14 pages.;;USPTO, Non-final Office Action for U.S. Appl. No. 15/709,418, dated Nov. 21, 2017, 15 pages.;;USPTO, Non-final Office Action for U.S. Appl. No. 16/881,816, dated Nov. 27, 2020, 15 pages.;;USPTO, Notice of Allowance for U.S. Appl. No. 16/230,788, dated Oct. 2, 2020, 15 pages.;;USPTO, Notice of Allowance for U.S. Appl. No. 15/350,040, dated Apr. 24, 2019, 16 pages.;;USPTO, First Action Interview, Office Action Summary for U.S. Appl. No. 16/003,661, dated Dec. 14, 2018, 16 pages.;;USPTO, Non-final Office Action for U.S. Appl. No. 16/560,815, dated May 18, 2020, 16 pages.;;USPTO, Notice of Allowance for U.S. Appl. No. 16/569,273, dated Feb. 20, 2020, 17 pages.;;USPTO, Non-final Office Action for U.S. Appl. No. 15/238,304, dated Jun. 7, 2018, 17 pages.;;USPTO, First Action Interview, Office Action Summary for U.S. Appl. No. 15/912,809, dated Feb. 18, 2020, 18 pages.;;USPTO, Notice of Allowance for U.S. Appl. No. 15/709,423, dated Oct. 9, 2019, 19 pages.;;USPTO, Notice of Allowance for U.S. Appl. No. 15/428,821, dated Jan. 10, 2018, 20 pages.;;USPTO, Notice of Allowance for U.S. Appl. No. 15/709,440, dated Aug. 6, 2019, 21 pages.;;USPTO, Notice of Allowance for U.S. Appl. No. 15/624,638, dated Feb. 28, 2019, 21 Pages.;;USPTO, Non-final Office Action for U.S. Appl. No. 15/709,423, dated May 2, 2019, 21 Pages.;;USPTO, Non-final Office Action for U.S. Appl. No. 16/569,273, dated Oct. 18, 2019, 21 pages.;;USPTO, Non-final Office Action for U.S. Appl. No. 14/618,962, dated Feb. 26, 2016, 25 pages.;;USPTO, Notice of Allowance for U.S. Appl. No. 15/415,506, dated Jul. 23, 2018, 25 pages.;;USPTO, Non-final Office Action for U.S. Appl. No. 15/428,821, dated May 18, 2017, 30 pages.;;USPTO, First Action Interview, Pre-Interview Communication for U.S. Appl. No. 15/709,440, dated May 16, 2019, 4 pages.;;USPTO, First Action Interview, Pre-Interview Communication for U.S. Appl. No. 15/624,637, dated Oct. 19, 2018, 4 pages.;;USPTO, First Action Interview, Office Action Summary for U.S. Appl. No. 15/350,040, dated Oct. 30, 2018, 4 pages.;;USPTO, Non-final Office Action for U.S. Appl. No. 15/946,342, dated Jul. 26, 2018, 40 pages.;;USPTO, First Action Interview, Pre-Interview Communication for U.S. Appl. No. 15/415,506, dated Apr. 5, 2018, 5 pages.;;USPTO, First Action Interview, Pre-Interview Communication for U.S. Appl. No. 16/436,632, dated Aug. 14, 2020, 5 pages.;;USPTO, Notice of Allowance for U.S. Appl. No. 15/386,162, dated Aug. 9, 2019, 5 pages.;;USPTO, First Action Interview, Office Action Summary for U.S. Appl. No. 15/624,637, dated Jan. 25, 2019, 5 pages.;;USPTO, First Action Interview, Pre-Interview Communication for U.S. Appl. No. 15/912,796, dated Jan. 8, 2020, 5 pages.;;USPTO, First Action Interview, Pre-Interview Communication for U.S. Appl. No. 15/350,040, dated Jul. 16, 2018, 5 pages.;;USPTO, First Action Interview, Office Action Summary for U.S. Appl. No. 15/912,796, dated Mar. 13, 2020, 5 pages.;;USPTO, First Action Interview, Pre-Interview Communication for U.S. Appl. No. 15/912,809, dated Nov. 22, 2019, 5 pages.;;USPTO, First Action Interview, Pre-Interview Communication for U.S. Appl. No. 15/386,760, dated Nov. 6, 2018, 5 pages.;;USPTO, First Action Interview, Office Action Summary for U.S. Appl. No. 16/436,632, dated Nov. 6, 2020, 5 pages.;;USPTO, Notice of Allowance for U.S. Appl. No. 15/624,637, dated Apr. 19, 2019, 6 pages.;;USPTO, First Action Interview, Pre-Interview Communication for U.S. Appl. No. 16/003,661, dated Aug. 29, 2018, 6 pages.;;USPTO, Notice of Allowance for U.S. Appl. No. 15/238,304, dated Apr. 5, 2019, 7 pages.;;USPTO, First Action Interview, Office Action Summary for U.S. Appl. No. 15/386,760, dated Jan. 30, 2019, 8 pages.;;USPTO, Notice of Allowance for Design U.S. Appl. No. 29/503,386, dated Jul. 13, 2016, 8 pages.;;USPTO, Final Office Action for U.S. Appl. No. 15/912,809, dated Jun. 24, 2020, 8 pages.;;USPTO, Notice of Allowance for U.S. Appl. No. 15/386,760, dated Apr. 24, 2020, 9 pages.;;USPTO, Notice of Allowance for U.S. Appl. No. 15/912,796, dated Aug. 20, 2020, 9 pages.;;USPTO, Non-final Office Action for Design U.S. Appl. No. 29/503,386, dated Feb. 1, 2016, 9 pages.;;Vinyals, O. et al., “Show and Tell: A Neural Image Caption Generator”, arXiv:1411.4555v2 [cs.CV], Apr. 20, 2015, pp. 1-9.;;WIPO, International Preliminary Report on Patentability for International Patent Application No. PCT/US2017/52333, dated Dec. 4, 2018, 15 pages.;;WIPO, Written Opinion of the International Preliminary Examining Authority for International Patent Application No. PCT/US2017/52333, dated Aug. 17, 2018, 5 pages.;;WIPO, “International Search Report and Written Opinion PCT application No. PCT/US2017/052333”, dated Nov. 30, 2017, 15 pages.;;Yeh, et al., “Searching the web with mobile images for location recognition”, Proceedings of the 2004 IEEE Computer Society Conference on Pattern Recognition, vol. 2, Jun.-Jul. 2004, pp. 1-6.;;Zhao, et al., “Cloud-based push-styled mobile botnets: a case study of exploiting the cloud to device messaging service”, Proceedings ACSAC '12, Proceedings of the 28th Annual Computer Security Applications Conference, ACM Digital Library, Dec. 3, 2012, pp. 119-128.;;USPTO, Notice of Allowance for U.S. Appl. No. 17/340,868, dated Sep. 9, 2022, 15 pages.;;USPTO, Notice of Allowance for U.S. Appl. No. 17/110,166, dated Oct. 27, 2022, 9 pages.;;USPTO, Non-final Office Action for U.S. Appl. No. 17/110,166, dated Apr. 28, 2022, 10 pages.;;USPTO, Notice of Allowance for U.S. Appl. No. 16/881,816, dated Feb. 4, 2021, 15 pages.;;USPTO, Non-final Office Action for U.S. Appl. No. 17/340,868, dated Jun. 3, 2022, 15 pages.",ACTIVE
234,TW,B,TW I413778 B,143-589-199-474-414,2013-11-01,2013,TW 97139125 A,2008-10-13,US 99876307 P;;US 98650807 A,2007-10-12,Adjustable test pattern results latency,,TERADYNE INC,MCGOLDRICK MICHAEL F;;BORROZ WILLIAM T;;ENG STEPHEN K;;MILLEY DAVID A,,https://lens.org/143-589-199-474-414,Granted Patent,no,4,0,12,12,0,G01R31/31726;;G01R31/31813;;G11C29/10;;G11C29/56;;G11C29/10;;G01R31/31813;;G01R31/31726;;G11C29/56,,,0,0,,,,ACTIVE
235,US,A1,US 2019/0197364 A1,172-930-933-002-912,2019-06-27,2019,US 201816230788 A,2018-12-21,US 201816230788 A;;US 201762609522 P,2017-12-22,FUNCTIONAL IMAGE ARCHIVING,"Some implementations related to archiving of functional images. In some implementations, a method includes accessing images and determining one or more functional labels corresponding to each of the images and one or more confidence scores corresponding to the functional labels. A functional image score is determined for each of the images based on the functional labels having a corresponding confidence score that meets a respective threshold for the functional labels. In response to determining that the functional image score meets a functional image score threshold, a functional image signal is provided that indicates that one or more of the images that meet the functional image score threshold are functional images. The functional images are determined to be archived, and are archived by associating an archive attribute with the functional images such that functional images having the archive attribute are excluded from display in views of the images.",GOOGLE LLC,CHENG SHINKO;;KIM EUNYOUNG;;DAI SHENGYANG;;KHANDELWAL MADHUR;;ENG KRISTINA;;LOXTON DAVID,GOOGLE LLC (2018-12-21),https://lens.org/172-930-933-002-912,Patent Application,yes,0,16,4,4,0,G06F16/51;;G06F18/2433;;G06F16/51;;G06F16/113;;G06F18/2433,G06K9/62;;G06F16/11;;G06F16/51,,0,0,,,,ACTIVE
236,US,A1,US 2004/0099422 A1,068-659-558-506-995,2004-05-27,2004,US 71704603 A,2003-11-19,US 71704603 A;;US 13802002 A,2002-05-02,Subsea riser separator system,"
   A preferred embodiment of the inventive fluid delivery system comprises a vertical liquid/vapor separator and riser assembly that comprises a multi-phase separator inlet, a vapor outlet and riser, and a liquid outlet port connected to a hydraulically-driven centrifugal pump. By controlling the operational speed of the pump, the level of the separated liquid within the separator can be controlled without the need for control valves. The vertical separator is capable of low pressure operation and large variations in controlled liquid levels within the separator, allowing the relatively slow reaction time pump to control the liquid level from low pressure wells penetrating low pressure reservoirs. 
",LUSH DAVID;;ENG JONATHAN;;UCOK HIKMET;;HOPGOOD DAVE;;LANDECK CHRIS;;CARMON KEN,LUSH DAVID;;ENG JONATHAN;;UCOK HIKMET;;HOPGOOD DAVE;;LANDECK CHRIS;;CARMON KEN,,https://lens.org/068-659-558-506-995,Patent Application,yes,24,20,6,6,0,E21B43/01;;E21B43/36;;E21B43/36;;E21B43/01,E21B43/01;;E21B43/36,166/357;;166/265,0,0,,,,EXPIRED
237,EP,A4,EP 2212787 A4,086-120-469-306-40X,2010-12-22,2010,EP 08838186 A,2008-10-10,US 2008/0079456 W;;US 99876307 P;;US 98650807 A,2007-10-12,ADJUSTABLE TEST PATTERN RESULTS LATENCY,,TERADYNE INC,MCGOLDRICK MICHAEL F;;BORROZ WILLIAM T;;ENG STEPHEN K;;MILLEY DAVID A,,https://lens.org/086-120-469-306-40X,Search Report,no,2,0,12,12,0,G01R31/31726;;G01R31/31813;;G11C29/10;;G11C29/56;;G11C29/10;;G01R31/31813;;G01R31/31726;;G11C29/56,G06F11/00;;G01R31/28;;G01R31/3181;;G01R31/319;;G01R31/3193;;G11C29/56,,1,1,063-818-200-213-18X,10.1109/autest.2005.1609214,"JONES C ET AL: ""User-centric digital test architecture"", AUTOTESTCON, 2005. IEEE SEPT. 26, 2005, PISCATAWAY, NJ, USA,IEEE, 26 September 2005 (2005-09-26), pages 665 - 672, XP010910953, ISBN: 978-0-7803-9101-7, DOI: 10.1109/AUTEST.2005.1609214",ACTIVE
238,US,B1,US 11326460 B1,114-847-535-798-483,2022-05-10,2022,US 202117376497 A,2021-07-15,US 202117376497 A,2021-07-15,Airfoil profile for a turbine nozzle,"An airfoil profile for a turbine nozzle of a gas turbine is provided. The turbine nozzle may include an airfoil portion having an uncoated nominal profile substantially in accordance with Cartesian coordinate values of X, Y, and Z set forth in Table 1, wherein the X, Y, and Z coordinates are distances in inches measured in a Cartesian coordinate system, the corresponding X and Y coordinates, when connected by a smooth continuous arc, define one of a plurality of airfoil profile sections at each Z distance, and the plurality of airfoil profile sections, when joined together by smooth continuous arcs, define an airfoil shape.",DOOSAN HEAVY IND & CONSTRUCTION CO LTD,KIM JINUK;;KIM KWANGIL;;KOPKO JASON;;GREENBERG JEFF;;ENG DARRYL;;DAY DAVID,DOOSAN HEAVY INDUSTRIES & CONSTRUCTION CO. LTD (2021-06-07),https://lens.org/114-847-535-798-483,Granted Patent,yes,21,2,2,2,0,F01D9/041;;F05D2250/74;;Y02T50/60;;F01D9/041;;F01D5/141;;F01D5/288;;F05D2240/35;;F05D2220/32;;F01D9/041;;F05D2240/128;;F05D2220/32;;F05D2240/10;;F01D5/141;;F01D5/143,F01D9/04;;F01D5/14,,0,0,,,,ACTIVE
239,US,B2,US 7788564 B2,107-939-117-201-984,2010-08-31,2010,US 98650807 A,2007-11-21,US 98650807 A;;US 99876307 P,2007-10-12,Adjustable test pattern results latency,"A digital test instrument and a test method provide adjustable results latency. A digital test instrument includes a pattern controller configured to generate a sequence of test patterns, responsive, at least in part, to a pass/fail result, a pattern memory configured to supply the generated sequence of test patterns to a unit under test, a pattern results collection unit configured to receive at least one result value from the unit under test and to determine a pass/fail result for at least one supplied test pattern, and a synchronization unit configured to provide a no-result indication to the pattern controller during a preset number of pattern cycles following the start of a test, the preset number of pattern cycles based on a results latency of the test instrument, and to provide pass/fail results to the pattern controller after the preset number of pattern cycles.",TERADYNE INC,MCGOLDRICK MICHAEL F;;BORROZ WILLIAM T;;ENG STEPHEN K;;MILLEY DAVID A,TERADYNE INC (2008-04-01),https://lens.org/107-939-117-201-984,Granted Patent,yes,12,2,12,12,0,G01R31/31726;;G01R31/31813;;G11C29/10;;G11C29/56;;G11C29/10;;G01R31/31813;;G01R31/31726;;G11C29/56,G06F11/00,714/738;;714/744,3,1,063-818-200-213-18X,10.1109/autest.2005.1609214,"C. Jones et al., ""User-Centric Digital Test Architecture"", IEEE Autotestcon, Sep. 26-29, 2005.;;L-Series Language Manual, Teradyne, Inc., 3 pages, 2009.;;M9-Series Digital Test Instrument Help, Teradyne, Inc., 6 pages, 2009.",ACTIVE
240,HK,A1,HK 1075108 A1,011-374-472-690-501,2005-12-02,2005,HK 05107416 A,2005-08-24,US 4101301 A;;US 0240167 W,2001-12-28,Multiple mode power throttle mechanism,,INTEL CORP,BURNS JAMES;;AYERS DAVID;;ENG MARSHA;;GROCHOWSKI EDWARD;;RUSU STEFAN;;TIWARI VIVEK,,https://lens.org/011-374-472-690-501,Patent Application,no,0,0,9,9,0,G06F1/3203;;G06F1/3243;;G06F9/3017;;G06F9/3836;;G06F9/3869;;G06F9/3873;;G06F9/384;;Y02D10/00;;G06F9/3858;;G06F9/3836;;G06F9/3873;;G06F1/3203;;G06F1/3243;;G06F9/3017;;G06F9/3869;;G06F9/384;;Y02D10/00;;G06F9/3858,G06F/;;G06F1/32;;G06F9/318,,0,0,,,,DISCONTINUED
241,US,B2,US 10891526 B2,087-093-570-858-44X,2021-01-12,2021,US 201816230788 A,2018-12-21,US 201816230788 A;;US 201762609522 P,2017-12-22,Functional image archiving,"Some implementations related to archiving of functional images. In some implementations, a method includes accessing images and determining one or more functional labels corresponding to each of the images and one or more confidence scores corresponding to the functional labels. A functional image score is determined for each of the images based on the functional labels having a corresponding confidence score that meets a respective threshold for the functional labels. In response to determining that the functional image score meets a functional image score threshold, a functional image signal is provided that indicates that one or more of the images that meet the functional image score threshold are functional images. The functional images are determined to be archived, and are archived by associating an archive attribute with the functional images such that functional images having the archive attribute are excluded from display in views of the images.",GOOGLE LLC,CHENG SHINKO;;KIM EUNYOUNG;;DAI SHENGYANG;;KHANDELWAL MADHUR;;ENG KRISTINA;;LOXTON DAVID,GOOGLE LLC (2018-12-21),https://lens.org/087-093-570-858-44X,Granted Patent,yes,135,0,4,4,0,G06F16/51;;G06F18/2433;;G06F16/51;;G06F16/113;;G06F18/2433,G06K9/62;;G06F16/11;;G06F16/51,,52,6,050-779-373-968-993;;054-041-864-047-958;;055-642-994-424-491;;092-251-043-517-741;;006-757-908-435-833;;067-825-083-591-587,10.1007/s10032-006-0020-2;;10.1145/2598153.2598162;;10.1145/2939672;;10.1145/240080.240326;;10.1109/cvpr.2015.7298935;;10.1109/cvpr.2004.1315147,"WIPO, International Preliminary Report on Patentability for International Patent Application No. PCT/US2018/021028, dated Nov. 28, 2019, 10 pages.;;USPTO, First Action Interview, Pre-Interview Communication for U.S. Appl. No. 15/912,796, dated Jan. 8, 2020, 5 pages.;;USPTO, First Action Interview, Pre-Interview Communication for U.S. Appl. No. 15/912,809, dated Nov. 22, 2019, 5 pages.;;USPTO, Final Office Action for U.S. Appl. No. 15/912,809, dated Jun. 24, 2020, 8 pages.;;USPTO, Notice of Allowance for U.S. Appl. No. 15/912,809, dated Sep. 11, 2020, 12 pages.;;USPTO, Notice of Allowance for U.S. Appl. No. 15/912,796, dated Aug. 20, 2020, 9 pages.;;USPTO, First Action Interview, Office Action Summary for U.S. Appl. No. 15/912,809, dated Feb. 18, 2020, 18 pages.;;USPTO, Notice of Allowance for U.S. Appl. No. 16/569,273, dated Feb. 20, 2020, 17 pages.;;USPTO, First Action Interview, Office Action Summary for U.S. Appl. No. 15/912,796, dated Mar. 13, 2020, 5 pages.;;USPTO, Non-final Office Action for U.S. Appl. No. 16/569,273, dated Oct. 18, 2019, 21 pages.;;EPO, Written Opinion of the International Preliminary Examining Authority for International Patent Application No. PCT/US2018/021028, dated Jun. 14, 2019, 11 pages.;;Chen, et al., “A Survey of Document Image Classification: problem statement, classifier architecture and performance evaluation,” International Journal of Document Analysis and Recognition (IJDAR), vol. 10, No. 1, Aug. 3, 2006, pp. 1-16.;;APO, Notice of Acceptance for Australian Patent Application No. 2015214298, dated Apr. 20, 2018, 3 pages.;;APO, Examination Report No. 1 for Australian Patent Application No. 2015214298, dated Apr. 24, 2017, 3 pages.;;APO, Examination Report No. 2 for Australian Patent Application No. 2015214298, dated Nov. 2, 2017, 3 pages.;;USPTO, International Search Report and Written Opinion for International Patent Application No. PCT/US2015/014414, dated May 11, 2015, 8 pages.;;Blippar, “Computer Vision API”, www.web.blippar.com/computer-vision-api, 2018, 4 pages.;;Chen, et al., “Bezel Copy: An Efficient Cross-0Application Copy-Paste Technique for Touchscreen Smartphones.”, Advanced Visual Interfaces, ACM, New York, New York, May 27, 2014, pp. 185-192.;;EPO, International Search Report and Written Opinion for International Patent Application No. PCT/US2016/068083, dated Mar. 9, 2017, 13 pages.;;EPO, International Search Report for International Patent Application No. PCT/US2017/052713, dated Dec. 5, 2017, 4 pages.;;EPO, International Search Report for International Patent Application No. PCT/US2018/022501, dated May 14, 2018, 4 pages.;;EPO, International Search Report for International Patent Application No. PCT/US2017/052349, dated Dec. 13, 2017, 5 pages.;;EPO, International Search Report for International Patent Application No. PCT/US2017/057044, dated Jan. 18, 2018, 5 pages.;;EPO, Written Opinion for International Patent Application No. PCT/US2017/052713, dated Dec. 5, 2017, 6 pages.;;EPO, International Search Report for International Patent Application No. PCT/US2018/022503, dated Aug. 16, 2018, 6 pages.;;EPO, Written Opinion for International Patent Application No. PCT/US2017/052349, dated Dec. 13, 2017, 6 pages.;;EPO, Written Opinion for International Patent Application No. PCT/US2018/022501, dated May 14, 2018, 6 pages.;;EPO, Extended European Search Report for European Patent Application No. 15746410.8, dated Sep. 5, 2017, 7 pages.;;EPO, Written Opinion for International Patent Application No. PCT/US2018/022503, dated Aug. 16, 2018, 8 pages.;;EPO, Written Opinion for International Patent Application No. PCT/US2017/057044, dated Jan. 18, 2018, 8 pages.;;EPO, Written Opinion of the International Preliminary Examining Authority for International Patent Application No. PCT/US2017/052349, dated Aug. 6, 2018, 9 pages.;;Fuxman, ““Aw, so cute!”: Allo helps you respond to shared photos”, Google Research Blog, https://research.googleblog.com/2016/05/aw-so-cute-allo-helps-you-respond-to.html, May 18, 2016, 6 pages.;;Kannan, et al., “Smart Reply: Automated Response Suggestions for Email”, Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, KDD '16, ACM Press, New York, New York, Aug. 13, 2016, pp. 955-965.;;Khandelwal, “Hey Allo! Meet Google's Al-powered Smart Messaging App”, The Hacker News, http://web.archive.org/web/20160522155700/https://thehackernews.com/2016/05/google-allo-messenger.html, May 19, 2016, 3 pages.;;Lee, et al., “Supporting multi-user, multi-applet workspaces in CBE”, Proceedings of the 1996 ACM conference on Computer supported cooperative work, ACM, Nov. 16, 1996, 10 pages.;;Microsoft Corporation, “Windows Messenger for Windows XP”, Retrieved from Internet: http://web.archive.org/web/20030606220012/messenger.msn.com/support/features.asp?client=0 on Sep. 22, 2005, Jun. 6, 2003, 3 pages.;;EPO, International Search Report and Written Opinion for International Application No. PCT/US2018/021028, dated Jun. 15, 2018, 11 pages.;;Pinterest, “Pinterest Lens”, www.help.pinterest.com/en/articles/pinterest-lens, 2 pages.;;Russell, “Google Allo is the Hangouts Killer We've Been Waiting For”, Retrieved from the Internet: http://web.archive.org/web/20160519115534/https://www.technobuffalo.com/2016/05/18/google-allo-hangouts-replacement/, May 18, 2016, 3 pages.;;USPTO, Notice of Allowance for U.S. Appl. No. 15/709,418, dated Mar. 1, 2018, 11 pages.;;USPTO, Notice of Allowance for U.S. Appl. No. 14/618,962, dated Nov. 8, 2016, 14 pages.;;USPTO, Non-final Office Action for U.S. Appl. No. 15/709,418, dated Nov. 21, 2017, 15 pages.;;USPTO, Notice of Allowance for U.S. Appl. No. 15/428,821, dated Jan. 10, 2018, 20 pages.;;USPTO, Non-final Office Action for U.S. Appl. No. 14/618,962, dated Feb. 26, 2016, 25 pages.;;USPTO, Notice of Allowance for U.S. Appl. No. 15/415,506, dated Jul. 23, 2018, 25 pages.;;USPTO, Non-final Office Action for U.S. Appl. No. 15/428,821, dated May 18, 2017, 30 pages.;;USPTO, First Action Interview, Office Action Summary for U.S. Appl. No. 15/350,040, dated Oct. 30, 2018, 4 pages.;;USPTO, Non-final Office Action for U.S. Appl. No. 15/946,342, dated Jul. 26, 2018, 40 pages.;;USPTO, First Action Interview, Pre-Interview Communication for U.S. Appl. No. 15/415,506, dated Apr. 5, 2018, 5 pages.;;USPTO, First Action Interview, Pre-Interview Communication for U.S. Appl. No. 15/350,040, dated Jul. 16, 2018, 5 pages.;;Vinyals, et al., “Show and Tell: A Neural Image Caption Generator”, arXiv:1411.4555v2 [cs.CV], Apr. 20, 2015, pp. 1-9.;;Yeh, et al., “Searching the web with mobile images for location recognition”, Proceedings of the 2004 IEEE Computer Society Conference on Pattern Recognition, vol. 2, Jun.-Jul. 2004, pp. 1-6.",ACTIVE
242,US,B2,US 6680436 B2,174-635-447-111-874,2004-01-20,2004,US 82154901 A,2001-03-29,US 82154901 A;;US 21802900 P,2000-07-12,Reflow encapsulant,"
    A reflow encapsulant is used with substrate and an electronic device. The encapsulant is configured to cure when the assembly is heated so as to reflow solder bumps connecting the substrate and electronic device. The encapsulant includes inorganic filler in an amount of 8% to 20% by weight. The amount of filler provided is sufficiently high to lower the CTE of the encapsulant so as to enhance cured material properties and prevent undue expansion and solder joint damage, but low enough so that the solder joints are not affected by filler particles during reflow. 
",SEAGATE TECHNOLOGY LLC,XU ANTAI;;ECHOLS ROBERT MICHAEL;;YEH ENG SIONG DAVID;;PETERSON MICHAEL JOHN,SEAGATE TECHNOLOGY LLC (2001-03-15),https://lens.org/174-635-447-111-874,Granted Patent,yes,15,14,2,2,0,H01L21/563;;H01L21/563;;H01L24/29;;H01L24/29;;H01L2224/05568;;H01L2224/05568;;H01L2224/05573;;H01L2224/05573;;H01L2224/16225;;H01L2224/16225;;H01L2224/73203;;H01L2224/73203;;H01L2224/73204;;H01L2224/73204;;H01L2224/83192;;H01L2224/83192;;H01L2924/00014;;H01L2924/00014;;H01L2924/01013;;H01L2924/01013;;H01L2924/01033;;H01L2924/01033;;H01L2924/01082;;H01L2924/01082;;H01L2924/14;;H01L2924/14;;H01L2924/351;;H01L2924/351;;H05K3/284;;H05K3/284;;H05K3/3436;;H05K3/3436;;H05K2201/0209;;H05K2201/0209;;H05K2201/10977;;H05K2201/10977;;Y02P70/50;;Y02P70/50,H01L21/56;;H05K3/28;;H05K3/34,174/52.2;;361/760;;361/762;;257/789,0,0,,,,EXPIRED
243,US,B1,US 11454119 B1,153-577-087-762-045,2022-09-27,2022,US 202117377522 A,2021-07-16,US 202117377522 A,2021-07-16,Internal core profile for a turbine nozzle airfoil,"An internal core profile for a second stage turbine nozzle airfoil of a gas turbine is provided. The turbine nozzle may include an airfoil core having an uncoated nominal profile substantially in accordance with Cartesian coordinate values of X, Y, and Z set forth in Table 1, wherein the X, Y, and Z coordinates are distances in inches measured in a Cartesian coordinate system, the corresponding X and Y coordinates, when connected by a smooth continuous arc, define one of a plurality of airfoil core profile sections at each Z distance, and the plurality of airfoil core profile sections, when joined together by smooth continuous arcs, define an airfoil core shape.",DOOSAN ENERBILITY CO LTD,KIM JINUK;;KIM KWANGIL;;BROWN BARRY;;GREENBERG JEFF;;ENG DARRYL;;DAY DAVID,DOOSAN HEAVY INDUSTRIES & CONSTRUCTION CO. LTD (2021-05-18),https://lens.org/153-577-087-762-045,Granted Patent,yes,26,0,2,2,0,F01D5/141;;F01D9/065;;F05D2230/90;;F01D5/288;;F05D2250/74;;Y02T50/60;;F01D9/041;;F01D5/141;;F01D5/187;;F01D5/288;;F05D2240/35;;F05D2220/32;;F01D9/02;;F05D2240/12;;F05D2220/32;;F01D9/041;;F01D9/047;;F01D5/148;;F01D9/04;;F01D5/141;;F01D5/187;;F01D5/18;;F01D5/188,F01D9/02;;F01D5/14;;F01D5/18;;F01D9/04,,0,0,,,,ACTIVE
244,AU,B2,AU 763152 B2,052-634-711-183-01X,2003-07-17,2003,AU 2000/056558 A,2000-09-07,SG 2000036293 A,2000-06-28,Temperature controlled container,,FRASER AND NEAVE LTD,ENG LAWRENCE LIM SIM;;LENG DAVID TAY PUAY;;TAT JANSEN TAN CHIN,,https://lens.org/052-634-711-183-01X,Granted Patent,no,3,0,9,9,0,,B65D/;;B65D81/18;;B65D81/24;;B65D81/38;;B65D88/74;;F25D/;;F25D3/00,,0,0,,,,EXPIRED
245,EP,A4,EP 2515782 A4,101-700-383-124-43X,2013-06-19,2013,EP 10842710 A,2010-12-21,US 28842009 P;;US 2010/0061481 W,2009-12-21,POWDER-FREE GLOVE WITH STABLE AND FAST-ACTING ANTIMICROBIAL COATING,,ANSELL LTD,ENG AIK HWEE;;TANG LOK SI;;LUCAS DAVID M;;WAN AHMAD WAN ASHRUZI,,https://lens.org/101-700-383-124-43X,Search Report,no,4,0,10,10,0,A41D19/0058;;A41D19/015;;A61B42/00;;A41D31/305;;A41D19/0058;;A41D19/015;;A61B42/00;;A41D31/305,A61B19/04;;A41D19/015;;B32B25/08;;B32B27/14,,0,0,,,,ACTIVE
246,CN,A,CN 115592234 A,005-033-949-959-174,2023-01-13,2023,CN 202211395770 A,2015-03-26,US 201414228481 A;;CN 201580028200 A;;US 69336910 A;;US 201161537013 P;;US 2015/0022648 W,2010-01-25,Control system and method for constructing tapered structure,"A control system for forming a tapered structure includes a sensor that provides feedback to a machine for forming the tapered structure, the machine including at least three rollers having at least one bending roller and at least two guide rollers. The guide roller may include a roller row having a plurality of rollers. The machine may also include an adjustment mechanism to position at least one roller, where the diameter of the tapered structure being formed is controlled by the relative position of the rollers. The machine may also include a joining element to join the edges of the material blank together as it rolls across the rollers to form a tapered structure. The control system may also include a controller to receive feedback from the sensor and send a control signal based on the feedback to the adjustment mechanism to position the at least one roll.",KEYSTONE TOWER SYSTEMS INC,TAKATA ROSALIND K;;SMITH ERIC D;;BRIDGES DANIEL;;ENG DAVID;;SLOCUM ALEXANDER H,,https://lens.org/005-033-949-959-174,Patent Application,no,0,0,29,92,0,B21C37/124;;B21C37/128;;B21C37/18;;B23K9/0325;;B23K37/053;;B21C37/126;;B21C37/122;;A61K38/00;;Y02E10/72;;B21C37/122;;B21C37/124;;B21C37/128;;B21C37/18;;B23K9/0325;;B23K37/053;;B23K2101/045;;B21C37/126;;B23K9/0325;;B21C37/124;;B21C37/128;;B21C37/185;;B21C37/122,B23K5/08,,0,0,,,,PENDING
247,WO,A2,WO 2011/084778 A2,025-764-107-532-734,2011-07-14,2011,US 2010/0061481 W,2010-12-21,US 28842009 P,2009-12-21,POWDER-FREE GLOVE WITH STABLE AND FAST-ACTING ANTIMICROBIAL COATING,"Provided, among other things, is a elastomeric medical glove having an antimicrobial surface coating comprising: a polymeric layer, and a dried, non-tacky coating on a surface of the polymeric layer, the coating comprising an antimicrobial agent, a wax agent, a lubricant, and a water-soluble wetting agent; wherein the glove comprises a residual powder of less than 2 mg per glove.",ANSELL HEALTHCARE PROD LLC;;ENG AIK HWEE;;TANG LOK SI;;LUCAS DAVID M;;WAN AHMAD WAN ASHRUZI,ENG AIK HWEE;;TANG LOK SI;;LUCAS DAVID M;;WAN AHMAD WAN ASHRUZI,,https://lens.org/025-764-107-532-734,Patent Application,yes,7,0,10,10,0,A41D19/0058;;A41D19/015;;A61B42/00;;A41D31/305;;A41D19/0058;;A41D19/015;;A61B42/00;;A41D31/305,A61B19/04;;A41D19/015;;B32B25/08;;B32B27/14,,1,0,,,"MATERIAL SAFETY DATA SHEET, 30 November 2010 (2010-11-30), Retrieved from the Internet <URL:http://www4.dowcorning.com/DataFiles/090007b2815b86ad.pdf>",PENDING
248,CA,A1,CA 2188481 A1,106-216-022-998-18X,1998-04-22,1998,CA 2188481 A,1996-10-22,CA 2188481 A,1996-10-22,Assay Container with Insert and Method of Use,,HOWLETT JAY R;;GHOSH RISHI;;PANDIAN SITHIAN;;AW ENG JOM;;SMITH DAVID I,HOWLETT JAY R;;GHOSH RISHI;;PANDIAN SITHIAN;;AW ENG JOM;;SMITH DAVID I,,https://lens.org/106-216-022-998-18X,Patent Application,no,0,0,1,1,0,B01L3/00;;G01N33/545,B01L3/00;;G01N33/545,,0,0,,,,PENDING
249,EP,B1,EP 2515782 B1,011-091-508-755-179,2015-12-16,2015,EP 10842710 A,2010-12-21,US 28842009 P;;US 2010/0061481 W,2009-12-21,POWDER-FREE GLOVE WITH STABLE AND FAST-ACTING ANTIMICROBIAL COATING,,ANSELL LTD,ENG AIK HWEE;;TANG LOK SI;;LUCAS DAVID M;;WAN AHMAD WAN ASHRUZI,,https://lens.org/011-091-508-755-179,Granted Patent,yes,9,0,10,10,0,A41D19/0058;;A41D19/015;;A61B42/00;;A41D31/305;;A41D19/0058;;A41D19/015;;A61B42/00;;A41D31/305,A61B19/04;;A41D19/015;;B32B25/08;;B32B27/14,,0,0,,,,ACTIVE
250,WO,A3,WO 2011/084778 A3,027-511-938-552-979,2011-10-20,2011,US 2010/0061481 W,2010-12-21,US 28842009 P,2009-12-21,POWDER-FREE GLOVE WITH STABLE AND FAST-ACTING ANTIMICROBIAL COATING,"Provided, among other things, is a elastomeric medical glove having an antimicrobial surface coating comprising: a polymeric layer, and a dried, non-tacky coating on a surface of the polymeric layer, the coating comprising an antimicrobial agent, a wax agent, a lubricant, and a water-soluble wetting agent; wherein the glove comprises a residual powder of less than 2 mg per glove.",ANSELL HEALTHCARE PROD LLC;;ENG AIK HWEE;;TANG LOK SI;;LUCAS DAVID M;;WAN AHMAD WAN ASHRUZI,ENG AIK HWEE;;TANG LOK SI;;LUCAS DAVID M;;WAN AHMAD WAN ASHRUZI,,https://lens.org/027-511-938-552-979,Search Report,yes,5,0,10,10,0,A41D19/0058;;A41D19/015;;A61B42/00;;A41D31/305;;A41D19/0058;;A41D19/015;;A61B42/00;;A41D31/305,A61B19/04;;A41D19/015;;B32B25/08;;B32B27/14,,0,0,,,,PENDING
251,EP,A1,EP 0576509 A1,078-098-588-713-018,1994-01-05,1994,EP 92906803 A,1992-03-18,DE 9200238 W;;DE 4109202 A,1991-03-18,MEDICAL APPLIANCE FOR GENERATING A THERAPEUTICAL PARAMETER.,"Un appareil médical permet de générer un paramètre thérapeutique d'un patient en fonction d'au moins un premier paramètre capté à l'intérieur du coprs et dépendant d'un deuxième paramètre. La génération du paramètre de traitement est modifiée par variation d'un deuxième paramètre réglable, de sorte que la différence entre les valeurs du premier paramètre atteigne un maximum aux limites de la gamme de variation du premier paramètre dans le cadre du traitement du patient. L'ajustement du deuxième paramètre réglable est enregistré dans une mémoire et le paramètre de taitement est ensuite réglé à l'intérieur de la gamme de variation du premier paramètre, alors que le deuxième paramètre ainsi obtenu est retenu.",BIOTRONIK MESS & THERAPIEG,SCHALDACH MAX;;HASTINGS DAVID MICRO SYSTEMS E;;KULP BARRY D MICRO SYSTEMS ENG,"BIOTRONIK GMBH & CO. KG (2004-04-14);;BIOTRONIK SE & CO. KG, DE (2011-12-19)",https://lens.org/078-098-588-713-018,Patent Application,yes,0,0,6,6,0,A61N1/365;;A61N1/36514;;A61N1/365;;A61N1/36514,A61N1/365,,0,0,,,,EXPIRED
252,US,A1,US 2022/0048218 A1,123-033-681-527-108,2022-02-17,2022,US 202117219638 A,2021-03-31,US 202117219638 A;;US 201815748861 A;;US 2016/0044721 W;;US 201562199265 P,2015-07-31,STABILIZED COMPOSITIONS AND PROCESS FOR PRODUCING SAME,"Stabilized compositions having an organic material to be stabilized and a resin masterbatch system provided as closed end pellets are provided herein, along with processes for producing stabilized articles.",CYTEC IND INC,KOZAKIEWICZ JOSEPH;;ENG JERRY MON HEI;;GUPTA RAM B;;VANZIN DAVID;;MAJMUDAR SHAILESH,,https://lens.org/123-033-681-527-108,Patent Application,yes,0,0,26,26,0,C08J3/226;;B29B9/12;;C08J2423/12;;C08J2423/14;;C08J2423/06;;C08J2425/12;;C08K5/3435;;C08K5/46;;C08K9/10;;C08J3/226;;C08K9/10;;C08L2310/00;;B29B9/12;;C08L33/26;;C08J3/126;;C08J2400/22;;B29B9/06;;B29B9/10;;B29B9/12;;C08J3/226;;C08K5/005;;C08K5/101;;C08K5/3432;;C08K9/10;;C08L23/00;;C08L25/04;;B01J13/02;;C08J3/22;;C08K9/10;;C08L101/00;;C09K15/00;;C08L2310/00;;B29B9/12;;B29B9/14;;C08J2400/22;;C08J3/226;;C08L33/26;;C08J3/126;;C08K9/10;;B29B9/06;;B29B2009/166;;C08K5/13;;C08K5/3435;;C08K5/46;;C08L23/06;;C08L23/12;;C08L23/14;;C08L25/06;;C08L25/12,B29B9/06;;B29B9/12;;C08J3/12;;C08J3/22;;C08K5/13;;C08K5/3435;;C08K5/46;;C08K9/10;;C08L23/06;;C08L23/12;;C08L23/14;;C08L25/06;;C08L25/12;;C08L33/26,,0,0,,,,PENDING
253,TW,B,TW 380137 B,192-582-087-163-721,2000-01-21,2000,TW 84101733 A,1995-02-24,US 20607494 A,1994-03-04,Process for making an epoxide,"A process for synthesizing the epoxide of the formula (I) which consists of, at minimum, formation of a halohydrin from the allyl acetonide reactant, followed by base-induced cyclization, the epoxide product I being useful as an intermediate for the synthesis of inhibitors of renin or HIV protease or other proteases.",MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;MALIGRES PETER E;;REIDER PAUL J;;ROSSEN KAI,,https://lens.org/192-582-087-163-721,Granted Patent,no,0,0,40,41,0,C07D263/52;;C07D413/06;;A61P31/12;;A61P31/18;;A61P37/04;;C07D413/06,A61K31/44;;A61K31/4406;;A61K31/4418;;C07D213/36;;A61P31/12;;A61P37/04;;C07D263/52;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
254,EP,A2,EP 2515782 A2,004-046-897-846-392,2012-10-31,2012,EP 10842710 A,2010-12-21,US 28842009 P;;US 2010/0061481 W,2009-12-21,POWDER-FREE GLOVE WITH STABLE AND FAST-ACTING ANTIMICROBIAL COATING,,ANSELL LTD,ENG AIK HWEE;;TANG LOK SI;;LUCAS DAVID M;;WAN AHMAD WAN ASHRUZI,,https://lens.org/004-046-897-846-392,Patent Application,yes,0,0,10,10,0,A41D19/0058;;A41D19/015;;A61B42/00;;A41D31/305;;A41D19/0058;;A41D19/015;;A61B42/00;;A41D31/305,A61B19/04;;A41D19/015;;B32B25/08;;B32B27/14,,0,0,,,,ACTIVE
255,AU,A1,AU 2010/339710 A1,155-087-774-548-13X,2012-07-19,2012,AU 2010/339710 A,2010-12-21,US 28842009 P;;US 2010/0061481 W,2009-12-21,Powder-free glove with stable and fast-acting antimicrobial coating,"Provided, among other things, is a elastomeric medical glove having an antimicrobial surface coating comprising: a polymeric layer, and a dried, non-tacky coating on a surface of the polymeric layer, the coating comprising an antimicrobial agent, a wax agent, a lubricant, and a water-soluble wetting agent; wherein the glove comprises a residual powder of less than 2 mg per glove.",ANSELL LTD,ENG AIK HWEE;;TANG LOK SI;;LUCAS DAVID M;;WAN AHMAD WAN ASHRUZI,,https://lens.org/155-087-774-548-13X,Patent Application,no,0,0,10,10,0,A41D19/0058;;A41D19/015;;A61B42/00;;A41D31/305;;A41D19/0058;;A41D19/015;;A61B42/00;;A41D31/305,A41D19/015;;A61B19/04;;B32B25/08;;B32B27/14,,0,0,,,,INACTIVE
256,AU,B2,AU 2010/339710 B2,151-910-939-728-706,2015-07-16,2015,AU 2010/339710 A,2010-12-21,US 28842009 P;;US 2010/0061481 W,2009-12-21,Powder-free glove with stable and fast-acting antimicrobial coating,"Provided, among other things, is a elastomeric medical glove having an antimicrobial surface coating comprising: a polymeric layer, and a dried, non-tacky coating on a surface of the polymeric layer, the coating comprising an antimicrobial agent, a wax agent, a lubricant, and a water-soluble wetting agent; wherein the glove comprises a residual powder of less than 2 mg per glove.",ANSELL LTD,ENG AIK HWEE;;TANG LOK SI;;LUCAS DAVID M;;WAN AHMAD WAN ASHRUZI,,https://lens.org/151-910-939-728-706,Granted Patent,no,1,0,10,10,0,A41D19/0058;;A41D19/015;;A61B42/00;;A41D31/305;;A41D19/0058;;A41D19/015;;A61B42/00;;A41D31/305,A41D19/015;;A61B19/04;;B32B25/08;;B32B27/14,,0,0,,,,INACTIVE
257,US,A1,US 2011/0145975 A1,156-852-160-786-661,2011-06-23,2011,US 97429610 A,2010-12-21,US 97429610 A;;US 28842009 P,2009-12-21,P0WDER-FREE GLOVE WITH STABLE AND FAST ACTING MICROBIAL COATING,"Provided, among other things, is a elastomeric medical glove having an antimicrobial surface coating comprising: a polymeric layer, and a dried, non-tacky coating on a surface of the polymeric layer, the coating comprising an antimicrobial agent, a wax agent, a lubricant, and a water-soluble wetting agent; wherein the glove comprises a residual powder of less than 2 mg per glove.",ANSELL LTD,ENG AIK HWEE;;TANG LOK SI;;LUCAS DAVID M;;WAN AHMAD WAN ASHRUZI,ANSELL HEALTHCARE PRODUCTS LLC (2011-06-23),https://lens.org/156-852-160-786-661,Patent Application,yes,66,7,10,10,0,A41D19/0058;;A41D19/015;;A61B42/00;;A41D31/305;;A41D19/0058;;A41D19/015;;A61B42/00;;A41D31/305,A41D19/00;;A41D19/015;;A41D19/04;;B05D3/02,2/161.7;;2/167;;427/2.3,0,0,,,,DISCONTINUED
258,CN,A,CN 102762164 A,000-310-134-055-925,2012-10-31,2012,CN 201080063393 A,2010-12-21,US 2010/0061481 W;;US 28842009 P,2009-12-21,Powder-free glove with stable and fast-acting antimicrobial coating,"Provided, among other things, is a elastomeric medical glove having an antimicrobial surface coating comprising: a polymeric layer, and a dried, non-tacky coating on a surface of the polymeric layer, the coating comprising an antimicrobial agent, a wax agent, a lubricant, and a water-soluble wetting agent; wherein the glove comprises a residual powder of less than 2 mg per glove.",ANSELL HEALTHCARE PROD LLC,HWEE ENG AIK;;SI TANG LOK;;LUCAS DAVID M;;ASHRUZI WAN AHMAD WAN,,https://lens.org/000-310-134-055-925,Patent Application,no,8,4,10,10,0,A41D19/0058;;A41D19/015;;A61B42/00;;A41D31/305;;A41D19/0058;;A41D19/015;;A61B42/00;;A41D31/305,A61B19/04;;A41D19/015;;B32B25/08;;B32B27/14,,0,0,,,,INACTIVE
259,US,A1,US 2008/0275365 A1,185-212-009-188-120,2008-11-06,2008,US 74472207 A,2007-05-04,US 74472207 A,2007-05-04,Methods of Transferring Data to a Medical Test Device,"Disclosed are various preferred embodiments for dynamic transfer of information from a test sensor to an analyte medical test device. Exemplary embodiments include various containers, systems and methods.",GUTHRIE BRIAN;;SHUY ENG KIM;;SANSOM GORDON GEORGE;;TAYLOR DAVID;;TORRIE KEITH;;MARSHALL ROBERT;;HOWARTH DAVID;;DAY EMMA,GUTHRIE BRIAN;;SHUY ENG KIM;;SANSOM GORDON GEORGE;;TAYLOR DAVID;;TORRIE KEITH;;MARSHALL ROBERT;;HOWARTH DAVID;;DAY EMMA,LIFESCAN SCOTLAND LTD (2007-05-06),https://lens.org/185-212-009-188-120,Patent Application,yes,3,18,1,1,0,A61B5/1495;;A61B5/1495;;A61B5/14532;;A61B5/14532;;A61B2562/0295;;A61B2562/0295;;A61B2562/085;;A61B2562/085;;G01N2035/00108;;G01N2035/00108,A61B5/00;;C12M1/00;;C12M3/00;;C12Q1/00;;C12Q1/54;;G01N1/12,600/584;;435/14;;435/283.1;;435/287.1;;435/4;;73/864.72,0,0,,,,DISCONTINUED
260,US,A1,US 2008/0274552 A1,192-161-731-602-794,2008-11-06,2008,US 74470707 A,2007-05-04,US 74470707 A,2007-05-04,Dynamic Information Transfer,"Disclosed are various preferred embodiments for dynamic transfer of information from a test sensor to an analyte medical test device. Exemplary embodiments include various containers, systems and methods.",GUTHRIE BRIAN;;SHUY ENG KIM;;SANSOM GORDON GEORGE;;TAYLOR DAVID;;TORRIE KEITH;;MARSHALL ROBERT;;HOWARTH DAVID;;DAY EMMA,GUTHRIE BRIAN;;SHUY ENG KIM;;SANSOM GORDON GEORGE;;TAYLOR DAVID;;TORRIE KEITH;;MARSHALL ROBERT;;HOWARTH DAVID;;DAY EMMA,LIFESCAN SCOTLAND LTD (2007-05-06),https://lens.org/192-161-731-602-794,Patent Application,yes,96,2,1,1,0,B01L3/545;;B01L3/545;;B01L2200/148;;B01L2200/148;;B01L2300/021;;B01L2300/021;;B01L2300/0825;;B01L2300/0825;;G01N33/48771;;G01N33/48771;;G01N27/3274;;G01N27/3274;;Y10T436/10;;Y10T436/10,G01N33/487;;G01N31/00,436/8;;422/55;;422/58;;422/61;;422/68.1,0,0,,,,DISCONTINUED
261,BR,A,BR 8405250 A,033-336-788-578-891,1985-08-27,1985,BR 8405250 A,1984-10-17,US 54310783 A,1983-10-18,SISTEMA PARA VISUALIZACAO DE TEXTO,,DIGITAL EQUIPMENT CORP,DINITTO ROBERT SALVATORE;;PORCHER THOMAS COURTENAY;;ENG JOHN WAI;;NAMIAS CHARLES;;HUGHES DAVID BRUCE,,https://lens.org/033-336-788-578-891,Patent Application,no,0,0,21,21,0,G09G5/393;;G06F3/14;;G09G5/393,G06F3/153;;G06F3/14;;G06T11/20;;G09G5/18;;G09G5/393,,0,0,,,,DISCONTINUED
262,DK,A,DK 498884 A,116-671-621-999-931,1985-04-19,1985,DK 498884 A,1984-10-18,US 54310783 A,1983-10-18,ARRANGEMENT TIL TILVEJEBRINGELSE AF DATASIGNALER TIL ET DATAVISNINGSANLAEG,,DIGITAL EQUIPMENT CORP,DINITTO ROBERT SALVATORE;;PORCHER THOMAS COURTENAY;;ENG JOHN WAI;;NAMIAS CHARLES;;HUGHES DAVID BRUCE,,https://lens.org/116-671-621-999-931,Patent Application,no,0,0,21,21,0,G09G5/393;;G06F3/14;;G09G5/393,G06F3/153;;G06F3/14;;G06T11/20;;G09G5/18;;G09G5/393,,0,0,,,,EXPIRED
263,US,A1,US 2015/0205381 A1,127-918-959-169-397,2015-07-23,2015,US 201414158579 A,2014-01-17,US 201414158579 A,2014-01-17,MOBILE GAMING CONTROLLER WITH INTEGRATED VIRTUAL MOUSE,"A method is enacted in a computer system operatively coupled to a hand-actuated input device. The method includes the action of determining automatically which form of user input to offer a process running on the computer system, the user input including position data from the input device. The method also includes the action of offering the position data to the process in the form determined.",NVIDIA CORP,ENG DAVID LEE;;VARJE ILKKA;;BRUCKERT KEVIN;;SEIS RICHARD J;;BOSNJAKOVIC ANDRIJA;;ODOROVIC ALEKSANDAR,NVIDIA CORPORATION (2014-01-14),https://lens.org/127-918-959-169-397,Patent Application,yes,10,2,1,1,0,A63F13/214;;A63F13/214;;A63F13/23;;A63F13/23;;A63F13/26;;A63F13/26;;A63F13/31;;A63F13/31;;A63F13/42;;A63F13/42;;G06F3/0383;;G06F3/0383;;G06F3/038;;G06F3/038;;G06F3/0489;;G06F3/0489,G06F3/038;;A63F13/23;;G06F3/0488,,0,0,,,,DISCONTINUED
264,DE,D1,DE 69524578 D1,052-727-406-254-726,2002-01-24,2002,DE 69524578 T,1995-02-27,US 20607494 A;;US 9502347 W,1994-03-04,VERFAHREN ZUR HERSTELLUNG VON EPOXIDEN,"A process for synthesizing the epoxide of formula (I) consists of, at a minimum, formation of a halohydrin form the allyl acetonide reactant, followed by base-induced cyclization, the epoxide product (I) being useful as an intermediate for the synthesis of inhibitors of renin or HIV protease or other proteases.",MERCK & CO INC,ASKIN DAVID;;ENG K;;MALIGRES E;;REIDER J;;ROSSEN KAI;;VOLANTE P;;UPADHYAY VEENA,"MERCK SHARP & DOHME CORP., NEW JERSEY, N.J., US (2010-09-23);;SCHERING CORPORATION, US (2012-12-13)",https://lens.org/052-727-406-254-726,Granted Patent,no,0,0,40,41,0,C07D263/52;;C07D413/06;;A61P31/12;;A61P31/18;;A61P37/04;;C07D413/06,C07D213/36;;A61K31/44;;A61K31/4406;;A61K31/4418;;A61P31/12;;A61P37/04;;C07D263/52;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
265,ZA,B,ZA 848032 B,102-215-219-141-067,1985-06-26,1985,ZA 848032 A,1984-10-15,US 54310783 A,1983-10-18,ARRANGEMENT FOR PROVIDING DATA SIGNALS FOR A DATA DISPLAY SYSTEM,,DIGITAL EQUIPMENT CORP,ENG JOHN WAI;;NAMIAS CHARLES;;PORCHER THOMAS COURTENAY;;HUGHES DAVID BRUCE;;DINITTO ROBERT SALVATORE,,https://lens.org/102-215-219-141-067,Granted Patent,no,0,0,21,21,0,G09G5/393;;G06F3/14;;G09G5/393,G06F3/14;;G06F3/153;;G06T11/20;;G09G5/18;;G09G5/393,,0,0,,,,EXPIRED
266,AU,A,AU 1984/034436 A,193-000-763-324-062,1985-04-26,1985,AU 1984/034436 A,1984-10-17,US 54310783 A,1983-10-18,ARRANGEMENT FOR PROVIDING DATA SIGNALS FOR A DATA DISPLAY SYSTEM,,DIGITAL EQUIPMENT CORP,DINITTO ROBERT SALVATORE;;PORCHER THOMAS COURTENAY;;ENG JOHN WAI;;NAMIAS CHARLES;;HUGHES DAVID BRUCE,,https://lens.org/193-000-763-324-062,Patent Application,no,0,0,21,21,0,G09G5/393;;G06F3/14;;G09G5/393,G06F3/153;;G06F3/14;;G06T11/20;;G09G5/18;;G09G5/393,,0,0,,,,EXPIRED
267,CA,A,CA 1234436 A,019-353-425-621-579,1988-03-22,1988,CA 465216 A,1984-10-11,US 54310783 A,1983-10-18,ARRANGEMENT FOR PROVIDING DATA SIGNALS FOR A DATA DISPLAY SYSTEM,"The present invention includes a microprocessor which acts to generate groups of its signals from its read only memory (ROM), thereby forming character representations of groups of coded signals, such as ASCII coded signals, coming from a main data processing device. The groups of bit signals are temporarily stored in a buffer which at a subsequent time transmits, in parallel, groups of said bit signals to a bit map memory through logic circuitry. The group, or block, transfer of these bit signals in parallel occurs during horizontal or vertical blank periods. The parallel transfer during the blank periods provides part of the basis for acceleration of the transfer of data to a display device as compared with the prior art. In addition, the microprocessor provides address information signals to a graphic display controller, which in turn provides starting addresses for the location of the bit signals in addition, a bit map memory device is employed to provide pixel information to a CRT display device to create the characters to be displayed.",DIGITAL EQUIPMENT CORP,DINITTO ROBERT S;;PORCHER THOMAS C;;ENG JOHN W;;NAMIAS CHARLES;;HUGHES DAVID B,,https://lens.org/019-353-425-621-579,Granted Patent,no,0,0,21,21,0,G09G5/393;;G06F3/14;;G09G5/393,G06F3/153;;G06F3/14;;G06T11/20;;G09G5/18;;G09G5/393,375-15,0,0,,,,EXPIRED
268,WO,A2,WO 2010/048477 A2,108-715-515-752-697,2010-04-29,2010,US 2009/0061787 W,2009-10-23,US 10825408 P,2008-10-24,IMPROVED PROCESS FOR PREPARATION OF COUPLED PRODUCTS FROM 4-AMINO-3-CYANOQUINOLINES USING STABILIZED INTERMEDIATES,This invention discloses improved methods for coupling a 4-(amino)-2-butenoyl group to an amino group at the 6- or 7-position of a 4-amino-3-quinolinecarbonitrile by generating a stabilized 4-(amino)-2-butenoyl chloride hydrochloride.,WYETH LLC;;GONTCHAROV ALEXANDER;;ENG KAN KAUNG;;SUTHERLAND KAREN;;SEBASTIAN ALICE;;YU QING;;PLACE DAVID WILLIAM,GONTCHAROV ALEXANDER;;ENG KAN KAUNG;;SUTHERLAND KAREN;;SEBASTIAN ALICE;;YU QING;;PLACE DAVID WILLIAM,,https://lens.org/108-715-515-752-697,Patent Application,yes,0,25,2,2,0,C07D401/12,C07D401/12,,0,0,,,,PENDING
269,FI,A0,FI 844086 A0,199-053-938-835-452,1984-10-17,1984,FI 844086 A,1984-10-17,US 54310783 A,1983-10-18,SYSTEM FOER TEXTDISPLAY.,,DIGITAL EQUIPMENT CORP,DINITTO ROBERT SALVATORE;;PORCHER THOMAS COURTENAY;;ENG JOHN WAI;;NAMIAS CHARLES;;HUGHES DAVID BRUCE,,https://lens.org/199-053-938-835-452,Patent Application,no,0,0,21,21,0,G09G5/393;;G06F3/14;;G09G5/393,G06F3/153;;G06F3/14;;G06T11/20;;G09G5/18;;G09G5/393,,0,0,,,,DISCONTINUED
270,DE,T2,DE 69524578 T2,123-384-171-972-468,2002-07-18,2002,DE 69524578 T,1995-02-27,US 20607494 A;;US 9502347 W,1994-03-04,VERFAHREN ZUR HERSTELLUNG VON EPOXIDEN,"A process for synthesizing the epoxide of formula (I) consists of, at a minimum, formation of a halohydrin form the allyl acetonide reactant, followed by base-induced cyclization, the epoxide product (I) being useful as an intermediate for the synthesis of inhibitors of renin or HIV protease or other proteases.",MERCK & CO INC,ASKIN DAVID;;ENG K;;MALIGRES E;;REIDER J;;ROSSEN KAI;;VOLANTE P;;UPADHYAY VEENA,"MERCK SHARP & DOHME CORP., NEW JERSEY, N.J., US (2010-09-23);;SCHERING CORPORATION, US (2012-12-13)",https://lens.org/123-384-171-972-468,Granted Patent,no,0,0,40,41,0,C07D263/52;;C07D413/06;;A61P31/12;;A61P31/18;;A61P37/04;;C07D413/06,C07D213/36;;A61K31/44;;A61K31/4406;;A61K31/4418;;A61P31/12;;A61P37/04;;C07D263/52;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
271,KR,B1,KR 900006942 B1,128-165-554-041-902,1990-09-25,1990,KR 840006422 A,1984-10-17,US 54310783 A,1983-10-18,DATA SIGNAL PROVIDING APPARATUS FOR DATA DISPLAY SYSTEM,"The microprocessor responds to groups of coded signals from the main data processing system. In response to each group of coded signals, the system provides a raster of bit signals from a ROM means, of which bit signals graphically define the text character assigned to the coded set of signals being received. In other words, if eight bits of ascii coded signals are transmitted from the main data processing device, that group of signals causes, in a preferred embodiment, the generation of a raster of 8 to 10 bits from the ROM in the microprocessor. In the microprocessor, ten bytes of data are stored in ROM memory for each possible text character to be shown. The raster of bit signals are block transferred from the ROM of the microporcessor to buffer.",DIGITAL EQUIPMENT CORP,DINITE ROBERT S;;POTURE TOMAS K;;NAMIAS CHARLS;;ENG JOHN Y;;HUGHS DAVID B,,https://lens.org/128-165-554-041-902,Granted Patent,no,0,1,21,21,0,G09G5/393;;G06F3/14;;G09G5/393,G06F3/153;;G06F3/14;;G06T11/20;;G09G5/18;;G09G5/393,,0,0,,,,EXPIRED
272,DK,B,DK 166300 B,139-792-038-865-106,1993-03-29,1993,DK 498884 A,1984-10-18,US 54310783 A,1983-10-18,ARRANGEMENT TIL TILVEJEBRINGELSE AF DATASIGNALER TIL ET DATAVISNINGSANLAEG,,DIGITAL EQUIPMENT CORP,DINITTO ROBERT SALVATORE;;PORCHER THOMAS COURTENAY;;ENG JOHN WAI;;NAMIAS CHARLES;;HUGHES DAVID BRUCE,,https://lens.org/139-792-038-865-106,Patent Application,no,0,0,21,21,0,G09G5/393;;G06F3/14;;G09G5/393,G06F3/153;;G06F3/14;;G06T11/20;;G09G5/18;;G09G5/393,,0,0,,,,EXPIRED
273,MX,A,MX 157393 A,144-659-260-283-594,1988-11-21,1988,MX 20305184 A,1984-10-15,US 54310783 A,1983-10-18,SISTEMA MEJORADO PARA TRANSMITIR TEXTOS DE SENALES DE INFORMACION DESDE UNA COMPUTADORA HASTA UN DISPOSITIVO EXHIBIDOR,,DIGITAL EQUIPMENT F,DINITTO ROBERT SALVATORE;;PORCHER THOMAS COURTENAY;;ENG JOHN WAI;;NAMIAS CHARLES;;HUGHES DAVID BRUCE,,https://lens.org/144-659-260-283-594,Granted Patent,no,0,0,21,21,0,G09G5/393;;G06F3/14;;G09G5/393,G06F3/153;;G06F3/14;;G06T11/20;;G09G5/18;;G09G5/393,05-4;;55-5,0,0,,,,EXPIRED
274,GR,B,GR 80595 B,122-479-326-571-753,1985-01-25,1985,GR 840180595 A,1984-10-11,US 54310783 A,1983-10-18,IMPROVED ARRANGEMENT FOR PROVIDING DATA SIGNALS FOR A DATA DISPLAY SYSTEM,,DIGITAL EQUIPMENT CORP,ROBERT DINITTO SALVATORE;;THOMAS PORCHER COURTENAY;;JOHN ENG WAI;;CHARLES NAMIAS;;DAVID HUGHES BRUCE,,https://lens.org/122-479-326-571-753,Granted Patent,no,0,0,21,21,0,G09G5/393;;G06F3/14;;G09G5/393,G06F3/153;;G06F3/14;;G06T11/20;;G09G5/18;;G09G5/393,,0,0,,,,EXPIRED
275,WO,A3,WO 2010/048477 A3,178-360-284-071-227,2011-02-24,2011,US 2009/0061787 W,2009-10-23,US 10825408 P,2008-10-24,IMPROVED PROCESS FOR PREPARATION OF COUPLED PRODUCTS FROM 4-AMINO-3-CYANOQUINOLINES USING STABILIZED INTERMEDIATES,This invention discloses improved methods for coupling a 4-(amino)-2-butenoyl group to an amino group at the 6- or 7-position of a 4-amino-3-quinolinecarbonitrile by generating a stabilized 4-(amino)-2-butenoyl chloride hydrochloride.,WYETH LLC;;GONTCHAROV ALEXANDER;;ENG KAN KAUNG;;SUTHERLAND KAREN;;SEBASTIAN ALICE;;YU QING;;PLACE DAVID WILLIAM,GONTCHAROV ALEXANDER;;ENG KAN KAUNG;;SUTHERLAND KAREN;;SEBASTIAN ALICE;;YU QING;;PLACE DAVID WILLIAM,,https://lens.org/178-360-284-071-227,Search Report,yes,1,0,2,2,0,C07D401/12,C07D401/12,,1,1,057-053-478-490-406,15715478;;10.1021/jm040159c.s001;;10.1021/jm040159c,"TSOU H-R ET AL: ""Optimization of 6,7-Disubstituted-4-(arylamino)quinoline-3-carbonitr iles as Orally Active, Irreverible Inhibitors of HEGFR-2 Kinase Activity"", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, US, vol. 48, 27 January 2005 (2005-01-27), pages 1107 - 1131, XP002414228, ISSN: 0022-2623",PENDING
276,DK,D0,DK 498884 D0,107-499-498-331-857,1984-10-18,1984,DK 498884 A,1984-10-18,US 54310783 A,1983-10-18,ARRANGEMENT TIL TILVEJEBRINGELSE AF DATASIGNALER TIL ET DATAVISNINGSANLAEG,,DIGITAL EQUIPMENT CORP,DINITTO ROBERT SALVATORE;;PORCHER THOMAS COURTENAY;;ENG JOHN WAI;;NAMIAS CHARLES;;HUGHES DAVID BRUCE,,https://lens.org/107-499-498-331-857,Patent Application,no,0,0,21,21,0,G09G5/393;;G06F3/14;;G09G5/393,G06F3/153;;G06F3/14;;G06T11/20;;G09G5/18;;G09G5/393,,0,0,,,,EXPIRED
277,AU,B2,AU 568159 B2,081-661-086-912-533,1987-12-17,1987,AU 1984/034436 A,1984-10-17,US 54310783 A,1983-10-18,ARRANGEMENT FOR PROVIDING DATA SIGNALS FOR A DATA DISPLAY SYSTEM,,DIGITAL EQUIPMENT CORP,DINITTO ROBERT SALVATORE;;PORCHER THOMAS COURTENAY;;ENG JOHN WAI;;NAMIAS CHARLES;;HUGHES DAVID BRUCE,,https://lens.org/081-661-086-912-533,Granted Patent,no,2,0,21,21,0,G09G5/393;;G06F3/14;;G09G5/393,G06F3/153;;G06F3/14;;G06T11/20;;G09G5/18;;G09G5/393,,0,0,,,,EXPIRED
278,FI,L,FI 844086 L,081-322-268-213-948,1985-04-19,1985,FI 844086 A,1984-10-17,US 54310783 A,1983-10-18,SYSTEM FOER TEXTDISPLAY.,,DIGITAL EQUIPMENT CORP,DINITTO ROBERT SALVATORE;;PORCHER THOMAS COURTENAY;;ENG JOHN WAI;;NAMIAS CHARLES;;HUGHES DAVID BRUCE,,https://lens.org/081-322-268-213-948,Abstract,no,0,0,21,21,0,G09G5/393;;G06F3/14;;G09G5/393,G06F3/153;;G06F3/14;;G06T11/20;;G09G5/18;;G09G5/393,,0,0,,,,DISCONTINUED
279,DK,C,DK 166300 C,088-662-828-682-626,1993-08-30,1993,DK 498884 A,1984-10-18,US 54310783 A,1983-10-18,ARRANGEMENT TIL TILVEJEBRINGELSE AF DATASIGNALER TIL ET DATAVISNINGSANLAEG,,DIGITAL EQUIPMENT CORP,DINITTO ROBERT SALVATORE;;PORCHER THOMAS COURTENAY;;ENG JOHN WAI;;NAMIAS CHARLES;;HUGHES DAVID BRUCE,,https://lens.org/088-662-828-682-626,Granted Patent,no,0,0,21,21,0,G09G5/393;;G06F3/14;;G09G5/393,G06F3/153;;G06F3/14;;G06T11/20;;G09G5/18;;G09G5/393,,0,0,,,,EXPIRED
280,ES,T3,ES 2372635 T3,072-075-119-048-270,2012-01-25,2012,ES 09010915 T,2004-12-07,US 52792803 P;;US 58482304 P,2003-12-08,"OXAZOL, DERIVADOS DE TETRACICLINAS.","Un procedimiento de preparación de un compuesto de fórmula o una sal del mismo aceptable desde el punto de vista farmacéutico, en la que: X se selecciona de hidrógeno, amino, NR 11 R 12 , alquilo de 1 a 12 átomos de carbono sustituido en forma opcional, arilo de 6, 10 o 14 átomos de carbono sustituido en forma opcional, vinilo sustituido en forma opcional, alquinilo de 2 a 12 átomos de carbono sustituido en forma opcional y halógeno; R 1 y R 2 son cada uno independientemente H o alquilo de 1 a 12 átomos de carbono o R 1 y R 2 cuando se toman en forma opcional junto con el átomo de nitrógeno al cual cada uno está unido forman un anillo hidrocarburo saturado de 3 a 7 miembros; R 11 y R 12 son cada uno independientemente H o alquilo de 1 a 12 átomos de carbono o R 11 y R 12 cuando se toman en forma opcional junto con el átomo de nitrógeno al cual cada uno está unido forman un anillo hidrocarburo saturado de 3 a 7 miembros; Y se selecciona de hidrógeno, alquilo de 1 a 12 átomos de carbono sustituido en forma opcional, arilo de 6, 10 o 14 átomos de carbono sustituido en forma opcional, alquenilo de 2 a 12 átomos de carbono sustituido en forma opcional, vinilo, alquinilo de 2 a 12 átomos de carbono sustituido en forma opcional y halógeno; que comprende uno de los siguientes: i) hidrolizar una amina sustituida de fórmula: en la que las variables son las definidas anteriormente, con ácido para dar un compuesto de fórmula y si se desea convertir el producto en una sal del mismo aceptable desde el punto de vista farmacéutico; o (ii) hacer reaccionar un compuesto de cloro de fórmula: en la que las variables son las definidas anteriormente, con ácido para dar una 9-(2clorometilcarbonilamino)sustituido-6-desmetil-6-desoxitetraciclina de fórmula en la que las variables son las definidas anteriormente, seguido por hacer reeaccionar 9-(2-clorometilcarbonilamino)sustituido-6-desmetil-6-desoxitetraciclina con una amina R 1 R 2 NH para dar el compuesto de fórmula en la que las variables son las definidas anteriormente, y aislar el compuesto o una sal del mismo aceptable desde el punto de vista farmacéutico.",WYETH LLC,SUM PHAIK-ENG;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES,,https://lens.org/072-075-119-048-270,Granted Patent,no,0,0,43,44,0,A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04;;C07C2603/46;;A61P31/04;;C07D263/62;;C07D263/54;;C07D263/52;;C07C237/26;;C07D413/04;;A61K31/65;;C07D417/04;;C07D413/06;;C07D263/52;;C07C2603/46,C07D263/52;;A61K31/423;;A61K31/65;;A61P31/04;;C07C237/26;;C07D413/04;;C07D413/06;;C07D417/04,,0,0,,,,ACTIVE
281,AU,B2,AU 2010/224224 B2,091-240-619-859-630,2015-01-22,2015,AU 2010/224224 A,2010-03-10,US 72014610 A;;US 15925209 P;;US 2010/0026783 W,2009-03-11,Powder-free antimicrobial coated glove,"Provided herein are powder-free elastomeric articles exhibiting good antimicrobial and anti-blocking properties. Also provided herein are methods for the manufacture of such articles substantially free from antimicrobial interfering materials, as well as packaging means for maintaining antimicrobial efficacy.",ANSELL LTD,ENG AIK HWEE;;LAI HEE MENG;;LIM KUANG LENG;;TING KOON MEOW;;LUCAS DAVID M,,https://lens.org/091-240-619-859-630,Granted Patent,no,3,0,12,12,0,A41D19/0055;;A61L31/10;;A61L31/145;;A61L2300/404;;A61L2300/608;;A61L2300/622;;A61L31/16;;A41D31/305;;A41D19/0055;;A61L31/10;;A61L31/145;;A61L2300/404;;A61L2300/608;;A61L2300/622;;A41D31/305;;A61L31/16,A41D19/00;;A61B19/00;;A61L31/10,,0,0,,,,ACTIVE
282,WO,A3,WO 2006/017051 A3,095-206-822-399-39X,2006-04-27,2006,US 2005/0023593 W,2005-07-01,US 58709904 P,2004-07-12,AUTO-IGNITION GASOLINE ENGINE COMBUSTION CHAMBER AND METHOD,"A combustion chamber for an internal combustion engine includes a closed end cylinder having an axis. A piston is reciprocable in the cylinder and includes a generally flat rim having an inner edge surrounding a recessed bowl into which the fuel is primarily injected, the bowl having a floor and a surrounding side formed by an arcuate surface connecting tangentially with the floor and extending to the rim inner edge. A spark plug has a centerline through the spark gap and is offset to one side of the cylinder axis with the spark gap extending into the combustion chamber toward the axis. A fuel injector is offset to an opposite side of the axis with the spray tip aimed to direct a generally conical fuel spray into the piston bowl with a portion of the fuel spray passing near the spark gap. Various dimensional characteristics are disclosed.",GEN MOTORS CORP,NAJT PAUL M;;KUO TANG-WEI;;CLEARY DAVID J;;ENG JAMES A;;BROWN BARRY L,,https://lens.org/095-206-822-399-39X,Search Report,yes,3,0,6,7,0,F02B23/101;;F02B1/12;;F02B2075/125;;F02D13/0215;;F02D13/0265;;F02F1/242;;F02M26/01;;Y02T10/12,F02F3/26;;F02B17/00,,0,0,,,,PENDING
283,PE,A1,PE 20050995 A1,116-234-329-318-638,2006-01-11,2006,PE 2004001203 A,2004-12-07,US 52792803 P;;US 58482304 P,2003-12-08,DERIVADOS OXAZOL DE TETRACICLINAS,"SE REFIERE A UN COMPUESTO DE FORMULA (I), DONDE X ES H, AMINO, VINILO, OPCIONALMENTE SUSTITUIDOS, ENTRE OTROS; A"" ES A, B, DONDE R ES ALQUILO, ALQUENILO, ALQUINILO OPCIONALMENTE SUSTITUIDOS, ENTRE OTROS; Y ES H, ALQUILO, ARILO, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: (6AR,7AS,8S,11AS)-5,8-BIS(DIMETILAMINO)-2-(2,2-DIFENILVINIL)-9,11A,12-TRIHIDROXI-11,13-DIOXO-6,6A,7,7A,8,11,11A,13-OCTAHIDROTETRACENO[2,1-D][1,3]OXAZOL-10-CARBOXAMIDA; (7AS,8S,11AS)-8-(DIMETILAMINO)-9,11A,13-TRIHIDROXI-2-(2-METIL-1-PROPENIL)-11,12-DIOXO-7,7A,8,11,11A,12-HEXAHIDRONAFTACENOL[2,1-D][1,3]OXAZOL-10-CARBOXAMIDA; (6AR,7AS,8S,11AS)-2-TER-BUTIL-5,8-BIS(DIMETILAMINO)-9,11A,12-TRIHIDROXI-11,13-DIOXO-6,6A,7,7A,8,11,11A,13-OCTAHIDROTETRACENO[2,1-D][1,3]OXAZOL-10-CARBOXAMIDA; ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA Y A UN PROCESO DE PREPARACION. DICHOS COMPUESTOS EXHIBEN ACTIVIDAD ANTIBACTERIANA CONTRA UN AMPLIO ESPECTRO DE ORGANISMOS LOS CUALES SON RESISTENTES A TETRACICLINAS Y OTROS ANTIBIOTICOS",WYETH CORP,SUM PHAIK-ENG;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES,,https://lens.org/116-234-329-318-638,Patent Application,no,0,0,43,44,0,A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04;;C07C2603/46;;A61P31/04;;C07D263/62;;C07D263/54;;C07D263/52;;C07C237/26;;C07D413/04;;A61K31/65;;C07D417/04;;C07D413/06;;C07D263/52;;C07C2603/46,A61K31/423;;A61K31/65;;A61P31/04;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04,,0,0,,,,DISCONTINUED
284,EP,A2,EP 0145530 A2,145-127-377-352-361,1985-06-19,1985,EP 84402086 A,1984-10-17,US 54310783 A,1983-10-18,Arrangement for providing data signals for a data display system.,"@ The present invention includes a microprocessor (15) which acts to generate rasters of its signals from its read only memory (ROM), thereby forming character representations of groups of coded signals, such as ASCII coded signals, coming from a main data processing device. The rasters of bit signals are temporarily stored in a buffer (23) which at a subsequent time transmits, in parallel, groups of said bit signals to a bit map memory (33) through logic circuitry. The group, or block, transfer of these bit signals in parallel occurs during horizontal or vertical blank periods. The parallel transfer during the blank periods provides part of the basis for acceleration of the transfer of data to a display device as compared with the prior art. In addition, the microprocessor provides address information signals to a graphic display controller (19), which in turn provides starting addresses for the location of the bit signals. In addition, a bit map memory device is employed to provide pixel information to a CRT display device (51) to create the characters to be displayed.",DIGITAL EQUIPMENT CORP,DI NITTO ROBERT SALVATORE;;PORCHER THOMAS COURTENAY;;ENG JOHN WAI;;NAMIAS CHARLES;;HUGHES DAVID BRUCE,,https://lens.org/145-127-377-352-361,Patent Application,yes,0,0,21,21,0,G09G5/393;;G06F3/14;;G09G5/393,G06F3/153;;G06F3/14;;G06T11/20;;G09G5/18;;G09G5/393,,0,0,,,,DISCONTINUED
285,AT,T1,AT E525365 T1,167-880-961-677-569,2011-10-15,2011,AT 09010915 T,2004-12-07,US 52792803 P;;US 58482304 P,2003-12-08,"OXAZOL, DERIVATE AUS TETRACYCLINEN",,WYETH LLC,SUM PHAIK-ENG;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES,,https://lens.org/167-880-961-677-569,Granted Patent,no,0,0,43,44,0,A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04;;C07C2603/46;;A61P31/04;;C07D263/62;;C07D263/54;;C07D263/52;;C07C237/26;;C07D413/04;;A61K31/65;;C07D417/04;;C07D413/06;;C07D263/52;;C07C2603/46,A61K31/423;;A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04,,0,0,,,,INACTIVE
286,GT,A,GT 200400259 A,012-982-604-806-226,2005-09-14,2005,GT 200400259 A,2004-12-08,US 52792803 P,2003-12-08,DERIVADOS OXAZOL DE TETRACICLINAS,LA PRESENTE INVENCION SE REFIERE A COMPUESTOS QUE SON UTILES COMO AGENTES ANTIBIOTICOS Y EXHIBEN ACTIVIDAD ANTIBACTERIANA CONTRA UN AMPLIO ESPECTRO DE MICROORGANISMOS INCLUYENDO A AQUELLOS RESISTENTES A TETRACICLINAS Y OTROS ANTIBIOTICOS.,,SUM PHAIK-ENG;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES,,https://lens.org/012-982-604-806-226,Amended Application,no,0,0,1,44,0,,A61K31/4184;;A61P31/00;;A61P31/04;;C07D263/52,,0,0,,,,PENDING
287,US,A1,US 2006/0016420 A1,074-976-176-919-475,2006-01-26,2006,US 89944204 A,2004-07-26,US 89944204 A,2004-07-26,Valve and fueling strategy for operating a controlled auto-ignition four-stroke internal combustion engine,Part load operating point for a controlled auto-ignition four-stroke internal combustion engine is reduced without compromising combustion stability through a valve control operative to establish low pressure conditions within the combustion chamber into which fuel and exhaust gases are introduced. Combustion chamber pressures during the intake cycle are controlled lower as engine load decreases. Combusted gases are recirculated into the combustion chamber through a variety of internal and external recirculation mechanizations. A split-injection fuel control is implemented during low part load operation whereas a single-injection fuel control is implemented during intermediate and high part load operation. Split-injections are characterized by lean fuel/air ratios and single-injections are characterized by either lean or stoichiometric fuel/air ratios. Controlled autoignition is thereby enabled through an extended range of engine loads while maintaining acceptable combustion stability and emissions.,KUO TANG-WEI;;BROWN BARRY L;;NAJT PAUL M;;ENG JAMES A;;CLEARY DAVID J,KUO TANG-WEI;;BROWN BARRY L;;NAJT PAUL M;;ENG JAMES A;;CLEARY DAVID J,GM GLOBAL TECHNOLOGY OPERATIONS LLC (2005-01-19);;GENERAL MOTORS CORPORATION (2004-07-27),https://lens.org/074-976-176-919-475,Patent Application,yes,56,17,7,7,0,F02D13/0207;;F02D13/0207;;F02B1/12;;F02B1/12;;F02B2075/027;;F02B2075/027;;F02B2075/125;;F02B2075/125;;F02D13/0238;;F02D13/0238;;F02D13/0242;;F02D13/0242;;F02D13/0273;;F02D13/0273;;F02D41/402;;F02D41/402;;Y02T10/12;;Y02T10/12;;Y02T10/40;;Y02T10/40,F02B3/00,123/299,0,0,,,,ACTIVE
288,EP,B1,EP 2593875 B1,195-244-243-353-533,2018-05-16,2018,EP 11807453 A,2011-07-13,US 83634110 A;;US 2011/0043850 W,2010-07-14,OUT-OF-BAND ACCESS TO STORAGE DEVICES THROUGH PORT-SHARING HARDWARE,,INTEL CORP,EDWARDS DAVID A;;GAN CHAI HUAT;;OOI ENG HUN;;GOKULRANGAN VENKAT R;;KHOSRAVI HORMUZD M,,https://lens.org/195-244-243-353-533,Granted Patent,yes,4,0,15,15,0,G06F3/0604;;G06F3/0617;;G06F3/0659;;G06F3/067;;G06F3/0604;;G06F3/0617;;G06F3/0659;;G06F3/067;;G06F13/14;;G06F13/16;;G06F3/0604;;G06F3/0659;;G06F3/067;;G06F3/0617,G06F3/06;;G06F13/14;;G06F9/30;;G06F9/44;;G06F13/16,,0,0,,,,ACTIVE
289,TW,B,TW I443580 B,020-160-966-638-191,2014-07-01,2014,TW 100123107 A,2011-06-30,US 83634110 A,2010-07-14,Out-of-band access to storage devices through port-sharing hardware,,INTEL CORP,EDWARDS DAVID A;;OOI ENG HUN;;GOKULRANGAN VENKAT R;;KHOSRAVI HORMUZD M;;GAN CHAI HUAT,,https://lens.org/020-160-966-638-191,Granted Patent,no,0,0,15,15,0,G06F3/0604;;G06F3/0617;;G06F3/0659;;G06F3/067;;G06F3/0604;;G06F3/0617;;G06F3/0659;;G06F3/067;;G06F13/14;;G06F13/16;;G06F3/0604;;G06F3/0659;;G06F3/067;;G06F3/0617,,,0,0,,,,INACTIVE
290,US,B2,US 7152559 B2,038-711-489-048-640,2006-12-26,2006,US 89944204 A,2004-07-26,US 89944204 A,2004-07-26,Valve and fueling strategy for operating a controlled auto-ignition four-stroke internal combustion engine,Part load operating point for a controlled auto-ignition four-stroke internal combustion engine is reduced without compromising combustion stability through a valve control operative to establish low pressure conditions within the combustion chamber into which fuel and exhaust gases are introduced. Combustion chamber pressures during the intake cycle are controlled lower as engine load decreases. Combusted gases are recirculated into the combustion chamber through a variety of internal and external recirculation mechanizations. A split-injection fuel control is implemented during low part load operation whereas a single-injection fuel control is implemented during intermediate and high part load operation. Split-injections are characterized by lean fuel/air ratios and single-injections are characterized by either lean or stoichiometric fuel/air ratios. Controlled autoignition is thereby enabled through an extended range of engine loads while maintaining acceptable combustion stability and emissions.,GEN MOTORS CORP,KUO TANG-WEI;;BROWN BARRY L;;NAJT PAUL M;;ENG JAMES A;;CLEARY DAVID J,GM GLOBAL TECHNOLOGY OPERATIONS LLC (2005-01-19);;GENERAL MOTORS CORPORATION (2004-07-27),https://lens.org/038-711-489-048-640,Granted Patent,yes,58,30,7,7,0,F02D13/0207;;F02D13/0207;;F02B1/12;;F02B1/12;;F02B2075/027;;F02B2075/027;;F02B2075/125;;F02B2075/125;;F02D13/0238;;F02D13/0238;;F02D13/0242;;F02D13/0242;;F02D13/0273;;F02D13/0273;;F02D41/402;;F02D41/402;;Y02T10/12;;Y02T10/12;;Y02T10/40;;Y02T10/40,F02B3/04;;F02M25/07,123/90.15;;123/299;;123/568.14,0,0,,,,ACTIVE
291,EP,B1,EP 2157085 B1,053-270-828-851-95X,2011-09-21,2011,EP 09010915 A,2004-12-07,EP 04813199 A;;US 52792803 P;;US 58482304 P,2003-12-08,"Oxazole, derivatives of tetracyclines",,WYETH LLC,SUM PHAIK-ENG;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES,,https://lens.org/053-270-828-851-95X,Granted Patent,yes,2,0,43,44,0,A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04;;C07C2603/46;;A61P31/04;;C07D263/62;;C07D263/54;;C07D263/52;;C07C237/26;;C07D413/04;;A61K31/65;;C07D417/04;;C07D413/06;;C07D263/52;;C07C2603/46,C07D263/52;;A61K31/423;;A61K31/65;;A61P31/04;;C07C237/26;;C07D413/04;;C07D413/06;;C07D417/04,,1,0,,,"SUM ET AL.: J. MED. CHEM., vol. 37, no. 1, 1994, pages 184-188, XP002323590",ACTIVE
292,NO,L,NO 20062629 L,065-806-313-693-938,2006-09-06,2006,NO 20062629 A,2006-06-08,US 52792803 P;;US 58482304 P;;US 2004/0040850 W,2003-12-08,Oksazolderivater av tetrackliner,"Foreliggende oppfinnelse tilveiebringer forbindelser med formel I hvor A"", X og Y er som definert i beskrivelsen. Disse forbindelser er anvendelige som antibakterielle midler.",WYETH CORP,SUM PHAIK-ENG;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES,,https://lens.org/065-806-313-693-938,Abstract,no,0,0,43,44,0,A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04;;C07C2603/46;;A61P31/04;;C07D263/62;;C07D263/54;;C07D263/52;;C07C237/26;;C07D413/04;;A61K31/65;;C07D417/04;;C07D413/06;;C07D263/52;;C07C2603/46,C07D263/52;;A61K31/423;;A61K31/65;;C07C237/26;;C07D413/04;;C07D413/06;;C07D417/04,,0,0,,,,DISCONTINUED
293,US,B2,US 7176225 B2,116-484-427-720-948,2007-02-13,2007,US 762104 A,2004-12-08,US 762104 A;;US 58482304 P;;US 52792803 P,2003-12-08,Oxazole derivatives of tetracyclines,"This invention provides compounds of the formula: wherein A″, X and Y are defined in the specification. These compounds are useful as antibacterial agents.",WYETH CORP,SUM PHAIK-ENG;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES,WYETH (2005-01-04),https://lens.org/116-484-427-720-948,Granted Patent,yes,16,5,43,44,0,A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04;;C07C2603/46;;A61P31/04;;C07D263/62;;C07D263/54;;C07D263/52;;C07C237/26;;C07D413/04;;A61K31/65;;C07D417/04;;C07D413/06;;C07D263/52;;C07C2603/46,A61K31/423;;A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04,514/375;;548/223,8,4,030-436-807-720-881;;148-332-819-466-078;;004-556-152-988-177;;045-968-397-840-179,10360756;;10.1016/s0960-894x(99)00216-4;;10.1021/jm00027a023;;8289194;;2802561;;pmc172657;;10.1128/aac.33.8.1373;;10.1111/j.1365-2958.1990.tb02025.x;;2181236,"Phaik-Eng Sum and Peter Petersen, Bioorganic & Medicinal Chemistry Letters, vol. 9, pp. 1459-1462, 1999.;;Phaik-Eng Sum, et al., Abstract (1 page) and Poster (29 pages), 18<SUP>th </SUP>International Symposium on Medicinal Chemistry, Copenhagen, Denmark, Aug. 15-19, 2004.;;Phaik-Eng Sum, et al.; J. Med. Chem.; vol. 37; No. 1; pp. 184-188; 1994.;;International Search Report, Apr. 14, 2005.;;Chopra, Handbook of Experimental Pharmacology, Springer-Verlag, vol. 78, pp. 317-392, 1985.;;Richard C. Larock, Comprehensive Transformations, VCH Publishers, pp. 411-415; 1989.;;S. B. Levy, et al.; Antimicrob; Agents Chemotherapy; vol. 33; pp. 1373-1374; 1989.;;A.A. Salyers, et al.; Mol. Microbiol. vol. 4; pp. 151-156; 1990.",INACTIVE
294,WO,A1,WO 2005/056538 A1,153-615-312-548-577,2005-06-23,2005,US 2004/0040850 W,2004-12-07,US 52792803 P;;US 58482304 P,2003-12-08,OXAZOLE DERIVATIVES OF TETRACYCLINES,"This invention provides compounds of the formula: wherein A', X and Y are defined in the specification. These compounds are useful as antibacterial agents.",WYETH CORP;;SUM PHAIK-ENG;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES,SUM PHAIK-ENG;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES,,https://lens.org/153-615-312-548-577,Patent Application,yes,2,16,43,44,0,A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04;;C07C2603/46;;A61P31/04;;C07D263/62;;C07D263/54;;C07D263/52;;C07C237/26;;C07D413/04;;A61K31/65;;C07D417/04;;C07D413/06;;C07D263/52;;C07C2603/46,A61K31/423;;A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04,,1,1,148-332-819-466-078,10.1021/jm00027a023;;8289194,"SUM ET AL., J. MED. CHEM., vol. 37, no. 1, 1994, pages 184 - 188, XP002323590",PENDING
295,EP,A4,EP 2405779 A4,197-835-439-686-409,2014-04-09,2014,EP 10751335 A,2010-03-10,US 2010/0026783 W;;US 15925209 P;;US 72014610 A,2009-03-11,POWDER-FREE ANTIMICROBIAL COATED GLOVE,,ANSELL LTD,ENG AIK HWEE;;LAI HEE MENG;;LIM KUANG LENG;;TING KOON MEOW;;LUCAS DAVID M,,https://lens.org/197-835-439-686-409,Search Report,no,3,0,12,12,0,A61L31/16;;A61L31/16;;A41D19/0055;;A41D19/0055;;A41D31/305;;A41D31/305;;A61L31/10;;A61L31/10;;A61L31/145;;A61L31/145;;A61L2300/404;;A61L2300/404;;A61L2300/608;;A61L2300/608;;A61L2300/622;;A61L2300/622,A41D19/00;;A61B19/00;;A61L31/10;;A61L31/14;;A61L31/16,,1,0,,,See also references of WO 2010104924A1,ACTIVE
296,US,B1,US 6971365 B1,192-814-524-312-490,2005-12-06,2005,US 98752304 A,2004-11-12,US 98752304 A;;US 58709904 P,2004-07-12,Auto-ignition gasoline engine combustion chamber and method,"A combustion chamber for an internal combustion engine includes a closed end cylinder having an axis. A piston is reciprocable in the cylinder and includes a generally flat rim having an inner edge surrounding a recessed bowl into which the fuel is primarily injected, the bowl having a floor and a surrounding side formed by an arcuate surface connecting tangentially with the floor and extending to the rim inner edge. A spark plug has a centerline through the spark gap and is offset to one side of the cylinder axis with the spark gap extending into the combustion chamber toward the axis. A fuel injector is offset to an opposite side of the axis with the spray tip aimed to direct a generally conical fuel spray into the piston bowl with a portion of the fuel spray passing near the spark gap. Various dimensional characteristics are disclosed.",GEN MOTORS CORP,NAJT PAUL M;;KUO TANG-WEI;;CLEARY DAVID J;;ENG JAMES A;;BROWN BARRY L,GM GLOBAL TECHNOLOGY OPERATIONS LLC (2005-01-19);;GENERAL MOTORS CORPORATION (2004-11-03),https://lens.org/192-814-524-312-490,Granted Patent,yes,12,85,1,7,0,F02D13/0215;;F02D13/0215;;F02B1/12;;F02B1/12;;F02B23/101;;F02B23/101;;F02B2075/125;;F02B2075/125;;F02D13/0253;;F02D13/0253;;F02D13/0265;;F02D13/0265;;F02D13/0273;;F02D13/0273;;F02D41/3035;;F02D41/3035;;F02D41/3041;;F02D41/3041;;F02D41/402;;F02D41/402;;F02F1/242;;F02F1/242;;F02M26/01;;F02M26/01;;Y02T10/12;;Y02T10/12,F02B1/12;;F02B5/00;;F02B23/10;;F02B75/12;;F02D13/02;;F02D41/30;;F02D41/40;;F02F1/24;;F02M25/07,123/305;;123/285;;123/260,0,0,,,,ACTIVE
297,DE,B4,DE 112005001606 B4,017-539-343-608-875,2010-06-02,2010,DE 112005001606 T,2005-07-01,US 58709904 P;;US 2005/0023593 W,2004-07-12,benzinmotor,,GEN MOTORS CORP,NAJT PAUL M;;KUO TANG-WEI;;CLEARY DAVID J;;ENG JAMES A;;BROWN BARRY L,,https://lens.org/017-539-343-608-875,Granted Patent,no,7,0,6,7,0,F02B23/101;;F02B1/12;;F02B2075/125;;F02D13/0215;;F02D13/0265;;F02F1/242;;F02M26/01;;Y02T10/12,F02F3/26;;F02B17/00,,0,0,,,,ACTIVE
298,CN,A,CN 102985914 A,050-785-944-738-122,2013-03-20,2013,CN 201180034333 A,2011-07-13,US 2011/0043850 W;;US 83634110 A,2010-07-14,Out-of-band access to storage devices through port-sharing hardware,"A method, apparatus, system, and computer program product for enabling out-of-band access to storage devices through port-sharing hardware. Providing out-of-band access to storage devices enables system management functions to be performed when an operating system is non-functional as well as when the operating system is active. Storage commands originating with a management service can be interleaved with storage commands issued by the host operating system. The host operating system maintains ownership and control over its storage devices, but management activities can be performed while the host operating system is operational.",INTEL CORP,EDWARDS DAVID A;;GAN CHAI HUAT;;OOI ENG HUN;;GOKULRANGAN VENKAT R;;KHOSRAVI HORMUZD M,,https://lens.org/050-785-944-738-122,Patent Application,no,4,2,15,15,0,G06F3/0604;;G06F3/0617;;G06F3/0659;;G06F3/067;;G06F3/0604;;G06F3/0617;;G06F3/0659;;G06F3/067;;G06F13/14;;G06F13/16;;G06F3/0604;;G06F3/0659;;G06F3/067;;G06F3/0617,G06F13/14;;G06F9/30;;G06F9/44;;G06F13/16,,0,0,,,,INACTIVE
299,US,A1,US 2008/0064667 A1,086-552-751-163-915,2008-03-13,2008,US 63813806 A,2006-12-13,US 63813806 A;;US 762104 A;;US 58482304 P;;US 52792803 P,2003-12-08,OXAZOLE DERIVATIVES OF TETRACYCLINES,"This invention provides compounds of the formula: wherein A″, X and Y are defined in the specification. These compounds are useful as antibacterial agents.",WYETH CORP,SUM PHAIK-ENG;;HOW DAVID B;;HOPPER DARRIN W;;VERA MATTHEW D;;SABATINI JOSHUA J,,https://lens.org/086-552-751-163-915,Patent Application,yes,14,8,43,44,0,A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04;;C07C2603/46;;A61P31/04;;C07D263/62;;C07D263/54;;C07D263/52;;C07C237/26;;C07D413/04;;A61K31/65;;C07D417/04;;C07D413/06;;C07D263/52;;C07C2603/46,A61K31/65;;A61K31/423;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04,514/152;;548/218,0,0,,,,INACTIVE
300,EP,B1,EP 1692117 B1,161-277-761-426-226,2009-09-30,2009,EP 04813199 A,2004-12-07,US 2004/0040850 W;;US 52792803 P;;US 58482304 P,2003-12-08,OXAZOLE DERIVATIVES OF TETRACYCLINES,,WYETH CORP,SUM PHAIK-ENG;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES,WYETH LLC (2010-04-21),https://lens.org/161-277-761-426-226,Granted Patent,yes,2,0,43,44,0,A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04;;C07C2603/46;;A61P31/04;;C07D263/62;;C07D263/54;;C07D263/52;;C07C237/26;;C07D413/04;;A61K31/65;;C07D417/04;;C07D413/06;;C07D263/52;;C07C2603/46,C07D263/52;;A61K31/423;;A61K31/65;;A61P31/04;;C07C237/26;;C07D413/04;;C07D413/06;;C07D417/04,,1,0,,,"SUM ET AL.: J. MED. CHEM., vol. 37, no. 1, 1994, pages 184-188, XP002323590",ACTIVE
301,DE,T5,DE 112005001606 T5,179-519-136-206-124,2007-05-31,2007,DE 112005001606 T,2005-07-01,US 58709904 P;;US 2005/0023593 W,2004-07-12,Brennkammer und Verfahren für einen Selbstzündungsbenzinmotor,,GEN MOTORS CORP,NAJT PAUL M;;KUO TANG-WEI;;CLEARY DAVID J;;ENG JAMES A;;BROWN BARRY L,,https://lens.org/179-519-136-206-124,Patent Application,no,0,1,6,7,0,F02B23/101;;F02B1/12;;F02B2075/125;;F02D13/0215;;F02D13/0265;;F02F1/242;;F02M26/01;;Y02T10/12,F02F3/26;;F02B17/00,,0,0,,,,ACTIVE
302,EP,A4,EP 2593875 A4,198-427-719-419-077,2014-07-16,2014,EP 11807453 A,2011-07-13,US 83634110 A;;US 2011/0043850 W,2010-07-14,OUT-OF-BAND ACCESS TO STORAGE DEVICES THROUGH PORT-SHARING HARDWARE,,INTEL CORP,EDWARDS DAVID A;;GAN CHAI HUAT;;OOI ENG HUN;;GOKULRANGAN VENKAT R;;KHOSRAVI HORMUZD M,,https://lens.org/198-427-719-419-077,Search Report,no,1,0,15,15,0,G06F3/0604;;G06F3/0617;;G06F3/0659;;G06F3/067;;G06F3/0604;;G06F3/0617;;G06F3/0659;;G06F3/067;;G06F13/14;;G06F13/16;;G06F3/0604;;G06F3/0659;;G06F3/067;;G06F3/0617,G06F13/14;;G06F3/06;;G06F9/30;;G06F9/44;;G06F13/16,,0,0,,,,ACTIVE
303,US,A1,US 2003/0126479 A1,040-393-729-951-849,2003-07-03,2003,US 4109201 A,2001-12-28,US 4109201 A,2001-12-28,Digital throttle for multiple operating points,"
   A processor includes a digital throttle to monitor the activity of various units of the processor's instruction execution pipeline. The monitored activity is scaled according to the current operating point of the processor and a power state is determined from the scaled activity. If the power state reaches a first threshold, the operating point of the processor is adjusted and a new scaling factor is selected to determine the power state. 
",BURNS JAMES S.;;RUSU STEFAN;;AYERS DAVID J.;;GROCHOWSKI EDWARD T.;;ENG MARSHA;;TIWARI VIVEK,BURNS JAMES S;;RUSU STEFAN;;AYERS DAVID J;;GROCHOWSKI EDWARD T;;ENG MARSHA;;TIWARI VIVEK,INTEL CORPORATION (2002-04-05);;SONY CORPORATION OF AMERICA (2014-04-02),https://lens.org/040-393-729-951-849,Patent Application,yes,64,79,2,2,0,G06F1/3203;;G06F1/3237;;G06F1/3243;;G06F9/3017;;G06F9/3869;;G06F9/3873;;Y02D10/00;;G06F9/3869;;G06F1/3203;;G06F9/3017;;G06F1/3243;;G06F1/3237;;G06F9/3873;;Y02D10/00,G06F1/32;;G06F9/318,7133,0,0,,,,EXPIRED
304,TW,A,TW 201216162 A,175-373-929-125-733,2012-04-16,2012,TW 100123107 A,2011-06-30,US 83634110 A,2010-07-14,Out-of-band access to storage devices through port-sharing hardware,"A method, apparatus, system, and computer program product for enabling out-of-band access to storage devices through port-sharing hardware. Providing out-of-band access to storage devices enables system management functions to be performed when an operating system is non-functional as well as when the operating system is active. Storage commands originating with a management service can be interleaved with storage commands issued by the host operating system. The host operating system maintains ownership and control over its storage devices, but management activities can be performed while the host operating system is operational.",INTEL CORP,EDWARDS DAVID A;;OOI ENG HUN;;GOKULRANGAN VENKAT R;;KHOSRAVI HORMUZD M;;GAN CHAI HUAT,,https://lens.org/175-373-929-125-733,Patent of Addition,no,0,0,15,15,0,G06F3/0604;;G06F3/0617;;G06F3/0659;;G06F3/067;;G06F3/0604;;G06F3/0617;;G06F3/0659;;G06F3/067;;G06F13/14;;G06F13/16;;G06F3/0604;;G06F3/0659;;G06F3/067;;G06F3/0617,G06F13/10;;G06F9/445,,0,0,,,,INACTIVE
305,DE,B4,DE 112005001819 B4,169-963-713-304-292,2016-08-25,2016,DE 112005001819 T,2005-06-21,US 89944204 A;;US 2005/0021936 W,2004-07-26,Verfahren zum Betreiben eines Viertakt-Verbrennungsmotors,"Verfahren zum Betreiben eines Viertakt-Verbrennungsmotors, der eine Brennkammer mit variablem Volumen, die durch einen Kolben definiert ist, der in einem Zylinder zwischen einem oberen Totpunkt und einem unteren Totpunkt hin- und herbeweglich ist, Einlass- und Auslasskanäle und Einlass- und Auslassventile umfasst, die während sich wiederholender, aufeinander folgender Ausstoß-, Ansaug-, Verdichtungs- und Arbeitstakte des Kolbens gesteuert werden, das umfasst, dass: Ausstoßereignisse vorgesehen werden, während denen das Auslassventil offen ist, um verbrannte Gase aus der Brennkammer auszustoßen; während eines Teillastmotorbetriebes die Einlass- und Auslassventile derart während des Ansaugtaktes gesteuert werden, dass in der Brennkammer Bedingungen mit unteratmosphärischem Druck entstehen, wobei während des Teillastmotorbetriebes die Einlassventile ferner derart während des Ansaugtaktes in Abhängigkeit der Motorlast gesteuert werden, dass sie umso später öffnen, je geringer die Motorlast ist; und Ansaugereignisse vorgesehen werden, während denen das Einlassventil offen ist, um frische Luft in die Brennkammer einzulassen; dadurch gekennzeichnet, dass während des Ansaugtakts in der Brennkammer zurückgeführte Abgase durch interne Abgasrückführung hergestellt werden, wobei die interne Abgasrückführung umfasst, dass Abgase, die während des Ausstoßtaktes durch das geöffnete Auslassventil in den Auslasskanal ausgestoßen werden, während des Ansaugtaktes infolge erneuten Öffnens des Auslassventils durch das geöffnete Auslassventil in die Brennkammer zurückgesaugt werden.",GEN MOTORS CORP,KUO TANG-WEI;;BROWN BARRY L;;NAJT PAUL M;;ENG JAMES A;;CLEARY DAVID J,,https://lens.org/169-963-713-304-292,Granted Patent,no,9,0,7,7,0,F02D13/0207;;F02D13/0207;;F02B1/12;;F02B1/12;;F02B2075/027;;F02B2075/027;;F02B2075/125;;F02B2075/125;;F02D13/0238;;F02D13/0238;;F02D13/0242;;F02D13/0242;;F02D13/0273;;F02D13/0273;;F02D41/402;;F02D41/402;;Y02T10/12;;Y02T10/12;;Y02T10/40;;Y02T10/40,F02B3/00;;F01L1/34;;F02D13/02,,1,0,,,"Woschni: Verbrennungsmotoren - Skriptum zur Vorlesung. 2. Auflage. München : Eigenverlag, 1988. Seite 114-115. - ISBN 0-00",ACTIVE
306,KR,A,KR 20060105047 A,051-369-585-719-58X,2006-10-09,2006,KR 20067013606 A,2004-12-07,US 2004/0040850 W;;US 52792803 P;;US 58482304 P,2003-12-08,OXAZOLE DERIVATIVES OF TETRACYCLINES,"wherein A"", X and Y are defined in the specification. These compounds are useful as antibacterial agents.",WYETH CORP,SUM PHAIK ENG;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES,,https://lens.org/051-369-585-719-58X,Patent Application,no,0,0,43,44,0,A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04;;C07C2603/46;;A61P31/04;;C07D263/62;;C07D263/54;;C07D263/52;;C07C237/26;;C07D413/04;;A61K31/65;;C07D417/04;;C07D413/06;;C07D263/52;;C07C2603/46,C07D263/62;;A61K31/423;;A61K31/65;;C07C237/26;;C07D263/52;;C07D263/54;;C07D413/04;;C07D413/06;;C07D417/04,,0,0,,,,INACTIVE
307,EP,A1,EP 1692117 A1,078-055-973-547-511,2006-08-23,2006,EP 04813199 A,2004-12-07,US 2004/0040850 W;;US 52792803 P;;US 58482304 P,2003-12-08,OXAZOLE DERIVATIVES OF TETRACYCLINES,,WYETH CORP,SUM PHAIK-ENG;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES,WYETH LLC (2010-04-21),https://lens.org/078-055-973-547-511,Patent Application,yes,0,0,43,44,0,A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04;;C07C2603/46;;A61P31/04;;C07D263/62;;C07D263/54;;C07D263/52;;C07C237/26;;C07D413/04;;A61K31/65;;C07D417/04;;C07D413/06;;C07D263/52;;C07C2603/46,C07D263/52;;A61K31/423;;A61K31/65;;A61P31/04;;C07C237/26;;C07D413/04;;C07D413/06;;C07D417/04,,0,0,,,,ACTIVE
308,US,A1,US 2010/0233223 A1,084-332-629-170-620,2010-09-16,2010,US 72014610 A,2010-03-09,US 72014610 A;;US 15925209 P,2009-03-11,Powder-Free Antimicrobial Coated Glove,"Provided herein are powder-free elastomeric articles exhibiting good antimicrobial and anti-blocking properties. Also provided herein are methods for the manufacture of such articles substantially free from antimicrobial interfering materials, as well as packaging means for maintaining antimicrobial efficacy.",ANSELL LTD,ENG AIK HWEE;;LAI HEE MENG;;LIM KUANG LENG;;TING KOON MEOW;;LUCAS DAVID M,ANSELL LIMITED (2010-05-03),https://lens.org/084-332-629-170-620,Patent Application,yes,58,6,12,12,0,A61L31/16;;A61L31/16;;A41D19/0055;;A41D19/0055;;A41D31/305;;A41D31/305;;A61L31/10;;A61L31/10;;A61L31/145;;A61L31/145;;A61L2300/404;;A61L2300/404;;A61L2300/608;;A61L2300/608;;A61L2300/622;;A61L2300/622,A01N25/34;;A01N31/02;;A01N31/14;;A01N33/12;;A01N37/52;;A01N59/16;;A01P1/00;;A01P3/00;;A61K31/08;;A61K31/085;;B05D3/00,424/404;;424/402;;514/635;;514/643;;514/721;;514/739;;514/718;;514/738;;424/618;;424/641;;427/2.3,0,0,,,,INACTIVE
309,WO,A2,WO 2012/009436 A2,114-446-134-250-292,2012-01-19,2012,US 2011/0043850 W,2011-07-13,US 83634110 A,2010-07-14,OUT-OF-BAND ACCESS TO STORAGE DEVICES THROUGH PORT-SHARING HARDWARE,"A method, apparatus, system, and computer program product for enabling out-of-band access to storage devices through port-sharing hardware. Providing out-of-band access to storage devices enables system management functions to be performed when an operating system is non-functional as well as when the operating system is active. Storage commands originating with a management service can be interleaved with storage commands issued by the host operating system. The host operating system maintains ownership and control over its storage devices, but management activities can be performed while the host operating system is operational.",INTEL CORP;;EDWARDS DAVID A;;GAN CHAI HUAT;;OOI ENG HUN;;GOKULRANGAN VENKAT R;;KHOSRAVI HORMUZD M,EDWARDS DAVID A;;GAN CHAI HUAT;;OOI ENG HUN;;GOKULRANGAN VENKAT R;;KHOSRAVI HORMUZD M,,https://lens.org/114-446-134-250-292,Patent Application,yes,1,0,15,15,0,G06F3/0604;;G06F3/0617;;G06F3/0659;;G06F3/067;;G06F3/0604;;G06F3/0617;;G06F3/0659;;G06F3/067;;G06F13/14;;G06F13/16;;G06F3/0604;;G06F3/0659;;G06F3/067;;G06F3/0617,G06F13/14;;G06F9/30;;G06F9/44;;G06F13/16,,0,0,,,,PENDING
310,WO,A2,WO 2002/067890 A2,109-378-088-465-045,2002-09-06,2002,EP 0200328 W,2002-01-14,GB 0102235 A,2001-01-29,METHOD AND PRODUCT FOR SKIN LIGHTENING,"A method and cosmetic product for lightening skin is provided, the method including wiping the skin with a cosmetic towelette. Impregnated on the towelette is an alphahydroxy carboxylic acid or salt thereof and a sunscreen agent.",UNILEVER PLC;;UNILEVER NV;;LEVER HINDUSTAN LTD,GOTT ROBERT EDWARD;;HAGUE JONATHAN DAVID;;LIM ENG-BENG;;SLAVTCHEFF CRAIG STEPHEN;;ZNAIDEN ALEXANDER PAUL,,https://lens.org/109-378-088-465-045,Patent Application,yes,0,0,4,4,0,A61K8/0208;;A61Q19/02;;A61Q19/02;;A61K8/0208,A61K8/02;;A61K9/70;;A61K31/19;;A61Q19/02,,0,0,,,,PENDING
311,DE,D1,DE 602004023417 D1,115-593-925-005-601,2009-11-12,2009,DE 602004023417 T,2004-12-07,US 52792803 P;;US 58482304 P;;US 2004/0040850 W,2003-12-08,OXAZOLDERIVATE VON TETRACYCLINEN,,WYETH CORP,SUM PHAIK-ENG;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES,,https://lens.org/115-593-925-005-601,Granted Patent,no,0,0,43,44,0,A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04;;C07C2603/46;;A61P31/04;;C07D263/62;;C07D263/54;;C07D263/52;;C07C237/26;;C07D413/04;;A61K31/65;;C07D417/04;;C07D413/06;;C07D263/52;;C07C2603/46,C07D263/52;;A61K31/423;;A61K31/65;;A61P31/04;;C07C237/26;;C07D413/04;;C07D413/06;;C07D417/04,,0,0,,,,ACTIVE
312,AU,A1,AU 2004/297243 A1,003-092-481-919-333,2005-06-23,2005,AU 2004/297243 A,2004-12-07,US 52792803 P;;US 58482304 P;;US 2004/0040850 W,2003-12-08,Oxazole derivatives of tetracyclines,,WYETH CORP,HOPPER DARRIN WILLIAM;;SUM PHAIK-ENG;;SABATINI JOSHUA JAMES;;HOW DAVID BRIAN;;VERA MATTHEW DOUGLAS,,https://lens.org/003-092-481-919-333,Patent Application,no,0,0,43,44,0,A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04;;C07C2603/46;;A61P31/04;;C07D263/62;;C07D263/54;;C07D263/52;;C07C237/26;;C07D413/04;;A61K31/65;;C07D417/04;;C07D413/06;;C07D263/52;;C07C2603/46,A61K31/423;;A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04,,0,0,,,,INACTIVE
313,CR,A,CR 8437 A,043-438-045-962-147,2006-10-06,2006,CR 8437 A,2006-06-06,US 52792803 P;;US 58482304 P,2003-12-08,DERIVADOS DE OXAZOL DE TETRACICLINA,Esta invencion suministra compuesto de la formula. Estos compuestos son utiles como agentes antibacterianos.,WYETH LLC,PHAIK-ENG SUM;;DAVID BRIAN HOW;;DARRIN WILLIAM HOPPER;;MATTHEW DOUGLAS VERA;;JOSHUA JAMES SABATINI,,https://lens.org/043-438-045-962-147,Patent Application,no,0,0,43,44,0,A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04;;C07C2603/46;;A61P31/04;;C07D263/62;;C07D263/54;;C07D263/52;;C07C237/26;;C07D413/04;;A61K31/65;;C07D417/04;;C07D413/06;;C07D263/52;;C07C2603/46,A61K31/423;;A61K31/65;;A61P31/04;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04,,0,0,,,,DISCONTINUED
314,WO,A3,WO 2012/009436 A3,051-602-138-579-341,2012-04-26,2012,US 2011/0043850 W,2011-07-13,US 83634110 A,2010-07-14,OUT-OF-BAND ACCESS TO STORAGE DEVICES THROUGH PORT-SHARING HARDWARE,"A method, apparatus, system, and computer program product for enabling out-of-band access to storage devices through port-sharing hardware. Providing out-of-band access to storage devices enables system management functions to be performed when an operating system is non-functional as well as when the operating system is active. Storage commands originating with a management service can be interleaved with storage commands issued by the host operating system. The host operating system maintains ownership and control over its storage devices, but management activities can be performed while the host operating system is operational.",INTEL CORP;;EDWARDS DAVID A;;GAN CHAI HUAT;;OOI ENG HUN;;GOKULRANGAN VENKAT R;;KHOSRAVI HORMUZD M,EDWARDS DAVID A;;GAN CHAI HUAT;;OOI ENG HUN;;GOKULRANGAN VENKAT R;;KHOSRAVI HORMUZD M,,https://lens.org/051-602-138-579-341,Search Report,yes,3,0,15,15,0,G06F3/0604;;G06F3/0617;;G06F3/0659;;G06F3/067;;G06F3/0604;;G06F3/0617;;G06F3/0659;;G06F3/067;;G06F13/14;;G06F13/16;;G06F3/0604;;G06F3/0659;;G06F3/067;;G06F3/0617,G06F9/30;;G06F13/14;;G06F9/44;;G06F13/16,,0,0,,,,PENDING
315,EP,A1,EP 2405779 A1,108-554-990-027-860,2012-01-18,2012,EP 10751335 A,2010-03-10,US 2010/0026783 W;;US 15925209 P;;US 72014610 A,2009-03-11,POWDER-FREE ANTIMICROBIAL COATED GLOVE,,ANSELL LTD,ENG AIK HWEE;;LAI HEE MENG;;LIM KUANG LENG;;TING KOON MEOW;;LUCAS DAVID M,,https://lens.org/108-554-990-027-860,Patent Application,yes,0,0,12,12,0,A61L31/16;;A61L31/16;;A41D19/0055;;A41D19/0055;;A41D31/305;;A41D31/305;;A61L31/10;;A61L31/10;;A61L31/145;;A61L31/145;;A61L2300/404;;A61L2300/404;;A61L2300/608;;A61L2300/608;;A61L2300/622;;A61L2300/622,A41D19/00;;A61L31/10;;A61L31/14;;A61L31/16,,0,0,,,,ACTIVE
316,US,A1,US 2012/0017011 A1,131-579-268-862-476,2012-01-19,2012,US 83634110 A,2010-07-14,US 83634110 A,2010-07-14,OUT-OF-BAND ACCESS TO STORAGE DEVICES THROUGH PORT-SHARING HARDWARE,"A method, apparatus, system, and computer program product for enabling out-of-band access to storage devices through port-sharing hardware. Providing out-of-band access to storage devices enables system management functions to be performed when an operating system is non-functional as well as when the operating system is active. Storage commands originating with a management service can be interleaved with storage commands issued by the host operating system. The host operating system maintains ownership and control over its storage devices, but management activities can be performed while the host operating system is operational.",EDWARDS DAVID A;;OOI ENG HUN;;GOKULRANGAN VENKAT R;;KHOSRAVI HORMUZD M;;GAN CHAI HUAT,EDWARDS DAVID A;;OOI ENG HUN;;GOKULRANGAN VENKAT R;;KHOSRAVI HORMUZD M;;GAN CHAI HUAT,INTEL CORPORATION (2010-06-27),https://lens.org/131-579-268-862-476,Patent Application,yes,2,6,15,15,0,G06F3/0604;;G06F3/0617;;G06F3/0659;;G06F3/067;;G06F3/0604;;G06F3/0617;;G06F3/0659;;G06F3/067;;G06F13/14;;G06F13/16;;G06F3/0604;;G06F3/0659;;G06F3/067;;G06F3/0617,G06F3/00,710/5,0,0,,,,ACTIVE
317,EC,A,EC SP066605 A,199-699-115-297-422,2006-10-25,2006,EC SP066605 A,2006-06-05,US 52792803 P;;US 58482304 P,2003-12-08,DERIVADOS OXAZOL DE TETRACICLINA,"Esta invención suministra compuestos de la fórmula I:en donde A"", X y Y son según se definió en la especificación. Estos compuestos son útiles como agentes antibacterianos.",WYETH CORP,SUM PHAIK-ENG;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES,,https://lens.org/199-699-115-297-422,Patent Application,no,0,0,43,44,0,A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04;;C07C2603/46;;A61P31/04;;C07D263/62;;C07D263/54;;C07D263/52;;C07C237/26;;C07D413/04;;A61K31/65;;C07D417/04;;C07D413/06;;C07D263/52;;C07C2603/46,A61K31/423;;A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04,,0,0,,,,PENDING
318,AU,B2,AU 2004/297243 B2,087-175-978-568-488,2011-02-17,2011,AU 2004/297243 A,2004-12-07,US 52792803 P;;US 58482304 P;;US 2004/0040850 W,2003-12-08,Oxazole derivatives of tetracyclines,,WYETH LLC,HOPPER DARRIN WILLIAM;;SUM PHAIK-ENG;;SABATINI JOSHUA JAMES;;HOW DAVID BRIAN;;VERA MATTHEW DOUGLAS,,https://lens.org/087-175-978-568-488,Granted Patent,no,0,0,43,44,0,A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04;;C07C2603/46;;A61P31/04;;C07D263/62;;C07D263/54;;C07D263/52;;C07C237/26;;C07D413/04;;A61K31/65;;C07D417/04;;C07D413/06;;C07D263/52;;C07C2603/46,A61K31/423;;A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04,,0,0,,,,INACTIVE
319,PA,A1,PA 8619001 A1,140-263-403-239-130,2005-08-04,2005,PA 8619001 A,2004-12-03,US 52688303 P,2003-12-04,BIARIL SULFONAMIDAS Y METODO PARA EL USO DE LAS MISMAS,"LA PRESENTE INVENCION DIVULGA BIARIL SULFONAMIDAS Y SUS USOS, POR EJEMPLO COMO INHIBIDORES DE METALOPROTEINASAS.",WYETH CORP,HU YONGHAN;;XIANG JASON SHAOYUN;;TAM STEVE YIK-KAI;;SUM PHAIK-ENG;;HOW DAVID BRIAN,,https://lens.org/140-263-403-239-130,Patent Application,no,0,0,39,39,0,A61K31/4188;;A61K31/424;;A61K31/429;;C07C311/29;;C07C311/46;;C07D213/30;;C07D213/64;;C07D213/643;;C07D215/14;;C07D215/227;;C07D215/233;;C07D217/18;;C07D235/12;;C07D239/34;;C07D239/60;;C07D261/14;;C07D263/22;;C07D263/58;;C07D277/64;;C07D277/68;;C07D295/096;;C07D295/192;;C07D307/79;;C07D307/80;;C07D307/82;;C07D307/84;;C07D319/18;;C07D321/10;;C07D333/20;;C07D333/36;;C07D333/66;;C07C2601/08;;C07C2602/10;;A61P1/00;;A61P1/02;;A61P1/04;;A61P1/16;;A61P11/00;;A61P11/06;;A61P13/12;;A61P17/02;;A61P19/00;;A61P19/02;;A61P19/04;;A61P19/08;;A61P19/10;;A61P21/00;;A61P25/00;;A61P27/02;;A61P29/00;;A61P3/00;;A61P35/00;;A61P35/04;;A61P37/00;;A61P37/06;;A61P43/00;;A61P7/00;;A61P9/00;;A61P9/10;;A61P9/14;;A61P3/10;;C07D213/30;;C07D217/18;;C07D319/18;;C07D215/227;;C07D295/096;;C07D321/10;;C07C311/29;;C07D277/64;;C07D213/643;;A61K31/4188;;A61K31/424;;C07D215/233;;C07D263/22;;C07D307/84;;C07D213/64;;C07C311/46;;A61K31/429;;C07D295/192;;C07D215/14;;C07D307/79;;C07D333/20;;C07D261/14;;C07D239/34;;C07D307/80;;C07D333/66;;C07D239/60;;C07D277/68;;C07D307/82;;C07D263/58;;C07D333/36;;C07D235/12;;C07C2601/08;;C07C2602/10,A61K31/198;;A61K31/33;;C07B45/00;;C07C311/29;;C07C311/46;;C07D213/30;;C07D213/64;;C07D213/643;;C07D215/14;;C07D215/22;;C07D215/227;;C07D215/233;;C07D217/18;;C07D235/12;;C07D239/34;;C07D239/60;;C07D261/14;;C07D263/22;;C07D263/58;;C07D277/64;;C07D277/68;;C07D295/08;;C07D295/096;;C07D295/18;;C07D295/192;;C07D307/79;;C07D307/80;;C07D307/82;;C07D307/84;;C07D319/18;;C07D321/10;;C07D333/20;;C07D333/36;;C07D333/66,,0,0,,,,PENDING
320,CN,B,CN 102438473 B,155-731-518-557-568,2014-11-26,2014,CN 201080019053 A,2010-03-10,US 2010/0026783 W;;US 15925209 P;;US 72014610 A,2009-03-11,Powder-free antimicrobial coated glove,,ANSELL HEALTHCARE PROD LLC,ENG AIK HWEE;;LAI HEE MENG;;LIM KUANG LENG;;TING KOON MEOW;;LUCAS DAVID M,,https://lens.org/155-731-518-557-568,Granted Patent,no,0,0,12,12,0,A61L31/16;;A61L31/16;;A41D19/0055;;A41D19/0055;;A41D31/305;;A41D31/305;;A61L31/10;;A61L31/10;;A61L31/145;;A61L31/145;;A61L2300/404;;A61L2300/404;;A61L2300/608;;A61L2300/608;;A61L2300/622;;A61L2300/622,A41D19/00;;A61B19/00;;A61L31/10,,0,0,,,,ACTIVE
321,WO,A3,WO 2009/017825 A3,152-423-364-797-505,2009-03-26,2009,US 2008/0009327 W,2008-08-01,US 96310407 P,2007-08-02,NOVEL LIPOXYGENASE INHIBITORS AS NEUROPROTECTIVE AGENTS,"The present invention relates to the identification of inhibitors of lipoxygenase enzymes. Methods are presented for using novel lipoxygenase inhibitors: LOXBlock-1 and LOXBlock-3, and other candidate lipoxygenase inhibitors identified by similar screening strategies, in therapy and diagnostics for neurodegenerative disorders.",GEN HOSPITAL CORP;;VAN LEYEN KLAUS;;HOLMAN THEODORE R;;LO ENG H;;JACOBSON MATTHEW P;;HOWELLS DAVID W,VAN LEYEN KLAUS;;HOLMAN THEODORE R;;LO ENG H;;JACOBSON MATTHEW P;;HOWELLS DAVID W,,https://lens.org/152-423-364-797-505,Search Report,yes,0,0,3,3,0,A61K31/37;;A61K31/38;;A61K31/40;;A61K31/47;;A61K45/06;;A61P25/16;;A61P25/28;;A61K31/38;;A61K31/37;;A61K45/06;;A61K31/40;;A61K31/47,A61K31/47;;A61K31/381;;A61K31/403,,7,7,027-773-469-638-242;;003-334-651-376-570;;093-620-732-227-819;;068-618-032-079-107;;049-527-684-077-198;;091-519-920-421-564;;012-861-323-706-519,10.1021/jm050639j;;16480270;;10.1016/s0002-9440(10)63724-8;;pmc1615676;;15111312;;16647138;;10.1016/j.brainresrev.2006.02.002;;15105833;;10.1038/sj.cdd.4401395;;10.1074/jbc.m307075200;;12917400;;pmc1910692;;9535216;;10.1096/fasebj.12.6.439;;17960827;;pmc2759176;;10.1002/jnr.21543,"KENYON V ET AL.: ""Novel human lipoxygenase inhibitors discovered using virtual screening with homology models."", J MED. CHEM., vol. 49, no. 4, 23 February 2006 (2006-02-23), pages 1356 - 63;;PRATICO D. ET AL.: ""12/15-lipoxygenase is increased in Alzheimer's disease: possible involvement in brain oxidative stress."", AM. J. PATHOL., vol. 164, no. 5, May 2004 (2004-05-01), pages 1655 - 62;;PHILLIS J.W. ET AL.: ""Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders."", BRAIN RES. REV., vol. 52, no. 2, September 2006 (2006-09-01), pages 201 - 43;;LEBEAU A. ET AL.: ""Blockade of 12-lipoxygenase expression protects cortical neurons from apoptosis induced by beta-amyloid peptide."", CELL DEATH DIFFER., vol. 11, no. 8, August 2004 (2004-08-01), pages 875 - 84;;KHANNA S. ET AL.: ""Molecular basis of vitamin E action: tocotrienol modulates 12-lipoxygenase, a key mediator of glutamate-induced neurodegeneration."", J. BIOL. CHEM., vol. 278, no. 44, 31 October 2003 (2003-10-31), pages 43508 - 15;;UZ T. ET AL.: ""Aging-associated up-regulation of neuronal 5-lipoxygenase expression: putative role in neuronal vulnerability."", FASEB J., vol. 12, no. 6, April 1998 (1998-04-01), pages 439 - 49;;VAN LEYEN K. ET AL.: ""Novel lipoxygenase inhibitors as neuroprotective reagents."", J. NEUROSCI. RES., vol. 86, no. 4, 2008, pages 904 - 9",PENDING
322,US,A1,US 2005/0153944 A1,047-515-439-868-825,2005-07-14,2005,US 762104 A,2004-12-08,US 762104 A;;US 58482304 P;;US 52792803 P,2003-12-08,Oxazole derivatives of tetracyclines,"This invention provides compounds of the formula: wherein A″, X and Y are defined in the specification. These compounds are useful as antibacterial agents.",WYETH CORP,SUM PHAIK-ENG;;HOW DAVID B;;HOPPER DARRIN W;;VERA MATTHEW D;;SABATINI JOSHUA J,WYETH (2005-01-04),https://lens.org/047-515-439-868-825,Patent Application,yes,0,3,43,44,0,A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04;;C07C2603/46;;A61P31/04;;C07D263/62;;C07D263/54;;C07D263/52;;C07C237/26;;C07D413/04;;A61K31/65;;C07D417/04;;C07D413/06;;C07D263/52;;C07C2603/46,A61K31/423;;A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04,514/152;;548/218,0,0,,,,INACTIVE
323,CN,B,CN 1985084 B,072-177-636-780-782,2010-05-05,2010,CN 200580023673 A,2005-07-01,US 2005/0023593 W;;US 58709904 P,2004-07-12,Combustion chamber used in internal combustion engine,"A combustion chamber for an internal combustion engine includes a closed end cylinder having an axis. A piston is reciprocable in the cylinder and includes a generally flat rim having an inner edge surrounding a recessed bowl into which the fuel is primarily injected, the bowl having a floor and a surrounding side formed by an arcuate surface connecting tangentially with the floor and extending tothe rim inner edge. A spark plug has a centerline through the spark gap and is offset to one side of the cylinder axis with the spark gap extending into the combustion chamber toward the axis. A fuelinjector is offset to an opposite side of the axis with the spray tip aimed to direct a generally conical fuel spray into the piston bowl with a portion of the fuel spray passing near the spark gap.Various dimensional characteristics are disclosed.",GEN MOTORS CORP,NAJT PAUL M;;ENG JAMES A;;BROWN BARRY L;;TANG-WEI KUO;;CLEARY DAVID J,,https://lens.org/072-177-636-780-782,Granted Patent,no,0,0,6,7,0,F02B23/101;;F02B1/12;;F02B2075/125;;F02D13/0215;;F02D13/0265;;F02F1/242;;F02M26/01;;Y02T10/12,F02F3/26;;F02B17/00,,0,0,,,,ACTIVE
324,US,A,US 4625203 A,067-163-854-697-196,1986-11-25,1986,US 54310783 A,1983-10-18,US 54310783 A,1983-10-18,Arrangement for providing data signals for a data display system,"The present invention includes a microprocessor which acts to generate groups of its signals from its read only memory (ROM) thereby forming character representations of groups of coded signals, such as ASCII coded signals, coming from a main data processing device. The groups of bit signals are temporarily stored in a buffer which at a subsequent time transmits, in parallel, groups of said bit signals to a bit map memory through some logic circuitry. The group, or block, transfer of said bit signals in parallel, occurs during horizontal or vertical blank periods. The parallel transfer during the blank periods provides part of the basis for acceleration of the data to a display device as compared with the prior art. In addition, the microprocessor provides address information signals to a graphic display controller, which in turn provides starting addresses, for the locations of the bit signals. In addition a bit map memory device is employed to provide pixel information to a CRT display device to create the characters which are to be shown.",DIGITAL EQUIPMENT CORP,DINITTO ROBERT S;;PORCHER THOMAS C;;ENG JOHN W;;NAMIAS CHARLES S;;HUGHES DAVID B,DIGITAL EQUIPMENT CORPORATION (1983-10-04);;HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (1999-12-09),https://lens.org/067-163-854-697-196,Granted Patent,yes,4,5,21,21,0,G09G5/393;;G06F3/14;;G09G5/393,G06F3/14;;G06F3/153;;G06T11/20;;G09G5/18;;G09G5/393,340/750,0,0,,,,EXPIRED
325,WO,A2,WO 2009/017825 A2,117-201-048-816-775,2009-02-05,2009,US 2008/0009327 W,2008-08-01,US 96310407 P,2007-08-02,NOVEL LIPOXYGENASE INHIBITORS AS NEUROPROTECTIVE AGENTS,"The present invention relates to the identification of inhibitors of lipoxygenase enzymes. Methods are presented for using novel lipoxygenase inhibitors: LOXBlock-1 and LOXBlock-3, and other candidate lipoxygenase inhibitors identified by similar screening strategies, in therapy and diagnostics for neurodegenerative disorders.",GEN HOSPITAL CORP;;VAN LEYEN KLAUS;;HOLMAN THEODORE R;;LO ENG H;;JACOBSON MATTHEW P;;HOWELLS DAVID W,VAN LEYEN KLAUS;;HOLMAN THEODORE R;;LO ENG H;;JACOBSON MATTHEW P;;HOWELLS DAVID W,,https://lens.org/117-201-048-816-775,Patent Application,yes,0,2,3,3,0,A61K31/37;;A61K31/38;;A61K31/40;;A61K31/47;;A61K45/06;;A61P25/16;;A61P25/28;;A61K31/38;;A61K31/37;;A61K45/06;;A61K31/40;;A61K31/47,A61K31/47;;A61K31/38;;A61K31/40,,0,0,,,,PENDING
326,AU,A1,AU 2010/224224 A1,114-775-764-807-611,2011-10-20,2011,AU 2010/224224 A,2010-03-10,US 72014610 A;;US 15925209 P;;US 2010/0026783 W,2009-03-11,Powder-free antimicrobial coated glove,"Provided herein are powder-free elastomeric articles exhibiting good antimicrobial and anti-blocking properties. Also provided herein are methods for the manufacture of such articles substantially free from antimicrobial interfering materials, as well as packaging means for maintaining antimicrobial efficacy.",ANSELL LTD,HWEE ENG AIK;;MENG LAI HEE;;LENG LIM KUANG;;MEOW TING KOON;;LUCAS DAVID M,,https://lens.org/114-775-764-807-611,Patent Application,no,0,0,12,12,0,A61L31/16;;A61L31/16;;A41D19/0055;;A41D19/0055;;A41D31/305;;A41D31/305;;A61L31/10;;A61L31/10;;A61L31/145;;A61L31/145;;A61L2300/404;;A61L2300/404;;A61L2300/608;;A61L2300/608;;A61L2300/622;;A61L2300/622,A41D19/00;;A61B19/00;;A61L31/10,,0,0,,,,ACTIVE
327,EP,A3,EP 0145530 A3,032-721-715-883-320,1989-07-26,1989,EP 84402086 A,1984-10-17,US 54310783 A,1983-10-18,ARRANGEMENT FOR PROVIDING DATA SIGNALS FOR A DATA DISPLAY SYSTEM,"@ The present invention includes a microprocessor (15) which acts to generate rasters of its signals from its read only memory (ROM), thereby forming character representations of groups of coded signals, such as ASCII coded signals, coming from a main data processing device. The rasters of bit signals are temporarily stored in a buffer (23) which at a subsequent time transmits, in parallel, groups of said bit signals to a bit map memory (33) through logic circuitry. The group, or block, transfer of these bit signals in parallel occurs during horizontal or vertical blank periods. The parallel transfer during the blank periods provides part of the basis for acceleration of the transfer of data to a display device as compared with the prior art. In addition, the microprocessor provides address information signals to a graphic display controller (19), which in turn provides starting addresses for the location of the bit signals. In addition, a bit map memory device is employed to provide pixel information to a CRT display device (51) to create the characters to be displayed.",DIGITAL EQUIPMENT CORPORATION,"DI NITTO, ROBERT SALVATORE;;PORCHER, THOMAS COURTENAY;;ENG, JOHN WAI;;NAMIAS, CHARLES;;HUGHES, DAVID BRUCE",,https://lens.org/032-721-715-883-320,Search Report,yes,3,0,21,21,0,G09G5/393;;G06F3/14;;G09G5/393,G06F3/153;;G06F3/14;;G06T11/20;;G09G5/18;;G09G5/393,,0,0,,,,DISCONTINUED
328,US,B2,US 7365087 B2,045-081-947-642-090,2008-04-29,2008,US 63813806 A,2006-12-13,US 63813806 A;;US 762104 A;;US 58482304 P;;US 52792803 P,2003-12-08,Oxazole derivatives of tetracyclines,"This invention provides compounds of the formula: wherein A″, X and Y are defined in the specification. These compounds are useful as antibacterial agents.",WYETH CORP,SUM PHAIK-ENG;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES,,https://lens.org/045-081-947-642-090,Granted Patent,yes,16,0,43,44,0,A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04;;C07C2603/46;;A61P31/04;;C07D263/62;;C07D263/54;;C07D263/52;;C07C237/26;;C07D413/04;;A61K31/65;;C07D417/04;;C07D413/06;;C07D263/52;;C07C2603/46,A61K31/423;;A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04,514/375;;548/223;;552/206,7,4,004-556-152-988-177;;045-968-397-840-179;;148-332-819-466-078;;030-436-807-720-881,2802561;;pmc172657;;10.1128/aac.33.8.1373;;10.1111/j.1365-2958.1990.tb02025.x;;2181236;;10.1021/jm00027a023;;8289194;;10360756;;10.1016/s0960-894x(99)00216-4,"Chopra, Handbook of Experimental Pharmacology, Springer-Verlag, vol. 78, pp. 317-392, 1985.;;Richard C. Larock, Comprehensive Transformations, VCH Publishers, pp. 411-415; 1989.;;S. B. Levy, et al.; Antimicrob; Agents Chemotherapy; vol. 33; pp. 1373-1374; 1989.;;A.A. Salyers, et al.; Mol. Microbiol. vol. 4; pp. 151-156; 1990.;;Phaik-Eng Sum, et al., J. Med. Chem.; vol. 37, No. 1; pp. 184-188, 1994.;;Phaik-Eng Sum and Peter Petersen, Bioorganic & Medicinal Chemistry Letters, vol. 9, pp. 1459-1462, 1999.;;Phaik-Eng Sum, et al., Abstract (1 page) and Poster (29 pages), 18<SUP>th </SUP>International Symposium on Medicinal Chemistry, Copenhagen, Denmark, Aug. 15-19, 2004.",INACTIVE
329,WO,A2,WO 2006/017051 A2,078-213-300-072-516,2006-02-16,2006,US 2005/0023593 W,2005-07-01,US 58709904 P,2004-07-12,AUTO-IGNITION GASOLINE ENGINE COMBUSTION CHAMBER AND METHOD,"A combustion chamber for an internal combustion engine includes a closed end cylinder having an axis. A piston is reciprocable in the cylinder and includes a generally flat rim having an inner edge surrounding a recessed bowl into which the fuel is primarily injected, the bowl having a floor and a surrounding side formed by an arcuate surface connecting tangentially with the floor and extending to the rim inner edge. A spark plug has a centerline through the spark gap and is offset to one side of the cylinder axis with the spark gap extending into the combustion chamber toward the axis. A fuel injector is offset to an opposite side of the axis with the spray tip aimed to direct a generally conical fuel spray into the piston bowl with a portion of the fuel spray passing near the spark gap. Various dimensional characteristics are disclosed.",GEN MOTORS CORP,NAJT PAUL M;;KUO TANG-WEI;;CLEARY DAVID J;;ENG JAMES A;;BROWN BARRY L,,https://lens.org/078-213-300-072-516,Patent Application,yes,0,7,6,7,0,F02B23/101;;F02B1/12;;F02B2075/125;;F02D13/0215;;F02D13/0265;;F02F1/242;;F02M26/01;;Y02T10/12,F02F3/26;;F02B17/00,,0,0,,,,PENDING
330,TW,A,TW 200528437 A,082-356-471-473-165,2005-09-01,2005,TW 93137032 A,2004-12-01,US 52792803 P;;US 58482304 P,2003-12-08,Oxazole derivatives of tetracyclines,"The invention provides compounds of the formula: , wherein A"", X and Y are defined in the specification. These compounds are useful as antibacterial agents.",WYETH CORP,SUM PHAIK-ENG;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES,,https://lens.org/082-356-471-473-165,Patent of Addition,no,0,0,43,44,0,A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04;;C07C2603/46;;A61P31/04;;C07D263/62;;C07D263/54;;C07D263/52;;C07C237/26;;C07D413/04;;A61K31/65;;C07D417/04;;C07D413/06;;C07D263/52;;C07C2603/46,A61K31/423;;A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04,,0,0,,,,PENDING
331,CA,A1,CA 2546895 A1,099-187-160-322-821,2005-06-23,2005,CA 2546895 A,2004-12-07,US 52792803 P;;US 58482304 P;;US 2004/0040850 W,2003-12-08,OXAZOLE DERIVATIVES OF TETRACYCLINES,,WYETH CORP,HOW DAVID BRIAN;;SUM PHAIK-ENG;;HOPPER DARRIN WILLIAM;;SABATINI JOSHUA JAMES;;VERA MATTHEW DOUGLAS,,https://lens.org/099-187-160-322-821,Patent Application,no,0,0,43,44,0,A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04;;C07C2603/46;;A61P31/04;;C07D263/62;;C07D263/54;;C07D263/52;;C07C237/26;;C07D413/04;;A61K31/65;;C07D417/04;;C07D413/06;;C07D263/52;;C07C2603/46,C07D263/52;;A61K31/423;;A61K31/65;;A61P31/04;;C07C237/26;;C07D413/04;;C07D413/06;;C07D417/04,,0,0,,,,DISCONTINUED
332,EP,B1,EP 2405779 B1,136-593-772-784-369,2017-03-08,2017,EP 10751335 A,2010-03-10,US 2010/0026783 W;;US 15925209 P;;US 72014610 A,2009-03-11,POWDER-FREE ANTIMICROBIAL COATED GLOVE,,ANSELL LTD,ENG AIK HWEE;;LAI HEE MENG;;LIM KUANG LENG;;TING KOON MEOW;;LUCAS DAVID M,,https://lens.org/136-593-772-784-369,Granted Patent,yes,10,1,12,12,0,A61L31/16;;A61L31/16;;A41D19/0055;;A41D19/0055;;A41D31/305;;A41D31/305;;A61L31/10;;A61L31/10;;A61L31/145;;A61L31/145;;A61L2300/404;;A61L2300/404;;A61L2300/608;;A61L2300/608;;A61L2300/622;;A61L2300/622,A41D19/00;;A61L31/10;;A61L31/14;;A61L31/16,,0,0,,,,ACTIVE
333,WO,A3,WO 2002/067890 A3,190-655-765-753-686,2002-10-17,2002,EP 0200328 W,2002-01-14,GB 0102235 A,2001-01-29,METHOD AND PRODUCT FOR SKIN LIGHTENING,"A method and cosmetic product for lightening skin is provided, the method including wiping the skin with a cosmetic towelette. Impregnated on the towelette is an alphahydroxy carboxylic acid or salt thereof and a sunscreen agent.",UNILEVER PLC;;UNILEVER NV;;LEVER HINDUSTAN LTD,GOTT ROBERT EDWARD;;HAGUE JONATHAN DAVID;;LIM ENG-BENG;;SLAVTCHEFF CRAIG STEPHEN;;ZNAIDEN ALEXANDER PAUL,,https://lens.org/190-655-765-753-686,Search Report,yes,5,0,4,4,0,A61K8/0208;;A61Q19/02;;A61Q19/02;;A61K8/0208,A61K8/02;;A61K9/70;;A61K31/19;;A61Q19/02,,1,0,,,"CHEMICAL ABSTRACTS, vol. 133, no. 26, 25 December 2000, Columbus, Ohio, US; abstract no. 366202, KURODA, AKIHIRO ET AL: ""Skin - lightening sheet packs containing keratinolytic ingredients"" XP002205377",PENDING
334,ES,T3,ES 2331574 T3,051-610-141-734-859,2010-01-08,2010,ES 04813199 T,2004-12-07,US 52792803 P;;US 58482304 P,2003-12-08,DERIVADOS OXAZOLICOS DE TETRACICLINAS.,"Compuesto de Fórmula (I): **ver fórmula** en la que: X se selecciona de entre hidrógeno, amino, NR11R12, alquilo de 1 a 12 átomos de carbono opcionalmente sustituido, arilo de 6, 10 ó 14 átomos de carbono opcionalmente sustituido, vinilo opcionalmente sustituido, alquinilo de 2 a 12 átomos de carbono opcionalmente sustituido, y halógeno; A"" es un resto seleccionado de entre el grupo: ** ver fórmula** R11 y R12 son cada uno independientemente H o alquilo de 1 a 12 átomos de carbono, o R11 y R12, cuando se toman opcionalmente junto con el átomo de nitrógeno al que cada uno está unido, forman un anillo hidrocarbonado saturado de 3 a 7 miembros; Y se selecciona de entre hidrógeno, alquilo de 1 a 12 átomos de carbono opcionalmente sustituido, arilo de 6, 10 ó 14 átomos de carbono opcionalmente sustituido, alquenilo de 2 a 12 átomos de carbono opcionalmente sustituido, vinilo, alquinilo de 2 a 12 átomos de carbono opcionalmente sustituido y halógeno; R se selecciona de entre alquilo de 1 a 12 átomos de carbono opcionalmente sustituido, alquenilo de 2 a 12 átomos de carbono opcionalmente sustituido, alquinilo de 2 a 12 átomos de carbono opcionalmente sustituido, -CH2NR1R2, arilo de 6, 10 ó 14 átomos de carbono opcionalmente sustituido, aralquilo de 7 a 16 átomos de carbono opcionalmente sustituido, aroilo de 7 a 13 átomos de carbono opcionalmente sustituido, SR3, heteroarilo de 5 ó 6 átomos anulares opcionalmente sustituido, que contiene 1 a 4 heteroátomos que pueden ser iguales o diferentes, seleccionados independientemente de nitrógeno, oxígeno y azufre, y heteroarilcarbonilo de 5 ó 6 átomos anulares opcionalmente sustituido que contiene 1 a 4 heteroátomos que pueden ser iguales o diferentes, seleccionados independientemente de nitrógeno, oxígeno y azufre; R1 y R2 son cada uno independientemente H o alquilo de 1 a 12 átomos de carbono, o R1 y R2, cuando se toman opcionalmente junto con el átomo de nitrógeno al que cada uno está unido, forman un anillo hidrocarbonado saturado de 3 a 7 miembros; R3 es alquilo de 1 a 12 átomos de carbono opcionalmente sustituido, -CH2-arilo opcionalmente sustituido, aralquilo de 7 a 16 átomos de carbono opcionalmente sustituido, aroilo, -CH2(CO)OCH2-arilo opcionalmente sustituido, -CH2-alquenilo de 2 a 12 átomos de carbono opcionalmente sustituido, y -CH2-alquinilo de 2 a 12 átomos de carbono opcionalmente sustituido; con la condición de que cuando X es NR11R12 y R1 es hidrógeno, entonces R2 sea metilo, etilo, n-propilo, n-butilo, 1-metiloetilo, 1-metilpropilo, 2-metilpropilo o 1,1-dimetiletilo; y de que cuando R1 es metilo o etilo, entonces R2 sea metilo, etilo, n-propilo, 1-metiletilo, n-propilo, 1-metilpropilo, o 2-metilpropilo; o un tautómero o sales farmacéuticamente aceptables del mismo.",WYETH CORP,SUM PHAIK-ENG;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES,,https://lens.org/051-610-141-734-859,Granted Patent,no,0,0,43,44,0,A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04;;C07C2603/46;;A61P31/04;;C07D263/62;;C07D263/54;;C07D263/52;;C07C237/26;;C07D413/04;;A61K31/65;;C07D417/04;;C07D413/06;;C07D263/52;;C07C2603/46,C07D263/52;;A61K31/423;;A61K31/65;;A61P31/04;;C07C237/26;;C07D413/04;;C07D413/06;;C07D417/04,,0,0,,,,ACTIVE
335,WO,A1,WO 2010/104924 A1,062-427-532-503-293,2010-09-16,2010,US 2010/0026783 W,2010-03-10,US 15925209 P;;US 72014610 A,2009-03-11,POWDER-FREE ANTIMICROBIAL COATED GLOVE,"Provided herein are powder-free elastomeric articles exhibiting good antimicrobial and anti-blocking properties. Also provided herein are methods for the manufacture of such articles substantially free from antimicrobial interfering materials, as well as packaging means for maintaining antimicrobial efficacy.",ANSELL HEALTHCARE PROD LLC;;ENG AIK HWEE;;LAI HEE MENG;;LIM KUANG LENG;;TING KOON MEOW;;LUCAS DAVID M,ENG AIK HWEE;;LAI HEE MENG;;LIM KUANG LENG;;TING KOON MEOW;;LUCAS DAVID M,,https://lens.org/062-427-532-503-293,Patent Application,yes,49,8,12,12,0,A61L31/16;;A61L31/16;;A41D19/0055;;A41D19/0055;;A41D31/305;;A41D31/305;;A61L31/10;;A61L31/10;;A61L31/145;;A61L31/145;;A61L2300/404;;A61L2300/404;;A61L2300/608;;A61L2300/608;;A61L2300/622;;A61L2300/622,A41D19/00;;A61B19/00;;A61L31/10,,5,2,041-327-727-454-807;;042-022-749-349-37X,10.1213/00000539-194101000-00064;;10.1016/j.ijheh.2006.04.006;;16750419,"See also references of EP 2405779A4;;GOODMAN; GILMAN'S: ""The Pharmacological Basis of Therapeutics"", 2005, MCGRAW-HILL;;INFECT. CONTROL HOSP. EPIDEMIOL., vol. 28, 2007, pages 191 - 197;;INT. J. ENVIRON. HEALTH, vol. 209, 2006, pages 477 - 487;;DERMATITIS, vol. 16, 2005, pages 22 - 27",PENDING
336,US,B2,US 9149567 B2,053-357-813-873-138,2015-10-06,2015,US 72014610 A,2010-03-09,US 72014610 A;;US 15925209 P,2009-03-11,Powder-free antimicrobial coated glove,"Provided herein are powder-free elastomeric articles exhibiting good antimicrobial and anti-blocking properties. Also provided herein are methods for the manufacture of such articles substantially free from antimicrobial interfering materials, as well as packaging means for maintaining antimicrobial efficacy.",ENG AIK HWEE;;LAI HEE MENG;;LIM KUANG LENG;;TING KOON MEOW;;LUCAS DAVID M;;ANSELL LTD,ENG AIK HWEE;;LAI HEE MENG;;LIM KUANG LENG;;TING KOON MEOW;;LUCAS DAVID M,ANSELL LIMITED (2010-05-03),https://lens.org/053-357-813-873-138,Granted Patent,yes,66,2,12,12,0,A61L31/16;;A61L31/16;;A41D19/0055;;A41D19/0055;;A41D31/305;;A41D31/305;;A61L31/10;;A61L31/10;;A61L31/145;;A61L31/145;;A61L2300/404;;A61L2300/404;;A61L2300/608;;A61L2300/608;;A61L2300/622;;A61L2300/622,A01N25/34;;A01N31/02;;A01N31/14;;A01N33/12;;A01N37/52;;A01N59/16;;A01P1/00;;A01P3/00;;A41D19/00;;A61K31/08;;A61K31/085;;A61L31/10;;A61L31/14;;A61L31/16;;B05D3/00,,7,3,042-022-749-349-37X;;009-240-181-281-198;;024-341-601-402-379,10.1016/j.ijheh.2006.04.006;;16750419;;15996346;;10.1097/01206501-200503000-00004;;17265401;;10.1086/510866,"Preliminary Report on Patentability and Written Opinion of the International Searching Authority mailed Sep. 22, 2011 for PCT Application No. PCT/US2010/026783.;;Shintre, Milind S., et al., ""Efficacy of an alcohol-based healthcare hand rub containing synergistic combination of farnesol and benzethonium chloride"", International Journal of Hygiene and Environmental Health 209, (2006), 477-487 pgs.;;Modak, Shanta et al., ""A Topical Cream Containing a Zinc Gel (Allergy Guard) as a Prophylactic against Latex Glove-Related Contact Dermatitis"", Dermatitis, vol. 16, No. 1, (Mar. 2005), 22-27 pgs.;;Shintre, Milind S., et al., ""Evaluation of an Alcohol-Based Surgical Hand Disinfectant Containing a Synergistic Combination of Farnesol and Benzethonium Chloride for Immediate and Persistent Activity Against Resident Hand Flora of Volunteers and With a Novel in Vitro Pig Skin Model"", Infection Control and Hospital Epidemiology, vol. 28, No. 2, (Feb. 2007), 191-197 pgs.;;PCT International Search Report/Written Opinion in PCT/US10/26783, dated Apr. 29, 2010, 10 pp.;;Second Office Action from the Chinese Patent Office dated Jan. 24, 2014 for corresponding Chinese Patent Application No. 201080019053.8, 16 pages.;;Japanese Office Action for Patent Application No. P2011-554138 dated Nov. 26, 2013; 6 pages.",INACTIVE
337,EP,A1,EP 2157085 A1,156-633-732-266-62X,2010-02-24,2010,EP 09010915 A,2004-12-07,EP 04813199 A;;US 52792803 P;;US 58482304 P,2003-12-08,"Oxazole, derivatives of tetracyclines","This invention provides compounds of the formula:
  
wherein A"", X and Y are defined in the specification. These compounds are useful as antibacterial agents or may be hydrolysed to give 9-(2-substituted aminomethylcarbonylamino)substituted-6-demethyl-6-deoxytetracycline derivatives.",WYETH LLC,SUM PHAIK-ENG;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES,,https://lens.org/156-633-732-266-62X,Patent Application,yes,16,0,43,44,0,A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04;;C07C2603/46;;A61P31/04;;C07D263/62;;C07D263/54;;C07D263/52;;C07C237/26;;C07D413/04;;A61K31/65;;C07D417/04;;C07D413/06;;C07D263/52;;C07C2603/46,C07D263/52;;A61K31/423;;A61K31/65;;A61P31/04;;C07C237/26;;C07D413/04;;C07D413/06;;C07D417/04,,3,2,148-332-819-466-078;;004-556-152-988-177,10.1021/jm00027a023;;8289194;;2802561;;pmc172657;;10.1128/aac.33.8.1373,"SUM ET AL., J. MED. CHEM., vol. 37, no. 1, 1994, pages 184 - 188, XP002323590;;CHOPRA: ""Handbook of Experimental Pharmacology"", vol. 78, 1985, SPRINGER-VERLAG, pages: 317 - 392;;S. B. LEVY ET AL., ANTIMICROB. AGENTS CHEMOTHERAPY, vol. 33, 1989, pages 1373 - 1374",ACTIVE
338,US,B2,US 8281043 B2,087-776-438-914-144,2012-10-02,2012,US 83634110 A,2010-07-14,US 83634110 A,2010-07-14,Out-of-band access to storage devices through port-sharing hardware,"A method, apparatus, system, and computer program product for enabling out-of-band access to storage devices through port-sharing hardware. Providing out-of-band access to storage devices enables system management functions to be performed when an operating system is non-functional as well as when the operating system is active. Storage commands originating with a management service can be interleaved with storage commands issued by the host operating system. The host operating system maintains ownership and control over its storage devices, but management activities can be performed while the host operating system is operational.",EDWARDS DAVID A;;OOI ENG HUN;;GOKULRANGAN VENKAT R;;KHOSRAVI HORMUZD M;;GAN CHAI HUAT;;INTEL CORP,EDWARDS DAVID A;;OOI ENG HUN;;GOKULRANGAN VENKAT R;;KHOSRAVI HORMUZD M;;GAN CHAI HUAT,INTEL CORPORATION (2010-06-27),https://lens.org/087-776-438-914-144,Granted Patent,yes,10,5,15,15,0,G06F3/0604;;G06F3/0617;;G06F3/0659;;G06F3/067;;G06F3/0604;;G06F3/0617;;G06F3/0659;;G06F3/067;;G06F13/14;;G06F13/16;;G06F3/0604;;G06F3/0659;;G06F3/067;;G06F3/0617,G06F5/00;;G06F3/00,710/5;;710/6;;710/36;;710/40;;710/58,1,0,,,"International Search Report for International Application No. PCT/US20111043850, dated Feb. 27, 2012, 11 pages.",ACTIVE
339,US,A1,US 2012/0053220 A1,083-319-563-857-688,2012-03-01,2012,US 67156708 A,2008-08-01,US 67156708 A;;US 96310407 P;;US 2008/0009327 W,2007-08-02,NOVEL LIPOXYGENASE INHIBITORS AS NEUROPROTECTIVE AGENTS,"The present invention relates to the identification of inhibitors of lipoxygenase enzymes. Methods are presented for using novel lipoxygenase inhibitors: LOXBlock-1 and LOXBlock-3, and other candidate lipoxygenase inhibitors identified by similar screening strategies, in therapy and diagnostics for neurodegenerative disorders.",VAN LEYEN KLAUS;;HOLMAN THEODORE R;;LO ENG H;;JACOBSON MATTHEW P;;HOWELLS DAVID W;;GEN HOSPITAL CORP;;FLOREY NEUROSCIENCE INST;;UNIV CALIFORNIA,VAN LEYEN KLAUS;;HOLMAN THEODORE R;;LO ENG H;;JACOBSON MATTHEW P;;HOWELLS DAVID W,THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (2011-11-10);;FLOREY NEUROSCIENCE INSTITUTES (2011-11-15);;THE GENERAL HOSPITAL CORPORATION D/B/A MASSACHUSETTS GENERAL HOSPITAL (2011-10-28),https://lens.org/083-319-563-857-688,Patent Application,yes,1,4,3,3,0,A61K31/37;;A61K31/38;;A61K31/40;;A61K31/47;;A61K45/06;;A61P25/16;;A61P25/28;;A61K31/38;;A61K31/37;;A61K45/06;;A61K31/40;;A61K31/47,A61K31/415;;A61K31/381;;A61P25/16;;A61P25/28;;C12N9/99,514/407;;435/184;;514/443,2,2,022-283-144-043-079;;027-773-469-638-242,10.1016/s0006-8993(01)02491-x;;11516426;;10.1021/jm050639j;;16480270,"Arai (Neuroprotective effects of lipoxygenase inhibitors against ischemic injury in rat hippocampal slice cultures, Brain Research 904, (2001), pages 167-172);;Kenyon (Novel Human Lipoxygenase Inhibitors Discovered using virtual Screening with Homology Models, Journal Med. Chem. 2006, 49, pages 1356-1363).",DISCONTINUED
340,UA,C2,UA 83266 C2,169-393-551-797-538,2008-06-25,2008,UA A200606344 A,2004-12-07,US 52792803 P;;US 58482304 P;;US 2004/0040850 W,2003-12-08,OXAZOLE DERIVATIVES OF TETRACYCLINES,"This invention provides compounds of the formula: wherein A"", X and Y are defined in the specification. These compounds are useful as antibacterial agents., (I)",WYETH CORP,SUM PHAIK-ENG;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES,,https://lens.org/169-393-551-797-538,Limited Patent,no,0,0,43,44,0,A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04;;C07C2603/46;;A61P31/04;;C07D263/62;;C07D263/54;;C07D263/52;;C07C237/26;;C07D413/04;;A61K31/65;;C07D417/04;;C07D413/06;;C07D263/52;;C07C2603/46,C07D263/52;;A61K31/423;;A61K31/65;;A61P31/04;;C07C237/26;;C07D413/04;;C07D413/06;;C07D417/04,,0,0,,,,EXPIRED
341,TW,A,TW 200305074 A,176-009-363-180-033,2003-10-16,2003,TW 91135847 A,2002-12-11,US 4101301 A,2001-12-28,Multiple mode power throttle mechanism,"A processor includes a digital throttle to monitor the activity of various units of the processor's instruction execution pipeline, and to determine a power state for the processor from the monitored activity. One of two or more power control mechanisms is engaged, responsive to the power state of the processor reaching a threshold.",INTEL CORP,BURNS JAMES S;;RUSU STEFAN;;AYERS DAVID J;;GROCHOWSKI EDWARD T;;ENG MARSHA;;VIVEK TIWARI,,https://lens.org/176-009-363-180-033,Patent of Addition,no,0,0,9,9,0,G06F1/3203;;G06F1/3243;;G06F9/3017;;G06F9/3836;;G06F9/3869;;G06F9/3873;;G06F9/384;;Y02D10/00;;G06F9/3858;;G06F9/3836;;G06F9/3873;;G06F1/3203;;G06F1/3243;;G06F9/3017;;G06F9/3869;;G06F9/384;;Y02D10/00;;G06F9/3858,G06F1/32;;G06F9/318,,0,0,,,,PENDING
342,US,B2,US 7281140 B2,010-701-428-007-823,2007-10-09,2007,US 4109201 A,2001-12-28,US 4109201 A,2001-12-28,Digital throttle for multiple operating points,"A processor includes a digital throttle to monitor the activity of various units of the processor's instruction execution pipeline. The monitored activity is scaled according to the current operating point of the processor and a power state is determined from the scaled activity. If the power state reaches a first threshold, the operating point of the processor is adjusted and a new scaling factor is selected to determine the power state.",INTEL CORP,BURNS JAMES S;;RUSU STEFAN;;AYERS DAVID J;;GROCHOWSKI EDWARD T;;ENG MARSHA;;TIWARI VIVEK,INTEL CORPORATION (2002-04-05);;SONY CORPORATION OF AMERICA (2014-04-02),https://lens.org/010-701-428-007-823,Granted Patent,yes,67,30,2,2,0,G06F1/3203;;G06F1/3237;;G06F1/3243;;G06F9/3017;;G06F9/3869;;G06F9/3873;;Y02D10/00;;G06F9/3869;;G06F1/3203;;G06F9/3017;;G06F1/3243;;G06F1/3237;;G06F9/3873;;Y02D10/00,G06F1/32;;G06F1/04;;G06F9/318,713/300;;713/323,5,0,,,"U.S. Appl. No. 10/206,610, filed Jul. 26, 2002, ""A VCC Adaptive Dynamically Variable Frequency Clock System for High Performance, Low Power Microprocessors,"" 48 pages including Figures.;;U.S. Appl. No. 09/471,795, filed Dec. 23, 1999, ""Microprocessor with Digital Power Throttle,"" 31 pages including Figures.;;U.S. Appl. No. 10/041,013, filed Dec. 28, 2001, ""Multiple Mode Power Throttle Mechanism,"" 32 pages including Figures.;;U.S. Appl. No. 10/227,125, filed Aug. 23, 2002, ""An Apparatus for Thermal Management of Multiple Core Microprocessors,"" 21 pages including Figures.;;U.S. Appl. No. 10/044,865, filed Oct. 22, 2001, ""An Adaptive Variable Frequency Clock System for High Performance Low Power Microprocessors,"" 35 pages including Figures.",EXPIRED
343,US,A1,US 2003/0126478 A1,045-093-805-135-227,2003-07-03,2003,US 4101301 A,2001-12-28,US 4101301 A,2001-12-28,Multiple mode power throttle mechanism,"
   A processor includes a digital throttle to monitor the activity of various units of the processor's instruction execution pipeline, and to determine a power state for the processor from the monitored activity. One of two or more power control mechanisms is engaged, responsive to the power state of the processor reaching a threshold. 
",BURNS JAMES S.;;RUSU STEFAN;;AYERS DAVID J.;;GROCHOWSKI EDWARD T.;;ENG MARSHA;;TIWARI VIVEK,BURNS JAMES S;;RUSU STEFAN;;AYERS DAVID J;;GROCHOWSKI EDWARD T;;ENG MARSHA;;TIWARI VIVEK,INTEL CORPORATION (2002-04-03),https://lens.org/045-093-805-135-227,Patent Application,yes,41,127,9,9,0,G06F1/3203;;G06F1/3243;;G06F9/3017;;G06F9/3836;;G06F9/3869;;G06F9/3873;;G06F9/384;;Y02D10/00;;G06F9/3858;;G06F9/3836;;G06F9/3873;;G06F1/3203;;G06F1/3243;;G06F9/3017;;G06F9/3869;;G06F9/384;;Y02D10/00;;G06F9/3858,G06F1/32;;G06F9/318,7133,0,0,,,,EXPIRED
344,KR,A,KR 20130031886 A,098-286-742-383-189,2013-03-29,2013,KR 20137000756 A,2011-07-13,US 83634110 A;;US 2011/0043850 W,2010-07-14,OUT-OF-BAND ACCESS TO STORAGE DEVICES THROUGH PORT-SHARING HARDWARE,,INTEL CORP,EDWARDS DAVID A;;GAN CHAI HUAT;;OOI ENG HUN;;GOKULRANGAN VENKAT R;;KHOSRAVI HORMUZD M,,https://lens.org/098-286-742-383-189,Patent Application,no,0,0,15,15,0,G06F3/0604;;G06F3/0617;;G06F3/0659;;G06F3/067;;G06F3/0604;;G06F3/0617;;G06F3/0659;;G06F3/067;;G06F13/14;;G06F13/16;;G06F3/0604;;G06F3/0659;;G06F3/067;;G06F3/0617,G06F9/30;;G06F9/44;;G06F13/16,,0,0,,,,INACTIVE
345,US,A1,US 2008/0177080 A1,136-357-414-804-599,2008-07-24,2008,US 5385608 A,2008-03-24,US 5385608 A;;US 63813806 A;;US 762104 A;;US 58482304 P;;US 52792803 P,2003-12-08,OXAZOLE DERIVATIVES OF TETRACYCLINES,"This invention provides compounds of the formula: wherein A″, X and Y are defined in the specification. These compounds are useful as antibacterial agents.",WYETH CORP,SUM PHAIK-ENG;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES,,https://lens.org/136-357-414-804-599,Patent Application,yes,14,0,43,44,0,A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04;;C07C2603/46;;A61P31/04;;C07D263/62;;C07D263/54;;C07D263/52;;C07C237/26;;C07D413/04;;A61K31/65;;C07D417/04;;C07D413/06;;C07D263/52;;C07C2603/46,A61K31/423;;C07D263/52;;A61K31/65;;C07C237/26;;C07D413/04;;C07D413/06;;C07D417/04,548/223,0,0,,,,DISCONTINUED
346,US,A,US 4410273 A,187-683-761-682-227,1983-10-18,1983,US 24213981 A,1981-03-09,US 24213981 A,1981-03-09,Scanning laser spectrometer,"A scanning spectrometer incorporating a scanning diode laser powered with a controllable injection current. The injection current control may be set at predetermined discrete levels. These levels may be varied in accordance with signals derived from a servo loop, and may have superimposed upon them a cyclically varying substantially constant amplitude current. The laser output is directed via a beam splitter to both sample and reference cells. The material in the reference cell is so selected as to provide absorption features at each of the desired frequencies. The cyclically varying current is provided with an amplitude sufficient to cause a frequency amplitude at least as great as the maximum breadth of each of these spectral features of interest. The preselected bias currents are selected so as to provide lasing action of the diode at or near each of the selected frequencies. A phase-locked amplifier tuned to the frequency of the cyclically varying current senses the position of the scanned laser output relative to that of the associated absorption feature and provides an error signal to adjust the bias current so as to center the cyclically scanned laser frequency on the selected absorption feature.",LASER ANALYTICS INC,MANTZ ARLAN W;;WALL DAVID L;;CHAPMAN DUDLEY M;;ENG RICHARD S;;NILL KENNETH W,LASER ANALYTICS INC. A CORP. OF MASS (1981-03-06);;LASER PHOTONICS INC. A DE CORP (1989-02-01);;LASER PHOTONICS INC. A CORP. OF DE (1990-03-02),https://lens.org/187-683-761-682-227,Granted Patent,yes,2,63,1,1,0,G01J3/02;;G01J3/0286;;G01J3/4338;;G01N21/39;;G01J3/4338;;G01N21/39;;G01J3/0286;;G01J3/02,G01N21/39,356/319;;356/51;;250/339;;250/345;;250/354.1,0,0,,,,EXPIRED
347,CN,A,CN 102438473 A,019-319-889-160-492,2012-05-02,2012,CN 201080019053 A,2010-03-10,US 2010/0026783 W;;US 15925209 P;;US 72014610 A,2009-03-11,Powder-free antimicrobial coated glove,"Provided herein are powder-free elastomeric articles exhibiting good antimicrobial and anti-blocking properties. Also provided herein are methods for the manufacture of such articles substantially free from antimicrobial interfering materials, as well as packaging means for maintaining antimicrobial efficacy.",ANSELL HEALTHCARE PROD LLC,HWEE ENG AIK;;MENG LAI HEE;;LENG LIM KUANG;;MEOW TING KOON;;LUCAS DAVID M,,https://lens.org/019-319-889-160-492,Patent Application,no,10,2,12,12,0,A61L31/16;;A61L31/16;;A41D19/0055;;A41D19/0055;;A41D31/305;;A41D31/305;;A61L31/10;;A61L31/10;;A61L31/145;;A61L31/145;;A61L2300/404;;A61L2300/404;;A61L2300/608;;A61L2300/608;;A61L2300/622;;A61L2300/622,A41D19/00;;A61B19/00;;A61L31/10,,0,0,,,,ACTIVE
348,EP,A2,EP 2593875 A2,137-560-769-544-343,2013-05-22,2013,EP 11807453 A,2011-07-13,US 83634110 A;;US 2011/0043850 W,2010-07-14,OUT-OF-BAND ACCESS TO STORAGE DEVICES THROUGH PORT-SHARING HARDWARE,,INTEL CORP,EDWARDS DAVID A;;GAN CHAI HUAT;;OOI ENG HUN;;GOKULRANGAN VENKAT R;;KHOSRAVI HORMUZD M,,https://lens.org/137-560-769-544-343,Patent Application,yes,0,0,15,15,0,G06F3/0604;;G06F3/0617;;G06F3/0659;;G06F3/067;;G06F3/0604;;G06F3/0617;;G06F3/0659;;G06F3/067;;G06F13/14;;G06F13/16;;G06F3/0604;;G06F3/0659;;G06F3/067;;G06F3/0617,G06F13/14;;G06F3/06;;G06F9/30;;G06F9/44;;G06F13/16,,0,0,,,,ACTIVE
349,DE,T5,DE 112005001819 T5,157-058-044-212-677,2007-05-24,2007,DE 112005001819 T,2005-06-21,US 89944204 A;;US 2005/0021936 W,2004-07-26,Ventil- und Kraftstoffbeaufschlagungsstrategie zum Betreiben eines Viertakt-Verbrennungsmotors mit gesteuerter Selbstzündung,,GEN MOTORS CORP,KUO TANG-WEI;;BROWN BARRY L;;NAJT PAUL M;;ENG JAMES A;;CLEARY DAVID J,,https://lens.org/157-058-044-212-677,Patent Application,no,0,3,7,7,0,F02D13/0207;;F02D13/0207;;F02B1/12;;F02B1/12;;F02B2075/027;;F02B2075/027;;F02B2075/125;;F02B2075/125;;F02D13/0238;;F02D13/0238;;F02D13/0242;;F02D13/0242;;F02D13/0273;;F02D13/0273;;F02D41/402;;F02D41/402;;Y02T10/12;;Y02T10/12;;Y02T10/40;;Y02T10/40,F02B3/00,,0,0,,,,ACTIVE
350,BR,A,BR PI0417421 A,176-623-866-012-103,2007-03-13,2007,BR PI0417421 A,2004-12-07,US 52792803 P;;US 58482304 P;;US 2004/0040850 W,2003-12-08,"composto, composição farmacêutica, método para tratamento ou controle de infecções bacterianas, processo para preparação do composto e produto manufaturado","""COMPOSTO, COMPOSIçãO FARMACêUTICA, MéTODO PARA TRATAMENTO OU CONTROLE DE INFECçõES BACTERIANAS, PROCESSO PARA PREPARAçãO DO COMPOSTO E PRODUTO MANUFATURADO"". A presente invenção providencia compostos de fórmula: onde A<39><39>, X e I são como indicados no relatório descritivo. Os referidos compostos são úteis como agentes antibacterianos.",WYETH CORP,SUM PHAIK-ENG;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES,,https://lens.org/176-623-866-012-103,Patent Application,no,0,0,43,44,0,A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04;;C07C2603/46;;A61P31/04;;C07D263/62;;C07D263/54;;C07D263/52;;C07C237/26;;C07D413/04;;A61K31/65;;C07D417/04;;C07D413/06;;C07D263/52;;C07C2603/46,A61K31/423;;A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04,,0,0,,,,DISCONTINUED
351,CO,A2,CO 5700818 A2,182-516-400-152-909,2006-11-30,2006,CO 06055450 A,2006-06-08,US 52792803 P;;US 58482304 P,2003-12-08,DERIVADOS DE OXAZOL DE TETRACICLINA,"De acuerdo con la presente invención, se suministran compuestos representados por la Fórmula (I); En donde: X se selecciona del grupo hidrógeno, amino, NR11R12, alquilo de 1 a 12 átomos de carbono opcionalmente sustituido, arilo de 6, 10 o 14 átomos de carbono opcionalmente sustituido, vinilo opcionalmente sustituido, alquinilo de 2 a 12 átomos de carbono opcionalmente sustituido y halógeno;A"" es una porción seleccionada del grupo: R11 y R12 son cada uno independientemente H o alquilo de 1 a 12 átomos de carbono o R11 y R12 cuando se toman opcionalmente juntos con el átomo de nitrógeno al cual cada uno está unido forman un anillo de hidrocarburo saturado de 3 a 7 miembros; Y se selecciona de hidrógeno, alquilo de 1 a 12 átomos de carbono opcionalmente sustituido, arilo de 6, 10 o 14 átomos de carbono opcionalmente sustituido, alquenilo de 2 a 12 átomos de carbono opcionalmente sustituido, vinilo, alquinilo de 2 a 12 átomos de carbono opcionalmente sustituido y halógeno;R se selecciona de alquilo de 1 a 12 átomos de carbono opcionalmente sustituido, alquenilo de 2 a 12 átomos de carbono opcionalmente sustituido, alquinilo de 2 a 12 átomos de carbono opcionalmente sustituido, -CH2NR1R2, arilo de 6, 10 o 14 átomos de carbono opcionalmente sustituido, aralquilo de 7 a 16 átomos de carbono opcionalmente sustituido, aroilo de 7 a 13 átomos de carbono opcionalmente sustituido, SR3, heteroarilo de 5 o 6 átomos por anillo opcionalmente sustituido, que contiene 1 a 4 heteroátomos que pueden ser iguales o diferentes, independientemente seleccionados de nitrógeno, oxígeno y azufre, y heteroarilcarbonilo de 5 o 6 átomos por anillo opcionalmente sustituido que contiene 1 a 4 heteroátomos que pueden ser iguales o diferentes, independientemente seleccionados de nitrógeno, oxígeno y azufre; ...",WYETH CORP,SUM PHAIK-ENG;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES,,https://lens.org/182-516-400-152-909,Patent Application,no,0,0,43,44,0,A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04;;C07C2603/46;;A61P31/04;;C07D263/62;;C07D263/54;;C07D263/52;;C07C237/26;;C07D413/04;;A61K31/65;;C07D417/04;;C07D413/06;;C07D263/52;;C07C2603/46,A61K31/423;;A61K31/65;;A61P31/04;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04,,0,0,,,,PENDING
352,MY,A,MY 146098 A,186-035-803-975-326,2012-06-29,2012,MY PI20045049 A,2004-12-07,US 52792803 P;;US 58482304 P,2003-12-08,OXAZOLE DERIVATIVES OF TETRACYCLINES,"THIS INVENTION PROVIDES COMPOUNDS OF THE FORMULA: WHEREIN A"", X AND Y ARE DEFINED IN THE SPECIFICATION. THESE COMPOUNDS ARE USEFUL AS ANTIBACTERIAL AGENTS.",WYETH CORP,PHAIK-ENG SUM;;BRIAN HOW DAVID;;WILLIAM HOPPER DARRIN;;DOUGLAS VERA MATTHEW;;JAMES SABATINI JOSHUA,,https://lens.org/186-035-803-975-326,Granted Patent,no,0,0,43,44,0,A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04;;C07C2603/46;;A61P31/04;;C07D263/62;;C07D263/54;;C07D263/52;;C07C237/26;;C07D413/04;;A61K31/65;;C07D417/04;;C07D413/06;;C07D263/52;;C07C2603/46,A61K31/65;;A61K31/423;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04,,0,0,,,,ACTIVE
353,US,B2,US 6931559 B2,184-244-986-482-302,2005-08-16,2005,US 4101301 A,2001-12-28,US 4101301 A,2001-12-28,Multiple mode power throttle mechanism,"A processor includes a digital throttle to monitor the activity of various units of the processor's instruction execution pipeline, and to determine a power state for the processor from the monitored activity. One of two or more power control mechanisms is engaged, responsive to the power state of the processor reaching a threshold.",INTEL CORP,BURNS JAMES S;;RUSU STEFAN;;AYERS DAVID J;;GROCHOWSKI EDWARD T;;ENG MARSHA;;TIWARI VIVEK,INTEL CORPORATION (2002-04-03),https://lens.org/184-244-986-482-302,Granted Patent,yes,43,66,9,9,0,G06F1/3203;;G06F1/3243;;G06F9/3017;;G06F9/3836;;G06F9/3869;;G06F9/3873;;G06F9/384;;Y02D10/00;;G06F9/3858;;G06F9/3836;;G06F9/3873;;G06F1/3203;;G06F1/3243;;G06F9/3017;;G06F9/3869;;G06F9/384;;Y02D10/00;;G06F9/3858,G06F1/32;;G06F9/318,713/340;;713/320;;713/321;;710/15;;710/18,5,0,,,"U.S. Appl. No. 10/206,610, filed Jul. 26, 2002, ""A VCC Adaptive Dynamically Variable Frequency Clock System for High Performance, Low Power Microprocessors,"" 48 pages including Figures.;;U.S. Appl. No. 09/471,795, filed Dec. 23, 1999, ""Microprocessor with Digital Power Throttle,"" 31 pages including Figures.;;U.S. Appl. No. 10/041,092, filed Dec. 28, 2001, ""Digital Throttle for Multiple Operating Points,"" 30 pages including Figures.;;U.S. Appl. No. 10/227,125, filed Aug. 23, 2002, ""An Apparatus for Thermal Management of Multiple Core Microprocessors,"" 21 pages including Figures.;;U.S. Appl. No. 10/044,865, filed Oct. 22, 2001, ""An Adaptive Variable Frequency Clock System for High Performance Low Power Microprocessors,"" 35 pages including Figures.",EXPIRED
354,WO,A1,WO 2006/023040 A1,186-830-880-704-928,2006-03-02,2006,US 2005/0021936 W,2005-06-21,US 89944204 A,2004-07-26,VALVE AND FUELING STRATEGY FOR OPERATING A CONTROLLED AUTO-IGNITION FOUR-STROKE INTERNAL COMBUSTION ENGINE,Part load operating point for a controlled auto-ignition four-stroke internal combustion engine is reduced without compromising combustion stability through a valve control operative to establish low pressure conditions within the combustion chamber into which fuel and exhaust gases are introduced. Combustion chamber pressures during the intake cycle are controlled lower as engine load decreases. Combusted gases are recirculated into the combustion chamber through a variety of internal and external recirculation mechanizations. A split-injection fuel control is implemented during low part load operation whereas a single-injection fuel control is implemented during intermediate and high part load operation. Split-injections are characterized by lean fuel/air ratios and single-injections are characterized by either lean or stoichiometric fuel/air ratios. Controlled autoignition is thereby enabled through an extended range of engine loads while maintaining acceptable combustion stability and emissions.,GEN MOTORS CORP,KUO TANG-WEI;;BROWN BARRY L;;NAJT PAUL M;;ENG JAMES A;;CLEARY DAVID J,,https://lens.org/186-830-880-704-928,Patent Application,yes,3,0,7,7,0,F02D13/0207;;F02D13/0207;;F02B1/12;;F02B1/12;;F02B2075/027;;F02B2075/027;;F02B2075/125;;F02B2075/125;;F02D13/0238;;F02D13/0238;;F02D13/0242;;F02D13/0242;;F02D13/0273;;F02D13/0273;;F02D41/402;;F02D41/402;;Y02T10/12;;Y02T10/12;;Y02T10/40;;Y02T10/40,F02B3/00,,0,0,,,,PENDING
355,SG,A1,SG 148216 A1,196-598-339-929-634,2008-12-31,2008,SG 2008090144 A,2004-12-07,US 52792803 P;;US 58482304 P,2003-12-08,OXAZOLE DERIVATIVES OF TETRACYCLINES,"OXAZOLE DERIVATIVES OF TETRACYCLINES This invention provides compounds of the formula: wherein A', X and Y are defined in the specification. These compounds are useful as antibacterial agents.",WYETH CORP,PHAIK-ENG SUM;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES,,https://lens.org/196-598-339-929-634,Patent Application,no,0,0,43,44,0,A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04;;C07C2603/46;;A61P31/04;;C07D263/62;;C07D263/54;;C07D263/52;;C07C237/26;;C07D413/04;;A61K31/65;;C07D417/04;;C07D413/06;;C07D263/52;;C07C2603/46,A61K31/423;;A61K31/65;;C07C237/26;;C07D263/52;;C07D413/04;;C07D413/06;;C07D417/04,,0,0,,,,PENDING
356,WO,A1,WO 2016/164508 A1,066-362-568-289-795,2016-10-13,2016,US 2016/0026313 W,2016-04-07,US 201562145838 P,2015-04-10,"FORMULATION AND AEROSOL CANISTERS, INHALERS, AND THE LIKE CONTAINING THE FORMULATION","Compositions containing albuterol, ipratropium, and a propellant as well as aerosol canisters and inhalers, such as metered dose inhalers, containing such compositions.",3M INNOVATIVE PROPERTIES CO,ZHU KEWU;;SCHULTZ DAVID W;;DRAKE JAMES B;;CHEN YU;;PAN MEI-LING;;YAP ENG SENG,,https://lens.org/066-362-568-289-795,Patent Application,yes,3,6,4,4,0,A61K9/008;;A61K31/46;;A61K31/137;;A61P11/06;;A61K9/008;;A61K31/46;;A61K31/137;;A61M15/0065;;A61M15/009,A61K9/00;;A61K31/137;;A61K31/46,,0,0,,,,PENDING
357,WO,A2,WO 2007/008994 A2,125-401-958-041-872,2007-01-18,2007,US 2006/0027066 W,2006-07-11,US 69759005 P,2005-07-11,GLUTAMATE AGGRECANASE INHIBITORS,The present invention relates to modulators of metalloproteinase activity.,WYETH CORP;;SUM PHAIK-ENG;;HOW DAVID BRIAN;;SABATINI JOSHUA JAMES;;XIANG JASON SHAOYUN;;IPEK MANUS;;FEYFANT ERIC,SUM PHAIK-ENG;;HOW DAVID BRIAN;;SABATINI JOSHUA JAMES;;XIANG JASON SHAOYUN;;IPEK MANUS;;FEYFANT ERIC,,https://lens.org/125-401-958-041-872,Patent Application,yes,0,7,28,28,0,C07B2200/07;;C07C231/16;;C07C233/83;;C07C235/84;;C07C237/22;;C07C237/42;;C07C259/06;;C07C323/32;;C07D213/38;;C07D213/82;;C07D239/26;;C07D239/42;;C07D277/30;;C07D307/52;;C07D307/68;;C07D307/79;;C07D307/85;;C07D317/58;;C07D333/20;;C07D333/22;;C07D333/28;;C07D333/38;;C07D409/04;;C07C2601/02;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/08;;C07C2603/18;;C07C2603/74;;A61P1/02;;A61P1/04;;A61P1/16;;A61P11/00;;A61P11/06;;A61P13/12;;A61P17/00;;A61P19/00;;A61P19/02;;A61P19/04;;A61P25/00;;A61P27/02;;A61P29/00;;A61P35/00;;A61P37/06;;A61P43/00;;A61P9/00;;A61P9/10;;A61P9/14;;A61P3/10;;C07D213/56;;C07D213/82;;C07D317/58;;C07D333/24;;C07D277/30;;C07D213/38;;C07D239/26;;C07D239/42;;C07D307/52;;A61K31/4196;;A61K31/4192;;C07D213/82;;C07D317/58;;C07D333/28;;C07D213/38;;C07D277/30;;C07C259/06;;C07D307/52;;C07D239/26;;C07D307/85;;C07D333/38;;C07C235/84;;C07C323/32;;C07C231/16;;C07D333/20;;C07D409/04;;C07D307/68;;C07C233/83;;C07C237/42;;C07D307/79;;C07D333/22;;C07B2200/07;;C07C237/22;;C07D239/42;;C07C2601/14;;C07C2602/08;;C07C2601/18;;C07C2603/18;;C07C2601/02;;C07C2603/74;;C07C2601/08,,,0,0,,,,PENDING
358,CN,A,CN 116171325 A,007-512-467-825-385,2023-05-26,2023,CN 202180056421 A,2021-07-21,US 202063055775 P;;EP 2021070455 W,2020-07-23,Gene therapy vectors for eEF1A2 and uses thereof,"Provided herein is a gene therapy for nervous system diseases that uses recombinant adeno-associated virus (rAAV) virions as a vector to express an eEF1A2 protein or functional variants thereof. The rAAV virion may use a neuronal specific promoter, for example, a human synapsin 1 (hSYN) promoter. The capsid may be an AAV9 capsid or a functional variant thereof. Other promoters or capsids may be used. Further provided are methods of treatment, such as by intracerebral and/or intravenous rAAV virions, as well as other compositions and methods.",UCL BUSINESS PLC,WADDINGTON STEPHEN N;;KADAR RAHUL;;HERZOG CHRISTOPHER DAVID;;ENG JARED;;SACRAMENDO CARLOS;;SCHORG STEFAN;;D RICKS,,https://lens.org/007-512-467-825-385,Patent Application,no,0,0,10,10,0,C12N15/86;;C12N2750/14143;;C12N2830/008;;C12N2830/48;;C12N2830/50;;A61K48/0058;;C12N15/86;;A61K48/0058;;C12N2830/50;;C12N2830/008;;C12N2750/14143;;C12N2830/48;;A61P25/28;;A61K48/0041;;A61K48/0058;;C07K14/47;;C07K14/61;;C12N15/86;;C12N2750/14143;;C12N2750/14171,C12N15/86,,0,0,,,,PENDING
359,WO,A3,WO 2007/008994 A3,109-272-530-328-479,2007-07-12,2007,US 2006/0027066 W,2006-07-11,US 69759005 P,2005-07-11,GLUTAMATE AGGRECANASE INHIBITORS,"The present invention relates to compounds of the formula (I), which are modulators of metalloproteinase activity. and pharmaceutically acceptable salts thereof, wherein W is -C(O)-, -OC(O)-, -NHC(O)-, -C(O)O-, Or -C(O)NH-; R 1 is phenyl, heteroaryl, biphenyl, bicyciic aryi, tricyclic aryl, bicyclic heteroaryl. or tricyclic heteroaryl, each optionally substituted with one or more of R 5 or R 6 , and when Ri is substituted with more than one of R 5 or Re, the substituents can be identical or different; R 2 is hydrogen, (C 1 -C 6 ) alkyl, (C 2 -C 6 ) alkenyl, (C 2 -C 6 ) alkynyl, -(CH 2 ) n R 11 , -OH, or -0-(C 1 -C 6 ) alkyl; R 3 is -CO 2 H, -CONH 2 , -CONHOH, -CONHSO 2 R 7 , tetrazole, -SO 2 NHR 7 , -SO 3 H, -PO(OH)NH 2 , -PO(OH)OR 7 , -CONHR 7 , -COOR 7 , an acid mimetic group, or a 5 or 6-membered heterocycloalkyl or heteroaryl containing 1 to 4 heteroatoms selected from O, N, S; R 4 is -CO 2 H, -CONH 2 , -(CH 2 ) n OR 7 , or -CONR 9 R 10 ;",WYETH CORP;;SUM PHAIK-ENG;;HOW DAVID BRIAN;;SABATINI JOSHUA JAMES;;XIANG JASON SHAOYUN;;IPEK MANUS;;FEYFANT ERIC,SUM PHAIK-ENG;;HOW DAVID BRIAN;;SABATINI JOSHUA JAMES;;XIANG JASON SHAOYUN;;IPEK MANUS;;FEYFANT ERIC,,https://lens.org/109-272-530-328-479,Search Report,yes,7,0,28,28,0,C07B2200/07;;C07C231/16;;C07C233/83;;C07C235/84;;C07C237/22;;C07C237/42;;C07C259/06;;C07C323/32;;C07D213/38;;C07D213/82;;C07D239/26;;C07D239/42;;C07D277/30;;C07D307/52;;C07D307/68;;C07D307/79;;C07D307/85;;C07D317/58;;C07D333/20;;C07D333/22;;C07D333/28;;C07D333/38;;C07D409/04;;C07C2601/02;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/08;;C07C2603/18;;C07C2603/74;;A61P1/02;;A61P1/04;;A61P1/16;;A61P11/00;;A61P11/06;;A61P13/12;;A61P17/00;;A61P19/00;;A61P19/02;;A61P19/04;;A61P25/00;;A61P27/02;;A61P29/00;;A61P35/00;;A61P37/06;;A61P43/00;;A61P9/00;;A61P9/10;;A61P9/14;;A61P3/10;;C07D213/56;;C07D213/82;;C07D317/58;;C07D333/24;;C07D277/30;;C07D213/38;;C07D239/26;;C07D239/42;;C07D307/52;;A61K31/4196;;A61K31/4192;;C07D213/82;;C07D317/58;;C07D333/28;;C07D213/38;;C07D277/30;;C07C259/06;;C07D307/52;;C07D239/26;;C07D307/85;;C07D333/38;;C07C235/84;;C07C323/32;;C07C231/16;;C07D333/20;;C07D409/04;;C07D307/68;;C07C233/83;;C07C237/42;;C07D307/79;;C07D333/22;;C07B2200/07;;C07C237/22;;C07D239/42;;C07C2601/14;;C07C2602/08;;C07C2601/18;;C07C2603/18;;C07C2601/02;;C07C2603/74;;C07C2601/08,C07C237/22;;A61K31/166;;A61K31/36;;A61K31/381;;A61K31/426;;A61K31/4409;;C07C231/16;;C07C235/84;;C07C237/42;;C07C259/06;;C07C323/41;;C07D213/56;;C07D277/30;;C07D317/58;;C07D333/24,,19,9,063-459-526-705-764;;133-138-970-429-276;;058-248-900-440-161;;010-180-753-764-093;;017-124-709-788-643;;005-309-356-564-817;;020-141-402-754-29X;;020-486-672-198-354;;103-951-165-031-189,10.1016/j.bmc.2005.04.051;;15908222;;1732532;;10.1021/jm00079a003;;7057425;;10.1021/jm00344a018;;10.1016/s0968-0896(00)00051-1;;10882019;;8544182;;10.1021/jm00026a013;;10.1021/jm00193a022;;109616;;9784104;;10.1021/jm980298s;;2719954;;10.1021/bi00431a047;;2704023;;10.1021/jm00124a003,"TAKAHASHI K ET AL: ""Novel matrix metalloproteinase inhibitors: Generation of lead compounds by the in silico fragment-based approach"", BIOORGANIC & MEDICINAL CHEMISTRY, vol. 13, no. 14, 15 July 2005 (2005-07-15), pages 4527 - 4543, XP004928368, ISSN: 0968-0896;;F. MAKOVEC ET AL.: ""Structure-Antigastrin Activity Relationships of New (R)-4-Benzamido-5-oxopentanoic Acid Derivatives"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 35, no. 1, 1992, pages 28 - 38, XP002413065;;J. R. PIPER, J. A. MONTGOMERY: ""Syntheses of .alpha.- and .gamma.-substituted Amides, Peptides, and Esters of Methotrexate and Their Evaluation as Inhibitors of Folate Metabolism"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 25, no. 2, 1982, pages 182 - 187, XP002413066;;DATABASE BEILSTEIN BEILSTEIN INSTITUTE FOR ORGANIC CHEMISTRY, FRANKFURT-MAIN, DE; XP002413080, Database accession no. BRN 3152508;;DATABASE BEILSTEIN BEILSTEIN INSTITUTE FOR ORGANIC CHEMISTRY, FRANKFURT-MAIN, DE; XP002413081, Database accession no. BRN 3149561;;DATABASE BEILSTEIN BEILSTEIN INSTITUTE FOR ORGANIC CHEMISTRY, FRANKFURT-MAIN, DE; XP002413082, Database accession no. BRN 2790059;;DATABASE BEILSTEIN BEILSTEIN INSTITUTE FOR ORGANIC CHEMISTRY, FRANKFURT-MAIN, DE; XP002413083, Database accession no. BRN 9663820;;DATABASE BEILSTEIN BEILSTEIN INSTITUTE FOR ORGANIC CHEMISTRY, FRANKFURT-MAIN, DE; XP002413084, Database accession no. BRN 3210937;;DATABASE BEILSTEIN BEILSTEIN INSTITUTE FOR ORGANIC CHEMISTRY, FRANKFURT-MAIN, DE; XP002413085, Database accession no. BRN 2600925;;D. L. BOGER ET AL.: ""Conformationally Restricted Analogues Designed for Selective Inhibition of GAR Tfase Versus Thymidylate Synthase or Dihydrofolate Reductase"", BIOORG. MED. CHEM., vol. 8, no. 5, 2000, pages 1075 - 1086, XP002413067;;DATABASE BEILSTEIN BEILSTEIN INSTITUTE FOR ORGANIC CHEMISTRY, FRANKFURT-MAIN, DE; XP002413086, Database accession no. BRN 55943;;DATABASE BEILSTEIN BEILSTEIN INSTITUTE FOR ORGANIC CHEMISTRY, FRANKFURT-MAIN, DE; XP002413087, Database accession no. BRN 2894932;;C. J. SPRINGER ET AL.: ""Optimization of Alkylating Agent Prodrugs Derived from Phenol and Aniline Mustards: A New Clinical Candidate Prodrug (ZD2767) for Antibody-Directed Enzyme Prodrug Therapy (ADEPT)"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 38, no. 26, 1995, pages 5051 - 5065, XP002413068;;J. E. MARTINELLI; M. CHAYKOVSKY: ""Methotrexate Analogues. 12. Synthesis and Biological properties of Some Aza Homologues"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 22, no. 7, 1979, pages 869 - 874, XP002413069;;D. J. AUGERI ET AL.: ""Potent and Selective Non-Cysteine-Containing Inhibitors of Protein Farnesyltransferase"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 41, no. 22, 1998, pages 4288 - 4300, XP002413070;;DATABASE CAPLUS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; SAKYO, KATSUFUMI ET AL: ""Inhibitory effect of methotrexate on matrix metalloproteinase-1 (collagenase) production by synovial fibroblasts"", XP002413088, retrieved from STN Database accession no. 1997:137341;;U. KUEFNER ET AL.: ""Carboxypeptidase-Mediated Release of Methotrexate from Methotrexate .alpha.-Peptides"", BIOCHEMISTRY, vol. 28, no. 5, 1989, pages 2288 - 2297, XP002429817;;F. MAKOVEC ET AL.: ""New glutamic and aspartic derivatives with potent CCK-antagonistic activity"", EUR. J. MED. CHEM.-CHIM. THER., vol. 21, no. 1, 1986, pages 9 - 20, XP009082343;;J. F. KERWIN, JR. ET AL: ""Hybrid Cholecystokinin (CCK) Antagonist: New Implications in the Design and Modification of CCK Antagonists"", J. MED. CHEM., vol. 32, no. 4, 1989, pages 739 - 742, XP002429816",PENDING
360,GT,A,GT 200600306 A,111-551-134-953-567,2007-03-29,2007,GT 200600306 A,2006-07-11,US 69759005 P,2005-07-11,INHIBIDORES DE GLUTAMATO AGRECANASA,"LA PRESENTE INVENCIÓN SE REFIERE A COMPUESTOS DE LA FÓRMULA GENERAL I EN LA QUE R1,R2,R3,R4,W,M,P, SON GRUPOS FUNCIONALES DESCRITOS EN EL EXPEDIENTE. ESTOS COMPUESTOS SON INHIBIDORES DE METALOPROTEINASAS POR LO QUE SON DE UTILIDAD EN CUADROS DE OSTEOARTRITIS.",,SUM PHAIK-ENG;;HOW DAVID BRIAN;;SABATINI JOSHUA JAMES;;XIANG JASON SHAOYUN;;IPEK MANUS;;FEYFANT ERIC,,https://lens.org/111-551-134-953-567,Amended Application,no,0,0,28,28,0,C07B2200/07;;C07C231/16;;C07C233/83;;C07C235/84;;C07C237/22;;C07C237/42;;C07C259/06;;C07C323/32;;C07D213/38;;C07D213/82;;C07D239/26;;C07D239/42;;C07D277/30;;C07D307/52;;C07D307/68;;C07D307/79;;C07D307/85;;C07D317/58;;C07D333/20;;C07D333/22;;C07D333/28;;C07D333/38;;C07D409/04;;C07C2601/02;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/08;;C07C2603/18;;C07C2603/74;;A61P1/02;;A61P1/04;;A61P1/16;;A61P11/00;;A61P11/06;;A61P13/12;;A61P17/00;;A61P19/00;;A61P19/02;;A61P19/04;;A61P25/00;;A61P27/02;;A61P29/00;;A61P35/00;;A61P37/06;;A61P43/00;;A61P9/00;;A61P9/10;;A61P9/14;;A61P3/10;;C07D213/56;;C07D213/82;;C07D317/58;;C07D333/24;;C07D277/30;;C07D213/38;;C07D239/26;;C07D239/42;;C07D307/52;;A61K31/4196;;A61K31/4192;;C07D213/82;;C07D317/58;;C07D333/28;;C07D213/38;;C07D277/30;;C07C259/06;;C07D307/52;;C07D239/26;;C07D307/85;;C07D333/38;;C07C235/84;;C07C323/32;;C07C231/16;;C07D333/20;;C07D409/04;;C07D307/68;;C07C233/83;;C07C237/42;;C07D307/79;;C07D333/22;;C07B2200/07;;C07C237/22;;C07D239/42;;C07C2601/14;;C07C2602/08;;C07C2601/18;;C07C2603/18;;C07C2601/02;;C07C2603/74;;C07C2601/08,A61P19/00;;A61P35/00;;C07C233/57;;C07D403/12,,0,0,,,,PENDING
361,MY,A,MY 144590 A,189-803-269-775-217,2011-10-14,2011,MY PI20063291 A,2006-07-11,US 69759005 P,2005-07-11,GLUTAMATE AGGRECANASE INHIBITORS,"THE PRESENT INVENTION RELATES TO MODULATOR, OF METALLOPROTEINASE ACTIVITY.",WYETH CORP,SUM PHAIK-ENG;;HOW DAVID BRIAN;;SABATINI JOSHUA JAMES;;XIANG JASON SHAOYUN;;IPEK MANUS;;FEYFANT ERIC,,https://lens.org/189-803-269-775-217,Granted Patent,no,0,0,28,28,0,C07B2200/07;;C07C231/16;;C07C233/83;;C07C235/84;;C07C237/22;;C07C237/42;;C07C259/06;;C07C323/32;;C07D213/38;;C07D213/82;;C07D239/26;;C07D239/42;;C07D277/30;;C07D307/52;;C07D307/68;;C07D307/79;;C07D307/85;;C07D317/58;;C07D333/20;;C07D333/22;;C07D333/28;;C07D333/38;;C07D409/04;;C07C2601/02;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/08;;C07C2603/18;;C07C2603/74;;A61P1/02;;A61P1/04;;A61P1/16;;A61P11/00;;A61P11/06;;A61P13/12;;A61P17/00;;A61P19/00;;A61P19/02;;A61P19/04;;A61P25/00;;A61P27/02;;A61P29/00;;A61P35/00;;A61P37/06;;A61P43/00;;A61P9/00;;A61P9/10;;A61P9/14;;A61P3/10;;C07D213/56;;C07D213/82;;C07D317/58;;C07D333/24;;C07D277/30;;C07D213/38;;C07D239/26;;C07D239/42;;C07D307/52;;A61K31/4196;;A61K31/4192;;C07D213/82;;C07D317/58;;C07D333/28;;C07D213/38;;C07D277/30;;C07C259/06;;C07D307/52;;C07D239/26;;C07D307/85;;C07D333/38;;C07C235/84;;C07C323/32;;C07C231/16;;C07D333/20;;C07D409/04;;C07D307/68;;C07C233/83;;C07C237/42;;C07D307/79;;C07D333/22;;C07B2200/07;;C07C237/22;;C07D239/42;;C07C2601/14;;C07C2602/08;;C07C2601/18;;C07C2603/18;;C07C2601/02;;C07C2603/74;;C07C2601/08,A61K31/166,,0,0,,,,ACTIVE
362,US,A1,US 2018/0071231 A1,171-354-529-229-112,2018-03-15,2018,US 201615564466 A,2016-04-07,US 201615564466 A;;US 201562145838 P;;US 2016/0026313 W,2015-04-10,"FORMULATION AND AEROSOL CANISTERS, INHALERS, AND THE LIKE CONTAINING THE FORMULATION","Compositions containing albuterol, ipratropium, and a propellant as well as aerosol canisters and inhalers, such as metered dose inhalers, containing such compositions.",3M INNOVATIVE PROPERTIES CO,ZHU KEWU;;SCHULTZ DAVID W;;DRAKE JAMES B;;CHEN YU;;PAN MEI-LING;;YAP ENG SENG,KINDEVA DRUG DELIVERY L.P (2020-04-22);;3M INNOVATIVE PROPERTIES COMPANY (2017-09-20),https://lens.org/171-354-529-229-112,Patent Application,yes,4,0,4,4,0,A61K9/008;;A61K31/46;;A61K31/137;;A61P11/06;;A61K9/008;;A61K31/46;;A61K31/137;;A61M15/0065;;A61M15/009,A61K31/137;;A61K9/00;;A61K31/46;;A61M15/00,,0,0,,,,DISCONTINUED
363,CA,A1,CA 2614930 A1,127-583-669-627-829,2007-01-18,2007,CA 2614930 A,2006-07-11,US 69759005 P;;US 2006/0027066 W,2005-07-11,GLUTAMATE AGGRECANASE INHIBITORS,"The present invention relates to compounds of the formula (I), which are modulators of metalloproteinase activity. and pharmaceutically acceptable salts thereof, wherein W is -C(O)-, -OC(O)-, -NHC(O)-, -C(O)O-, Or -C(O)NH-; R1 is phenyl, heteroaryl, biphenyl, bicyciic aryi, tricyclic aryl, bicyclic heteroaryl. or tricyclic heteroaryl, each optionally substituted with one or more of R5 or R6, and when Ri is substituted with more than one of R5 or Re, the substituents can be identical or different; R2 is hydrogen, (C1 -C6) alkyl, (C2-C6) alkenyl, (C2-C6) alkynyl, -(CH2)nR11 , -OH, or -0-(C1-C6) alkyl; R3 is -CO2H, -CONH2, -CONHOH, -CONHSO2R7, tetrazole, -SO2NHR7, -SO3H, - PO(OH)NH2, -PO(OH)OR7, -CONHR7, -COOR7, an acid mimetic group, or a 5 or 6- membered heterocycloalkyl or heteroaryl containing 1 to 4 heteroatoms selected from O, N, S; R4 is -CO2H, -CONH2, -(CH2)nOR7, or -CONR9R10;",WYETH CORP,XIANG JASON SHAOYUN;;IPEK MANUS;;SABATINI JOSHUA JAMES;;HOW DAVID BRIAN;;FEYFANT ERIC;;SUM PHAIK-ENG,,https://lens.org/127-583-669-627-829,Patent Application,no,0,0,28,28,0,C07B2200/07;;C07C231/16;;C07C233/83;;C07C235/84;;C07C237/22;;C07C237/42;;C07C259/06;;C07C323/32;;C07D213/38;;C07D213/82;;C07D239/26;;C07D239/42;;C07D277/30;;C07D307/52;;C07D307/68;;C07D307/79;;C07D307/85;;C07D317/58;;C07D333/20;;C07D333/22;;C07D333/28;;C07D333/38;;C07D409/04;;C07C2601/02;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/08;;C07C2603/18;;C07C2603/74;;A61P1/02;;A61P1/04;;A61P1/16;;A61P11/00;;A61P11/06;;A61P13/12;;A61P17/00;;A61P19/00;;A61P19/02;;A61P19/04;;A61P25/00;;A61P27/02;;A61P29/00;;A61P35/00;;A61P37/06;;A61P43/00;;A61P9/00;;A61P9/10;;A61P9/14;;A61P3/10;;C07D213/56;;C07D213/82;;C07D317/58;;C07D333/24;;C07D277/30;;C07D213/38;;C07D239/26;;C07D239/42;;C07D307/52;;A61K31/4196;;A61K31/4192;;C07D213/82;;C07D317/58;;C07D333/28;;C07D213/38;;C07D277/30;;C07C259/06;;C07D307/52;;C07D239/26;;C07D307/85;;C07D333/38;;C07C235/84;;C07C323/32;;C07C231/16;;C07D333/20;;C07D409/04;;C07D307/68;;C07C233/83;;C07C237/42;;C07D307/79;;C07D333/22;;C07B2200/07;;C07C237/22;;C07D239/42;;C07C2601/14;;C07C2602/08;;C07C2601/18;;C07C2603/18;;C07C2601/02;;C07C2603/74;;C07C2601/08,C07C237/22;;A61K31/166;;A61K31/36;;A61K31/381;;A61K31/426;;A61K31/4409;;C07C231/16;;C07C235/84;;C07C237/42;;C07C259/06;;C07C323/41;;C07D213/56;;C07D277/30;;C07D317/58;;C07D333/24,,0,0,,,,DISCONTINUED
364,US,A1,US 2023/0017328 A1,131-627-584-700-894,2023-01-19,2023,US 202117375595 A,2021-07-14,US 202117375595 A,2021-07-14,TURBINE NOZZLE ASSEMBLY AND GAS TURBINE INCLUDING THE SAME,"A gas turbine nozzle assembly of a gas turbine is provided. The turbine nozzle assembly may include a turbine nozzle extending from an inner diameter to an outer diameter and having an airfoil-shaped cross section having a leading edge and a trailing edge, and a pressure side and a suction side each of which extends from the leading edge to the trailing edge, wherein the turbine nozzle may include a hollow airfoil including a plurality of cavities positioned in the airfoil, an insert positioned in one or more of the plurality of cavities of the hollow airfoil, a plurality of cover plates, at least one of which is positioned at one of the inner diameter and at the outer diameter, and a plurality of impingement pans, at least one of which is positioned at one of the inner diameter and at the outer diameter.",DOOSAN ENERBILITY CO LTD,CHONG GENE;;KIM YEJEE;;ENG DARRYL;;DAY DAVID;;MUN YOUNGGI;;BERNIER BRYAN;;SEO HONGSEUNG;;LEE JAEBIN,DOOSAN HEAVY INDUSTRIES & CONSTRUCTION CO. LTD (2021-05-18),https://lens.org/131-627-584-700-894,Patent Application,yes,7,0,3,3,0,F01D9/065;;F05D2260/201;;F05D2240/81;;F05D2240/121;;F01D5/189;;F01D9/041;;F01D5/188;;F01D5/183;;F05D2240/35;;F05D2220/32;;F01D25/12;;F05D2240/128;;F05D2260/201;;F05D2220/32,F01D25/12,,0,0,,,,ACTIVE
365,US,A1,US 2006/0051966 A1,199-426-577-682-911,2006-03-09,2006,US 26616705 A,2005-11-03,US 26616705 A;;US 6364505 A;;US 54783904 P,2004-02-26,In-situ chamber clean process to remove by-product deposits from chemical vapor etch chamber,"A method and apparatus for cleaning a processing chamber comprising blocking a flow of cooling fluid to a channel within a support member within a processing chamber, elevating the support member to be within about 0.1 inches of a gas distribution plate, heating the gas distribution plate, and introducing a thermally conductive gas through the gas distribution plate into the processing chamber.",APPLIED MATERIALS INC,OR DAVID T;;CHOU JING-PEI;;PHAN SEE-ENG;;LU XINLIANG;;KAO CHIEN-TEH;;CHANG MEI,APPLIED MATERIALS INC (2005-10-28),https://lens.org/199-426-577-682-911,Patent Application,yes,98,229,1,94,0,H01J37/32082;;H01J37/32357;;H01J37/32522;;H01J2237/2001;;H01L21/67069;;H01L21/67109;;H01L2924/0002;;C23C16/4405;;H01L21/67109;;H01J37/32082;;H01L21/67069;;H01J37/32357;;H01J2237/2001;;H01J37/32522;;H01L2924/0002;;H01L21/00;;C23C16/4405;;H01J37/32;;H01L21/461;;H01L21/302,H01L21/461;;B08B6/00;;C23F1/00;;H01J37/32;;H01L21/00;;H01L21/302;;H01L21/8238;;H01L23/12,438/706;;438/905;;438/715;;134/1.3,0,0,,,,DISCONTINUED
366,AU,A1,AU 2006/268183 A1,005-165-568-022-69X,2007-01-18,2007,AU 2006/268183 A,2006-07-11,US 69759005 P;;US 2006/0027066 W,2005-07-11,Glutamate aggrecanase inhibitors,,WYETH CORP,IPEK MANUS;;SUM PHAIK-ENG;;SABATINI JOSHUA JAMES;;XIANG JASON SHAOYUN;;HOW DAVID BRIAN;;FEYFANT ERIC,,https://lens.org/005-165-568-022-69X,Patent Application,no,0,0,28,28,0,C07B2200/07;;C07C231/16;;C07C233/83;;C07C235/84;;C07C237/22;;C07C237/42;;C07C259/06;;C07C323/32;;C07D213/38;;C07D213/82;;C07D239/26;;C07D239/42;;C07D277/30;;C07D307/52;;C07D307/68;;C07D307/79;;C07D307/85;;C07D317/58;;C07D333/20;;C07D333/22;;C07D333/28;;C07D333/38;;C07D409/04;;C07C2601/02;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/08;;C07C2603/18;;C07C2603/74;;A61P1/02;;A61P1/04;;A61P1/16;;A61P11/00;;A61P11/06;;A61P13/12;;A61P17/00;;A61P19/00;;A61P19/02;;A61P19/04;;A61P25/00;;A61P27/02;;A61P29/00;;A61P35/00;;A61P37/06;;A61P43/00;;A61P9/00;;A61P9/10;;A61P9/14;;A61P3/10;;C07D213/56;;C07D213/82;;C07D317/58;;C07D333/24;;C07D277/30;;C07D213/38;;C07D239/26;;C07D239/42;;C07D307/52;;A61K31/4196;;A61K31/4192;;C07D213/82;;C07D317/58;;C07D333/28;;C07D213/38;;C07D277/30;;C07C259/06;;C07D307/52;;C07D239/26;;C07D307/85;;C07D333/38;;C07C235/84;;C07C323/32;;C07C231/16;;C07D333/20;;C07D409/04;;C07D307/68;;C07C233/83;;C07C237/42;;C07D307/79;;C07D333/22;;C07B2200/07;;C07C237/22;;C07D239/42;;C07C2601/14;;C07C2602/08;;C07C2601/18;;C07C2603/18;;C07C2601/02;;C07C2603/74;;C07C2601/08,C07C237/22;;A61K31/166;;A61K31/36;;A61K31/381;;A61K31/426;;A61K31/4409;;C07C231/16;;C07C235/84;;C07C237/42;;C07C259/06;;C07C323/41;;C07D213/56;;C07D277/30;;C07D317/58;;C07D333/24,,0,0,,,,INACTIVE
367,EP,A1,EP 3280393 A1,141-323-002-728-812,2018-02-14,2018,EP 16717065 A,2016-04-07,US 201562145838 P;;US 2016/0026313 W,2015-04-10,"FORMULATION AND AEROSOL CANISTERS, INHALERS, AND THE LIKE CONTAINING THE FORMULATION",,3M INNOVATIVE PROPERTIES CO,ZHU KEWU;;SCHULTZ DAVID W;;DRAKE JAMES B;;CHEN YU;;PAN MEI-LING;;YAP ENG SENG,,https://lens.org/141-323-002-728-812,Patent Application,yes,0,0,4,4,0,A61K9/008;;A61K31/46;;A61K31/137;;A61P11/06;;A61K9/008;;A61K31/46;;A61K31/137;;A61M15/0065;;A61M15/009,A61K9/00;;A61K31/137;;A61K31/46,,0,0,,,,DISCONTINUED
368,US,A1,US 2007/0043066 A1,192-138-888-749-545,2007-02-22,2007,US 48400506 A,2006-07-11,US 48400506 A;;US 69759005 P,2005-07-11,Glutamate aggrecanase inhibitors,The present invention relates to modulators of metalloproteinase activity.,WYETH CORP,SUM PHAIK-ENG;;HOW DAVID B;;SABATINI JOSHUA J;;XIANG JASON S;;IPEK MANUS;;FEYFANT ERIC,WYETH (2006-09-25),https://lens.org/192-138-888-749-545,Patent Application,yes,30,70,28,28,0,C07B2200/07;;C07C231/16;;C07C233/83;;C07C235/84;;C07C237/22;;C07C237/42;;C07C259/06;;C07C323/32;;C07D213/38;;C07D213/82;;C07D239/26;;C07D239/42;;C07D277/30;;C07D307/52;;C07D307/68;;C07D307/79;;C07D307/85;;C07D317/58;;C07D333/20;;C07D333/22;;C07D333/28;;C07D333/38;;C07D409/04;;C07C2601/02;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/08;;C07C2603/18;;C07C2603/74;;A61P1/02;;A61P1/04;;A61P1/16;;A61P11/00;;A61P11/06;;A61P13/12;;A61P17/00;;A61P19/00;;A61P19/02;;A61P19/04;;A61P25/00;;A61P27/02;;A61P29/00;;A61P35/00;;A61P37/06;;A61P43/00;;A61P9/00;;A61P9/10;;A61P9/14;;A61P3/10;;C07D213/56;;C07D213/82;;C07D317/58;;C07D333/24;;C07D277/30;;C07D213/38;;C07D239/26;;C07D239/42;;C07D307/52;;A61K31/4196;;A61K31/4192;;C07D213/82;;C07D317/58;;C07D333/28;;C07D213/38;;C07D277/30;;C07C259/06;;C07D307/52;;C07D239/26;;C07D307/85;;C07D333/38;;C07C235/84;;C07C323/32;;C07C231/16;;C07D333/20;;C07D409/04;;C07D307/68;;C07C233/83;;C07C237/42;;C07D307/79;;C07D333/22;;C07B2200/07;;C07C237/22;;C07D239/42;;C07C2601/14;;C07C2602/08;;C07C2601/18;;C07C2603/18;;C07C2601/02;;C07C2603/74;;C07C2601/08,A61K31/505;;A61K31/165;;A61K31/198;;A61K31/34;;A61K31/381;;A61K31/44,514/275;;514/447;;514/471;;514/563;;514/616;;514/464;;514/357;;544/330;;549/76;;562/450;;564/152;;546/315;;549/493,0,0,,,,INACTIVE
369,ES,T3,ES 2167419 T3,023-745-644-106-312,2002-05-16,2002,ES 95911105 T,1995-02-27,US 20607494 A,1994-03-04,PROCEDIMIENTO DE FABRICACION DE UN EPOXIDO.,"A process for synthesizing the epoxide of formula (I) consists of, at a minimum, formation of a halohydrin form the allyl acetonide reactant, followed by base-induced cyclization, the epoxide product (I) being useful as an intermediate for the synthesis of inhibitors of renin or HIV protease or other proteases.",MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;MALIGRES PETER E;;REIDER PAUL J;;ROSSEN KAI;;VOLANTE RALPH P,,https://lens.org/023-745-644-106-312,Granted Patent,no,0,0,40,41,0,C07D263/52;;C07D413/06;;A61P31/12;;A61P31/18;;A61P37/04;;C07D413/06,A61K31/44;;A61K31/4406;;A61K31/4418;;C07D213/36;;A61P31/12;;A61P37/04;;C07D263/52;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
370,ZA,B,ZA 200800379 B,030-263-562-574-042,2011-06-29,2011,ZA 200800379 A,2008-01-10,US 69759005 P;;US 2006/0027066 W,2005-07-11,GLUTAMATE AGGRECANASE INHIBITORS,,WYETH CORP,HOW DAVID BRIAN;;IPEK MANUS;;FEYFANT ERIC;;SABATINI JOSHUA JAMES;;SUM PHAIK-ENG;;XIANG JASON SHAOYUN,,https://lens.org/030-263-562-574-042,Granted Patent,no,0,0,28,28,0,C07B2200/07;;C07C231/16;;C07C233/83;;C07C235/84;;C07C237/22;;C07C237/42;;C07C259/06;;C07C323/32;;C07D213/38;;C07D213/82;;C07D239/26;;C07D239/42;;C07D277/30;;C07D307/52;;C07D307/68;;C07D307/79;;C07D307/85;;C07D317/58;;C07D333/20;;C07D333/22;;C07D333/28;;C07D333/38;;C07D409/04;;C07C2601/02;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/08;;C07C2603/18;;C07C2603/74;;A61P1/02;;A61P1/04;;A61P1/16;;A61P11/00;;A61P11/06;;A61P13/12;;A61P17/00;;A61P19/00;;A61P19/02;;A61P19/04;;A61P25/00;;A61P27/02;;A61P29/00;;A61P35/00;;A61P37/06;;A61P43/00;;A61P9/00;;A61P9/10;;A61P9/14;;A61P3/10;;C07D213/56;;C07D213/82;;C07D317/58;;C07D333/24;;C07D277/30;;C07D213/38;;C07D239/26;;C07D239/42;;C07D307/52;;A61K31/4196;;A61K31/4192;;C07D213/82;;C07D317/58;;C07D333/28;;C07D213/38;;C07D277/30;;C07C259/06;;C07D307/52;;C07D239/26;;C07D307/85;;C07D333/38;;C07C235/84;;C07C323/32;;C07C231/16;;C07D333/20;;C07D409/04;;C07D307/68;;C07C233/83;;C07C237/42;;C07D307/79;;C07D333/22;;C07B2200/07;;C07C237/22;;C07D239/42;;C07C2601/14;;C07C2602/08;;C07C2601/18;;C07C2603/18;;C07C2601/02;;C07C2603/74;;C07C2601/08,,,0,0,,,,ACTIVE
371,CN,A,CN 101505751 A,001-548-601-196-572,2009-08-12,2009,CN 200780030958 A,2007-08-23,US 83956806 P,2006-08-23,8-hydroxyquinoline compounds and methods thereof,"The present invention relates to 8-Hydroxyquinoline Compounds; compositions comprising an 8-Hydroxyquinoline Compound; and methods for treating or preventing a metalloproteinase-related disorder, such as, an arthritic disorder, osteoarthritis, malignant neoplasm, rheumatoid arthritis, asthma, chronic obstructive pulmonary disease, atherosclerosis, age-related macular degeneration, myocardial infarction, a corneal ulceration, an ocular surface disease, hepatitis, an aortic aneurysm, tendonitis, a central nervous system disorder, abnormal wound healing, angiogenesis, restenosis, cirrhosis, multiple sclerosis, glomerulonephritis, graft versus host disease, diabetes, an inflammatory bowel disease, shock, invertebral disc degeneration, stroke, osteopenia or a periodontal disease or comprising administering an effective dose of an 8-Hydroxyquinoline Compound to a mammal in need thereof.",WYETH CORP,SABRINA LOMBARDI;;MARK LAAKSO LEIF;;GULNAZ KHAFIZOVA;;BRIAN HOW DAVID;;JAMES SABATINI JOSHUA;;ENG SUM PHAIK,,https://lens.org/001-548-601-196-572,Patent Application,no,0,8,10,10,0,C07D215/26;;C07D215/28;;C07D401/06;;C07D401/12;;C07D405/06;;C07D409/10;;C07D417/10;;A61P9/10;;C07D215/28;;C07D401/06;;C07D405/06;;C07D417/10;;C07D215/26;;C07D409/10;;C07D401/12,A61K31/47;;C07D215/16,,0,0,,,,DISCONTINUED
372,AR,A1,AR 104209 A1,149-414-071-725-927,2017-07-05,2017,AR P160100948 A,2016-04-08,US 201562145838 P,2015-04-10,"FORMULACIÓN Y CONTENEDORES DE AEROSOL, INHALADORES Y SIMILARES QUE CONTIENEN LA FORMULACIÓN","Reivindicación 1: Una composición que comprende albuterol en partículas o una sal farmacéuticamente aceptable o su solvato; ipratropio en partículas o una sal farmacéuticamente aceptable o su solvato; al menos uno de los siguientes: 1,1,1,2,3,3,3-heptafluoropropano y 1,1,1,2-tetrafluoro-etano. Reivindicación 13: Una lata de aerosol que comprende una composición de acuerdo con cualquiera de las reivindicaciones anteriores.",3M INNOVATIVE PROPERTIES CO,ENG SENG YAP;;MEI PAN;;YU LING - CHEN;;JAMES B DRAKE;;DAVID WILLIAM SCHULTZ;;KEWU ZHU,,https://lens.org/149-414-071-725-927,Patent Application,no,0,0,4,4,0,A61K9/008;;A61K31/46;;A61K31/137;;A61P11/06;;A61K9/008;;A61K31/46;;A61K31/137;;A61M15/0065;;A61M15/009,A61K9/72;;A61K31/137;;A61K31/46;;A61P11/06,,0,0,,,,PENDING
373,US,B2,US 11608754 B2,155-232-390-101-724,2023-03-21,2023,US 202117375595 A,2021-07-14,US 202117375595 A,2021-07-14,Turbine nozzle assembly and gas turbine including the same,"A gas turbine nozzle assembly of a gas turbine is provided. The turbine nozzle assembly may include a turbine nozzle extending from an inner diameter to an outer diameter and having an airfoil-shaped cross section having a leading edge and a trailing edge, and a pressure side and a suction side each of which extends from the leading edge to the trailing edge, wherein the turbine nozzle may include a hollow airfoil including a plurality of cavities positioned in the airfoil, an insert positioned in one or more of the plurality of cavities of the hollow airfoil, a plurality of cover plates, at least one of which is positioned at one of the inner diameter and at the outer diameter, and a plurality of impingement pans, at least one of which is positioned at one of the inner diameter and at the outer diameter.",DOOSAN ENERBILITY CO LTD,CHONG GENE;;KIM YEJEE;;ENG DARRYL;;DAY DAVID;;MUN YOUNGGI;;BERNIER BRYAN;;SEO HONGSEUNG;;LEE JAEBIN,DOOSAN HEAVY INDUSTRIES & CONSTRUCTION CO. LTD (2021-05-18),https://lens.org/155-232-390-101-724,Granted Patent,yes,26,0,3,3,0,F01D9/065;;F05D2260/201;;F05D2240/81;;F05D2240/121;;F01D5/189;;F01D9/041;;F01D5/188;;F01D5/183;;F05D2240/35;;F05D2220/32;;F01D25/12;;F05D2240/128;;F05D2260/201;;F05D2220/32,F01D25/12,,0,0,,,,ACTIVE
374,BR,A2,BR PI0613030 A2,184-240-819-354-647,2012-01-03,2012,BR PI0613030 A,2006-07-11,US 69759005 P;;US 2006/0027066 W,2005-07-11,composto de fàrmula i; composto ou sal farmaceuticamente aceitÁvel do composto; mÉtodo para modular a atividade de uma metaloproteinase em animal que dele necessite; composiÇço; mÉtodo para tratamento de um distérbio relacionado a metaloproteinase em animal que dele necessite; mÉtodo de sintetizar um composto; composto de fàrmula ii,COMPOSTO DE FàRMULA I COMPOSTO OU SAL FARMACEUTICAMENTE ACEITÁVEL DO COMPOSTO; MÉTODO PARA MODULAR A ATIVIDADE DE UMA METALOPROTEINASE EM ANIMAL QUE DELE NECESSITE; COMPOSIÇçO; MÉTODO PARA TRATAMENTO DE UM DISTéRBIO RELACIONADO A METALOPROTEINASE EM ANIMAL QUE DELE NECESSITE; MÉTODO DE SINTETIZAR UM COMPOSTO; COMPOSTO DE FàRMULA II. A presente invenção refere-se à modulação da atividade de metaloproteinase.,WYETH CORP,SUM PHAIK-ENG;;HOW DAVID BRIAN;;SABATINI JOSHUA JAMES;;XIANG JASON SHAOYUN;;IPEK MANUS;;FEYFANT ERIC,,https://lens.org/184-240-819-354-647,Patent Application,no,0,0,28,28,0,C07B2200/07;;C07C231/16;;C07C233/83;;C07C235/84;;C07C237/22;;C07C237/42;;C07C259/06;;C07C323/32;;C07D213/38;;C07D213/82;;C07D239/26;;C07D239/42;;C07D277/30;;C07D307/52;;C07D307/68;;C07D307/79;;C07D307/85;;C07D317/58;;C07D333/20;;C07D333/22;;C07D333/28;;C07D333/38;;C07D409/04;;C07C2601/02;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/08;;C07C2603/18;;C07C2603/74;;A61P1/02;;A61P1/04;;A61P1/16;;A61P11/00;;A61P11/06;;A61P13/12;;A61P17/00;;A61P19/00;;A61P19/02;;A61P19/04;;A61P25/00;;A61P27/02;;A61P29/00;;A61P35/00;;A61P37/06;;A61P43/00;;A61P9/00;;A61P9/10;;A61P9/14;;A61P3/10;;C07D213/56;;C07D213/82;;C07D317/58;;C07D333/24;;C07D277/30;;C07D213/38;;C07D239/26;;C07D239/42;;C07D307/52;;A61K31/4196;;A61K31/4192;;C07D213/82;;C07D317/58;;C07D333/28;;C07D213/38;;C07D277/30;;C07C259/06;;C07D307/52;;C07D239/26;;C07D307/85;;C07D333/38;;C07C235/84;;C07C323/32;;C07C231/16;;C07D333/20;;C07D409/04;;C07D307/68;;C07C233/83;;C07C237/42;;C07D307/79;;C07D333/22;;C07B2200/07;;C07C237/22;;C07D239/42;;C07C2601/14;;C07C2602/08;;C07C2601/18;;C07C2603/18;;C07C2601/02;;C07C2603/74;;C07C2601/08,C07C237/22;;A61K31/166;;A61K31/36;;A61K31/381;;A61K31/426;;A61K31/4409;;C07C231/16;;C07C235/84;;C07C237/42;;C07C259/06;;C07C323/41;;C07D213/56;;C07D277/30;;C07D317/58;;C07D333/24,,0,0,,,,DISCONTINUED
375,SG,A,SG 11201803235S A,024-039-583-313-50X,2018-05-30,2018,SG 11201803235S A,2016-11-10,US 201562285933 P;;SG 2016050557 W,2015-11-12,METHOD OF MANUFACTURING A HYBRID SUBSTRATE,,UNIV NANYANG TECH;;MASSACHUSETTS INST TECHNOLOGY,LEE KWANG HONG;;TAN CHUAN SENG;;FITZGERALD EUGENE A;;BAO SHUYU;;LEE ENG KIAN;;KOHEN DAVID,,https://lens.org/024-039-583-313-50X,Unknown,no,0,0,6,6,0,H01L21/8258;;H01L21/3245;;H01L28/00;;H01L21/02002;;H01L21/76251;;H01L21/3245;;H01L21/02002;;H01L28/00;;H01L21/8258;;H01L21/02054;;H01L21/304;;H01L21/30604;;H01L21/76251;;H01L24/27;;H01L24/29;;H01L24/83;;H01L2224/27452;;H01L2224/29186;;H01L2224/83002;;H01L2224/83005;;H01L2224/83011;;H01L2224/83013;;H01L2224/83019;;H01L2224/8389;;H01L2924/10253;;H01L2924/10329,H01L27/02;;H01L21/304;;H01L21/324;;H01L27/12,,0,0,,,,PENDING
376,WO,A1,WO 2010/104931 A1,131-393-861-839-781,2010-09-16,2010,US 2010/0026793 W,2010-03-10,US 15926609 P;;US 72015510 A,2009-03-11,POWDER-FREE ANTI-BLOCKING COATED GLOVE,"Provided herein are powder-free elastomeric articles exhibiting therapeutic properties, and anti-blocking properties. Also provided herein are methods for the manufacture of such articles that are substantially free from interfering materials, as well as packaging means for maintaining therapeutic efficacy.",ANSELL HEALTHCARE PROD LLC;;ENG AIK HWEE;;LAI HEE MENG;;LIM KUANG LENG;;TING KOON MEOW;;LUCAS DAVID M;;NARASIMHAN DAVE,ENG AIK HWEE;;LAI HEE MENG;;LIM KUANG LENG;;TING KOON MEOW;;LUCAS DAVID M;;NARASIMHAN DAVE,,https://lens.org/131-393-861-839-781,Patent Application,yes,6,4,9,9,0,A61L31/10;;A61L31/16;;A61L2300/404;;A61L2300/452;;A61L2300/608;;A61B42/00;;A41D19/0082;;A61L2300/404;;A61L2300/608;;A61L31/10;;A61L2300/452;;A61L31/16;;A61B42/00,A61B19/04,,1,0,,,See also references of EP 2405848A4,PENDING
377,CN,A,CN 115627027 A,136-643-771-428-867,2023-01-20,2023,CN 202211292615 A,2016-07-29,US 201562199265 P;;CN 201680056552 A;;US 2016/0044721 W,2015-07-31,Encapsulated stabilizer composition,"The present invention provides a resin masterbatch composition as an end-closed pellet having a core and an outer layer encapsulating the core wherein the core comprises at least one additive and the outer layer comprises a polymer wherein the thickness of the outer layer is from 0.001 mm to 1 cm. A stabilized composition is prepared from an organic material to be stabilized and the resin masterbatch composition. A method for producing the resin masterbatch composition includes co-extruding a core material in tubular form encapsulated by an outer layer to form a filled tube wherein the core material comprises at least one additive and the outer layer comprises a polymer; feeding the filled tube into a sealing device that cuts the filled tube into a plurality of discontinuous segment seals and simultaneously seals each end of each discontinuous segment, thereby forming end-closed pellets; and cooling the end-closed pellets.",CYTEC IND INC,TYJHUS DIRK;;TEJHUIS ERIK;;KOZAKIEWICZ JOSEPH;;ENG JERRY MON HEI;;GUPTA RAM B;;VANZIN DAVID;;MAJIMDAR SAURABH,,https://lens.org/136-643-771-428-867,Patent Application,no,1,0,26,26,0,C08J3/226;;B29B9/12;;C08J2423/12;;C08J2423/14;;C08J2423/06;;C08J2425/12;;C08K5/3435;;C08K5/46;;C08K9/10;;C08J3/226;;C08K9/10;;C08L2310/00;;B29B9/12;;C08L33/26;;C08J3/126;;C08J2400/22;;B29B9/06;;B29B9/10;;B29B9/12;;C08J3/226;;C08K5/005;;C08K5/101;;C08K5/3432;;C08K9/10;;C08L23/00;;C08L25/04;;B01J13/02;;C08J3/22;;C08K9/10;;C08L101/00;;C09K15/00;;C08L2310/00;;B29B9/12;;B29B9/14;;C08J2400/22;;C08J3/226;;C08L33/26;;C08J3/126;;C08K9/10;;B29B9/06;;B29B2009/166;;C08K5/13;;C08K5/3435;;C08K5/46;;C08L23/06;;C08L23/12;;C08L23/14;;C08L25/06;;C08L25/12,C08L23/12;;B29B9/12;;C08J3/22;;C08K5/3435;;C08K5/46;;C08K9/10;;C08L23/06;;C08L23/14;;C08L25/12,,0,0,,,,PENDING
378,CA,A1,CA 3198184 A1,030-927-987-890-023,2022-05-27,2022,CA 3198184 A,2021-11-17,US 202063114795 P;;US 2021/0059608 W,2020-11-17,SYSTEMS AND METHODS FOR LEGAL RESEARCH NAVIGATION,Computer systems and corresponding methods are provided for computer assisted research in a network are provided that generate interface screens that include a map view of a plurality of selectable objects disposed in a nuclear arrangement in segmented rings about a first level object. The computing device is configured to receive selections of the displayed objects and expand the display to include additional segmented levels all surrounding the first level object.,THOMSON REUTERS GLOBAL ENTPR CENTRE GMBH,KITAEV ERICA GANN;;PATERSON DAVID THOMAS;;CLARK MICHAEL ENG POH;;SRAMEK MEGAN ANNE;;ALES DEACON;;COLBERT EMILY,,https://lens.org/030-927-987-890-023,Patent Application,no,0,0,7,7,0,G06F16/338;;G06F3/0482;;G06F16/248;;G06F3/0484,G06F16/00,,0,0,,,,PENDING
379,PT,A,PT 104882 A,041-268-530-930-438,2011-06-14,2011,PT 10488209 A,2009-12-11,PT 10488209 A,2009-12-11,UM ELÉCTRODO SECO E ACTIVO PARA BIO-SINAIS USANDO COMO MATERIAL DE INTERFACE UM HÍBRIDO ORGÂNICO-INORGÂNICO,"A INVENÇÃO AQUI APRESENTADA É UM BIO-ELÉCTRODO QUE É CARACTERIZADO PELO USO DE UM MATERIAL HÍBRIDO ORGÂNICO-INORGÂNICO OBTIDO PELO MÉTODO SOL-GEL USADO COMO INTERFACE ELÉCTRODO-PELE. ALÉM DISSO, A INCORPORAÇÃO DE UM PRÉ-AMPLIFICADOR DE SINAL E CIRCUITO DE PROCESSAMENTO DE SINAL NUMA PCB FLEXÍVEL DEIXA ESTE ELÉCTRODO MENOS SENSÍVEL A VARIAÇÕES REFERENTES A IMPEDÂNCIA NA INTERFACE ELÉCTRODO-PELE REDUZINDO, ASSIM, ARTEFACTOS INTRODUZIDOS POR MOVIMENTO E RUÍDO. O MATERIAL DE INTERFACE HÍBRIDO ORGÂNICO-INORGÂNICO NUNCA FOI USADO ANTERIORMENTE PARA ESTE TIPO DE APLICAÇÃO E ATRAVÉS DA INCORPORAÇÃO DE TODAS AS PARTES AQUI DESCRITAS RESULTA, ASSIM, NA INVENÇÃO DE UM NOVO ELÉCTRODO SECO, ACTIVO E FLEXÍVEL. EM SUMÁRIO, ESTA INVENÇÃO CONSISTE NUM NOVO ELÉCTRODO SECO E ACTIVO FLEXÍVEL QUE, EM COMBINAÇÃO COM A ELECTRÓNICA DESCRITA, USA UM HÍBRIDO ORGÂNICO-INORGÂNICO COMO UM MATERIAL DE INTERFACE ELÉCTRODO-PELE.",UNIV AVEIRO;;IEETA INST DE ENGENHARIA ELECTRONICA E TELEMATICA DE AVEIRO,CUNHA JOAO PAULO TRIGUEIROS DA SILVA;;CARLOS LUIS ANTONIO FERREIRA MARTINS DAIS;;ENG DAVID MANUEL DIETEREN RIBEIRO,"UNIVERSIDADE DE AVEIRO, PT (2012-10-04)",https://lens.org/041-268-530-930-438,Patent Application,no,0,2,2,2,0,A61B5/411;;A61B5/6804;;A61B5/6843;;A61B2562/125;;A61B2562/164;;A61B2562/0215;;A61B5/25;;A61B5/291;;A61B5/296;;A61B5/265;;A61B5/263;;A61B5/251,A61B5/296,,0,0,,,,PENDING
380,PT,T,PT 3328929 T,080-788-452-856-327,2019-07-16,2019,PT 16751423 T,2016-07-29,US 201562199265 P,2015-07-31,ENCAPSULATED STABILIZER COMPOSITIONS,,CYTEC IND INC,DINAND TIJHUIS;;ERWIN TIJHUIS;;JOSEPH KOZAKIEWICZ;;JERRY MON HEI ENG;;RAM B GUPTA;;DAVID VANZIN;;SHAILESH MAJMUDAR,,https://lens.org/080-788-452-856-327,Patent Application,no,0,0,26,26,0,C08J3/226;;B29B9/12;;C08J2423/12;;C08J2423/14;;C08J2423/06;;C08J2425/12;;C08K5/3435;;C08K5/46;;C08K9/10;;C08J3/226;;C08K9/10;;C08L2310/00;;B29B9/12;;C08L33/26;;C08J3/126;;C08J2400/22;;B29B9/06;;B29B9/10;;B29B9/12;;C08J3/226;;C08K5/005;;C08K5/101;;C08K5/3432;;C08K9/10;;C08L23/00;;C08L25/04;;B01J13/02;;C08J3/22;;C08K9/10;;C08L101/00;;C09K15/00;;C08L2310/00;;B29B9/12;;B29B9/14;;C08J2400/22;;C08J3/226;;C08L33/26;;C08J3/126;;C08K9/10;;B29B9/06;;B29B2009/166;;C08K5/13;;C08K5/3435;;C08K5/46;;C08L23/06;;C08L23/12;;C08L23/14;;C08L25/06;;C08L25/12,C08K5/13;;C08K5/3435,,0,0,,,,PENDING
381,SG,A1,SG 96543 A1,083-783-339-595-379,2003-06-16,2003,SG 200000008 A,2000-01-06,SG 200000008 A,2000-01-06,A METHOD AND APPARATUS FOR CAPTURING AND RECORDING AUDIO AND VIDEO DATA ON OPTICAL STORAGE MEDIA,,SERIAL SYSTEM LTD,WANG ZHIHONG;;TAN KAY HING;;LIM KIM SENG;;LOW GIM ENG;;TUNG YAN SING DAVID;;WU HONGGANG,,https://lens.org/083-783-339-595-379,Patent Application,no,3,0,3,3,0,H04N5/85;;H04N9/8042;;H04N9/8063;;H04N9/8042;;H04N5/85;;H04N9/8063,H04N5/85;;H04N9/804;;H04N9/806,,0,0,,,,PENDING
382,TW,A,TW 201216931 A,108-830-886-965-839,2012-05-01,2012,TW 100133499 A,2011-09-16,US 88434110 A,2010-09-17,Antimicrobial disposable absorbent articles,"Disposable absorbent articles comprising an absorbent material and an antimicrobial composition are disclosed. The antimicrobial composition includes a carrier comprising fatty alcohol and a poly(alkyleneoxy) polymer, and an antimicrobial agent. The antimicrobial composition may be coated on to component substrates such as nonwovens and films, that are incorporated into disposable absorbent articles, such as disposable infant diapers, adult incontinence articles, feminine hygiene articles such as sanitary napkins, wound dressings, bandages, panty liners and tampons, personal care wipes and household wipes to provide odor control, and control of microbial growth.",3M INNOVATIVE PROPERTIES CO,AMOS DAVID THOMAS;;STATHAM ALEXIS SARAH;;CHONG CONKLIN BATHSHEBA ENG-FUI;;SVAROVSKY MICHAEL JAMES;;WOOD LEIGH EARL,,https://lens.org/108-830-886-965-839,Patent of Addition,no,0,0,16,19,0,A61L15/26;;A61L15/46;;A61L15/46;;A61F13/15;;A61L15/46;;A61L2300/214;;A61L2300/214;;A61L2300/22;;A61L2300/22;;A61L2300/404;;A61L2300/404;;A61L2300/802;;A61L2300/802;;A61P31/00,A61F13/15,,0,0,,,,PENDING
383,CN,A,CN 108137863 A,116-572-997-508-05X,2018-06-08,2018,CN 201680056552 A,2016-07-29,US 201562199265 P;;US 2016/0044721 W,2015-07-31,ENCAPSULATED STABILIZER COMPOSITIONS,"Resin masterbatch compositions are provided as closed end pellets having a core including at least one additive and an outer layer comprising a polymer encapsulating the core, in which the thickness of the outer layer if from 0.001 mm to 1 cm. A stabilized composition is prepared from an organic material to be stabilized and the resin masterbatch composition. A process for producing the resin masterbatch composition includes co-extruding in tubular form a core material encapsulated by an outer layer, wherein the core material comprises at least one additive, and the outer layer comprises a polymer, to form a filled tube; passing the filled tube into a sealing device that cuts the filled tube into multiple discrete segments seals and simultaneously seals each end of each discrete segment, thereby forming closed end pellets; and cooling the closed end pellets.",CYTEC IND INC,TIJHUIS DINAND;;TIJHUIS ERWIN;;KOZAKIEWIZ JOSEPH;;ENG JERRY MON HEI;;GUPTA RAM B;;VANZIN DAVID;;MAJMUDAR SHAILESH,,https://lens.org/116-572-997-508-05X,Patent Application,no,4,1,26,26,0,C08J3/226;;B29B9/12;;C08J2423/12;;C08J2423/14;;C08J2423/06;;C08J2425/12;;C08K5/3435;;C08K5/46;;C08K9/10;;C08J3/226;;C08K9/10;;C08L2310/00;;B29B9/12;;C08L33/26;;C08J3/126;;C08J2400/22;;B29B9/06;;B29B9/10;;B29B9/12;;C08J3/226;;C08K5/005;;C08K5/101;;C08K5/3432;;C08K9/10;;C08L23/00;;C08L25/04;;B01J13/02;;C08J3/22;;C08K9/10;;C08L101/00;;C09K15/00;;C08L2310/00;;B29B9/12;;B29B9/14;;C08J2400/22;;C08J3/226;;C08L33/26;;C08J3/126;;C08K9/10;;B29B9/06;;B29B2009/166;;C08K5/13;;C08K5/3435;;C08K5/46;;C08L23/06;;C08L23/12;;C08L23/14;;C08L25/06;;C08L25/12,C08K9/10;;B29B9/00;;C08J3/22,,0,0,,,,DISCONTINUED
384,WO,A1,WO 2022/108960 A1,196-045-100-915-820,2022-05-27,2022,US 2021/0059608 W,2021-11-17,US 202063114795 P,2020-11-17,SYSTEMS AND METHODS FOR LEGAL RESEARCH NAVIGATION,Computer systems and corresponding methods are provided for computer assisted research in a network are provided that generate interface screens that include a map view of a plurality of selectable objects disposed in a nuclear arrangement in segmented rings about a first level object. The computing device is configured to receive selections of the displayed objects and expand the display to include additional segmented levels all surrounding the first level object.,THOMSON REUTERS ENTPR CENTRE GMBH;;KITAEV ERICA GANN,KITAEV ERICA GANN;;PATERSON DAVID THOMAS;;CLARK MICHAEL ENG POH;;SRAMEK MEGAN ANNE;;ALES DEACON;;COLBERT EMILY,,https://lens.org/196-045-100-915-820,Patent Application,yes,3,0,7,7,0,G06F16/338;;G06F3/0482;;G06F16/248;;G06F3/0484,G06F16/00,,0,0,,,,PENDING
385,JP,A,JP 2020062892 A,015-430-514-894-705,2020-04-23,2020,JP 2020004988 A,2020-01-16,US 201562199265 P,2015-07-31,ENCAPSULATED STABILIZER COMPOSITIONS,"To provide masterbatch compositions that reduce storage agglomeration and shipping agglomeration caused by stickiness due to migration of an additive having a paste state or a wax property, or having a low melting point.SOLUTION: Resin masterbatch compositions are provided as closed end pellets having an outer layer thickness of from 0.001 mm to 1 cm, the resin masterbatch compositions are obtained: by loading the outer layer provided as a polymer into an outer extrusion head via a connection 4; by loading a core material provided as a stabilizer into an inner extrusion head pump via a connection 3; by forming a filling tube that is simultaneously filled with the core material in a die opening 6; and by leading both materials to a closing device 8 for sealing and cutting to simultaneously cut and seal each end (closed end) of the tubes.SELECTED DRAWING: Figure 6",CYTEC IND INC,DINAND TIJHUIS;;ERWIN TIJHUIS;;JOSEPH KOZAKIEWIZ;;JERRY MON HEI ENG;;RAM B GUPTA;;DAVID VANZIN;;SHAILESH MAJMUDAR,,https://lens.org/015-430-514-894-705,Patent Application,no,3,0,26,26,0,C08J3/226;;B29B9/12;;C08J2423/12;;C08J2423/14;;C08J2423/06;;C08J2425/12;;C08K5/3435;;C08K5/46;;C08K9/10;;C08J3/226;;C08K9/10;;C08L2310/00;;B29B9/12;;C08L33/26;;C08J3/126;;C08J2400/22;;B29B9/06;;B29B9/10;;B29B9/12;;C08J3/226;;C08K5/005;;C08K5/101;;C08K5/3432;;C08K9/10;;C08L23/00;;C08L25/04;;B01J13/02;;C08J3/22;;C08K9/10;;C08L101/00;;C09K15/00;;C08L2310/00;;B29B9/12;;B29B9/14;;C08J2400/22;;C08J3/226;;C08L33/26;;C08J3/126;;C08K9/10;;B29B9/06;;B29B2009/166;;C08K5/13;;C08K5/3435;;C08K5/46;;C08L23/06;;C08L23/12;;C08L23/14;;C08L25/06;;C08L25/12,B29B9/06;;B29B7/88;;B29C48/05;;B29C48/154;;C08J3/22,,0,0,,,,ACTIVE
386,CN,B,CN 102438541 B,054-051-093-606-967,2014-12-03,2014,CN 201080019052 A,2010-03-10,US 2010/0026793 W;;US 15926609 P;;US 72015510 A,2009-03-11,Powder-free anti-blocking coated glove,,ANSELL HEALTHCARE PROD LLC,ENG AIK HWEE;;LAI HEE MENG;;LIM KUANG LENG;;TING KOON MEOW;;LUCAS DAVID M;;NARASIMHAN DAVE,,https://lens.org/054-051-093-606-967,Granted Patent,no,0,0,9,9,0,A61L31/10;;A61L31/16;;A61L2300/404;;A61L2300/452;;A61L2300/608;;A61B42/00;;A41D19/0082;;A61L2300/404;;A61L2300/608;;A61L31/10;;A61L2300/452;;A61L31/16;;A61B42/00,A61B19/04,,0,0,,,,INACTIVE
387,BR,B1,BR 112018001961 B1,070-499-280-067-394,2022-04-26,2022,BR 112018001961 A,2016-07-29,US 2016/0044721 W;;US 201562199265 P,2015-07-31,"Composição, uso de uma composição, e, processos para produção de uma composição e de um artigo","composições de masterbatch de resina são proporcionadas como péletes com extremidades fechadas tendo um núcleo incluindo pelo menos um aditivo e uma camada exterior compreendendo um polímero encapsulando o núcleo, nas quais a espessura da camada exterior é de 0,001 mm a 1 cm. uma composição estabilizada é preparada a partir de um material orgânico a ser estabilizado e da composição de masterbatch de resina. um processo para produção da composição de masterbatch de resina inclui coextrusão em forma tubular de um material nuclear encapsulado por uma camada exterior, em que o material nuclear compreende pelo menos um aditivo, e a camada exterior compreende um polímero, para formar um tubo cheio; passagem do tubo cheio em um dispositivo de selagem que corta o tubo cheio em múltiplos segmentos discretos sela e simultaneamente sela cada extremidade de cada segmento discreto, formando deste modo péletes com extremidades fechadas; e resfriamento dos péletes com extremidades fechadas.",CYTEC IND INC,VANZIN DAVID;;TIJHUIS DINAND;;TIJHUIS ERWIN;;JERRY MON HEI ENG;;KOZAKIEWICZ JOSEPH;;RAM B GUPTA;;MAJMUDAR SHAILESH,,https://lens.org/070-499-280-067-394,Granted Patent,no,0,0,26,26,0,C08J3/226;;B29B9/12;;C08J2423/12;;C08J2423/14;;C08J2423/06;;C08J2425/12;;C08K5/3435;;C08K5/46;;C08K9/10;;C08J3/226;;C08K9/10;;C08L2310/00;;B29B9/12;;C08L33/26;;C08J3/126;;C08J2400/22;;B29B9/06;;B29B9/10;;B29B9/12;;C08J3/226;;C08K5/005;;C08K5/101;;C08K5/3432;;C08K9/10;;C08L23/00;;C08L25/04;;B01J13/02;;C08J3/22;;C08K9/10;;C08L101/00;;C09K15/00;;C08L2310/00;;B29B9/12;;B29B9/14;;C08J2400/22;;C08J3/226;;C08L33/26;;C08J3/126;;C08K9/10;;B29B9/06;;B29B2009/166;;C08K5/13;;C08K5/3435;;C08K5/46;;C08L23/06;;C08L23/12;;C08L23/14;;C08L25/06;;C08L25/12,B29B9/00;;C08J3/22;;C08K9/10,,0,0,,,,ACTIVE
388,SA,B1,SA 518390842 B1,156-191-875-273-637,2021-06-28,2021,SA 518390842 A,2018-01-30,US 201562199265 P;;US 2016/0044721 W,2015-07-31,ENCAPSULATED STABILIZER COMPOSITIONS,"Resin masterbatch compositions are provided as closed end pellets having a core including at least one additive and an outer layer comprising a polymer encapsulating the core, in which the thickness of the outer layer if from 0.001 mm to 1 cm. A stabilized composition is prepared from an organic material to be stabilized and the resin masterbatch composition. A process for producing the resin masterbatch composition includes co-extruding in tubular form a core material encapsulated by an outer layer, wherein the core material comprises at least one additive, and the outer layer comprises a polymer, to form a filled tube; passing the filled tube into a sealing device that cuts the filled tube into multiple discrete segments seals and simultaneously seals each end of each discrete segment, thereby forming closed end pellets; and cooling the closed end pellets.",CYTEC IND INC,ENG JERRY MON HEI;;TIJHUIS ERWIN;;TIJHUIS DINAND;;GUPTA RAM B;;VANZIN DAVID;;KOZAKIEWICZ JOSEPH;;MAJMUDAR SHAILESH,,https://lens.org/156-191-875-273-637,Granted Patent,no,0,0,26,26,0,C08J3/226;;B29B9/12;;C08J2423/12;;C08J2423/14;;C08J2423/06;;C08J2425/12;;C08K5/3435;;C08K5/46;;C08K9/10;;C08J3/226;;C08K9/10;;C08L2310/00;;B29B9/12;;C08L33/26;;C08J3/126;;C08J2400/22;;B29B9/06;;B29B9/10;;B29B9/12;;C08J3/226;;C08K5/005;;C08K5/101;;C08K5/3432;;C08K9/10;;C08L23/00;;C08L25/04;;B01J13/02;;C08J3/22;;C08K9/10;;C08L101/00;;C09K15/00;;C08L2310/00;;B29B9/12;;B29B9/14;;C08J2400/22;;C08J3/226;;C08L33/26;;C08J3/126;;C08K9/10;;B29B9/06;;B29B2009/166;;C08K5/13;;C08K5/3435;;C08K5/46;;C08L23/06;;C08L23/12;;C08L23/14;;C08L25/06;;C08L25/12,,,0,0,,,,ACTIVE
389,RU,C1,RU 2679252 C1,000-443-000-497-962,2019-02-06,2019,RU 2018106903 A,2016-07-29,US 201562199265 P;;US 2016/0044721 W,2015-07-31,INCAPSULATED COMPOSITIONS BASED ON STABILIZER,"FIELD: chemical industry.SUBSTANCE: invention relates to a masterbatch-based composition containing a resin for producing an encapsulated at least one stabilizer for protecting organic polymers (plastics), to the use of compositions on the basis of masterbatches, to a method for producing them, to stabilized compositions containing compositions on the basis of a masterbatch, as well as to a method for producing products. Masterbatch composition is an encapsulated stabilizer masterbatch composition. Composition is presented in the form of closed-end pellets, having a core containing at least one additive, and an outer layer containing a polymer encapsulating the core. Thickness of the outer layer is from 0.001 mm to 1 cm. Stabilized composition is obtained from an organic material to be stabilized and a masterbatch composition containing a resin. Method of obtaining the composition on the basis of masterbatches containing resin, involves co-extruding into a tubular form to form a filled tube of core material encapsulated with an outer layer. Core material contains at least one additive, the outer layer contains a polymer. Method involves passing the filled tube through the soldering device. Using a soldering device, cut the filled tube into several discrete segments to be soldered, simultaneously solder each end of each discrete segment with the formation of the resulting pellets with closed ends. Carry out the cooling of the pellets with closed ends.EFFECT: invention provides improved characteristics of concentrates containing stabilizers encapsulated in a synthetic thermoplastic polymer matrix, facilitates processing, storage, transportation and final processing.15 cl, 6 dwg, 10 ex, 6 tbl",CYTEC IND INC,TIJHUIS DINAND;;TIJHUIS ERWIN;;KOZAKIEWICZ JOSEPH;;ENG JERRY MON HEI;;GUPTA RAM B;;VANZIN DAVID;;MAJMUDAR SHAILESH,,https://lens.org/000-443-000-497-962,Granted Patent,no,8,0,26,26,0,C08J3/226;;B29B9/12;;C08J2423/12;;C08J2423/14;;C08J2423/06;;C08J2425/12;;C08K5/3435;;C08K5/46;;C08K9/10;;C08J3/226;;C08K9/10;;C08L2310/00;;B29B9/12;;C08L33/26;;C08J3/126;;C08J2400/22;;B29B9/06;;B29B9/10;;B29B9/12;;C08J3/226;;C08K5/005;;C08K5/101;;C08K5/3432;;C08K9/10;;C08L23/00;;C08L25/04;;B01J13/02;;C08J3/22;;C08K9/10;;C08L101/00;;C09K15/00;;C08L2310/00;;B29B9/12;;B29B9/14;;C08J2400/22;;C08J3/226;;C08L33/26;;C08J3/126;;C08K9/10;;B29B9/06;;B29B2009/166;;C08K5/13;;C08K5/3435;;C08K5/46;;C08L23/06;;C08L23/12;;C08L23/14;;C08L25/06;;C08L25/12,C08K9/10;;B01J13/02;;C08J3/22;;C08L101/00;;C09K15/00,,0,0,,,,ACTIVE
390,CA,C,CA 2993973 C,020-943-112-670-834,2021-06-22,2021,CA 2993973 A,2016-07-29,US 201562199265 P;;US 2016/0044721 W,2015-07-31,ENCAPSULATED STABILIZER COMPOSITIONS,"Resin masterbatch compositions are provided as closed end pellets having a core including at least one additive and an outer layer comprising a polymer encapsulating the core, in which the thickness of the outer layer if from 0.001 mm to 1 cm. A stabilized composition is prepared from an organic material to be stabilized and the resin masterbatch composition. A process for producing the resin masterbatch composition includes co-extruding in tubular form a core material encapsulated by an outer layer, wherein the core material comprises at least one additive, and the outer layer comprises a polymer, to form a filled tube; passing the filled tube into a sealing device that cuts the filled tube into multiple discrete segments seals and simultaneously seals each end of each discrete segment, thereby forming closed end pellets; and cooling the closed end pellets.",CYTEC IND INC,TIJHUIS DINAND;;TIJHUIS ERWIN;;KOZAKIEWICZ JOSEPH;;ENG JERRY MON HEI;;GUPTA RAM B;;VANZIN DAVID;;MAJMUDAR SHAILESH,,https://lens.org/020-943-112-670-834,Granted Patent,no,0,0,26,26,0,C08J3/226;;B29B9/12;;C08J2423/12;;C08J2423/14;;C08J2423/06;;C08J2425/12;;C08K5/3435;;C08K5/46;;C08K9/10;;C08J3/226;;C08K9/10;;C08L2310/00;;B29B9/12;;C08L33/26;;C08J3/126;;C08J2400/22;;B29B9/06;;B29B9/10;;B29B9/12;;C08J3/226;;C08K5/005;;C08K5/101;;C08K5/3432;;C08K9/10;;C08L23/00;;C08L25/04;;B01J13/02;;C08J3/22;;C08K9/10;;C08L101/00;;C09K15/00;;C08L2310/00;;B29B9/12;;B29B9/14;;C08J2400/22;;C08J3/226;;C08L33/26;;C08J3/126;;C08K9/10;;B29B9/06;;B29B2009/166;;C08K5/13;;C08K5/3435;;C08K5/46;;C08L23/06;;C08L23/12;;C08L23/14;;C08L25/06;;C08L25/12,C08K9/10;;B29B9/00;;C08J3/22,,0,0,,,,ACTIVE
391,AU,A1,AU 2010/224231 A1,085-554-248-979-266,2011-10-27,2011,AU 2010/224231 A,2010-03-10,US 15926609 P;;US 72015510 A;;US 2010/0026793 W,2009-03-11,Powder-free anti-blocking coated glove,"Provided herein are powder-free elastomeric articles exhibiting therapeutic properties, and anti-blocking properties. Also provided herein are methods for the manufacture of such articles that are substantially free from interfering materials, as well as packaging means for maintaining therapeutic efficacy.",ANSELL LTD,HWEE ENG AIK;;MENG LAI HEE;;LENG LIM KUANG;;MEOW TING KOON;;LUCAS DAVID M;;DAVE NARASIMHAN,,https://lens.org/085-554-248-979-266,Patent Application,no,0,0,9,9,0,A61L31/10;;A61L31/16;;A61L2300/404;;A61L2300/452;;A61L2300/608;;A61B42/00;;A41D19/0082;;A61L2300/404;;A61L2300/608;;A61L31/10;;A61L2300/452;;A61L31/16;;A61B42/00,A61B19/04,,0,0,,,,INACTIVE
392,CN,A,CN 115295660 A,117-667-855-616-918,2022-11-04,2022,CN 202210357449 A,2022-04-02,US 202117307323 A,2021-05-04,Trenchless single photon avalanche diode,"The invention relates to a trench-free single photon avalanche diode, and relates to a structure of a single photon avalanche diode and a method of forming the structure of a single photon avalanche diode. The structure includes a semiconductor substrate having a top surface, a semiconductor layer on the top surface of the semiconductor substrate, a light absorbing layer on a portion of the semiconductor layer, and a doped region in a portion of the semiconductor layer. The doped region is disposed in a portion of the semiconductor layer adjacent to the light absorbing layer.",GLOBALFOUNDRIES SG PTE LTD,ZHENG PING;;TOH ENG HUAT;;QUEK ELGIN KIOK BOONE;;CHONG KIAN SAU DAVID;;TANG JOHN H M,,https://lens.org/117-667-855-616-918,Patent Application,no,0,0,5,5,0,H01L31/107;;H01L31/1075;;H01L31/1804;;H01L27/14645;;H01L27/14627;;H01L27/14689;;H01L27/1461;;H01L27/1463;;H01L31/1075;;H01L31/028;;H01L27/1461;;H01L27/14645;;H01L31/107;;H01L27/1463;;H01L27/14689;;H01L27/14627,H01L31/107;;H01L31/18,,0,0,,,,PENDING
393,ES,T3,ES 2735148 T3,193-149-465-910-018,2019-12-16,2019,ES 16751423 T,2016-07-29,US 201562199265 P;;US 2016/0044721 W,2015-07-31,Composiciones estabilizantes encapsuladas,"Una composición de lote maestro de la resina proporcionada como pellets con extremos cerrados que comprenden: un núcleo que comprende al menos un establizante, donde dicho, estabilizante comprende al menos uno de un estabilizante de la luz con aminas impedidas (HALS), un fosfonito o fosfito orgánico, un fenol impedido, un compuesto de cromano, un absorbente de la luz ultravioleta (UV), un benzoato impedido, una hidroxilamina, un óxido de amina terciaria y un inhibidor de la polimerización por radicales libres, y una capa externa que comprende un polímero termoplástico, teniendo dicha capa externa un espesor de 0.001 mm a 1 cm, donde el núcleo está encapsulado por la capa externa y los pellets están sellados en cada extremo.",CYTEC IND INC,TIJHUIS DINAND;;TIJHUIS ERWIN;;KOZAKIEWICZ JOSEPH;;ENG JERRY MON HEI;;GUPTA RAM B;;VANZIN DAVID;;MAJMUDAR SHAILESH,,https://lens.org/193-149-465-910-018,Granted Patent,no,0,0,26,26,0,C08J3/226;;B29B9/12;;C08J2423/12;;C08J2423/14;;C08J2423/06;;C08J2425/12;;C08K5/3435;;C08K5/46;;C08K9/10;;C08J3/226;;C08K9/10;;C08L2310/00;;B29B9/12;;C08L33/26;;C08J3/126;;C08J2400/22;;B29B9/06;;B29B9/10;;B29B9/12;;C08J3/226;;C08K5/005;;C08K5/101;;C08K5/3432;;C08K9/10;;C08L23/00;;C08L25/04;;B01J13/02;;C08J3/22;;C08K9/10;;C08L101/00;;C09K15/00;;C08L2310/00;;B29B9/12;;B29B9/14;;C08J2400/22;;C08J3/226;;C08L33/26;;C08J3/126;;C08K9/10;;B29B9/06;;B29B2009/166;;C08K5/13;;C08K5/3435;;C08K5/46;;C08L23/06;;C08L23/12;;C08L23/14;;C08L25/06;;C08L25/12,C08K5/13;;C08K5/3435,,0,0,,,,ACTIVE
394,EP,A4,EP 2405848 A4,022-638-803-841-462,2014-04-09,2014,EP 10751340 A,2010-03-10,US 2010/0026793 W;;US 15926609 P;;US 72015510 A,2009-03-11,POWDER-FREE ANTI-BLOCKING COATED GLOVE,,ANSELL LTD,ENG AIK HWEE;;LAI HEE MENG;;LIM KUANG LENG;;TING KOON MEOW;;LUCAS DAVID M;;NARASIMHAN DAVE,,https://lens.org/022-638-803-841-462,Search Report,no,2,0,9,9,0,A61L31/10;;A61L31/16;;A61L2300/404;;A61L2300/452;;A61L2300/608;;A61B42/00;;A41D19/0082;;A61L2300/404;;A61L2300/608;;A61L31/10;;A61L2300/452;;A61L31/16;;A61B42/00,A61B19/04;;A61L31/10;;A61L31/16,,1,0,,,See also references of WO 2010104931A1,ACTIVE
395,EP,A1,EP 2405848 A1,058-355-182-039-907,2012-01-18,2012,EP 10751340 A,2010-03-10,US 2010/0026793 W;;US 15926609 P;;US 72015510 A,2009-03-11,POWDER-FREE ANTI-BLOCKING COATED GLOVE,,ANSELL LTD,ENG AIK HWEE;;LAI HEE MENG;;LIM KUANG LENG;;TING KOON MEOW;;LUCAS DAVID M;;NARASIMHAN DAVE,,https://lens.org/058-355-182-039-907,Patent Application,yes,0,0,9,9,0,A61L31/10;;A61L31/16;;A61L2300/404;;A61L2300/452;;A61L2300/608;;A61B42/00;;A41D19/0082;;A61L2300/404;;A61L2300/608;;A61L31/10;;A61L2300/452;;A61L31/16;;A61B42/00,A61L31/10;;A61L31/16,,0,0,,,,ACTIVE
396,EP,A4,EP 3375011 A4,092-574-673-338-859,2019-06-12,2019,EP 16864677 A,2016-11-10,US 201562285933 P;;SG 2016050557 W,2015-11-12,METHOD OF MANUFACTURING A HYBRID SUBSTRATE,,UNIV NANYANG TECH;;MASSACHUSETTS INST TECHNOLOGY,LEE KWANG HONG;;TAN CHUAN SENG;;FITZGERALD EUGENE A;;BAO SHUYU;;LEE ENG KIAN KENNETH;;KOHEN DAVID,,https://lens.org/092-574-673-338-859,Search Report,no,2,0,6,6,0,H01L21/8258;;H01L21/3245;;H01L28/00;;H01L21/02002;;H01L21/76251;;H01L21/3245;;H01L21/02002;;H01L28/00;;H01L21/8258;;H01L21/02054;;H01L21/304;;H01L21/30604;;H01L21/76251;;H01L24/27;;H01L24/29;;H01L24/83;;H01L2224/27452;;H01L2224/29186;;H01L2224/83002;;H01L2224/83005;;H01L2224/83011;;H01L2224/83013;;H01L2224/83019;;H01L2224/8389;;H01L2924/10253;;H01L2924/10329,H01L21/762;;H01L21/02;;H01L21/304;;H01L21/324;;H01L27/02;;H01L27/12,,2,1,008-013-928-107-539,10.1109/icsict.2014.7021178,"CHANG YONGWEI ET AL: ""GaAs-on-insulator fabricated via ion-cut in epitaxial GaAs /Ge substrate"", 2014 12TH IEEE INTERNATIONAL CONFERENCE ON SOLID-STATE AND INTEGRATED CIRCUIT TECHNOLOGY (ICSICT), IEEE, 28 October 2014 (2014-10-28), pages 1 - 3, XP032727591, ISBN: 978-1-4799-3296-2, [retrieved on 20150123], DOI: 10.1109/ICSICT.2014.7021178;;See also references of WO 2017082825A1",DISCONTINUED
397,US,A1,US 2014/0325478 A1,122-166-186-341-990,2014-10-30,2014,US 201414327884 A,2014-07-10,US 201414327884 A;;US 18232808 A,2008-07-30,VISUALIZATION OF COMPLEX SYSTEMS USING BUILDINGS,"Provided herein are approaches for generating a visualization of software code using a set of buildings. Specifically, one approach comprises: representing software code using a set of buildings in a virtual city environment, wherein each building of the set of buildings represent a software solution; displaying the set of buildings in the virtual city environment; and displaying a plurality of floors and a plurality of rooms within each of the plurality of floors of the set of buildings, wherein each of the plurality of floors of a building of the set of buildings represents a software component of the software solution represented by the building, and wherein each of the plurality of rooms within each floor of the building represents a different version of the software component represented by the floor of the building.",IBM,DILLENBERGER DONNA N ENG;;JOHNSON SANDRA K;;MISHRA SHARAD;;MITCHELL JOAN L;;STOOR BENJAMIN J;;WARD DAVID,INTERNATIONAL BUSINESS MACHINES CORPORATION (2014-07-03),https://lens.org/122-166-186-341-990,Patent Application,yes,7,0,3,3,0,G06Q10/00;;G06Q10/00;;G06F8/70,G06F9/44,717/120,4,3,120-336-389-075-73X;;042-546-774-027-572;;077-969-276-717-487,10.1145/602464.602467;;10.1145/365181.365236;;10.1109/vissof.2007.4290709,"Lanza, ""The Evolution Matrix: Recovering Software Evolution using Software Visualization Techniques"", 2001, Proceedings of the 4th International Workshop on Principles of Software Evolution.;;Lieberman et al. “Will Software Ever Work?”, March 2001, Communications of the ACM, Volume 44 Issue 3.;;D’Ambros et al. “A Bug’s Life Visualizing a Bug Database"", June 2007, 4th IEEE International Workshop on Visualizing Software for Understanding and Analysis.;;Phil Factor, “Why do we call them ‘Bugs’?”, June 2007, retrieved from: https://www.simple-talk.com/blogs/2007/06/01/why-do-we-call-them-bugs/.",DISCONTINUED
398,AU,A1,AU 2021/381766 A1,132-631-305-413-437,2023-06-08,2023,AU 2021/381766 A,2021-11-17,US 202063114795 P;;US 2021/0059608 W,2020-11-17,SYSTEMS AND METHODS FOR LEGAL RESEARCH NAVIGATION,Computer systems and corresponding methods are provided for computer assisted research in a network are provided that generate interface screens that include a map view of a plurality of selectable objects disposed in a nuclear arrangement in segmented rings about a first level object. The computing device is configured to receive selections of the displayed objects and expand the display to include additional segmented levels all surrounding the first level object.,THOMSON REUTERS ENTPR CENTRE GMBH,KITAEV ERICA GANN;;PATERSON DAVID THOMAS;;CLARK MICHAEL ENG POH;;SRAMEK MEGAN ANNE;;ALES DEACON;;COLBERT EMILY,,https://lens.org/132-631-305-413-437,Patent Application,no,0,0,7,7,0,G06F16/338;;G06F3/0482;;G06F16/248;;G06F3/0484,G06F16/00,,0,0,,,,PENDING
399,US,A1,US 2023/0359327 A1,085-981-184-788-634,2023-11-09,2023,US 202318216884 A,2023-06-30,US 202318216884 A;;US 202117528303 A;;US 202063114795 P,2020-11-17,SYSTEMS AND METHODS FOR LEGAL RESEARCH NAVIGATION,Computer systems and corresponding methods are provided for computer assisted research in a network are provided that generate interface screens that include a map view of a plurality of selectable objects disposed in a nuclear arrangement in segmented rings about a first level object. The computing device is configured to receive selections of the displayed objects and expand the display to include additional segmented levels all surrounding the first level object.,THOMSON REUTERS ENTPR CENTRE GMBH,PATERSON DAVID THOMAS;;KITAEV ERICA GANN;;CLARK MICHAEL ENG POH;;SRAMEK MEGAN ANNE;;ALES DEACON;;COLBERT EMILY,,https://lens.org/085-981-184-788-634,Patent Application,yes,0,0,7,7,0,G06F16/338;;G06F3/0482;;G06F16/248;;G06F3/0484,G06F3/0482;;G06F3/0484;;G06F16/248,,0,0,,,,PENDING
400,WO,A1,WO 2017/023755 A1,111-755-027-736-924,2017-02-09,2017,US 2016/0044721 W,2016-07-29,US 201562199265 P,2015-07-31,ENCAPSULATED STABILIZER COMPOSITIONS,"Resin masterbatch compositions are provided as closed end pellets having a core including at least one additive and an outer layer comprising a polymer encapsulating the core, in which the thickness of the outer layer if from 0.001 mm to 1 cm. A stabilized composition is prepared from an organic material to be stabilized and the resin masterbatch composition. A process for producing the resin masterbatch composition includes co-extruding in tubular form a core material encapsulated by an outer layer, wherein the core material comprises at least one additive, and the outer layer comprises a polymer, to form a filled tube; passing the filled tube into a sealing device that cuts the filled tube into multiple discrete segments seals and simultaneously seals each end of each discrete segment, thereby forming closed end pellets; and cooling the closed end pellets.",CYTEC IND INC,TIJHUIS DINAND;;TIJHUIS ERWIN;;KOZAKIEWIZ JOSEPH;;ENG JERRY MON HEI;;GUPTA RAM B;;VANZIN DAVID;;MAJMUDAR SHAILESH,,https://lens.org/111-755-027-736-924,Patent Application,yes,2,3,26,26,0,C08J3/226;;B29B9/12;;C08J2423/12;;C08J2423/14;;C08J2423/06;;C08J2425/12;;C08K5/3435;;C08K5/46;;C08K9/10;;C08J3/226;;C08K9/10;;C08L2310/00;;B29B9/12;;C08L33/26;;C08J3/126;;C08J2400/22;;B29B9/06;;B29B9/10;;B29B9/12;;C08J3/226;;C08K5/005;;C08K5/101;;C08K5/3432;;C08K9/10;;C08L23/00;;C08L25/04;;B01J13/02;;C08J3/22;;C08K9/10;;C08L101/00;;C09K15/00;;C08L2310/00;;B29B9/12;;B29B9/14;;C08J2400/22;;C08J3/226;;C08L33/26;;C08J3/126;;C08K9/10;;B29B9/06;;B29B2009/166;;C08K5/13;;C08K5/3435;;C08K5/46;;C08L23/06;;C08L23/12;;C08L23/14;;C08L25/06;;C08L25/12,C08K9/10;;B29B9/00;;C08J3/22,,1,0,,,"ANONYMOUS: ""SKIN TECHNOLOGY(TM) - Addcomp Holland"", 1 January 2012 (2012-01-01), XP055308636, Retrieved from the Internet <URL:http://www.addcomp.nl/showcases/6-skin-technology> [retrieved on 20161007]",PENDING
401,US,B2,US 10974417 B2,157-340-145-893-407,2021-04-13,2021,US 201615748861 A,2016-07-29,US 201615748861 A;;US 201562199265 P;;US 2016/0044721 W,2015-07-31,Encapsulated stabilizer compositions,"Resin masterbatch compositions are provided as closed end pellets having a core including at least one additive and an outer layer comprising a polymer encapsulating the core, in which the thickness of the outer layer if from 0.001 mm to 1 cm. A stabilized composition is prepared from an organic material to be stabilized and the resin masterbatch composition. A process for producing the resin masterbatch composition includes co-extruding in tubular form a core material encapsulated by an outer layer, wherein the core material comprises at least one additive, and the outer layer comprises a polymer, to form a filled tube; passing the filled tube into a sealing device that cuts the filled tube into multiple discrete segments seals and simultaneously seals each end of each discrete segment, thereby forming closed end pellets; and cooling the closed end pellets.",CYTEC IND INC,TIJHUIS DINAND;;TIJHUIS ERWIN;;KOZAKIEWICZ JOSEPH;;ENG JERRY MON HEI;;GUPTA RAM B;;VANZIN DAVID;;MAJMUDAR SHAILESH,CYTEC INDUSTRIES INC (2018-01-23),https://lens.org/157-340-145-893-407,Granted Patent,yes,20,0,26,26,0,C08J3/226;;B29B9/12;;C08J2423/12;;C08J2423/14;;C08J2423/06;;C08J2425/12;;C08K5/3435;;C08K5/46;;C08K9/10;;C08J3/226;;C08K9/10;;C08L2310/00;;B29B9/12;;C08L33/26;;C08J3/126;;C08J2400/22;;B29B9/06;;B29B9/10;;B29B9/12;;C08J3/226;;C08K5/005;;C08K5/101;;C08K5/3432;;C08K9/10;;C08L23/00;;C08L25/04;;B01J13/02;;C08J3/22;;C08K9/10;;C08L101/00;;C09K15/00;;C08L2310/00;;B29B9/12;;B29B9/14;;C08J2400/22;;C08J3/226;;C08L33/26;;C08J3/126;;C08K9/10;;B29B9/06;;B29B2009/166;;C08K5/13;;C08K5/3435;;C08K5/46;;C08L23/06;;C08L23/12;;C08L23/14;;C08L25/06;;C08L25/12,B29B9/06;;B29B9/12;;B29B9/14;;B29B9/16;;C08J3/12;;C08J3/22;;C08K5/13;;C08K5/3435;;C08K5/46;;C08K9/10;;C08L23/06;;C08L23/12;;C08L23/14;;C08L25/06;;C08L25/12;;C08L33/26,,3,0,,,"Anonymous: “Skin Technology (TM)—Addcomp Holland”, Jan. 1, 2012 (Jan. 1, 2012), XP55308636, Retrieved from the Internet: URL:http://www.addcomp.nl/showcases/6-skin-technology [retrieved on Oct. 7, 2016], the whole document.;;The International Preliminary Report on Patentability of PCT/US2016/044721; dated Nov. 2, 2017.;;Written Opinion and International Search Report of PCT/US2016/044721; dated Oct. 27, 2016.",ACTIVE
402,EP,B1,EP 2405848 B1,161-191-498-819-403,2016-08-03,2016,EP 10751340 A,2010-03-10,US 2010/0026793 W;;US 15926609 P;;US 72015510 A,2009-03-11,POWDER-FREE ANTI-BLOCKING COATED GLOVE,,ANSELL LTD,ENG AIK HWEE;;LAI HEE MENG;;LIM KUANG LENG;;TING KOON MEOW;;LUCAS DAVID M;;NARASIMHAN DAVE,,https://lens.org/161-191-498-819-403,Granted Patent,yes,8,0,9,9,0,A61L31/10;;A61L31/16;;A61L2300/404;;A61L2300/452;;A61L2300/608;;A61B42/00;;A41D19/0082;;A61L2300/404;;A61L2300/608;;A61L31/10;;A61L2300/452;;A61L31/16;;A61B42/00,A61L31/10;;A61L31/16,,0,0,,,,ACTIVE
403,US,A1,US 2018/0222087 A1,043-593-796-750-639,2018-08-09,2018,US 201615748861 A,2016-07-29,US 201615748861 A;;US 201562199265 P;;US 2016/0044721 W,2015-07-31,ENCAPSULATED STABILIZER COMPOSITIONS,"Resin masterbatch compositions are provided as closed end pellets having a core including at least one additive and an outer layer comprising a polymer encapsulating the core, in which the thickness of the outer layer if from 0.001 mm to 1 cm. A stabilized composition is prepared from an organic material to be stabilized and the resin masterbatch composition. A process for producing the resin masterbatch composition includes co-extruding in tubular form a core material encapsulated by an outer layer, wherein the core material comprises at least one additive, and the outer layer comprises a polymer, to form a filled tube; passing the filled tube into a sealing device that cuts the filled tube into multiple discrete segments seals and simultaneously seals each end of each discrete segment, thereby forming closed end pellets; and cooling the closed end pellets.",CYTEC IND INC,TIJHUIS DINAND;;TIJHUIS ERWIN;;KOZAKIEWICZ JOSEPH;;ENG JERRY MON HEI;;GUPTA RAM B;;VANZIN DAVID;;MAJMUDAR SHAILESH,CYTEC INDUSTRIES INC (2018-01-23),https://lens.org/043-593-796-750-639,Patent Application,yes,0,7,26,26,0,C08J3/226;;B29B9/12;;C08J2423/12;;C08J2423/14;;C08J2423/06;;C08J2425/12;;C08K5/3435;;C08K5/46;;C08K9/10;;C08J3/226;;C08K9/10;;C08L2310/00;;B29B9/12;;C08L33/26;;C08J3/126;;C08J2400/22;;B29B9/06;;B29B9/10;;B29B9/12;;C08J3/226;;C08K5/005;;C08K5/101;;C08K5/3432;;C08K9/10;;C08L23/00;;C08L25/04;;B01J13/02;;C08J3/22;;C08K9/10;;C08L101/00;;C09K15/00;;C08L2310/00;;B29B9/12;;B29B9/14;;C08J2400/22;;C08J3/226;;C08L33/26;;C08J3/126;;C08K9/10;;B29B9/06;;B29B2009/166;;C08K5/13;;C08K5/3435;;C08K5/46;;C08L23/06;;C08L23/12;;C08L23/14;;C08L25/06;;C08L25/12,B29B9/06;;B29B9/12;;C08K5/13;;C08K5/3435;;C08K5/46;;C08L23/06;;C08L23/12;;C08L23/14;;C08L25/06;;C08L25/12,,0,0,,,,ACTIVE
404,HK,A1,HK 1042803 A1,082-826-651-831-170,2002-08-23,2002,HK 02103232 A,2002-04-30,SG 2000000083 A,2000-01-06,A METHOD AND APPARATUS FOR CAPTURING AND RECORDING AUDIO AND VIDEO DATA ON OPTICAL STORAGE MEDIA,,SERIAL SYSTEM LTD,ZIHHONG WANG;;KAY HING TAN;;KIM SENG LIM;;GIM ENG LOW;;YAN SING DAVID TUNG;;HONGGANG WU,,https://lens.org/082-826-651-831-170,Patent Application,no,0,0,1,1,0,,H04N/,,0,0,,,,PENDING
405,WO,A1,WO 2017/082825 A1,159-179-328-633-370,2017-05-18,2017,SG 2016050557 W,2016-11-10,US 201562285933 P,2015-11-12,METHOD OF MANUFACTURING A HYBRID SUBSTRATE,"A method (100) of manufacturing a hybrid substrate (180) is disclosed, which comprises: bonding a first semiconductor substrate (102) to a first combined substrate via at least one layer of dielectric material (106) to form a second combined substrate, the first combined substrate includes a layer of lll-V compound semiconductor (108) and a second semiconductor substrate, the layer of lll-V compound semiconductor arranged intermediate the layer of dielectric material and second semiconductor substrate; removing the second semiconductor substrate from the second combined substrate to expose at least a portion of the layer of lll-V compound semiconductor to obtain a third combined substrate; and annealing the third combined substrate at a temperature about 250 °C to 1000 °C to reduce threading dislocation density of the layer of lll-V compound semiconductor to obtain the hybrid substrate.",UNIV NANYANG TECH;;MASSACHUSETTS INST TECHNOLOGY,LEE KWANG HONG;;TAN CHUAN SENG;;FITZGERALD EUGENE A;;BAO SHUYU;;LEE ENG KIAN KENNETH;;KOHEN DAVID,,https://lens.org/159-179-328-633-370,Patent Application,yes,3,1,6,6,0,H01L21/8258;;H01L21/3245;;H01L28/00;;H01L21/02002;;H01L21/76251;;H01L21/3245;;H01L21/02002;;H01L28/00;;H01L21/8258;;H01L21/02054;;H01L21/304;;H01L21/30604;;H01L21/76251;;H01L24/27;;H01L24/29;;H01L24/83;;H01L2224/27452;;H01L2224/29186;;H01L2224/83002;;H01L2224/83005;;H01L2224/83011;;H01L2224/83013;;H01L2224/83019;;H01L2224/8389;;H01L2924/10253;;H01L2924/10329,H01L27/02;;H01L21/304;;H01L21/324;;H01L27/12,,4,2,008-013-928-107-539;;067-835-899-344-596,10.1109/icsict.2014.7021178;;10.1016/s0022-0248(02)02218-2,"CHANG, YONGWEI ET AL.: ""GaAs-on-insulator fabricated via ion-cut in epitaxial GaAs/Ge substrate"", SOLID-STATE AND INTEGRATED CIRCUIT TECHNOLOGY (ICSICT), 2014 12TH IEEE INTERNATIONAL CONFERENCE ON. IEEE, 28 October 2014 (2014-10-28), pages 1 - 3, XP032727591;;LEE, KWANG HONG ET AL.: ""Defects reduction of Ge epitaxial film in a german ium- on-insulator wafer by annealing in oxygen ambient"", APL MATERIALS, vol. 3, no. 1, 7 January 2015 (2015-01-07), pages 1 - 7, XP012193369;;CENGHER, D. ET AL.: ""Fabrication of GaAs laser diodes on Si using low-temperature bonding of MBE-grown GaAs wafers with Si wafers"", JOURNAL OF CRYSTAL GROWTH, vol. 251, no. 1-4, 2003, pages 754 - 759, XP004416209;;See also references of EP 3375011A4",PENDING
406,US,B2,US 11733833 B2,005-490-587-657-825,2023-08-22,2023,US 202117528303 A,2021-11-17,US 202117528303 A;;US 202063114795 P,2020-11-17,Systems and methods for legal research navigation,Computer systems and corresponding methods are provided for computer assisted research in a network are provided that generate interface screens that include a map view of a plurality of selectable objects disposed in a nuclear arrangement in segmented rings about a first level object. The computing device is configured to receive selections of the displayed objects and expand the display to include additional segmented levels all surrounding the first level object.,PATERSON DAVID THOMAS;;KITAEV ERICA GANN;;CLARK MICHAEL ENG POH;;SRAMEK MEGAN ANNE;;ALES DEACON;;COLBERT EMILY;;THOMSON REUTERS ENTPR CENTRE GMBH,PATERSON DAVID THOMAS;;KITAEV ERICA GANN;;CLARK MICHAEL ENG POH;;SRAMEK MEGAN ANNE;;ALES DEACON;;COLBERT EMILY,,https://lens.org/005-490-587-657-825,Granted Patent,yes,14,0,7,7,0,G06F16/338;;G06F3/0482;;G06F16/248;;G06F3/0484,G06F3/048;;G06F3/0482;;G06F3/0484;;G06F16/248,,4,1,072-928-239-238-089,10.1109/iv.2007.92,"Rusu et al., Real-time Interactive Visualization of Information Hierarchies, 2007, IEEE, 7 pages.;;Yee et al., Animated Exploration of Dynamic Graphs with Radial Layout, 2001, IEEE, 8 pages.;;PCT International Search Report and Written Opinion for International Application No. PCT/US21/59608, dated Feb. 7, 2022, 6 pages.;;International Preliminary Report on Patentability and Written Opinion of the International Search Authority, dated May 16, 2023 (PCT Appl. No. PCT/US2021/059608 (5 pages).",ACTIVE
407,CN,A,CN 102438541 A,026-947-296-784-428,2012-05-02,2012,CN 201080019052 A,2010-03-10,US 2010/0026793 W;;US 15926609 P;;US 72015510 A,2009-03-11,Powder-free anti-blocking coated glove,"Provided herein are powder-free elastomeric articles exhibiting therapeutic properties, and anti-blocking properties. Also provided herein are methods for the manufacture of such articles that are substantially free from interfering materials, as well as packaging means for maintaining therapeutic efficacy.",ANSELL HEALTHCARE PROD LLC,HWEE ENG AIK;;MENG LAI HEE;;LENG LIM KUANG;;MEOW TING KOON;;LUCAS DAVID M;;DAVE NARASIMHAN,,https://lens.org/026-947-296-784-428,Patent Application,no,10,0,9,9,0,A61L31/10;;A61L31/16;;A61L2300/404;;A61L2300/452;;A61L2300/608;;A61B42/00;;A41D19/0082;;A61L2300/404;;A61L2300/608;;A61L31/10;;A61L2300/452;;A61L31/16;;A61B42/00,A61B19/04,,0,0,,,,INACTIVE
408,EP,A1,EP 3375011 A1,167-080-239-741-687,2018-09-19,2018,EP 16864677 A,2016-11-10,US 201562285933 P;;SG 2016050557 W,2015-11-12,METHOD OF MANUFACTURING A HYBRID SUBSTRATE,,UNIV NANYANG TECH;;MASSACHUSETTS INST TECHNOLOGY,LEE KWANG HONG;;TAN CHUAN SENG;;FITZGERALD EUGENE A;;BAO SHUYU;;LEE ENG KIAN KENNETH;;KOHEN DAVID,,https://lens.org/167-080-239-741-687,Patent Application,yes,0,0,6,6,0,H01L21/8258;;H01L21/3245;;H01L28/00;;H01L21/02002;;H01L21/76251;;H01L21/3245;;H01L21/02002;;H01L28/00;;H01L21/8258;;H01L21/02054;;H01L21/304;;H01L21/30604;;H01L21/76251;;H01L24/27;;H01L24/29;;H01L24/83;;H01L2224/27452;;H01L2224/29186;;H01L2224/83002;;H01L2224/83005;;H01L2224/83011;;H01L2224/83013;;H01L2224/83019;;H01L2224/8389;;H01L2924/10253;;H01L2924/10329,H01L27/02;;H01L21/304;;H01L21/324;;H01L27/12,,0,0,,,,DISCONTINUED
409,US,A1,US 2010/0031229 A1,003-182-564-898-805,2010-02-04,2010,US 18232808 A,2008-07-30,US 18232808 A,2008-07-30,VISUALIZATION OF COMPLEX SYSTEMS USING BUILDINGS,The present invention relates to the visualization of a complex system such as a software offering using a set of buildings. A method for generating a visualization of a complex system using a set of buildings in accordance with an embodiment of the present invention includes: representing each of a plurality of complex systems using a respective set of buildings in a virtual city environment. The set of buildings in the virtual city environment is displayed.,DILLENBERGER DONNA N ENG;;JOHNSON SANDRA K;;MISHRA SHARAD;;MITCHELL JOAN L;;STOOR BENJAMIN J;;WARD DAVID,DILLENBERGER DONNA N ENG;;JOHNSON SANDRA K;;MISHRA SHARAD;;MITCHELL JOAN L;;STOOR BENJAMIN J;;WARD DAVID,INTERNATIONAL BUSINESS MACHINES CORPORATION (2008-07-29),https://lens.org/003-182-564-898-805,Patent Application,yes,11,1,3,3,0,G06Q10/00;;G06Q10/00;;G06F8/70,G06F9/44,717/105,12,9,008-462-582-812-559;;130-801-274-947-626;;038-764-229-076-134;;044-561-361-366-996;;047-008-868-525-752;;028-034-283-887-889;;175-448-438-826-58X;;156-634-685-537-048;;105-447-089-699-83X,10.1109/hicss.2001.927261;;10.1109/icpc.2007.30;;10.1109/iceccs.2007.20;;10.1109/wcre.2007.26;;10.1007/3-540-63623-4_42;;10.1109/enabl.2000.883704;;10.1109/iv.2003.1217996;;10.1145/268411.268415;;10.1145/1056018.1056025,"Till Schümmer, ""Lost and Found in Software Space"", 2001, 34th Hawaii International Conference on System Sciences.;;Marti et al. ""WeatherTank: A Tangible Interface using Weather Metaphors"", 2001, MIT Tech Report.;;Wettel et al. ""Program Comprehension through Software Habitability"", June 2007, 15th IEEE International Conference on Program Comprehension..;;Panas et al. ""Communicating Software Architecture using a Unified Single-View Visualization"", July 11-14, 2007, 12th IEEE International Conference on Engineering Complex Computer Systems;;Alam et al. ""EvoSpaces Visualization Tool: Exploring Software Architecture in 3D"", Oct. 28-31 2007, 14th Working Conference on Reverse Engineering.;;Raphael Marmier ""Test-driving EvoSpaces: software visualisation in the real world"", 2007, Thesis, Haute ecole de gestion de Geneve, pages 1-5.;;Dieberger ""A City Metaphor to Support Navigation in Complex Information Spaces"", 1997, Lecture Notes in Computer Science Volume 1329, pages 53-67.;;Santos et al. ""Experiments in Information Visualization Using 3D Metaphoric Worlds"", 2000, Proceedings of the 9th IEEE International Workshops on Enabling Technologies: Infrastructure for Collaborative Enterprises.;;Panas, Berrigan, et al. ""A 3D Metaphor for Software Production Visualization"", 2003, Proceedings of the Seventh International Conference on Information Visualization.;;Belzer et al. ""Software Landscape Visualizing the Structure of Large Software Systems"", 2004, Proceedings of the Sixth Joint Eurographics - IEEE TCVG conference on Visualization.;;Doppke et al. ""Software Process Modeling and Execution within Virtual Environments"", 1998, ACM Transactions on Software Engineering and Methodology, Vol. 7, No. 1, pages 1-40.;;Voinea et al. ""CVSscan: Visualization of Code Evolution"", 2005, Proceedings of the 2005 ACM symposium on Software visualization, pages 47-56.",INACTIVE
410,US,A1,US 2018/0330982 A1,021-205-668-332-728,2018-11-15,2018,US 201615774454 A,2016-11-10,US 201615774454 A;;US 201562285933 P;;SG 2016050557 W,2015-11-12,METHOD OF MANUFACTURING A HYBRID SUBSTRATE,"A method of manufacturing a hybrid substrate is disclosed, which comprises: bonding a first semiconductor substrate to a first combined substrate via at least one layer of dielectric material to form a second combined substrate, the first combined substrate includes a layer of III-V compound semiconductor and a second semiconductor substrate, the layer of III-V compound semiconductor arranged intermediate the layer of dielectric material and second semiconductor substrate; removing the second semiconductor substrate from the second combined substrate to expose at least a portion of the layer of III-V compound semiconductor to obtain a third combined substrate; and annealing the third combined substrate at a temperature about 250° C. to 1000° C. to reduce threading dislocation density of the layer of III-V compound semiconductor to obtain the hybrid substrate.",UNIV NANYANG TECH;;MASSACHUSETTS INST TECHNOLOGY,LEE KWANG HONG;;TAN CHUAN SENG;;FITZGERALD EUGENE A;;BAO SHUYU;;LEE ENG KIAN KENNETH;;KOHEN DAVID,MASSACHUSETTS INSTITUTE OF TECHNOLOGY (2016-11-25);;NANYANG TECHNOLOGICAL UNIVERSITY (2016-11-25),https://lens.org/021-205-668-332-728,Patent Application,yes,0,0,6,6,0,H01L21/8258;;H01L21/3245;;H01L28/00;;H01L21/02002;;H01L21/76251;;H01L21/3245;;H01L21/02002;;H01L28/00;;H01L21/8258;;H01L21/02054;;H01L21/304;;H01L21/30604;;H01L21/76251;;H01L24/27;;H01L24/29;;H01L24/83;;H01L2224/27452;;H01L2224/29186;;H01L2224/83002;;H01L2224/83005;;H01L2224/83011;;H01L2224/83013;;H01L2224/83019;;H01L2224/8389;;H01L2924/10253;;H01L2924/10329,H01L21/762;;H01L21/02;;H01L21/324;;H01L23/00,,0,0,,,,DISCONTINUED
411,EP,B1,EP 3328929 B1,011-197-644-584-621,2019-04-17,2019,EP 16751423 A,2016-07-29,US 201562199265 P;;US 2016/0044721 W,2015-07-31,ENCAPSULATED STABILIZER COMPOSITIONS,,CYTEC IND INC,TIJHUIS DINAND;;TIJHUIS ERWIN;;KOZAKIEWICZ JOSEPH;;ENG JERRY MON HEI;;GUPTA RAM B;;VANZIN DAVID;;MAJMUDAR SHAILESH,,https://lens.org/011-197-644-584-621,Granted Patent,yes,2,0,26,26,0,C08J3/226;;B29B9/12;;C08J2423/12;;C08J2423/14;;C08J2423/06;;C08J2425/12;;C08K5/3435;;C08K5/46;;C08K9/10;;C08J3/226;;C08K9/10;;C08L2310/00;;B29B9/12;;C08L33/26;;C08J3/126;;C08J2400/22;;B29B9/06;;B29B9/10;;B29B9/12;;C08J3/226;;C08K5/005;;C08K5/101;;C08K5/3432;;C08K9/10;;C08L23/00;;C08L25/04;;B01J13/02;;C08J3/22;;C08K9/10;;C08L101/00;;C09K15/00;;C08L2310/00;;B29B9/12;;B29B9/14;;C08J2400/22;;C08J3/226;;C08L33/26;;C08J3/126;;C08K9/10;;B29B9/06;;B29B2009/166;;C08K5/13;;C08K5/3435;;C08K5/46;;C08L23/06;;C08L23/12;;C08L23/14;;C08L25/06;;C08L25/12,C08K5/13;;C08K5/3435,,1,0,,,"Anonymous: ""SKIN TECHNOLOGY(TM) - Addcomp Holland"", , 1 January 2012 (2012-01-01), XP55308636, Retrieved from the Internet: URL:http://www.addcomp.nl/showcases/6-skin -technology [retrieved on 2016-10-07]",ACTIVE
412,PL,T3,PL 3328929 T3,016-616-991-569-587,2019-09-30,2019,PL 16751423 T,2016-07-29,US 201562199265 P;;EP 16751423 A;;US 2016/0044721 W,2015-07-31,ENCAPSULATED STABILIZER COMPOSITIONS,,CYTEC IND INC,TIJHUIS DINAND;;TIJHUIS ERWIN;;KOZAKIEWICZ JOSEPH;;ENG JERRY MON HEI;;GUPTA RAM B;;VANZIN DAVID;;MAJMUDAR SHAILESH,,https://lens.org/016-616-991-569-587,Patent Application,no,0,0,26,26,0,C08J3/226;;B29B9/12;;C08J2423/12;;C08J2423/14;;C08J2423/06;;C08J2425/12;;C08K5/3435;;C08K5/46;;C08K9/10;;C08J3/226;;C08K9/10;;C08L2310/00;;B29B9/12;;C08L33/26;;C08J3/126;;C08J2400/22;;B29B9/06;;B29B9/10;;B29B9/12;;C08J3/226;;C08K5/005;;C08K5/101;;C08K5/3432;;C08K9/10;;C08L23/00;;C08L25/04;;B01J13/02;;C08J3/22;;C08K9/10;;C08L101/00;;C09K15/00;;C08L2310/00;;B29B9/12;;B29B9/14;;C08J2400/22;;C08J3/226;;C08L33/26;;C08J3/126;;C08K9/10;;B29B9/06;;B29B2009/166;;C08K5/13;;C08K5/3435;;C08K5/46;;C08L23/06;;C08L23/12;;C08L23/14;;C08L25/06;;C08L25/12,C08K5/13;;C08K5/3435,,0,0,,,,PENDING
413,US,B2,US 8813023 B2,037-130-582-335-642,2014-08-19,2014,US 18232808 A,2008-07-30,US 18232808 A,2008-07-30,Visualization of complex systems using buildings,The present invention relates to the visualization of a complex system such as a software offering using a set of buildings. A method for generating a visualization of a complex system using a set of buildings in accordance with an embodiment of the present invention includes: representing each of a plurality of complex systems using a respective set of buildings in a virtual city environment. The set of buildings in the virtual city environment is displayed.,DILLENBERGER DONNA N ENG;;JOHNSON SANDRA K;;MISHRA SHARAD;;MITCHELL JOAN L;;STOOR BENJAMIN J;;WARD DAVID;;IBM,DILLENBERGER DONNA N ENG;;JOHNSON SANDRA K;;MISHRA SHARAD;;MITCHELL JOAN L;;STOOR BENJAMIN J;;WARD DAVID,INTERNATIONAL BUSINESS MACHINES CORPORATION (2008-07-29),https://lens.org/037-130-582-335-642,Granted Patent,yes,11,2,3,3,0,G06Q10/00;;G06Q10/00;;G06F8/70,G06F9/44,717/104;;715/757,12,9,008-462-582-812-559;;130-801-274-947-626;;038-764-229-076-134;;044-561-361-366-996;;047-008-868-525-752;;028-034-283-887-889;;175-448-438-826-58X;;156-634-685-537-048;;105-447-089-699-83X,10.1109/hicss.2001.927261;;10.1109/icpc.2007.30;;10.1109/iceccs.2007.20;;10.1109/wcre.2007.26;;10.1007/3-540-63623-4_42;;10.1109/enabl.2000.883704;;10.1109/iv.2003.1217996;;10.1145/268411.268415;;10.1145/1056018.1056025,"Till Schümmer, ""Lost and Found in Software Space"", 2001, 34th Hawaii International Conference on System Sciences.;;Marti et al. ""WeatherTank: A Tangible Interface using Weather Metaphors"", 2001, MIT Tech Report.;;Wettel et al. ""Program Comprehension through Software Habitability"", Jun. 2007, 15th IEEE International Conference on Program Comprehension.;;Panas et al. ""Communicating Software Architecture using a Unified Single-View Visualization"", Jul. 11-14, 2007, 12th IEEE International Conference on Engineering Complex Computer Systems.;;Alam et al. ""EvoSpaces Visualization Tool: Exploring Software Architecture in 3D"", Oct. 28-31 2007, 14th Working Conference on Reverse Engineering.;;Raphael Marmier ""Test-driving EvoSpaces: software visualisation in the real world"", 2007, Thesis, Haute ecole de gestion de Geneve, pp. 1-5.;;Dieberger ""A City Metaphor to Support Navigation in Complex Information Spaces"", 1997, Lecture Notes in Computer Science vol. 1329, pp. 53-67.;;Santos et al. ""Experiments in Information Visualization Using 3D Metaphoric Worlds"", 2000, Proceedings of the 9th IEEE International Workshops on Enabling Technologies: Infrastructure for Collaborative Enterprises.;;Panas, Berrigan, et al. ""A 3D Metaphor for Software Production Visualization"", 2003, Proceedings of the Seventh International Conference on Information Visualization.;;Belzer et al. ""Software Landscape Visualizing the Structure of Large Software Systems"", 2004, Proceedings of the Sixth Joint Eurographics-IEEE TCVG conference on Visualization.;;Doppke et al. ""Software Process Modeling and Execution within Virtual Environments"", 1998, ACM Transactions on Software Engineering and Methodology, vol. 7, No. 1, pp. 1-40.;;Voinea et al. ""CVSscan: Visualization of Code Evolution"", 2005, Proceedings of the 2005 ACM symposium on Software visualization, pp. 47-56.",INACTIVE
414,KR,A,KR 20180036742 A,041-784-986-108-558,2018-04-09,2018,KR 20187005663 A,2016-07-29,US 201562199265 P;;US 2016/0044721 W,2015-07-31,캡슐화된 안정제 조성물,"적어도 1종의 첨가제를 포함하는 코어와, 이 코어를 캡슐화하는 중합체를 포함하는 외부 층을 포함하며, 여기서 외부 층은 두께가 0.001 ㎜ 내지 1 ㎝인, 수지 마스터배치 조성물이 말단 폐쇄형 펠릿으로서 제공된다. 안정화 조성물은 안정화되는 유기 재료와 수지 마스터배치 조성물로부터 제조된다. 수지 마스터배치 조성물을 제조하기 위한 방법은, 중합체를 포함하는 외부 층에 의해 캡슐화된, 적어도 1종의 첨가제를 포함하는 코어 재료를 튜브형으로 공압출하여, 충전된 튜브를 제조하는 단계; 충전된 튜브를 다수의 불연속 분절 밀봉체들로 절단함과 동시에 각각의 불연속 분절의 각 말단을 밀봉하는 밀봉 장치에, 상기 충전된 튜브를 통과시켜 말단 폐쇄형 펠릿을 제조하는 단계; 및 말단 폐쇄형 펠릿을 냉각시키는 단계를 포함한다.",CYTEC IND INC,TIJHUIS DINAND;;TIJHUIS ERWIN;;KOZAKIEWICZ JOSEPH;;ENG JERRY MON HEI;;GUPTA RAM B;;VANZIN DAVID;;MAJMUDAR SHAILESH,,https://lens.org/041-784-986-108-558,Patent Application,no,0,0,26,26,0,C08J3/226;;B29B9/12;;C08J2423/12;;C08J2423/14;;C08J2423/06;;C08J2425/12;;C08K5/3435;;C08K5/46;;C08K9/10;;C08J3/226;;C08K9/10;;C08L2310/00;;B29B9/12;;C08L33/26;;C08J3/126;;C08J2400/22;;B29B9/06;;B29B9/10;;B29B9/12;;C08J3/226;;C08K5/005;;C08K5/101;;C08K5/3432;;C08K9/10;;C08L23/00;;C08L25/04;;B01J13/02;;C08J3/22;;C08K9/10;;C08L101/00;;C09K15/00;;C08L2310/00;;B29B9/12;;B29B9/14;;C08J2400/22;;C08J3/226;;C08L33/26;;C08J3/126;;C08K9/10;;B29B9/06;;B29B2009/166;;C08K5/13;;C08K5/3435;;C08K5/46;;C08L23/06;;C08L23/12;;C08L23/14;;C08L25/06;;C08L25/12,C08J3/22;;B29B9/10;;B29B9/12;;C08K5/00;;C08K5/101;;C08K5/3432;;C08K9/10;;C08L23/00;;C08L25/04,,0,0,,,,ACTIVE
415,ZA,B,ZA 201800568 B,097-261-776-267-664,2023-07-26,2023,ZA 201800568 A,2018-01-26,US 201562199265 P;;US 2016/0044721 W,2015-07-31,ENCAPSULATED STABILIZER COMPOSITIONS,,CYTEC IND INC,TIJHUIS DINAND;;TIJHUIS ERWIN;;KOZAKIEWICZ JOSEPH;;ENG JERRY MON HEI;;GUPTA RAM B;;VANZIN DAVID;;MAJMUDAR SHAILESH,,https://lens.org/097-261-776-267-664,Granted Patent,no,0,0,26,26,0,C08J3/226;;B29B9/12;;C08J2423/12;;C08J2423/14;;C08J2423/06;;C08J2425/12;;C08K5/3435;;C08K5/46;;C08K9/10;;C08J3/226;;C08K9/10;;C08L2310/00;;B29B9/12;;C08L33/26;;C08J3/126;;C08J2400/22;;B29B9/06;;B29B9/10;;B29B9/12;;C08J3/226;;C08K5/005;;C08K5/101;;C08K5/3432;;C08K9/10;;C08L23/00;;C08L25/04;;B01J13/02;;C08J3/22;;C08K9/10;;C08L101/00;;C09K15/00;;C08L2310/00;;B29B9/12;;B29B9/14;;C08J2400/22;;C08J3/226;;C08L33/26;;C08J3/126;;C08K9/10;;B29B9/06;;B29B2009/166;;C08K5/13;;C08K5/3435;;C08K5/46;;C08L23/06;;C08L23/12;;C08L23/14;;C08L25/06;;C08L25/12,,,0,0,,,,ACTIVE
416,US,A1,US 2001/0021307 A1,038-373-349-988-148,2001-09-13,2001,US 75313100 A,2000-12-28,SG 200000008 A,2000-01-06,Method and apparatus for capturing and recording audio and video data on optical storage media,"
   The present invention is a digital audio and video recorder that captures audio and video data in real time, replays and records on Compact Disc CD Read or Read Write optical storage media on the fly, The system architecture of isolating high frequency video components minimizes noise and outputs MPEG compliant signals. By interfacing the present invention with an audio drive that accepts streaming data, the present invention not only captures and replays video in real time without a host processor, but also records audio and video streams on optical storage media without the need for buffer management overhead. As such, a consumer digital audio and video recorder is realized. 
",WANG ZHIHONG;;TAN KAY HING;;LIM KIM SENG;;LOW GIM ENG;;TUNG DAVID Y.S.;;WU HONGGANG,WANG ZHIHONG;;TAN KAY HING;;LIM KIM SENG;;LOW GIM ENG;;TUNG DAVID Y S;;WU HONGGANG,SERIAL SYSTEM LTD (2001-02-22),https://lens.org/038-373-349-988-148,Patent Application,yes,3,10,3,3,0,H04N5/85;;H04N9/8042;;H04N9/8063;;H04N9/8042;;H04N5/85;;H04N9/8063,H04N5/85;;H04N9/804;;H04N9/806,386/96;;386/111;;386/126,0,0,,,,DISCONTINUED
417,TW,A,TW 201729355 A,037-955-896-549-914,2017-08-16,2017,TW 105136899 A,2016-11-11,US 201562285933 P,2015-11-12,Method of manufacturing a hybrid substrate,"A method (100) of manufacturing a hybrid substrate (180) is disclosed, which comprises: bonding a first semiconductor substrate (102) to a first combined substrate via at least one layer of dielectric material (106) to form a second combined substrate, the first combined substrate includes a layer of III-V compound semiconductor (108) and a second semiconductor substrate, the layer of III-V compound semiconductor arranged intermediate the layer of dielectric material and second semiconductor substrate; removing the second semiconductor substrate from the second combined substrate to expose at least a portion of the layer of III-V compound semiconductor to obtain a third combined substrate; and annealing the third combined substrate at a temperature about 250 DEG C to 1000 DEG C to reduce threading dislocation density of the layer of III-V compound semiconductor to obtain the hybrid substrate.",UNIV NANYANG TECH;;MASSACHUSETTS INST TECHNOLOGY,LEE KWANG HONG;;TAN CHUAN SENG;;FITZGERALD EUGENE A;;BAO SHU-YU;;LEE ENG KIAN;;KOHEN DAVID,,https://lens.org/037-955-896-549-914,Patent of Addition,no,0,0,6,6,0,H01L21/8258;;H01L21/3245;;H01L28/00;;H01L21/02002;;H01L21/76251;;H01L21/3245;;H01L21/02002;;H01L28/00;;H01L21/8258;;H01L21/02054;;H01L21/304;;H01L21/30604;;H01L21/76251;;H01L24/27;;H01L24/29;;H01L24/83;;H01L2224/27452;;H01L2224/29186;;H01L2224/83002;;H01L2224/83005;;H01L2224/83011;;H01L2224/83013;;H01L2224/83019;;H01L2224/8389;;H01L2924/10253;;H01L2924/10329,H01L21/8258,,0,0,,,,PENDING
418,EP,A1,EP 4248331 A1,159-505-212-883-803,2023-09-27,2023,EP 21895473 A,2021-11-17,US 202063114795 P;;US 2021/0059608 W,2020-11-17,SYSTEMS AND METHODS FOR LEGAL RESEARCH NAVIGATION,,THOMSON REUTERS ENTPR CENTRE GMBH,PATERSON DAVID THOMAS;;CLARK MICHAEL ENG POH;;SRAMEK MEGAN ANNE;;ALES DEACON;;COLBERT EMILY;;KITAEV ERICA GANN,,https://lens.org/159-505-212-883-803,Patent Application,yes,0,0,7,7,0,G06F16/338;;G06F3/0482;;G06F16/248;;G06F3/0484,G06F16/00,,0,0,,,,PENDING
419,HU,T2,HU E044832 T2,010-713-276-496-055,2019-11-28,2019,HU E16751423 A,2016-07-29,US 201562199265 P,2015-07-31,ENCAPSULATED STABILIZER COMPOSITIONS,,CYTEC IND INC,TIJHUIS DINAND;;TIJHUIS ERWIN;;KOZAKIEWICZ JOSEPH;;ENG JERRY MON HEI;;GUPTA RAM B;;VANZIN DAVID;;MAJMUDAR SHAILESH,,https://lens.org/010-713-276-496-055,Amended Patent,no,0,0,26,26,0,C08J3/226;;B29B9/12;;C08J2423/12;;C08J2423/14;;C08J2423/06;;C08J2425/12;;C08K5/3435;;C08K5/46;;C08K9/10;;C08J3/226;;C08K9/10;;C08L2310/00;;B29B9/12;;C08L33/26;;C08J3/126;;C08J2400/22;;B29B9/06;;B29B9/10;;B29B9/12;;C08J3/226;;C08K5/005;;C08K5/101;;C08K5/3432;;C08K9/10;;C08L23/00;;C08L25/04;;B01J13/02;;C08J3/22;;C08K9/10;;C08L101/00;;C09K15/00;;C08L2310/00;;B29B9/12;;B29B9/14;;C08J2400/22;;C08J3/226;;C08L33/26;;C08J3/126;;C08K9/10;;B29B9/06;;B29B2009/166;;C08K5/13;;C08K5/3435;;C08K5/46;;C08L23/06;;C08L23/12;;C08L23/14;;C08L25/06;;C08L25/12,C08K5/13,,0,0,,,,PENDING
420,AU,B2,AU 2010/224231 B2,079-827-233-180-324,2013-05-23,2013,AU 2010/224231 A,2010-03-10,US 15926609 P;;US 72015510 A;;US 2010/0026793 W,2009-03-11,Powder-free anti-blocking coated glove,"Provided herein are powder-free elastomeric articles exhibiting therapeutic properties, and anti-blocking properties. Also provided herein are methods for the manufacture of such articles that are substantially free from interfering materials, as well as packaging means for maintaining therapeutic efficacy.",ANSELL LTD,ENG AIK HWEE;;LAI HEE MENG;;LIM KUANG LENG;;TING KOON MEOW;;LUCAS DAVID M;;NARASIMHAN DAVE,,https://lens.org/079-827-233-180-324,Granted Patent,no,2,0,9,9,0,A61L31/10;;A61L31/16;;A61L2300/404;;A61L2300/452;;A61L2300/608;;A61B42/00;;A41D19/0082;;A61L2300/404;;A61L2300/608;;A61L31/10;;A61L2300/452;;A61L31/16;;A61B42/00,A61B19/04,,0,0,,,,INACTIVE
421,US,A1,US 2010/0229282 A1,094-241-978-582-956,2010-09-16,2010,US 72015510 A,2010-03-09,US 72015510 A;;US 15926609 P,2009-03-11,Powder-Free Anti-Blocking Coated Glove,"Provided herein are powder-free elastomeric articles exhibiting therapeutic properties, and anti-blocking properties. Also provided herein are methods for the manufacture of such articles that are substantially free from interfering materials, as well as packaging means for maintaining therapeutic efficacy.",ANSELL LTD,ENG AIK HWEE;;LAI HEE MENG;;LIM KUANG LENG;;TING KOON MEOW;;LUCAS DAVID M;;NARASIMHAN DAVE,ANSELL LIMITED (2010-04-30),https://lens.org/094-241-978-582-956,Patent Application,yes,57,1,9,9,0,A61L31/10;;A61L31/16;;A61L2300/404;;A61L2300/452;;A61L2300/608;;A61B42/00;;A41D19/0082;;A61L2300/404;;A61L2300/608;;A61L31/10;;A61L2300/452;;A61L31/16;;A61B42/00,A41D19/00;;A41D19/02;;B65D85/18,2/161.7;;2/168;;206/278;;2/169,0,0,,,,DISCONTINUED
422,US,A1,US 2022/0155917 A1,127-410-455-144-623,2022-05-19,2022,US 202117528303 A,2021-11-17,US 202117528303 A;;US 202063114795 P,2020-11-17,SYSTEMS AND METHODS FOR LEGAL RESEARCH NAVIGATION,Computer systems and corresponding methods are provided for computer assisted research in a network are provided that generate interface screens that include a map view of a plurality of selectable objects disposed in a nuclear arrangement in segmented rings about a first level object. The computing device is configured to receive selections of the displayed objects and expand the display to include additional segmented levels all surrounding the first level object.,PATERSON DAVID THOMAS;;KITAEV ERICA GANN;;CLARK MICHAEL ENG POH;;SRAMEK MEGAN ANNE;;ALES DEACON;;COLBERT EMILY;;THOMSON REUTERS ENTPR CENTRE GMBH,PATERSON DAVID THOMAS;;KITAEV ERICA GANN;;CLARK MICHAEL ENG POH;;SRAMEK MEGAN ANNE;;ALES DEACON;;COLBERT EMILY,,https://lens.org/127-410-455-144-623,Patent Application,yes,8,0,7,7,0,G06F16/338;;G06F3/0482;;G06F16/248;;G06F3/0484,G06F3/0484;;G06F3/0482;;G06F16/248,,2,1,072-928-239-238-089,10.1109/iv.2007.92,"Rusu et al., Real-time Interactive Visualization of Information Hierarchies, 2007, IEEE, 7 pages.;;Yee et al., Animated Exploration of Dynamic Graphs with Radial Layout, 2001, IEEE, 8 pages.",ACTIVE
423,TR,T4,TR 201910378 T4,015-615-073-217-266,2019-08-21,2019,TR 201910378 T,2016-07-29,US 201562199265 P,2015-07-31,Kapsüllü stabilizör bileşimler.,"Reçine ana karışım bileşimleri, en az bir katkı maddesini içeren bir çekirdeğe ve çekirdeği kapsülleyen bir polimeri içeren bir dış katmana sahip olan kapalı uç pelletleri olarak sağlanır, burada dış katmanın kalınlığı, 0.001 mm ila 1 cm?dir. Stabilize edilmiş bir bileşim, stabilize edilecek bir organik materyalden ve reçine ana karışım bileşiminden hazırlanır. Reçine ana karışım bileşiminin üretilmesine yönelik bir proses aşağıdaki adımları içerir: bir dış katman tarafından kapsüllenen bir çekirdek materyalin tübüler formda birlikte ekstrüde edilmesi, burada dolu bir tüp oluşturmak üzere çekirdek materyal, en az bir katkı maddesini içerir ve dış katman, bir polimeri içerir; dolu tüpü birçok ayrı bölüme kesen ve eş zamanlı olarak her bir ayrı bölümün her bir ucunu yalıtan bir yalıtma cihazından kapalı tüpün geçirilmesi, böylece kapalı uçlu pelletlerin oluşturulması; ve kapalı uçlu pelletlerin soğutulması.",CYTEC IND INC,DINAND TIJHUIS;;ERWIN TIJHUIS;;JOSEPH KOZAKIEWICZ;;JERRY MON HEI ENG;;RAM B GUPTA;;DAVID VANZIN;;SHAILESH MAJMUDAR,,https://lens.org/015-615-073-217-266,Granted Patent,no,0,0,26,26,0,C08J3/226;;B29B9/12;;C08J2423/12;;C08J2423/14;;C08J2423/06;;C08J2425/12;;C08K5/3435;;C08K5/46;;C08K9/10;;C08J3/226;;C08K9/10;;C08L2310/00;;B29B9/12;;C08L33/26;;C08J3/126;;C08J2400/22;;B29B9/06;;B29B9/10;;B29B9/12;;C08J3/226;;C08K5/005;;C08K5/101;;C08K5/3432;;C08K9/10;;C08L23/00;;C08L25/04;;B01J13/02;;C08J3/22;;C08K9/10;;C08L101/00;;C09K15/00;;C08L2310/00;;B29B9/12;;B29B9/14;;C08J2400/22;;C08J3/226;;C08L33/26;;C08J3/126;;C08K9/10;;B29B9/06;;B29B2009/166;;C08K5/13;;C08K5/3435;;C08K5/46;;C08L23/06;;C08L23/12;;C08L23/14;;C08L25/06;;C08L25/12,C08K5/13;;C08K5/3435,,0,0,,,,ACTIVE
424,CA,A1,CA 2993973 A1,061-678-180-612-84X,2017-02-09,2017,CA 2993973 A,2016-07-29,US 201562199265 P;;US 2016/0044721 W,2015-07-31,ENCAPSULATED STABILIZER COMPOSITIONS,"Resin masterbatch compositions are provided as closed end pellets having a core including at least one additive and an outer layer comprising a polymer encapsulating the core, in which the thickness of the outer layer if from 0.001 mm to 1 cm. A stabilized composition is prepared from an organic material to be stabilized and the resin masterbatch composition. A process for producing the resin masterbatch composition includes co-extruding in tubular form a core material encapsulated by an outer layer, wherein the core material comprises at least one additive, and the outer layer comprises a polymer, to form a filled tube; passing the filled tube into a sealing device that cuts the filled tube into multiple discrete segments seals and simultaneously seals each end of each discrete segment, thereby forming closed end pellets; and cooling the closed end pellets.",CYTEC IND INC,TIJHUIS DINAND;;TIJHUIS ERWIN;;KOZAKIEWICZ JOSEPH;;ENG JERRY MON HEI;;GUPTA RAM B;;VANZIN DAVID;;MAJMUDAR SHAILESH,,https://lens.org/061-678-180-612-84X,Patent Application,no,0,0,26,26,0,C08J3/226;;B29B9/12;;C08J2423/12;;C08J2423/14;;C08J2423/06;;C08J2425/12;;C08K5/3435;;C08K5/46;;C08K9/10;;C08J3/226;;C08K9/10;;C08L2310/00;;B29B9/12;;C08L33/26;;C08J3/126;;C08J2400/22;;B29B9/06;;B29B9/10;;B29B9/12;;C08J3/226;;C08K5/005;;C08K5/101;;C08K5/3432;;C08K9/10;;C08L23/00;;C08L25/04;;B01J13/02;;C08J3/22;;C08K9/10;;C08L101/00;;C09K15/00;;C08L2310/00;;B29B9/12;;B29B9/14;;C08J2400/22;;C08J3/226;;C08L33/26;;C08J3/126;;C08K9/10;;B29B9/06;;B29B2009/166;;C08K5/13;;C08K5/3435;;C08K5/46;;C08L23/06;;C08L23/12;;C08L23/14;;C08L25/06;;C08L25/12,C08K9/10;;B29B9/00;;C08J3/22,,0,0,,,,ACTIVE
425,BR,A2,BR 112018001961 A2,069-979-071-900-359,2019-05-14,2019,BR 112018001961 A,2016-07-29,US 2016/0044721 W;;US 201562199265 P,2015-07-31,"composição, uso de uma composição, e, processos para produção de uma composição e de um artigo.","composições de masterbatch de resina são proporcionadas como péletes com extremidades fechadas tendo um núcleo incluindo pelo menos um aditivo e uma camada exterior compreendendo um polímero encapsulando o núcleo, nas quais a espessura da camada exterior é de 0,001 mm a 1 cm. uma composição estabilizada é preparada a partir de um material orgânico a ser estabilizado e da composição de masterbatch de resina. um processo para produção da composição de masterbatch de resina inclui coextrusão em forma tubular de um material nuclear encapsulado por uma camada exterior, em que o material nuclear compreende pelo menos um aditivo, e a camada exterior compreende um polímero, para formar um tubo cheio; passagem do tubo cheio em um dispositivo de selagem que corta o tubo cheio em múltiplos segmentos discretos sela e simultaneamente sela cada extremidade de cada segmento discreto, formando deste modo péletes com extremidades fechadas; e resfriamento dos péletes com extremidades fechadas.",CYTEC IND INC,DAVID VANZIN;;DINAND TIJHUIS;;ERWIN TIJHUIS;;JERRY MON HEI ENG;;JOSEPH KOZAKIEWICZ;;RAM B GUPTA;;SHAILESH MAJMUDAR,,https://lens.org/069-979-071-900-359,Patent Application,no,0,0,26,26,0,C08J3/226;;B29B9/12;;C08J2423/12;;C08J2423/14;;C08J2423/06;;C08J2425/12;;C08K5/3435;;C08K5/46;;C08K9/10;;C08J3/226;;C08K9/10;;C08L2310/00;;B29B9/12;;C08L33/26;;C08J3/126;;C08J2400/22;;B29B9/06;;B29B9/10;;B29B9/12;;C08J3/226;;C08K5/005;;C08K5/101;;C08K5/3432;;C08K9/10;;C08L23/00;;C08L25/04;;B01J13/02;;C08J3/22;;C08K9/10;;C08L101/00;;C09K15/00;;C08L2310/00;;B29B9/12;;B29B9/14;;C08J2400/22;;C08J3/226;;C08L33/26;;C08J3/126;;C08K9/10;;B29B9/06;;B29B2009/166;;C08K5/13;;C08K5/3435;;C08K5/46;;C08L23/06;;C08L23/12;;C08L23/14;;C08L25/06;;C08L25/12,B29B9/00;;C08J3/22;;C08K9/10,,0,0,,,,ACTIVE
426,EP,A1,EP 3328929 A1,105-301-580-266-223,2018-06-06,2018,EP 16751423 A,2016-07-29,US 201562199265 P;;US 2016/0044721 W,2015-07-31,ENCAPSULATED STABILIZER COMPOSITIONS,,CYTEC IND INC,TIJHUIS DINAND;;TIJHUIS ERWIN;;KOZAKIEWICZ JOSEPH;;ENG JERRY MON HEI;;GUPTA RAM B;;VANZIN DAVID;;MAJMUDAR SHAILESH,,https://lens.org/105-301-580-266-223,Patent Application,yes,0,0,26,26,0,C08J3/226;;B29B9/12;;C08J2423/12;;C08J2423/14;;C08J2423/06;;C08J2425/12;;C08K5/3435;;C08K5/46;;C08K9/10;;C08J3/226;;C08K9/10;;C08L2310/00;;B29B9/12;;C08L33/26;;C08J3/126;;C08J2400/22;;B29B9/06;;B29B9/10;;B29B9/12;;C08J3/226;;C08K5/005;;C08K5/101;;C08K5/3432;;C08K9/10;;C08L23/00;;C08L25/04;;B01J13/02;;C08J3/22;;C08K9/10;;C08L101/00;;C09K15/00;;C08L2310/00;;B29B9/12;;B29B9/14;;C08J2400/22;;C08J3/226;;C08L33/26;;C08J3/126;;C08K9/10;;B29B9/06;;B29B2009/166;;C08K5/13;;C08K5/3435;;C08K5/46;;C08L23/06;;C08L23/12;;C08L23/14;;C08L25/06;;C08L25/12,C08K9/10;;B29B9/00;;C08J3/22,,0,0,,,,ACTIVE
427,MX,A,MX 2018001168 A,153-731-086-897-856,2018-07-06,2018,MX 2018001168 A,2016-07-29,US 201562199265 P;;US 2016/0044721 W,2015-07-31,ENCAPSULATED STABILIZER COMPOSITIONS.,"Resin masterbatch compositions are provided as closed end pellets having a core including at least one additive and an outer layer comprising a polymer encapsulating the core, in which the thickness of the outer layer if from 0.001 mm to 1 cm. A stabilized composition is prepared from an organic material to be stabilized and the resin masterbatch composition. A process for producing the resin masterbatch composition includes co-extruding in tubular form a core material encapsulated by an outer layer, wherein the core material comprises at least one additive, and the outer layer comprises a polymer, to form a filled tube; passing the filled tube into a sealing device that cuts the filled tube into multiple discrete segments seals and simultaneously seals each end of each discrete segment, thereby forming closed end pellets; and cooling the closed end pellets.",CYTEC IND INC,RAM B GUPTA;;JERRY MON HEI ENG;;JOSEPH KOZAKIEWICZ;;DINAND TIJHUIS;;ERWIN TIJHUIS;;DAVID VANZIN;;SHAILESH MAJMUDAR,,https://lens.org/153-731-086-897-856,Patent Application,no,0,0,26,26,0,C08J3/226;;B29B9/12;;C08J2423/12;;C08J2423/14;;C08J2423/06;;C08J2425/12;;C08K5/3435;;C08K5/46;;C08K9/10;;C08J3/226;;C08K9/10;;C08L2310/00;;B29B9/12;;C08L33/26;;C08J3/126;;C08J2400/22;;B29B9/06;;B29B9/10;;B29B9/12;;C08J3/226;;C08K5/005;;C08K5/101;;C08K5/3432;;C08K9/10;;C08L23/00;;C08L25/04;;B01J13/02;;C08J3/22;;C08K9/10;;C08L101/00;;C09K15/00;;C08L2310/00;;B29B9/12;;B29B9/14;;C08J2400/22;;C08J3/226;;C08L33/26;;C08J3/126;;C08K9/10;;B29B9/06;;B29B2009/166;;C08K5/13;;C08K5/3435;;C08K5/46;;C08L23/06;;C08L23/12;;C08L23/14;;C08L25/06;;C08L25/12,C08K9/10;;B29B9/00;;C08J3/22,,0,0,,,,PENDING
428,FI,A0,FI 963452 A0,093-150-103-501-877,1996-09-03,1996,FI 963452 A,1996-09-03,US 20607494 A;;US 9502347 W,1994-03-04,Menetelmä epoxidin valmistamiseksi,"A process for synthesizing the epoxide of formula (I) consists of, at a minimum, formation of a halohydrin form the allyl acetonide reactant, followed by base-induced cyclization, the epoxide product (I) being useful as an intermediate for the synthesis of inhibitors of renin or HIV protease or other proteases.",MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;MALIGRES PETER E;;REIDER PAUL J;;ROSSEN KAI;;VOLANTE RALPH P;;UPADHYAY VEENA,MERCK SHARP & DOHME CORP. (2010-03-16),https://lens.org/093-150-103-501-877,Patent Application,no,0,0,40,41,0,C07D263/52;;C07D413/06;;A61P31/12;;A61P31/18;;A61P37/04;;C07D413/06,A61K31/44;;C07D213/36;;A61K31/4406;;A61K31/4418;;A61P31/12;;A61P37/04;;C07D263/52;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
429,DK,T3,DK 0748319 T3,041-178-992-497-406,2002-03-18,2002,DK 95911105 T,1995-02-27,US 20607494 A;;US 9502347 W,1994-03-04,Fremgangsmåde til fremstilling af et epoxid,"A process for synthesizing the epoxide of formula (I) consists of, at a minimum, formation of a halohydrin form the allyl acetonide reactant, followed by base-induced cyclization, the epoxide product (I) being useful as an intermediate for the synthesis of inhibitors of renin or HIV protease or other proteases.",MERCK & CO INC,VOLANTE RALPH P;;ROSSEN KAI;;ASKIN DAVID;;ENG KAN K;;MALIGRES PETER E;;REIDER PAUL J;;UPADHYAY VEENA,,https://lens.org/041-178-992-497-406,Granted Patent,no,0,0,40,41,0,C07D263/52;;C07D413/06;;A61P31/12;;A61P31/18;;A61P37/04;;C07D413/06,C07D213/36;;A61K31/44;;A61K31/4406;;A61K31/4418;;A61P31/12;;A61P37/04;;C07D263/52;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
430,CA,C,CA 2183976 C,181-683-737-305-829,2005-02-01,2005,CA 2183976 A,1995-02-27,US 20607494 A;;US 9502347 W,1994-03-04,PROCESS FOR MAKING AN EPOXIDE,"A process for synthesizing the epoxide of formula (I) consists of, at a minimum, formation of a halohydrin form the allyl acetonide reactant, followed by base-induced cyclization, the epoxide product (I) being useful as an intermediate for the synthesis of inhibitors of renin or HIV protease or other proteases.",MERCK & CO INC,MALIGRES PETER E;;ASKIN DAVID;;ENG KAN K;;REIDER PAUL J;;VOLANTE RALPH P;;UPADHYAY VEENA;;ROSSEN KAI,,https://lens.org/181-683-737-305-829,Granted Patent,no,0,0,40,41,0,C07D263/52;;C07D413/06;;A61P31/12;;A61P31/18;;A61P37/04;;C07D413/06,C07D213/36;;A61K31/44;;A61K31/4406;;A61K31/4418;;A61P31/12;;A61P37/04;;C07D263/52;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
431,PT,E,PT 748319 E,020-879-782-517-405,2002-05-31,2002,PT 95911105 T,1995-02-27,US 20607494 A,1994-03-04,PROCESSO PARA FABRICO DE UM EPOXIDO,"A process for synthesizing the epoxide of formula (I) consists of, at a minimum, formation of a halohydrin form the allyl acetonide reactant, followed by base-induced cyclization, the epoxide product (I) being useful as an intermediate for the synthesis of inhibitors of renin or HIV protease or other proteases.",MERCK & CO INC,MALIGRES PETER E;;ASKIN DAVID;;VOLANTE RALPH P;;ENG KAN K;;REIDER PAUL J;;ROSSEN KAI;;UPADHYAY VEENA,,https://lens.org/020-879-782-517-405,Granted Patent,no,0,0,40,41,0,C07D263/52;;C07D413/06;;A61P31/12;;A61P31/18;;A61P37/04;;C07D413/06,A61K31/44;;A61K31/4406;;A61K31/4418;;C07D213/36;;A61P31/12;;A61P37/04;;C07D263/52;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
432,HR,A2,HR P950096 A2,108-913-178-329-667,1997-06-30,1997,HR P950096 A,1995-03-02,US 20607494 A,1994-03-04,PROCESS FOR MAKING AN EPOXIDE,"A process for synthesizing the epoxide of formula (I) consists of, at a minimum, formation of a halohydrin form the allyl acetonide reactant, followed by base-induced cyclization, the epoxide product (I) being useful as an intermediate for the synthesis of inhibitors of renin or HIV protease or other proteases.",MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;MALIGRES PETER E;;REIDER PAUL J;;ROSSEN KAI;;VOLANTE RALPH P;;UPADHYAY VEENA,"MERCK SHARP & DOHME CORP., US (2010-04-08)",https://lens.org/108-913-178-329-667,Patent Application,no,0,0,40,41,0,C07D263/52;;C07D413/06;;A61P31/12;;A61P31/18;;A61P37/04;;C07D413/06,A61K31/44;;A61K31/4406;;A61K31/4418;;C07D213/36;;A61P31/12;;A61P37/04;;C07D263/52;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
433,HU,A,HU T75611 A,111-270-010-174-915,1997-05-28,1997,HU 9602412 A,1995-02-27,US 20607494 A;;US 9502347 W,1994-03-04,PROCESS FOR MAKING AN EPOXIDE,"A process for synthesizing the epoxide of formula (I) consists of, at a minimum, formation of a halohydrin form the allyl acetonide reactant, followed by base-induced cyclization, the epoxide product (I) being useful as an intermediate for the synthesis of inhibitors of renin or HIV protease or other proteases.",MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;MALIGRES PETER E;;REIDER PAUL J;;ROSSEN KAI;;UPADHYAY VEENA;;VOLANTE RALPH P,"MERCK SHARP & DOHME CORP., US (2010-05-28)",https://lens.org/111-270-010-174-915,Unknown,no,0,0,40,41,0,C07D263/52;;C07D413/06;;A61P31/12;;A61P31/18;;A61P37/04;;C07D413/06,A61K31/44;;A61K31/4406;;A61K31/4418;;C07D213/36;;A61P31/12;;A61P37/04;;C07D263/52;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
434,US,A1,US 2010/0211555 A1,057-981-941-794-404,2010-08-19,2010,US 38872109 A,2009-02-19,US 38872109 A,2009-02-19,EFFICIENT INTEGRATION BETWEEN AN EXTERNAL WORKLOAD MANAGER AND AN RDBMS,"According to one embodiment of the present invention, a system, method and computer program product is provided for integrating an external workload manager with a database system. The method according to one embodiment includes a method comprises: receiving a request in a database component, the request including a cross component token; starting a new unit of work in workload management software in the database component, in response to the request; determining, from a cross component workload management unit, a transaction class and a synchronization code using the database component; finding an internal workload in the workload management software that matches the transaction class and the synchronization code of the cross component workload management unit; and using the matching internal workload for the new unit of work.",IBM,BIRD PAUL MILLER;;DILLENBERGER DONNA N ENG;;HULBER MARK FRANCIS;;MANNERS DAVID CREE;;WONG FRANCIS;;YOCOM PETER B,INTERNATIONAL BUSINESS MACHINES CORPORATION (2009-01-22),https://lens.org/057-981-941-794-404,Patent Application,yes,5,0,2,2,0,G06F16/217;;G06F16/217,G06F17/30,707/703;;X707E17005;;X707E17045;;X707E17014,0,0,,,,INACTIVE
435,EP,A1,EP 4242004 A1,012-421-483-250-750,2023-09-13,2023,EP 23157650 A,2023-02-20,US 202263269003 P;;US 202318166370 A,2022-03-08,A PRINTING APPARATUS,"Examples of the present disclosure relate generally to a printing apparatus and, more particularly, to apparatuses, systems, and methods for printing utilizing laser print head and reactive media.
",HAND HELD PROD INC,DJAYAPUTRA DAVID PRATAMA;;GO FLORANTE SUMALINOG;;LIM ENG HING;;LIM CHIN CHEAN;;OUNG KAR BOON;;SOH TECK SIONG,,https://lens.org/012-421-483-250-750,Patent Application,yes,9,0,2,8,0,B41J3/4075;;B41J11/04;;B41J11/00244,B41J3/407;;B41J2/44;;B41J11/00;;B41J11/04;;G03G15/20,,0,0,,,,PENDING
436,US,A1,US 2023/0182484 A1,057-432-106-565-518,2023-06-15,2023,US 202318166370 A,2023-02-08,US 202318166370 A;;IN 202111046460 A;;US 202117646631 A;;US 202263269003 P;;US 202163133685 P;;US 202163145865 P;;US 202163201659 P,2021-01-04,PRINTING APPARATUS,"Examples of the present disclosure relate generally to a printing apparatus and, more particularly, to apparatuses, systems, and methods for printing utilizing laser print head and reactive media.",HAND HELD PROD INC,DJAYAPUTRA DAVID PRATAMA;;GO FLORANTE SUMALINOG;;LIM ENG HING;;LIM CHIN CHEAN;;OUNG KAR BOON;;SOH TECK SIONG,HAND HELD PRODUCTS INC (2022-03-03),https://lens.org/057-432-106-565-518,Patent Application,yes,0,0,1,8,0,B41M5/26;;B65H2513/51;;B65H2513/52;;B65H2801/12;;B41J11/00244;;B65H2301/4132;;B65H20/02;;B65H2404/1523;;B41J2/38;;B41J2202/30;;B41J2/33505;;B41J11/0015,B41J2/38;;B41J2/335;;B41J11/00,,0,0,,,,PENDING
437,US,B2,US 8583604 B2,092-145-551-751-834,2013-11-12,2013,US 38872109 A,2009-02-19,US 38872109 A,2009-02-19,Efficient integration between an external workload manager and an RDBMS,"According to one embodiment of the present invention, a system, method and computer program product is provided for integrating an external workload manager with a database system. The method according to one embodiment includes a method comprises: receiving a request in a database component, the request including a cross component token; starting a new unit of work in workload management software in the database component, in response to the request; determining, from a cross component workload management unit, a transaction class and a synchronization code using the database component; finding an internal workload in the workload management software that matches the transaction class and the synchronization code of the cross component workload management unit; and using the matching internal workload for the new unit of work.",BIRD PAUL MILLER;;DILLENBERGER DONNA N ENG;;HULBER MARK FRANCIS;;MANNERS DAVID CREE;;WONG FRANCIS;;YOCOM PETER B;;IBM,BIRD PAUL MILLER;;DILLENBERGER DONNA N ENG;;HULBER MARK FRANCIS;;MANNERS DAVID CREE;;WONG FRANCIS;;YOCOM PETER B,INTERNATIONAL BUSINESS MACHINES CORPORATION (2009-01-22),https://lens.org/092-145-551-751-834,Granted Patent,yes,5,0,2,2,0,G06F16/217;;G06F16/217,G06F17/30,707/687;;707/689;;709/203;;705/4,3,0,,,"""Orchestration Case Study: Integrating WebShere and DB2 Orchestration with Enterprise Workload Manager"", IMB Corporation 2004.;;Rogers et al., ""z/OS Version 1 Release 8 Implementation"", ibm.com/redbooks, Feb. 2007.;;""Technology Showcase"", IBM Centers for Advanced Studies: CASCON archives, 2004.",INACTIVE
438,US,A1,US 2020/0229319 A1,158-480-910-818-481,2020-07-16,2020,US 201916247350 A,2019-01-14,US 201916247350 A,2019-01-14,COOLING CONTAINER,"Example containers are provided to retain and cool electronic devices in environments where power and/or coolant (e.g., airflow) is limited or finite. In examples, a container can include a housing and a conduit system. The housing can include a plurality of sides including a front side and a back side, and can be structured to retain at least a first computing device. In addition, the housing can provide for a first and second inlet opening and a first and second outlet opening on the back side of the container. The conduit system can be provided within the housing to guide the airflow received from each of the first and second outlet openings through an interior volume of the container to cause the airflow to exit from each of the first and second outlet openings. Further, the conduit system can include a plurality of structures that combine to guide at least a portion of the airflow received through the first and second inlet openings through a top region of the interior volume as the airflow is moved from the back side of the container to the front side of the container. Further still, the conduit system can guide at least a portion of the warmed airflow to a bottom region of the interior volume as the warmed airflow is moved from the front side to the back side of the container.",HEWLETT PACKARD ENTPR DEV LP,SCOTT MICHAEL;;CUDA BRET;;PETERSEN DAVID;;GOH ENG LIM;;FERNANDEZ MARK R;;KICHURY JOHN;;BEHRINGER ROBERT;;SZULGIT CALANDRA,HEWLETT PACKARD ENTERPRISE DEVELOPMENT LP (2019-01-11),https://lens.org/158-480-910-818-481,Patent Application,yes,0,1,2,2,0,H05K7/20727;;G06F1/20;;H05K7/20145;;H05K7/20172;;H05K7/20736;;G06F1/20,H05K7/20;;G06F1/20,,0,0,,,,ACTIVE
439,KR,A,KR 20230011845 A,173-212-685-999-556,2023-01-25,2023,KR 20220006003 A,2022-01-14,US 202117375595 A,2021-07-14,TURBINE NOZZLE AND GAS TURBINE INCLUDING THE SAME,"A gas turbine nozzle assembly of a gas turbine is provided. The turbine nozzle assembly may include a turbine nozzle extending from an inner diameter to an outer diameter and having an airfoil-shaped cross section having a leading edge and a trailing edge, and a pressure side and a suction side each of which extends from the leading edge to the trailing edge, wherein the turbine nozzle may include a hollow airfoil including a plurality of cavities positioned in the airfoil, an insert positioned in one or more of the plurality of cavities of the hollow airfoil, a plurality of cover plates, at least one of which is positioned at one of the inner diameter and at the outer diameter, and a plurality of impingement pans, at least one of which is positioned at one of the inner diameter and at the outer diameter.",DOOSAN ENERBILITY CO LTD,GENE CHONG;;KIM YE JEE;;DARRYL ENG;;DAVID DAY;;MUN YOUNGGI;;BRYAN BERNIE;;SEO HONGSEUNG;;LEE JAE BIN,,https://lens.org/173-212-685-999-556,Patent Application,no,0,0,3,3,0,F01D9/065;;F05D2260/201;;F05D2240/81;;F05D2240/121;;F01D5/189;;F01D9/041;;F01D5/188;;F01D5/183;;F05D2240/35;;F05D2220/32;;F01D25/12;;F05D2240/128;;F05D2260/201;;F05D2220/32,F01D9/04;;F01D5/18,,0,0,,,,DISCONTINUED
440,CA,A1,CA 2183976 A1,037-601-717-812-206,1995-09-08,1995,CA 2183976 A,1995-02-27,US 20607494 A;;US 9502347 W,1994-03-04,PROCESS FOR MAKING AN EPOXIDE,"A process for synthesizing the epoxide of formula (I) consists of, at a minimum, formation of a halohydrin form the allyl acetonide reactant, followed by base-induced cyclization, the epoxide product (I) being useful as an intermediate for the synthesis of inhibitors of renin or HIV protease or other proteases.",MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;MALIGRES PETER E;;REIDER PAUL J;;ROSSEN KAI;;VOLANTE RALPH P;;UPADHYAY VEENA,,https://lens.org/037-601-717-812-206,Patent Application,no,0,0,40,41,0,C07D263/52;;C07D413/06;;A61P31/12;;A61P31/18;;A61P37/04;;C07D413/06,C07D213/36;;A61K31/44;;A61K31/4406;;A61K31/4418;;A61P31/12;;A61P37/04;;C07D263/52;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
441,AU,A,AU 1995/018828 A,099-591-140-216-866,1995-09-18,1995,AU 1995/018828 A,1995-02-27,US 20607494 A;;US 9502347 W,1994-03-04,Process for making an epoxide,"A process for synthesizing the epoxide of formula (I) consists of, at a minimum, formation of a halohydrin form the allyl acetonide reactant, followed by base-induced cyclization, the epoxide product (I) being useful as an intermediate for the synthesis of inhibitors of renin or HIV protease or other proteases.",MERCK SHARP & DOHME,ASKIN DAVID;;ENG KAN K;;MALIGRES PETER E;;REIDER PAUL J;;ROSSEN KAI;;VOLANTE RALPH P;;UPADHYAY VEENA,,https://lens.org/099-591-140-216-866,Patent Application,no,0,0,40,41,0,C07D263/52;;C07D413/06;;A61P31/12;;A61P31/18;;A61P37/04;;C07D413/06,C07D213/36;;A61K31/44;;A61K31/4406;;A61K31/4418;;A61P31/12;;A61P37/04;;C07D263/52;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
442,FI,B,FI 120259 B,182-491-311-378-756,2009-08-31,2009,FI 963452 A,1996-09-03,US 20607494 A;;US 9502347 W,1994-03-04,Menetelmä epoksidin valmistamiseksi,"A process for synthesizing the epoxide of formula (I) consists of, at a minimum, formation of a halohydrin form the allyl acetonide reactant, followed by base-induced cyclization, the epoxide product (I) being useful as an intermediate for the synthesis of inhibitors of renin or HIV protease or other proteases.",MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;MALIGRES PETER E;;REIDER PAUL J;;ROSSEN KAI;;VOLANTE RALPH P;;UPADHYAY VEENA,MERCK SHARP & DOHME CORP. (2010-03-16),https://lens.org/182-491-311-378-756,Patent Application,no,0,0,40,41,0,C07D263/52;;C07D413/06;;A61P31/12;;A61P31/18;;A61P37/04;;C07D413/06,C07D213/36;;A61K31/44;;C07D413/06;;A61K31/4406;;A61K31/4418;;A61P31/12;;A61P37/04;;C07D263/52;;C07D413/04,,0,0,,,,EXPIRED
443,SI,T1,SI 0748319 T1,029-170-168-133-304,2002-04-30,2002,SI 9530548 T,1995-02-27,EP 95911105 A;;US 9502347 W;;US 20607494 A,1994-03-04,PROCESS FOR MAKING AN EPOXIDE,,MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;MALIGRES PETER E;;REIDER PAUL J;;ROSSEN KAI;;VOLANTE RALPH P;;UPADHYAY VEENA,,https://lens.org/029-170-168-133-304,Granted Patent,no,0,0,1,41,0,,C07D263/52;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
444,YU,B,YU 49010 B,053-601-730-572-374,2003-04-30,2003,YU 14595 A,1995-03-03,US 20607494 A,1994-03-04,PROCESS FOR MAKING AN EPOXIDE,"A process for synthesizing the epoxide of formula (I) consists of, at a minimum, formation of a halohydrin form the allyl acetonide reactant, followed by base-induced cyclization, the epoxide product (I) being useful as an intermediate for the synthesis of inhibitors of renin or HIV protease or other proteases.",MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;MALIGRES PETER K;;REIDER PAUL J;;ROSSEN KAI;;VOLANTE RALPH P;;UPADHYAY VEENA,,https://lens.org/053-601-730-572-374,Granted Patent,no,0,0,40,41,0,C07D263/52;;C07D413/06;;A61P31/12;;A61P31/18;;A61P37/04;;C07D413/06,C07D213/36;;A61K31/44;;A61K31/4406;;A61K31/4418;;A61P31/12;;A61P37/04;;C07D263/52;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
445,RO,B1,RO 117696 B1,033-319-782-165-08X,2002-06-28,2002,RO 9601750 A,1995-02-27,US 20607494 A;;US 9502347 W,1994-03-04,PROCESS FOR MAKING AN EPOXIDE COMPOUND,"The invention relates to a process for synthesizing the epoxide compound having the formula (I) which consists in forming the halohydrin using a reactant of allyl acetonide followed by base-induced cyclization, the resulting epoxide compound being useful as an intermediate for the synthesis of renin inhibitors or HIV protease or other products.",MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;MALIGRES PETER E;;REIDER PAUL J;;ROSSEN KAI;;VOLANTE RALPH P;;UPADHYAY VEENA,,https://lens.org/033-319-782-165-08X,Granted Patent,no,0,0,40,41,0,C07D263/52;;C07D413/06;;A61P31/12;;A61P31/18;;A61P37/04;;C07D413/06,A61K31/44;;A61K31/4406;;A61K31/4418;;C07D213/36;;A61P31/12;;A61P37/04;;C07D263/52;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
446,HU,D0,HU 9602412 D0,197-617-944-905-873,1996-11-28,1996,HU 9602412 A,1995-02-27,US 20607494 A;;US 9502347 W,1994-03-04,PROCESS FOR MAKING AN EPOXIDE,"A process for synthesizing the epoxide of formula (I) consists of, at a minimum, formation of a halohydrin form the allyl acetonide reactant, followed by base-induced cyclization, the epoxide product (I) being useful as an intermediate for the synthesis of inhibitors of renin or HIV protease or other proteases.",MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;MALIGRES PETER E;;REIDER PAUL J;;ROSSEN KAI;;UPADHYAY VEENA;;VOLANTE RALPH P,"MERCK SHARP & DOHME CORP., US (2010-05-28)",https://lens.org/197-617-944-905-873,Patent Application,no,0,0,40,41,0,C07D263/52;;C07D413/06;;A61P31/12;;A61P31/18;;A61P37/04;;C07D413/06,C07D213/36;;A61K31/44;;A61K31/4406;;A61K31/4418;;A61P31/12;;A61P37/04;;C07D263/52;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
447,EP,A1,EP 0748319 A1,010-511-178-100-293,1996-12-18,1996,EP 95911105 A,1995-02-27,US 9502347 W;;US 20607494 A,1994-03-04,PROCESS FOR MAKING AN EPOXIDE,"A process for synthesizing the epoxide of formula (I) consists of, at a minimum, formation of a halohydrin form the allyl acetonide reactant, followed by base-induced cyclization, the epoxide product (I) being useful as an intermediate for the synthesis of inhibitors of renin or HIV protease or other proteases.",MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;MALIGRES PETER E;;REIDER PAUL J;;ROSSEN KAI;;VOLANTE RALPH P;;UPADHYAY VEENA,"MERCK SHARP & DOHME CORP., US (2013-05-14);;MERCK SHARP & DOHME CORP., RAHWAY, US (2013-05-14);;MERCK SHARP & DOHME CORP.; US (2010-04-07);;SCHERING CORPORATION, US (2013-03-18);;MERCK  SHARP & DOHME CORP. (2012-10-19);;MERCK & CO., INC. (2007-10-15)",https://lens.org/010-511-178-100-293,Patent Application,yes,0,0,40,41,0,C07D263/52;;C07D413/06;;A61P31/12;;A61P31/18;;A61P37/04;;C07D413/06,C07D213/36;;A61K31/44;;A61K31/4406;;A61K31/4418;;A61P31/12;;A61P37/04;;C07D263/52;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
448,US,B2,US 11464133 B2,035-478-813-889-023,2022-10-04,2022,US 201916247350 A,2019-01-14,US 201916247350 A,2019-01-14,Cooling container,"Example containers are provided to retain and cool electronic devices in environments where power and/or coolant (e.g., airflow) is limited or finite. In examples, a container can include a housing and a conduit system. The housing can include a plurality of sides including a front side and a back side, and can be structured to retain at least a first computing device. In addition, the housing can provide for a first and second inlet opening and a first and second outlet opening on the back side of the container. The conduit system can be provided within the housing to guide the airflow received from each of the first and second outlet openings through an interior volume of the container to cause the airflow to exit from each of the first and second outlet openings. Further, the conduit system can include a plurality of structures that combine to guide at least a portion of the airflow received through the first and second inlet openings through a top region of the interior volume as the airflow is moved from the back side of the container to the front side of the container. Further still, the conduit system can guide at least a portion of the warmed airflow to a bottom region of the interior volume as the warmed airflow is moved from the front side to the back side of the container.",HEWLETT PACKARD ENTPR DEV LP,SCOTT MICHAEL;;CUDA BRET;;PETERSEN DAVID;;GOH ENG LIM;;FERNANDEZ MARK R;;KICHURY JOHN;;BEHRINGER ROBERT;;SZULGIT CALANDRA,HEWLETT PACKARD ENTERPRISE DEVELOPMENT LP (2019-01-11),https://lens.org/035-478-813-889-023,Granted Patent,yes,26,0,2,2,0,H05K7/20727;;G06F1/20;;H05K7/20145;;H05K7/20172;;H05K7/20736;;G06F1/20,H05K7/20;;G06F1/20,,2,0,,,"Boeing, “Active Thermal Control System (ATCS) Overview,” Aug. 29, 2017, pp. 1-19, Retrieved from the Internet on Jul. 24, 2018 at URL: <web.archive.org/web/20170829114606/https://www.nasa.gov/pdf/473486main_iss_atcs overview.pdf>.;;ESA, “Columbus: Europe's Laboratory on the International Space Station,” Oct. 1999, pp. 1-39, BR-144.",ACTIVE
449,NZ,A,NZ 281866 A,097-396-245-045-999,1998-05-27,1998,NZ 28186695 A,1995-02-27,US 20607494 A;;US 9502347 W,1994-03-04,"EPOXIDE SYNTHESIS OF CONDENSED 1,3-OXAZOLES","A process for synthesizing the epoxide of formula (I) consists of, at a minimum, formation of a halohydrin form the allyl acetonide reactant, followed by base-induced cyclization, the epoxide product (I) being useful as an intermediate for the synthesis of inhibitors of renin or HIV protease or other proteases.",MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;MALIGRES PETER E;;REIDER PAUL J;;ROSSEN KAI;;VOLANTE RALPH P;;UPADHYAY VEENA,,https://lens.org/097-396-245-045-999,Patent Application,no,0,0,40,41,0,C07D263/52;;C07D413/06;;A61P31/12;;A61P31/18;;A61P37/04;;C07D413/06,A61K31/44;;A61K31/4406;;A61K31/4418;;C07D213/36;;A61P31/12;;A61P37/04;;C07D263/52;;C07D413/04;;C07D413/06,,0,0,,,,DISCONTINUED
450,HR,B1,HR P950096 B1,173-810-128-221-194,2002-06-30,2002,HR P950096 A,1995-03-02,US 20607494 A,1994-03-04,PROCESS FOR MAKING AN EPOXIDE,"A process for synthesizing the epoxide of formula (I) consists of, at a minimum, formation of a halohydrin form the allyl acetonide reactant, followed by base-induced cyclization, the epoxide product (I) being useful as an intermediate for the synthesis of inhibitors of renin or HIV protease or other proteases.",MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;MALIGRES PETER E;;REIDER PAUL J;;ROSSEN KAI;;VOLANTE RALPH P;;UPADHYAY VEENA,"MERCK SHARP & DOHME CORP., US (2010-04-08)",https://lens.org/173-810-128-221-194,Granted Patent,no,0,0,40,41,0,C07D263/52;;C07D413/06;;A61P31/12;;A61P31/18;;A61P37/04;;C07D413/06,A61K31/44;;A61K31/4406;;A61K31/4418;;C07D213/36;;A61P31/12;;A61P37/04;;C07D263/52;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
451,CZ,A3,CZ 254396 A3,000-582-512-654-810,1997-01-15,1997,CZ 254396 A,1995-02-27,US 20607494 A,1994-03-04,PROCESS FOR PREPARING EPOXIDE,"A process for synthesizing the epoxide of formula (I) consists of, at a minimum, formation of a halohydrin form the allyl acetonide reactant, followed by base-induced cyclization, the epoxide product (I) being useful as an intermediate for the synthesis of inhibitors of renin or HIV protease or other proteases.",MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;MALIGRES PETER E;;REIDER PAUL J;;ROSSEN KAI;;VOLANTE RALPH P;;UPADHYAY VEENA,,https://lens.org/000-582-512-654-810,Patent Application,no,0,0,40,41,0,C07D263/52;;C07D413/06;;A61P31/12;;A61P31/18;;A61P37/04;;C07D413/06,C07D213/36;;A61K31/44;;A61K31/4406;;A61K31/4418;;A61P31/12;;A61P37/04;;C07D263/52;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
452,AU,B2,AU 690231 B2,092-143-238-320-449,1998-04-23,1998,AU 1995/018828 A,1995-02-27,US 20607494 A;;US 9502347 W,1994-03-04,Process for making an epoxide,"A process for synthesizing the epoxide of formula (I) consists of, at a minimum, formation of a halohydrin form the allyl acetonide reactant, followed by base-induced cyclization, the epoxide product (I) being useful as an intermediate for the synthesis of inhibitors of renin or HIV protease or other proteases.",MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;MALIGRES PETER E;;REIDER PAUL J;;ROSSEN KAI;;VOLANTE RALPH P;;UPADHYAY VEENA,,https://lens.org/092-143-238-320-449,Granted Patent,no,0,0,40,41,0,C07D263/52;;C07D413/06;;A61P31/12;;A61P31/18;;A61P37/04;;C07D413/06,C07D213/36;;A61K31/44;;A61K31/4406;;A61K31/4418;;A61P31/12;;A61P37/04;;C07D263/52;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
453,MX,A,MX 9603871 A,178-916-410-513-198,1997-07-31,1997,MX 9603871 A,1995-02-27,US 9502347 W;;US 20607494 A,1994-03-04,PROCESS FOR MAKING AN EPOXIDE.,"A process for synthesizing the epoxide of formula (I) consists of, at a minimum, formation of a halohydrin form the allyl acetonide reactant, followed by base-induced cyclization, the epoxide product (I) being useful as an intermediate for the synthesis of inhibitors of renin or HIV protease or other proteases.",MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;MALIGRES PETER E;;REIDER PAUL J;;ROSSEN KAI;;VOLANTE RALPH P;;UPADHYAY VEENA,,https://lens.org/178-916-410-513-198,Patent Application,no,0,0,40,41,0,C07D263/52;;C07D413/06;;A61P31/12;;A61P31/18;;A61P37/04;;C07D413/06,A61K31/44;;A61K31/4406;;A61K31/4418;;C07D213/36;;A61P31/12;;A61P37/04;;C07D263/52;;C07D413/04;;C07D413/06,,0,0,,,,PENDING
454,SK,A3,SK 112296 A3,060-905-332-550-010,1997-02-05,1997,SK 112296 A,1995-02-27,US 20607494 A;;US 9502347 W,1994-03-04,PROCESS FOR MAKING AN EPOXIDE AND EPOXIDE MADE BY THIS METHOD,"A process for synthesising the epoxide of formula (I) consists of, at a minimum, formation of a halohydrin form the alyl acetonide reactant, followed by base-induced cyclisation, the epoxide product (I) being useful as an intermediate for the synthesis of inhibitors of renin or HIV protease or other proteases.",MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;MALIGRES PETER E;;REIDER PAUL J;;ROSSEN KAI;;VOLANTE RALPH P;;UPADHYAY VEENA,"MERCK SHARP & DOHME CORP., RAHWAY, NJ, US (2010-04-29)",https://lens.org/060-905-332-550-010,Patent Application,no,0,0,40,41,0,C07D263/52;;C07D413/06;;A61P31/12;;A61P31/18;;A61P37/04;;C07D413/06,A61K31/44;;A61K31/4406;;A61K31/4418;;C07D213/36;;A61P31/12;;A61P37/04;;C07D263/52;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
455,CZ,B6,CZ 291816 B6,068-410-497-413-520,2003-06-18,2003,CZ 254396 A,1995-02-27,US 20607494 A,1994-03-04,Process for preparing epoxy resins,"The present invention concerns a process for preparing an epoxy resin of the general formula I wherein the preparation process comprises preparing halohidrin from allyl acetonide. The halohidrin is the treated with a base to induce cyclization. The obtained epoxy resin is usable as an intermediate for the synthesis of renin inhibitors, HIV protease as well as other proteases.",MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;MALIGRES PETER E;;REIDER PAUL J;;ROSSEN KAI;;VOLANTE RALPH P;;UPADHYAY VEENA,,https://lens.org/068-410-497-413-520,Granted Patent,no,0,0,40,41,0,C07D263/52;;C07D413/06;;A61P31/12;;A61P31/18;;A61P37/04;;C07D413/06,C07D213/36;;A61K31/44;;A61K31/4406;;A61K31/4418;;A61P31/12;;A61P37/04;;C07D263/52;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
456,AT,T1,AT E210662 T1,022-584-837-239-612,2001-12-15,2001,AT 95911105 T,1995-02-27,US 20607494 A;;US 9502347 W,1994-03-04,VERFAHREN ZUR HERSTELLUNG VON EPOXIDEN,"A process for synthesizing the epoxide of formula (I) consists of, at a minimum, formation of a halohydrin form the allyl acetonide reactant, followed by base-induced cyclization, the epoxide product (I) being useful as an intermediate for the synthesis of inhibitors of renin or HIV protease or other proteases.",MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;MALIGRES PETER E;;REIDER PAUL J;;ROSSEN KAI;;VOLANTE RALPH P;;UPADHYAY VEENA,,https://lens.org/022-584-837-239-612,Granted Patent,no,0,0,40,41,0,C07D263/52;;C07D413/06;;A61P31/12;;A61P31/18;;A61P37/04;;C07D413/06,C07D213/36;;A61K31/44;;A61K31/4406;;A61K31/4418;;A61P31/12;;A61P37/04;;C07D263/52;;C07D413/04;;C07D413/06,,0,0,,,,PENDING
457,BR,A,BR 9506977 A,070-661-579-579-813,1997-09-02,1997,BR 9506977 A,1995-02-27,US 20607494 A;;US 9502347 W,1994-03-04,Processo para sintetizar um epóxido e composto,"A process for synthesizing the epoxide of formula (I) consists of, at a minimum, formation of a halohydrin form the allyl acetonide reactant, followed by base-induced cyclization, the epoxide product (I) being useful as an intermediate for the synthesis of inhibitors of renin or HIV protease or other proteases.",MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;MALIGRES PETER E;;REIDER PAUL J;;ROSSEN KAI;;VOLANTE RALPH P;;UPADHYAY VEENA,MERCK SHARP AND DOHME CORP. (US) (2011-04-05),https://lens.org/070-661-579-579-813,Patent Application,no,0,0,40,41,0,C07D263/52;;C07D413/06;;A61P31/12;;A61P31/18;;A61P37/04;;C07D413/06,C07D213/36;;A61K31/44;;A61K31/4406;;A61K31/4418;;A61P31/12;;A61P37/04;;C07D263/52;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
458,EP,B1,EP 0748319 B1,101-200-482-015-385,2001-12-12,2001,EP 95911105 A,1995-02-27,US 9502347 W;;US 20607494 A,1994-03-04,PROCESS FOR MAKING AN EPOXIDE,"A process for synthesizing the epoxide of formula (I) consists of, at a minimum, formation of a halohydrin form the allyl acetonide reactant, followed by base-induced cyclization, the epoxide product (I) being useful as an intermediate for the synthesis of inhibitors of renin or HIV protease or other proteases.",MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;MALIGRES PETER E;;REIDER PAUL J;;ROSSEN KAI;;VOLANTE RALPH P;;UPADHYAY VEENA,"MERCK SHARP & DOHME CORP., US (2013-05-14);;MERCK SHARP & DOHME CORP., RAHWAY, US (2013-05-14);;MERCK SHARP & DOHME CORP.; US (2010-04-07);;SCHERING CORPORATION, US (2013-03-18);;MERCK  SHARP & DOHME CORP. (2012-10-19);;MERCK & CO., INC. (2007-10-15)",https://lens.org/101-200-482-015-385,Granted Patent,yes,2,0,40,41,0,C07D263/52;;C07D413/06;;A61P31/12;;A61P31/18;;A61P37/04;;C07D413/06,C07D213/36;;A61K31/44;;A61K31/4406;;A61K31/4418;;A61P31/12;;A61P37/04;;C07D263/52;;C07D413/04;;C07D413/06,,1,0,,,"TETRAHEDRON LETTERS, vol. 35,no. 5, 31 January 1994 OXFORD GB, pages 673-676, DAVID ASKIN ET AL 'Highly diastereoselective reaction of a chiral,non-racemic amide enolate with (s)-glycidyl tosylate.Synthesis of the orally active HIV-1 protease inhibitor L-735,524 '",EXPIRED
459,TW,B,TW 327635 B,089-950-854-449-468,1998-03-01,1998,TW 85109161 A,1996-07-26,US 51260295 A,1995-08-08,Process for making an epoxide,"A process for synthesizing the epoxde of the formula (I) (I) which comprises the following steps: (a) in aqueous sodium carbonate, contacting about 0.5 and about 1.0 equivalent of 1,3-dichloro-5,5-dimethylhydantoin and one equivalent of allyl acetonide of formula II (II) in which the allyl acetonide is dissolved in isopropyl acetate; (b) cooling the mixture formed to temperatures between about 5℃ and about 10℃; (c) adding excessive aqueous sodium iodide solution therein and maintaining the temperature of the reaction mixture at about 21℃ to about 25℃, then curing the reaction mixture for a period of between about 1 hour and about 8 hours; (d) adding sodium sulphite aqueous solution therein to terminate the reaction in order to produce an iodo alcohol of formula III, and (III) (e) adding methanol solution of sodium methoxide therein to induce the formation of the epoxide of formula I.",MERCK & CO INC,DAVID ASKIN;;KAN K ENG;;PETER E MALIGES;;PAUL J REIDER;;KAI ROSSEN;;RALPH P VOLANTE;;VEENA UPADHYAY,,https://lens.org/089-950-854-449-468,Granted Patent,no,0,0,10,10,0,C07D263/52;;C07D413/06;;C07D413/06;;C07D263/52,C07D263/52,,0,0,,,,EXPIRED
460,HU,B1,HU 222750 B1,192-609-613-434-526,2003-09-29,2003,HU 9602412 A,1995-02-27,US 20607494 A;;US 9502347 W,1994-03-04,PROCESS FOR MAKING AN EPOXIDE,"A process for synthesizing the epoxide of formula (I) consists of, at a minimum, formation of a halohydrin form the allyl acetonide reactant, followed by base-induced cyclization, the epoxide product (I) being useful as an intermediate for the synthesis of inhibitors of renin or HIV protease or other proteases.",MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;MALIGRES PETER E;;REIDER PAUL J;;ROSSEN KAI;;UPADHYAY VEENA;;VOLANTE RALPH P,"MERCK SHARP & DOHME CORP., US (2010-05-28)",https://lens.org/192-609-613-434-526,Granted Patent,no,0,0,40,41,0,C07D263/52;;C07D413/06;;A61P31/12;;A61P31/18;;A61P37/04;;C07D413/06,A61K31/44;;C07D213/36;;A61K31/4406;;A61K31/4418;;A61P31/12;;A61P37/04;;C07D263/52;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
461,JP,A,JP 2023131121 A,045-509-970-718-158,2023-09-21,2023,JP 2023025923 A,2023-02-22,US 202263269003 P;;US 202318166370 A,2022-03-08,PRINTING APPARATUS,"To provide, generally, a printing apparatus, and more specifically, an apparatus, system and method for printing by means of a laser print head and a reactive medium.SOLUTION: A printing apparatus 100 comprises a preheating assembly. The preheating assembly comprises: a first drive roller 132 and a second drive roller 134 positioned in direct contact with a top surface of a print medium; and a rotating preheating component configured to preheat the print medium, the rotating preheating component being positioned in direct contact with a bottom surface of the print medium, where an aperture between the first drive roller 132, the second drive roller 134 and the rotating preheating component defines a print medium path through the preheating assembly.SELECTED DRAWING: Figure 1",HAND HELD PROD INC,DAVID PRATAMA DJAYAPUTRA;;FLORANTE SUMALINOG GO;;LIM ENG HING;;LIM CHIN CHEAN;;OUNG KAR BOON;;SOH TECK SIONG,,https://lens.org/045-509-970-718-158,Patent Application,no,0,0,2,8,0,B41J3/4075;;B41J11/04;;B41J11/00244,B41J2/38;;B41J29/00,,0,0,,,,PENDING
462,FI,A,FI 963452 A,197-403-432-764-903,1996-09-03,1996,FI 963452 A,1996-09-03,US 20607494 A;;US 9502347 W,1994-03-04,Menetelmä epoxidin valmistamiseksi,"A process for synthesizing the epoxide of formula (I) consists of, at a minimum, formation of a halohydrin form the allyl acetonide reactant, followed by base-induced cyclization, the epoxide product (I) being useful as an intermediate for the synthesis of inhibitors of renin or HIV protease or other proteases.",MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;MALIGRES PETER E;;REIDER PAUL J;;ROSSEN KAI;;VOLANTE RALPH P;;UPADHYAY VEENA,MERCK SHARP & DOHME CORP. (2010-03-16),https://lens.org/197-403-432-764-903,Patent Application,no,0,0,40,41,0,C07D263/52;;C07D413/06;;A61P31/12;;A61P31/18;;A61P37/04;;C07D413/06,A61K31/44;;C07D213/36;;A61K31/4406;;A61K31/4418;;A61P31/12;;A61P37/04;;C07D263/52;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
463,SK,B6,SK 283067 B6,036-971-259-836-914,2003-02-04,2003,SK 112296 A,1995-02-27,US 20607494 A;;US 9502347 W,1994-03-04,Process for making an epoxide,"A process for synthesising the epoxide of formula (I) consists of, at a minimum, formation of a halohydrin form the alyl acetonide reactant, followed by base-induced cyclisation, the epoxide product (I) being useful as an intermediate for the synthesis of inhibitors of renin or HIV protease or other proteases.",MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;MALIGRES PETER E;;REIDER PAUL J;;ROSSEN KAI;;VOLANTE RALPH P;;UPADHYAY VEENA,"MERCK SHARP & DOHME CORP., RAHWAY, NJ, US (2010-04-29)",https://lens.org/036-971-259-836-914,Granted Patent,no,0,0,40,41,0,C07D263/52;;C07D413/06;;A61P31/12;;A61P31/18;;A61P37/04;;C07D413/06,A61K31/44;;A61K31/4406;;A61K31/4418;;A61P31/12;;C07D213/36;;A61P37/04;;C07D263/52;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
464,WO,A1,WO 1995/023797 A1,041-487-370-450-303,1995-09-08,1995,US 9502347 W,1995-02-27,US 20607494 A,1994-03-04,PROCESS FOR MAKING AN EPOXIDE,"A process for synthesizing the epoxide of formula (I) consists of, at a minimum, formation of a halohydrin form the allyl acetonide reactant, followed by base-induced cyclization, the epoxide product (I) being useful as an intermediate for the synthesis of inhibitors of renin or HIV protease or other proteases.",MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;MALIGRES PETER E;;REIDER PAUL J;;ROSSEN KAI;;VOLANTE RALPH P;;UPADHYAY VEENA,,https://lens.org/041-487-370-450-303,Patent Application,yes,2,14,40,41,0,C07D263/52;;C07D413/06;;A61P31/12;;A61P31/18;;A61P37/04;;C07D413/06,A61K31/44;;A61K31/4406;;A61K31/4418;;C07D213/36;;A61P31/12;;A61P37/04;;C07D263/52;;C07D413/04;;C07D413/06,,1,1,027-450-444-460-744,10.1016/s0040-4039(00)75787-x,"DAVID ASKIN ET AL: ""Highly diastereoselective reaction of a chiral,non-racemic amide enolate with (s)-glycidyl tosylate.Synthesis of the orally active HIV-1 protease inhibitor L-735,524"", TETRAHEDRON LETTERS, vol. 35, no. 5, 31 January 1994 (1994-01-31), OXFORD GB, pages 673 - 676",PATENTED
465,US,B1,US 6303464 B1,131-072-141-980-130,2001-10-16,2001,US 77438296 A,1996-12-30,US 77438296 A,1996-12-30,Method and structure for reducing interconnect system capacitance through enclosed voids in a dielectric layer,"A reduced capacitance interconnect system. A first metal layer is formed to a predetermined level above a first dielectric layer which is formed on a semiconductor substrate. The first metal layer level forms multiple interconnect lines wherein each interconnect line is separated from each adjacent interconnect line by a trench including a trench having a highest aspect ratio. A second dielectric layer is formed on the first metal layer and in the trenches between the interconnect lines such that an enclosed void having a void tip substantially level with the top of the metal layer is formed in at least each trench having an aspect ratio above a predetermined minimum aspect ratio, wherein the enclosed void in the trench having the highest aspect ratio has a void volume which is at least 15% of the volume of the trench.",INTEL CORP,GAW ENG T;;VU QUAT T;;FRASER DAVID B;;CHIANG CHIEN;;YOUNG IAN A;;MARIEB THOMAS N D,INTEL CORPORATION (1997-04-09),https://lens.org/131-072-141-980-130,Granted Patent,yes,22,85,1,1,0,H01L21/7682;;H01L21/7682,H01L21/768,438/422;;438/411;;438/421;;438/619;;438/631;;438/778;;257/758,2,0,,,"S. Wolf, ""Silicon Processing for the VLSI Era"", vol. 2, Lattice Press, pp. 194-199, 1990.*;;IBM Technical Disclosure Bulletin, Reduced Capacitance Interconnect System Using Decomposition of Air Gap Filler Material, Sep. 1995, vol. 38, No. 9, pp. 137-140.",EXPIRED
466,US,A1,US 2006/0048099 A1,034-812-719-113-944,2006-03-02,2006,US 92912904 A,2004-08-27,US 92912904 A,2004-08-27,Debugging applications under different permissions,"A system and method that allows developers to debug a component while it is restricted by any arbitrary set of specific permissions, or restricted by an existing permission set associated with a security “zone.” A security sandbox is mimicked within the development environment so that developers can study how applications perform inside the sandbox. Developers are able create any sandbox and debug inside it, where violating any bound of the artificial sandbox will throw a security exception and drop the user out on the exact line of code which generated the error, as well as provide helpful information about how to correct the error.",MICROSOFT CORP,TEMPLIN DAVID K;;FEE GREGORY D;;GRYKO IZYDOR;;CANTWELL JAMES G;;ENG MICHAEL;;DRAINE SEAN C;;SAAD STEPHANIE S,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2004-08-27),https://lens.org/034-812-719-113-944,Patent Application,yes,20,54,2,2,0,G06F11/321;;G06F11/321;;G06F21/53;;G06F21/53,G06F9/44,717/124,0,0,,,,ACTIVE
467,CA,A1,CA 3050505 A1,046-367-371-280-735,2020-02-07,2020,CA 3050505 A,2019-07-24,US 201816057682 A,2018-08-07,ARTICLES AND COMPOSITIONS COMPRISING HOST POLYMERS AND CHROMOPHORES AND METHODS OF PRODUCING THE SAME,"Compositions and articles including host polymers and chromophores and methods of producing the same are provided. In an exemplary embodiment, an article includes a host polymer with a host polymer refractive index. The article also includes a chromophore with a chromophore refractive index that is greater than the host polymer refractive index. The chromophore refractive index changes with changes in an electric field, and the chromophore is dissolved within the host polymer. The article has an article refractive index that is between the host polymer refractive index and the chromophore refractive index.",GENERAL DYNAMICS MISSION SYSTEMS INC,SWAN MICHAEL CRAIG;;SYLVESTER GARRETT S;;ENG DAVID L K;;CARLSON WILLIAM B;;SULLIVAN PHILIP A;;PHELAN GREGORY D,,https://lens.org/046-367-371-280-735,Patent Application,no,0,0,4,4,0,C08F8/48;;C08F220/22;;C08F2810/20;;C08F2810/30;;C08F2810/50;;G02F1/3617;;G02F1/3615;;G02F1/061;;C08G18/8116;;C08G18/8061;;C08G18/2805;;C08G18/674;;C08G18/6765;;C08G18/678;;C08K5/5475;;G02F1/3611;;C09B23/0066;;C09B69/105;;C08K5/1535,G02F1/19;;G02B1/04;;H04B10/25,,0,0,,,,DISCONTINUED
468,EP,A1,EP 3613810 A1,119-143-515-306-02X,2020-02-26,2020,EP 19186437 A,2019-07-16,US 201816057682 A,2018-08-07,ARTICLES AND COMPOSITIONS COMPRISING HOST POLYMERS AND CHROMOPHORES AND METHODS OF PRODUCING THE SAME,"Compositions and articles including host polymers and chromophores and methods of producing the same are provided. In an exemplary embodiment, an article includes a host polymer with a host polymer refractive index. The article also includes a chromophore with a chromophore refractive index that is greater than the host polymer refractive index. The chromophore refractive index changes with changes in an electric field, and the chromophore is dissolved within the host polymer. The article has an article refractive index that is between the host polymer refractive index and the chromophore refractive index.
",GENERAL DYNAMICS MISSION SYSTEMS INC,SWAN MICHAEL CRAIG;;SYLVESTER GARRETT S;;ENG DAVID L K;;CARLSON WILLIAM B;;SULLIVAN PHILIP A;;PHELAN GREGORY D,,https://lens.org/119-143-515-306-02X,Patent Application,yes,3,0,4,4,0,C08F8/48;;C08F220/22;;C08F2810/20;;C08F2810/30;;C08F2810/50;;G02F1/3617;;G02F1/3615;;G02F1/061;;C08G18/8116;;C08G18/8061;;C08G18/2805;;C08G18/674;;C08G18/6765;;C08G18/678;;C08K5/5475;;G02F1/3611;;C09B23/0066;;C09B69/105;;C08K5/1535,C08L101/12;;C08F8/48;;C08F220/22;;C08F220/34;;C08F220/40;;C08G18/28;;C08G18/67;;C08G18/80;;C08G18/81;;C08J3/215;;C08J3/24;;C08J7/12;;C08K5/00;;C08K5/5475;;C08L33/14;;C08L101/04;;C09B67/00;;C09B69/10;;G02F1/061;;G02F1/361,,2,1,072-303-768-636-963,10.1063/1.126857,"SHI YONGQIANG ET AL: ""Electro-optic polymer modulators with 0.8 V half-wave voltage"", APPLIED PHYSICS LETTERS, A I P PUBLISHING LLC, US, vol. 77, no. 1, 3 July 2000 (2000-07-03), pages 1 - 3, XP012026007, ISSN: 0003-6951, DOI: 10.1063/1.126857;;CHENG ZHANGLARRY R. DALTON: ""Low V Electrooptic Modulators from CLD-1: Chromophore Design and Synthesis, Material Processing, and Characterization"", CHEMISTRY OR MATERIALS, vol. 13, 2001, pages 3043 - 3050",DISCONTINUED
469,AU,A,AU 1993/033210 A,158-055-139-082-062,1993-07-19,1993,AU 1993/033210 A,1992-12-11,US 81144891 A,1991-12-19,Refrigeration working fluid,,EXXON RESEARCH ENGINEERING CO,COMPANY EXXON RESEARCH AND ENG;;ANTIKA SHLOMO;;DIETZ THOMAS G;;SCHLOSBERG RICHARD H;;TURNER DAVID W;;WEISGERBER GEORGE A,,https://lens.org/158-055-139-082-062,Patent Application,no,0,0,3,3,0,C09K5/045;;C10M105/38;;C10M105/42;;C10M105/44;;C10M171/008;;C10M2207/283;;C10M2207/30;;C10M2211/022;;C10M2211/06;;C10N2040/00;;C10N2040/34;;C10N2040/30;;C10N2040/38;;C10N2040/40;;C10N2040/32;;C10N2040/42;;C10N2040/36;;C10N2040/44;;C10N2040/50;;C09K5/045;;C10M2211/06;;C10M105/44;;C10M171/008;;C10M105/38;;C10M105/42;;C10M2211/022;;C10M2207/283;;C10M2207/30;;C10N2040/00;;C10N2040/30;;C10N2040/32;;C10N2040/34;;C10N2040/36;;C10N2040/38;;C10N2040/40;;C10N2040/42;;C10N2040/44;;C10N2040/50,C09K5/04;;C10M105/38;;C10M105/42;;C10M105/44;;C10M171/00,,0,0,,,,PENDING
470,US,A1,US 2020/0033344 A1,155-925-890-424-10X,2020-01-30,2020,US 201916539742 A,2019-08-13,US 201916539742 A;;US 201615189646 A;;US 201615079013 A;;US 201314138991 A;;US 201361783529 P,2013-03-14,DETECTION METHODS EMPLOYING HCV CORE LIPID AND DNA BINDING DOMAIN MONOCLONAL ANTIBODIES,"The present disclosure provides detection methods employing HCV core lipid binding domain and DNA binding domain monoclonal antibodies or antibody fragments. In certain embodiments, the lipid binding domain monoclonal antibody or antibody fragment recognizes an epitope in amino acids 141 to 161 of HCV core protein and the DNA binding domain antibody or antibody fragment recognizes an epitope in amino acids 95-123 (e.g., in amino acids 99-117) of HCV core protein.",ABBOTT LAB;;ICAHN SCHOOL MED MOUNT SINAI,ZIEMANN ROBERT;;AHLBERG APRIL;;HAWKSWORTH DAVID;;TIEMAN BRYAN;;MUERHOFF A SCOTT;;MAROHNIC CHRISTOPHER;;OTIS KATHY;;BRANCH ANDREA;;ENG FRANCIS,ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (2017-01-10);;ABBOTT LABORATORIES (2017-06-19),https://lens.org/155-925-890-424-10X,Patent Application,yes,1,0,28,28,616,C07K2317/34;;C07K2317/92;;G01N2800/52;;C07K16/109;;G01N33/5767;;C07K16/109;;G01N2800/52;;C07K2317/34;;C07K2317/92;;G01N33/5767;;G01N2333/186;;G01N2469/10;;C07K2317/56,G01N33/576;;C07K16/10,,0,0,,,,DISCONTINUED
471,US,B2,US 10444242 B2,182-728-967-416-308,2019-10-15,2019,US 201615189646 A,2016-06-22,US 201615189646 A;;US 201615079013 A;;US 201314138991 A;;US 201361783529 P,2013-03-14,Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodies,"The present disclosure provides detection methods employing HCV core lipid binding domain and DNA binding domain monoclonal antibodies or antibody fragments. In certain embodiments, the lipid binding domain monoclonal antibody or antibody fragment recognizes an epitope in amino acids 141 to 161 of HCV core protein and the DNA binding domain antibody or antibody fragment recognizes an epitope in amino acids 95-123 (e.g., in amino acids 99-117) of HCV core protein.",ABBOTT LAB;;ICAHN SCHOOL MED MOUNT SINAI,ZIEMANN ROBERT;;AHLBERG APRIL;;HAWKSWORTH DAVID;;TIEMAN BRYAN;;MUERHOFF A SCOTT;;MAROHNIC CHRISTOPHER;;OTIS KATHY;;BRANCH ANDREA;;ENG FRANCIS,ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (2017-01-10);;ABBOTT LABORATORIES (2017-06-19),https://lens.org/182-728-967-416-308,Granted Patent,yes,237,0,28,28,616,C07K2317/34;;C07K2317/92;;G01N2800/52;;C07K16/109;;G01N33/5767;;C07K16/109;;G01N2800/52;;C07K2317/34;;C07K2317/92;;G01N33/5767;;G01N2333/186;;G01N2469/10;;C07K2317/56,G01N33/576;;C07K16/10,,232,176,005-576-090-054-612;;000-690-847-889-484;;033-261-430-402-230;;035-872-873-163-027;;174-783-722-981-415;;018-634-106-105-088;;028-385-018-876-542;;020-302-793-258-828;;025-395-146-381-464;;085-277-440-303-853;;033-688-911-017-272;;072-378-691-723-546;;001-071-432-838-232;;005-119-615-003-591;;100-049-580-404-573;;038-383-743-124-048;;130-545-497-144-994;;066-749-017-721-197;;011-962-497-035-168;;029-694-380-116-357;;075-499-401-604-101;;079-806-655-840-908;;043-425-934-172-29X;;008-195-244-544-850;;033-797-614-829-293;;009-217-085-655-748;;002-264-966-090-625;;045-973-584-083-157;;085-727-974-637-837;;006-672-302-443-262;;094-685-907-794-422;;031-693-481-397-220;;074-817-300-512-106;;004-693-912-584-687;;034-352-146-381-268;;004-701-796-869-470;;106-002-465-051-338;;025-046-032-214-179;;089-630-305-405-857;;021-485-212-364-595;;021-223-164-593-106;;133-481-101-889-252;;006-473-737-224-964;;052-396-504-150-679;;009-834-359-838-087;;133-481-101-889-252;;018-739-484-132-607;;019-056-777-302-554;;011-557-225-473-026;;123-418-483-972-881;;028-862-168-091-90X;;181-448-152-035-827;;024-566-886-688-557;;005-522-074-909-162;;087-448-981-335-707;;016-251-721-517-200;;065-145-385-150-339;;063-161-621-710-260;;018-961-022-027-383;;057-611-511-425-029;;024-741-755-965-636;;017-150-654-990-340;;022-395-830-273-268;;153-697-003-263-81X;;049-838-291-060-166;;000-645-926-070-618;;041-863-374-864-841;;018-846-180-145-197;;035-081-115-342-527;;042-580-612-937-564;;009-483-512-107-343;;039-668-643-193-383;;049-134-753-209-354;;024-995-475-936-443;;002-664-741-683-318;;034-331-211-704-877;;075-547-110-214-465;;029-611-134-469-353;;063-594-509-760-018;;008-295-808-131-540;;006-381-447-194-711;;028-513-653-434-288;;046-775-870-571-708;;112-204-849-270-508;;026-531-521-458-647;;010-968-985-790-331;;001-990-503-646-471;;096-243-714-380-025;;032-728-154-591-070;;016-599-925-793-124;;129-722-134-945-53X;;005-438-533-368-843;;022-023-983-891-895;;048-623-783-675-63X;;025-173-207-852-618;;085-764-009-624-439;;026-865-754-985-464;;064-741-687-897-846;;001-467-559-709-949;;069-144-826-896-138;;030-323-674-660-051;;032-937-042-023-803;;119-726-733-538-800;;008-243-180-100-102;;042-204-626-457-327;;014-729-984-201-416;;039-004-732-914-566;;027-477-313-726-928;;067-989-569-547-827;;047-388-844-780-414;;029-624-853-937-144;;026-048-786-530-595;;043-078-062-054-638;;119-988-581-178-446;;149-154-754-262-45X;;022-474-955-131-082;;022-839-958-943-325;;003-752-183-823-430;;063-263-492-125-344;;093-067-181-692-392;;070-972-809-242-473;;017-216-732-209-839;;095-386-846-016-358;;010-157-107-750-37X;;014-441-450-357-325;;073-554-764-469-216;;055-933-943-437-663;;071-707-020-428-907;;017-195-617-198-871;;039-676-361-532-623;;070-318-112-524-781;;051-940-176-386-905;;045-094-249-115-990;;003-097-377-914-607;;044-369-216-298-341;;102-998-349-535-48X;;006-574-964-805-278;;026-012-929-845-355;;168-113-989-624-417;;094-863-547-996-627;;000-690-847-889-484;;044-130-866-206-58X;;029-470-103-902-381;;040-084-261-148-364;;029-667-686-534-996;;038-836-532-167-549;;055-542-669-483-094;;000-528-468-811-462;;029-196-219-214-397;;086-764-123-669-338;;143-467-932-790-298;;123-171-555-829-362;;110-064-055-648-252;;022-749-691-910-241;;106-753-778-592-300;;028-556-422-116-012;;003-762-234-479-609;;045-149-256-448-908;;042-543-082-578-564;;012-911-427-937-162;;058-206-259-826-732;;012-369-544-741-057;;095-334-545-560-259;;024-362-609-661-351;;010-916-105-450-247;;129-277-633-038-069;;030-630-100-818-462;;071-155-323-758-994;;016-219-576-017-946;;036-653-867-344-303;;083-682-746-271-264;;018-765-831-306-27X;;030-607-398-087-475;;023-676-781-371-861;;019-080-688-368-615;;114-496-581-076-500,8603958;;10.1093/infdis/173.4.808;;10.1080/15216549800203412;;9762417;;1560463;;10.1016/0022-2836(92)91010-m;;1367769;;10.1038/nbt1291-1369;;10.1038/nbt1291-1373;;1369462;;10907088;;10.2144/00291ov01;;10.1016/0022-1759(89)90093-8;;2514231;;10.1073/pnas.79.22.6777;;pmc347216;;6294651;;1565653;;pmc48911;;10.1073/pnas.89.8.3576;;10.1038/ng0594-13;;8075633;;pmc2212477;;10.1084/jem.188.3.483;;9687526;;10.1002/j.1460-2075.1993.tb05706.x;;pmc413258;;7679990;;10.1073/pnas.0913380107;;10.2210/pdb3kqu/pdb;;10.2210/pdb3kqk/pdb;;pmc2818896;;20080715;;10.1016/0022-2836(92)90639-2;;1507232;;1385989;;10.3233/hab-1992-3204;;10.1093/bioinformatics/5.2.151;;2720464;;7529221;;10.1159/000150361;;8341653;;10.1073/pnas.90.14.6444;;pmc46948;;10.1093/nar/19.15.4133;;pmc328552;;1908075;;10.1016/s0167-5699(00)01667-4;;10916139;;10.1016/s0167-7799(97)84205-9;;9081300;;10.1099/0022-1317-81-8-1913;;10900028;;10.3171/jns.1989.71.1.0105;;2567778;;10.1038/264415a0;;1004567;;2531466;;10.1126/science.2531466;;10.1016/0076-6879(91)03005-2;;10.1016/0076-6879(91)96002-9;;1762568;;10.1073/pnas.85.16.5879;;3045807;;pmc281868;;10.1073/pnas.88.10.4084;;pmc51602;;1851991;;7897213;;10.4049/jimmunol.154.7.3310;;10.1016/s0021-9258(20)82142-5;;6327676;;2459288;;pmc2189025;;10.1084/jem.168.3.1099;;10.1093/clinchem/45.3.432;;10053055;;10.1038/341544a0;;2677748;;10933786;;010933786;;10.1021/bi000749m;;1717254;;pmc452979;;10.1002/j.1460-2075.1991.tb07819.x;;10.1016/s0021-9258(18)61209-8;;3558345;;2242580;;10.1093/clinchem/36.11.1969;;10.4049/jimmunol.155.4.1994;;7636250;;16806144;;10.1016/j.clinbiochem.2006.04.023;;10.1093/protein/8.10.1057;;8771187;;1656258;;10.1056/nejm199111073251901;;10.1021/bc0000280;;10995216;;10.1016/j.bmcl.2004.01.105;;15081031;;10.1016/j.bmcl.2005.11.062;;16343903;;10.1016/j.bmcl.2004.05.062;;15225697;;10.1021/bc0000280;;10995216;;14535708;;10.1021/ol035323p;;10.1021/ol990141+;;10823204;;10.1021/jo980047r;;1280771;;10.1056/nejm199212313272702;;10.1093/nar/25.17.3389;;9254694;;pmc146917;;7658022;;10.1016/0022-1759(95)00086-p;;pmc2409116;;18420934;;10.1126/science.1154315;;10.1016/s0009-9120(02)00343-0;;12413604;;8755564;;pmc38836;;10.1073/pnas.93.15.7843;;10.1073/pnas.91.9.3809;;pmc43671;;8170992;;pmc52428;;10.1073/pnas.88.18.7978;;1896445;;10.1110/ps.8.4.921;;10211839;;pmc2144313;;10.1126/science.3285471;;3285471;;10.4049/jimmunol.141.11.4053;;3141512;;pmc1536886;;6839548;;3140379;;10.1126/science.3140379;;10.1093/clinchem/38.11.2203;;1424112;;10.1038/nbt0697-553;;9181578;;pmc1193582;;16103187;;10.1128/jvi.79.17.11353-11365.2005;;10.1159/000462204;;1379394;;10.1111/j.1423-0410.1992.tb01201.x;;10.1016/0022-1759(95)00016-4;;7769243;;7423373;;10.1016/s0065-2776(08)60674-4;;7872158;;10685998;;10.1046/j.1537-2995.2000.40020143.x;;10.1073/pnas.89.10.4285;;1350088;;pmc49066;;2523562;;10.1126/science.2523562;;10.1016/0022-2836(87)90412-8;;3681981;;10.1038/342877a0;;2687698;;10.1016/0022-2836(92)90224-8;;1404389;;10.1038/352624a0;;1907718;;8232322;;10.1016/0161-5890(93)90097-u;;7516563;;10.1016/s0923-2494(94)80039-1;;10.1046/j.1537-2995.1994.34994378281.x;;8091469;;7511194;;10.1016/s0140-6736(94)92054-0;;7511196;;7511195;;10.1016/0002-8703(87)90645-4;;3591601;;10.1021/bi980270i;;9649307;;8923286;;10.1002/(sici)1096-9071(199611)50:3<221::aid-jmv3>3.0.co;2-b;;pmc554253;;10.1002/j.1460-2075.1985.tb03694.x;;3924594;;10.1002/ana.410250406;;2634975;;10.1590/s1517-83822011000100039;;pmc3768914;;24031636;;10.1128/jvi.01679-08;;pmc2655593;;19129450;;15718488;;10.1373/clinchem.2004.040089;;10.1016/0022-2836(70)90057-4;;5420325;;10.1038/312604a0;;6095112;;10.1016/0167-8140(96)01718-5;;8735485;;10.1073/pnas.88.8.3392;;pmc51453;;1849654;;10.1016/0161-5890(91)90163-e;;1905784;;10.1096/fasebj.9.1.7821752;;7821752;;2481588;;10.1002/eji.1830191209;;10.1073/pnas.85.8.2444;;pmc280013;;3162770;;17113062;;10.1016/j.cca.2006.10.006;;10.1016/s0378-1119(96)00627-0;;10.1016/s0969-2126(94)00113-8;;7704521;;8360482;;10.4049/jimmunol.151.5.2623;;pmc298637;;2513570;;10.1073/pnas.86.24.10029;;9145317;;10.1089/hyb.1997.16.153;;10.1002/1522-7243(200007/08)15:4<239::aid-bio587>3.0.co;2-w;;10931636;;10931637;;10.1002/1522-7243(200007/08)15:4<245::aid-bio588>3.0.co;2-3;;3127726;;10.1038/332323a0;;9356443;;10.1073/pnas.94.23.12297;;pmc24913;;8302875;;pmc521435;;10.1073/pnas.91.3.969;;10.1073/pnas.79.6.1979;;pmc346105;;6804947;;10.1099/0022-1317-77-11-2721;;8922465;;2761602;;10.1056/nejm198908313210904;;7576128;;10.1111/j.1600-0897.1995.tb00916.x;;10.1016/0378-1119(95)00821-7;;8647439;;2692852;;10.1007/bf00340712;;85430;;12869112;;10.1046/j.1537-2995.2003.00482.x;;10.1615/critrevimmunol.v22.i3.20;;12498382;;10.1074/jbc.m707329200;;17942391;;11986321;;10.1074/jbc.m202069200;;pmc47274;;8367454;;10.1073/pnas.90.17.7995;;7688398;;10.4049/jimmunol.151.4.2296;;3285470;;10.1126/science.3285470;;10.1016/0196-8858(81)90046-4;;9038083;;10.1093/protein/7.6.805;;7937712;;10.1128/jvi.75.17.8289-8297.2001;;pmc115073;;11483774;;pmc3203626;;10.1093/molbev/msr121;;21546353;;10.1038/314452a0;;3920533;;1475190;;10.1093/nar/20.23.6287;;pmc334518;;10512716;;10.1006/jmbi.1999.3128;;10.1093/nar/22.22.4673;;pmc308517;;7984417;;10.1038/6179;;10052355;;10.1073/pnas.77.7.4216;;pmc349802;;6933469;;10.1126/science.2451287;;2451287;;15903235;;10.1021/bp040016j;;7541226;;10.1002/jmr.300080122;;1724720;;10.1016/0003-2697(91)90424-r;;10.1038/321522a0;;3713831;;8338253;;1804254;;10.1111/j.1749-6632.1971.tb13550.x;;5290024;;10.1080/15216549800203412;;9762417;;10.3109/00365519909168335;;10.1080/00365519909168335;;10.1515/cclm.1999.159;;10726817;;10.1007/978-1-59259-385-9_10;;6292436;;10.1016/0022-2836(82)90103-6;;10.1016/s0958-1669(02)00354-3;;12482519;;10.1002/eji.1830240426;;8149964;;9371600;;10.1128/jvi.71.12.9400-9409.1997;;pmc230244;;10.1128/jvi.76.14.6944-6956.2002;;12072495;;pmc136341;;10.1002/eji.1830240308;;8125126;;8597629;;10.3233/hab-1995-6303;;10.1016/0161-5890(94)90100-7;;7935496;;10.1007/978-3-662-04605-0;;10.1046/j.1537-2995.1992.32993110750.x;;1471243;;1172191;;10.1038/256495a0;;10.1126/science.2496467;;2496467;;7108955;;10.1016/0022-2836(82)90515-0;;2218494;;10.1126/science.2218494;;10.1128/jcm.43.8.3877-3883.2005;;pmc1234013;;16081925;;7570915;;10.1046/j.1537-2995.1995.351096026366.x;;10.1126/science.3919445;;3919445;;10.1016/s0167-5699(00)01668-6;;10916138;;10.1006/jmbi.1996.0548;;8876650;;10.1007/978-1-4615-1291-2_2;;11418978;;10.1038/nbt0792-779;;1368267;;1882703;;10.1002/bio.1170060208;;10.1038/348552a0;;2247164;;10.1111/j.1751-1097.1965.tb09300.x;;10.1038/ng0297-146;;9020839;;10.1016/0140-6736(90)93377-2;;1979411;;1698283;;10.1093/nar/18.17.5322;;pmc332193;;10.1016/j.jviromet.2008.12.009;;19135481;;pmc392030;;10.1073/pnas.81.21.6851;;6436822;;10.1126/science.3929380;;3929380;;1642894;;6396369,"Wang et al. (Journal of Infectious Diseases, 1996, vol. 173, p. 808-821).;;Filatov, V.L. et al., “Epitope mapping of anti-troponin I monoclonal antibodies,” Biochem. Mol. Biol. Int. (1998) 45 (6):1179-1187.;;Foote, J. et al., “Antibody frame work residues affecting the confirmation of the hypervariable loops,” J. Mol. Biol. (1992) 224:487-499.;;Fuchs et al., “Targeting Recombinant Antibodies to the Surface of Echerichia coli: Fusion to a Peptidoglycan Associated Lipoprotein,” Biotechnology, 9:1370-1372 (1991).;;Garrard et al., FAB Assembly and Enrichment in a Monovalent Phage Display System, Biotechnology, 9:1373-1377 (1991).;;Gavilondo et al., “Antibody engineering at the millennium,” Biotechniques, (2000) 29(1):128-132, 134-136, 138.;;Giege, R. et al., “An introduction to the crystalligenesis of biological macromolecules,” Crystallization of Nucleic Acids and Proteins, a Practical Approach, 2nd Edition, Oxford University Press, New York (1999) 20 1-16.;;Gillies et al., “High-level expression of chimeric antibodies using adapted cDNA variable region cassettes,” J. Immunol. Methods (1989) 125:191-202.;;Goodson, J.M. et al., Medical Applications of Controlled Release, Chapter 6, Dental Applications (1984) 2:115-138.;;Gorman et al., “The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection,” Proc. Natl. Acad. Sci. USA (1982) 79(22):6777-6781.;;Gram et al., “In vitro selection and affinity maturation of antibodies from a naive combinatorial immunoglobulin library,” Proc. Natl. Acad. Sci. USA, 89(8):3576-3580 (1992).;;Green et al., “Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light Chain YACs,” Nat. Genet., 7(1):13-21 (1994).;;Green et al., “Regulation of B cell development by variable gene complexity in mice reconstituted with human immunoglobulin yeast artificial chromosomes,” J. Exp. Med., 188(3):483-495 (1998).;;Griffiths et al., “Human anti-self antibodies with high specificity from phage display libraries,” EMBO J., 12 (2):725-734 (1993).;;Gu et al., “Three conformational snapshots of the hepatitis C virus NS3 helicase reveal a ratchet translocation mechanism,” Proc. Natl. Acad. Sci. USA (2010) 107(2):521-528.;;Hawkins et al., “Selection of phage antibodies by binding affinity. Mimicking affinity maturation,” J. Mol. Biol., 226 (3):889-896 (1992).;;Hay et al., “Bacteriophage cloning and Escherichia coli expression of a human IgM Fab,” Hum. Antibodies Hybridomas, 3(2):81-85 (1992).;;Higgins et al., “Fast and sensitive multiple sequence alignments on a micro computer,” CABIOS (1989) 5(2):151-153.;;Hino, “Diagnosis of hepatitis C,” Intervirology, 37(2):77-86 (1994).;;Hollinger et al., ““Diabodies”: small bivalent and bispecific antibody fragments,” Proc. Natl. Acad. Sci. USA, 90 (14):6444-6448 (1993).;;Hoogenboom et al., “Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains,” Nucleic Acids Res., 19(15):4133-4137 (1991).;;Hoogenboom et al., “Natural and designer binding sites made by phage display technology,” Immunol. Today, 21 (8)371-378 (2000).;;Hoogenboom, “Designing and optimizing library selection strategies for generating high-affinity antibodies,” Trends Biotechnol., 15(2):62-70 (1997).;;Hope, et al., “Sequence motifs required for lipid droplet association and protein stability are 1, 6-9 and 19 unique to the hepatitus C virus core protein”. J Gen Virol. 2000 vol. 81(Pt. 8), p. 1913-1925; Abstract; p. 1914, Fig 1; p. 1915, col. 2, last para and Table 1; p. 1916, col. 1 and Fig 2; p. 1917, col. 2, top and middle para; p. 1918, col. 1, para 1; and p. 1919, Fig 3 (13 pages).;;Howard, M.A. et al., “Intracerebral drug delivery in rats with lesion-induced memory deficits,” J. Neurosurg. (1989) 71:105-112.;;Huber et al., “Crystallographic structure studies of an IgG molecule and an Fc fragment,” Nature, 264(5585):415-420 (1976).;;Huse et al., “Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda,” Science, 246(4935):1275-1281 (1989).;;Huston et al., “Protein engineering of single-chain Fv analogs and fusion proteins,” Methods Enzymol., 203:46-88 (1991).;;Huston et al., “Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli,” Proc. Natl. Acad. Sci. USA, 85(16):5879-5883 (1988).;;Hytest 1999 Product Catalog, 3 pages.;;Jayaraman et al., “Polymerase chain reaction-mediated gene synthesis: synthesis of a gene coding for isozyme C of horseradish peroxidase,” Proc. Natl. Acad. Sci. USA (1991) 88(10):4084-4088.;;Hytest 2000 General Product Catalog, 3 pages.;;Hytest 2001-2002 General Product Catalog, 3 pages.;;Hytest 2001 Cardiac Markers Panel, 4 pages.;;Hytest 2003 General Product Catalog, 3 pages.;;Hytest 2004-2005 General Product Catalog, 3 pages.;;Hytest 2004 Cardiac Markers Panel, 4 pages.;;Hytest 2005-2006 General Product Catalog, 3 pages.;;Hytest 2005 Markers of Cardiovascular Diseases Catalog, 4 pages.;;Hytest 2006-2007—General Product Catalog, 3 pages.;;Hytest 2007-2008 General Product Catalog, 3 pages.;;Hytest 2007 markers of Cardiovascular Diseases Catalog, 4 pages.;;Hytest 2008-2009 General Product Catalog, 3 pages.;;Hytest 2008 Markers of Cardiovascular Diseases and Metabolis Syndrome, 4 pages.;;International Search Report and Written Opinion for Application No. PCT/US2013/077487 dated Apr. 22, 2014 (23 pages).;;International Search Report and Written Opinion for Application No. PCT/US2010/024979 dated May 6, 2010 (16 pages).;;International Search Report and Written Opinion for Application No. PCT/US2013/077504 dated Jul. 1, 2014 (14 pages).;;Patent Cooperation Treaty, Notification of the International Search Report and Written Opinion for Application No. PCT/US2013/077499 dated May 20, 2014 (21 pages).;;Jackson et al., “In vitro antibody maturation. Improvement of a high affinity, neutralizing antibody against IL-1 beta,” J. Immunol., 154(7)3310-3319 (1995).;;Jay et al., “Chemical synthesis of a biologically active gene for human immune interferon-gamma. Prospect for site-specific mutagenesis and structure-function studies,” J. Biol. Chem. (1984) 259(10):6311-6317.;;Wallick, S.C. et al., “Glycosylation of a VH residue of a monoclonal antibody against alpha(1-6) dextran increases its affinity for antigens,” Exp. Med. (1988) 168:1099-1109.;;Wallemacq et al., “Evaluation of the new AxSYM cyclosporine assay: comparison with TDx monoclonal whole blood and Emit cyclosporine assays,” Clin. Chem., 45(3):432-435 (1999).;;Ward et al., “Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli,” Nature, 341(6242):544-546 (1989).;;West et al., “Crystal structure and immunoglobulin G binding properties of the human major histocompatibility complex-related Fc receptor(,),” Biochemistry, 39(32):9698-9708 (2000).;;Winnaker et al., From Genes to Cones, Verlagsgesellschaft, Weinheim, Germany (1987).;;Wright, A. et al., “Antibody variable region glycosylation: position effects on antigen binding and carbohydrate structure,” EMBO J. (1991) 10:2717-2723.;;Wu et al, “Receptor-mediated in vitro gene transformation by a soluble DNA carrier system,” J. Biol. Chem. (1987) 262:4429-4432.;;Yatscoff et al., “Abbott TDx monoclonal antibody assay evaluated for measuring cyclosporine in whole blood,” Clin. Chem., 36(11):1969-1973 (1990).;;Yelton et al., “Affinity maturation of the BR96 anti-carcinoma antibody by codon-based mutagenesis,” J. Immunol., 155(4):1994-2004 (1995).;;Ylikotila et al., “Utilization of recombinant fab fragments in a cTnl immunoassay conducted in spot wells,” Clinc. Biochem. (2006) 39:843-850.;;United States Patent Office Action for U.S. Appl. No. 14/139,053 dated Oct. 6, 2015 (15 pages).;;United States Patent Office Action for U.S. Appl. No. 14/139,108 dated Jan. 21, 2015 (11 pages).;;United States Patent Office Notice of Allowance for U.S. Appl. No. 14/139,108 dated Jul. 17, 2015 (5 pages).;;United States Patent Office Action for U.S. Appl. No. 12/391,937 dated Feb. 24, 2011 (15 pages).;;United States Patent Office Notice of Allowance for U.S. Appl. No. 12/391,937 dated Aug. 5, 2011 (13 pages).;;United States Patent Office Notice of Allowance for U.S. Appl. No. 14/035,420 dated Feb. 27, 2015 (8 pages).;;United States Patent Office Action for U.S. Appl. No. 14/035,420 dated Mar. 18, 2014 (9 pages).;;United States Patent Office Action for U.S. Appl. No. 90/012,377 dated Feb. 6, 2013 (15 pages).;;United States Patent Office Action for U.S. Appl. No. 14/461,082 dated Apr. 15, 2016 (7 pages).;;United States Patent Office Action for U.S. Appl. No. 14/138,053 dated May 4, 2016 (8 pages).;;United States Patent Office Advisory Action for U.S. Appl. No. 14/138,053 dated Jul. 20, 2016 (5 pages).;;United States Patent Office Action for U.S. Appl. No. 14/138,053 dated Oct. 21, 2016 (6 pages).;;United States Patent Office Action for U.S. Appl. No. 14/138,053 dated May 8, 2017 (10 pages).;;United States Patent Office Action for U.S. Appl. No. 14/851,471 dated Apr. 20, 2017 (14 pages).;;European Patent Office for Application No. 13878437.6 dated Sep. 1, 2017 (6 pages).;;United States Patent Office Action for U.S. Appl. No. 14/461,082 dated Aug. 9, 2017 (5 pages).;;United States Patent Office Action for U.S. Appl. No. 14/851,471 dated Aug. 9, 2017 (10 pages).;;European Patent Office for Application No. 13878042.4 dated Oct. 24, 2017 (4 pages).;;European Extended Search Report for Application No. 13878042.4 dated Sep. 29, 2016 (8 pages).;;European Extended Search Report for Application No. 13880371.3 dated Oct. 10, 2016 (13 pages).;;United States Patent Office Action for U.S. Appl. No. 14/138,991 dated Sep. 21, 2015 (9 pages).;;United States Patent Office Action for U.S. Appl. No. 14/138,991 dated Feb. 23, 2016 (7 pages).;;Zapata et al., “Engineering linear F(ab')2 fragments for efficient production in Escherichia coli and enhanced antiproliferative activity,” Protein Eng., 8(10):1057-1062 (1995).;;Aach et al., “Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays,” N. Engl. J. Med., 325(19):1325-1329 (1991).;;Adamczyk et al., “Modulation of the Chemiluminescent Signal from N10-(3-Sulfopropyl)-N-Sulfonylacridinium-9-carboxamides,” Tetrahedron, 55:10899-10914 (1999).;;Adamczyk et al., “Chemiluminescence quenching of pteroic acid-N-sulfonyl-acridinium-9-carboxamide conjugates by folate binding protein,” Bioorg. Med. Chem. Lett., 14(9):2313-2317 (2004).;;Adamczyk et al., “Chemiluminescent acridinium-9-carboxamide boronic acid probes: application to a homogeneous glycated hemoglobin assay,” Bioorg. Med. Chem. Lett., 16(5):1324-1328 (2006).;;Adamczyk et al., “Intrinsic factor-mediated modulation of cyanocobalamin-N-sulfonyl-acridinium-9-carboxamide chemiluminescence,” Bioorg. Med. Chem. Lett., 14(15):3917-3921 (2004).;;Adamczyk et al., “Linker-mediated modulation of the chemiluminescent signal from N(10)-(3-SulfopropyI)-N-sulfonylacridinium-9-carboxamide tracers,” Bioconjug. Chem., 11(5):714-724 (2000).;;Adamczyk et al., “Regiodependent luminescence quenching of biotinylated N-sulfonyl-acridinium-9-carboxamides by avidin,” Org. Lett., 5(21):3779-3782 (2003).;;Adamczyk et al., “Synthesis of a chemiluminescent acridinium hydroxylamine (AHA) for the direct detection of abasic sites in DNA,” Org. Lett. 1(5):779-781 (1999).;;Adamczyk et al., “Neopentyl 3-Triflyloxypropanesulfonate. A Reactive Sulfopropylation Reagent for the Preparation of Chemiluminescent Labels,” J. Org. Chem., 63:5636-5639 (1998).;;Alter et al., “The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team,” N. Engl. J. Med., 327(27):1899-1905 (1992).;;Altschul, S.F. et al., “Gapped BLAST and PSI-BLAST: a new generation of protein database search programs,” Nucleic Acids Res. (1997) 25:3389-3402.;;Ames et al., “Conversion of murine Fabs isolated from a combinatorial phage display library to full length immunoglobulins,” J. Immunol. Methods, 184(2):177-186 (1995).;;Anthony et al., “Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc,” Science, 320 (5874):373-376 (2008).;;Azzazy et al., “Phage display technology: clinical applications and recent innovations,” Clin. Biochem., 35(6):425-445 (2002).;;Babcook et al., “A novel strategy for generating monoclonal antibodies from single, isolated lymphocytes producing antibodies of defined specificities,” Proc. Natl. Acad. Sci. USA, 93(15):7843-7848 (1996).;;Barbas et al., “In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1 to enhance affinity and broaden strain cross-reactivity,” Proc. Natl. Acad. Sci. USA, 91(9):3809-3813 (1994).;;Barbas et al., “Assembly of combinatorial antibody libraries on phage surfaces: the gene III site,” Proc. Natl. Acad. Sci. USA, 88(18):7978-7982 (1991).;;Beckett et al., “A minimal peptide substrate in biotin holoenzyme synthetase-catalyzed biotinylation,” Protein Sci. (1999) 8(4):921-929.;;Better et al., “Escherichia coli secretion of an active chimeric antibody fragment,” Science, 240(4855):1041-1043 (1988).;;Biedler et al., “Cloning and high level expression of a chimeric antibody with specificity for human carcinoembryonic antigen,” J. Immunol., 141(11):4053-4060 (1988).;;Biewenga et al., “IgA1 half molecules in human multiple myeloma and the in vitro production of similar fragments from intact IgA1 molecules,” Clin. Exp. Immunol., 51(2):395-400 (1983).;;Bird et al., “Single-chain antigen-binding proteins,” Science, 242(4877):423-426 (1988).;;Bodor, G.S. et al., “Development of monoclonal antibodies for an assay of cardiac Troponin-I and preliminary results in suspected cases of myocardial infarction,” Clinical Chem. (1992) 38:2203-2214.;;Boder, E.T. et al., “Yeast surface display for screening combinatorial polypeptide libraries,” Nature Biotech. (1997) 15:553-557.;;Boulant et al., “Hepatitis C virus core protein is a dimeric alpha-helical protein exhibiting membrane protein features,” J. Virol., 79(17):11353-11365 (2005).;;Bresters et al., “Enhanced sensitivity of a second generation ELISA for antibody to hepatitis C virus,” Vox Sang, 62 (4):213-217 (1992).;;Brinkmann et al., “Phage display of disulfide-stabilized Fv fragments,” J. Immunol. Methods, 182(1):41-50 (1995).;;Buchwald, H. et al., “Long-term, continuous intravenous heparin administration by an implantable infusion pump in ambulatory patients with recurrent venous thrombosis,” Surgery (1980) 88:507-516.;;Burton et al., “Human antibodies from combinatorial libraries,” Adv. Immunol., 57:191-280 (1994).;;Busch et al., “Committee report. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: Report of the Interorganizational Task Force on Nucleic Acid Amplification Testing of Blood Donors,” Transfusion, 40(2):143-159 (2000).;;Carter et al., “Humanization of an anti-p185HER2 antibody for human cancer therapy,” Proc. Natl. Acad. Sci. USA, 89(10):4285-4289 (1992).;;Choo et al., “Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome,” Science, 244 (4902):359-362 (1989).;;Chothia et al., “Canonical structures for the hypervariable regions of immunoglobulins,” J. Mol. Biol., 196(4):901-917 (1987).;;Chothia et al., “Conformations of immunoglobulin hypervariable regions,” Nature, 342(6252):877-883 (1989).;;Chothia, C. et al., “Structural repertoire of the human VH segments,” J. Mol. Biol. (1992) 227:799-817.;;Clackson et al., “Making antibody fragments using phage display libraries,” Nature, 352(6336):624-628 (1991).;;Cleek et al., “Biodegradable polymeric carriers for a bFGF antibody for cardiovascular application,” Pro. Int. Symp. Control. Rel. Bioact. Mater (1997) 24:853-854.;;Co, M.S. et al., “Genetically engineered deglycosylation of the variable domain increases the affinity of an anti-CD33 monoclonal antibody,” Mol. Immunol (1993) 30:1361-1367.;;Colman, P.M., “Effects of amino acid sequence changes on antibody-antigen interactions,” Research in Immunology (1994) 145:33-36.;;Courouce et al., “Anti-hepatitis C virus (anti-HCV) seroconversion in patients undergoing hemodialysis: comparison of second- and third-generation anti-HCV assays,” Transfusion, 34(9):790-795 (1994).;;Courouce et al., “Significance of NS3 and NS5 antigens in screening for HCV antibody,” Lancet, 343 (8901):853-854 (1994).;;Cummins, B. et al., “Cardiac-specific troponin radioimmunoassay in the diagnosis of acute myocardial infarction,” Am. Heart Journal (1987) 113:1333-1344.;;Dall'Acqua et al., “Contribution of domain interface residues to the stability of antibody CH3 domain homodimers,” Biochemistry, 37(26):9266-9273 (1998).;;Ferns et al., “Characterisation of a panel of monoclonal antibodies raised against recombinant 1, 6, 9, and 19 HCV core protein”. J Med Virol. 1996 vol. 50(3), p. 221-229. Abstract (9 pages).;;Dijkema et al., “Cloning and expression of the chromosomal immune interferon gene of the rat,” EMBO J. (1985) 4 (3):761-767.;;During et al., “Controlled release of dopamine from a polymeric brain implant: in vivo characterization,” Ann. Neurol. (1989) 25:351-356.;;El-Emshaty et al., “Diagnostic performance of an immunoassay for simultaneous detection of HCV core antigen and antibodies among haemodialysis patients,”Brazilian Journal of Microbiology (2011) 42: 303-309.;;Eng et al., “Internal initiation stimulates production of p8 minicore, a member of a newly discovered family of hepatitis C virus core protein isoforms,” J. Virol., 83(7)3104-3114 (2009).;;Erikkson, S. et al., “Comparison of cardiac troponin. Immunoassays variably affected by circulating autoantibodies,” Clin. Chem. (2005) 51(5):848-855.;;Needleman et al., J. Mol. Biol. (1970) 48:443.;;Neuberger et al., “Recombinant antibodies possessing novel effector functions,” Nature (1984) 312:604-608.;;Ning et al., “Intratumoral radioimmunotherapy of a human colon cancer xenograft using a sustained-released gel,” Radiotherapy and Oncology (1996) 39:179-189.;;Ogata et al., “Nucleide sequence and mutation rate of the H strain of hepatitis C virus,” Proc. Natl. Acad. Sci. USA (1991) 88(8):3392-3396.;;Padlan et al., “A possible procedure for reducing the immunogenicity of antibody variable domains while preserving their ligand-binding properties,” Mol. Immunol., 28(4-5):489-498 (1991).;;Padlan et al., “Identification of specificity-determining residues in antibodies,” FASEB J., 9(1):133-139 (1995).;;Panina-Bordignon et al., “Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells,” Eur. J. Immunol., 19(12):2237-2242 (1989).;;Paul, Fundamental Immunology, 3rd Edition (1993) pp. 292-295, under the heading “FV Structure and Diversity in Three Dimensions”.;;Pearson et al., “Improved tools for biological sequence comparison,” Proc. Natl. Acad. Sci. (1988) 85:2444-2448.;;Peronnet et al., “Isoelectric point determination of cardiac troponin I forms present 1n plasma from patients with myocardial infarction,” (2007) 377(1-2):243-247.;;Persic et al., “An integrated vector system for the eukaryotic expression of antibodies or their fragments after selection from phage display libraries,” Gene, 187(1):9-18 (1997).;;Poljak, “Production and structure of diabodies,” Structure, 2(12):1121-1123 (1994).;;Presta et al., “Humanization of an antibody directed against IgE,” J. Immunol., 151(5):2623-2632 (1993).;;Queen et al., “A humanized antibody that binds to the interleukin 2 receptor,” Proc. Natl. Acad. Sci. USA (1989) 86 (24):10029-10033.;;Quinn, F. et al., “36 Bulk Reagent Random-access analyzer: Architect; 2000,” The Immunoassay Handbook, 2nd Edition (2001) 363-367.;;Rama, D. et al., “Epitope localization of monoclonal antibodies used in human troponin I immunoenzymometric assay,” Hybridoma (1997) 16(2):153-157.;;Razavi et al., “Stable and versatile active acridinium esters I,” Luminescence, 15(4):239-244 (2000).;;Razavi et al., “Stable and versatile active acridinium esters II,” Luminescence, 15(4):245-249 (2000).;;Reverse Translate a Protein (1998) (www.vivo.colostae.edu/molkit/translate/index.html), 1 page.;;Riechmann et al., “Reshaping human antibodies for therapy,” Nature, 332(6162):323-327 (1988).;;Roberts et al., “RNA-peptide fusions for the in vitro selection of peptides and proteins,” Proc. Natl. Acad. Sci. USA, 94(23):12297-12302 (1997).;;Roguska et al, “Humanization of murine monoclonal antibodies through variable domain resurfacing,” Proc. Natl. Acad. Sci. USA, 91(3):969-973 (1994).;;Rudikoff et al., “Single amino acid substitution altering antigen-binding specificity,” Proc. Natl. Acad. Sci USA (1982) 79(6):1979-1983.;;Sallberg et al., “Immunogenicity and antigenicity of the ATPase/helicase domain of the hepatitis C virus non-structural 3 protein,” J. Gen. Virol. (1996) 77(Pt 11):2721-2728.;;Sambrook et al., A Laboratory Manual, Molecular Cloning, 2nd Edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York (1989) 30 pages.;;Saudek et al., “A preliminary trial of the programmable implantable medication system for insulin delivery,” N. Engl. J. Med. (1989) 321:574-579.;;Sawai et al., “Direct production of the Fab fragment derived from the sperm immobilizing antibody using polymerase chain reaction and cDNA expression vectors,” Am. J. Reprod. Immunol., 34(1):26-34 (1995).;;Schier et al., “Identification of functional and structural amino-acid residues by parsimonious mutagenesis,” Gene, 169 (2):147-155 (1996).;;Schiestl et al., “High efficiency transformation of intact yeast cells using single stranded nucleic acids as a carrier,” Current Genetics (1989) 16(5-6):339-346.;;Seligmann et al., Immunochemical Study of a Human Myeloma IgG1 Half Molecule (*), Ann. Immunol., 129:855-870 (1978).;;Shah et al., “Combination HCV core antigen and antibody assay on a fully automated chemiluminescence analyzer,” Transfusion (2003) 43:1067-1074.;;Shapiro et al., “DNA target motifs of somatic mutagenesis in antibody genes,” Crit. Rev. Immunol., 22(3):183-200 (2002).;;Shavinskaya et al. (The Journal of Biological Chemistry 2007, p. 37158-37169).;;Shields, R.L. et al., “Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human FcyRIII and antibody dependent cellular toxicity,” J. Biol. Chem. (2002) 277:26733-26740.;;Shu et al., “Secretion of a single-gene-encoded immunoglobulin from myeloma cells,” Proc. Natl. Acad. Sci. USA, 90 (17):7995-7999 (1993).;;Sims et al., “A humanized CD18 antibody can block function without cell destruction,” J. Immunol., 151(4):2296-2308 (1993).;;Skerra et al., “Assembly of a functional immunoglobulin Fv fragment in Escherichia coli,” Science, 240 (4855):1038-1041 (1988).;;Smith et al., “Comparison of biosequences,” Appl. Math. (1981) 2:482-489.;;Song et al., “Antibody mediated lung targeting of long-circulating emulsions,” PDA Journal of Pharmaceutical Science and Technology (1995) 50:372-377.;;Studnicka et al., “Human-engineered monoclonal antibodies retain full specific binding activity by preserving non-CDR complementarity-modulating residues,” Protein Eng., 7(6):805-814 (1994).;;Table Showing Codon-amino acid Abbreviations (www.hgmd.cf.ac.uk/docs/cd_amino.html), printed Jan. 23, 2013, 3 pages.;;Tai et al., “Structural-based mutational analysis of the hepatitis C Virus NS3 helicase,” J. Virology (2001) 74 (17):8289-8207.;;Tamura et al., “MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods,” Mol. Biol. Evol., 28(10):2731-2739 (2011).;;Takeda et al., “Constsruction of chimaeric processed immunoglobulin genes containing mouse variable and human constant region sequences,” Nature (1985) 314:452-454.;;Taylor et al., “A transgenic mouse that expresses a diversity of human sequence heavy and light chain immunoglobulins,” Nucleic Acids Res., 20(23):6287-6295 (1992).;;Thies et al., “Folding and association of the antibody domain CH3: prolyl isomerization preceeds dimerization,” J. Mol. Biol., 293(1):67-79 (1999).;;Thompson et al., “Clustal W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice,” Nucleic Acids Res., 22(22):4673-4680 (1994).;;Umana et al., “Engineered glycoforms of an antineuro-blastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity,” Nat. Biotech. (1999) 17:176-181.;;Urlaub et al., “Isolation of Chinese hamster cell mutants deficient in dehydrofolate reductase activity,” Proc. Natl. Acad. Sci. (1980) 77:4216-4220.;;Verhoeyen et al., “Reshaping human antibodies: grafting an antilysozyme activity,” Science, 239(4847):1534-1536 (1988).;;Jefferis, R. et al., “Glycosylation of recombinant antibody therapeutics,” Biotechnol. Prog. (2005) 21:11-16.;;Johnsson et al., “Comparison of methods for immobilization to carboxymethyl dextran sensor surfaces by analysis of the specific activity of monoclonal antibodies,” J. Mol. Recognit., 8(1-2):125-131 (1995).;;Johnsson et al., “Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors,” Anal. Biochem., 198(2):268-277 (1991).;;Jones et al., “Replacing the complementarity-determining regions in a human antibody with those from a mouse,” Nature, 321(6069):522-525 (1986).;;Jonsson et al., “Introducing a biosensor based technology for real-time biospecific interaction analysis,” Ann. Biol. Clin. (Paris), 51(1):19-26 (1993).;;Jonsson et al., “Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology,” Biotechniques, 11(5):620-627 (1991).;;Kabat et al., “Attempts to locate complementarity-determining residues in the variable positions of light and heavy chains,” Ann. NY Acad. Sci., 190:382-393 (1971).;;Kabat et al, Sequences of Proteins of Immunological Interest, National Institutes of Health, Bethesda, Maryland (1987) and (1991), 4th Edition, 4 pages.;;Kabat et al., Sequences of Proteins of Immunological Interest, 5th Edition, Department of Health and Human Services, NIH Publication No. 91-3242 (1991), 11 pages.;;Katrukha et al., “Degradation of cardiac troponin: implication for reliable immunodetection,” Clin. Chem. (1998) 44 (12):2433-2440.;;Katrukha, “Troponin. Measurement: the concept of a precise immunoassay,” Clin. Lab. Internat. (2006) 30(5):14-16.;;Katrukha, “New approach to standardization of human cardiac Troponin I (cTnI),” Scand. J. Clin. Lab. Invest. (1999) 59(Suppl 230):124-127.;;Katrukha, “Biochemical factors influencing measurement of cardiac troponin I in serum,” Clin. Chem. Lab Med. (1999) 37(11/12):1091-1095.;;Katrukha, “Antibody selection strategies in cardiac troponin assays,” Cardiac Markers, Second Edition 173-185.;;Kaufman, R.J. et al., “Amplification and expression of sequences cotransfected with a modular dihydrofolate reductase complementary DNA gene,” Mol. Biol. (1982) 159:601-621.;;Kellerman et al., “Antibody discovery: the use of transgenic mice to generate human monoclonal antibodies for therapeutics,” Curr. Opin. Biotechnol., 13(6):593-597 (2002).;;Kettleborough et al., “Isolation of tumor cell-specific single-chain Fv from immunized mice using phage-antibody ibraries and the re-construction of whole antibodies from these antibody fragments,” Eur. J. Immunol., 24(4):952-958 (1994).;;Kim et al., “Mutational analysis of the hepatitis C virus RNA helicase,” J. Virology (1997) 71(12):9400-9409.;;Kim et al., “Template requirements for De Novo RNA synthesis by hepatitis C virus nonstructural protein 5B polymerase on the viral X RNA,” J. Virology (2002) 76(14):6944-6956.;;Kim et al., “Identifying amino acid residues that influence plasma clearance of murine IgG1 fragment by site-directed mutagenesis,” Eur. J. Immunol. (1994) 24(3):542-548.;;Kipriyanov, S.M. et al., “Single-chain antibody streptavidin fusions: tetrameric bifunctional ScFv-complexes with biotin binding activity and enhanced affinity to antigen,” Human Antibodies and Hybridomas (1995) 6:93-101.;;Kipriyanov, S.M. et al., “Recombinant single-chain Fv fragments carrying c-terminal cysteine residues: production of bivalent and biotinylated miniantibodies,” Mol. Immunol. (1994) 31:1047-1058.;;Kontermann, Antibody Engineering, p. 790, Springer-Verlag, New York (2001).;;Kleinman et al., “Increased detection of hepatitis C virus (HCV)-infected blood donors by a multiple-antigen HCV enzyme immunoassay,” Transfusion, 32(9):805-813 (1992).;;Kohler et al., “Continuous cultures of fused cells secreting antibody of predefined specificity,” Nature, 256 (5517):495-497 (1975).;;Kuo et al., “An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis,” Science, 244(4902):362-364 (1989).;;Kyte et al., “A simple method for displaying the hydropathic character of a protein,” J. Mol. Biol., 157(1):105-132 (1982).;;Lam et al., “Microencapsulation of recombinant humanized monoclonal antibody for local delivery,” Proc. Int'l Symp. Control Rel. Bioact. Mater. (1997) 24:759-760.;;Langer et al., “Chemical physical structure of polymers as carriers for controlled release of bioactive agents: a review,” J. Macromol. Sci. Rev. Macromol. Chem. (1983) 23:61-126.;;Langer et al., “New methods of drug delivery,” Science (1990) 249:1527-1533.;;Laperche et al., “Simultaneous Detection of Hepatitus C Virus (HVC) Core Antigen and Anti- 1, 6-9, and 19 HCV Antibodies Improves the Early Detection of HCV Infection”. J Clin Microbiol. 2005, vol. 43(8), p. 3877-3883. Entire Documentation, especially Abstract (8 pages).;;Lee et al., “Increased detection of hepatitis C virus infection in commercial plasma donors by a third-generation screening assay,” Transfusion, 35(10):845-849 (1995).;;Levy, R.J. et al., “Inhibition of calcification of bioprosthetic heart valves by local controlled-release diphosphonate,” Science (1985) 228:190-192.;;Little et al., “Of mice and men: hybridoma and recombinant antibodies,” Immunol. Today, 21(8):364-370 (2000).;;MacCallum et al., “Antibody-antigen interactions: contact analysis and binding site topography,” J. Mol. Biol., 262 (5):732-745 (1996).;;Marchalonis et al., “Evolutionary factors in the emergence of the combinatorial germline antibody repertoire,” Adv. Exp. Med. Biol., 484:13-30 (2001).;;Marks et al., “By-passing immunization: building high affinity human antibodies by chain shuffling,” Biotechnology (NY), 10(7):779-783 (1992).;;Mattingly, “Chemiluminescent 10-methyl-acridinium-9-(N-sulphonylcarboxamide) salts. Synthesis and kinetics of light emission,” J. Biolumin. Chemilumin., 6(2):107-114 (1991).;;McCafferty et al., “Phage antibodies: filamentous phage displaying antibody variable domains,” Nature, 348 (6301):552-554 (1990).;;McCapara et al., “Chemiluminescence Involving Peroxide Decompositions,” Photochemistry and Photobiology, 4:1111-1121 (1965).;;Medical Applicants of Controlled Release, Langer and Wise (eds), CRC Press, Boca Raton, Florida (1974).;;Mendez et al., “Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice,” Nat. Genet., 15(2):146-156 (1997).;;Mimms et al., “Specificity of anti-HCV ELISA assessed by reactivity to three immunodominant HCV regions,” Lancet, 336(8730):1590-1591 (1990).;;Mizushima et al., “pEF-BOS, a powerful mammalian expression vector,” Nucleic Acids Research (1990) 18:5322-5323.;;Morota et al., “A new sensitive and automated chemiluminescent microparticle immunoassay for quantitative determination of hepatitis C virus core antigen,” J. Virol. Methods, 157(1):8-14 (2009). et al.",ACTIVE
472,JP,A,JP 2020030405 A,049-352-468-883-10X,2020-02-27,2020,JP 2019142640 A,2019-08-02,US 201816057682 A,2018-08-07,"ARTICLES AND COMPOSITIONS COMPRISING HOST POLYMERS AND CHROMOPHORES, AND METHODS OF PRODUCING THE SAME","To provide compositions and articles comprising host polymers and chromophores, and methods of producing the same.SOLUTION: In an exemplary embodiment, an article contains a host polymer with a host polymer refractive index. The article also contains a chromophore with a chromophore refractive index that is greater than the host polymer refractive index. The chromophore refractive index changes with changes in an electric field, and the chromophore is dissolved in the host polymer. The article has an article refractive index that is between the host polymer refractive index and the chromophore refractive index.SELECTED DRAWING: Figure 1",GENERAL DYNAMICS MISSION SYSTEMS INC,MICHAEL CRAIG SWAN;;GARRETT S SYLVESTER;;DAVID L K ENG;;WILLIAM B CARLSON;;PHILIP A SULLIVAN;;GREGORY D PHELAN,,https://lens.org/049-352-468-883-10X,Patent Application,no,0,0,4,4,0,C08F8/48;;C08F220/22;;C08F2810/20;;C08F2810/30;;C08F2810/50;;G02F1/3617;;G02F1/3615;;G02F1/061;;C08G18/8116;;C08G18/8061;;C08G18/2805;;C08G18/674;;C08G18/6765;;C08G18/678;;C08K5/5475;;G02F1/3611;;C09B23/0066;;C09B69/105;;C08K5/1535,G02F1/361;;C08F20/24,,0,0,,,,PENDING
473,US,B2,US 7814308 B2,120-638-899-480-595,2010-10-12,2010,US 92912904 A,2004-08-27,US 92912904 A,2004-08-27,Debugging applications under different permissions,"A system and method that allows developers to debug a component while it is restricted by any arbitrary set of specific permissions, or restricted by an existing permission set associated with a security “zone.” A security sandbox is mimicked within the development environment so that developers can study how applications perform inside the sandbox. Developers are able create any sandbox and debug inside it, where violating any bound of the artificial sandbox will throw a security exception and drop the user out on the exact line of code which generated the error, as well as provide helpful information about how to correct the error.",MICROSOFT CORP,TEMPLIN DAVID KEHL;;FEE GREGORY DARRELL;;GRYKO IZYDOR;;CANTWELL JAMES GORDON;;ENG MICHAEL;;DRAINE SEAN CONWAY;;SAAD STEPHANIE SWEENY,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2004-08-27),https://lens.org/120-638-899-480-595,Granted Patent,yes,20,6,2,2,0,G06F11/321;;G06F11/321;;G06F21/53;;G06F21/53,H04L9/00,713/152;;713/166;;726/22;;717/117;;717/124;;717/127;;718/100,12,7,102-646-574-923-762;;150-496-162-467-81X;;102-646-574-923-762;;020-808-391-081-802;;006-919-915-428-42X;;069-989-887-235-557;;071-097-443-695-745,10.1109/4236.735984;;10.1145/68210.69220;;10.1109/4236.735984;;10.1109/acsac.2001.991522;;10.1145/937527.937528;;10.1145/583854.582452;;10.1145/581271.581273,"Support@iona.com, Running Orbix Java Clients, www.iona.com, 2000, pp. 1-7.;;Peterson et al, A Flexible Containment Mechanism for Executing Untrusted Code, USENIX, 2002, pp. 1-19.;;Valentin Razmov, Security in Untrusted Code Environments: Missing Pieces of the Puzzle, University of Washington, 2002, pp. 1-22.;;Downing et al, Dictionary of Computer and Internet Terms, 2000, pp. 1-3, 68-69, 122-123, 166-167, 290-291, 424-425, 468-469, 492-493.;;Aviel D. Rubin et al, Mobile Code Security, pp. 30-34, 1998 IEEE.;;David L. Black et al, ""The Mach Exception Handling Facility"", pp. 45-56, ACM SIGPLAN and SIGOPS workshop, 1988.;;Aviel D. Rubin, ""Mobile Code Security"", pp. 30-34, Internet Computing, IEEE, 1998.;;David M. Wheeler, ""Java Security Extensions for a Java Server in a Hostile Environment"", pp. 1-10 , Computer Security Applications Conference, 2001.;;Li Gong, Java 2 Platform Security Architecture, Version 1.0, pp. 1-70, Sun Microsystems, Inc., Oct. 1998.;;Jaeger, T. et al., ""Policy Management Using Access Control Spaces"", ACM Transactions on Information and System Security, Aug. 2003, 6(3), 327-364.;;Koved, L. et al., ""Access Rights Analysis for Java"", OOPSLA, 2002, 359-372.;;Swift, M.M. et al, Improving the Granularity of Access Control for Windows 2000,ACM Transactions on Information and System Security, Nov. 2002, 5(4), 398-437.",ACTIVE
474,US,A1,US 2003/0235227 A1,110-686-259-187-597,2003-12-25,2003,US 17480502 A,2002-06-19,US 17480502 A,2002-06-19,Spot-size-converted laser for unisolated transmission,"
    A transmit optical subassembly (TOSA) includes a spot-size-converted (SSC) semiconductor laser coupled to an optical fiber without a lens or isolator. The spot-size-converted semiconductor laser includes an active region and an expander region that expands the spot size of the laser while maintaining efficient active laser performance. The SSC laser is coupled to a submount and passively aligned to an optical fiber positioned within a V-shaped groove formed within the submount. The SSC laser includes a narrow far field advantageous for providing a high coupling efficiency and high quality data transmission. The SSC laser is resistant to back reflection and produces a 1.3 or 1.55 micron optical wavelength and a data rate ranging from 1 to 10 Gbps. The TOSA provides high coupled power due to narrow far field, with potential extra reflection resistance due to absorption and mode transfer losses in coupling reflections through the expander back into the active region. The TOSA meets industry specifications (SDH/SONET) for 15 km transmission and has a maximum optical path penalty of less than 1 dB at a bit error ratio of 10 ¹⁰ for up to 14 dB back reflection. 
",CHAND NARESH;;ENG JULIE;;FISCHER MARTIN CHRISTIAN;;KIELY PHILIP ANTHONY;;KLOTZKIN DAVID J.;;KOJIMA KEISUKE;;TOHMON GENJI;;XU YAN,CHAND NARESH;;ENG JULIE;;FISCHER MARTIN CHRISTIAN;;KIELY PHILIP ANTHONY;;KLOTZKIN DAVID J;;KOJIMA KEISUKE;;TOHMON GENJI;;XU YAN,AGERE SYSTEMS INC (2002-09-13);;TRIQUINT TECHNOLOGY HOLDING CO (2003-01-02),https://lens.org/110-686-259-187-597,Patent Application,yes,3,5,1,1,0,G02B6/1228;;G02B6/4203;;G02B6/4228;;H01S5/1014;;H01S5/32391;;H01S2301/185;;H01S5/02326;;H01S5/02251;;G02B6/1228;;H01S5/32391;;G02B6/4228;;H01S2301/185;;H01S5/1014;;G02B6/4203;;H01S5/02251;;H01S5/02326,G02B6/122;;G02B6/42;;H01S5/00;;H01S5/02;;H01S5/026;;H01S5/323,372 5,0,0,,,,DISCONTINUED
475,US,A1,US 2017/0052184 A1,188-643-912-338-379,2017-02-23,2017,US 201615189646 A,2016-06-22,US 201615189646 A;;US 201615079013 A;;US 201314138991 A;;US 201361783529 P,2013-03-14,DETECTION METHODS EMPLOYING HCV CORE LIPID AND DNA BINDING DOMAIN MONOCLONAL ANTIBODIES,"The present disclosure provides detection methods employing HCV core lipid binding domain and DNA binding domain monoclonal antibodies or antibody fragments. In certain embodiments, the lipid binding domain monoclonal antibody or antibody fragment recognizes an epitope in amino acids 141 to 161 of HCV core protein and the DNA binding domain antibody or antibody fragment recognizes an epitope in amino acids 95-123 (e.g., in amino acids 99-117) of HCV core protein.",ABBOTT LAB;;ICAHN SCHOOL MED MOUNT SINAI,ZIEMANN ROBERT;;AHLBERG APRIL;;HAWKSWORTH DAVID;;TIEMAN BRYAN;;MUERHOFF A SCOTT;;MAROHNIC CHRISTOPHER;;OTIS KATHY;;BRANCH ANDREA;;ENG FRANCIS,ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (2017-01-10);;ABBOTT LABORATORIES (2017-06-19),https://lens.org/188-643-912-338-379,Patent Application,yes,6,11,28,28,616,C07K2317/34;;C07K2317/92;;G01N2800/52;;C07K16/109;;G01N33/5767;;C07K16/109;;G01N2800/52;;C07K2317/34;;C07K2317/92;;G01N33/5767;;G01N2333/186;;G01N2469/10;;C07K2317/56,C07K16/10;;G01N33/576,,2,2,005-576-090-054-612;;005-576-090-054-612,8603958;;10.1093/infdis/173.4.808;;8603958;;10.1093/infdis/173.4.808,"Wang et al. (Journal of Infectious Diseases, 1996, Vol. 173, p. 808-821);;Wang et al. (Journal of Infectious Diseases, 1996, Vol. 173, p. 808-821)",ACTIVE
476,AU,B2,AU 2006/268183 B2,141-373-053-522-676,2012-08-09,2012,AU 2006/268183 A,2006-07-11,US 69759005 P;;US 2006/0027066 W,2005-07-11,Glutamate aggrecanase inhibitors,"The present invention relates to compounds of the formula (I), which are modulators of metalloproteinase activity. and pharmaceutically acceptable salts thereof, wherein W is -C(O)-, -OC(O)-, -NHC(O)-, -C(O)O-, Or -C(O)NH-; Ris phenyl, heteroaryl, biphenyl, bicyciic aryi, tricyclic aryl, bicyclic heteroaryl. or tricyclic heteroaryl, each optionally substituted with one or more of R or R, and when Ri is substituted with more than one of R or Re, the substituents can be identical or different; Ris hydrogen, (C -C) alkyl, (C-C) alkenyl, (C-C) alkynyl, -(CH)R , -OH, or -0-(C-C) alkyl; R is -COH, -CONH, -CONHOH, -CONHSOR, tetrazole, -SONHR, -SOH, -PO(OH)NH, -PO(OH)OR, -CONHR, -COOR, an acid mimetic group, or a 5 or 6-membered heterocycloalkyl or heteroaryl containing 1 to 4 heteroatoms selected from O, N, S; R is -COH, -CONH, -(CH)OR, or -CONRR;",WYETH CORP,SUM PHAIK-ENG;;IPEK MANUS;;HOW DAVID BRIAN;;FEYFANT ERIC;;XIANG JASON SHAOYUN;;SABATINI JOSHUA JAMES;;TAM STEVE YIKKAI,,https://lens.org/141-373-053-522-676,Granted Patent,no,2,0,28,28,0,C07B2200/07;;C07C231/16;;C07C233/83;;C07C235/84;;C07C237/22;;C07C237/42;;C07C259/06;;C07C323/32;;C07D213/38;;C07D213/82;;C07D239/26;;C07D239/42;;C07D277/30;;C07D307/52;;C07D307/68;;C07D307/79;;C07D307/85;;C07D317/58;;C07D333/20;;C07D333/22;;C07D333/28;;C07D333/38;;C07D409/04;;C07C2601/02;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/08;;C07C2603/18;;C07C2603/74;;A61P1/02;;A61P1/04;;A61P1/16;;A61P11/00;;A61P11/06;;A61P13/12;;A61P17/00;;A61P19/00;;A61P19/02;;A61P19/04;;A61P25/00;;A61P27/02;;A61P29/00;;A61P35/00;;A61P37/06;;A61P43/00;;A61P9/00;;A61P9/10;;A61P9/14;;A61P3/10;;C07D213/56;;C07D213/82;;C07D317/58;;C07D333/24;;C07D277/30;;C07D213/38;;C07D239/26;;C07D239/42;;C07D307/52;;A61K31/4196;;A61K31/4192;;C07D213/82;;C07D317/58;;C07D333/28;;C07D213/38;;C07D277/30;;C07C259/06;;C07D307/52;;C07D239/26;;C07D307/85;;C07D333/38;;C07C235/84;;C07C323/32;;C07C231/16;;C07D333/20;;C07D409/04;;C07D307/68;;C07C233/83;;C07C237/42;;C07D307/79;;C07D333/22;;C07B2200/07;;C07C237/22;;C07D239/42;;C07C2601/14;;C07C2602/08;;C07C2601/18;;C07C2603/18;;C07C2601/02;;C07C2603/74;;C07C2601/08,C07C237/22;;A61K31/166;;A61K31/36;;A61K31/381;;A61K31/426;;A61K31/4409;;C07C231/16;;C07C235/84;;C07C237/42;;C07C259/06;;C07C323/41;;C07D213/56;;C07D277/30;;C07D317/58;;C07D333/24,,2,2,133-138-970-429-276;;058-248-900-440-161,1732532;;10.1021/jm00079a003;;7057425;;10.1021/jm00344a018,"Makovec, F. et al., J. Med. Chem., 1992, vol. 35, pages 28-38;;Piper, J. R. et al., J. Med. Chem., 1982, vol. 25, pages 182-187",INACTIVE
477,US,A1,US 2020/0048428 A1,059-323-820-961-809,2020-02-13,2020,US 201816057682 A,2018-08-07,US 201816057682 A,2018-08-07,ARTICLES AND COMPOSITIONS COMPRISING HOST POLYMERS AND CHROMOPHORES AND METHODS OF PRODUCING THE SAME,"Compositions and articles including host polymers and chromophores and methods of producing the same are provided. In an exemplary embodiment, an article includes a host polymer with a host polymer refractive index. The article also includes a chromophore with a chromophore refractive index that is greater than the host polymer refractive index. The chromophore refractive index changes with changes in an electric field, and the chromophore is dissolved within the host polymer. The article has an article refractive index that is between the host polymer refractive index and the chromophore refractive index.",GENERAL DYNAMICS MISSION SYSTEMS INC,SWAN MICHAEL CRAIG;;SYLVESTER GARRETT S;;ENG DAVID L K;;CARLSON WILLIAM B;;SULLIVAN PHILIP A;;PHELAN GREGORY D,GENERAL DYNAMICS MISSION SYSTEMS INC (2018-07-25),https://lens.org/059-323-820-961-809,Patent Application,yes,3,2,4,4,0,C08F8/48;;C08F220/22;;C08F2810/20;;C08F2810/30;;C08F2810/50;;G02F1/3617;;G02F1/3615;;G02F1/061;;C08G18/8116;;C08G18/8061;;C08G18/2805;;C08G18/674;;C08G18/6765;;C08G18/678;;C08K5/5475;;G02F1/3611;;C09B23/0066;;C09B69/105;;C08K5/1535,C08K5/1535,,0,0,,,,DISCONTINUED
478,RS,B,RS 49879 B,035-442-794-773-783,2008-08-07,2008,YU 45896 A,1996-08-07,US 51260295 A,1995-08-08,PROCESS FOR MAKING AN EPOXIDE,"Postupak sinteze epoksida formule I, naznačen time da obuhvata sledeće korake: (a) spajanje jednog ekvivalenta alilacetonida formule II, gde je pomenuti alilacetonid rastvoren u izopropilacetatu, sa vodenim rastvorom natrijumbikarbonata i između 0.5 i 0.1 ekvivalenata 1,3-dihloro-5,5-dimetilhidantoina, hlađenje dobijene smeše između 5°C i 10°C, dodavanje vodenog rastvora natrijumjodida u višku, zagrevanjem reakcione smeše do temperature od 21°C do 25°C ili spajanje jednog ekvivalenta alilacetonida formule II, gde je pomenuti alilacetonid rastvoren u THF, sa vodenim rastvorom natrijumbikarbonata i sa jodom u višku; (b) ostavljanje dobijene smeše da odstoji od između 1 časa do 8 časova; (c) gašenje dodavanjem vodenog rastvora natrijumsulfita, da bi se formirao jodohidrin formule III, i (d) prevođenje jodohidrina formule III u epoksid formule I na uobičajen način.",MERCK & CO INC,ASKIN DAVID;;ENG KAN K.;;MALIGRES PETER E.;;REIDER PAUL J.;;ROSSEN KAI;;VOLANTE RA1PH P.;;UPADHYAY VEENA;;WEISSMAN STEVEN,,https://lens.org/035-442-794-773-783,Granted Patent,no,0,0,10,10,0,C07D263/52;;C07D413/06;;C07D413/06;;C07D263/52,C07D301/27;;C07D263/52;;C07D413/06,,0,0,,,,EXPIRED
479,EP,A1,EP 1919879 A1,147-262-277-174-451,2008-05-14,2008,EP 06790037 A,2006-08-29,US 2006/0033516 W;;US 71311205 P,2005-08-31,9-AMINOCARBONYLSUBSTITUTED DERIVATIVES OF GLYCYLCYCLINES,,WYETH CORP,SUM PHAIK-ENG;;MANSOUR TAREK SUHAYL;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES;;SHIM JAECHUL,,https://lens.org/147-262-277-174-451,Patent Application,yes,0,0,21,21,0,C07C237/26;;C07C271/22;;C07D207/416;;C07D209/42;;C07D213/81;;C07D213/82;;C07D215/48;;C07D307/68;;C07D307/84;;C07D317/34;;C07D333/38;;C07C2601/02;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2603/46;;C07C2603/74;;A61P31/04;;C07D237/26;;C07C271/22;;C07D209/42;;A61K31/165;;C07D333/38;;C07D307/84;;C07D207/416;;C07D209/42;;C07D213/82;;C07D213/81;;C07D215/48;;C07C271/22;;C07D317/34;;C07D307/68;;C07C237/26;;C07C2601/14;;C07C2601/02;;C07C2603/46;;C07C2601/04;;C07C2601/08;;C07C2603/74,C07D237/26;;A61K31/165;;C07C271/22;;C07D209/42;;C07D213/80;;C07D215/48;;C07D319/06;;C07D333/38,,0,0,,,,DISCONTINUED
480,AU,A1,AU 2006/285043 A1,108-128-410-117-64X,2007-03-08,2007,AU 2006/285043 A,2006-08-29,US 71311205 P;;US 2006/0033516 W,2005-08-31,9-aminocarbonylsubstituted derivatives of glycylcyclines,,WYETH CORP,HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;SHIM JAECHUL;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES;;MANSOUR TAREK SUHAYL;;SUM PHAIK-ENG,,https://lens.org/108-128-410-117-64X,Patent Application,no,0,0,21,21,0,C07C237/26;;C07C271/22;;C07D207/416;;C07D209/42;;C07D213/81;;C07D213/82;;C07D215/48;;C07D307/68;;C07D307/84;;C07D317/34;;C07D333/38;;C07C2601/02;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2603/46;;C07C2603/74;;A61P31/04;;C07D237/26;;C07C271/22;;C07D209/42;;A61K31/165;;C07D333/38;;C07D307/84;;C07D207/416;;C07D209/42;;C07D213/82;;C07D213/81;;C07D215/48;;C07C271/22;;C07D317/34;;C07D307/68;;C07C237/26;;C07C2601/14;;C07C2601/02;;C07C2603/46;;C07C2601/04;;C07C2601/08;;C07C2603/74,C07D237/26;;A61K31/165;;C07C271/22;;C07D209/42;;C07D213/80;;C07D215/48;;C07D319/06;;C07D333/38,,0,0,,,,DISCONTINUED
481,CR,A,CR 9773 A,012-218-307-459-789,2008-04-02,2008,CR 9773 A,2008-02-29,US 71311205 P,2005-08-31,DERIVADOS DE GLICILCICLINAS SUSTITUIDOS CON 9-AMINOCARBONILO,"Esta invencion suministra compuestos de la Formula I que tienen la estructura: donde R1, R2, R3 y A se definen en la especificacion o una sal farmaceuticamente aceptable de estos se utiliza como agentes antibacteriales. Los compuestos de acuerdo a la Formula (II): en donde Q, R4, R5 y R6 Y A que se definen en la especificacion se utilizan como intermedios quimicos.",WYETH CORP,SUM PHAIK-ENG;;MANSOUR TAREK SUHAYL;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES;;SHIM JAECHUL,,https://lens.org/012-218-307-459-789,Patent Application,no,0,0,21,21,0,C07C237/26;;C07C271/22;;C07D207/416;;C07D209/42;;C07D213/81;;C07D213/82;;C07D215/48;;C07D307/68;;C07D307/84;;C07D317/34;;C07D333/38;;C07C2601/02;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2603/46;;C07C2603/74;;A61P31/04;;C07D237/26;;C07C271/22;;C07D209/42;;A61K31/165;;C07D333/38;;C07D307/84;;C07D207/416;;C07D209/42;;C07D213/82;;C07D213/81;;C07D215/48;;C07C271/22;;C07D317/34;;C07D307/68;;C07C237/26;;C07C2601/14;;C07C2601/02;;C07C2603/46;;C07C2601/04;;C07C2601/08;;C07C2603/74,C07D237/26,,0,0,,,,DISCONTINUED
482,TW,A,TW 200800209 A,098-394-023-506-662,2008-01-01,2008,TW 95125258 A,2006-07-11,US 69759005 P,2005-07-11,Glutamate aggrecanase inhibitors,The present invention relates to modulators of metalloproteinase activity.,WYETH CORP,SUM PHAIK-ENG;;HOW DAVID BRIAN;;SABATINI JOSHUA JAMES;;XIANG JASON SHAOYUN;;IPEK MANUS;;TAM STEVE YIK-KAI;;FEYFANT ERIC,,https://lens.org/098-394-023-506-662,Patent of Addition,no,0,0,28,28,0,C07B2200/07;;C07C231/16;;C07C233/83;;C07C235/84;;C07C237/22;;C07C237/42;;C07C259/06;;C07C323/32;;C07D213/38;;C07D213/82;;C07D239/26;;C07D239/42;;C07D277/30;;C07D307/52;;C07D307/68;;C07D307/79;;C07D307/85;;C07D317/58;;C07D333/20;;C07D333/22;;C07D333/28;;C07D333/38;;C07D409/04;;C07C2601/02;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/08;;C07C2603/18;;C07C2603/74;;A61P1/02;;A61P1/04;;A61P1/16;;A61P11/00;;A61P11/06;;A61P13/12;;A61P17/00;;A61P19/00;;A61P19/02;;A61P19/04;;A61P25/00;;A61P27/02;;A61P29/00;;A61P35/00;;A61P37/06;;A61P43/00;;A61P9/00;;A61P9/10;;A61P9/14;;A61P3/10;;C07D213/56;;C07D213/82;;C07D317/58;;C07D333/24;;C07D277/30;;C07D213/38;;C07D239/26;;C07D239/42;;C07D307/52;;A61K31/4196;;A61K31/4192;;C07D213/82;;C07D317/58;;C07D333/28;;C07D213/38;;C07D277/30;;C07C259/06;;C07D307/52;;C07D239/26;;C07D307/85;;C07D333/38;;C07C235/84;;C07C323/32;;C07C231/16;;C07D333/20;;C07D409/04;;C07D307/68;;C07C233/83;;C07C237/42;;C07D307/79;;C07D333/22;;C07B2200/07;;C07C237/22;;C07D239/42;;C07C2601/14;;C07C2602/08;;C07C2601/18;;C07C2603/18;;C07C2601/02;;C07C2603/74;;C07C2601/08,A61K31/505;;A61K31/165;;A61K31/198,,0,0,,,,PENDING
483,WO,A1,WO 2007/027599 A1,095-668-345-509-74X,2007-03-08,2007,US 2006/0033516 W,2006-08-29,US 71311205 P,2005-08-31,9-AMINOCARBONYLSUBSTITUTED DERIVATIVES OF GLYCYLCYCLINES,"This invention provides compounds of Formula (I) having the structure where R 1 , R 2 , R 3 and A are defined in the specification or a pharmaceutically acceptable salt thereof useful as antibacterial agents. Compounds according to Formula (II): where Q, R 4 , R 5 , and R 6 and A are defined in the specification are useful as chemical intermediates.",WYETH CORP;;SUM PHAIK-ENG;;MANSOUR TAREK SUHAYL;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES;;SHIM JAECHUL,SUM PHAIK-ENG;;MANSOUR TAREK SUHAYL;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES;;SHIM JAECHUL,,https://lens.org/095-668-345-509-74X,Patent Application,yes,6,1,21,21,0,C07C237/26;;C07C271/22;;C07D207/416;;C07D209/42;;C07D213/81;;C07D213/82;;C07D215/48;;C07D307/68;;C07D307/84;;C07D317/34;;C07D333/38;;C07C2601/02;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2603/46;;C07C2603/74;;A61P31/04;;C07D237/26;;C07C271/22;;C07D209/42;;A61K31/165;;C07D333/38;;C07D307/84;;C07D207/416;;C07D209/42;;C07D213/82;;C07D213/81;;C07D215/48;;C07C271/22;;C07D317/34;;C07D307/68;;C07C237/26;;C07C2601/14;;C07C2601/02;;C07C2603/46;;C07C2601/04;;C07C2601/08;;C07C2603/74,C07D237/26;;A61K31/165;;C07C271/22;;C07D209/42;;C07D213/80;;C07D215/48;;C07D319/06;;C07D333/38,,1,1,148-332-819-466-078,10.1021/jm00027a023;;8289194,"P.-E SUM ET AL: ""Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines"", JOURNAL OF MEDICINAL CHEMISTRY., vol. 37, no. 1, 1994, USAMERICAN CHEMICAL SOCIETY. WASHINGTON., pages 184 - 188, XP002417786",PENDING
484,PE,A1,PE 20070428 A1,103-188-418-968-863,2007-06-07,2007,PE 2006001055 A,2006-08-31,US 71311205 P,2005-08-31,DERIVADOS DE GLICILCICLINAS SUSTITUIDOS CON 9-AMINOCARBONILO COMO AGENTES ANTIBACTERIANOS,"SE REFIERE A COMPUESTOS DE FORMULA (I) DONDE A ES UN COMPUESTO DE FORMULA (II) O ESTA AUSENTE, DONDE R4 ES H, ALQUILO(C1-C12) OPCIONALMENTE SUSTITUIDO CON HALOGENO, AMINO, CN, ENTRE OTROS SUSTITUYENTES, ALQUENILO(C2-C12) OPCIONALMENTE SUSTITUIDO, ENTRE OTROS; R1 ES H, OH, AMINO, HALOGENO, ENTRE OTROS; R2 ES H, HALOGENO, ALQUILO(C1-C12) OPCIONALMENTE SUSTITUIDO CON AMINO, CN, FENILO, ENTRE OTROS SUSTITUYENTES, ALQUENILO(C2-C12) OPCIONALMENTE SUSTITUIDO, ENTRE OTROS; R3 ES UN COMPUESTO DE FORMULA (III), (IV), ENTRE OTROS, DONDE R5 ES ALQUILO(C1-C12) OPCIONALMENTE SUSTITUIDO, ARALQUILO(C7-C16), ALQUENILO(C2-C12), ENTRE OTROS; R6 ES H, CICLOALQUILO(C3-C6) O ALQUILO(C1-C12) OPCIONALMENTE SUSTITUIDO CON HALOGENO, CN, FENILO, ENTRE OTROS SUSTITUYENTES; R10 ES H O ALQUILO(C1-C12). SON COMPUESTOS PREFERIDOS: 2-METILPROPANOATO DE ({[(2-{[(7S,10aS)-9-(AMINOCARBONIL)-4,7-BIS(DIMETILAMINO)-1,8,10a,11-TETRAHIDROXI-10,12-DIOXO-5,5a,6,6a,7,10,10a,12-OCTAHIDROTETRACEN-2-IL]AMINO}-2-OXOETIL)(BUTIL)AMINO]CARBONIL}OXI)METILO, 4-METOXIBENZOATO DE ({[(2-{[(7S,10aS)-9-(AMINOCARBONIL)-4,7-BIS(DIMETILAMINO)-1,8,10a,11-TETRAHIDROXI-10,12-DIOXO-5,5a,6,6a,7,10,10a,12-OCTAHIDROTETRACEN-2-IL]AMINO}-2-OXOETIL)(BUTIL)AMINO]CARBONIL}OXI)METILO, ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA Y UN PROCEDIMIENTO DE PREPARACION. DICHOS COMPUESTOS SON ANTIBACTERIANOS",WYETH CORP,SUM PHAIK-ENG;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES;;SHIM JAECHUL;;MANSOUR TAREK SUHAYL;;HOW DAVID BRIAN,,https://lens.org/103-188-418-968-863,Patent Application,no,0,0,21,21,0,C07C237/26;;C07C271/22;;C07D207/416;;C07D209/42;;C07D213/81;;C07D213/82;;C07D215/48;;C07D307/68;;C07D307/84;;C07D317/34;;C07D333/38;;C07C2601/02;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2603/46;;C07C2603/74;;A61P31/04;;C07D237/26;;C07C271/22;;C07D209/42;;A61K31/165;;C07D333/38;;C07D307/84;;C07D207/416;;C07D209/42;;C07D213/82;;C07D213/81;;C07D215/48;;C07C271/22;;C07D317/34;;C07D307/68;;C07C237/26;;C07C2601/14;;C07C2601/02;;C07C2603/46;;C07C2601/04;;C07C2601/08;;C07C2603/74,A61K31/165;;C07C271/22;;C07D209/42;;C07D213/80;;C07D215/48;;C07D237/26;;C07D319/06;;C07D333/38,,0,0,,,,DISCONTINUED
485,AR,A1,AR 057978 A1,098-156-931-224-296,2008-01-09,2008,AR P060103829 A,2006-08-31,US 71311205 P,2005-08-31,"COMPUESTOS PARA TRATAR UN DESORDEN DEL SISTEMA NERVIOSO CENTRAL RELACIONADO CON O AFECTADO POR EL RECEPTOR 5-HT6, COMPOSICION FARMACEUTICA QUE LO CONTIENE Y METODO PARA LA PREPARACION DEL COMPUESTO","Reivindicacion 1: Un compuesto representado por la formula (1); caracterizado porque A es un resto de estructura de formula (2) o está ausente; R1 se selecciona de hidrogeno, -OH, amino, -NR7R8, halogeno, alquilo C1-12, opcionalmente sustituidos con 1 a 3 sustituyentes independientemente seleccionados del grupo de halogeno, amino, ciano, cicloalquilo C3-6, alquilo C1-12, fenilo, hidroxilo, alcoxi C1-12, N-alquilo C1-12, N-cicloalquilo C3-6, heterociclilo de 3 a 8 átomos en anillo, arilo, ariloxi y N-(alquilo C1-12)arilo, en donde dicho arilo, ariloxi y arilo del N(alquilo C1-12)-arilo puede ser opcionalmente sustituido con 1 a 3 sustituyentes independientemente seleccionados de halogeno, nitro, ciano, alquenilo, hidroxilo, alquilo, haloalquilo, alcoxi, amino, alquilamino, dialquilamino, carboxilo, alcoxicarbonilo, aril-C(O)-, CH3-C(O)-NH-, aralquilo, ariloxi, heterociclilo y fenilo, alquenilo C2-12 opcionalmente sustituidos con 1 a 3 sustituyentes independientemente seleccionados del grupo de fenilo, heteroarilo, halogeno, amino, ciano, alquilo, hidroxilo, alcoxi, arilo, alquinilo y N-(alquilo C1-12)-arilo, en donde dicho arilo y arilo de N-(alquilo C1-12)-arilo puede ser opcionalmente sustituido con 1 a 3 sustituyentes independientemente seleccionados de halogeno, nitro, ciano, alquenilo, hidroxilo, alquilo, haloalquilo, alcoxi, amino, alquilamino, dialquilamino, carboxilo, alcoxicarbonilo, aril-C(O)-, CH3-C(O)-NH-, ariloxi, heterociclilo y fenilo, y alquinilo C2-12 opcionalmente sustituido con 1 a 3 sustituyentes independientemente seleccionados del grupo halogeno, amino, ciano, alquilo, hidroxilo, y alcoxi; R2 se selecciona de hidrogeno, halogeno, alquilo C1-12, opcionalmente sustituidos con 1 a 3 sustituyentes independientemente seleccionados del grupo de halogeno, amino, ciano, cicloalquilo C3-6, alquilo C1-12, fenilo, hidroxilo, alcoxi C1-12, N-alquilo C1-12, N-cicloalquilo C3-6, heterociclilo de 3 a 8 átomos en anillo, arilo, ariloxi y N-(alquilo C1-12)-arilo, en donde dicho arilo, ariloxi y arilo del N-(alquilo C1-12)-arilo puede ser opcionalmente sustituido con 1 a 3 sustituyentes independientemente seleccionados de halogeno, nitro, ciano, alquenilo, hidroxilo, alquilo, haloalquilo, alcoxi, amino, alquilamino, dialquilamino, carboxilo, alcoxicarbonilo, aril-C(O)-, CH3-C(O)-NH-, aralquilo, ariloxi, heterociclilo y fenilo, alquenilo C2-12 opcionalmente sustituidos con 1 a 3 sustituyentes independientemente seleccionados del grupo de fenilo, heteroarilo, halogeno, amino, ciano, alquilo, hidroxilo, alcoxi, arilo, alquinilo y N-(alquilo C1-12)-arilo, en donde dicho arilo y arilo del N-(alquilo C1-12)-arilo puede ser opcionalmente sustituido con 1 a 3 sustituyentes independientemente seleccionados de halogeno, nitro, ciano, alquenilo, hidroxilo, alquilo, haloalquilo, alcoxi, amino, alquilamino, dialquilamino, carboxilo, alcoxicarbonilo, aril-C(O)-, CH3-C(O)-NH-, aralquilo, ariloxi, heterociclilo y fenilo, y alquinilo C2-12 opcionalmente sustituido con 1 a 3 sustituyentes independientemente seleccionados del grupo halogeno, amino, ciano, alquilo, hidroxilo, y alcoxi; R3 es una parte de R9, o un resto seleccionado del grupo de formulas (3); R4 se selecciona de hidrogeno, alquilo C1-12, opcionalmente sustituidos con 1 a 3 sustituyentes independientemente seleccionados del grupo de halogeno, amino, ciano, cicloalquilo C3-6, alquilo C1-12, fenilo, hidroxilo, alcoxi C1-12, N-alquilo C1-12, N-cicloalquilo C3-6, heterociclilo de 3 a 8 átomos en anillo, arilo, ariloxi y N-(alquilo C1-12)-arilo, en donde dicho arilo, ariloxi y arilo del N-(alquilo C1-12)-arilo puede ser opcionalmente sustituido con 1 a 3 sustituyentes independientemente seleccionados de halogeno, nitro, ciano, alquenilo, hidroxilo, alquilo, haloalquilo, alcoxi, amino, alquilamino, dialquilamino, carboxilo, alcoxicarbonilo, aril-C(O)-, CH3-C(O)-NH-, aralquilo, ariloxi, heterociclilo y fenilo, alquenilo C2-12 opcionalmente sustituidos con 1 a 3 sustituyentes independientemente seleccionados del grupo de fenilo, heteroarilo, halogeno, amino, ciano, alquilo, hidroxilo, alcoxi, arilo, alquinilo y N-(alquilo C1-12)-arilo, en donde dicho arilo y arilo del N- (alquilo C1-12)-arilo puede ser opcionalmente sustituido con 1 a 3 sustituyentes independientemente seleccionados de halogeno, nitro, ciano, alquenilo, hidroxilo, alquilo, haloalquilo, alcoxi, amino, alquilamino, dialquilamino, carboxilo, alcoxicarbonilo, aril-C(O)-, CH3-C(O)-NH-, aralquilo, ariloxi, heterociclilo y fenilo, alquinilo C2-12 opcionalmente sustituido con 1 a 3 sustituyentes independientemente seleccionados del grupo halogeno, amino, ciano, alquilo, hidroxilo, y alcoxi, arilo de 6, 10 o 14 átomos de carbono dicho arilo es opcionalmente sustituido con 1 a 3 sustituyentes independientemente seleccionados entre halogeno, nitro, ciano, alquenilo, hidroxilo, alquilo, haloalquilo, alcoxi, amino, alquilamino, dialquilamino, carboxilo, alcoxicarbonilo, aril-C(O)-, CH3-C(O)-NH-, aralquilo, ariloxi, heterociclilo y fenilo, N-(alquilo C1-12)-arilo, dicho arilo es opcionalmente sustituido con 1 a 3 sustituyentes independientemente seleccionados entre halogeno, nitro, ciano, alquenilo, hidroxilo, alquilo, haloalquilo, alcoxi, amino, alquilamino, dialquilamino, carboxilo, alcoxicarbonilo, aril-C(O)-, CH3-C(O)-NH-, aralquilo, ariloxi, heterociclilo y fenilo, aralquilo de 7 a 16 átomos de carbono opcionalmente sustituido, aroilo de 7 a 13 átomos de carbono opcionalmente sustituidos, SR3, heteroarilo opcionalmente sustituido y heteroarilcarbonilo opcionalmente sustituido; R5 se selecciona de alquilo C1-12 opcionalmente sustituidos con 1 a 3 sustituyentes independientemente seleccionados del grupo de halogeno, amino, ciano, cicloalquilo C3-6, alquilo C1-12, fenilo, hidroxilo, alcoxi C1-12, N-alquilo C1-12, N-cicloalquilo C3-6, heterociclilo de 3 a 8 átomos en anillo, arilo de 6, 10 o 14 átomos de carbono, ariloxi y N-(alquilo C1-12)-arilo, en donde dicho arilo, ariloxi y arilo del N-(alquilo C1-12)-arilo, puede ser opcionalmente sustituido con 1 a 3 sustituyentes independientemente seleccionados entre halogeno, nitro, ciano, alquenilo, hidroxilo, alquilo, haloalquilo, alcoxi, amino, alquilamino, dialquilamino, carboxilo, alcoxicarbonilo, aril-C(O)-, CH3-C(O)-NH-, aralquilo, ariloxi, heterociclilo y fenilo, aralquilo C7-16 opcionalmente sustituido, aroilo, -CH2-(CO)OCH2- arilo, dicho arilo es opcionalmente sustituido con 1 a 3 sustituyentes independientemente seleccionados entre halogeno, nitro, ciano, alquenilo, hidroxilo, alquilo, haloalquilo, alcoxi, amino, alquilamino, dialquilamino, carboxilo, alcoxicarbonilo, ariloxi y fenilo, alquenilo C2-12 opcionalmente sustituido, heteroarilo opcionalmente sustituido, arilo de 6, 10 o 14 átomos de carbono opcionalmente sustituido, alquinilo C2-12 opcionalmente sustituido, cicloalquilo de3 a 6 átomos en anillo, aril- CH=CH-, cicloalquil-alquilo; y adamantilo; R6 se selecciona de hidrogeno, alquilo C1-12 opcionalmente sustituidos con 1 a 3 sustituyentes independientemente seleccionados del grupo de halogeno, amino, ciano, cicloalquilo C3-6, alquilo C1-12, fenilo, hidroxilo, alcoxi C1-12, N-alquilo C1-12, N-cicloalquilo C3-6, heterociclilo de 3 a 8 átomos en anillo, arilo, ariloxi y N-(alquilo C1-12)-arilo, en donde dicho arilo, ariloxi y arilo del N-(alquilo C1-12)-arilo puede ser opcionalmente sustituido con 1 a 3 sustituyentes independientemente seleccionados de halogeno, nitro, ciano, alquenilo, hidroxilo, alquilo, haloalquilo, alcoxi, amino, alquilamino, dialquilamino, carboxilo, alcoxicarbonilo, aril-C(O)-, CH3-C(O)-NH-, aralquilo, ariloxi, heterociclilo y fenilo, y cicloalquilo C3-6; R7 y R8 son cada uno independientemente H o alquilo C1-12 o R7 y R8 cuando son opcionalmente tomados juntos con el átomo de nitrogeno al cual cada uno está sujeto forman un anillo heterociclilo de 3 a 8 miembros; R9 es aralquilo C7-16 opcionalmente sustituido o alquilo C1-12; R10 es H o alquilo C1-12; o una sal farmacéuticamente aceptable de éstos.",WYETH CORP,SUM PHAIK-ENG;;HOW DAVID BRAIN;;MANSOUR TAREK SUHAYI;;SHIM JAECHUL;;HOOPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES,,https://lens.org/098-156-931-224-296,Patent Application,no,0,0,21,21,0,C07C237/26;;C07C271/22;;C07D207/416;;C07D209/42;;C07D213/81;;C07D213/82;;C07D215/48;;C07D307/68;;C07D307/84;;C07D317/34;;C07D333/38;;C07C2601/02;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2603/46;;C07C2603/74;;A61P31/04;;C07D237/26;;C07C271/22;;C07D209/42;;A61K31/165;;C07D333/38;;C07D307/84;;C07D207/416;;C07D209/42;;C07D213/82;;C07D213/81;;C07D215/48;;C07C271/22;;C07D317/34;;C07D307/68;;C07C237/26;;C07C2601/14;;C07C2601/02;;C07C2603/46;;C07C2601/04;;C07C2601/08;;C07C2603/74,,,0,0,,,,PENDING
486,US,A1,US 2023/0081067 A1,133-472-274-723-125,2023-03-16,2023,US 202217895665 A,2022-08-25,US 202217895665 A;;US 202163237963 P,2021-08-27,SYSTEM AND METHOD FOR QUERY ACCELERATION FOR USE WITH DATA ANALYTICS ENVIRONMENTS,"In accordance with an embodiment, described herein is a system and method for providing query acceleration with a computing environment such as, for example, a business intelligence environment, database, data warehouse, or other type of environment that supports data analytics. A middle layer is provided as a long-term table data storage format; and one more acceleration formats, or acceleration tables, can be periodically regenerated from the middle layer, wherein a determination can be made as to whether an accelerated table exists for a dataset table, and if so, then the accelerated table is used to process the query.",ORACLE INT CORP,MITTAL ASHISH;;ENG KENNETH;;MASCARENHAS ALEXTAIR;;WONG DAVID;;HEBBAR PRAFUL;;GE YI;;RAJAGOPALAN MAHADEVAN;;BOLSIUS ROGER;;RANGANATHAN VIJAYAKUMAR;;LOTIA SAMAR,ORACLE INTERNATIONAL CORPORATION (2022-08-23),https://lens.org/133-472-274-723-125,Patent Application,yes,3,1,2,2,0,G06F16/2282;;G06F16/24539;;G06F16/24552;;G06F16/2471;;G06F16/256;;G06F16/27;;G06F16/24549;;G06F16/258;;G06F16/254,G06F16/25;;G06F16/2453,,0,0,,,,PENDING
487,CA,A1,CA 2620600 A1,128-762-071-622-839,2007-03-08,2007,CA 2620600 A,2006-08-29,US 71311205 P;;US 2006/0033516 W,2005-08-31,9-AMINOCARBONYLSUBSTITUTED DERIVATIVES OF GLYCYLCYCLINES,,WYETH CORP,HOPPER DARRIN WILLIAM;;HOW DAVID BRIAN;;SHIM JAECHUL;;SABATINI JOSHUA JAMES;;SUM PHAIK-ENG;;MANSOUR TAREK SUHAYL;;VERA MATTHEW DOUGLAS,,https://lens.org/128-762-071-622-839,Patent Application,no,0,0,21,21,0,C07C237/26;;C07C271/22;;C07D207/416;;C07D209/42;;C07D213/81;;C07D213/82;;C07D215/48;;C07D307/68;;C07D307/84;;C07D317/34;;C07D333/38;;C07C2601/02;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2603/46;;C07C2603/74;;A61P31/04;;C07D237/26;;C07C271/22;;C07D209/42;;A61K31/165;;C07D333/38;;C07D307/84;;C07D207/416;;C07D209/42;;C07D213/82;;C07D213/81;;C07D215/48;;C07C271/22;;C07D317/34;;C07D307/68;;C07C237/26;;C07C2601/14;;C07C2601/02;;C07C2603/46;;C07C2601/04;;C07C2601/08;;C07C2603/74,C07D237/26;;A61K31/165;;C07C271/22;;C07D209/42;;C07D213/80;;C07D215/48;;C07D319/06;;C07D333/38,,0,0,,,,DISCONTINUED
488,ZA,B,ZA 200802775 B,114-523-073-238-818,2009-06-24,2009,ZA 200802775 A,2008-03-28,US 71311205 P,2005-08-31,9-aminocarbonylsubstituted derivatives of glycylcyclines,,WYETH CORP,PHAIK-ENG SUM;;BRIAN HOW DAVID;;DOUGLAS VERA MATTHEW;;JAECHUL SHIM;;SUHAYL MANSOUR TAREK;;WILLIAM HOPPER DARRIN;;JAMES SABATINI JOSHUA,,https://lens.org/114-523-073-238-818,Granted Patent,no,0,0,21,21,0,C07C237/26;;C07C271/22;;C07D207/416;;C07D209/42;;C07D213/81;;C07D213/82;;C07D215/48;;C07D307/68;;C07D307/84;;C07D317/34;;C07D333/38;;C07C2601/02;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2603/46;;C07C2603/74;;A61P31/04;;C07D237/26;;C07C271/22;;C07D209/42;;A61K31/165;;C07D333/38;;C07D307/84;;C07D207/416;;C07D209/42;;C07D213/82;;C07D213/81;;C07D215/48;;C07C271/22;;C07D317/34;;C07D307/68;;C07C237/26;;C07C2601/14;;C07C2601/02;;C07C2603/46;;C07C2601/04;;C07C2601/08;;C07C2603/74,A61K/;;C07C/;;C07D/,,0,0,,,,ACTIVE
489,TW,A,TW 200745053 A,011-672-804-457-534,2007-12-16,2007,TW 95132259 A,2006-08-31,US 71311205 P,2005-08-31,9-Aminocarbonylsubstituted derivatives of glycylcyclines,"This invention provides compounds of Formula I having the structure, where R1, R2, R3 and A are defined in the specification or a pharmaceutically acceptable salt thereof useful as antibacterial agents. Compounds according to Formula (II): where Q, R4, R5, and R6 and A are defined in the specification are useful as chemical intermediates.",WYETH CORP,SUM PHAIK-ENG;;MANSOUR TAREK SUHAYL;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES;;SHIM JAECHUL,,https://lens.org/011-672-804-457-534,Patent of Addition,no,0,0,21,21,0,C07C237/26;;C07C271/22;;C07D207/416;;C07D209/42;;C07D213/81;;C07D213/82;;C07D215/48;;C07D307/68;;C07D307/84;;C07D317/34;;C07D333/38;;C07C2601/02;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2603/46;;C07C2603/74;;A61P31/04;;C07D237/26;;C07C271/22;;C07D209/42;;A61K31/165;;C07D333/38;;C07D307/84;;C07D207/416;;C07D209/42;;C07D213/82;;C07D213/81;;C07D215/48;;C07C271/22;;C07D317/34;;C07D307/68;;C07C237/26;;C07C2601/14;;C07C2601/02;;C07C2603/46;;C07C2601/04;;C07C2601/08;;C07C2603/74,C07D237/26;;A61K31/165;;C07C271/22,,0,0,,,,PENDING
490,WO,A1,WO 2023/028330 A1,145-765-856-011-069,2023-03-02,2023,US 2022/0041715 W,2022-08-26,US 202163237963 P;;US 202217895665 A,2021-08-27,SYSTEM AND METHOD FOR QUERY ACCELERATION FOR USE WITH DATA ANALYTICS ENVIRONMENTS,"In accordance with an embodiment, described herein is a system and method for providing query acceleration with a computing environment such as, for example, a business intelligence environment, database, data warehouse, or other type of environment that supports data analytics. A middle layer is provided as a long-term table data storage format; and one more acceleration formats, or acceleration tables, can be periodically regenerated from the middle layer, wherein a determination can be made as to whether an accelerated table exists for a dataset table, and if so, then the accelerated table is used to process the query.",ORACLE INT CORP,MITTAL ASHISH;;ENG KENNETH;;MASCARENHAS ALEXTAIR;;WONG DAVID;;HEBBAR PRAFUL;;GE YI;;RAJAGOPALAN MAHADEVAN;;BOLSIUS ROGER;;RANGANATHAN VIJAYAKUMAR;;LOTIA SAMAR,,https://lens.org/145-765-856-011-069,Patent Application,yes,3,0,2,2,0,G06F16/2282;;G06F16/24539;;G06F16/24552;;G06F16/2471;;G06F16/256;;G06F16/27;;G06F16/24549;;G06F16/258;;G06F16/254,G06F16/22;;G06F16/2453;;G06F16/2455;;G06F16/2458;;G06F16/25;;G06F16/27,,7,3,059-774-196-569-995;;026-902-759-458-110;;128-847-130-378-956,10.1016/j.datak.2006.11.002;;10.1109/sera.2010.13;;10.1109/icde.2004.1319994,"LI ET AL: ""Load balancing and data placement for multi-tiered database systems"", DATA & KNOWLEDGE ENGINEERING, ELSEVIER BV, NL, vol. 62, no. 3, 14 May 2007 (2007-05-14), pages 523 - 546, XP022077998, ISSN: 0169-023X, DOI: 10.1016/J.DATAK.2006.11.002;;WESLEY LEONARD ET AL: ""Cross Engine Database Joining"", SOFTWARE ENGINEERING RESEARCH, MANAGEMENT AND APPLICATIONS (SERA), 2010 EIGHTH ACIS INTERNATIONAL CONFERENCE ON, IEEE, PISCATAWAY, NJ, USA, 24 May 2010 (2010-05-24), pages 19 - 26, XP031692454, ISBN: 978-0-7695-4075-7;;MEHMET ALTINEL ET AL: ""Cache tables"", PROCEEDINGS OF THE TWENTY-NINTH INTERNATIONAL CONFERENCE ON VERY LARGE DATABASES : BERLIN, GERMANY, 9 - 12 SEPTEMBER, 2003, MORGAN KAUFMAN, ORLANDO, FLA, 9 September 2003 (2003-09-09), pages 718 - 729, XP058151670, ISBN: 978-0-12-722442-8;;C BORNHÖVD ET AL: ""Adaptive Database Caching with DBCache"", BULLETIN OF THE TECHNICAL COMMITTEE ON DATA ENGINEERING, vol. 27, no. 2, 1 June 2004 (2004-06-01), pages 11 - 18, XP055356469;;PERAKELARSONJONATHANGOLDSTEIN ET AL: ""MTCache: Mid-Tier Database Caching for SQL Server"", 30 April 2004 (2004-04-30), XP055121022, Retrieved from the Internet <URL:http://research.microsoft.com/en-us/um/people/jrzhou/pub/mtcachedebull.pdf> [retrieved on 20140602];;LARSON P-A ET AL: ""MTCache: transparent mid-tier database caching in SQL server"", PROCEEDINGS. 20TH INTERNATIONAL CONFERENCE ON DATA ENGINEERING - 30 MARCH-2 APRIL 2004 - BOSTON, MA, USA, IEEE COMPUT. SOC, LOS ALAMITOS, CA, USA, 30 March 2004 (2004-03-30), pages 177 - 188, XP010713763, ISBN: 978-0-7695-2065-0, DOI: 10.1109/ICDE.2004.1319994;;ANONYMOUS: ""IBM Information Integrator joins the IBM WebSphere brand"", 1 March 2005 (2005-03-01), pages 1 - 37, XP093008508, Retrieved from the Internet <URL:http://www.ibm.com/common/ssi/rep_ca/8/897/ENUS205-048/ENUS205048.PDF> [retrieved on 20221215]",PENDING
491,NO,L,NO 20081103 L,150-275-176-095-915,2008-05-20,2008,NO 20081103 A,2008-03-03,US 71311205 P;;US 2006/0033516 W,2005-08-31,9-Aminoklarbonylsubstituerte derivater av glycylcykliner,"Foreliggende oppfinnelse tilveiebringer forbindelser med formel I som har strukturen hvor R1, R2, R3 og A er definert i beskrivelsen, eller et farmasøytisk akseptabelt salt derav, anvendelige som antibakterielle midler. Forbindelser med formel (II): hvor Q, R4, R5 og R6 og A er definert i beskrivelsen, er anvendelige som kjemiske mellomprodukter.",WYETH CORP,SUM PHAIK-ENG;;MANSOUR TAREK SUHAYL;;HOW DAVID BRIAN;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES;;HOPPER DARRIN WILLIAM;;SHIM JAECHUL,,https://lens.org/150-275-176-095-915,Abstract,no,0,0,21,21,0,C07C237/26;;C07C271/22;;C07D207/416;;C07D209/42;;C07D213/81;;C07D213/82;;C07D215/48;;C07D307/68;;C07D307/84;;C07D317/34;;C07D333/38;;C07C2601/02;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2603/46;;C07C2603/74;;A61P31/04;;C07D237/26;;C07C271/22;;C07D209/42;;A61K31/165;;C07D333/38;;C07D307/84;;C07D207/416;;C07D209/42;;C07D213/82;;C07D213/81;;C07D215/48;;C07C271/22;;C07D317/34;;C07D307/68;;C07C237/26;;C07C2601/14;;C07C2601/02;;C07C2603/46;;C07C2601/04;;C07C2601/08;;C07C2603/74,C07D237/26,,0,0,,,,DISCONTINUED
492,US,B2,US 8101590 B2,117-488-605-351-044,2012-01-24,2012,US 51397206 A,2006-08-31,US 51397206 A;;US 71311205 P,2005-08-31,9-aminocarbonylsubstituted derivatives of glycylcyclines,"This invention provides compounds of Formula I having the structure where R 1 , R 2 , R 3 and A are defined in the specification or a pharmaceutically acceptable salt thereof useful as antibacterial agents. Compounds according to Formula (II): where Q, R 4 , R 5 , R 6 and R 10 and A are defined in the specification are useful as chemical intermediates.",SUM PHAIK-ENG;;MANSOUR TAREK SUHAYL;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES;;SHIM JAECHUL;;WYETH LLC,SUM PHAIK-ENG;;MANSOUR TAREK SUHAYL;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES;;SHIM JAECHUL,WYETH LLC (2006-08-25),https://lens.org/117-488-605-351-044,Granted Patent,yes,20,0,21,21,0,C07C237/26;;C07C271/22;;C07D207/416;;C07D209/42;;C07D213/81;;C07D213/82;;C07D215/48;;C07D307/68;;C07D307/84;;C07D317/34;;C07D333/38;;C07C2601/02;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2603/46;;C07C2603/74;;A61P31/04;;C07D237/26;;C07C271/22;;C07D209/42;;A61K31/165;;C07D333/38;;C07D307/84;;C07D207/416;;C07D209/42;;C07D213/82;;C07D213/81;;C07D215/48;;C07C271/22;;C07D317/34;;C07D307/68;;C07C237/26;;C07C2601/14;;C07C2601/02;;C07C2603/46;;C07C2601/04;;C07C2601/08;;C07C2603/74,A61K31/65;;C07C237/26,514/152;;552/203,8,6,148-332-819-466-078;;003-702-621-223-705;;005-739-229-828-621;;004-556-152-988-177;;021-643-156-003-437;;045-968-397-840-179,10.1021/jm00027a023;;8289194;;6488397;;10.1248/cpb.32.2241;;10.1007/978-3-642-70304-1_6;;2802561;;pmc172657;;10.1128/aac.33.8.1373;;10.1055/s-1990-27124;;10.1111/j.1365-2958.1990.tb02025.x;;2181236,"Phaik-Eng Sum, et al.; J. Med. Chem.; vol. 37; pp. 184-188; 1994.;;Fumio Sakamoto, et al., Chem. Pharm. Bull,; vol. 32(6); pp. 2241-2248; 1984.;;I. Chopra; Handbook of Experimental Pharmacology; vol. 78; pp. 317-392; 1985.;;Stuart B. Levy, et al.; Antimicrobial Agents and Chemotherapy; vol. 33,. No. 8; pp. 1373-1374; 1989.;;Richard C. Larock, Comprehensive Organic Transformations, VCH Publishers, pp. 411-415, 1989.;;Michael Folkmann and Frantz J. Lund; Synthesis; pp. 1159-1166; 1990.;;A.A. Salyers, et al.; Molecular Microbiology; vol. 4(1); pp. 151-156; 1990.;;NCCLS, 2000 Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard-Fifth Edition: M7-A5, vol. 20, No. 2, National Committee for Clinical Laboratory Standards, Wayne, PA.",INACTIVE
493,BR,A2,BR PI0615300 A2,024-879-555-383-967,2009-07-14,2009,BR PI0615300 A,2006-08-29,US 71311205 P;;US 2006/0033516 W,2005-08-31,"composto; composição farmacêutica; método para a preparação, tratamento ou controle de infecções bacterianas em animais de sangue quente; uso de um composto; e método para a preparação de compostos representados pela fórmula (i)","COMPOSTO; COMPOSIçãO FARMACêUTICA; MéTODO PARA A PREPARAçãO, TRATAMENTO OU CONTROLE DE INFECçõES BACTERIANAS EM ANIMAIS DE SANGUE QUENTE; USO DE UM COMPOSTO; E MéTODO PARA A PREPARAçãO DE COMPOSTOS REPRESENTADOS PELA FóRMULA (1). Trata-se de proporcionar compostos de Fórmula (1) tendo a estrutura onde R2 12, R2 22, R2 32 e A são definidos no relatório descritivo ou um sal farmaceuticamente aceitável destes úteis como agentes antibacterianos. Os compostos de acordo com a Fórmula (II) onde Q, R2 42, R2 52, e R2 62 e A são definidos no relatório descritivo, são úteis como intermediários químicos.",WYETH CORP,SUM PHAIK-ENG;;MANSOUR TAREK SUHAYL;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES;;SHIM JAECHUL,,https://lens.org/024-879-555-383-967,Patent Application,no,0,0,21,21,0,C07C237/26;;C07C271/22;;C07D207/416;;C07D209/42;;C07D213/81;;C07D213/82;;C07D215/48;;C07D307/68;;C07D307/84;;C07D317/34;;C07D333/38;;C07C2601/02;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2603/46;;C07C2603/74;;A61P31/04;;C07D237/26;;C07C271/22;;C07D209/42;;A61K31/165;;C07D333/38;;C07D307/84;;C07D207/416;;C07D209/42;;C07D213/82;;C07D213/81;;C07D215/48;;C07C271/22;;C07D317/34;;C07D307/68;;C07C237/26;;C07C2601/14;;C07C2601/02;;C07C2603/46;;C07C2601/04;;C07C2601/08;;C07C2603/74,C07D237/26;;A61K31/165;;C07C271/22;;C07D209/42;;C07D213/80;;C07D215/48;;C07D319/06;;C07D333/38,,0,0,,,,DISCONTINUED
494,US,A1,US 2007/0049564 A1,044-182-410-447-347,2007-03-01,2007,US 51397206 A,2006-08-31,US 51397206 A;;US 71311205 P,2005-08-31,9-Aminocarbonylsubstituted derivatives of glycylcyclines,"This invention provides compounds of Formula I having the structure where R 1 , R 2 , R 3 and A are defined in the specification or a pharmaceutically acceptable salt thereof useful as antibacterial agents. Compounds according to Formula (II): where Q, R 4 , R 5 , R 6 and R 10 and A are defined in the specification are useful as chemical intermediates.",WYETH CORP,SUM PHAIK-ENG;;MANSOUR TAREK S;;HOW DAVID B;;HOPPER DARRIN W;;VERA MATTHEW D;;SABATINI JOSHUA J;;SHIM JAECHUL,WYETH LLC (2006-08-25),https://lens.org/044-182-410-447-347,Patent Application,yes,17,1,21,21,0,C07C237/26;;C07C271/22;;C07D207/416;;C07D209/42;;C07D213/81;;C07D213/82;;C07D215/48;;C07D307/68;;C07D307/84;;C07D317/34;;C07D333/38;;C07C2601/02;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2603/46;;C07C2603/74;;A61P31/04;;C07D237/26;;C07C271/22;;C07D209/42;;A61K31/165;;C07D333/38;;C07D307/84;;C07D207/416;;C07D209/42;;C07D213/82;;C07D213/81;;C07D215/48;;C07C271/22;;C07D317/34;;C07D307/68;;C07C237/26;;C07C2601/14;;C07C2601/02;;C07C2603/46;;C07C2601/04;;C07C2601/08;;C07C2603/74,A61K31/65;;C07C237/26,514/152;;552/203,0,0,,,,INACTIVE
495,GT,A,GT 200600395 A,163-912-025-369-772,2007-05-08,2007,GT 200600395 A,2006-08-31,US 71311205 P,2005-08-31,DERIVADOS DE GLICILCICLINAS SUSTITUIDOS CON 9-AMINOCARBONILO,"ESTA INVENCIÓN SUMINISTRA COMPUESTOS DE LA FÓRMULA I, O UNA SAL FARMACÉUTICAMENTE ACEPTABLE. ESTOS COMPUESTOS SE UTILIZAN COMO AGENTES ANTIBACTERIALES. LOS COMPUESTOS DE ACUERDO A LA FORMULA II, SE UTILIZAN COMO INTERMEDIARIOS QUÍMICOS.",,SUM PHAIK-ENG;;MANSOUR TAREK SUHAYL;;HOW DAVID BRIAN;;HOOPER DARRIN WILLIAM;;VERA MATHEW DOUGLAS;;SABATINI JOSHUA JAMES;;SHIM JAECHUL,,https://lens.org/163-912-025-369-772,Amended Application,no,0,0,21,21,0,C07C237/26;;C07C271/22;;C07D207/416;;C07D209/42;;C07D213/81;;C07D213/82;;C07D215/48;;C07D307/68;;C07D307/84;;C07D317/34;;C07D333/38;;C07C2601/02;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2603/46;;C07C2603/74;;A61P31/04;;C07D237/26;;C07C271/22;;C07D209/42;;A61K31/165;;C07D333/38;;C07D307/84;;C07D207/416;;C07D209/42;;C07D213/82;;C07D213/81;;C07D215/48;;C07C271/22;;C07D317/34;;C07D307/68;;C07C237/26;;C07C2601/14;;C07C2601/02;;C07C2603/46;;C07C2601/04;;C07C2601/08;;C07C2603/74,A61K31/167;;A61K31/65;;A61P31/04,,0,0,,,,PENDING
496,YU,A,YU 45896 A,148-218-949-309-960,1999-06-15,1999,YU 45896 A,1996-08-07,US 51260295 A,1995-08-08,PROCESS FOR MAKING AN EPOXIDE,"Postupak za sintetizovanje epoksida formule sastoji se od, minimalno, obrazovanja halohidrina iz alil acetonid reagensa, a zatim bazno-indukovane ciklizacije, epoksidni proizvod I je korisan kao intermedijar za sintetizovanje inhibitora renina ili HIV proteaze ili drugih proteaza.",MERCK & CO INC,DAVID ASKIN;;KAN ENG;;PETER MALIGRES E;;PAUL REIDER J;;KAI ROSSEN;;RALPH VOLANTE P;;VEENA UPADHYAY;;STEVEN WEISSMAN A,,https://lens.org/148-218-949-309-960,Patent Application,no,0,0,10,10,0,C07D263/52;;C07D413/06;;C07D413/06;;C07D263/52,C07D263/52;;C07D413/06,,0,0,,,,EXPIRED
497,EC,A,EC SP088230 A,194-518-483-770-482,2008-04-28,2008,EC SP088230 A,2008-02-28,US 71311205 P,2005-08-31,DERIVADOS DE GLICILCICLINAS SUSTITUIDOS CON 9-AMINOCARBONILO,"Esta invención suministra compuestos de la Fórmula I que tienen la estructura (I), donde R1, R2, R3 y A se definen en la especificación o una sal farmacéuticamente aceptable de estos se utiliza como agentes antibacteriales. Los compuestos de acuerdo a la Fórmula (II), en donde Q, R4, R5, y R6 y A que se definen en la especificación se utilizan como intermedios químicos.",WYETH CORP,SUM PHAIK-ENG;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES;;MANSOUR TAREK SUHAYL;;SHIM JAECHUL,,https://lens.org/194-518-483-770-482,Patent Application,no,0,0,21,21,0,C07C237/26;;C07C271/22;;C07D207/416;;C07D209/42;;C07D213/81;;C07D213/82;;C07D215/48;;C07D307/68;;C07D307/84;;C07D317/34;;C07D333/38;;C07C2601/02;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2603/46;;C07C2603/74;;A61P31/04;;C07D237/26;;C07C271/22;;C07D209/42;;A61K31/165;;C07D333/38;;C07D307/84;;C07D207/416;;C07D209/42;;C07D213/82;;C07D213/81;;C07D215/48;;C07C271/22;;C07D317/34;;C07D307/68;;C07C237/26;;C07C2601/14;;C07C2601/02;;C07C2603/46;;C07C2601/04;;C07C2601/08;;C07C2603/74,C07D237/26,,0,0,,,,PENDING
498,AU,A,AU 1996/067652 A,027-305-906-553-136,1997-03-05,1997,AU 1996/067652 A,1996-08-05,US 51260295 A;;US 9612715 W,1995-08-08,Process for making an epoxide via the iodohydrin,,MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;MALIGRES PETER E;;REIDER PAUL J;;ROSSEN KAI;;VOLANTE RALPH P;;UPADHYAY VEENA;;WEISSMAN STEVEN A,,https://lens.org/027-305-906-553-136,Patent Application,no,0,0,10,10,0,C07D263/52;;C07D413/06;;C07D413/06;;C07D263/52,C07D263/52;;C07D413/06,,0,0,,,,PENDING
499,US,A,US 4849977 A,129-193-960-039-837,1989-07-18,1989,US 8601387 A,1987-08-17,US 8601387 A;;US 78832285 A,1985-10-17,D-5 Channel bank control structure and controller,A channel bank unit for interfacing baseband user signals with a PCM carrier communications channel. The channel bank unit includes a circuit allowing verification of the transmission interity between the channel bank unit and external equipment having two-way communication with the channel bank unit. The circuit includes a first portion for evaluating the reception integrity of signals received from the external equipment and a second portion for imposing a parity sense on the signals transmitted to the external equipment that is related to the evaluation results of the first portion.,AMERICAN TELEPHONE & TELEGRAPH,BAUN JR PHILIP J;;CARRIERE JOSEPH F;;ENG STEPHEN K;;LANDRY JOSEPH E;;LEE JONGHEE;;NOLAN THOMAS M;;RHODES DAVID C,,https://lens.org/129-193-960-039-837,Granted Patent,yes,7,9,1,6,0,H04J3/04;;H04Q11/04;;H04Q11/04;;H04J3/04,H04J3/04;;H04Q11/04,371/49,0,0,,,,EXPIRED
500,WO,A1,WO 1997/006164 A1,139-727-940-258-545,1997-02-20,1997,US 9612715 W,1996-08-05,US 51260295 A,1995-08-08,PROCESS FOR MAKING AN EPOXIDE VIA THE IODOHYDRIN,"A process for synthesizing the epoxide of formula (I), consists of, at a minimum, formation of a halohydrin from the allyl acetonide reactant, followed by base-induced cyclization, the epoxide product (I) being useful as an intermediate for the synthesis of inhibitors of renin or HIV protease or other proteases.",MERCK & CO INC;;ASKIN DAVID;;ENG KAN K;;MALIGRES PETER E;;REIDER PAUL J;;ROSSEN KAI;;VOLANTE RALPH P;;UPADHYAY VEENA;;WEISSMAN STEVEN A,ASKIN DAVID;;ENG KAN K;;MALIGRES PETER E;;REIDER PAUL J;;ROSSEN KAI;;VOLANTE RALPH P;;UPADHYAY VEENA;;WEISSMAN STEVEN A,,https://lens.org/139-727-940-258-545,Patent Application,yes,1,1,10,10,0,C07D263/52;;C07D413/06;;C07D413/06;;C07D263/52,C07D263/52;;C07D413/06,,4,3,024-958-590-239-923;;027-450-444-460-744;;077-587-887-297-860,10.1021/jo00098a012;;10.1016/s0040-4039(00)75787-x;;10.1021/jo00036a004,"MASUDA,H. ET AL.: ""A New Synthetic Method of Preparing Iodohydrin and Bromohydrin Derivatives through in Situ Generation of Hypohalous Acids from H5IO6 and NaBrO3 in the Presence of HaHSO3"", J.ORG.CHEM., vol. 59, no. 19, 1994, WASHINGTON, pages 5550 - 5555, XP002019407;;ASKIN,D. ET AL.: ""Highly Diastereoselective Reaction of a Chiral, Non-Racemic Amide Enolate with (S)-Glycidyl Tosylate. Synthesis of the Orally Active HIV-1 Protease Inhibitor L-735,524"", TETRAHEDRON LETT., vol. 35, no. 5, 1994, OXFORD, pages 673 - 676, XP002019408;;ASKIN,D. ET AL.: ""Highly Diastereoselective Alkylations of Chiral Amide Enolates: New Routes to Hydroxyethylene Dipeptide Isostere Inhibitors of HIV-1 Protease"", J.ORG.CHEM., vol. 57, no. 10, 1992, WASHINGTON, pages 2771 - 2773, XP002019409;;TAMARU,Y. ET AL.: ""1,3-Asymetric Induction: Highly Stereoselective Synthesis of 2,4-Trans-Disubstituted gasmma-Butyrolactones and gamma-Butyrothiolacones"", J.AM.CHEM.SOC., vol. 104, no. 4, 1984, WASHINGTON, pages 1079 - 1085, XP002019410",PENDING
501,HR,A2,HR P960369 A2,182-357-419-356-105,1998-04-30,1998,HR P960369 A,1996-08-06,US 51260295 A,1995-08-08,PROCESS FOR THE PREPARATION OF EPOXIDE,,MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;MALIGRES PETER E;;REIDER PAUL J;;ROSSEN KAI;;VOLANTE RALPH P;;UPADHYAY VEENA;;WEISSMAN STEVEN A,"MERCK SHARP & DOHME CORP., US (2010-04-08)",https://lens.org/182-357-419-356-105,Patent Application,no,0,0,10,10,0,C07D263/52;;C07D413/06;;C07D413/06;;C07D263/52,C07D263/52;;C07D413/06,,0,0,,,,EXPIRED
502,US,A1,US 2008/0256309 A1,059-818-949-673-845,2008-10-16,2008,US 73405907 A,2007-04-11,US 73405907 A;;US 73409707 A,2007-04-11,MAINTAIN OWNING APPLICATION INFORMATION OF DATA FOR A DATA STORAGE SYSTEM,"A data storage system writes data supplied from a host to data storage in accordance with write I/O of an owning application. A workload manager directs the processing of the supplied data in accordance with the write I/O of the owning application, provides service workload identification describing the write I/O, a storage subsystem control adds the service workload identification to record set information for the data, and a journal management system stores the record set information in a journal. The journaled information, for example, may be employed for performing forensic analysis of data corruption events or to perform security audits, etc.",BOYD KENNETH WAYNE;;DILLENBERGER DONNA ENG;;KERN ROBERT FREDERIC;;MICKA WILLIAM FRANK;;PALM JEFFREY WILLIAM;;SHACKELFORD DAVID MICHAEL;;WILDING MARK FRANCIS,BOYD KENNETH WAYNE;;DILLENBERGER DONNA ENG;;KERN ROBERT FREDERIC;;MICKA WILLIAM FRANK;;PALM JEFFREY WILLIAM;;SHACKELFORD DAVID MICHAEL;;WILDING MARK FRANCIS,INTERNATIONAL BUSINESS MACHINES CORPORATION (2007-05-03);;GLOBALFOUNDRIES U.S. 2 LLC (2015-06-29);;GLOBALFOUNDRIES INC (2015-09-10),https://lens.org/059-818-949-673-845,Patent Application,yes,15,1,11,13,0,G06F11/34;;G06F11/3466;;G06F11/3466;;G06F11/3476;;G06F11/3476;;G06F11/349;;G06F11/349;;G06F13/14;;G06F15/16;;G06F21/00,G06F12/16;;G06F3/00,711/161;;710/5,0,0,,,,INACTIVE
503,US,A,US 5728840 A,006-477-465-325-048,1998-03-17,1998,US 51260295 A,1995-08-08,US 51260295 A;;US 47235295 A;;US 20607494 A,1994-03-04,Process for making an epoxide,"A process for synthesizing the epoxide of the formula ##STR1## consists of, at a minimum, formation of a halohydrin from the allyl acetonide reactat, followed by base-induced cyclization, the epoxide product I being useful as an intermediate for the synthesis of inhibitors of renin or HIV protease or other proteases.",MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;MALIGRES PETER E;;REIDER PAUL J;;ROSSEN KAI;;VOLANTE RALPH P;;UPADHYAY VEENA;;WEISSMAN STEVEN A,NABISCO TECHNOLOGY COMPANY (1997-01-01);;MERCK SHARP & DOHME CORP (2012-04-26),https://lens.org/006-477-465-325-048,Granted Patent,yes,7,7,10,10,0,C07D263/52;;C07D413/06;;C07D413/06;;C07D263/52,C07D263/52;;C07D413/06,548/217,4,3,024-958-590-239-923;;077-587-887-297-860;;175-197-863-397-364,10.1021/jo00098a012;;10.1021/jo00036a004;;10.1021/ja00316a044,"Masuda, et al., J. Org. Chem. 1994, 59(19), 5550 5555.;;Askin, et al., J. Org. Chem. 1992, 57(10), 2771 2773.;;Tamaru, et al., J. Am. Chem. Soc., 1984, 104(4), 1079 1085.;;Askin et al Tetrah. Lett. vol. 35 pp. 673 676 (Feb. 1994).",EXPIRED
504,EP,A4,EP 3171809 A4,000-386-564-976-477,2018-03-14,2018,EP 15824882 A,2015-07-22,US 201462027364 P;;AU 2015/000425 W,2014-07-22,COMBINATION GLOVE FOR DETECTING BREACH OF HYDROPHILIC FLUID,,ANSELL LTD,ENG AIK HWEE;;THANNIMALAI THANABALAN;;KHOR ALBERT;;TANG LOK SI;;PHAM THI HAO;;LUCAS DAVID M;;LOPEZ ANTHONY;;CHAK CHOY YUEN,,https://lens.org/000-386-564-976-477,Search Report,no,6,0,6,6,0,A41D19/0006;;A61B42/30;;A41D19/0006;;A41D19/0024;;A41D19/01594,A61B34/00;;A61B42/30,,1,0,,,See also references of WO 2016011480A1,DISCONTINUED
505,AU,A1,AU 2015/292239 A1,038-519-062-012-921,2017-02-09,2017,AU 2015/292239 A,2015-07-22,US 201462027364 P;;AU 2015/000425 W,2014-07-22,Combination glove for detecting breach of hydrophilic fluid,"Provided for example is a combination glove comprising: (a) an top elastomer layer with an inner surface, the top elastomer layer being translucent or transparent; (b) an bottom elastomer layer with an outer surface, the bottom elastomer layer being darker than the top elastomer layer; and (c) a space or seam between the layers, wherein to either the inner-top or the outer-bottom surface has been adhered a hydrophilicity promoting composition of (i) a polyvinyl alcohol or (ii) an alkyl-aryl compound or a siloxane compound having a pendent one to two oxy-polymers, or (iii) a quaternary amine including an alkyl of C8 to C24, wherein the oxy-polymer is (1 ) a poly-oxyalkylene polymer that is predominantly oxyethylene or (2) a polyvinyl alcohol, wherein the hydrophilicity promoting composition enhances the spreading in the space or seam of any of the hydrophilic or aqueous fluid that breaches the top or bottom elastomer layer.",ANSELL LTD,ENG AIK HWEE;;THANNIMALAI THANABALAN;;KHOR ALBERT;;TANG LOK SI;;PHAM THI HAO;;LUCAS DAVID M;;LOPEZ ANTHONY;;CHAK CHOY YUEN,,https://lens.org/038-519-062-012-921,Patent Application,no,0,0,6,6,0,A41D19/0006;;A61B42/30;;A41D19/0006;;A41D19/0024;;A41D19/01594,A61B42/00,,0,0,,,,DISCONTINUED
506,KR,A,KR 20080041722 A,078-966-472-145-511,2008-05-13,2008,KR 20087007460 A,2008-03-27,US 71311205 P,2005-08-31,9-AMINOCARBONYL SUBSTITUTED DERIVATIVES OF GLYCYLCYCLINES,"This invention provides compounds of Formula (I) having the structure where R1, R2, R3 and A are defined in the specification or a pharmaceutically acceptable salt thereof useful as antibacterial agents. Compounds according to Formula (II): where Q, R4, R5, and R6 and A are defined in the specification are useful as chemical intermediates.",WYETH CORP,SUM PHAIK ENG;;MANSOUR TAREK SUHAYL;;HOW DAVID BRIAN;;HOPPER DARRIN WILIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES;;SHIM JAE CHUL,,https://lens.org/078-966-472-145-511,Patent Application,no,0,1,21,21,0,C07C237/26;;C07C271/22;;C07D207/416;;C07D209/42;;C07D213/81;;C07D213/82;;C07D215/48;;C07D307/68;;C07D307/84;;C07D317/34;;C07D333/38;;C07C2601/02;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2603/46;;C07C2603/74;;A61P31/04;;C07D237/26;;C07C271/22;;C07D209/42;;A61K31/165;;C07D333/38;;C07D307/84;;C07D207/416;;C07D209/42;;C07D213/82;;C07D213/81;;C07D215/48;;C07C271/22;;C07D317/34;;C07D307/68;;C07C237/26;;C07C2601/14;;C07C2601/02;;C07C2603/46;;C07C2601/04;;C07C2601/08;;C07C2603/74,A61K31/165;;C07D237/26;;C07C271/22;;C07D209/42,,0,0,,,,DISCONTINUED
507,BR,A,BR 9609879 A,010-886-852-399-743,1999-03-23,1999,BR 9609879 A,1996-08-05,US 51260295 A;;US 9612715 W,1995-08-08,Processo para sintetizar epóxido,,MERCK & CO INC,REIDER PAUL J;;MALIGRES PETER E;;UPADHYAY VEENA;;ENG KAN K;;VOLANTE RALPH P;;ASKIN DAVID;;ROSSEN KAI;;WEISSMAN STEVEN A,,https://lens.org/010-886-852-399-743,Patent Application,no,0,0,10,10,0,C07D263/52;;C07D413/06;;C07D413/06;;C07D263/52,C07D263/52;;C07D413/06,,0,0,,,,DISCONTINUED
508,US,B1,US 10599199 B1,135-509-911-886-218,2020-03-24,2020,US 201715849486 A,2017-12-20,US 201715849486 A,2017-12-20,Systems and methods for power management at device shutdown,"A method is disclosed. The method can include receiving a command to shut down an electronic device based on a measurement of power delivery to the electronic device. After receiving the command to shut down, the method can determine whether an indication of remaining power capacity at the electronic device exceeds a threshold value. The method can shut down the electronic device and, after shutting down the electronic device, in accordance with a determination that the indication of remaining power capacity exceeds the threshold value, automatically reboot the electronic device. In accordance with a determination that the indication of the remaining power capacity does not exceed the threshold value, automatically rebooting the electronic device can be foregone.",APPLE INC,DE LA CROPTE DE CHANTERAC CYRIL;;ENG MICHAEL;;ECKERT KAREN;;PELOSI ALESSANDRO;;DEMURO DAVID M;;STERZ STEPHEN D;;RUHTER NICHOLAS W,APPLE INC (2018-01-16),https://lens.org/135-509-911-886-218,Granted Patent,yes,57,4,1,1,0,G06F1/28;;G06F1/3212;;G06F1/3234;;G06F1/3296;;G06F9/4406;;G06F9/4418;;Y02D10/00,G06F1/28;;G06F1/3296;;G06F9/4401,,14,2,109-902-125-211-49X;;043-777-150-357-260,10.1145/317456.317461;;10.1145/142750.143072,"Notice of Allowance dated Nov. 30, 2017, for U.S. Appl. No. 14/817,572, filed Aug. 4, 2015, 26 pages.;;Notice of Allowance dated Oct. 25, 2018, for U.S. Appl. No. 14/799,370, filed Jul. 14, 2015, five pages.;;Danish Search Report dated Apr. 20, 2017, for Application No. PA 2017 70089, eight pages.;;Final Office Action dated Mar. 23, 2017, for U.S. Appl. No. 14/817,572, filed Aug. 4, 2015, 13 pages.;;Final Office Action dated Apr. 27, 2017, for U.S. Appl. No. 14/799,370, filed Jul. 14, 2015, 19 pages.;;International Search Report dated Jan. 29, 2016, for PCT Patent Application No. PCT/US2015/043487, eight pages.;;Lee, S.K. et al. (Apr. 1985). “A Multi-Touch Three Dimensional Touch-Sensitive Tablet,” Proceedings of CHI: ACM Conference on Human Factors in Computing Systems, pp. 21-25.;;Non-Final Office Action dated Aug. 12, 2016, for U.S. Appl. No. 14/799,370, filed Jul. 14, 2015, fourteen pages.;;Non-Final Office Action dated Sep. 12, 2016, for U.S. Appl. No. 14/817,572, filed Aug. 4, 2015, eight pages.;;Non-Final Office Action dated Dec. 1, 2017, for U.S. Appl. No. 14/799,370, filed Jul. 14, 2015, 23 pages.;;Rubine, D.H. (Dec. 1991). “The Automatic Recognition of Gestures,” CMU-CS-91-202, Submitted in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy in Computer Science at Carnegie Mellon University, 285 pages.;;Rubine, D.H. (May 1992). “Combining Gestures and Direct Manipulation,” CHI ' 92, pp. 659-660.;;Westerman, W. (Spring 1999). “Hand Tracking, Finger Identification, and Chordic Manipulation on a Multi-Touch Surface,” A Dissertation Submitted to the Faculty of the University of Delaware in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy in Electrical Engineering, 364 pages.;;Final Office Action dated Jul. 26, 2018, for U.S. Appl. No. 14/799,370, filed Jul. 14, 2015, six pages.",ACTIVE
509,HR,B1,HR P960369 B1,131-739-853-268-339,2009-05-31,2009,HR P960369 A,1996-08-06,US 51260295 A,1995-08-08,PROCESS FOR THE PREPARATION OF EPOXIDE,"Postupak sinteze epoksida formule I, naznačen time što, (A) postupak sadrži slijedeće korake: (a) dovođenje u dodir jednog ekvivalenta alil acetonida formule II, gdje je spomenuti alil acetonid otopljen u izopropil acetatu, s vodenom otopinom natrij bikarbonata i između 0.5 i 1.0 ekvivalenata 1,3-dikloro-5,5-dimetilhidantoina; (b) hlađenje dobivene smjese na između 5°C i 10°C; (c) dodavanje u smjesu vodenog natrij jodida u suvišku, grijanje reakcijske smjese na između 21°C i 25°C, a nakon toga ostavljanje reakcijske smjese da stoji tijekom razdoblja od 1 do 8 sati; (d) prekidanje reakcije dodavanjem vodenog natrij sulfita, čime nastaje jodohidrin formule III, i (e) dodavanje natrij metoksida u metanolu da bi se potaknulo oblikovanje epoksida formule I; ili (B) postupak sadrži slijedeće korake: (a) dovođenje u dodir jednog ekvivalenta alil acetonida formule II, gdje je taj acetonid otopljen u THF, s vodenom otopinom natrij bikarbonata i joda u suvišku; (b) ostavljanja reakcijske smjese da stoji tijekom razdoblja od 3 do 8 sati; (c) prekidanje reakcije dodavanjem vodenog natrij sulfita, čime nastaje (d) dodavanje natrij metoksida u metanolu da bi se potaknulo stvaranje epoksida formule I; ili (C) postupak sadrži slijedeće korake: (a) dovođenje u dodir jednog ekvivalenta alil acetonida formule IIgdje je taj alil acetonid otopljen u izopropil acetatu, s vodenom otopinom natrij bikarbonata i između 1.0 i 2.0 ekvivalenta N-klorosukcinimida; (b) hlađenje dobivene smjese na između 5°C i 10°C; (c) dodavanje u smjesu vodenog natrij jodida u suvišku, grijanje reakcijske smjese na između 21°C i 25°C a nakon toga ostavljanje reakcijske smjese da stoji tijekom razdoblja između 1 i 8 sati; (d) prekidanje reakcije dodavanjem vodenog natrij sulfita, čime nastaje jodohidrin formule III, i (e) dodavanje natrij metoksida u metanolu da bi se potaknulo oblikovanje epoksida formule I. Patent sadrži još 1 patentni zahtjev.",MERCK & CO INC,ASKIN DAVID;;ENG KAN K;;MALIGRES PETER E;;REIDER PAUL J;;ROSSEN KAI;;VOLANTE RALPH P;;UPADHYAY VEENA;;WEISSMAN STEVEN A,"MERCK SHARP & DOHME CORP., US (2010-04-08)",https://lens.org/131-739-853-268-339,Granted Patent,no,2,0,10,10,0,C07D263/52;;C07D413/06;;C07D413/06;;C07D263/52,C07D413/06;;C07D263/52,,0,0,,,,EXPIRED
510,WO,A1,WO 2016/011480 A1,013-722-264-154-107,2016-01-28,2016,AU 2015/000425 W,2015-07-22,US 201462027364 P,2014-07-22,COMBINATION GLOVE FOR DETECTING BREACH OF HYDROPHILIC FLUID,"Provided for example is a combination glove comprising: (a) an top elastomer layer with an inner surface, the top elastomer layer being translucent or transparent; (b) an bottom elastomer layer with an outer surface, the bottom elastomer layer being darker than the top elastomer layer; and (c) a space or seam between the layers, wherein to either the inner-top or the outer-bottom surface has been adhered a hydrophilicity promoting composition of (i) a polyvinyl alcohol or (ii) an alkyl-aryl compound or a siloxane compound having a pendent one to two oxy-polymers, or (iii) a quaternary amine including an alkyl of C8 to C24, wherein the oxy-polymer is (1 ) a poly-oxyalkylene polymer that is predominantly oxyethylene or (2) a polyvinyl alcohol, wherein the hydrophilicity promoting composition enhances the spreading in the space or seam of any of the hydrophilic or aqueous fluid that breaches the top or bottom elastomer layer.",ANSELL LTD,ENG AIK HWEE;;THANNIMALAI THANABALAN;;KHOR ALBERT;;TANG LOK SI;;PHAM THI HAO;;LUCAS DAVID M;;LOPEZ ANTHONY;;CHAK CHOY YUEN,,https://lens.org/013-722-264-154-107,Patent Application,yes,6,2,6,6,0,A41D19/0006;;A61B42/30;;A41D19/0006;;A41D19/0024;;A41D19/01594,A61B19/04,,1,0,,,See also references of EP 3171809A4,PENDING
511,CN,A,CN 107072731 A,019-349-992-417-29X,2017-08-18,2017,CN 201580050883 A,2015-07-22,US 201462027364 P;;AU 2015/000425 W,2014-07-22,Combination glove for detecting breach of hydrophilic fluid,"Provided for example is a combination glove comprising: (a) an top elastomer layer with an inner surface, the top elastomer layer being translucent or transparent; (b) an bottom elastomer layer with an outer surface, the bottom elastomer layer being darker than the top elastomer layer; and (c) a space or seam between the layers, wherein to either the inner-top or the outer-bottom surface has been adhered a hydrophilicity promoting composition of (i) a polyvinyl alcohol or (ii) an alkyl-aryl compound or a siloxane compound having a pendent one to two oxy-polymers, or (iii) a quaternary amine including an alkyl of C8 to C24, wherein the oxy-polymer is (1 ) a poly-oxyalkylene polymer that is predominantly oxyethylene or (2) a polyvinyl alcohol, wherein the hydrophilicity promoting composition enhances the spreading in the space or seam of any of the hydrophilic or aqueous fluid that breaches the top or bottom elastomer layer.",ANSELL LTD,ENG AIK HWEE;;THANNIMALAI THANABALAN;;KHOR ALBERT;;TANG LOK SI;;PHAM THI HAO;;LUCAS DAVID M;;LOPEZ ANTHONY;;CHAK CHOY YUEN,,https://lens.org/019-349-992-417-29X,Patent Application,no,5,2,6,6,0,A41D19/0006;;A61B42/30;;A41D19/0006;;A41D19/0024;;A41D19/01594,A61B42/10,,0,0,,,,DISCONTINUED
512,US,A1,US 2008/0256310 A1,080-606-836-136-687,2008-10-16,2008,US 73409707 A,2007-04-11,US 73409707 A,2007-04-11,MAINTAIN OWNING APPLICATION INFORMATION OF DATA FOR A DATA STORAGE SYSTEM,"A data storage system writes data supplied from a host to data storage in accordance with write I/O of an owning application. A workload manager directs the processing of the supplied data in accordance with the write I/O of the owning application, provides service workload identification describing the write I/O, a storage subsystem control adds the service workload identification to record set information for the data, and a journal management system stores the record set information in a journal. The journaled information, for example, may be employed for performing forensic analysis of data corruption events or to perform security audits, etc.",BOYD KENNETH WAYNE;;DILLENBERGER DONNA ENG;;KERN ROBERT FREDERIC;;MICKA WILLIAM FRANK;;PALM JEFFREY WILLIAM;;SHACKELFORD DAVID MICHAEL;;WILDING MARK FRANCIS,BOYD KENNETH WAYNE;;DILLENBERGER DONNA ENG;;KERN ROBERT FREDERIC;;MICKA WILLIAM FRANK;;PALM JEFFREY WILLIAM;;SHACKELFORD DAVID MICHAEL;;WILDING MARK FRANCIS,INTERNATIONAL BUSINESS MACHINES CORPORATION (2007-05-03);;GLOBALFOUNDRIES U.S. 2 LLC (2015-06-29);;GLOBALFOUNDRIES INC (2015-09-10),https://lens.org/080-606-836-136-687,Patent Application,yes,12,1,2,13,0,G06F11/2064;;G06F11/2074;;G06F2201/855;;G06F11/2064;;G06F2201/855;;G06F11/2074,G06F3/00;;G06F12/16,711/161;;710/5,0,0,,,,INACTIVE
513,US,B2,US 7610459 B2,027-093-467-749-142,2009-10-27,2009,US 73405907 A,2007-04-11,US 73405907 A;;US 73409707 A,2007-04-11,Maintain owning application information of data for a data storage system,"A data storage system writes data supplied from a host to data storage in accordance with write I/O of an owning application. A workload manager directs the processing of the supplied data in accordance with the write I/O of the owning application, provides service workload identification describing the write I/O, a storage subsystem control adds the service workload identification to record set information for the data, and a journal management system stores the record set information in a journal. The journaled information, for example, may be employed for performing forensic analysis of data corruption events or to perform security audits, etc.",IBM,BOYD KENNETH WAYNE;;DILLENBERGER DONNA ENG;;KERN ROBERT FREDERIC;;MICKA WILLIAM FRANK;;PALM JEFFREY WILLIAM;;SHACKELFORD DAVID MICHAEL;;WILDING MARK FRANCIS,INTERNATIONAL BUSINESS MACHINES CORPORATION (2007-05-03);;GLOBALFOUNDRIES U.S. 2 LLC (2015-06-29);;GLOBALFOUNDRIES INC (2015-09-10),https://lens.org/027-093-467-749-142,Granted Patent,yes,16,2,11,13,0,G06F11/34;;G06F11/3466;;G06F11/3466;;G06F11/3476;;G06F11/3476;;G06F11/349;;G06F11/349;;G06F13/14;;G06F15/16;;G06F21/00,G06F12/16;;G06F3/00,711/161;;710/5;;710/8;;710/9;;710/10;;710/16;;710/33;;711/154;;711/162;;714/6;;714/15,1,0,,,"""Input/Output Event Analysis"", IBM Technical Disclosure Bulletin, vol. 40, No. 07, Jul. 1997, pp. 117-128.",INACTIVE
514,US,B1,US 11363133 B1,029-826-675-873-402,2022-06-14,2022,US 201715849533 A,2017-12-20,US 201715849533 A,2017-12-20,Battery health-based power management,"A method of an electronic device that includes a power source is disclosed. The method determines a health of the power source, a temperature of the power source, and a state of charge of the power source. The method then sets a performance state cap for the electronic device based on at least the health of the power source.",APPLE INC,DE LA CROPTE DE CHANTERAC CYRIL;;DEMURO DAVID M;;ANANNY JOHN;;ECKERT KAREN;;ENG MICHAEL;;RUHTER NICHOLAS W;;STERZ STEPHEN D,APPLE INC (2018-03-08),https://lens.org/029-826-675-873-402,Granted Patent,yes,186,0,1,1,0,H04W52/0261;;Y02D30/70;;H04M1/72403;;G01R31/392;;G01R31/3648;;G01R31/382;;H04M1/73;;G01R31/3648;;H04W52/0261;;G01R31/392,H04M1/73;;G01R31/36;;G01R31/392;;H04W52/02,,43,2,109-902-125-211-49X;;043-777-150-357-260,10.1145/317456.317461;;10.1145/142750.143072,"Final Office Action dated Jul. 26, 2018, for U.S. Appl. No. 14/799,370, filed Jul. 14, 2015, six pages.;;Notice of Allowance dated Oct. 25, 2018, for U.S. Appl. No. 14/799,370, filed Jul. 14, 2015, five pages.;;Danish Search Report dated Apr. 20, 2017, for Application No. PA 2017 70089, eight pages.;;Final Office Action dated Mar. 23, 2017, for U.S. Appl. No. 14/817,572, filed Aug. 4, 2015, 13 pages.;;Final Office Action dated Apr. 27, 2017, for U.S. Appl. No. 14/799,370, filed Jul. 14, 2015, 19 pages.;;International Search Report dated Jan. 29, 2016, for PCT Patent Application No. PCT/US2015/043487, eight pages.;;Lee, S.K. et al. (Apr. 1985). “A Multi-Touch Three Dimensional Touch-Sensitive Tablet,” Proceedings of CHI: ACM Conference on Human Factors in Computing Systems, pp. 21-25.;;Non-Final Office Action dated Aug. 12, 2016, for U.S. Appl. No. 14/799,370, filed Jul. 14, 2015, fourteen pages.;;Non-Final Office Action dated Sep. 12, 2016, for U.S. Appl. No. 14/817,572, filed Aug. 4, 2015, eight pages.;;Non-Final Office Action dated Dec. 1, 2017, for U.S. Appl. No. 14/799,370, filed Jul. 14, 2015, 23 pages.;;Rubine, D.H. (Dec. 1991). “The Automatic Recognition of Gestures,” CMU-CS-91-202, Submitted in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy in Computer Science at Carnegie Mellon University, 285 pages.;;Rubine, D.H. (May 1992). “Combining Gestures and Direct Manipulation,” CHI' 92, pp. 659-660.;;Westerman, W. (Spring 1999). “Hand Tracking, Finger Identification, and Chordic Manipulation on a Multi-Touch Surface,” A Dissertation Submitted to the Faculty of the University of Delaware in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy in Electrical Engineering, 364 pages.;;Notice of Allowance dated Nov. 30, 2017, for U.S. Appl. No. 14/817,572, filed Aug. 4, 2015, 26 pages.;;Final Office Action received for U.S. Appl. No. 15/849,546, dated Jan. 16, 2020, 10 pages.;;U.S. Appl. No. 61/924,200, filed Jan. 6, 2014, by Kaiser et al.;;Non-Final Office Action received for U.S. Appl. No. 15/849,486, dated Apr. 23, 2019, 11 pages.;;Non-Final Office Action received for U.S. Appl. No. 15/849,546, dated Jul. 10, 2019, 14 pages.;;Non-Final Office Action received for U.S. Appl. No. 15/902,401, dated Jul. 19, 2019, 11 pages.;;Notice of Allowance received for U.S. Appl. No. 15/849,486, dated Nov. 14, 2019, 15 pages.;;Notice of Allowance received for U.S. Appl. No. 15/902,401, dated Dec. 4, 2019, 8 pages.;;Notice of Allowance received for U.S. Appl. No. 16/275,031, dated Sep. 19, 2019, 7 pages.;;Supplemental Notice of Allowance received for U.S. Appl. No. 15/902,401, dated Feb. 3, 2020, 2 pages.;;Supplemental Notice of Allowance received for U.S. Appl. No. 15/902,401, dated Feb. 13, 2020, 2 pages.;;Applicant Initiated Interview Summary received for U.S. Appl. No. 15/849,546, dated Jun. 15, 2020, 3 pages.;;Final Office Action received for U.S. Appl. No. 14/812,904, dated Jun. 9, 2016, 12 pages.;;Final Office Action received for U.S. Appl. No. 15/481,392, dated Jan. 3, 2019, 10 pages.;;Non-Final Office Action received for U.S. Appl. No. 14/812,904, dated Jan. 26, 2016, 14 pages.;;Non-Final Office Action received for U.S. Appl. No. 15/481,392, dated Jul. 3, 2018, 8 pages.;;Notice of Allowance received for U.S. Appl. No. 14/812,904, dated Jan. 6, 2017, 5 pages.;;Non-Final Office Action received for U.S. Appl. No. 16/730,743, dated Jul. 10, 2020, 16 pages.;;Non-Final Office Action received for U.S. Appl. No. 16/503,349, dated Oct. 27, 2020, 7 pages.;;Search Report received for Chinese Patent Application No. 201580047640.0, dated Oct. 16, 2020, 4 pages (2 pages of English Translation & 2 pages of Official Copy).;;Notice of Allowance received for U.S. Appl. No. 15/849,546, dated Jun. 19, 2020, 11 pages.;;Applicant-Initiated Interview Summary received for U.S. Appl. No. 15/849,546, dated Jun. 15, 2020, 2 pages.;;Notice of Allowance received for U.S. Appl. No. 16/841,352, dated Oct. 27, 2020, 13 pages.;;Corrected Notice of Allowance received for U.S. Appl. No. 16/730,743, dated Jan. 19, 2021, 2 pages.;;Corrected Notice of Allowance received for U.S. Appl. No. 16/841,352, dated Dec. 2, 2020, 2 Pages.;;Notice of Allowance received for U.S. Appl. No. 16/503,349, dated Apr. 12, 2021, 5 pages.;;Notice of Allowance received for U.S. Appl. No. 16/730,743, dated Dec. 21, 2020, 5 pages.;;Corrected Notice of Allowability received for U.S. Appl. No. 17/157,391, dated Dec. 30, 2021, 2 pages.;;Non-Final Office Action received for U.S. Appl. No. 17/157,391, dated Aug. 23, 2021, 12 pages.;;Notice of Allowance received for U.S. Appl. No. 17/157,391, dated Dec. 17, 2021, 8 pages.",ACTIVE
515,US,A1,US 2016/0033418 A1,062-067-871-703-525,2016-02-04,2016,US 201514806132 A,2015-07-22,US 201514806132 A;;US 201462027364 P,2014-07-22,COMBINATION GLOVE FOR DETECTING BREACH OF HYDROPHILIC FLUID,"Provided for example is a combination glove comprising: (a) an top elastomer layer with an inner surface, the top elastomer layer being translucent or transparent; (b) an bottom elastomer layer with an outer surface, the bottom elastomer layer being darker than the top elastomer layer; and (c) a space or seam between the layers, wherein to either the inner-top or the outer-bottom surface has been adhered a hydrophilicity promoting composition of (i) a polyvinyl alcohol or (ii) an alkyl-aryl compound or a siloxane compound having a pendent one to two oxy-polymers, or (iii) a quaternary amine including an alkyl of C8 to C24, wherein the oxy-polymer is (1) a poly-oxyalkylene polymer that is predominantly oxyethylene or (2) a polyvinyl alcohol, wherein the hydrophilicity promoting composition enhances the spreading in the space or seam of any of the hydrophilic or aqueous fluid that breaches the top or bottom elastomer layer.",ANSELL LTD,ENG AIK HWEE;;THANNIMALAI THANABALAN;;KHOR ALBERT;;TANG LOK SI;;PHAM THI HAO;;LUCAS DAVID M;;LOPEZ ANTHONY;;CHAK CHOY YUEN,ANSELL LIMITED (2015-08-12),https://lens.org/062-067-871-703-525,Patent Application,yes,7,7,6,6,0,A41D19/0006;;A61B42/30;;A41D19/0006;;A41D19/0024;;A41D19/01594,G01N21/78;;A41D19/00,,0,0,,,,DISCONTINUED
516,US,B2,US 7613888 B2,071-304-874-112-264,2009-11-03,2009,US 73409707 A,2007-04-11,US 73409707 A,2007-04-11,Maintain owning application information of data for a data storage system,"A data storage system writes data supplied from a host to data storage in accordance with write I/O of an owning application. A workload manager directs the processing of the supplied data in accordance with the write I/O of the owning application, provides service workload identification describing the write I/O, a storage subsystem control adds the service workload identification to record set information for the data, and a journal management system stores the record set information in a journal. The journaled information, for example, may be employed for performing forensic analysis of data corruption events or to perform security audits, etc.",IBM,BOYD KENNETH WAYNE;;DILLENBERGER DONNA ENG;;KERN ROBERT FREDERIC;;MICKA WILLIAM FRANK;;PALM JEFFREY WILLIAM;;SHACKELFORD DAVID MICHAEL;;WILDING MARK FRANCIS,INTERNATIONAL BUSINESS MACHINES CORPORATION (2007-05-03);;GLOBALFOUNDRIES U.S. 2 LLC (2015-06-29);;GLOBALFOUNDRIES INC (2015-09-10),https://lens.org/071-304-874-112-264,Granted Patent,yes,14,2,2,13,0,G06F11/2064;;G06F11/2074;;G06F2201/855;;G06F11/2064;;G06F2201/855;;G06F11/2074,G06F12/16;;G06F3/00,711/161;;710/5;;710/8;;710/9;;710/10;;710/16;;710/33;;711/154;;711/162;;714/6;;714/15,1,0,,,"""Input/Output Event Analysis"", IBM Technical Disclosure Bulletin, vol. 40, No. 07, Jul. 1997, pp. 117-128.",INACTIVE
517,EP,A1,EP 3171809 A1,083-292-569-933-242,2017-05-31,2017,EP 15824882 A,2015-07-22,US 201462027364 P;;AU 2015/000425 W,2014-07-22,COMBINATION GLOVE FOR DETECTING BREACH OF HYDROPHILIC FLUID,,ANSELL LTD,ENG AIK HWEE;;THANNIMALAI THANABALAN;;KHOR ALBERT;;TANG LOK SI;;PHAM THI HAO;;LUCAS DAVID M;;LOPEZ ANTHONY;;CHAK CHOY YUEN,,https://lens.org/083-292-569-933-242,Patent Application,yes,0,0,6,6,0,A41D19/0006;;A61B42/30;;A41D19/0006;;A41D19/0024;;A41D19/01594,A61B34/00,,0,0,,,,DISCONTINUED
518,WO,A1,WO 2021/050928 A1,177-625-437-075-777,2021-03-18,2021,US 2020/0050472 W,2020-09-11,US 201962898835 P,2019-09-11,DEEP LEARNING SYSTEM FOR DIFFERENTIAL DIAGNOSIS OF SKIN DISEASES,"The present disclosure is directed to a deep learning system for differential diagnoses of skin diseases. In particular, the system performs a method that can include obtaining a plurality of images that respectively depict a portion of a patient's skin. The method can include determining, using a machine-learned skin condition classification model, a plurality of embeddings respectively for the plurality of images. The method can include combining the plurality of embeddings to obtain a unified representation associated with the portion of the patient's skin. The method can include determining, using the machine-learned skin condition classification model, a skin condition classification for the portion of the patient's skin, the skin condition classification produced by the machine-learned skin condition classification model by processing the unified representation, wherein the skin condition classification identifies one or more skin conditions selected from a plurality of potential skin conditions.",GOOGLE LLC,DUNN ROBERT CARTER;;JAIN AYUSH;;BUI PEGGY YEN PHUONG;;ENG CLARA;;WAY DAVID HENRY;;LI KANG;;GUPTA VISHAKHA;;GALLEGOS JESSICA;;AI DENNIS;;LIU YUN;;COZ DAVID;;LIU YUAN,,https://lens.org/177-625-437-075-777,Patent Application,yes,3,5,3,3,0,G16H30/20;;G16H30/40;;G16H50/20;;G16H10/60;;G16H50/20;;G16H30/40,G16H30/20;;G16H30/40;;G16H50/20,,0,0,,,,PENDING
519,EP,A1,EP 4010908 A1,099-696-101-323-184,2022-06-15,2022,EP 20780848 A,2020-09-11,US 201962898835 P;;US 2020/0050472 W,2019-09-11,DEEP LEARNING SYSTEM FOR DIFFERENTIAL DIAGNOSIS OF SKIN DISEASES,,GOOGLE LLC,DUNN ROBERT CARTER;;JAIN AYUSH;;BUI PEGGY YEN PHUONG;;ENG CLARA;;WAY DAVID HENRY;;LI KANG;;GUPTA VISHAKHA;;GALLEGOS JESSICA;;AI DENNIS;;LIU YUN;;COZ DAVID;;LIU YUAN,,https://lens.org/099-696-101-323-184,Patent Application,yes,0,0,3,3,0,G16H30/20;;G16H30/40;;G16H50/20;;G16H10/60;;G16H50/20;;G16H30/40,G16H30/20;;G16H30/40;;G16H50/20,,0,0,,,,PENDING
520,US,A1,US 2022/0359062 A1,099-711-320-326-61X,2022-11-10,2022,US 202017620445 A,2020-09-11,US 202017620445 A;;US 201962898835 P;;US 2020/0050472 W,2019-09-11,Deep Learning System for Differential Diagnosis of Skin Diseases,"The present disclosure is directed to a deep learning system for differential diagnoses of skin diseases. In particular, the system performs a method that can include obtaining a plurality of images that respectively depict a portion of a patient's skin. The method can include determining, using a machine-learned skin condition classification model, a plurality of embeddings respectively for the plurality of images. The method can include combining the plurality of embeddings to obtain a unified representation associated with the portion of the patient's skin. The method can include determining, using the machine-learned skin condition classification model, a skin condition classification for the portion of the patients skin, the skin condition classification produced by the machine-learned skin condition classification model by processing the unified representation, wherein the skin condition classification identifies one or more skin conditions selected from a plurality of potential skin conditions.",GOOGLE LLC,DUNN ROBERT CARTER;;JAIN AYUSH;;BUI PEGGY YEN PHUONG;;ENG CLARA;;WAY DAVID HENRY;;LI KANG;;GUPTA VISHAKHA;;GALLEGOS JESSICA;;AI DENNIS;;LIU YUN;;COZ DAVID;;LIU YUAN,GOOGLE LLC (2019-10-07),https://lens.org/099-711-320-326-61X,Patent Application,yes,0,1,3,3,0,G16H30/20;;G16H30/40;;G16H50/20;;G16H10/60;;G16H50/20;;G16H30/40,G16H30/40;;G16H10/60;;G16H50/20,,0,0,,,,PENDING
521,US,A1,US 2020/0192432 A1,066-785-350-957-812,2020-06-18,2020,US 201916707740 A,2019-12-09,US 201916707740 A;;US 201514852592 A,2015-09-13,MULTI-ORIENTATION DISPLAY DEVICE,"A computing device includes a flexible display screen, a housing to house at least one processor device and at least one memory element, and a first wing to support a side portion of the display screen. The front face of the housing includes a center portion of the display screen. The first wing is connected to the housing by a hinge, the first wing configured to swivel about an axis defined by the hinge. The hinge is configured to lock the first wing in at least two wing positions, a first of the wing positions supports the side portion of the display screen in a first orientation, a second of the wing positions supports the side portion of the display screen in a second orientation, and the side portion of the display screen is active in the first orientation and hidden in the second orientation.",INTEL CORP,YEE CHEE CHUN;;BROWNING DAVID W;;CHEAH BOK ENG;;KONG JACKSON CHUNG PENG;;LIM MIN SUET;;LOO HOWE YIN;;OH POH TAT,,https://lens.org/066-785-350-957-812,Patent Application,yes,2,12,9,9,0,G06F3/1407;;G06F3/0488;;G06F1/1626;;G06F1/1641;;G06F1/1643;;G06F1/1652;;G06F2203/04102;;G06F1/1641;;G06F1/1643;;G06F1/1626;;G06F1/1652;;G06F1/1675;;G06F3/041;;G06F2203/04102,G06F1/16;;G06F3/041,,0,0,,,,PENDING
522,US,A1,US 2021/0322770 A1,067-966-988-252-714,2021-10-21,2021,US 202117364609 A,2021-06-30,US 202117364609 A;;US 201715699873 A;;US 201662393268 P,2016-09-12,IDENTIFICATION OF COMPROMISED COMPONENTS IN A MEDICAL SYSTEM,"In some examples of selecting a target therapy delivery site for treating a patient condition, a relatively high frequency electrical stimulation signal is delivered to at least two areas within a first region (e.g., an anterior nucleus of the thalamus) of a brain of a patient, and changes in brain activity (e.g., as indicated by bioelectrical brain signals) within a second region (e.g., a hippocampus) of the brain of the patient in response to the delivered stimulation are determined. The target therapy delivery site, an electrode combination, or both, may be selected based on the changes in brain activity.",MEDTRONIC INC,GIFTAKIS JONATHON E;;DENISON TIMOTHY J;;STYPULKOWSKI PAUL H;;STANSLASKI SCOTT R;;RAIKE ROBERT S;;ENG MAE;;LINDE DAVID E;;ADAMSKI THOMAS,MEDTRONIC INC (2017-09-05),https://lens.org/067-966-988-252-714,Patent Application,yes,2,0,3,3,0,A61N1/36142;;A61N2001/083;;A61N1/3614;;A61N1/0534;;A61N1/36185;;A61N1/0531;;A61N1/36082;;A61N1/3614;;A61N1/0534;;A61N1/36185;;A61N1/0531;;A61N1/36082;;A61N1/36142;;A61N2001/083,A61N1/36,,0,0,,,,PENDING
523,WO,A1,WO 2008/125538 A1,131-542-361-755-238,2008-10-23,2008,EP 2008054163 W,2008-04-07,US 73405907 A;;US 73409707 A,2007-04-11,SERVICE WORKLOAD IDENTIFICATION IN A DATA STORAGE SYSTEM,"A data storage systemwrites data supplied from a host to data storage in accordance with write I/O of an owning application. A workload manager directs the processing of the supplied data in accordance with the write I/O of the owning application, provides service workload identification describing the write I/O, a storage subsystem control adds the service workload identification to record set information for the data, and a journal management system stores the record set information in a journal. The journaled information, for example, may be employed for performing forensic analysis of data corruption events or to perform security audits, etc.",IBM;;IBM UK;;WILDING MARK FRANCIS;;BOYD KENNETH WAYNE;;PALM JEFFREY WILLIAM;;KERN ROBERT FREDERIC;;SHACKELFORD DAVID MICHAEL;;MICKA WILLIAM FRANK;;DILLENBERGER DONNA N ENG,WILDING MARK FRANCIS;;BOYD KENNETH WAYNE;;PALM JEFFREY WILLIAM;;KERN ROBERT FREDERIC;;SHACKELFORD DAVID MICHAEL;;MICKA WILLIAM FRANK;;DILLENBERGER DONNA N ENG,,https://lens.org/131-542-361-755-238,Patent Application,yes,6,0,11,13,0,G06F11/34;;G06F11/3466;;G06F11/3466;;G06F11/3476;;G06F11/3476;;G06F11/349;;G06F11/349;;G06F13/14;;G06F15/16;;G06F21/00,G06F11/34,,0,0,,,,PENDING
524,CN,A,CN 107924214 A,164-128-986-879-656,2018-04-17,2018,CN 201680048257 A,2016-08-12,US 201514852592 A;;US 2016/0046654 W,2015-09-13,Multi-orientation display device,"A computing device includes a flexible display screen, a housing to house at least one processor device and at least one memory element, and a first wing to support a side portion of the display screen. The front face of the housing includes a center portion of the display screen. The first wing is connected to the housing by a hinge, the first wing configured to swivel about an axis defined by the hinge. The hinge is configured to lock the first wing in at least two wing positions, a first of the wing positions supports the side portion of the display screen in a first orientation, a second of the wing positions supports the side portion of the display screen in a second orientation, and the side portion of the display screen is active in the first orientation and hidden in the second orientation.",INTEL CORP,YEE CHEE CHUN;;BROWNING DAVID W;;CHEAH BOK ENG;;KONG JACKSON CHUNG PENG;;LIM MIN SUET;;LOO HOWE YIN;;OH POH TAT,,https://lens.org/164-128-986-879-656,Patent Application,no,5,3,9,9,0,G06F3/1407;;G06F3/0488;;G06F1/1626;;G06F1/1641;;G06F1/1643;;G06F1/1652;;G06F2203/04102;;G06F1/1641;;G06F1/1643;;G06F1/1626;;G06F1/1652;;G06F1/1675;;G06F3/041;;G06F2203/04102,G06F1/16;;H04M1/02,,0,0,,,,ACTIVE
525,US,A1,US 2017/0075388 A1,004-831-275-249-837,2017-03-16,2017,US 201514852592 A,2015-09-13,US 201514852592 A,2015-09-13,MULTI-ORIENTATION DISPLAY DEVICE,"A computing device includes a flexible display screen, a housing to house at least one processor device and at least one memory element, and a first wing to support a side portion of the display screen. The front face of the housing includes a center portion of the display screen. The first wing is connected to the housing by a hinge, the first wing configured to swivel about an axis defined by the hinge. The hinge is configured to lock the first wing in at least two wing positions, a first of the wing positions supports the side portion of the display screen in a first orientation, a second of the wing positions supports the side portion of the display screen in a second orientation, and the side portion of the display screen is active in the first orientation and hidden in the second orientation.",INTEL CORP,YEE CHEE CHUN;;BROWNING DAVID W;;CHEAH BOK ENG;;KONG JACKSON CHUNG PENG;;LIM MIN SUET;;LOO HOWE YIN;;OH POH TAT,INTEL CORPORATION (2011-09-08),https://lens.org/004-831-275-249-837,Patent Application,yes,5,18,9,9,0,G06F3/1407;;G06F3/0488;;G06F1/1626;;G06F1/1641;;G06F1/1643;;G06F1/1652;;G06F2203/04102;;G06F1/1641;;G06F1/1643;;G06F1/1626;;G06F1/1652;;G06F1/1675;;G06F3/041;;G06F2203/04102,G06F1/16;;G06F3/041,,0,0,,,,ACTIVE
526,US,B2,US 10503211 B2,196-701-467-303-92X,2019-12-10,2019,US 201514852592 A,2015-09-13,US 201514852592 A,2015-09-13,Multi-orientation display device,"A computing device includes a flexible display screen, a housing to house at least one processor device and at least one memory element, and a first wing to support a side portion of the display screen. The front face of the housing includes a center portion of the display screen. The first wing is connected to the housing by a hinge, the first wing configured to swivel about an axis defined by the hinge. The hinge is configured to lock the first wing in at least two wing positions, a first of the wing positions supports the side portion of the display screen in a first orientation, a second of the wing positions supports the side portion of the display screen in a second orientation, and the side portion of the display screen is active in the first orientation and hidden in the second orientation.",INTEL CORP,YEE CHEE CHUN;;BROWNING DAVID W;;CHEAH BOK ENG;;KONG JACKSON CHUNG PENG;;LIM MIN SUET;;LOO HOWE YIN;;OH POH TAT,INTEL CORPORATION (2011-09-08),https://lens.org/196-701-467-303-92X,Granted Patent,yes,10,4,9,9,0,G06F3/1407;;G06F3/0488;;G06F1/1626;;G06F1/1641;;G06F1/1643;;G06F1/1652;;G06F2203/04102;;G06F1/1641;;G06F1/1643;;G06F1/1626;;G06F1/1652;;G06F1/1675;;G06F3/041;;G06F2203/04102,H05K5/00;;G06F1/16;;G06F3/041;;H05K7/00,,2,0,,,"International Search Report and Written Opinion in International Application No. PCT/US2016/046654 dated Nov. 17, 2016.;;International Preliminary Report on Patentability in International Application No. PCT/US2016/046654, dated Mar. 22, 2018, 13 pages.",ACTIVE
527,WO,A1,WO 2017/044246 A1,050-395-606-912-593,2017-03-16,2017,US 2016/0046654 W,2016-08-12,US 201514852592 A,2015-09-13,MULTI-ORIENTATION DISPLAY DEVICE,"A computing device includes a flexible display screen, a housing to house at least one processor device and at least one memory element, and a first wing to support a side portion of the display screen. The front face of the housing includes a center portion of the display screen. The first wing is connected to the housing by a hinge, the first wing configured to swivel about an axis defined by the hinge. The hinge is configured to lock the first wing in at least two wing positions, a first of the wing positions supports the side portion of the display screen in a first orientation, a second of the wing positions supports the side portion of the display screen in a second orientation, and the side portion of the display screen is active in the first orientation and hidden in the second orientation.",INTEL CORP,YEE CHEE CHUN;;BROWNING DAVID W;;CHEAH BOK ENG;;KONG JACKSON CHUNG PENG;;LIM MIN SUET;;LOO HOWE YIN;;OH POH TAT,,https://lens.org/050-395-606-912-593,Patent Application,yes,5,3,9,9,0,G06F3/1407;;G06F3/0488;;G06F1/1626;;G06F1/1641;;G06F1/1643;;G06F1/1652;;G06F2203/04102;;G06F1/1641;;G06F1/1643;;G06F1/1626;;G06F1/1652;;G06F1/1675;;G06F3/041;;G06F2203/04102,G06F1/16;;H04M1/02,,0,0,,,,PENDING
528,EP,A1,EP 2135166 A1,127-125-082-094-164,2009-12-23,2009,EP 08735895 A,2008-04-07,EP 2008054163 W;;US 73405907 A;;US 73409707 A,2007-04-11,SERVICE WORKLOAD IDENTIFICATION IN A DATA STORAGE SYSTEM,,IBM,WILDING MARK FRANCIS;;BOYD KENNETH WAYNE;;PALM JEFFREY WILLIAM;;KERN ROBERT FREDERIC;;SHACKELFORD DAVID MICHAEL;;MICKA WILLIAM FRANK;;DILLENBERGER DONNA N ENG,,https://lens.org/127-125-082-094-164,Patent Application,yes,0,0,11,13,0,G06F11/34;;G06F11/3466;;G06F11/3466;;G06F11/3476;;G06F11/3476;;G06F11/349;;G06F11/349;;G06F13/14;;G06F15/16;;G06F21/00,G06F11/34,,1,0,,,See references of WO 2008125538A1,ACTIVE
529,EP,A3,EP 0220019 A3,091-383-059-176-433,1989-10-25,1989,EP 86307746 A,1986-10-08,US 78832285 A,1985-10-17,D-5 CHANNEL BANK CONTROL STRUCTURE AND CONTROLLER,"A channel bank unit (20) for interfacing baseband user signals with a PCM carrier communications channel. The channel bank unit (20) includes a digital port for communicating operational parameters between the channel bank unit and a system controller (10). The operational parameters provided to the channel bank unit (20) by the system controller (10) permit remote provisioning of the channel bank (20) to meet customer needs. A test port is also included in the channel bank unit (20) to permit remote testing of the channel bank unit by the system controller (10).  ",AMERICAN TELEPHONE AND TELEGRAPH COMPANY,"BAUN, PHILIP JOHN, JR.;;CARRIERE, JOSEPH FRANCIS;;ENG, STEPHEN KA-YEE;;LANDRY, JOSEPH ELIDE;;LEE, JONGHEE;;NOLAN, THOMAS MICHAEL;;RHODES, DAVID CRAIG",,https://lens.org/091-383-059-176-433,Search Report,yes,2,0,4,6,0,H04J3/04;;H04L25/49;;H04Q11/04,H04J3/00;;H04J3/04;;H04Q3/42;;H04Q11/04,,4,0,,,"Proceedings International Switching Symposium, May 7-11, 1979, pages 1094-1101; Paris, FR, M. KOEHLMARK et al.: ""Idees nouvelles sur la philosophie de l'exploitation et de la maintenance d'un reseau public de donnees synchrones"", page 1097, right-hand column, lines 47-55; page 1099, left-hand column, lines 1-11, line 16 - page 1100, right-hand column, line 3.;;Proceedings International Switching Symposium, May 7-11, 1979, pages 1102-1110; Paris, FR, S.R. TEVES et al.: ""Test de lignes d'abonnes et de jonctions dans un systeme de commutation numerique"", page 1104, left-hand column, lines 24-42; page 1105, left-hand column, paragraph 4 - page 1107, line 21.;;Proceedings International Switching Symposium, May 7-11, 1979, pages 991-995; Paris, FR, J.B. JACOB: ""La disponibilite du service telephonique du systeme E 10"", page 993, left-hand column, line 23 - page 994, left-hand column line 27.;;Communication and Transmission, Vol. 5, No. 2, June 1983, pages 5-26; Issy-les-Moulineaux, FR, R. GOUTTEBEL et al.: ""Les multiplexeurs numeriques et le reccordement d'abonnes analogiques"", page 10, column 2, line 8 - right-hand column, end; page 11, right-hand column, lines 11-17; page 18, left-hand column, line 1 - right-hand column, line 14.",DISCONTINUED
530,US,A1,US 2018/0071530 A1,160-617-755-805-600,2018-03-15,2018,US 201715699873 A,2017-09-08,US 201715699873 A;;US 201662393268 P,2016-09-12,IDENTIFICATION OF COMPROMISED COMPONENTS IN A MEDICAL SYSTEM,"In some examples of selecting a target therapy delivery site for treating a patient condition, a relatively high frequency electrical stimulation signal is delivered to at least two areas within a first region (e.g., an anterior nucleus of the thalamus) of a brain of a patient, and changes in brain activity (e.g., as indicated by bioelectrical brain signals) within a second region (e.g., a hippocampus) of the brain of the patient in response to the delivered stimulation are determined. The target therapy delivery site, an electrode combination, or both, may be selected based on the changes in brain activity.",MEDTRONIC INC,GIFTAKIS JONATHON E;;DENISON TIMOTHY J;;STYPULKOWSKI PAUL H;;STANSLASKI SCOTT R;;RAIKE ROBERT S;;ENG MAE;;LINDE DAVID E;;ADAMSKI THOMAS,MEDTRONIC INC (2017-09-05),https://lens.org/160-617-755-805-600,Patent Application,yes,1,10,3,3,0,A61N1/36142;;A61N2001/083;;A61N1/3614;;A61N1/0534;;A61N1/36185;;A61N1/0531;;A61N1/36082;;A61N1/3614;;A61N1/0534;;A61N1/36185;;A61N1/0531;;A61N1/36082;;A61N1/36142;;A61N2001/083,A61N1/05;;A61N1/36,,0,0,,,,ACTIVE
531,US,A1,US 2023/0409084 A1,000-432-026-953-942,2023-12-21,2023,US 202318458919 A,2023-08-30,US 202318458919 A;;US 201916707740 A;;US 201514852592 A,2015-09-13,MULTI-ORIENTATION DISPLAY DEVICE,"A computing device includes a flexible display screen, a housing to house at least one processor device and at least one memory element, and a first wing to support a side portion of the display screen. The front face of the housing includes a center portion of the display screen. The first wing is connected to the housing by a hinge, the first wing configured to swivel about an axis defined by the hinge. The hinge is configured to lock the first wing in at least two wing positions, a first of the wing positions supports the side portion of the display screen in a first orientation, a second of the wing positions supports the side portion of the display screen in a second orientation, and the side portion of the display screen is active in the first orientation and hidden in the second orientation.",INTEL CORP,YEE CHEE CHUN;;BROWNING DAVID W;;CHEAH BOK ENG;;KONG JACKSON CHUNG PENG;;LIM MIN SUET;;LOO HOWE YIN;;OH POH TAT,,https://lens.org/000-432-026-953-942,Patent Application,yes,0,0,9,9,0,G06F3/1407;;G06F3/0488;;G06F1/1626;;G06F1/1641;;G06F1/1643;;G06F1/1652;;G06F2203/04102;;G06F1/1641;;G06F1/1643;;G06F1/1626;;G06F1/1652;;G06F1/1675;;G06F3/041;;G06F2203/04102,G06F1/16;;G06F3/041,,0,0,,,,PENDING
532,CN,A,CN 101652756 A,066-051-235-673-010,2010-02-17,2010,CN 200880011633 A,2008-04-07,EP 2008054163 W;;US 73405907 A;;US 73409707 A,2007-04-11,Service workload identification in a data storage system,"A data storage systemwrites data supplied from a host to data storage in accordance with write I/O of an owning application. A workload manager directs the processing of the supplied data in accordance with the write I/O of the owning application, provides service workload identification describing the write I/O, a storage subsystem control adds the service workload identification to record set information for the data, and a journal management system stores the record set information in a journal. The journaled information, for example, may be employed for performing forensic analysis of datacorruption events or to perform security audits, etc.",IBM,FRANCIS WILDING MARK;;WAYNE BOYD KENNETH;;WILLIAM PALM JEFFREY;;FREDERIC KERN ROBERT;;MICHAEL SHACKELFORD DAVID;;FRANK MICKA WILLIAM;;ENG DILLENBERGER DONNA N,,https://lens.org/066-051-235-673-010,Patent Application,no,0,1,11,13,0,G06F11/34;;G06F11/3466;;G06F11/3466;;G06F11/3476;;G06F11/3476;;G06F11/349;;G06F11/349;;G06F13/14;;G06F15/16;;G06F21/00,G06F11/34,,0,0,,,,INACTIVE
533,US,B2,US 11077305 B2,046-285-592-240-180,2021-08-03,2021,US 201715699873 A,2017-09-08,US 201715699873 A;;US 201662393268 P,2016-09-12,Identification of compromised components in a medical system,"In some examples of selecting a target therapy delivery site for treating a patient condition, a relatively high frequency electrical stimulation signal is delivered to at least two areas within a first region (e.g., an anterior nucleus of the thalamus) of a brain of a patient, and changes in brain activity (e.g., as indicated by bioelectrical brain signals) within a second region (e.g., a hippocampus) of the brain of the patient in response to the delivered stimulation are determined. The target therapy delivery site, an electrode combination, or both, may be selected based on the changes in brain activity.",MEDTRONIC INC,GIFTAKIS JONATHON E;;DENISON TIMOTHY J;;STYPULKOWSKI PAUL H;;STANSLASKI SCOTT R;;RAIKE ROBERT S;;ENG MAE;;LINDE DAVID E;;ADAMSKI THOMAS,MEDTRONIC INC (2017-09-05),https://lens.org/046-285-592-240-180,Granted Patent,yes,18,0,3,3,0,A61N1/36142;;A61N2001/083;;A61N1/3614;;A61N1/0534;;A61N1/36185;;A61N1/0531;;A61N1/36082;;A61N1/3614;;A61N1/0534;;A61N1/36185;;A61N1/0531;;A61N1/36082;;A61N1/36142;;A61N2001/083,A61N1/36;;A61N1/05;;A61N1/08,,2,1,033-709-855-377-571,15519026;;10.1016/j.jacc.2004.07.042,"Gunderson: “An Algorithm to Predict Implantable Cardioverter-Defibrillator Lead Failure”, JACC vol. 44, No. 9, Nov. 2, 2004:1898-902.;;Baldauf: “Deep Brain Stimulation: A Pacemaker for Parkinson's Disease and More”, http://health.usnews.com, Jul. 15, 2009.",ACTIVE
534,CA,C,CA 1315368 C,118-483-765-385-036,1993-03-30,1993,CA 615994 A,1991-02-04,CA 520716 A;;US 78832285 A,1985-10-17,D-5 CHANNEL BANK CONTROL STRUCTURE AND CONTROLLER,"This invention relates to a circuit for encoding incoming user signals into an outgoing stream of digital words. Each digital word includes an outgoing parity bit. The current also decodes an incoming stream of digital words, each including an incoming parity bit. The circuit is comprised of a first unit for sensing deviation of parity of the incoming stream of digital words; and a second unit for developing a parity for the outgoing stream of digital words responsive to the first unit.",AMERICAN TELEPHONE & TELEGRAPH,BAUN PHILIP J JR;;CARRIERE JOSEPH F;;ENG STEPHEN KA-YEE;;LANDRY JOSEPH E;;LEE JONGHEE;;NOLAN THOMAS M;;RHODES DAVID C,,https://lens.org/118-483-765-385-036,Granted Patent,no,0,0,1,6,0,,H04J3/04;;H04J3/14,D43400075    M;;3540070    S,0,0,,,,EXPIRED
535,EP,A2,EP 0220019 A2,116-209-437-394-844,1987-04-29,1987,EP 86307746 A,1986-10-08,US 78832285 A,1985-10-17,D-5 channel bank control structure and controller.,"A channel bank unit (20) for interfacing baseband user signals with a PCM carrier communications channel. The channel bank unit (20) includes a digital port for communicating operational parameters between the channel bank unit and a system controller (10). The operational parameters provided to the channel bank unit (20) by the system controller (10) permit remote provisioning of the channel bank (20) to meet customer needs. A test port is also included in the channel bank unit (20) to permit remote testing of the channel bank unit by the system controller (10).  ",AMERICAN TELEPHONE & TELEGRAPH,BAUN PHILIP JOHN JR;;CARRIERE JOSEPH FRANCIS;;ENG STEPHEN KA-YEE;;LANDRY JOSEPH ELIDE;;LEE JONGHEE;;NOLAN THOMAS MICHAEL;;RHODES DAVID CRAIG,,https://lens.org/116-209-437-394-844,Patent Application,yes,0,3,4,6,0,H04J3/04;;H04L25/49;;H04Q11/04,H04J3/00;;H04J3/04;;H04Q3/42;;H04Q11/04,,0,0,,,,DISCONTINUED
536,CN,A,CN 114237541 A,045-595-604-443-426,2022-03-25,2022,CN 202111600637 A,2016-08-12,US 201514852592 A;;CN 201680048257 A;;US 2016/0046654 W,2015-09-13,Multi-directional display device,"The invention discloses a multi-directional display device. A computing device includes a flexible display screen, a housing for housing at least one processor device and at least one memory element, and a first wing for supporting a side portion of the display screen. The front face of the housing includes a central portion of the display screen. The first wing is connected to the housing by a hinge, the first wing configured to rotate about an axis defined by the hinge. The hinge is configured to lock the first wing at at least two wing portions, a first one of the wing portions supporting a side portion of the display screen in a first orientation, a second one of the wing portions supporting a side portion of the display screen in a second orientation, and the side portion of the display screen being active in the first orientation and hidden in the second orientation.",INTEL COMPANY,YEE CHEE CHYE;;BROWNING DAVID W;;CHEAH BOK ENG;;KONG JACKSON CHUNG PENG;;LIM MIN SUET;;LOO HOWE YIN;;OH POH TAT,,https://lens.org/045-595-604-443-426,Patent Application,no,0,0,9,9,0,G06F3/1407;;G06F3/0488;;G06F1/1626;;G06F1/1641;;G06F1/1643;;G06F1/1652;;G06F2203/04102;;G06F1/1641;;G06F1/1643;;G06F1/1626;;G06F1/1652;;G06F1/1675;;G06F3/041;;G06F2203/04102,G06F3/14;;G06F3/0488,,0,0,,,,PENDING
537,EP,B1,EP 2135166 B1,057-866-629-745-268,2016-06-22,2016,EP 08735895 A,2008-04-07,EP 2008054163 W;;US 73405907 A;;US 73409707 A,2007-04-11,SERVICE WORKLOAD IDENTIFICATION IN A DATA STORAGE SYSTEM,,IBM,WILDING MARK FRANCIS;;BOYD KENNETH WAYNE;;PALM JEFFREY WILLIAM;;KERN ROBERT FREDERIC;;SHACKELFORD DAVID MICHAEL;;MICKA WILLIAM FRANK;;DILLENBERGER DONNA N ENG,,https://lens.org/057-866-629-745-268,Granted Patent,yes,6,0,11,13,0,G06F11/34;;G06F11/3466;;G06F11/3466;;G06F11/3476;;G06F11/3476;;G06F11/349;;G06F11/349;;G06F13/14;;G06F15/16;;G06F21/00,G06F11/34,,0,0,,,,ACTIVE
538,CN,B,CN 101652756 B,093-707-137-567-415,2012-03-28,2012,CN 200880011633 A,2008-04-07,EP 2008054163 W;;US 73405907 A;;US 73409707 A,2007-04-11,Service workload identification in a data storage system,"A data storage systemwrites data supplied from a host to data storage in accordance with write I/O of an owning application. A workload manager directs the processing of the supplied data in accordance with the write I/O of the owning application, provides service workload identification describing the write I/O, a storage subsystem control adds the service workload identification to record set information for the data, and a journal management system stores the record set information in a journal. The journaled information, for example, may be employed for performing forensic analysis of data corruption events or to perform security audits, etc.",IBM,FRANCIS WILDING MARK;;WAYNE BOYD KENNETH;;WILLIAM PALM JEFFREY;;FREDERIC KERN ROBERT;;MICHAEL SHACKELFORD DAVID;;FRANK MICKA WILLIAM;;ENG DILLENBERGER DONNA N,,https://lens.org/093-707-137-567-415,Granted Patent,no,0,0,11,13,0,G06F11/34;;G06F11/3466;;G06F11/3466;;G06F11/3476;;G06F11/3476;;G06F11/349;;G06F11/349;;G06F13/14;;G06F15/16;;G06F21/00,G06F11/34,,0,0,,,,INACTIVE
539,KR,A,KR 20090127253 A,098-342-530-852-696,2009-12-10,2009,KR 20097015557 A,2008-04-07,US 73405907 A;;US 73409707 A,2007-04-11,SERVICE WORKLOAD IDENTIFICATION IN A DATA STORAGE SYSTEM,"A data storage systemwrites data supplied from a host to data storage in accordance with write I/O of an owning application. A workload manager directs the processing of the supplied data in accordance with the write I/O of the owning application, provides service workload identification describing the write I/O, a storage subsystem control adds the service workload identification to record set information for the data, and a journal management system stores the record set information in a journal. The journaled information, for example, may be employed for performing forensic analysis of data corruption events or to perform security audits, etc.",IBM,WILDING MARK FRANCIS;;BOYD KENNETH WAYNE;;PALM JEFFREY WILLIAM;;KERN ROBERT FREDERIC;;SHACKELFORD DAVID MICHAEL;;MICKA WILLIAM FRANK;;DILLENBERGER DONNA N ENG,,https://lens.org/098-342-530-852-696,Patent Application,no,0,0,11,13,0,G06F11/34;;G06F11/3466;;G06F11/3466;;G06F11/3476;;G06F11/3476;;G06F11/349;;G06F11/349;;G06F13/14;;G06F15/16;;G06F21/00,G06F13/14;;G06F15/16;;G06F21/00,,0,0,,,,INACTIVE
540,DE,T5,DE 112016004133 T5,178-236-509-439-996,2018-05-24,2018,DE 112016004133 T,2016-08-12,US 201514852592 A;;US 2016/0046654 W,2015-09-13,Anzeigegerät mit mehreren Ausrichtungen,"Ein Rechengerät beinhaltet einen flexiblen Anzeigebildschirm, ein Gehäuse zum Beherbergen mindestens eines Prozessorgerätes und mindestens eines Speicherelementes, und einen ersten Flügel zum Stützen eines Seitenabschnitts des Anzeigebildschirms. Die Vorderseite des Gehäuses beinhaltet einen Mittelabschnitt des Anzeigebildschirms. Der erste Flügel ist durch ein Scharnier mit dem Gehäuse verbunden, und der erste Flügel ist zum Schwenken um eine Achse, die durch das Scharnier definiert ist, konfiguriert. Das Scharnier ist zum Verriegeln des ersten Flügels in mindestens zwei Flügelpositionen konfiguriert, eine erste der Flügelpositionen stützt den Seitenabschnitt des Anzeigebildschirms in einer ersten Ausrichtung, eine zweite der Flügelpositionen stützt den Seitenabschnitt des Anzeigebildschirms in einer zweiten Ausrichtung, und der Seitenabschnitt des Anzeigebildschirms ist in der ersten Ausrichtung aktiv und in der zweiten Ausrichtung verborgen.",INTEL CORP,YEE CHEE CHUN;;BROWNING DAVID W;;CHEAH BOK ENG;;KONG JACKSON CHUNG PENG;;LIM MIN SUET;;LOO HOWE YIN;;OH POH TAT,,https://lens.org/178-236-509-439-996,Patent Application,no,1,0,9,9,0,G06F3/1407;;G06F3/0488;;G06F1/1626;;G06F1/1641;;G06F1/1643;;G06F1/1652;;G06F2203/04102;;G06F1/1641;;G06F1/1643;;G06F1/1626;;G06F1/1652;;G06F1/1675;;G06F3/041;;G06F2203/04102,G06F1/16;;H04M1/02,,0,0,,,,PENDING
541,EP,A2,EP 1902014 A2,152-720-370-340-596,2008-03-26,2008,EP 06787028 A,2006-07-11,US 2006/0027066 W;;US 69759005 P,2005-07-11,GLUTAMATE AGGRECANASE INHIBITORS,,WYETH CORP,SUM PHAIK-ENG;;HOW DAVID BRIAN;;SABATINI JOSHUA JAMES;;XIANG JASON SHAOYUN;;FEYFANT ERIC;;MANSOUR TAREK SUHAYL;;TAM STEVE YIKKAI;;SKOTNICKI JERAULD STANLEY,WYETH LLC (2010-04-21),https://lens.org/152-720-370-340-596,Patent Application,yes,0,0,28,28,0,C07B2200/07;;C07C231/16;;C07C233/83;;C07C235/84;;C07C237/22;;C07C237/42;;C07C259/06;;C07C323/32;;C07D213/38;;C07D213/82;;C07D239/26;;C07D239/42;;C07D277/30;;C07D307/52;;C07D307/68;;C07D307/79;;C07D307/85;;C07D317/58;;C07D333/20;;C07D333/22;;C07D333/28;;C07D333/38;;C07D409/04;;C07C2601/02;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/08;;C07C2603/18;;C07C2603/74;;A61P1/02;;A61P1/04;;A61P1/16;;A61P11/00;;A61P11/06;;A61P13/12;;A61P17/00;;A61P19/00;;A61P19/02;;A61P19/04;;A61P25/00;;A61P27/02;;A61P29/00;;A61P35/00;;A61P37/06;;A61P43/00;;A61P9/00;;A61P9/10;;A61P9/14;;A61P3/10;;C07D213/56;;C07D213/82;;C07D317/58;;C07D333/24;;C07D277/30;;C07D213/38;;C07D239/26;;C07D239/42;;C07D307/52;;A61K31/4196;;A61K31/4192;;C07D213/82;;C07D317/58;;C07D333/28;;C07D213/38;;C07D277/30;;C07C259/06;;C07D307/52;;C07D239/26;;C07D307/85;;C07D333/38;;C07C235/84;;C07C323/32;;C07C231/16;;C07D333/20;;C07D409/04;;C07D307/68;;C07C233/83;;C07C237/42;;C07D307/79;;C07D333/22;;C07B2200/07;;C07C237/22;;C07D239/42;;C07C2601/14;;C07C2602/08;;C07C2601/18;;C07C2603/18;;C07C2601/02;;C07C2603/74;;C07C2601/08,C07C237/22,,0,0,,,,DISCONTINUED
542,US,B1,US 6436823 B1,164-108-582-110-367,2002-08-20,2002,US 67973800 A,2000-10-05,US 67973800 A,2000-10-05,Method for forming a TiN layer on top of a metal silicide layer in a semiconductor structure and structure formed,"
    A method for forming a TiN layer on top of a metal silicide layer in a semiconductor structure without the formation of a thick amorphous layer containing Ti, Co and Si and the structure formed are provided. In the method, after a Ti layer is deposited on top of a metal silidide layer, a dual-step annealing process is conducted in which a low temperature annealing in a forming gas (or ammonia) at a temperature not higher than 500 C. is first conducted for less than 2 hours followed by a high temperature annealing in a nitrogen-containing gas (or ammonia) at a second temperature not lower than 500 for less than 2 hours to form the TiN layer. The present invention method prevents the problem usually caused by a thick amorphous material layer of TiSiCo which produces weakly bonded Ti which reacts with fluorine atoms from WF _{ 6 } during a subsequent CVD W deposition process and causes liner failure due to a volume expansion of the amorphous material. The maximum thickness of the amorphous material layer formed by the present invention method is less than 5 nm which minimizes the line failure problem. 
",IBM,CABRAL JR CYRIL;;ENG CHUNG-PING;;GIGNAC LYNNE MARIE;;LAVOIE CHRISTIAN;;O'NEIL PATRICIA;;PETERSON KIRK DAVID;;WAGNER TINA;;WANG YUN-YU;;WONG KEITH,GLOBALFOUNDRIES U.S. INC (2020-10-22);;INTERNATIONAL BUSINESS MACHINES CORPORATION (2000-09-18);;GLOBALFOUNDRIES U.S. 2 LLC (2015-06-29);;GLOBALFOUNDRIES INC (2015-09-10),https://lens.org/164-108-582-110-367,Granted Patent,yes,5,6,1,1,0,H01L21/28518;;H01L21/76856;;H01L2221/1078;;H01L21/76856;;H01L2221/1078;;H01L21/28518,H01L21/285;;H01L21/768,438/686;;438/570;;438/637;;438/653;;438/680;;257/384,0,0,,,,EXPIRED
543,NO,L,NO 20076678 L,052-039-486-742-05X,2008-03-14,2008,NO 20076678 A,2007-12-28,US 69759005 P;;US 2006/0027066 W,2005-07-11,Glutamataggrekanaseinhibitorer,,WYETH LLC,SUM PHAIK-ENG;;TAM STEVE YIK-KAI;;MANSOUR TAREK SUHAYL;;HOW DAVID BRIAN;;XIANG JASON SHAOYUN;;SABATINI JOSHUA JAMES;;FEYFANT ERIC;;SKOTNICKI JERAULD,,https://lens.org/052-039-486-742-05X,Abstract,no,0,0,28,28,0,C07B2200/07;;C07C231/16;;C07C233/83;;C07C235/84;;C07C237/22;;C07C237/42;;C07C259/06;;C07C323/32;;C07D213/38;;C07D213/82;;C07D239/26;;C07D239/42;;C07D277/30;;C07D307/52;;C07D307/68;;C07D307/79;;C07D307/85;;C07D317/58;;C07D333/20;;C07D333/22;;C07D333/28;;C07D333/38;;C07D409/04;;C07C2601/02;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/08;;C07C2603/18;;C07C2603/74;;A61P1/02;;A61P1/04;;A61P1/16;;A61P11/00;;A61P11/06;;A61P13/12;;A61P17/00;;A61P19/00;;A61P19/02;;A61P19/04;;A61P25/00;;A61P27/02;;A61P29/00;;A61P35/00;;A61P37/06;;A61P43/00;;A61P9/00;;A61P9/10;;A61P9/14;;A61P3/10;;C07D213/56;;C07D213/82;;C07D317/58;;C07D333/24;;C07D277/30;;C07D213/38;;C07D239/26;;C07D239/42;;C07D307/52;;A61K31/4196;;A61K31/4192;;C07D213/82;;C07D317/58;;C07D333/28;;C07D213/38;;C07D277/30;;C07C259/06;;C07D307/52;;C07D239/26;;C07D307/85;;C07D333/38;;C07C235/84;;C07C323/32;;C07C231/16;;C07D333/20;;C07D409/04;;C07D307/68;;C07C233/83;;C07C237/42;;C07D307/79;;C07D333/22;;C07B2200/07;;C07C237/22;;C07D239/42;;C07C2601/14;;C07C2602/08;;C07C2601/18;;C07C2603/18;;C07C2601/02;;C07C2603/74;;C07C2601/08,A61K31/166;;C07C237/22;;A61K31/381;;A61K31/4409;;C07C231/16;;C07C235/84;;C07C237/42;;C07C259/06;;C07C323/41;;C07D213/56;;C07D277/30;;C07D317/58;;C07D333/24,,0,0,,,,DISCONTINUED
544,CR,A,CR 9658 A,115-812-244-707-226,2008-03-07,2008,CR 9658 A,2008-01-11,CR 9658 A,2008-01-11,INHIBIDORES DE AGRECANASA GLUTAMATO,"La presente invencion se relaciona con los compuestos de formula ( I ), los cuales son moduladores de la actividad de la metaloproteinasa y las sales farmaceuticamente aceptables de estos, en donde W es C(O)-OC(O)--NHC(O)-, C(O)O, O-C(O)NH-, R1 ES FENILO, HETEROARILO, BIFENILO, ARILO BICICLICO, ARILO TRICICLICO , HETEROARILO BICICLICO O HETEROARILO TRICICLICO, cada uno se sustituye opcionalmente con uno o mas de R5 O R6 y cuando R1 se sustituye con mas de uno de R5 o R6, los sustituyentes pueden ser identicos o diferentes.",WYETH CORP,SUM PHAIK-ENG;;HOW DAVID BRIAN;;SABATINI JOSHUA JAMES;;XIANG JASON SHAOYUN;;FEYFANT ERIC;;TAM STEVE YIKKAI;;SKOTNICKI JERAULD STANLEY;;MANSOUR TAREK SUHAYL,,https://lens.org/115-812-244-707-226,Patent Application,no,0,0,1,1,0,,C07C237/22,,0,0,,,,DISCONTINUED
545,WO,A1,WO 1999/055940 A1,010-386-561-761-510,1999-11-04,1999,US 9904697 W,1999-03-03,US 6941798 A,1998-04-29,METHOD AND SYSTEM FOR SUPPLYING SEMI-CONDUCTOR SOURCE MATERIAL,"A method of supplying source material in a crystal puller used to grow single crystal semi-conductor material. Generally, the method includes receiving a bulk container of the source material at a facility having the crystal puller and configuring the bulk container of gravity feed of the source material from the container. The bulk container is transported to the crystal puller and a predetermined quantity of source material is dispensed directly from the bulk container into the crystal puller. Apparatus and a system for use in supplying source material are also disclosed.",MEMC ELECTRONIC MATERIALS,DESTEFANO MARK;;EOFF JAMES D SR;;SCHULTE THOMAS H;;ANDERSON JOHN M;;YAU ENG CHIN;;RUGGERI DONALD R;;BALDWIN DAVID W;;BADINO CHARLES L,,https://lens.org/010-386-561-761-510,Patent Application,yes,5,5,7,7,0,B66F9/06;;B66F9/187;;C30B15/00;;C30B15/02;;C30B15/02;;C30B15/02;;C30B15/00;;B66F9/187;;B66F9/06,B66F9/06;;B66F9/18;;C30B15/00;;C30B15/02,,5,0,,,"PATENT ABSTRACTS OF JAPAN vol. 015, no. 141 (C - 0822) 10 April 1991 (1991-04-10);;PATENT ABSTRACTS OF JAPAN vol. 8, no. 232 (C - 248) 25 October 1984 (1984-10-25);;PATENT ABSTRACTS OF JAPAN vol. 016, no. 126 (C - 0923) 31 March 1992 (1992-03-31);;PATENT ABSTRACTS OF JAPAN vol. 016, no. 219 (C - 0943) 22 May 1992 (1992-05-22);;PATENT ABSTRACTS OF JAPAN vol. 098, no. 005 30 April 1998 (1998-04-30)",PENDING
546,US,B2,US 7947712 B2,136-836-571-345-97X,2011-05-24,2011,US 89522207 A,2007-08-23,US 89522207 A;;US 83956806 P,2006-08-23,8-hydroxyquinoline compounds and methods thereof,"The present invention relates to 8-Hydroxyquinoline Compounds; compositions comprising an 8-Hydroxyquinoline Compound; and methods for treating or preventing a metalloproteinase-related disorder, such as, an arthritic disorder, osteoarthritis, malignant neoplasm, rheumatoid arthritis, asthma, chronic obstructive pulmonary disease, atherosclerosis, age-related macular degeneration, myocardial infarction, a corneal ulceration, an ocular surface disease, hepatitis, an aortic aneurysm, tendonitis, a central nervous system disorder, abnormal wound healing, angiogenesis, restenosis, cirrhosis, multiple sclerosis, glomerulonephritis, graft versus host disease, diabetes, an inflammatory bowel disease, shock, invertebral disc degeneration, stroke, osteopenia or a periodontal disease or comprising administering an effective dose of an 8-Hydroxyquinoline Compound to a mammal in need thereof.",WYETH LLC,BURSAVICH MATTHEW G;;LOMBARDI SABRINA;;GILBERT ADAM M;;LAAKSO LEIF MARK;;KHAFIZOVA GULNAZ;;HOW DAVID BRIAN;;SABATINI JOSHUA JAMES;;SUM PHAIK-ENG;;CLEMENS JEREMY,WYETH LLC (2007-11-20),https://lens.org/136-836-571-345-97X,Granted Patent,yes,7,10,10,10,0,C07D215/26;;C07D215/28;;C07D401/06;;C07D401/12;;C07D405/06;;C07D409/10;;C07D417/10;;A61P9/10;;C07D215/28;;C07D401/06;;C07D405/06;;C07D417/10;;C07D215/26;;C07D409/10;;C07D401/12,C07D215/04;;A61K31/04,514/312;;546/159;;546/167,17,13,015-819-655-270-379;;163-399-270-092-469;;011-766-933-291-451;;048-460-653-015-250;;006-276-644-758-470;;017-171-751-918-394;;044-818-906-136-295;;069-158-340-991-44X;;045-470-361-571-490;;078-419-272-100-703;;019-354-733-740-785;;065-838-084-916-478;;011-766-933-291-451,11087578;;10.1021/jm000244u;;2889432;;10.1002/ijc.20968;;15729694;;10.1016/0161-5890(91)90133-5;;1650428;;6811856;;10.1016/s1357-2725(00)00061-3;;11167130;;10.1074/jbc.274.33.23443;;10438522;;10.1016/s0945-053x(97)90052-4;;10438512;;10.1074/jbc.274.33.23349;;8995297;;10.1074/jbc.272.1.556;;10.1002/cber.19741070828;;10.1016/j.tetlet.2004.03.106;;10.1002/ijc.20968;;15729694,"Bakken, CA 134:25113, abstract only of J Med Chem, vol. 43(23), pp. 45344541, 2000.;;Taylor, CA 108:34675, abstract only of Archivos de invenstigacion Medica, 18(2), pp. 119-126, 1987.;;Berkson, Int j Cancer, vol. 115, pp. 701-710, 2005.;;Varga, CA 117:277, abstract only of Molecular Immunology, vol. 28(6-, 641-654, 1991.;;Scheibel, CA 97:138147, abstract only of Mol Pharm, vol. 22(1), pp. 140-144, 1982.;;Tang, Int. J. Biochem. Cell. Biol 33:33-44 (2001).;;Abbaszade et al., J. Biol. Chem 274:23443-23-450 (1999).;;Colige et al., Proc. Natl. Acad. Sci. USA 94:2374-2379 (1997).;;Vazquez et al., J. Biol. Chem. 274:23349-23357 (1999).;;Kuno et al., J. Biol. Chem. 272:556-562 (1997).;;Jerry March, Advanced Organic Chemistry: Reactions, Mechanisms and Structures, Fourth Edition, John Wiley & Sons, pp. 69-74 (1992).;;Mohrle, H. et al. Chem. Ber. 1974, 107, 2675.;;Pirrone, F. Gazz. Chim Ital. 1936, 66, 518.;;Pirrone, F. Gazz. Chim Ital. 1937, 67, 529.;;Shen, Liang et al. Tetrahedron Letters 2004, 45, 3961.;;Bradshaw, Jerald S. et al. Supremolecular Chemistry 2001, 13, 499.;;Berkson, R.G., International Journal of Cancer, 2005, vol. 115, No. 5 pp. 701-710.",INACTIVE
547,UA,C2,UA 94412 C2,046-900-376-580-609,2011-05-10,2011,UA A200800409 A,2006-07-11,US 69759005 P,2005-07-11,GLUTAMATE AGGRECANASE INHIBITORS,The present invention relates to modulators of metalloproteinase activity.,WYETH CORP,SUM PHAIK-ENG;;HOW DAVID BRIANS;;SABATINI JOSHUA JAMES;;XIANG JASON SHAOYUN;;FEYFANT ERIC;;TAM STEVE YIK-KAI;;SKOTNICKI JERAULD STANLEY;;MANSOUR TAREK SUHAYL,,https://lens.org/046-900-376-580-609,Limited Patent,no,0,0,28,28,0,C07B2200/07;;C07C231/16;;C07C233/83;;C07C235/84;;C07C237/22;;C07C237/42;;C07C259/06;;C07C323/32;;C07D213/38;;C07D213/82;;C07D239/26;;C07D239/42;;C07D277/30;;C07D307/52;;C07D307/68;;C07D307/79;;C07D307/85;;C07D317/58;;C07D333/20;;C07D333/22;;C07D333/28;;C07D333/38;;C07D409/04;;C07C2601/02;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/08;;C07C2603/18;;C07C2603/74;;A61P1/02;;A61P1/04;;A61P1/16;;A61P11/00;;A61P11/06;;A61P13/12;;A61P17/00;;A61P19/00;;A61P19/02;;A61P19/04;;A61P25/00;;A61P27/02;;A61P29/00;;A61P35/00;;A61P37/06;;A61P43/00;;A61P9/00;;A61P9/10;;A61P9/14;;A61P3/10;;C07D213/56;;C07D213/82;;C07D317/58;;C07D333/24;;C07D277/30;;C07D213/38;;C07D239/26;;C07D239/42;;C07D307/52;;A61K31/4196;;A61K31/4192;;C07D213/82;;C07D317/58;;C07D333/28;;C07D213/38;;C07D277/30;;C07C259/06;;C07D307/52;;C07D239/26;;C07D307/85;;C07D333/38;;C07C235/84;;C07C323/32;;C07C231/16;;C07D333/20;;C07D409/04;;C07D307/68;;C07C233/83;;C07C237/42;;C07D307/79;;C07D333/22;;C07B2200/07;;C07C237/22;;C07D239/42;;C07C2601/14;;C07C2602/08;;C07C2601/18;;C07C2603/18;;C07C2601/02;;C07C2603/74;;C07C2601/08,C07C237/22;;A61K31/166;;A61K31/36;;A61K31/381;;A61K31/426;;A61K31/4409;;C07C231/00;;C07C235/84;;C07C237/42;;C07C259/00;;C07C323/41;;C07D213/56;;C07D277/30;;C07D317/58;;C07D333/24,,0,0,,,,EXPIRED
548,US,B2,US 7553873 B2,107-823-998-302-130,2009-06-30,2009,US 48400506 A,2006-07-11,US 48400506 A;;US 69759005 P,2005-07-11,Glutamate aggrecanase inhibitors,The present invention relates to modulators of metalloproteinase activity.,WYETH CORP,SUM PHAIK-ENG;;SKOTNICKI JERAULD STANLEY;;TAM STEVE YIK-KAI;;MANSOUR TAREK SUHAYL;;HOW DAVID BRIAN;;SABATINI JOSHUA JAMES;;XIANG JASON SHAOYUN;;FEYFANT ERIC,WYETH (2006-09-25),https://lens.org/107-823-998-302-130,Granted Patent,yes,67,3,28,28,0,C07B2200/07;;C07C231/16;;C07C233/83;;C07C235/84;;C07C237/22;;C07C237/42;;C07C259/06;;C07C323/32;;C07D213/38;;C07D213/82;;C07D239/26;;C07D239/42;;C07D277/30;;C07D307/52;;C07D307/68;;C07D307/79;;C07D307/85;;C07D317/58;;C07D333/20;;C07D333/22;;C07D333/28;;C07D333/38;;C07D409/04;;C07C2601/02;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/08;;C07C2603/18;;C07C2603/74;;A61P1/02;;A61P1/04;;A61P1/16;;A61P11/00;;A61P11/06;;A61P13/12;;A61P17/00;;A61P19/00;;A61P19/02;;A61P19/04;;A61P25/00;;A61P27/02;;A61P29/00;;A61P35/00;;A61P37/06;;A61P43/00;;A61P9/00;;A61P9/10;;A61P9/14;;A61P3/10;;C07D213/56;;C07D213/82;;C07D317/58;;C07D333/24;;C07D277/30;;C07D213/38;;C07D239/26;;C07D239/42;;C07D307/52;;A61K31/4196;;A61K31/4192;;C07D213/82;;C07D317/58;;C07D333/28;;C07D213/38;;C07D277/30;;C07C259/06;;C07D307/52;;C07D239/26;;C07D307/85;;C07D333/38;;C07C235/84;;C07C323/32;;C07C231/16;;C07D333/20;;C07D409/04;;C07D307/68;;C07C233/83;;C07C237/42;;C07D307/79;;C07D333/22;;C07B2200/07;;C07C237/22;;C07D239/42;;C07C2601/14;;C07C2602/08;;C07C2601/18;;C07C2603/18;;C07C2601/02;;C07C2603/74;;C07C2601/08,A61K31/166;;A61K31/192;;C07C63/06;;C07C237/28,514/563;;514/616;;562/435;;562/450;;564/155,35,21,044-152-318-766-874;;010-565-065-156-032;;067-459-236-755-953;;186-806-217-523-311;;078-435-817-577-641;;094-405-332-950-885;;063-459-526-705-764;;067-153-357-417-094;;103-951-165-031-189;;020-486-672-198-354;;044-818-906-136-295;;069-158-340-991-44X;;078-419-272-100-703;;017-171-751-918-394;;045-470-361-571-490;;020-141-402-754-29X;;010-180-753-764-093;;133-138-970-429-276;;005-309-356-564-817;;058-248-900-440-161;;017-124-709-788-643,10.1002/chin.199025250;;10.1515/znb-1992-1223;;10930259;;10.1021/ol006019o;;10.1002/bip.1973.360120303;;10.1248/cpb.47.1193;;10478476;;10.1039/b006756n;;10.1016/j.bmc.2005.04.051;;15908222;;10.1016/s0957-4166(98)00183-9;;2704023;;10.1021/jm00124a003;;2719954;;10.1021/bi00431a047;;10.1074/jbc.274.33.23443;;10438522;;10.1016/s0945-053x(97)90052-4;;8995297;;10.1074/jbc.272.1.556;;10.1016/s1357-2725(00)00061-3;;11167130;;10438512;;10.1074/jbc.274.33.23349;;9784104;;10.1021/jm980298s;;10.1016/s0968-0896(00)00051-1;;10882019;;1732532;;10.1021/jm00079a003;;10.1021/jm00193a022;;109616;;7057425;;10.1021/jm00344a018;;8544182;;10.1021/jm00026a013,"Baker et al., Journal of Pharmaceutical Science, 1966, 55(3), pp. 295-30, Abstract from STN search report.;;Beyermann, et al., ""Rapid Continuous Peptide Synthesis via FMOC Amino Acid Chloride Coupling and 4-(aminomethyl)piperidine Deblocking"", Journal of Organic Chemistry, 55(2):721-728 (1990).;;Habermehl, et al., ""Synthesis of N-[(3-ethoxycarbonylmethyl)-cyclohexyl]-azetidin-2-yl-propionic Acid Hydrochloride"", Zeitschrift Fuer Naturforschung, B: Chemical Sciences, 47(2):1779-1784 (1992).;;Jobron, et al. ""Solid-Phase Synthesis of New S-Glycoamino Acid Building Blocks"", Organic Letters, 2(15):2265-2267 (2000).;;Moroder, et al., ""Cytochrome C. Part I.: Synthesis of the Protected Hexadecapeptide (Sequence 1-16) of Baker's Yeast Iso-1-Cytochrome C"", Biopolymers, 12(3):477-492 (1973).;;Okada, et al., ""Amino Acids and Peptides LVI: Synthesis of Pyrazinone Ring-Containing Opioid Mimetics and Examination of Their Opioid Receptor Binding Activity"", Tetrahedron, 55(50):14391-14406 (1999).;;Suresh Babu, et al., ""(Fluoren-9-ylmethoxy)carbonyl (Fmoc) Amino Acid Azides: Synthesis, Isolation, Characterisation, Stability and Application to Synthesis of Peptides"", J. Chem. Soc., Perkin Trust, 1:4328-4331 (2000).;;Takahashi, et al., ""Novel Matrix Metalloproteinase Inhibitors: Generation of Lead Compounds by the in Silico Fragment-Based Approach"", Bioorganic & Medicinal Chemistry, 13(14):4527-4543 (2005).;;Wen, et al., ""Synthesis of 9-Fluorenylmethoxycarbonyl-Protected Amino Aldehydes"", Tetrahedron: Asymmetry, 9(11):1855-1858 (1998).;;Kerwin, et al., ""Hybrid Cholecystokinin (CCK) Antagonists: New Implications in the Design and Modification of CCK Antagonists"", J. Med. Chem., 32:739-742 (1989).;;Kuefner, et al., ""Carboxypeptidase-Mediated Release of Methotrexate from Methotrexate alpha-Peptides"", Biochemistry, 28:2288-2297 (1989).;;International Search Report, Issued Apr. 27, 2007, in PCT/US2006/027066.;;Abbaszade, I. et al., ""Cloning anc Characterization of ADAMTS11, an Aggrecanase from the ADAMTS Family"", J Biol Chem , 274(33):23443-23450 (1999).;;Colige, A. et al., ""cDNA Cloning and Expression of Bovine Procollagen I N-Proteinase: A New Member of the Superfamily of Zinc-Metalloproteinases with Binding Sites for Cells and Other Matrix Components"", Proc Natl Acad Sci USA, 94:2374-2379 (1997).;;Kuno, et al., ""Molecular Cloning of a Gene Encoding a New Type of Metalloproteinase-disintegrin Family Protein with Thrombospondin Motifs as an Inflammation Associated Gene"", Journal of Biological Chemistry, 272(1):556-562 (1997).;;Tang, BL, ""ADAMTS: a Novel Family of Extracellular Matrix Proteases"", Int J. Biochem Cell Biol , 33:33-44 (2001).;;Vazquez, F. et al., ""METH-1, a Human Ortholog of ADAMTS-1 and METH-2 are Members of a New Family of Proteins with Angio-inhibitory Activity"", J Biol Chem , 274(33):23349-23357 (1999).;;Augeri, et al., ""Potent and Selective Non-Cysteine-Containing Inhibitors of Protein Farnesyltransferase"", Journal of Medicinal Chemistry, 41(22):4288-4300 (1998).;;Boger, et al., ""Conformationally Restricted Analogues Designed for Selective Inhibition of GAR Tfase Versus Thymidylate Synthase or Dihydrofolate Reductase"", Bioorg. Med. Chem., 8:1075-1086 (2000).;;Database Beilstein, XP002413080, Database Accession No. BRN 3152508.;;Database Beilstein, XP002413081, Database Accession No. BRN 3149561.;;Database Beilstein, XP002413082, Database Accession No. BRN 2790059.;;Database Beilstein, XP002413083, Database Accession No. BRN 9663820.;;Database Beilstein, XP002413084, Database Accession No. BRN 3210937.;;Database Beilstein, XP002413085, Database Accession No. BRN 2600925.;;Database Beilstein, XP002413086, Database Accession No. BRN 55943.;;Database Beilstein, XP002413087, Database Accession No. BRN 2894932.;;Database Caplus [Online], XP002413088, ""Inhibitory Effect of Methotrexate on Matrix Metalloproteinase-1 (Collagenase) Production by Synovial Fibroblasts"", Database Accession No. 1997:137341.;;Makovec, et al., ""Structure-Antigastrin Activity Relationships of New (R)-4-Benzamido-5-oxopentanoic Acid Derivatives"", Journal of Medicinal Chemistry, 35(1):28-38 (1992).;;Martinelli, et al., ""Methotrexate Analogues. 12: Synthesis and Biological Properties of Some Aza Homologues"", Journal of Medicinal Chemistry, 22(7):869-874 (1979).;;Piper, et al., ""Syntheses of alpha- and gamma-Substituted Amides, Peptides, and Esters of Methotrexate and Their Evaluation as Inhibitors of Folate Metabolism"", Journal of Medicinal Chemistry, 25(2):182-187 (1982).;;Springer, et al., ""Optimization of Alkylating Agent Prodrugs Derived from Phenol and Aniline Mustards: A New Clinical Candidate Prodrug (ZD2767) for Antibody-Directed Enzyme Prodrug Therapy (ADEPT)"", Journal of Medicinal Chemistry, 38(26):5051-5065 (1995).;;PCT Invitation to Pay Additional Fees with Partial International Search Report from PCT Application No. PCT/US2006/027066.;;F. Makovec et al. ""New glutamic and aspartic derivatives with potent CCK-antagonistic activity"" Eur. J. Med. Chem.-Chim. Ther., vol. 21, No. 1, 1986, pp. 9-20, XP009082343.;;""Poster at the OARSI World Congress on Osteoarthritis 2007 held from Dec. 6-9, 2007 in Fort Lauderdale, Florida"".",INACTIVE
549,US,A1,US 2010/0010012 A1,133-053-890-025-236,2010-01-14,2010,US 46584009 A,2009-05-14,US 46584009 A;;US 48400506 A;;US 69759005 P,2005-07-11,GLUTAMATE AGGRECANASE INHIBITORS,The present invention relates to modulators of metalloproteinase activity.,WYETH CORP,SUM PHAIK-ENG;;SKOTNICKI JERAULD STANLEY;;TAM STEVE YIK-KAI;;MANSOUR TAREK SUHAYL;;HOW DAVID BRIAN;;SABATINI JOSHUA JAMES;;XIANG JASON SHAOYUN;;FEYFANT ERIC,WYETH LLC (2009-11-09),https://lens.org/133-053-890-025-236,Patent Application,yes,2,0,28,28,0,C07B2200/07;;C07C231/16;;C07C233/83;;C07C235/84;;C07C237/22;;C07C237/42;;C07C259/06;;C07C323/32;;C07D213/38;;C07D213/82;;C07D239/26;;C07D239/42;;C07D277/30;;C07D307/52;;C07D307/68;;C07D307/79;;C07D307/85;;C07D317/58;;C07D333/20;;C07D333/22;;C07D333/28;;C07D333/38;;C07D409/04;;C07C2601/02;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/08;;C07C2603/18;;C07C2603/74;;A61P1/02;;A61P1/04;;A61P1/16;;A61P11/00;;A61P11/06;;A61P13/12;;A61P17/00;;A61P19/00;;A61P19/02;;A61P19/04;;A61P25/00;;A61P27/02;;A61P29/00;;A61P35/00;;A61P37/06;;A61P43/00;;A61P9/00;;A61P9/10;;A61P9/14;;A61P3/10;;C07D213/56;;C07D213/82;;C07D317/58;;C07D333/24;;C07D277/30;;C07D213/38;;C07D239/26;;C07D239/42;;C07D307/52;;A61K31/4196;;A61K31/4192;;C07D213/82;;C07D317/58;;C07D333/28;;C07D213/38;;C07D277/30;;C07C259/06;;C07D307/52;;C07D239/26;;C07D307/85;;C07D333/38;;C07C235/84;;C07C323/32;;C07C231/16;;C07D333/20;;C07D409/04;;C07D307/68;;C07C233/83;;C07C237/42;;C07D307/79;;C07D333/22;;C07B2200/07;;C07C237/22;;C07D239/42;;C07C2601/14;;C07C2602/08;;C07C2601/18;;C07C2603/18;;C07C2601/02;;C07C2603/74;;C07C2601/08,A61K31/4965;;A61K31/16;;A61K31/34;;A61K31/38;;A61K31/44;;C07C237/00;;C07D213/56;;C07D241/02;;C07D307/87;;C07D333/02,514/255.06;;564/153;;514/616;;549/462;;514/469;;546/316;;514/355;;514/438;;549/29;;544/336,0,0,,,,INACTIVE
550,US,A1,US 2008/0269213 A1,018-333-105-101-676,2008-10-30,2008,US 89522207 A,2007-08-23,US 89522207 A;;US 83956806 P,2006-08-23,8-Hydroxyquinoline compounds and methods thereof,"The present invention relates to 8-Hydroxyquinoline Compounds; compositions comprising an 8-Hydroxyquinoline Compound; and methods for treating or preventing a metalloproteinase-related disorder, such as, an arthritic disorder, osteoarthritis, malignant neoplasm, rheumatoid arthritis, asthma, chronic obstructive pulmonary disease, atherosclerosis, age-related macular degeneration, myocardial infarction, a corneal ulceration, an ocular surface disease, hepatitis, an aortic aneurysm, tendonitis, a central nervous system disorder, abnormal wound healing, angiogenesis, restenosis, cirrhosis, multiple sclerosis, glomerulonephritis, graft versus host disease, diabetes, an inflammatory bowel disease, shock, invertebral disc degeneration, stroke, osteopenia or a periodontal disease or comprising administering an effective dose of an 8-Hydroxyquinoline Compound to a mammal in need thereof.",WYETH CORP,BURSAVICH MATTHEW G;;LOMBARDI SABRINA;;GILBERT ADAM M;;LAAKSO LEIF MARK;;KHAFIZOVA GULNAZ;;HOW DAVID BRIAN;;SABATINI JOSHUA JAMES;;SUM PHAIK-ENG;;CLEMENS JEREMY,WYETH LLC (2007-11-20),https://lens.org/018-333-105-101-676,Patent Application,yes,2,11,10,10,0,C07D215/26;;C07D215/28;;C07D401/06;;C07D401/12;;C07D405/06;;C07D409/10;;C07D417/10;;A61P9/10;;C07D215/28;;C07D401/06;;C07D405/06;;C07D417/10;;C07D215/26;;C07D409/10;;C07D401/12,A61K31/5377;;A61K31/47;;A61K31/4709;;A61P9/10;;C07D215/14;;C07D401/12;;C07D413/02,514/235.2;;546/175;;514/314;;514/311;;544/128,0,0,,,,INACTIVE
551,EP,A1,EP 1080255 A1,047-046-545-601-228,2001-03-07,2001,EP 99909793 A,1999-03-03,US 9904697 W;;US 6941798 A,1998-04-29,METHOD AND SYSTEM FOR SUPPLYING SEMI-CONDUCTOR SOURCE MATERIAL,,MEMC ELECTRONIC MATERIALS,DESTEFANO MARK;;EOFF JAMES D SR;;SCHULTE THOMAS H;;ANDERSON JOHN M;;YAU ENG CHIN;;RUGGERI DONALD R;;BALDWIN DAVID W;;BADINO CHARLES L,,https://lens.org/047-046-545-601-228,Patent Application,yes,0,0,7,7,0,B66F9/06;;B66F9/187;;C30B15/00;;C30B15/02;;C30B15/02;;C30B15/02;;C30B15/00;;B66F9/187;;B66F9/06,B66F9/06;;B66F9/18;;C30B15/00;;C30B15/02,,0,0,,,,DISCONTINUED
552,US,A,US 6089285 A,087-705-191-582-118,2000-07-18,2000,US 6941798 A,1998-04-29,US 6941798 A,1998-04-29,Method and system for supplying semiconductor source material,"A method of supplying source material in a crystal puller used to grow single crystal semiconductor material. Generally, the method includes receiving a bulk container of the source material at a facility having the crystal puller and configuring the bulk container for gravity feed of the source material from the container. The bulk container is transported to the crystal puller and a predetermined quantity of source material is dispensed directly from the bulk container into the crystal puller. Apparatus and a system for use in supplying source material are also disclosed.",MEMC ELECTRONICS MATERIALS INC,DESTEFANO MARK;;EOFF SR JAMES DEAN;;SCHULTE THOMAS H;;ANDERSON JOHN M;;YAU ENG CHIN;;RUGGERI DONALD R;;BALDWIN DAVID W;;BADINO CHARLES LAWRENCE,MEMC ELECTRONIC MATERIALS INC (1998-06-22),https://lens.org/087-705-191-582-118,Granted Patent,yes,13,7,7,7,0,B66F9/06;;B66F9/187;;C30B15/00;;C30B15/02;;C30B15/02;;C30B15/02;;C30B15/00;;B66F9/187;;B66F9/06,B66F9/06;;B66F9/18;;C30B15/00;;C30B15/02,141/231;;141/1;;141/82;;141/129;;222/1;;222/146.2;;222/152;;222/160;;222/608;;222/611.1,1,0,,,"International Search Report, PCT/US99/04697, dated Jun. 11, 1999, pp. 1 3.",EXPIRED
553,KR,A,KR 20080031379 A,178-437-708-970-385,2008-04-08,2008,KR 20087003025 A,2008-02-04,US 69759005 P,2005-07-11,GLUTAMATE AGGRECANASE INHIBITORS,The present invention relates to modulators of metalloproteinase activity.,WYETH CORP,SUM PHAIK ENG;;HOW DAVID BRIAN;;SABATINI JOSHUA JAMES;;XIANG JASON SHAOYUN;;IPEK MANUS;;FEYFANT ERIC;;TAM STEVE;;SKOTNICKI JERAULD STANLEY;;MANSOUR TAREK SUHAYL,,https://lens.org/178-437-708-970-385,Patent Application,no,0,0,28,28,0,C07B2200/07;;C07C231/16;;C07C233/83;;C07C235/84;;C07C237/22;;C07C237/42;;C07C259/06;;C07C323/32;;C07D213/38;;C07D213/82;;C07D239/26;;C07D239/42;;C07D277/30;;C07D307/52;;C07D307/68;;C07D307/79;;C07D307/85;;C07D317/58;;C07D333/20;;C07D333/22;;C07D333/28;;C07D333/38;;C07D409/04;;C07C2601/02;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/08;;C07C2603/18;;C07C2603/74;;A61P1/02;;A61P1/04;;A61P1/16;;A61P11/00;;A61P11/06;;A61P13/12;;A61P17/00;;A61P19/00;;A61P19/02;;A61P19/04;;A61P25/00;;A61P27/02;;A61P29/00;;A61P35/00;;A61P37/06;;A61P43/00;;A61P9/00;;A61P9/10;;A61P9/14;;A61P3/10;;C07D213/56;;C07D213/82;;C07D317/58;;C07D333/24;;C07D277/30;;C07D213/38;;C07D239/26;;C07D239/42;;C07D307/52;;A61K31/4196;;A61K31/4192;;C07D213/82;;C07D317/58;;C07D333/28;;C07D213/38;;C07D277/30;;C07C259/06;;C07D307/52;;C07D239/26;;C07D307/85;;C07D333/38;;C07C235/84;;C07C323/32;;C07C231/16;;C07D333/20;;C07D409/04;;C07D307/68;;C07C233/83;;C07C237/42;;C07D307/79;;C07D333/22;;C07B2200/07;;C07C237/22;;C07D239/42;;C07C2601/14;;C07C2602/08;;C07C2601/18;;C07C2603/18;;C07C2601/02;;C07C2603/74;;C07C2601/08,C07D213/56;;C07D277/30;;C07D317/58;;C07D333/24,,0,0,,,,DISCONTINUED
554,US,B2,US 7998965 B2,162-790-035-423-665,2011-08-16,2011,US 46584009 A,2009-05-14,US 46584009 A;;US 48400506 A;;US 69759005 P,2005-07-11,Glutamate aggrecanase inhibitors,The present invention relates to modulators of metalloproteinase activity.,WYETH LLC,SUM PHAIK-ENG;;SKOTNICKI JERAULD STANLEY;;TAM STEVE YIK-KAI;;MANSOUR TAREK SUHAYL;;HOW DAVID BRIAN;;SABATINI JOSHUA JAMES;;XIANG JASON SHAOYUN;;FEYFANT ERIC,WYETH LLC (2009-11-09),https://lens.org/162-790-035-423-665,Granted Patent,yes,65,0,28,28,0,C07B2200/07;;C07C231/16;;C07C233/83;;C07C235/84;;C07C237/22;;C07C237/42;;C07C259/06;;C07C323/32;;C07D213/38;;C07D213/82;;C07D239/26;;C07D239/42;;C07D277/30;;C07D307/52;;C07D307/68;;C07D307/79;;C07D307/85;;C07D317/58;;C07D333/20;;C07D333/22;;C07D333/28;;C07D333/38;;C07D409/04;;C07C2601/02;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/08;;C07C2603/18;;C07C2603/74;;A61P1/02;;A61P1/04;;A61P1/16;;A61P11/00;;A61P11/06;;A61P13/12;;A61P17/00;;A61P19/00;;A61P19/02;;A61P19/04;;A61P25/00;;A61P27/02;;A61P29/00;;A61P35/00;;A61P37/06;;A61P43/00;;A61P9/00;;A61P9/10;;A61P9/14;;A61P3/10;;C07D213/56;;C07D213/82;;C07D317/58;;C07D333/24;;C07D277/30;;C07D213/38;;C07D239/26;;C07D239/42;;C07D307/52;;A61K31/4196;;A61K31/4192;;C07D213/82;;C07D317/58;;C07D333/28;;C07D213/38;;C07D277/30;;C07C259/06;;C07D307/52;;C07D239/26;;C07D307/85;;C07D333/38;;C07C235/84;;C07C323/32;;C07C231/16;;C07D333/20;;C07D409/04;;C07D307/68;;C07C233/83;;C07C237/42;;C07D307/79;;C07D333/22;;C07B2200/07;;C07C237/22;;C07D239/42;;C07C2601/14;;C07C2602/08;;C07C2601/18;;C07C2603/18;;C07C2601/02;;C07C2603/74;;C07C2601/08,A61K31/4965;;A61K31/16;;A61K31/34;;A61K31/38;;A61K31/44;;C07C237/00;;C07D241/02;;C07D307/87;;C07D333/02,514/255.06;;514/616;;514/469;;514/355;;514/438;;564/153;;549/462;;549/29;;544/336,28,22,056-849-887-175-420;;103-951-165-031-189;;020-486-672-198-354;;020-141-402-754-29X;;010-180-753-764-093;;133-138-970-429-276;;005-309-356-564-817;;058-248-900-440-161;;017-124-709-788-643;;044-152-318-766-874;;010-565-065-156-032;;067-459-236-755-953;;186-806-217-523-311;;078-435-817-577-641;;094-405-332-950-885;;063-459-526-705-764;;067-153-357-417-094;;044-818-906-136-295;;069-158-340-991-44X;;078-419-272-100-703;;017-171-751-918-394;;045-470-361-571-490,5960175;;10.1002/jps.2600550307;;2704023;;10.1021/jm00124a003;;2719954;;10.1021/bi00431a047;;9784104;;10.1021/jm980298s;;10.1016/s0968-0896(00)00051-1;;10882019;;1732532;;10.1021/jm00079a003;;10.1021/jm00193a022;;109616;;7057425;;10.1021/jm00344a018;;8544182;;10.1021/jm00026a013;;10.1002/chin.199025250;;10.1515/znb-1992-1223;;10930259;;10.1021/ol006019o;;10.1002/bip.1973.360120303;;10.1248/cpb.47.1193;;10478476;;10.1039/b006756n;;10.1016/j.bmc.2005.04.051;;15908222;;10.1016/s0957-4166(98)00183-9;;10.1074/jbc.274.33.23443;;10438522;;10.1016/s0945-053x(97)90052-4;;8995297;;10.1074/jbc.272.1.556;;10.1016/s1357-2725(00)00061-3;;11167130;;10438512;;10.1074/jbc.274.33.23349,"Baker et al., Journal of Pharmaceutical Sciences (1966), 55(3), p. 295-302.;;""Poster at the OARSI World Congress on Osteoarthritis 2007 held from Dec. 6-9, 2007 in Fort Lauderdale, Florida"".;;F. Makovec et al. ""New glutamic and aspartic derivatives with potent CCK-antagonistic activity"" Eur. J. Med. Chem.-Chim. Ther., vol. 21, No. 1, 1986, pp. 9-20, XP009082343.;;Baker et al., Journal of Pharmaceutical Science, 1966, 55(3), pp. 295-300, Abstract from STN search report.;;Kerwin, et al., ""Hybrid Cholecystokinin (CCK) Antagonists: New Implications in the Design and Modification of CCK Antagonists"", J. Med. Chem., 32:739-742 (1989).;;Kuefner, et al., ""Carboxypeptidase-Mediated Release of Methotrexate from Methotrexate alpha-Peptides"", Biochemistry, 28:2288-2297 (1989).;;International Search Report, Issued Apr. 27, 2007, in PCT/US2006/027066.;;Augeri, et al., ""Potent and Selective Non-Cysteine-Containing Inhibitors of Protein Famesyltransferase"", Journal of Medicinal Chemistry, 41(22):4288-4300 (1998).;;Boger, et al., ""Conformationally Restricted Analogues Designed for Selective Inhibition of GAR Tfase Versus Thymidylate Synthase or Dihydrofolate Reductase"", Bioorg. Med. Chem., 8:1075-1086 (2000).;;Database Caplus [Online], XP002413088, ""Inhibitory Effect of Methotrexate on Matrix Metalloproteinase-1 (Collagenase) Production by Synovial Fibroblasts"", Database Accession No. 1997:137341.;;Makovec, et al., ""Structure-Antigastrin Activity Relationships of New (R)-4-Benzamido-5-oxopentanoic Acid Derivatives"", Journal of Medicinal Chemistry, 35(1):28-38 (1992).;;Martinelli. et al., ""Methotrexate Analogues. 12. Synthesis and Biological Properties of Some Aza Homologues"", Journal of Medicinal Chemistry, 22(7):869-874 (1979).;;Piper, et al., ""Syntheses of alpha- and gamma-Substituted Amides, Peptides, and Esters of Methotrexate and Their Evaluation as Inhibitors of Folate Metabolism"", Journal of Medicinal Chemistry, 25(2):182-187 (1982).;;Springer, et al., ""Optimization of Alkylating Agent Prodrugs Derived from Phenol and Aniline Mustards: A New Clinical Candidate Prodrug (ZD2767) for Antibody-Directed Enzyme Prodrug Therapy (ADEPT)"", Journal of Medicinal Chemistry, 38(26):5051-5065 (1995).;;PCT Invitation to Pay Additional Fees with Partial International Search Report from PCT Application No. PCT/US2006/027066, (2006).;;Beyermann, et al., ""Rapid Continuous Peptide Synthesis via FMOC Amino Acid Chloride Coupling and 4-(aminomethyl)piperidine Deblocking"", Journal of Organic Chemistry, 55(2):721-728 (1990).;;Habermehl, et al., ""Synthesis of N-[(3-ethoxycarbonylmethyl)-cyclohexyl]-azetidin-2-yl-propionic Acid Hydrochloride""; Zeitschrift Fuer Naturforschung, B: Chemical Sciences, 47(2):1779-1784 (1992).;;Jobron, et al., ""Solid-Phase Synthesis of New S-Glycoamino Acid Building Blocks"", Organic Letters, 2(15):2265-2267 (2000).;;Moroder, et al., ""Cytochrome C. Part I.: Synthesis of the Protected Hexadecapeptide (Sequence 1-16) of Baker's Yeast Iso-1-Cytochrome C"", Biopolymers, 12(3):477-492 (1973).;;Okada, et al., ""Amino Acids and Peptides LVI: Synthesis of Pyrazinone Ring-Containing Opioid Mimetics and Examination of Their Opioid Receptor Binding Activity"", Tetrahedron, 55(50):14391-14406 (1999).;;Suresh Babu, et al., ""(Fluoren-9-ylmethoxy)carbonyl (Fmoc) Amino Acid Azides: Synthesis, Isolation, Characterisation, Stability and Application to Synthesis of Peptides"", J. Chem. Soc., Perkin Trust, 1:4328-4331 (2000).;;Takahashi, et al., ""Novel Matrix Metalloproteinase Inhibitors: Generation of Lead Compounds by the in Silico Fragment-Based Approach"", Bioorganic & Medicinal Chemistry, 13(14):4527-4543 (2005).;;Wen, et al., ""Synthesis of 9-Fluorenylmethoxycarbonyl-Protected Amino Aldehydes"", Tetrahedron: Asymmetry, 9(11):1855-1858 (1998).;;Abbaszade, I. et al., ""Cloning anc Characterization of ADAMTS11, an Aggrecanase from the ADAMTS Family"", J Biol Chem , 274(33):23443-23450 (1999).;;Colige, A. et al., ""cDNA Cloning and Expression of Bovine Procollagen I N-Proteinase: A New Member of the Superfamily of Zinc-Metalloproteinases with Binding Sites for Cells and Other Matrix Components"", Proc Natl Acad Sci USA, 94:2374-2379 (1997).;;Kuno, et al., ""Molecular Cloning of a Gene Encoding a New Type of Metalloproteinase-disintegrin Family Protein with Thrombospondin Motifs as an Inflammation Associated Gene"", Journal of Biological Chemistry, 272(1):556-562 (1997).;;Tang, BL, ""ADAMTS: a Novel Family of Extracellular Matrix Proteases"", Int J. Biochem Cell Biol , 33:33-44 (2001).;;Vazquez, F. et al., ""Meth-1, a Human Ortholog of ADAMTS-1, and METH-2 are Members of a New Family of Proteins with Angio-Inhibitory Activity"", J Biol Chem , 274(33):23349-23357 (1999).",INACTIVE
555,PE,A1,PE 20100809 A1,019-964-724-696-40X,2011-01-07,2011,PE 2010000448 A,2006-07-11,US 69759005 P,2005-07-11,INHIBIDORES DE GLUTAMATO DE METALOPROTEINASAS DE MATRIZ Y AGRECANASAS,"REFERIDA A UN COMPUESTO DE FORMULA (I), DONDE W ES C(O), OC(O), NHC(O), ENTRE OTROS; R1 ES BIFENILO OPCIONALMENTE SUSTITUIDO CON R5 O R6; R2 ES H, ALQUILO C1-C6, ALQUENILO C2-C6, ENTRE OTROS; R3 ES CO2H, CONH2, CONHOH, TETRAZOL, ENTRE OTROS; R4 ES CONR9R10; R5 ES CO-ALQUILO C1-C6, SO2-ALQUILO C1-C6, O-ARILO C6-C14, ENTRE OTROS; R6 ES H, HALOGENO, CN, CF3, NO2, ENTRE OTROS; R9 ES H O ALQUILO C1-C6 OPCIONALMENTE SUSTITUIDO CON R12; R10 ES ALQUILO C1-C6 OPCIONALMENTE SUSTITUIDO CON UNO O MAS R12; R12 ES ARILO C6-C14 OPCIONALMENTE SUSTITUIDO CON UNO O MAS R13; R13 ES HALOGENO, O-ALQUILO C1-C6, CO2H, OH, CF3, ENTRE OTROS; m ES 0; p ES 0 A 2; CON LA CONDICION DE QUE CUANDO R12 ES ARILO ENTONCES W ES C(O), R2 ES H, R4 ES CONR9R10 Y p ES 2. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON INHIBIDORES DE METALOPROTEINASAS, INCLUYENDO METALOPROTEINASAS DE MATRIZ (MMPs) Y AGRECANASAS",WYETH LLC,SUM PHAIK-ENG;;HOW DAVID BRIAN;;SABATINI JOSHUA JAMES;;XIANG JASON SHAOYUN;;FEYFANT ERIC;;TAM STEVE YIK-KAI;;SKOTNICKI JERAULD STANLEY;;MANSOUR TAREK SUHAYL,,https://lens.org/019-964-724-696-40X,Patent Application,no,0,0,28,28,0,C07B2200/07;;C07C231/16;;C07C233/83;;C07C235/84;;C07C237/22;;C07C237/42;;C07C259/06;;C07C323/32;;C07D213/38;;C07D213/82;;C07D239/26;;C07D239/42;;C07D277/30;;C07D307/52;;C07D307/68;;C07D307/79;;C07D307/85;;C07D317/58;;C07D333/20;;C07D333/22;;C07D333/28;;C07D333/38;;C07D409/04;;C07C2601/02;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/08;;C07C2603/18;;C07C2603/74;;A61P1/02;;A61P1/04;;A61P1/16;;A61P11/00;;A61P11/06;;A61P13/12;;A61P17/00;;A61P19/00;;A61P19/02;;A61P19/04;;A61P25/00;;A61P27/02;;A61P29/00;;A61P35/00;;A61P37/06;;A61P43/00;;A61P9/00;;A61P9/10;;A61P9/14;;A61P3/10;;C07D213/56;;C07D213/82;;C07D317/58;;C07D333/24;;C07D277/30;;C07D213/38;;C07D239/26;;C07D239/42;;C07D307/52;;A61K31/4196;;A61K31/4192;;C07D213/82;;C07D317/58;;C07D333/28;;C07D213/38;;C07D277/30;;C07C259/06;;C07D307/52;;C07D239/26;;C07D307/85;;C07D333/38;;C07C235/84;;C07C323/32;;C07C231/16;;C07D333/20;;C07D409/04;;C07D307/68;;C07C233/83;;C07C237/42;;C07D307/79;;C07D333/22;;C07B2200/07;;C07C237/22;;C07D239/42;;C07C2601/14;;C07C2602/08;;C07C2601/18;;C07C2603/18;;C07C2601/02;;C07C2603/74;;C07C2601/08,C07C237/00;;A61K31/16;;A61K31/34;;A61K31/38;;A61K31/44;;A61K31/4965;;C07D213/56;;C07D241/02;;C07D307/87;;C07D333/02,,0,0,,,,DISCONTINUED
556,US,A1,US 2013/0179496 A1,022-515-631-541-657,2013-07-11,2013,US 201213715735 A,2012-12-14,US 201213715735 A;;US 84214704 A,2004-05-10,SYSTEM AND METHOD FOR PROVISIONING AUDIOVISUAL WORKS,"A method for provisioning audiovisual works to a client includes maintaining categorization information specifying, for each of multiple audiovisual works, one or more of multiple categories. One or more of the categories are associated with each of multiple delivery slots in response to input from a client. For each of the delivery slots, a first audiovisual work from one of the categories associated with the respective delivery slot is provisioned for delivery to a location associated with the client.",BLOCKBUSTER L L C;;BLOCKBUSTER L L C,WYNN DOMINIC C;;WILLIAMS PHILIP M;;SIMONS MALACHI;;WILKINS NICHOLAS F;;MACROW ALISTAIR;;DUFTY NIGEL A;;ENG ALVIN;;DOHERTY MICHAEL J;;GROVES DAVID M,,https://lens.org/022-515-631-541-657,Patent Application,yes,0,3,5,5,0,G06Q30/06;;G06Q30/0645;;H04L67/01;;G06Q30/0645;;G06Q30/06;;H04L67/00;;H04L67/01,G06Q30/00;;H04L29/06;;G06Q99/00,709/203,0,0,,,,DISCONTINUED
557,EC,A,EC SP088092 A,020-770-783-986-159,2008-02-20,2008,EC SP088092 A,2008-01-10,US 69759005 P,2005-07-11,INHIBIDORES DE AGRECANASA GLUTAMATO,"La presente invención se relaciona con compuestos de fórmula I (I)los cuales son moduladores de la actividad metaloproteinasa, y sales farmacéuticamente aceptables de los mismos, donde W es -C(O)-, -OC(O)-, -NHC(O)-, -C(O)O-, o -C(O)NH-; R1 es fenilo, heteroarilo, bifenilo, arilo bicíclico, arilo tricíclico, heteroarilo bicíclico, o heteroarilo tricíclico, cada uno se sustituye opcionalmente con uno o más de R5 o R6, y cuando R1 se sustituye con más de uno de R5 o R6, los sustituyentes pueden ser idénticos o diferentes; R2 es hidrógeno, alquilo (C1-C6), alquenilo (C2-C6), alquinilo (C2-C6), -(CH2)nR11, -OH, o -O-alquilo (C1-C6); R3 es -CO2H, -CONH2, -CONHOH, -CONHSO2R7, tetrazol, -SO2NHR7, -SO3H, -PO(OH)NH2, -PO(OH)OR7, -CONHR7, -COOR7, un grupo de ácido mimético, o un heterocicloalquilo de 5 o 6 miembros o heteroarilo que contiene 1 a 4 heteroátomos seleccionados de O, N, S; R4 es -CO2H, -CONH2, -(CH2)nOR7, o -CONR9R10.",WYETH CORP,TAM STEVE YIK-KAI;;SUM PHAIK-ENG;;HOW DAVID BRIAN;;SABATINI JOSHUA JAMES;;XIANG JASON SHAOYUN;;FEYFANT ERIC;;MANSOUR TAREK SUHAYL;;SKOTNICKI JERAULD STANLEY,,https://lens.org/020-770-783-986-159,Patent Application,no,0,0,28,28,0,C07B2200/07;;C07C231/16;;C07C233/83;;C07C235/84;;C07C237/22;;C07C237/42;;C07C259/06;;C07C323/32;;C07D213/38;;C07D213/82;;C07D239/26;;C07D239/42;;C07D277/30;;C07D307/52;;C07D307/68;;C07D307/79;;C07D307/85;;C07D317/58;;C07D333/20;;C07D333/22;;C07D333/28;;C07D333/38;;C07D409/04;;C07C2601/02;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/08;;C07C2603/18;;C07C2603/74;;A61P1/02;;A61P1/04;;A61P1/16;;A61P11/00;;A61P11/06;;A61P13/12;;A61P17/00;;A61P19/00;;A61P19/02;;A61P19/04;;A61P25/00;;A61P27/02;;A61P29/00;;A61P35/00;;A61P37/06;;A61P43/00;;A61P9/00;;A61P9/10;;A61P9/14;;A61P3/10;;C07D213/56;;C07D213/82;;C07D317/58;;C07D333/24;;C07D277/30;;C07D213/38;;C07D239/26;;C07D239/42;;C07D307/52;;A61K31/4196;;A61K31/4192;;C07D213/82;;C07D317/58;;C07D333/28;;C07D213/38;;C07D277/30;;C07C259/06;;C07D307/52;;C07D239/26;;C07D307/85;;C07D333/38;;C07C235/84;;C07C323/32;;C07C231/16;;C07D333/20;;C07D409/04;;C07D307/68;;C07C233/83;;C07C237/42;;C07D307/79;;C07D333/22;;C07B2200/07;;C07C237/22;;C07D239/42;;C07C2601/14;;C07C2602/08;;C07C2601/18;;C07C2603/18;;C07C2601/02;;C07C2603/74;;C07C2601/08,C07C237/22,,0,0,,,,PENDING
558,PE,A1,PE 20070505 A1,193-103-819-976-505,2007-05-15,2007,PE 2006000825 A,2006-07-11,US 69759005 P,2005-07-11,INHIBIDORES DE GLUTAMATO DE METALOPROTEINASAS DE MATRIZ Y AGRECANASAS,"SE REFIERE A COMPUESTOS DE FORMULA (I) DONDE W ES -C(O)-, -OC(O)-, -NHC(O)-, ENTRE OTROS; R1 ES FENILO, BIFENILO, ARILO BICICLICO, ENTRE OTROS, OPCIONALMENTE SUSTITUIDOS CON R5 O R6, DONDE R5 ES NHSO2-ALQUILO(C1-C6), ALQUILO(C1-C6), O-CICLOALQUILO(C3-C6), ENTRE OTROS; R6 ES H, HALOGENO, CN, OCF3, CF3, ENTRE OTROS; R2 ES H, ALQUILO(C1-C6), ALQUENILO(C2-C6), OH, ENTRE OTROS; R3 ES CO2H, CONH2, TETRAZOL, ENTRE OTROS; R4 ES CO2H, CONH2, (CH2)nOR7, ENTRE OTROS, DONDE R7 ES H, ALQUILO(C1-C6), ALQUINILO(C2-C6), ENTRE OTROS; n ES DE 0 A 4; m ES DE 0 A 4; p ES DE 0 A 2. N2-(1,1'-BIFENIL-4-ILCARBONIL)-N1-BUTIL-L-?-GLUTAMINA, N2-(1,1'-BIFENIL-4-ILCARBONIL)-N1-CICLOHEXIL-L-?-GLUTAMINA, N1-BENCIL-N2-(4-TIEN-2-ILBENZOIL)-L- ?-GLUTAMINA, ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA Y A UN PROCEDIMIENTO DE PREPARACION. DICHOS COMPUESTOS SON INHIBIDORES DE METALOPROTEINASAS TAL COMO METALOPROTEINASA DE MATRIZ Y AGRECANASA SIENDO UTILES EN EL TRATAMIENTO DE OSTEOARTRITIS, ARTRITIS REUMATOIDE, ASMA, ATEROSCLEROSIS",WYETH CORP,SUM PHAIK-ENG;;HOW DAVID BRIAN;;XIANG JASON SHAOYUN;;FEYFANT ERIC;;SABATINI JOSHUA JAMES;;SKOTNICKI JERAULD STANLEY;;MANSOUR TAREK SUHAYL;;TAM STEVE YIK-KAI,,https://lens.org/193-103-819-976-505,Patent Application,no,0,0,28,28,0,C07B2200/07;;C07C231/16;;C07C233/83;;C07C235/84;;C07C237/22;;C07C237/42;;C07C259/06;;C07C323/32;;C07D213/38;;C07D213/82;;C07D239/26;;C07D239/42;;C07D277/30;;C07D307/52;;C07D307/68;;C07D307/79;;C07D307/85;;C07D317/58;;C07D333/20;;C07D333/22;;C07D333/28;;C07D333/38;;C07D409/04;;C07C2601/02;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/08;;C07C2603/18;;C07C2603/74;;A61P1/02;;A61P1/04;;A61P1/16;;A61P11/00;;A61P11/06;;A61P13/12;;A61P17/00;;A61P19/00;;A61P19/02;;A61P19/04;;A61P25/00;;A61P27/02;;A61P29/00;;A61P35/00;;A61P37/06;;A61P43/00;;A61P9/00;;A61P9/10;;A61P9/14;;A61P3/10;;C07D213/56;;C07D213/82;;C07D317/58;;C07D333/24;;C07D277/30;;C07D213/38;;C07D239/26;;C07D239/42;;C07D307/52;;A61K31/4196;;A61K31/4192;;C07D213/82;;C07D317/58;;C07D333/28;;C07D213/38;;C07D277/30;;C07C259/06;;C07D307/52;;C07D239/26;;C07D307/85;;C07D333/38;;C07C235/84;;C07C323/32;;C07C231/16;;C07D333/20;;C07D409/04;;C07D307/68;;C07C233/83;;C07C237/42;;C07D307/79;;C07D333/22;;C07B2200/07;;C07C237/22;;C07D239/42;;C07C2601/14;;C07C2602/08;;C07C2601/18;;C07C2603/18;;C07C2601/02;;C07C2603/74;;C07C2601/08,A61K31/165;;A61K31/185;;A61K31/198;;A61K31/34;;A61K31/381;;A61K31/44;;A61K31/505,,0,0,,,,ACTIVE
559,US,A1,US 2005/0246299 A1,024-950-288-576-156,2005-11-03,2005,US 96219104 A,2004-10-08,US 96219104 A;;US 92199301 A;;US 92219701 A;;US 22328900 P,2000-08-03,Electronic employee selection systems and methods,"An automated employee selection system can use a variety of techniques to provide information for assisting in selection of employees. For example, pre-hire and post-hire information can be collected electronically and used to build an artificial-intelligence based model. The model can then be used to predict a desired job performance criterion (e.g., tenure, number of accidents, sales level, or the like) for new applicants. A wide variety of features can be supported, such as electronic reporting. Pre-hire information identified as ineffective can be removed from a collected pre-hire information. For example, ineffective questions can be identified and removed from a job application. New items can be added and their effectiveness tested. As a result, a system can exhibit adaptive learning and maintain or increase effectiveness even under changing conditions.",UNICRU INC,SCARBOROUGH DAVID J;;CHAMBLESS BJORN;;BECKER RICHARD W;;CHECK THOMAS F;;CLAINOS DEME M;;ENG MAXWELL W;;LEVY JOEL R;;MERTZ ADAM N;;PAAJANEN GEORGE E;;SMITH DAVID R;;SMITH JOHN R,KRONOS TALENT MANAGEMENT INC (2001-08-03);;CADIENT LLC (2019-04-05),https://lens.org/024-950-288-576-156,Patent Application,yes,79,61,18,19,0,G06Q10/063;;G06Q10/063118;;G06Q10/0639;;G06Q10/10;;G06Q10/1053;;G06Q30/08;;G09B5/00;;G09B7/00;;G09B7/02;;G06Q10/10;;G06Q10/0639;;G09B7/00;;G06Q10/1053;;G06Q10/063;;G09B5/00;;G06Q10/063118;;G06Q30/08;;G09B7/02,G06E1/00;;G06F17/00;;G06N5/00;;G06Q10/00;;G09B5/00;;G09B7/00;;G09B7/02,706/21,0,0,,,,EXPIRED
560,US,A1,US 2002/0046199 A1,149-785-107-002-193,2002-04-18,2002,US 92219701 A,2001-08-02,US 92219701 A;;US 22328900 P,2000-08-03,Electronic employee selection systems and methods,"
   An automated employee selection system can use a variety of techniques to provide information for assisting in selection of employees. For example, pre-hire and post-hire information can be collected electronically and used to build an artificial-intelligence based model. The model can then be used to predict a desired job performance criterion (e.g., tenure, number of accidents, sales level, or the like) for new applicants. A wide variety of features can be supported, such as electronic reporting. Pre-hire information identified as ineffective can be removed from a collected pre-hire information. For example, ineffective questions can be identified and removed from a job application. New items can be added and their effectiveness tested. As a result, a system can exhibit adaptive learning and maintain or increase effectiveness even under changing conditions. 
",UNICRU INC,SCARBOROUGH DAVID J;;CHAMBLESS BJORN;;BECKER RICHARD W;;CHECK THOMAS F;;CLAINOS DEME M;;ENG MAXWELL W;;LEVY JOEL R;;MERTZ ADAM N;;PAAJANEN GEORGE E;;SMITH DAVID R;;SMITH JOHN R,KRONOS TALENT MANAGEMENT INC (2001-08-03);;CADIENT LLC (2019-04-05),https://lens.org/149-785-107-002-193,Patent Application,yes,72,105,18,19,0,G06Q10/063;;G06Q10/063118;;G06Q10/0639;;G06Q10/10;;G06Q10/1053;;G06Q30/08;;G09B5/00;;G09B7/00;;G09B7/02;;G06Q10/10;;G06Q10/0639;;G09B7/00;;G06Q10/1053;;G06Q10/063;;G09B5/00;;G06Q10/063118;;G06Q30/08;;G09B7/02,G06E1/00;;G06F17/00;;G06N5/00;;G06Q10/00;;G09B5/00;;G09B7/00;;G09B7/02,706/21,0,0,,,,EXPIRED
561,US,A1,US 2005/0114279 A1,155-428-195-999-545,2005-05-26,2005,US 91725204 A,2004-08-11,US 91725204 A;;US 92199301 A;;US 22328900 P,2000-08-03,Development of electronic employee selection systems and methods,"An automated employee selection system can use a variety of techniques to provide information for assisting in selection of employees. For example, pre-hire and post-hire information can be collected electronically and used to build an artificial-intelligence based model. The model can then be used to predict a desired job performance criterion (e.g., tenure, number of accidents, sales level, or the like) for new applicants. A wide variety of features can be supported, such as electronic reporting. Pre-hire information identified as ineffective can be removed from a collected pre-hire information. For example, ineffective questions can be identified and removed from a job application. New items can be added and their effectiveness tested. As a result, a system can exhibit adaptive learning and maintain or increase effectiveness even under changing conditions.",UNICRU INC,SCARBOROUGH DAVID J;;CHAMBLESS BJORN;;BECKER RICHARD W;;CHECK THOMAS F;;CLAINOS DEME M;;ENG MAXWELL W;;LEVY JOEL R;;MERTZ ADAM N;;PAAJANEN GEORGE E;;SMITH DAVID R;;SMITH JOHN R,KRONOS TALENT MANAGEMENT INC (2006-08-29);;CADIENT LLC (2019-04-05),https://lens.org/155-428-195-999-545,Patent Application,yes,27,52,18,19,0,G06Q10/063;;G06Q10/063118;;G06Q10/0639;;G06Q10/10;;G06Q10/1053;;G06Q30/08;;G09B5/00;;G09B7/00;;G09B7/02;;G06Q10/10;;G06Q10/0639;;G09B7/00;;G06Q10/1053;;G06Q10/063;;G09B5/00;;G06Q10/063118;;G06Q30/08;;G09B7/02,G06E1/00;;G06F17/00;;G06N5/00;;G06Q10/00;;G09B5/00;;G09B7/00;;G09B7/02,706/21;;705/1,0,0,,,,EXPIRED
562,US,A1,US 2010/0287110 A1,015-642-535-135-251,2010-11-11,2010,US 84197210 A,2010-07-22,US 84197210 A;;US 96219104 A;;US 92199301 A;;US 22328900 P,2000-08-03,ELECTRONIC EMPLOYEE SELECTION SYSTEMS AND METHODS,"An automated employee selection system can use a variety of techniques to provide information for assisting in selection of employees. For example, pre-hire and post-hire information can be collected electronically and used to build an artificial-intelligence based model. The model can then be used to predict a desired job performance criterion (e.g., tenure, number of accidents, sales level, or the like) for new applicants. A wide variety of features can be supported, such as electronic reporting. Pre-hire information identified as ineffective can be removed from a collected pre-hire information. For example, ineffective questions can be identified and removed from a job application. New items can be added and their effectiveness tested. As a result, a system can exhibit adaptive learning and maintain or increase effectiveness even under changing conditions.",KRONOS TALENT MAN INC,SCARBOROUGH DAVID J;;CHAMBLESS BJORN;;BECKER RICHARD W;;CHECK THOMAS F;;CLAINOS DEME M;;ENG MAXWELL W;;LEVY JOEL R;;MERTZ ADAM N;;PAAJANEN GEORGE E;;SMITH DAVID R;;SMITH JOHN R,KRONOS TALENT MANAGEMENT INC (2001-08-03),https://lens.org/015-642-535-135-251,Patent Application,yes,98,7,18,19,0,G06Q10/063;;G06Q10/063118;;G06Q10/0639;;G06Q10/10;;G06Q10/1053;;G06Q30/08;;G09B5/00;;G09B7/00;;G09B7/02;;G06Q10/10;;G06Q10/0639;;G09B7/00;;G06Q10/1053;;G06Q10/063;;G09B5/00;;G06Q10/063118;;G06Q30/08;;G09B7/02,G06E1/00;;G06F17/00;;G06N5/00;;G06N5/02;;G06Q10/00;;G09B5/00;;G09B7/00;;G09B7/02,705/321;;706/52,0,0,,,,DISCONTINUED
563,US,B2,US 7080057 B2,015-324-747-975-937,2006-07-18,2006,US 92219701 A,2001-08-02,US 92219701 A;;US 22328900 P,2000-08-03,Electronic employee selection systems and methods,"An automated employee selection system can use a variety of techniques to provide information for assisting in selection of employees. For example, pre-hire and post-hire information can be collected electronically and used to build an artificial-intelligence based model. The model can then be used to predict a desired job performance criterion (e.g., tenure, number of accidents, sales level, or the like) for new applicants. A wide variety of features can be supported, such as electronic reporting. Pre-hire information identified as ineffective can be removed from a collected pre-hire information. For example, ineffective questions can be identified and removed from a job application. New items can be added and their effectiveness tested. As a result, a system can exhibit adaptive learning and maintain or increase effectiveness even under changing conditions.",UNICRU INC,SCARBOROUGH DAVID J;;CHAMBLESS BJORN;;BECKER RICHARD W;;CHECK THOMAS F;;CLAINOS DEME M;;ENG MAXWELL W;;LEVY JOEL R;;MERTZ ADAM N;;PAAJANEN GEORGE E;;SMITH DAVID R;;SMITH JOHN R,KRONOS TALENT MANAGEMENT INC (2001-08-03);;CADIENT LLC (2019-04-05),https://lens.org/015-324-747-975-937,Granted Patent,yes,73,122,18,19,0,G06Q10/063;;G06Q10/063118;;G06Q10/0639;;G06Q10/10;;G06Q10/1053;;G06Q30/08;;G09B5/00;;G09B7/00;;G09B7/02;;G06Q10/10;;G06Q10/0639;;G09B7/00;;G06Q10/1053;;G06Q10/063;;G09B5/00;;G06Q10/063118;;G06Q30/08;;G09B7/02,G06N5/04;;G06E1/00;;G06F17/00;;G06N5/00;;G06Q10/00;;G09B5/00;;G09B7/00;;G09B7/02,706/60;;706/14;;706/12,100,11,120-462-215-961-309;;030-892-570-581-308;;051-241-940-403-887;;124-821-732-772-925;;075-793-976-009-167;;083-734-666-358-804;;014-173-240-534-719;;048-736-553-740-409;;173-292-133-183-834;;170-331-667-492-498;;026-046-145-273-454,10.1080/019697200124775;;10.1037/1082-989x.5.1.102;;10937325;;10.1037//1082-989x.5.1.102;;10.1111/j.1744-6570.1993.tb00882.x;;10.1145/130069.130075;;10.1145/219717.219768;;10.1145/242223.242268;;10.1016/s1366-5545(99)00030-7;;10.1145/299513.299612;;10.1145/240455.240468;;10.1002/j.1538-7305.1948.tb00917.x;;10.1016/0377-2217(94)90119-8,"Ajay K. Aggarwal, Selection of Surgical Residents: A Neural Network Approach, 2000, Cybernetics and Systems, 417-430.;;Garson, Neural Networks An Introductory Guide for Social Scientists, SAGE Publications, pp. 1-194, 1998.;;""NeuralWorks Professional II/PLUS,"" http://www.neuralware.com/products<SUB>-</SUB>pro2.jsp, pp. 1-3, Jul. 28, 2001.;;""Statistica Neural Networks,"" http://www.statsoft.com/stat<SUB>-</SUB>nn.html, pp. 1-11, Jul. 28, 2001.;;Scarborough, ""Tutorial on the Use of Neural Network Models for Personal Selection,"" Decision Sciences Institute Southwest Region Theory and Applications Proceedings 27<SUP>th </SUP>Annual Conference, pp. 151-153, Mar. 6-9, 1996.;;Marshall et al., ""Neural Network Modeling of Risk Assessment in Child Protective Services,"" Psychological Methods, vol. 5, No. 1, pp. 102-124, 2000.;;Aggarwal et al., ""Selection of Surgical Residents: A Neural Network Approach,"" Cybernetics and Systems: An International Journal, vol. 31, pp. 417-430, 2000.;;Collins et al., ""An Application of the Theory of Neural Computation to the Prediction of Workplace Behavior: An Illustration and Assessment of Network Analysis,"" Personnel Psychology, vol. 46, pp. 503-524, 1993.;;Mitchell, ""How to Reduce the High Cost of Turnover,"" Lawson Software, pp. 1-11, Jul. 12, 2001, or before.;;Page et al., ""Panel: Strategic Directions in Simulation Research,"" Proceedings of the 1999 Winter Simulation Conference, pp. 1509-1520, 1999.;;Mengel et al., ""Using a Neural Network to Predict Student Responses,"" ACM, pp. 669-676, 1992.;;Pentland et al., ""Modeling and Prediction of Human Behavior,"" M.I.T. Media Lab Perceptual Computing Technical Report, No. 433, pp. 1-7, 1999.;;Langley et al., ""Applications of Machine Learning and Rule Induction,"" Communications of the ACM, vol. 38, No. 11, pp. 55-64, Nov. 1995.;;""XpertRule(R) Miner, The Complete Data Mining Solution,"" http://www.attar.com/pages/info<SUB>-</SUB>xm/htm., pp. 1-5, Mar. 23, 2001.;;""The Wide Scale Deployment of Active Data Mining Solutions,"" http://www.attar.com/tutor/deploy.htm, pp. 1-7, Mar. 23, 2001.;;""A Hybrid GA-Heuristic Search Strategy,"" http://www.attar.com/pages/dev<SUB>-</SUB>gap.htm, pp. 1-6, Mar. 23, 2001.;;Doyle et al., ""Strategic Directions in Artificial Intelligence,"" ACM Computing Surveys, vol. 28, No. 4, pp. 653-670, Dec. 1996.;;Callaghan, ""Personalization on the Fly- SaffronOne, FrontMind Tap Advanced Technologies to Predict User Behavior, Make Recommendations,"" eWeek, p. 52, Oct. 23, 2000.;;Hensher et al., ""A Comparison of the Predictive Potential of Artificial Neural Networks and Nested Logit Models for Commuter Mode Choice,"" Transportation Research Part E: Logistic and Transportation Review, vol. 36, No. 3, pp. 155-172 (abstract only), Sep. 2000.;;Kahney, ""KnowledgeMiner 2 Digs Out More Info,"" MacWEEK, vol. 11, No. 40, pp. 23-24, Oct. 20, 1997.;;Rosen, ""Mining Database Treasures,"" Computing Canada, vol. 22, No. 20, pp. 42-43, Sep. 26, 1996.;;McLeod et al., ""Predicting Credit Risk: A Neural Network Approach,"" Journal of Retail Banking, vol. 15, No. 3, pp. 37-40, Fall 1993.;;""SaffronOne's Unique Product Features,"" http://www.saffrontech.com/pages/products/features.html, pp. 1-2, Mar. 22, 2001.;;Herschel et al., ""CKOS and Knowledge Management: Exploring Opportunities for Using Information Exchange Protocols,"" ACM, pp. 42-50, 1999.;;Hapgood, ""Embedded Logic,"" http://www2.cio.com/archive/050100<SUB>-</SUB>revisit<SUB>-</SUB>content.html, pp. 1-3, Mar. 23, 2001.;;Brachman et al., ""Mining Business Databases,"" Communications of the ACM, vol. 39, No. 11, pp. 42-48, Nov. 1996.;;Jordan et al., ""Neural Networks,"" The Computer Science and Engineering Handbook, Tucker (ed.), pp. 536-556, 1996.;;Scarborough, ""An Evaluation of Backpropagation Neural Network Modeling as an Alternative Methodology for Criterion Validation of Employee Selection Testing,"" Doctoral Dissertation (UMI Dissertation Services), University of Texas, 1995.;;Guion, ""Personnel Assessment, Selection, and Placement,"" Handbook of Industrial and Organizational Psychology, Consulting Psychologists Press, Inc., pp. 327-397, 1991.;;U.S. Appl. No. 60/211,044, filed Jun. 12, 2000, Dewar.;;""123Assess(TM)-Qualify Applicants in 10 Minutes!"" TekMetrics, 1998, 1 page.;;""The Science Behind Our Products-Profiles International, Inc.,"" Profiles International, Inc., website archived May 26, 2000, 2 pages.;;""ASSESS Expert System/Bigby, Havis & Associates, Inc.,"" page archived from www.bigby.com website, 2 pages, May 7, 1999.;;""assesspreview: ASSESS User Site Instructions,"" page archived from www.bigby.com website, 1 page, Oct. 12, 2000.;;""assesspreview: History of ASSESS,"" page archived from www.bigby.com website, 1 page, Oct. 11, 1999.;;""assesspreview: Welcome to the ASSESS Internet Online Preview,"" page archived from www.bigby.com website, 1 page, May 8, 1999.;;""assesspreview: What is ASSESS?,"" page archived from www.bigby.com website, 1 page, Oct. 11, 1999.;;""Custom Job Center,"" DecisionPoint Systems Hirelink Network advertisement, 2 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""DDI Launches Tech Spin-Off Targeting Small to Mid-Size Businesses,"" AdvantageHiring.com, http://www.advantagehiring.com/about/pr<SUB>-</SUB>DDIspinoff.asp, 2 pages, Sep. 17, 1999.;;""DecisionPoint Systems-Hiring Technology That Gives You A Competitive Advantage,"" DecisionPoint Systems HirePro(TM) advertisement, 2 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""DecisionPoint Systems -Imagine Being Able to Incorporate Your Company's Job Application, Skills Test, Background Checks and Tax Credit Paperwork Into One Simple Process."" DecisionPoint Systems advertisement, 4 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""Facts About DDI: Who We Are, What We Do,"" Development Dimensions International, Inc., http://www.ddiworld.com/about/pr<SUB>-</SUB>facts. asp, 3 pages, website visited on Nov. 2, 2004.;;""Highlights, The Bigby, Havis Newsletter: How Our Clients Use ASSESS,"" page archived from www.bigby.com website, 1 page, Oct. 8, 1999.;;""HirePro.com-The Technology to Select The Ideal Employee Is Now Online,"" DecisionPoint Systems HirePro.com advertisement, 2 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""HirePro(TM)-Automated Hiring System,"" DecisionPoint Systems HirePro(TM) advertisement, 2 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""HirePro(TM) Assessments-Application Assessment Tests for HirePro(TM),"" DecisionPoint Systems Assessment Series advertisement, 2 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""HirePro(TM),"" DecisionPoint Systems HirePro(TM) advertisement, 1 page, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""HirePro(TM),"" Retail Direct Mail Piece, 6 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""How Do You Stack Up Next to Training's New Guard?"" http://web.archive.org/web/19991012021341/ddiworld.com/newguard/index.htm, Development Dimensions International, Inc., 4 pages, website archived Oct. 12, 1999.;;""Nov. 18, 1997: More Firms Recruit Via the Internet,"" The Boston Globe, 2 pages, Nov. 14, 1997.;;""Online Recruiting Strategist,"" Hunt-Scanlon.com, http://www.hunt-scanlon.com/newsarchives/orsarchives/2000/jan.htm, 8 pages, Jan. 2000.;;""PR Newswire: TekMetrics Help EDS Select Top Sales Talent Online,"" http://www.google.com/search?hl=en&q=cache%3Awww.findarticles.com%2Fcf<SUB>-</SUB>dls%2Fm4PRN%2F1999<SUB>-</SUB>April<SUB>-</SUB>29%2F54502514%2Fpl%2Farticle.jhtml PR Newswire, Apr. 29, 1999.;;""Profitability is Built Upon Teamwork,"" Decision Point Data (predecessor company of Unicru, Inc.), mailed to prospective customers, 6 pages, 1997.;;""ReportView(TM)-Closed Loop Reporting for HirePro(TM),"" DecisionPoint Systems ReportView(TM) advertisement, 4 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""Saville & Holdsworth, Human Resource Consulting: ApView(TM) Net,"" page archived from www.shlusa.com website, 2 pages, Apr. 29, 1999.;;""SHL Aspen Tree Software-Solutions for Employee Selection,"" page archived from www.aspentree.com website, 1 page, Dec. 1, 1998.;;""SHL-HR Support Tools, Analytical Process, Decision-Support Tech,"" page archived from www.shlusa.com website, 1 page, Feb. 18, 1999.;;""Solutions for Managers, Professionals and Supervisors,"" page archived from www.bigby.com website, 2 pages, Feb. 9, 1999.;;Bylinsky, et al., ""Computers That Learn by Doing,"" Fortune, vol. 128, Issue 5, p96, 5p, 14c, 7 pages, Sep. 6, 1993.;;Glatzer, ""Neural Networks Take on Real-World Problems,"" (Abstract) Computer World, v26, n32, p21(1), 1 page, Aug. 10, 1992.;;Goodwin, ""As Job Seekers Turn to Net,"" (Brief Article) Computer Weekly, p6(1), Feb. 4, 1999.;;Lawton, ""Genetic Algorithms for Schedule Optimization,"" (Cover Story) AI Expert, v7, n5, p22(6), 7 pages, May 1992.;;Scarborough, ""Decision Point Systems,"" Presentation to potential customer, 38 pages, ten or fewer copies left with potential customer, Wilsonville, Oregon, before Jun. 2000.;;Scarborough, ""DPDNeurotech(TM),"" Power Point Presentation given to prospective employer Decision Point Data (predecessor company of Unicru, Inc.) 32 pages, electronic copy provided to Decision Point Data., Dec. 1998.;;Scarborough, ""Welcome, Portland State University,"" Presentation to about 15 people, Portland, Oregon, 20 pages, before May 2000.;;Schwartz, ""Where Neural Networks are Already at Work: Putting AI to Work in the Markets,"" (Abstract) Business Week, n3291, p136(2), 1 page, Nov. 2, 1992.;;Shannon, ""A Mathematical Theory of Communication,"" Reprinted with corrections from The Bell System Technical Journal, vol. 27, pp. 379-423, 623-656, 55 pages, Jul., Oct. 1948.;;""TekMetrics to Test Skills of Computer Sciences Corp. Job Candidates Over the Internet,"" EDP Weekly's IT Monitor, vol. 40, Issue 16, p. 6, Apr. 19, 1999.;;Liang et al., ""Theory and Methodology: Personnel Selection Using Fuzzy MCDM Algorithm,"" European Journal of Operational Research, vol. 78, pp. 22-33, 1994.;;""Brainbench-The Skills Authority: Account Registration,"" www.brainbench.com website archived May 11, 2000, 2 pages.;;""Brainbench-The Skills Authority: Looking for Qualified candidates?,"" www.brainbench.com website archived May 10, 2000, 1 page.;;""Brainbench-The Skills Authority: Welcome to Brainbench,"" www.brainbench.com website archived May 11, 2000, 2 pages.;;""Brainbench-The Skills Authority: About Our Assessments,"" www.brainbench.com website archived May 10, 2000, 2 pages.;;""Brainbench-The Skills Authority: Brainbench Certifications(TM),"" www.brainbench.com website archived May 24, 2000, 2 pages.;;""Are you ready to: Are you Ready?,"" www.brainbench.com website archived Mar. 2, 2000, 1 page.;;""Top Ten Scores List,"" www.brainbench.com website archived Jul. 1, 2002, listing scores from Feb. 2000, 1 page.;;""Brainbench-The Skills Authority: Frequently Asked Questions about Brainbench Certifications(TM),"" www.brainbench.com website archived May 10, 2000, 5 pages.;;""Legal Considerations When Using Testing: White Paper,"" www.tekmetrics.com website archived Apr. 17, 1999, 3 pages.;;""TekMetrics skills assessments & skills test & resume tracking: Frequently Asked Questions,"" www.tekmetrics.com website archived Apr. 24, 1999, 3 pages.;;""Top 10 Test Scores Lists,"" www.tekmetrics.com website archived Dec. 5, 1998, 1 page.;;""123Assess Demonstration,"" www.tekmetrics.com website archived Jan. 28, 1999, 2 pages.;;""Catalog,"" www.tekmetrics.com website archived Dec. 6, 1998, 3 pages.;;""Brainbench-The Skills Authority: Pricing,"" www.brainbench.com website archived May 10, 2000, 2 pages.;;""Brainbench-The Skills Authority: Top Ten Scores List,"" www.brainbench.com website archived May 11, 2000, 1 page.;;""Brainbench-The Skills Authority: See Where You Stand,"" www.brainbench.com website archived Apr. 19, 2000, 1 page.;;""Brainbench-The Skills Authority: Dear Affiliate,"" www.brainbench.com website archived May 11, 2000, 3 pages.;;""Brainbench-The Skills Authority: Sample Certificate,"" www.brainbench.com website archived May 11, 2000, 2 pages.;;""Brainbench-The Skills Authority: Online Skills Assessment Leader Brainbench Forms Partnership With Leading Quality-Rating Services Provider,"" www.brainbench.com website archived Jun. 6, 2000, 2 pages.;;""Brainbench-The Skills Authority: The Company,"" www.brainbench.com website archived May 11, 2000, 1 page.;;""Brainbench-The Skills Authority: Hear What Our Customers Are Saying . . . ,"" www.brainbench.com website archived May 10, 2000, 6 pages.;;""Brainbench-The Measure of Achievement: Mike Russiello,"" www.brainbench.com website archived May 1, 2003, 2 pages.;;""Brainbench-The Measure of Achievement: Completed Assessment,"" www.brainbench.com website archived May 1, 2003, page.;;""Brainbench-The Skills Authority: Privacy Policy,"" www.brainbench.com website archived May 10, 2000, 2 pages.;;""Brainbench-The Skills Authority: Test Developer,"" www.brainbench.com website archived May 10, 2000, 2 pages.;;""Brainbench-The Skills Authority: Test Alert,"" www.brainbench.com website archived Jun. 21, 2000, 2 pages.;;""Brainbench-The Skills Authority: Online Cert Prep(TM),"" www.brainbench.com website archived Jun. 22, 2000, 2 pages.;;""Brainbench-The Skills Authority: Take the Microsoft Challenge,"" www.brainbench.com website archived Mar. 3, 2000, 2 pages.;;""Brainbench-The Skills Authority: Assessment Center Demonstration,"" www.brainbench.com website archived May 12, 2000, 2 pages.;;""Brainbench-The Skills Authority: Online Public Transcript for Chastity Sterling,"" www.brainbench.com website archived May 11, 2003, 3 pages.;;""Brainbench-The Skills Authority: Global E-Market Company for Skilled Services Team with World's Largest Online Certification Authority,"" www.brainbench.com website press release dated Feb. 1, 2000, 2 pages.",EXPIRED
564,US,A1,US 2005/0273350 A1,086-028-509-379-389,2005-12-08,2005,US 4254405 A,2005-01-24,US 4254405 A;;US 92219701 A;;US 92199301 A;;US 22328900 P,2000-08-03,Electronic employee selection systems and methods,"An automated employee selection system can use a variety of techniques to provide information for assisting in selection of employees. For example, pre-hire and post-hire information can be collected electronically and used to build an artificial-intelligence based model. The model can then be used to predict a desired job performance criterion (e.g., tenure, number of accidents, sales level, or the like) for new applicants. A wide variety of features can be supported, such as electronic reporting. Pre-hire information identified as ineffective can be removed from a collected pre-hire information. For example, ineffective questions can be identified and removed from a job application. New items can be added and their effectiveness tested. As a result, a system can exhibit adaptive learning and maintain or increase effectiveness even under changing conditions.",UNICRU INC,SCARBOROUGH DAVID J;;CHAMBLESS BJORN;;BECKER RICHARD W;;CHECK THOMAS F;;CLAINOS DEME M;;ENG MAXWELL W;;LEVY JOEL R;;MERTZ ADAM N;;PAAJANEN GEORGE E;;SMITH DAVID R;;SMITH JOHN R,KRONOS TALENT MANAGEMENT INC (2001-08-03);;CADIENT LLC (2019-04-05),https://lens.org/086-028-509-379-389,Patent Application,yes,75,43,18,19,0,G06Q10/063;;G06Q10/063118;;G06Q10/0639;;G06Q10/10;;G06Q10/1053;;G06Q30/08;;G09B5/00;;G09B7/00;;G09B7/02;;G06Q10/10;;G06Q10/0639;;G09B7/00;;G06Q10/1053;;G06Q10/063;;G09B5/00;;G06Q10/063118;;G06Q30/08;;G09B7/02,G06E1/00;;G06F17/00;;G06N5/00;;G06Q10/00;;G09B5/00;;G09B7/00;;G09B7/02,705/1;;706/45,0,0,,,,EXPIRED
565,US,A1,US 2012/0215710 A1,163-854-677-105-809,2012-08-23,2012,US 201213458864 A,2012-04-27,US 201213458864 A;;US 201113030057 A;;US 96219104 A;;US 92199301 A;;US 92219701 A;;US 22328900 P,2000-08-03,ELECTRONIC EMPLOYEE SELECTION SYSTEMS AND METHODS,"An automated employee selection system can use a variety of techniques to provide information for assisting in selection of employees. For example, pre-hire and post-hire information can be collected electronically and used to build an artificial-intelligence based model. The model can then be used to predict a desired job performance criterion (e.g., tenure, number of accidents, sales level, or the like) for new applicants. A wide variety of features can be supported, such as electronic reporting. Pre-hire information identified as ineffective can be removed from a collected pre-hire information. For example, ineffective questions can be identified and removed from a job application. New items can be added and their effectiveness tested. As a result, a system can exhibit adaptive learning and maintain or increase effectiveness even under changing conditions.",SCARBOROUGH DAVID J;;CHAMBLESS BJORN;;BECKER RICHARD W;;CHECK THOMAS F;;CLAINOS DEME M;;ENG MAXWELL W;;LEVY JOEL R;;MERTZ ADAM N;;PAAJANEN GEORGE E;;SMITH DAVID R;;SMITH JOHN R;;KRONOS TALENT MAN INC,SCARBOROUGH DAVID J;;CHAMBLESS BJORN;;BECKER RICHARD W;;CHECK THOMAS F;;CLAINOS DEME M;;ENG MAXWELL W;;LEVY JOEL R;;MERTZ ADAM N;;PAAJANEN GEORGE E;;SMITH DAVID R;;SMITH JOHN R,KRONOS TALENT MANAGEMENT INC (2001-08-03),https://lens.org/163-854-677-105-809,Patent Application,yes,3,15,18,19,0,G06Q10/063;;G06Q10/063118;;G06Q10/0639;;G06Q10/10;;G06Q10/1053;;G06Q30/08;;G09B5/00;;G09B7/00;;G09B7/02;;G06Q10/10;;G06Q10/0639;;G09B7/00;;G06Q10/1053;;G06Q10/063;;G09B5/00;;G06Q10/063118;;G06Q30/08;;G09B7/02,G06E1/00;;G06Q10/06;;G06F17/00;;G06N5/00;;G06Q10/00;;G09B5/00;;G09B7/00;;G09B7/02,705/321,0,0,,,,DISCONTINUED
566,US,B2,US 8265977 B2,172-795-449-487-496,2012-09-11,2012,US 201113030057 A,2011-02-17,US 201113030057 A;;US 96219104 A;;US 92199301 A;;US 92219701 A;;US 22328900 P,2000-08-03,Electronic employee selection systems and methods,"An automated employee selection system can use a variety of techniques to provide information for assisting in selection of employees. For example, pre-hire and post-hire information can be collected electronically and used to build an artificial-intelligence based model. The model can then be used to predict a desired job performance criterion (e.g., tenure, number of accidents, sales level, or the like) for new applicants. A wide variety of features can be supported, such as electronic reporting. Pre-hire information identified as ineffective can be removed from a collected pre-hire information. For example, ineffective questions can be identified and removed from a job application. New items can be added and their effectiveness tested. As a result, a system can exhibit adaptive learning and maintain or increase effectiveness even under changing conditions.",SCARBOROUGH DAVID J;;CHAMBLESS BJORN;;BECKER RICHARD W;;CHECK THOMAS F;;CLAINOS DEME M;;ENG MAXWELL W;;LEVY JOEL R;;MERTZ ADAM N;;PAAJANEN GEORGE E;;SMITH DAVID R;;SMITH JOHN R;;KRONOS TALENT MAN INC,SCARBOROUGH DAVID J;;CHAMBLESS BJORN;;BECKER RICHARD W;;CHECK THOMAS F;;CLAINOS DEME M;;ENG MAXWELL W;;LEVY JOEL R;;MERTZ ADAM N;;PAAJANEN GEORGE E;;SMITH DAVID R;;SMITH JOHN R,KRONOS TALENT MANAGEMENT INC (2001-08-03);;CADIENT LLC (2019-04-05),https://lens.org/172-795-449-487-496,Granted Patent,yes,102,14,18,19,0,G06Q10/063;;G06Q10/063118;;G06Q10/0639;;G06Q10/10;;G06Q10/1053;;G06Q30/08;;G09B5/00;;G09B7/00;;G09B7/02;;G06Q10/10;;G06Q10/0639;;G09B7/00;;G06Q10/1053;;G06Q10/063;;G09B5/00;;G06Q10/063118;;G06Q30/08;;G09B7/02,G06E1/00;;G06Q10/00;;G06F17/00;;G06N5/00;;G09B5/00;;G09B7/00;;G09B7/02,705/7.17;;705/321;;706/21,101,0,,,"Hart, Ann Yeager. Predicting the tenure outcome of teachers based on variables known at the time of application. North Carolina State University. 1997.;;Stone, William Steve. North Carolina State University. Principal selection: An Application of nueral-network forecasting. 1993.;;U.S. Appl. No. 60/211,044, Dewar.;;""123Assess Demonstration,"" www.tekmetrics.com, website archived Jan. 28, 1999, 2 pages.;;""123Assess(TM)-Qualify Applicants in 10 minutes!"" TekMetrics, 1998, 1 pages.;;""1999 StoreWorks! Conference and Exhibition,"" Decision Point Data, Inc. (predecessor of Unicru, Inc.) May 1999, 13 pages.;;""A Hybrid GA-Heuristic Search Strategy,"" (Akeel Al-Attar) http://www.attar.com/pages/dev-gap.htm, Mar. 23, 2001, pp. 1-6.;;""A Technology Case Study for Human Resource Executive,"" Getting the High-Tech Hiring Edge, www.workindex.com/editorial/staff/sta0301.01.asp, Jan. 2003, 2 pages.;;""All About ApView,"" video (length 17:13), Aspen Tree Software, Inc., Mar. 7, 1997, video file ""TRAINING.avi."".;;""An Applied Look at Reducing Adverse Impact by Differentially Weighting Selection Measures,"" SIOP 2000, 15th Annual Conference, Hyatt Regency, New Orleans, USA, Apr. 14, 2000, 3 pages.;;""Applying Neural Networking Techniques to Prediction Problems in I-O Psychology,"" SIOP 2000, 15th Annual Conference, Hyatt Regency, New Orleans, USA, 2 pages, Apr. 15, 2000.;;""ApView Main Menu,"" Demo, Aspen Tree Software, Inc., Jun. 13, 1997, 30 pages.;;""Are you ready to: Are you Ready?,"" www.brainbench.com, website archived Mar. 2, 2000, 1 page.;;""Aspen Tree Software: The Total Solution to Employee Recruiting & Selection,"" Aspen Tree Software, Inc., Oct. 27, 1997, 29 pages.;;""Aspen Tree Software helps lessen resume overload,"" PC Week, vol. 14, No. 36, ZDNet, Aug. 25, 1997, p. 84.;;""Assess Expert System/Bigby, Havis & Associates, Inc.,"" page archived from www.bigby.com, website, May 7, 1999, 2 pages.;;""Assess v2-for Selection and Development,"" Bigby Havis & Associates, Inc., 5 pages, http://www.bigby.com/systesms/assessv2/System/main.asp, printed Aug. 5, 2005, showing applicants from 1998.;;""Assess v.2: Technical Manual,"" Bigby Havis & Associates, Inc., Dec. 2003, describing products from 1970-2003, 106 pages.;;""Assesspreview: ASSESS User Site Instructions,"" page archived from www.bigby.com website, Oct. 12, 2000, 1 page.;;""Assesspreview: History of ASSESS,"" page archived from www.bigby.com website, Oct. 11, 1999, 1 page.;;""Assesspreview: Welcom to the ASSESS Internet Online Preview,"" page archived from www.bigby.com website, May 8, 1999, 1 page.;;""Assesspreview: What is Assess?,"" page archived from www.bigby.com website, Oct. 11, 1999, 1 page.;;""Automated Technologies for Biodata Prediction Systems,"" SIOP 2000, 15th Annual Conference, Hyatt Regency, New Orleans, USA, Apr. 15, 2000, 2 pages.;;""Before You Begin: Welcome to SSA Online Help,"" http://www.web.archive.org/web/19980118183643/http://www.coopersclub/inethlp2.htm, 1998 6 pages.;;""Brainbench-The Measure of Achievement: A Skills-Based Employment Market,"" www.brainbench.com website white paper dated Jan. 24, 2009, 9 pages.;;""Brainbench-The Measure of Achievement: Completed Assessment,"" www.brainbench.com website archived May 1, 2003, 1 page.;;""Brainbench-The Measure of Achievement: Javascript Certification,"" www.brainbench.com website archived Apr. 4, 2001, 3 pages.;;""Brainbench-The Measure of Achievement: Mike Russiello,"" www.brainbench.com website archived May 1, 2003, 2 pages.;;""Brainbench-The Measure of Achievement: The Rise of Online Certifications,"" www.brainbench.com website white paper dated Jan. 26, 2000, 8 pages.;;""Brainbench-The Skills Authority: About our Assessments,"" www.brainbench.com website archived May 10, 2000, 2 pages.;;""Brainbench-The Skills Authority: Account Registration,"" www.brainbench.com website archived May 11, 2000, 2 pages.;;""Brainbench-The Skills Authority: Assessment Center Demonstration,"" www.brainbench.com website archived May 12, 2000, 2 pages.;;""Brainbench-The Skills Authority: Brainbench Certifications(TM),"" www.brainbench.com website archived May 24, 2000, 2 pages.;;""Brainbench-The Skills Authority: Brainbench to Develop/ Measure Talent for BTG to Staff Major Department of Education Project,"" www.brainbench.com website press release dated Feb. 11, 2000, 2 pages.;;""Brainbench-The Skills Authority: Brainbench VP to Discuss Rapid Growth of Online Certification Industry,"" www.brainbench.com website press release dated May 2, 2000, 2 pages.;;""Brainbench-The Skills Authority: Certifications Add Efficiency to the Employment Market,"" www.brainbench.com website white paper dated Jun. 7, 2000, 4 pages.;;""Brainbench-The Skills Authority: Data Warehousing Specialist Certification,"" www.brainbench.com website archived May 10, 2000, 2 pages.;;""Brainbench-The Skills Authority: Dear Affiliate,"" www.brainbench.com website archived May 11, 2000, 3 pages.;;""Brainbench-The Skills Authority: EDS Targets Training with Brainbench Test!,"" www.brainbench.com website press release dated Mar. 11, 1999, 2 pages.;;""Brainbench-The Skills Authority: FedSources, Inc. Teams Up with Brainbench for Online Skills Certification Service,"" www.brainbench.com website press release dated Oct. 22, 1999, 2 pages.;;""Brainbench-The Skills Authority: Frequently Asked Questions about Brainbench Certifications(TM),"" www.brainbench.com website archived May 10, 2000, 5 pages.;;""Brainbench-The Skills Authority: Global E-Market Company for Skilled Services Team with World's Largest Online Certification Authority,"" www.brainbench.com website press release dated Feb. 1, 2000, 2 pages.;;""Brainbench-The Skills Authority: Hear What Our Customers Are Saying . . . ,"" www.brainbench.com website archived May 10, 2000, 6 pages.;;""Brainbench-The Skills Authority: Looking for Qualified candidates?,"" www.brainbench.com website archived May 10, 2000, 1 page.;;""Brainbench-The Skills Authority: Microsoft Chooses Brainbench Tests to Prep the Market for Windows 2000,"" www.brainbench.com website press release dated Feb. 17, 2000, 2 pages.;;""Brainbench-The Skills Authority: Online Cert Prep(TM),"" www.brainbench.com website archived Jun. 22, 2000, 2 pages.;;""Brainbench-The Skills Authority: Online Public Transcript for Chastity Sterling,"" www.brainbench.com website archived May 11, 2000, 3 pages.;;""Brainbench-The Skills Authority: Online Skills Assessment Leader Brainbench Forms Partnership With Leading Quality-Rating Services Provider,"" www.brainbench.com website archived Jun. 6, 2000, 2 pages.;;""Brainbench-The Skills Authority: Pricing,"" www.brainbench.com website archived May 10, 2000, 2 pages.;;""Brainbench-The Skills Authority: Privacy Policy,"" www.brainbench.com website archived May 10, 2000, 2 pages.;;""Brainbench-The Skills Authority: Sample Certificate,"" www.brainbench.com website archived May 11, 2000, 2 pages.;;""Brainbench-The Skills Authority: See Where You Stand,"" www.brainbench.com website archived Apr. 19, 2000, 1 page.;;""Brainbench-The Skills Authority: Take the Microsoft Challenge,"" www.brainbench.com website archived Mar. 3, 2000, 2 pages.;;""Brainbench-The Skills Authority: Test Alert,"" www.brainbench.com website archived Jun. 21, 2000, 2 pages.;;""Brainbench-The Skills Authority: Test Developer,"" www.brainbench.com website archived May 10, 2000, 2 pages.;;""Brainbench-The Skills Authority: The Company,"" www.brainbench.com website archived May 11, 2000, 1 page.;;""Brainbench-The Skills Authority: Top Ten Scores List,"" www.brainbench.com website archived May 11, 2000, 1 page.;;""Brainbench-The Skills Authority: Welcome to Brainbench,"" www.brainbench.com website archived May 11, 2000, 2 pages.;;""CAPS-A Total Solution for Off-Site Screening and Scheduling,"" Demo, Aspen Tree Software, Inc., Apr. 24, 1997, 20 pages.;;""Catalog,"" www.tekmetrics.com website archived Dec. 6, 1998, 3 pages.;;""Companies: Registration,"" www.epredix.com, 8 pages, archived Jun. 2000.;;""Configuring Your Hardware and Browser,"" Virtual Learning Technologies, http://web.archive.org/web/19980524111629/http://www.proveit.com/browser.html, 2 pages, 1998.;;""Custom Job Center,"" DecisionPoint Systems Hirelink Network advertisement, 2 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""Customer Service and Clerical Potential Index(TM),"" candidate test, ePredix, Inc., 17 pages, Copyright 2001.;;""Customer Service and Clerical Potential Index(TM),"" technical manual, ePredix, Inc., 91 pages, Copyright 2001.;;""DDI Launches Tech Spin-Off Targeting Small to Mid-Size Businesses,"" AdvantageHiring.com, http://www.advantagehiring.com/about/pr-DDIspinoff.asp, 2 pages, Sep. 17, 1999.;;""DecisionPoint Systems-Hiring Technology That Gives You a Competitive Advantage,"" DecisionPoint Systems HirePro(TM) advertisement, 2 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""DecisionPoint Systems-Imagine Being Able to Incorporate Your Company's Job Application, Skills Test, Background Checks and Tax Credit Paperwork Into One Simple Process."" DecisionPoint Systems advertisement, 4 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""Example Campus Manager Process,"" Bigby Havis & Associates, Inc., 3 pages, Mar. 18, 1999.;;""Facts About DDI: Who We Are, What We Do,"" Development Dimensions International, Inc., http://www.ddiworld.com/about/pr-facts.asp, 3 pages, website visited on Nov. 2, 2004.;;""Get eCertified as a Java Programmer,"" http://www.tekmetrics.com, 1 pages, Nov. 16, 2000.;;""Getting Started: 1-2-3Assess,"" TekMetrics, Inc., www.tekmetrics.com, 3 pages, 1998.;;""Guide to Using Assess Internet,"" Bigby Havis & Associates, Inc., 13 pages, Mar. 1999.;;""Highlights, The Bigby, Havis Newsletter: How Our Clients Use ASSESS,"" page archived from www.bigby.com website, 1 page, Oct. 8, 1999.;;""HirePro.com-The Technology to Select the Ideal Employee Is Now Online,"" DecisionPoint Systems HirePro.com advertisement, 2 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""HirePro(TM)-Automated Hiring System,"" DecisionPoint Systems HirePro(TM) advertisement, 2 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""HirePro(TM) Assessments-Application Assessment Tests for HirePro(TM),"" DecisionPoint Systems Assessment Series advertisement, 2 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""HirePro(TM),"" DecisionPoint Systems HirePro(TM) advertisement, 1 page, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""HirePro(TM),"" Retail Direct Mail Piece, 6 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""How Do You Stack Up Next to Training's New Guard?"" http://web.archive.org/web/19991012021341/ddiworld.com/newguard/index.htm, Development Dimensions International, Inc., 4 pages, website archived Oct. 12, 1999.;;""Industry of Choice,"" Food Service Research Forum, 46 pages, Jan. 1997.;;""Interactive Interview Category Analysis Report,"" DPD Applicant Report, Decision Point Data, Inc. (predecessor company of Unicru, Inc.), 1 page, Apr. 1998.;;""Internet chats on line to replace paper CVS,"" UK: Launch of an Internet CV Package, Retail Week, p. 23 (1 page), Mar. 13, 1998.;;""Interview Guide for Tom Horn,"" Aspen Tree Software, Inc., Jun. 13, 1997, 17 pages.;;""Invoice, Assess for Internet Units,"" Bigby Havis & Associates, Inc., 1 pages, Feb. 16, 1999.;;""Know It All-Staffing Professionals,"" Know It All, Inc., http://web.archive.org/web/19991009154935/www.knowitallinc.com/staffing.html, 1 page, 1999.;;""Know It All-Technical Recruiters,"" Know It All, Inc., http://web.archive.org/web/19981206160646/www.knowitallinc.com/recruiter.html, 1 page, 1998.;;""Know It All-Training Directors,"" Know It All, Inc., http://web.archive.org/web/19991009192333/www.knowitallinc.com/training.html, 1 page, 1999.;;""Know It All, Inc.: About Us,"" Know It All, Inc., http://web.archive.org/web/19991109161725/www.knowitallinc.com/about.html, 1 page, 1999.;;""Know It All, Inc.: Features and Benefits,"" Know It All, Inc., http://web.archive.org/web/19991110092810/www.knowitallinc.com/software.html, 2 pages, 1999.;;""Legal Considerations When Using Testing: White Paper,"" www.tekmetrics.com website archived Apr. 17, 1999, 3 pages.;;""Management Information Packet for Customer Service and Sales Selection,"" Criterion International, Inc., 33 pages, May 12, 2000.;;""More Firms Recruit Via the Internet,"" Boston Globe, 2 pages, Nov. 18, 1997.;;""NeuralWorks Professional II/PLUS,"" http://www.neuralware.com/products-pro2.jsp, pp. 1-3, Jul. 28, 2001.;;""New Approaches to Combining Multiple Assessments for Predicting Criterion Outcomes,"" SIOP 2000, 15th Annual Conference, Hyatt Regency, New Orleans, USA, 2 pages, Apr. 14, 2000.;;""Nov. 18, 1997: More Firms Recruit Via the Internet,"" The Boston Globe, 2 pages, Nov. 14, 1997.;;""Online Recruiting Strategist,"" Hunt-Scanlon.com, http://www.hunt-scanlon.com/newsarchives/orsarchives/2000/jan.htm, 8 pages, Jan. 2000.;;""PR Newswire: TekMetrics Help EDS Select Top Sales Talent Online,"" 3 pages, http://www.google.com/search?h1=en&q=cache%3Awww.findarticles.com%2Fcf-dls%2Fm4PRN%2F1999-April-29%2F54502514%2Fpl%2Farticle.jhtml PR Newswire, Apr. 29, 1999.;;""Predicting Sales Success: An Examination of Alternative Predictors,"" SIOP 2000, 15th Annual Conference, Hyatt Regency, New Orleans, USA, 2 pages, Apr. 14, 2000.;;""Process Complete: Assessment Results,"" TekMetrics, Inc., http://www.pvv.org/~kentda/cv/filer/ProgrammerAptitudeTest.html, 3 pages, 1999.;;""Profitability is Built Upon Teamwork,"" Decision Point Data (predecessor company of Unicru, Inc.), mailed to prospective customers, 6 pages, 1997.",EXPIRED
567,US,A1,US 2011/0145161 A1,190-630-129-551-118,2011-06-16,2011,US 201113030057 A,2011-02-17,US 201113030057 A;;US 96219104 A;;US 92199301 A;;US 92219701 A;;US 22328900 P,2000-08-03,ELECTRONIC EMPLOYEE SELECTION SYSTEMS AND METHODS,"An automated employee selection system can use a variety of techniques to provide information for assisting in selection of employees. For example, pre-hire and post-hire information can be collected electronically and used to build an artificial-intelligence based model. The model can then be used to predict a desired job performance criterion (e.g., tenure, number of accidents, sales level, or the like) for new applicants. A wide variety of features can be supported, such as electronic reporting. Pre-hire information identified as ineffective can be removed from a collected pre-hire information. For example, ineffective questions can be identified and removed from a job application. New items can be added and their effectiveness tested. As a result, a system can exhibit adaptive learning and maintain or increase effectiveness even under changing conditions.",KRONOS TALENT MAN INC,SCARBOROUGH DAVID J;;CHAMBLESS BJORN;;BECKER RICHARD W;;CHECK THOMAS F;;CLAINOS DEME M;;ENG MAXWELL W;;LEVY JOEL R;;MERTZ ADAM N;;PAAJANEN GEORGE E;;SMITH DAVID R;;SMITH JOEL R,KRONOS TALENT MANAGEMENT INC (2001-08-03);;CADIENT LLC (2019-04-05),https://lens.org/190-630-129-551-118,Patent Application,yes,98,26,18,19,0,G06Q10/063;;G06Q10/063118;;G06Q10/0639;;G06Q10/10;;G06Q10/1053;;G06Q30/08;;G09B5/00;;G09B7/00;;G09B7/02;;G06Q10/10;;G06Q10/0639;;G09B7/00;;G06Q10/1053;;G06Q10/063;;G09B5/00;;G06Q10/063118;;G06Q30/08;;G09B7/02,G06E1/00;;G06F17/00;;G06N5/00;;G06Q10/00;;G09B5/00;;G09B7/00;;G09B7/02,705/321,2,0,,,"Hart, Ann Yeager. Predicting the tenure outcome of teachers based on variables known at the time of application. North Carolina State University. 1997.;;Stone, William Steve. North Carolina State University. Principal selection: An Application of nueral-network forecasting. 1993",EXPIRED
568,US,B2,US 7558767 B2,079-387-768-525-265,2009-07-07,2009,US 92199301 A,2001-08-02,US 92199301 A;;US 22328900 P,2000-08-03,Development of electronic employee selection systems and methods,"An automated employee selection system can use a variety of techniques to provide information for assisting in selection of employees. For example, pre-hire and post-hire information can be collected electronically and used to build an artificial-intelligence based model. The model can then be used to predict a desired job performance criterion (e.g., tenure, number of accidents, sales level, or the like) for new applicants. A wide variety of features can be supported, such as electronic reporting. Pre-hire information identified as ineffective can be removed from a collected pre-hire information. For example, ineffective questions can be identified and removed from a job application. New items can be added and their effectiveness tested. As a result, a system can exhibit adaptive learning and maintain or increase effectiveness even under changing conditions.",KRONOS TALENT MAN INC,SCARBOROUGH DAVID J;;CHAMBLESS BJORN;;BECKER RICHARD W;;CHECK THOMAS F;;CLAINOS DEME M;;ENG MAXWELL W;;LEVY JOEL R;;MERTZ ADAM N;;PAAJANEN GEORGE E;;SMITH DAVID R;;SMITH JOHN R,KRONOS TALENT MANAGEMENT INC (2001-08-03);;CADIENT LLC (2019-04-05),https://lens.org/079-387-768-525-265,Granted Patent,yes,86,19,18,19,0,G06Q10/063;;G06Q10/063118;;G06Q10/0639;;G06Q10/10;;G06Q10/1053;;G06Q30/08;;G09B5/00;;G09B7/00;;G09B7/02;;G06Q10/10;;G06Q10/0639;;G09B7/00;;G06Q10/1053;;G06Q10/063;;G09B5/00;;G06Q10/063118;;G06Q30/08;;G09B7/02,G06F15/18;;G06E1/00;;G06F17/00;;G06N5/00;;G06Q10/00;;G09B5/00;;G09B7/00;;G09B7/02,706/21;;706/46;;705/11,111,22,035-581-170-138-052;;015-522-231-004-037;;082-727-931-819-121;;134-205-020-805-497;;082-827-864-115-463;;084-503-007-462-905;;066-584-701-182-932;;030-892-570-581-308;;051-241-940-403-887;;124-821-732-772-925;;075-793-976-009-167;;083-734-666-358-804;;014-173-240-534-719;;048-736-553-740-409;;173-292-133-183-834;;170-331-667-492-498;;105-702-119-506-732;;092-917-039-596-166;;053-160-396-897-876;;082-727-931-819-121;;035-788-244-665-452;;116-814-374-807-642,10.1109/annes.1993.323046;;10.1109/3477.662769;;18255946;;10.1109/dmisp.1993.248616;;10.1006/jvbe.1999.1687;;10361841;;10.1037//0021-9010.84.2.177;;10.1037/0021-9010.84.2.177;;10.1109/ijcnn.2001.939574;;10.1145/276675.276697;;10.1037/1082-989x.5.1.102;;10937325;;10.1037//1082-989x.5.1.102;;10.1111/j.1744-6570.1993.tb00882.x;;10.1145/130069.130075;;10.1145/219717.219768;;10.1145/242223.242268;;10.1016/s1366-5545(99)00030-7;;10.1145/299513.299612;;10.1145/240455.240468;;10.1002/j.1538-7305.1948.tb00917.x;;10.1145/122399.122401;;7487861;;10.1002/bs.3830400402;;10.1145/324239.324280;;10.1109/dmisp.1993.248616;;10.1145/142750.142984;;10.1109/icnn.1994.374796,"Kirby et al, ""An Analysis of Applying Neural Networks for Employee Selection"", http://is.Ise.ac.uk/support/AMCIS/AMCIS1998/pdffiles/papers/T02-11.pdf, 1998.;;Kemp H. R., ""Knowledge-Based Simulation for Teaching"", IEEE Proceedings of the 1st New Zealand International Stream Conference on Artificial Neural Networks and Expert Systems, Nov. 1993.;;Steven Walczak, ""Neural Network Models for a Resource Allocation Problem"", IEEE Transaction on System, Man, and Cybernatics, Apr. 1998.;;Labate et al, ""Employee Skills Analysis Using a Hybrid Neural Network and Expert System"", IEEE International Conference on Developing and Managing Intelligent System Projects, Mar. 1993.;;Edward Kirby, Ojoung Kwon, Donna Dufner (""An Analysis of Applying Artifical Neural Networks for Employee Selection"" AMCIS 1998).;;Scott R Kaak, Hubert S Field, William F Giles, Dwight R Norris (""The weighted Application Blank"" Cornel Hotel and Restaurant Administration Quarterly, Apr. 1998).;;Decision Point Data, Inc (""1999 StoreWorks! Conference and Exhibition"" May 1999).;;Paula C. Morrow, James C. McElroy, Kathleen S. Laczniak, James B. Fenton ""Using Absenteeism and Performance to Predict Employee Turnover: Early Detection through Company Records"" Journal of Vocational Behavior 55, 358-374, 1999.;;Mark John Somers ""Application of two neural network paradigms to the study of voluntary employee turnover"" Journal of Applied Psychology, 1999, vol. 84. No. 2, p. 177-183.;;Chambless et al., ""Information-Theoretic Feature Selection for a Neural Behavioral Model,"" Proceedings of the International Joint Conference on Neural Networks, vol. 2, Jul. 15-19, 2001, pp. 1443-1448, 6 pages.;;Sahami et al ""SONIA: a service for organizing networked information autonomously"" Proceedings of the third ACM conference on Digital libraries, 1998.;;D. Koller and M. Sahami. Toward optimal feature slection. In L. Saitta, editor, Machine Learning: Proceedings of the Thirteenth International Conference, pp. 281-289.Morgan Kaufman, 1996.;;Garson, Neural Networks An Introductory Guide for Social Scientists, SAGE Publications, pp. 1-194, 1998.;;""NeuralWorks Professional II/PLUS,"" http://wwww.neuralware.com/products-pro2.jsp, pp. 1-3, Jul. 28, 2001.;;""Statistica Neural Networks,"" http://www.statsoft.com/stat-nn.html, pp. 1-11, Jul. 28, 2001.;;Scarborough, ""Tutorial on the Use of Neural Network Models for Personal Selection,"" Decision Sciences Institute Southwest Region Theory and Applications Proceedings 27th Annual Conference, pp. 151-153, Mar. 6-9, 1996.;;Marshall et al., ""Neural Network Modeling of Risk Assessment in Child Protective Services,"" Psychological Methods, vol. 5, No. 1, pp. 102-124, 2000.;;Aggarwal et al., ""Selection of Surgical Residents: A Neural Network Approach,"" Cybernetics and Systems: An International Journal, vol. 31, pp. 417-430, 2000.;;Collins et al., ""An Application of the Theory of Neural Computation to the Prediction of Workplace Behavior: An Illustration and Assessment of Network Analysis,"" Personnel Psychology, vol. 46, pp. 503-524, 1993.;;Mitchell, ""How to Reduce the High Cost of Turnover,"" Lawson Software, pp. 1-11, Jul. 12, 2001, or before.;;Page et al., ""Panel: Strategic Directions in Simulation Research,"" Proceedings of the 1999 Winter Simulation Conference, pp. 1509-1520, 1999.;;Mengel et al., ""Using a Neural Network to Predict Student Responses,"" ACM, pp. 669-676, 1992.;;Pentland et al., ""Modeling and Prediction of Human Behavior,"" M.I.T. Media Lab Perceptual Computing Technical Report, No. 433, pp. 1-7, 1999.;;Langley et al., ""Applications of Machine Learning and Rule Induction,"" Communications of the ACM, vol. 38, No. 11, pp. 55-64, Nov. 1995.;;""XpertRule(R) Miner, The Complete Data Mining Solution,"" http://www.attar.com/pages/info-xm/htm., pp. 1-5, Mar. 23, 2001.;;""The Wide Scale Deployment of Active Data Mining Solutions,"" http://www.attar.com/tutor/deploy.htm, pp. 1-7, Mar. 23, 2001.;;""A Hybrid GA-Heuristic Search Strategy,"" http://www.attar.com/pages/dev-gap.htm, pp. 1-6, Mar. 23, 2001.;;Doyle et al., ""Strategic Directions in Artificial Intelligence,"" ACM Computing Surveys, vol. 28, No. 4, pp. 653-670, Dec. 1996.;;Callaghan, ""Personalization on the Fly-SaffronOne, FrontMind Tap Advanced Technologies to Predict User Behavior, Make Recommendations,"" eWeek, p. 52, Oct. 23, 2000.;;Hensher et al., ""A Comparison of the Predictive Potential of Artificial Neural Networks and Nested Logit Models for Commuter Mode Choice,"" Transportation Research Part E: Logistic and Transportation Review, vol. 36, No. 3, pp. 155-172 (abstract only), Sep. 2000.;;Kahney, ""KnowledgeMiner 2 Digs Out More Info,"" MacWEEK, vol. 11, No. 40, pp. 23-24, Oct. 20, 1997.;;Rosen, ""Mining Database Treasures,"" Computing Canada, vol. 22, No. 20, pp. 42-43, Sep. 26, 1996.;;McLeod et al., ""Predicting Credit Risk: A Neural Network Approach,"" Journal of Retail Banking, vol. 15, No. 3, pp. 37-40, Fall 1993.;;""SaffronOne's Unique Product Features,"" http://www.saffrontech.com/pages/products/features.html, pp. 1-2, Mar. 22, 2001.;;Herschel et al., ""CKOS and Knowledge Management: Exploring Opportunities for Using Information Exchange Protocols,"" ACM, pp. 42-50, 1999.;;Hapgood, ""Embedded Logic,"" http://www2.cio.com/archive/050100-revisit-content.html, pp. 1-3, Mar. 23, 2001.;;Brachman et al., ""Mining Business Databases,"" Communications of the ACM, vol. 39, No. 11, pp. 42-48, Nov. 1996.;;Jordan et al., ""Neural Networks,"" The Computer Science and Engineering Handbook, Tucker (ed.), pp. 536-556, 1996.;;Scarborough, ""An Evaluation of Backpropagation Neural Network Modeling as an Alternative Methodology for Criterion Validation of Employee Selection Testing,"" Doctoral Dissertation (UMI Dissertation Services), University of North Texas, 1995.;;Guion, ""Personnel Assessment, Selection, and Placement,"" Handbook of Industrial and Organizational Psychology, Consulting Psychologists Press, Inc., pp. 327-397, 1991.;;""Assess Expert System/Bigby, Havis & Associates, Inc.,"" page archived from www.bigby.com website, 2 pages, May 7, 1999.;;""assesspreview: Assess User Site Instructions,"" page archived from www.bigby.com website, 1 page, Oct. 12, 2000.;;""assesspreview: History of Assess,"" page archived from www.bigby.com website, 1 page, Oct. 11, 1999.;;""assesspreview: Welcome to the Assess Internet Online Preview,"" page archived from www.bigby.com website, 1 page, May 8, 1999.;;""assesspreview: What is Assess?,"" page archived from www.bigby.com website, 1 page, Oct. 11, 1999.;;""Custom Job Center,"" DecisionPoint Systems Hirelink Network advertisement, 2 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""DDI Launches Tech Spin-Off Targeting Small to Mid-Size Businesses,"" AdvantageHiring.com, http://www.advantagehiring.com/about/pr-DDIspinoff.asp, 2 pages, Sep. 17, 1999.;;""DecisionPoint Systems-Hiring Technology That Gives You A Competitive Advantage,"" DecisionPoint Systems HirePro(TM) advertisement, 2 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""DecisionPoint Systems-Imagine Being Able to Incorporate Your Company's Job Application, Skills Test, Background Checks and Tax Credit Paperwork Into One Simple Process."" DecisionPoint Systems advertisement, 4 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""Facts About DDI: Who We Are, What We Do,"" Development Dimensions International, Inc., http://www.ddiworld.com/about/pr-facts.asp, 3 pages, website visited on Nov. 2, 2004.;;""Highlights, The Bigby, Havis Newsletter: How Our Clients Use Assess,"" page archived from www.bigby.com website, 1 page, Oct. 8, 1999.;;""HirePro.com-The Technology to Select The Ideal Employee Is Now Online,"" DecisionPoint Systems HirePro.com advertisement, 2 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""HirePro(TM)-Automated Hiring System,"" DecisionPoint Systems HirePro(TM) advertisement, 2 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""HirePro(TM) Assessments-Application Assessment Tests for HirePro(TM),"" DecisionPoint Systems Assessment Series advertisement, 2 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""HirePro(TM),"" DecisionPoint Systems HirePro(TM) advertisement, 1 page, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""HirePro(TM),"" Retail Direct Mail Piece, 6 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""How Do You Stack Up Next to Training's New Guard?"" http://web.archive.org/web/19991012021341/ddiworld.com/newguard/index.htm, Development Dimensions International, Inc., 4 pages, website archived Oct. 12, 1999.;;""Nov. 18, 1997: More Firms Recuit Via the Internet,"" The Boston Globe, 2 pages, Nov. 14, 1997.;;""Online Recruiting Strategist,"" Hunt-Scanlon.com, http://www.hunt-scanlon.com/newsarchives/orsarchives/2000/jan.htm, 8 pages, Jan. 2000.;;""PR Newswire: TekMetrics Help EDS Select Top Sales Talent Online,"" http://www.google.com/search?hl=en&q=cache%3Awww.findarticles.com%2Fcf-dls%2Fm4PRN%2F1999-April-29%2F54502514%2Fp1%2Farticle.jhtml PR Newswire, Apr. 29, 1999.;;""Profitability is Built Upon Teamwork,"" Decision Point Data (predecessor company of Unicru, Inc.), mailed to prospective customers, 6 pages, 1997.;;""ReportView(TM)-Closed Loop Reporting for HirePro(TM),"" DecisionPoint Systems ReportView(TM) advertisement, 4 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""Saville & Holdsworth, Human Resource Consulting: ApView(TM) Net,"" page archived from www.shlusa.com website, 2 pages, Apr. 29, 1999.;;""SHL Aspen Tree Software-Solutions for Employee Selection,"" page archived from www.aspentree.com website, 1 page, Dec. 1, 1998.;;""SHL-HR Support Tools, Analytical Process, Decision-Support Tech,"" page archived from www.shlusa.com website, 1 page, Feb. 18, 1999.;;""Solutions for Managers, Professionals and Supervisors,"" page archived from www.bigby.com website, 2 pages, Feb. 9, 1999.;;Bylinsky, et al., ""Computers That Learn by Doing,"" Fortune, vol. 128, Issue 5, p96, 5p, 14c, 7 pages, Sep. 6, 1993.;;Glatzer, ""Neural Networks Take on Real-World Problems,"" (Abstract) Computer World, v26, n32, p21(1), 1 page, Aug. 10, 1992.;;Goodwin, ""As Job Seekers Turn to Net,"" (Brief Article) Computer Weekly, p6(1), Feb. 4, 1999.;;Lawton, ""Genetic Algorithms for Schedule Optimization,"" (Cover Story) AI Expert, v7, n5, p22(6), 7 pages, May 1992.;;Scarborough, ""Decision Point Systems,"" Presentation to potential customer, 38 pages, ten or fewer copies left with potential customer, Wilsonville, Oregon before Jun. 2000.;;Scarborough, ""DPDNeurotech(TM),"" Power Point Presentation given to prospective employer Decision Point Data (predecessor company of Unicru, Inc.) 32 pages, electronic copy provided to Decision Point Data., Dec. 1998.;;Scarborough, ""Welcome, Portland State University,"" Presentation to about 15 people, Portland, Oregon, 20 pages, before May 2000.;;Schwartz, ""Where Neural Networks are Already at Work: Putting AI to Work in the Markets,"" (Abstract) Business Week, n3291, p136(2), 1 page, Nov. 2, 1992.;;Shannon, ""A Mathematical Theory of Communication,"" Reprinted with corrections from The Bell System Technical Journal, vol. 27, pp. 379-423, 623-656, 55 pages, Jul., Oct. 1948.;;U.S. Appl. No. 60/211,044, filed Jun. 12, 2000, Dewar.;;""An Applied Look at Reducing Adverse Impact by Differentially Weighting Selection Measures,"" SIOP 2000, 15th Annual Conference, Hyatt Regency, New Orleans, USA, 3 pages, Apr. 14, 2000.;;""New Approaches to Combining Multiple Assessments for Predicting Criterion Outcomes,"" SIOP 2000, 15th Annual Conference, Hyatt Regency, New Orleans, USA, 2 pages, Apr. 14, 2000.;;""Predicting Sales Success: An Examination of Alternative Predictors,"" SIOP 2000, 15th Annual Conference, Hyatt Regency, New Orleans, USA, 2 pages, Apr. 14, 2000.;;""Automated Technologies for Biodata Prediction Systems,"" SIOP 2000, 15th Annual Conference, Hyatt Regency, New Orleans, USA, 2 pages, Apr. 15, 2000.;;""Applying Neural Networking Techniques to Prediction Problems in I-O Psychology,"" SIOP 2000, 15th Annual Conference, Hyatt Regency, New Orleans, USA, 2 pages, Apr. 15, 2000.;;""Self-Organizing Maps and Commitment Profiles,"" SIOP 2000, 15th Annual Conference, Hyatt Regency, New Orleans, USA, 2 pages, Apr. 15, 2000.;;""Industry of Choice,"" Food Service Research Forum, 41 pages, Jan. 1997.;;""Aspen Tree Software: The Total Solution to Employee Recruiting & Selection,"" Aspen Tree Software, Inc., Oct. 27, 1997, 29 pages.;;""CAPS-A Total Solution for Off-Site Screening and Scheduling,"" Demo, Aspen Tree Software, Inc., Apr. 24, 1997, 20 pages.;;""Interview Guide for Tom Horn,"" Aspen Tree Software, Inc., Jun. 13, 1997, 17 pages.;;""123 Assess(TM) Qualify Applicants in 10 Minutes!"" TekMetrics, 1998, 1 page.;;""The Science Behind Our Products-Profiles International, Inc.,"" Profiles International, Inc., website archived May 26, 2000, 2 pages.;;Chang et al., ""The Development of a Computer-Based Decision Support System for Use in Evaluating Candidates for the Position of Programmer-Analyst,"" ACM SIGCPR Computer Personnel, vol. 13. Issue 1, pp. 9-19, Apr. 1991.;;Duong et al., ""A System of IAC Neural Networks as the Basis for Self-Organization in a Sociological Dynamical System Simulation,"" Behavioral Science, vol. 40, pp. 275-303, 1995.;;Franklin, Dianna, ""An Effective Way to Hire Technical Staff,"" User Services Conference: Proceedings of the 14th Annual ACM SIGUCCS Conference on User Services: Setting the Direction, pp. 137-142, 1986.;;Labate et al., ""Employee Skills Analysis Using a Hybrid Neural Network and Expert System,"" IEEE International Conference on Developing and Managing Intelligent System Projects, pp. 205-211, Mar. 1993.;;Lim et al., ""A Method for (Recruiting) Methods: Facilitating Human Factors Input to System Design,"" Conference on Human Factors in Computing Systems, Proceedings of the SIGCHI Conference on Human Factors in Computing Systems, pp. 549-556, 1992.;;Walczak, ""Categorizing University Student Applicants with Neural Networks,"" IEEE International Conference on Neural Networks, IEEE World Congress on Computational Intelligence, vol. 6, pp. 3680-3685, 1994.;;""1999 StoreWorks! Conference and Exhibition,"" Decision Point Data, Inc. (predecessor company of Unicru, Inc.), 13 pages, May 1999.;;""A Technology Case Study for Human Resource Executive,"" Getting the High-Tech Hiring Edge, 2 pages, www.workindex.com/editorial/staff/sta0301.01.asp, Jan. 2003.;;""Aspen Tree Software helps lessen resume overload,"" PC Week, vol. 14, No. 36, p. 84, ZDNet, Aug. 25, 1997.;;""Assess v2-for Selection and Development,"" Bigby Havis & Associates, Inc., 5 pages, http://www.bigby.com/systesms/assessv2/System/main.asp, printed Aug. 5, 2005, showing applicants from 1998.;;""Assess v.2: Technical Manual,"" Bigby Havis & Associates, Inc., 106 pages, Dec. 2003, describing products from 1970-2003.;;""Before You Begin: Welcome to SSA Online Help,"" http://web.archive.org/web/19980118183643/http://www.coopersclub.com/inethlp2.Htm, 6 pages, 1998.;;""Companies: Registration,"" www.epredix.com, 8 pages, archived Jun. 2000.;;""Configuring Your Hardware and Browser,"" Virtual Learning Technologies, http://web.archive.org/web/19980524111629/http://www.proveit.com/browser.html, 2 pages, 1998.;;""Customer Service and Clerical Potential Index(TM),"" candidate test, ePredix, Inc., 17 pages, Copyright 2001.;;""Customer Service and Clerical Potential Index(TM),"" technical manual, ePredix, Inc., 91 pages, Copyright 2001.;;""Example Campus Manager Process,"" Bigby Havis & Associates, Inc., 3 pages, Mar. 18, 1999.;;""Get eCertified as a Java Programmer,"" http://www.tekmetrics.com, 1 page, Nov. 16, 2000.;;""Getting Started: 1-2-3Assess,"" TekMetrics, Inc., www.tekmetrics.com, 3 pages, 1998.;;""Guide to Using Assess Internet,"" Bigby Havis & Associates, Inc., 13 pages, Mar. 1999.;;""Interactive Interview Category Analysis Report,"" DPD Applicant Report, Decision Point Data, Inc. (predecessor company of Unicru, Inc.), 1 page, Apr. 1998.;;""Internet chats on line to replace paper CVS,"" UK: Launch of an Internet CV Package, Retail Week, p. 23, (1 page) Mar. 13, 1998.;;""Invoice, Assess for Internet Units,"" Bigby Havis & Associates, Inc., 1 page, Feb. 16, 1999.",EXPIRED
569,US,A1,US 2010/0287111 A1,143-959-096-740-770,2010-11-11,2010,US 84197710 A,2010-07-22,US 84197710 A;;US 96219104 A;;US 92199301 A;;US 92219701 A;;US 22328900 P,2000-08-03,ELECTRONIC EMPLOYEE SELECTION SYSTEMS AND METHODS,"An automated employee selection system can use a variety of techniques to provide information for assisting in selection of employees. For example, pre-hire and post-hire information can be collected electronically and used to build an artificial-intelligence based model. The model can then be used to predict a desired job performance criterion (e.g., tenure, number of accidents, sales level, or the like) for new applicants. A wide variety of features can be supported, such as electronic reporting. Pre-hire information identified as ineffective can be removed from a collected pre-hire information. For example, ineffective questions can be identified and removed from a job application. New items can be added and their effectiveness tested. As a result, a system can exhibit adaptive learning and maintain or increase effectiveness even under changing conditions.",KRONOS TALENT MAN INC,SCARBOROUGH DAVID J;;CHAMBLESS BJORN;;BECKER RICHARD W;;CHECK THOMAS F;;CLAINOS DEME M;;ENG MAXWELL W;;LEVY JOEL R;;MERTZ ADAM N;;PAAJANEN GEORGE E;;SMITH DAVID R;;SMITH JOHN R,KRONOS TALENT MANAGEMENT INC (2001-08-03),https://lens.org/143-959-096-740-770,Patent Application,yes,98,13,18,19,0,G06Q10/063;;G06Q10/063118;;G06Q10/0639;;G06Q10/10;;G06Q10/1053;;G06Q30/08;;G09B5/00;;G09B7/00;;G09B7/02;;G06Q10/10;;G06Q10/0639;;G09B7/00;;G06Q10/1053;;G06Q10/063;;G09B5/00;;G06Q10/063118;;G06Q30/08;;G09B7/02,G06E1/00;;G06F17/00;;G06N5/00;;G06N5/02;;G06Q10/00;;G09B5/00;;G09B7/00;;G09B7/02,705/321;;706/52,0,0,,,,DISCONTINUED
570,WO,A2,WO 2002/013095 A2,172-330-840-267-517,2002-02-14,2002,US 0124323 W,2001-08-02,US 22328900 P,2000-08-03,ELECTRONIC EMPLOYEE SELECTION SYSTEMS AND METHODS,,UNICRU INC;;SCARBOROUGH DAVID J;;BECKER RICHARD W;;CHAMBLESS BJORN;;CHECK THOMAS F;;CLAINOS DEME M;;ENG MAXWELL W;;LEVY JOEL R;;MERTZ ADAM N;;SMITH DAVID R;;SMITH JOHN R;;PAAJANEN GEORGE E,SCARBOROUGH DAVID J;;BECKER RICHARD W;;CHAMBLESS BJORN;;CHECK THOMAS F;;CLAINOS DEME M;;ENG MAXWELL W;;LEVY JOEL R;;MERTZ ADAM N;;SMITH DAVID R;;SMITH JOHN R;;PAAJANEN GEORGE E,,https://lens.org/172-330-840-267-517,Patent Application,yes,0,8,18,19,0,G06Q10/063;;G06Q10/063118;;G06Q10/0639;;G06Q10/10;;G06Q10/1053;;G06Q30/08;;G09B5/00;;G09B7/00;;G09B7/02;;G06Q10/10;;G06Q10/0639;;G09B7/00;;G06Q10/1053;;G06Q10/063;;G09B5/00;;G06Q10/063118;;G06Q30/08;;G09B7/02,G06E1/00;;G06F17/00;;G06N5/00;;G06Q10/00;;G09B5/00;;G09B7/00;;G09B7/02,,0,0,,,,PENDING
571,US,A1,US 2002/0042786 A1,158-661-209-084-080,2002-04-11,2002,US 92199301 A,2001-08-02,US 92199301 A;;US 22328900 P,2000-08-03,Development of electronic employee selection systems and methods,"
   An automated employee selection system can use a variety of techniques to provide information for assisting in selection of employees. For example, pre-hire and post-hire information can be collected electronically and used to build an artificial-intelligence based model. The model can then be used to predict a desired job performance criterion (e.g., tenure, number of accidents, sales level, or the like) for new applicants. A wide variety of features can be supported, such as electronic reporting. Pre-hire information identified as ineffective can be removed from a collected pre-hire information. For example, ineffective questions can be identified and removed from a job application. New items can be added and their effectiveness tested. As a result, a system can exhibit adaptive learning and maintain or increase effectiveness even under changing conditions. 
",UNICRU INC,SCARBOROUGH DAVID J;;CHAMBLESS BJORN;;BECKER RICHARD W;;CHECK THOMAS F;;CLAINOS DEME M;;ENG MAXWELL W;;LEVY JOEL R;;MERTZ ADAM N;;PAAJANEN GEORGE E;;SMITH DAVID R;;SMITH JOHN R,KRONOS TALENT MANAGEMENT INC (2001-08-03);;CADIENT LLC (2019-04-05),https://lens.org/158-661-209-084-080,Patent Application,yes,76,127,18,19,0,G06Q10/063;;G06Q10/063118;;G06Q10/0639;;G06Q10/10;;G06Q10/1053;;G06Q30/08;;G09B5/00;;G09B7/00;;G09B7/02;;G06Q10/10;;G06Q10/0639;;G09B7/00;;G06Q10/1053;;G06Q10/063;;G09B5/00;;G06Q10/063118;;G06Q30/08;;G09B7/02,G06E1/00;;G06F17/00;;G06N5/00;;G06Q10/00;;G09B5/00;;G09B7/00;;G09B7/02,706/21,0,0,,,,EXPIRED
572,US,B2,US 7310626 B2,164-326-795-671-913,2007-12-18,2007,US 4254405 A,2005-01-24,US 4254405 A;;US 92219701 A;;US 92199301 A;;US 22328900 P,2000-08-03,Electronic employee selection systems and methods,"An automated employee selection system can use a variety of techniques to provide information for assisting in selection of employees. For example, pre-hire and post-hire information can be collected electronically and used to build an artificial-intelligence based model. The model can then be used to predict a desired job performance criterion (e.g., tenure, number of accidents, sales level, or the like) for new applicants. A wide variety of features can be supported, such as electronic reporting. Pre-hire information identified as ineffective can be removed from a collected pre-hire information. For example, ineffective questions can be identified and removed from a job application. New items can be added and their effectiveness tested. As a result, a system can exhibit adaptive learning and maintain or increase effectiveness even under changing conditions.",KRONOS TALENT MAN INC,SCARBOROUGH DAVID J;;CHAMBLESS BJORN;;BECKER RICHARD W;;CHECK THOMAS F;;CLAINOS DEME M;;ENG MAXWELL W;;LEVY JOEL R;;MERTZ ADAM N;;PAAJANEN GEORGE E;;SMITH DAVID R;;SMITH JOHN R,KRONOS TALENT MANAGEMENT INC (2001-08-03);;CADIENT LLC (2019-04-05),https://lens.org/164-326-795-671-913,Granted Patent,yes,76,53,18,19,0,G06Q10/063;;G06Q10/063118;;G06Q10/0639;;G06Q10/10;;G06Q10/1053;;G06Q30/08;;G09B5/00;;G09B7/00;;G09B7/02;;G06Q10/10;;G06Q10/0639;;G09B7/00;;G06Q10/1053;;G06Q10/063;;G09B5/00;;G06Q10/063118;;G06Q30/08;;G09B7/02,G06F17/00;;G06E1/00;;G06N5/00;;G06N5/04;;G06Q10/00;;G09B5/00;;G09B7/00;;G09B7/02,706/60;;706/14;;706/12,100,4,120-462-215-961-309;;170-331-667-492-498;;026-046-145-273-454;;030-892-570-581-308,10.1080/019697200124775;;10.1002/j.1538-7305.1948.tb00917.x;;10.1016/0377-2217(94)90119-8;;10.1037/1082-989x.5.1.102;;10937325;;10.1037//1082-989x.5.1.102,"Ajay K. Aggarwal, Selection of Surgical Residents: A Neural Network Approach, 2000, Cybernetics and Systems, 417-430.;;U.S. Appl. No. 60/211,044, filed Jun. 12, 2000, Dewar.;;""ASSESS Expert System/Bigby, Havis & Associates, Inc.,"" page archived from www.bigby.com website 2 pages, May 7, 1999.;;""assesspreview: ASSESS User Site Instructions,"" page archived from www.bigby.com website, 1 page Oct. 12, 2000.;;""assesspreview: History of ASSESS,"" page archived from www.bigby.com website, 1 page, Oct. 11, 1999.;;""assesspreview: Welcome to the ASSESS Internet Online Preview,"" page archived from www.bigby.com website, 1 page, May 8, 1999.;;""assesspreview: What is ASSESS?,"" page archived from www.bigby.com website, 1 page, Oct. 11, 1999.;;""Custom Job Center,"" DecisionPoint Systems Hirelink Network advertisement, 2 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""DDI Launches Tech Spin-Off Targeting Small to Mid-Size Businesses,"" AdvantageHiring.com, http://www.advantagehiring.com/about/pr<SUB>-</SUB>DDIspinoff.asp, 2 pages, Sep. 17, 1999.;;""DecisionPoint Systems-Hiring Technology That Gives You A Competitive Advantage,"" DecisionPoint Systems HirePro(TM) advertisement, 2 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""DecisionPoint Systems-Imagine Being Able to Incorporate Your Company's Job Application, Skills Test, Background Checks and Tax Credit Paperwork Into One Simple Process."" DecisionPoint Systems advertisement, 4 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""Facts About DDI: Who We Are, What We Do,"" Development Dimensions International, Inc., http://www.ddiworld.com/about/pr<SUB>-</SUB>facts.asp, 3 pages, website visited on Nov. 2, 2004.;;""Highlights, The Bigby, Havis Newsletter: How Our Clients Use ASSESS,"" page archived from www.bigby.com website, 1 page, Oct. 8, 1999.;;""HirePro.com-The Technology to Select The Ideal Employee Is Now Online,"" DecisionPoint Systems HirePro.com advertisement, 2 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""HirePro(TM)-Automated Hiring System,"" DecisionPoint Systems HirePro(TM) advertisement, 2 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""HirePro(TM) Assessments-Application Assessment Tests for HirePro(TM),"" DecisionPoint Systems Assessment Series advertisement, 2 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""HirePro(TM),"" DecisionPoint Systems HirePro(TM) advertisement, 1 page, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""HirePro(TM),"" Retail Direct Mail Piece, 6 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""How Do You Stack Up Next to Training's New Guard?"" http://web.archive.org/web/19991012021341/ddiworld.com/newguard/index.htm, Development Dimensions International, Inc., 4 pages, website archived Oct. 12, 1999.;;""Nov. 18, 1997: More Firms Recruit Via the Internet,"" The Boston Globe, 2 pages, Nov. 14, 1997.;;""Online Recruiting Strategist,"" Hunt-Scanlon.com, http://www.hunt-scanlon.com/newsarchive.orsarchives/2000/jan.htm, 8 pages, Jan. 2000.;;""PR Newswire: TekMetrics Help EDS Select Top Sales Talent Online,"" http://www.google.com/search?hl=en&q=cache%3Awww.findarticles.com%2Fcf<SUB>-</SUB>dls%2Fm4PRN%2F1999<SUB>-</SUB>April<SUB>-</SUB>29%2F54502514%Fpl%2Farticle.jhtml PR Newswire, Apr. 29, 1999.;;""Profitability is Built Upon Teamwork,"" Decision Point Data (predecessor company of Unicru, Inc.), mailed to prospective customers, 6 pages, 1997.;;""ReportView(TM)-Closed Loop Reporting for HirePro(TM),"" DecisionPoint Systems ReportView(TM) advertisement, 4 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""Saville & Holdsworth, Human Resource Consulting: ApView(TM) Net,"" page archived from www.shlusa.com website, 2 pages, Apr. 29, 1999.;;""SHL Aspen Tree Software-Solutions for Employee Selection,"" page archived from www.aspentree.com website, 1 page, Dec. 1, 1998.;;""SHL-HR Support Tools, Analytical Process, Decision-Support Tech,"" page archived from www.shlusa.com website, 1 page, Feb. 18, 1999.;;""Solutions for Managers, Professionals and Supervisors,"" page archived from www.bigby.com website, 2 pages, Feb. 9, 1999.;;Bylinsky, et al., ""Computers That Learn by Doing,"" Fortune, vol. 128, Issue 5, p96, 5p, 14c, 7 pages, Sep. 6, 1993.;;Glatzer, ""Neural Networks Take on Real-World Problems,"" (Abstract) Computer World, v26, n32, p21(1), 1 page, Aug. 10, 1992.;;Goodwin, ""As Job Seekers Turn to Net,"" (Brief Article) Computer Weekly, p6(1), Feb. 1, 1999.;;Lawton, ""Genetic Algorithms for Schedule Optimization,"" (Cover Story) AI Expert, v7, n5, p22(6), 7 pages, May 1992.;;Scarborough, ""Decision Point Systems,"" Presentation to potential customer, 38 pages, ten or fewer copies left with potential customer, Wilsonville, Oregon, before Jun. 2000.;;Scarborough, ""DPDNeurotech(TM),"" Power Point Presentation given to prospective employer Decision Point Data (predecessor company of Unicru, Inc.) 32 pages, electronic copy provided to Decision Point Data., Dec. 1998.;;Scarborough, ""Welcome, Portland State University,"" Presentation to about 15 people, Portland, Oregon, 20 pages, before May 2000.;;Schwartz, ""Where Neural Networks are Already at Work: Putting AI to Work in the Markets,"" (Abstract) Business Week, n3291, p136(2), 1 page, Nov. 2, 1992.;;Shannon, ""A Mathematical Theory of Communication,"" Reprinted with corrections from The Bell System Technical Journal, vol. 27, pp. 379-423, 623-656, 55 pages, Jul., Oct. 1948.;;""TekMetrics to Test Skills of Computer Sciences Corp. Job Candidates Over the Internet,""EDP Weekly's IT Monitor, vol. 40, Issue 16, p. 6, Apr. 19, 1999.;;Liang et al., ""Theory and Methodology: Personnel Selection Using Fuzzy MCDM Algorithm,"" European Journal of Operational Research, vol. 78, pp. 22-23, 1994.;;""Brainbench-The Skills Authority: Account Registration,"" www.brainbench.com website archived May 11, 2000, 2 pages.;;""Brainbench-The Skills Authority: Looking for Qualified candidates?,"" www.brainbench.com website archived May 10, 2000, 1 page.;;""Brainbench-The Skills Authority: Welcome to Brainbench,"" www.brainbench.com website archived May 11, 2000, 2 pages.;;""Brainbench-The Skills Authority: About Our Assessments,"" www.brainbench.com website archived May 10, 2000, 2 pages.;;""Brainbench-The Skills Authority: Brainbench Certifications(TM),"" www.brainbench.com website archived May 24, 2000, 2 pages.;;""Are you ready to: Are you Ready?,"" www.brainbench.com website archived Mar. 2, 2000, 1 page.;;""Top Ten Scores List,"" www.brainbench.com website archived Jul. 1, 2002, listing scores from Feb. 2000, 1 page.;;""Brainbench-The Skills Authority: Frequently Asked Questions about Brainbench Certifications(TM),"" www.brainbench.com website archived May 10, 2000, 5 pages.;;""Legal Considerations When Using Testing: White Paper,"" www.tekmetrics.com website archived Apr. 17, 1999, 3 pages.;;""TekMetrics skills assessments & skills test & resume tracking: Frequently Asked Questions,"" www.tekmetrics.com website archived Apr. 24, 1999, 3 pages.;;""Top 10 Test Scores Lists,"" www.tekmetrics.com website archived Dec. 5, 1998, 1 page.;;""123Assess Demonstration,"" www.tekmetrics.com website archived Jan. 28, 1999, 2 pages.;;""Catalog,"" www.tekmetrics.com website archived Dec. 6, 1998, 3 pages.;;""Brainbench-The Skills Authority: Pricing,"" www.brainbench.com website archived May 10, 2000, 2 pages.;;""Brainbench-The Skills Authority: Top Ten Scores List,"" www.brainbench.com website archived May 11, 2000, 1 page.;;""Brainbench-The Skills Authority: See Where You Stand,"" www.brainbench.com website archived Apr. 19, 2000, 1 page.;;""Brainbench-The Skills Authority: Dear Affiliate,"" www.brainbench.com website archived May 11, 2000, 3 pages.;;""Brainbench-The Skills Authority: Sample Certificate,"" www.brainbench.com website archived May 11, 2000, 2 pages.;;""Brainbench-The Skills Authority: Online Skills Assessment Leader Brainbench Forms Partnership With Leading Quality-Rating Services Provider,"" www.brainbench.com website archived Jun. 6, 2000, 2 pages.;;""Brainbench-The Skills Authority: The Company,"" www.brainbench.com website archived May 11, 2000, 1 page.;;""Brainbench-The Skills Authority: Hear What Our Customers Are Saying . . . ,"" www.brainbench.com website archived May 10, 2000, 6 pages.;;""Brainbench-The Measure of Achievement: Mike Russiello,"" www.brainbench.com website archived May 1, 2003, 2 pages.;;""Brainbench-The Measure of Achievement: Completed Assignment,"" www.brainbench.com website archived May 1, 2003, page.;;""Brainbench-The Skills Authority: Privacy Policy,"" www.brainbench.com website archived May 10, 2000, 2 pages.;;""Brainbench-The Skills Authority: Test Developer,"" www.brainbench.com website archived May 10, 2000, 2 pages.;;""Brainbench-The Skills Authority: Test Alert,"" www.brainbench.com website archived Jun. 21, 2000, 2 pages.;;""Brainbench-The Skills Authority: Online Cert Prep(TM),"" www.brainbench.com website archived Jun. 22, 2000, 2 pages.;;""Brainbench-The Skills Authority: Take the Microsoft Challenge,"" www.brainbench.com website archived Mar. 3, 2000, 2 pages.;;""Brainbench-The Skills Authority: Assessment Center Demonstration,"" www.brainbench.com website archived May 12, 2000, 2 pages.;;""Brainbench-The Skills Authority: Online Public Transcript for Chastity Sterling,"" www.brainbench.com website archived May 11, 2000, 3 pages.;;""Brainbench-The Skills Authority: Global E-Market Company for Skilled Services Team with World's Largest Online Certification Authority,"" www.brainbench.com website press release dated Feb. 1, 2000, 2 pages.;;""Brainbench-The Skills Authority: Brainbench VP to Discuss Rapid Growth of Online Certification Industry,"" www.brainbench.com website press release dated May 2, 2000, 2 pages.;;""Brainbench-The Skills Authority: Microsoft Chooses Brainbench Tests to Prep the Market for Windows 2000,"" www.brainbench.com website press release dated Feb. 17, 2000, 2 pages.;;""Brainbench-The Skills Authority: Brainbench to Develop/ Measure Talent for BTG To Staff Major Department of Education Project,"" www.brainbench.com website press release dated Feb. 11, 2000, 2 pages.;;""Brainbench-The Skills Authority: FedSources, Inc. Teams Up with Brainbench for Online Skills Certification Service,"" www.brainbench.com website press release dated Oct. 22, 1999, 2 pages.;;""Brainbench-The Skills Authority: EDS Targets Training with Brainbench Test!,"" www.brainbench.com website press release dated Mar. 11, 1999, 2 pages.;;""Brainbench-The Skills Authority: Certifications Add Efficiency to the Employment Market,"" www.brainbench.com website white paper dated Jun. 7, 2000, 4 pages.;;""Brainbench-The Measure of Achievement: A Skills-Based Employment Market,"" www.brainbench.com website white paper dated Jan. 24, 2000, 9 pages.;;""Brainbench-The Measurement of Achievement: The Rise of Online Certifications,"" www.brainbench.com website white paper dated Jan. 26, 2000, 8 pages.;;""Brainbench-The Skills Authority: Data Warehousing Specialist Certification,"" www.brainbench.com website archived May 10, 2000, 2 pages.;;""Brainbench-The Measurement of Achievement: Javascript Certification,"" www.brainbench.com website archived Apr. 4, 2001, 3 pages.;;""The Odd Friday Report: 1to1(R) Career Opportunities,"" Peppers and Rogers Group, www.1to1search.com, Feb. 11, 2000, 3 pages.;;""An Applied Look at Reducing Adverse Impact by Differentially Weighting Selection Measures,"" SIOP 2000, 15<SUP>th </SUP>Annual Conference, Hyatt Regency, New Orleans, USA, 3 pages, Apr. 14, 2000.;;""New Approaches to Combining Multiple Assessments for Predicting Criterion Outcomes,"" SIOP 2000, 15<SUP>th </SUP>Annual Conference, Hyatt Regency, New Orleans, USA, 2 pages, Apr. 14, 2000.;;""Predicting Sales Success: An Examination of Alternative Predictors,"" SIOP 2000, 15<SUP>th </SUP>Annual Conference, Hyatt Regency, New Orleans, USA, 2 pages, Apr. 14, 2000.;;""Automated Technologies for Biodata Prediction Systems,"" SIOP 2000, 15<SUP>th </SUP>Annual Conference, Hyatt Regency, New Orleans, USA, 2 pages, Apr. 15, 2000.;;""Applying Neural Networking Techniques to Prediction Problems in I-O Psychology,"" SIOP 2000, 15<SUP>th </SUP>Annual Conference, Hyatt Regency, New Orleans, USA, 2 pages, Apr. 15, 2000.;;""Self-Organizing Maps and Commitment Profiles,"" SIOP 2000, 15<SUP>th </SUP>Annual Conference, Hyatt Regency, New Orleans, USA, 2 pages, Apr. 15, 2000.;;""Industry of Choice,"" Food Service Research Forum, 41 pages, Jan. 1997.;;""Aspen Tree Software: The Total Solution to Employee Recruiting & Selection,"" Aspen Tree Software, Inc., Oct. 27, 1997, 29 pages.;;""CAPS-A Total Solution for Off-Site Screening and Scheduling,"" Demo, Aspen Tree Software, Inc., Apr. 24, 1997, 20 pages.;;""ApView Main Menu,"" Demo, Aspen Tree Software, Inc., Jun. 13, 1997, 30 pages.;;""Interview Guide for Tom Horn,"" Aspen Tree Software, Inc., Jun. 13, 1997, 17 pages.;;Aspen Tree Software video (Length 13:44), Aspen Tree Software, Inc., Mar. 10, 1997, video file ""ATS.avi"" on CD #1.;;Springboard video (Length 9:44), Aspen Tree Software, Inc., Apr. 30, 1998, video file ""Coopers<SUB>-</SUB>Net.avi"" on CD #1.;;""All About ApView"" video (Lenth 17:13), Aspen Tree Software, Inc., Mar. 7, 1997, video file ""TRAINING.avi"" on CD #1.;;Garson, Neural Networks An Introductory Guide for Social Scientists, SAGE Publications, pp. 1-194, 1998.;;""NeuralWorks Professional II/PLUS,"" http://www.neuralware.com/products<SUB>-</SUB>pro2.jsp, pp. 1-3, Jul. 28, 2001.;;""Statistica Neural Networks,"" http://www.statsoft.com/stat<SUB>-</SUB>nn.html, pp. 1-11, Jul. 28, 2001.;;Scarborough, ""Tutorial on the Use of Neural Network Models for Personal Selection,"" Decision Sciences Institute Southwest Region Theory and Applications Proceedings 27<SUP>th </SUP>Annual Conference, pp. 151-153, Mar. 6-9, 1996.;;Marshall et al., ""Neural Network Modeling of Risk Assessment in Child Protective Services,"" Psychological Methods, vol. 5, No. 1, pp. 102-124, 2000.",EXPIRED
573,CA,A1,CA 2417863 A1,153-382-316-456-384,2002-02-14,2002,CA 2417863 A,2001-08-02,US 22328900 P;;US 0124323 W,2000-08-03,ELECTRONIC EMPLOYEE SELECTION SYSTEMS AND METHODS,Published without an,UNICRU INC,MERTZ ADAM N;;SMITH DAVID R;;ENG MAXWELL W;;LEVY JOEL R;;SCARBOROUGH DAVID J;;CLAINOS DEME M;;CHECK THOMAS F;;SMITH JOHN R;;CHAMBLESS BJORN;;PAAJANEN GEORGE E;;BECKER RICHARD W,,https://lens.org/153-382-316-456-384,Patent Application,no,0,3,18,19,0,G06Q10/063;;G06Q10/063118;;G06Q10/0639;;G06Q10/10;;G06Q10/1053;;G06Q30/08;;G09B5/00;;G09B7/00;;G09B7/02;;G06Q10/10;;G06Q10/0639;;G09B7/00;;G06Q10/1053;;G06Q10/063;;G09B5/00;;G06Q10/063118;;G06Q30/08;;G09B7/02,G06E1/00;;G06F17/00;;G06N5/00;;G06Q10/00;;G09B5/00;;G09B7/00;;G09B7/02,,0,0,,,,DISCONTINUED
574,US,A1,US 2012/0078804 A1,064-185-901-407-293,2012-03-29,2012,US 201113243786 A,2011-09-23,US 201113243786 A;;US 96219104 A;;US 92199301 A;;US 92219701 A;;US 22328900 P,2000-08-03,ELECTRONIC EMPLOYEE SELECTION SYSTEMS AND METHODS,"An automated employee selection system can use a variety of techniques to provide information for assisting in selection of employees. For example, pre-hire and post-hire information can be collected electronically and used to build an artificial-intelligence based model. The model can then be used to predict a desired job performance criterion (e.g., tenure, number of accidents, sales level, or the like) for new applicants. A wide variety of features can be supported, such as electronic reporting. Pre-hire information identified as ineffective can be removed from a collected pre-hire information. For example, ineffective questions can be identified and removed from a job application. New items can be added and their effectiveness tested. As a result, a system can exhibit adaptive learning and maintain or increase effectiveness even under changing conditions.",SCARBOROUGH DAVID J;;CHAMBLESS BJORN;;BECKER RICHARD W;;CHECK THOMAS F;;CLAINOS DEME M;;ENG MAXWELL W;;LEVY JOEL R;;MERTZ ADAM N;;PAAJANEN GEORGE E;;SMITH DAVID R;;SMITH JOHN R;;KRONOS TALENT MAN INC,SCARBOROUGH DAVID J;;CHAMBLESS BJORN;;BECKER RICHARD W;;CHECK THOMAS F;;CLAINOS DEME M;;ENG MAXWELL W;;LEVY JOEL R;;MERTZ ADAM N;;PAAJANEN GEORGE E;;SMITH DAVID R;;SMITH JOHN R,KRONOS TALENT MANAGEMENT INC (2001-08-03),https://lens.org/064-185-901-407-293,Patent Application,yes,1,21,1,19,0,G06Q30/08;;G06Q30/08;;G06Q10/1053;;G06Q10/1053,G06Q10/06;;G06E1/00;;G06F17/00;;G06N5/00;;G06Q30/00,705/321,0,0,,,,DISCONTINUED
575,US,B2,US 7562059 B2,132-698-181-548-888,2009-07-14,2009,US 91725204 A,2004-08-11,US 91725204 A;;US 92199301 A;;US 22328900 P,2000-08-03,Development of electronic employee selection systems and methods,"An automated employee selection system can use a variety of techniques to provide information for assisting in selection of employees. For example, pre-hire and post-hire information can be collected electronically and used to build an artificial-intelligence based model. The model can then be used to predict a desired job performance criterion (e.g., tenure, number of accidents, sales level, or the like) for new applicants. A wide variety of features can be supported, such as electronic reporting. Pre-hire information identified as ineffective can be removed from a collected pre-hire information. For example, ineffective questions can be identified and removed from a job application. New items can be added and their effectiveness tested. As a result, a system can exhibit adaptive learning and maintain or increase effectiveness even under changing conditions.",KRONOS TALENT MAN INC,SCARBOROUGH DAVID J;;CHAMBLESS BJORN;;BECKER RICHARD W;;CHECK THOMAS F;;CLAINOS DEME M;;ENG MAXWELL W;;LEVY JOEL R;;MERTZ ADAM N;;PAAJANEN GEORGE E;;SMITH DAVID R;;SMITH JOHN R,KRONOS TALENT MANAGEMENT INC (2006-08-29);;CADIENT LLC (2019-04-05),https://lens.org/132-698-181-548-888,Granted Patent,yes,87,30,18,19,0,G06Q10/063;;G06Q10/063118;;G06Q10/0639;;G06Q10/10;;G06Q10/1053;;G06Q30/08;;G09B5/00;;G09B7/00;;G09B7/02;;G06Q10/10;;G06Q10/0639;;G09B7/00;;G06Q10/1053;;G06Q10/063;;G09B5/00;;G06Q10/063118;;G06Q30/08;;G09B7/02,G06F17/00;;G06E1/00;;G06N5/00;;G06Q10/00;;G09B5/00;;G09B7/00;;G09B7/02,706/21;;706/46;;705/11,106,11,082-727-931-819-121;;116-814-374-807-642;;092-917-039-596-166;;173-292-133-183-834;;051-241-940-403-887;;083-734-666-358-804;;014-173-240-534-719;;048-736-553-740-409;;075-793-976-009-167;;030-892-570-581-308;;124-821-732-772-925,10.1109/dmisp.1993.248616;;10.1109/icnn.1994.374796;;7487861;;10.1002/bs.3830400402;;10.1145/240455.240468;;10.1111/j.1744-6570.1993.tb00882.x;;10.1145/242223.242268;;10.1016/s1366-5545(99)00030-7;;10.1145/299513.299612;;10.1145/219717.219768;;10.1037/1082-989x.5.1.102;;10937325;;10.1037//1082-989x.5.1.102;;10.1145/130069.130075,"Labate et al, ""Employee Skills Analysis Using a Hybrid Neural Network and Expert System"", IEEE International Conference on Developing and Managing Intelligent Systems Projects, 1993.;;Steven Walczak, ""Categorizing University Student Applicants With Neural Networks"", IEEE ICNN, Jun. 27-Jul. 2, 1994.;;Duong et al, ""A System of IAC Neural Networks as the Basis for Self-Organization in a Sociological Dynamical System Simulation"", Behavioral Science, vol. 40, 1995.;;Edward Kirby, Ojoung Kwon, Donna Dufner (""An Analysis of Applying Artificial Neural Networks for Employee Selection"" AMCIS 1998).;;Scott R Kaak, Hubert S Field, William F Giles, Dwight R Norris (""The weighted Application Blank"" Cornel Hotel and Restaurant Administration Quarterly, Apr. 1998).;;Decision Point Data, Inc (""1999 StoreWorks! Conference and Exhibition"" May 1999).;;Ukwendu (""effects of satisfaction with performance evaluation systems on employee turnover"" 1998).;;U.S. Appl. No. 60/211,044, filed Jun. 12, 2000, Dewar.;;""A Hybrid GA-Heuristic Search Strategy,"" http://www.attar.com/pages/dev-gap.htm, pp. 1-6, Mar. 23, 2001.;;""An Applied Look at Reducing Adverse Impact by Differentially Weighting Selection Measures,"" SIOP 2000, 15th Annual Conference, Hyatt Regency, New Orleans, USA, 3 pages, Apr. 14, 2000.;;""Applied Neural Networking Techniques to Prediction Problems in I-O Psychology,"" SIOP 2000, 15th Annual Conference, Hyatt Regency, New Orleans, USA, 2 pages, Apr. 15, 2000.;;""Automated Technologies for Biodata Prediction Systems,"" SIOP 2000, 15th Annual Conference, Hyatt Regency, New Orleans, USA, 2 pages, Apr. 15, 2000.;;""Industry of Choice,"" Food Service Research Forum, 41 pages, Jan. 1997.;;""NeuralWorks Professional II/PLUS,"" http://www.neuralware.com/products-pro2.jsp, pp. 1-3, Jul. 28, 2001.;;""New Approaches to Combining Multiple Assessments for Predicting Criterion Outcomes,"" SIOP 2000, 15th Annual Conference, Hyatt Regency, New Orleans, USA, 2 pages, Apr. 14, 2000.;;""Predicting Sales Success: An Examination of Alternative Predictors,"" SIOP 2000, 15th Annual Conference, Hyatt Regency, New Orleans, USA, 2 pages, Apr. 14, 2000.;;""SaffronOne's Unique Product Features,"" http://www.saffrontech.com/pages/products/features.html, pp. 1-2, Mar. 22, 2001.;;""Self-Organizing Maps and Commitment Profiles,"" SIOP 2000, 15th Annual Conference, Hyatt Regency, New Orleans, USA, 2 pages, Apr. 15, 2000.;;""Statistica Neural Networks,"" http://www.statsoft.com/stat-nn.html, pp. 1-11, Jul. 28, 2001.;;""The Wide Scale Deployment of Active Data Mining Solutions,"" http://www.attar.com/tutor/deploy.htm, pp. 1-7, Mar. 23, 2001.;;""XpertRule(R) Miner, The Complete Data Mining Solution,"" http://www.attar.com/pages/info-xm/htm., pp. 1-5, Mar. 23, 2001.;;Aggarwal et al., ""Selection of Surgical Residents: A Neural Network Approach,"" Cybernetics and Systems: An International Journal, vol. 31, pp. 417-430, 2000.;;Brachman et al., ""Mining Business Databases,"" Communications of the ACM, vol. 39, No. 11, pp. 42-48, Nov. 1996.;;Callaghan, ""Personalization on the Fly- SaffronOne, FrontMind Tap Advanced Technologies to Predict User Behavior, Make Recommendations,"" eWeek, p. 52, Oct. 23, 2000.;;Collins et al., ""An Application of the Theory of Neural Computation to the Prediction of Workplace Behavior: An Illustration and Assessment of Network Analysis,"" Personnel Psychology, vol. 46, pp. 503-524, 1993.;;Doyle et al., ""Strategic Directions in Artificial Intelligence,"" ACM Computing Surveys, vol. 28, No. 4, pp. 653-670, Dec. 1996.;;Garson, Neural Networks An Introductory Guide for Social Scientists, SAGE Publications, pp. 1-194, 1998.;;Guion, ""Personnel Assessment, Selection, and Placement,"" Handbook of Industrial and Organizational Psychology, Consulting Psychologists Press, Inc., pp. 327-397, 1991.;;Hapgood, ""Embedded Logic,"" http://www2.cio.com/archive/050100-revisit-content.html, pp. 1-3, Mar. 23, 2001.;;Hensher et al., ""A Comparison of the Predictive Potential of Artificial Neural Networks and Nested Logit Models for Commuter Mode Choice,"" Transportation Research Part E: Logistic and Transportation Review, vol. 36, No. 3, pp. 155-172 (abstract only), Sep. 2000.;;Herschel et al., ""CKOS and Knowledge Management: Exploring Opportunities for Using Information Exchange Protocols,"" ACM, pp. 42-50, 1999.;;Jordan et al., ""Neural Networks,"" The Computer Science and Engineering Handbook, Tucker (ed.), pp. 536-556, 1996.;;Kahney, ""KnowledgeMiner 2 Digs Out More Info,"" MacWEEK, vol. 11, No. 40, pp. 23-24, Oct. 20, 1997.;;Langley et al., ""Applications of Machine Learning and Rule Induction,"" Communications of the ACM, vol. 38, No. 11, pp. 55-64, Nov. 1995.;;Marshall et al., ""Neural Network Modeling of Risk Assessment in Child Protective Services,"" Psychological Methods, vol. 5, No. 1, pp. 102-124, 2000.;;McLeod et al., ""Predicting Credit Risk: A Neural Network Approach,"" Journal of Retail Banking, vol. 15, No. 3, pp. 37-40, Fall 1993.;;Mengel et al., ""Using a Neural Network to Predict Student Responses,"" ACM, pp. 669-676, 1992.;;Mitchell, ""How to Reduce the High Cost of Turnover,"" Lawson Software, pp.1-11, Jul. 12, 2001, or before.;;Page et al., ""Panel: Strategic Directions in Simulation Research,"" Proceedings of the 1999 Winter Simulation Conference, pp. 1509-1520, 1999.;;Pentland et al., ""Modeling and Prediction of Human Behavior,"" M.I.T. Media Lab Perceptual Computing Technical Report, No. 433, pp. 1-7, 1999.;;Rosen, ""Mining Database Treasures,"" Computing Canada, vol. 22, No. 20, pp. 42-43, Sep. 26, 1996.;;Scarborough, ""An Evaluation of Backpropagation Neural Network Modeling as an Alternative Methodology for Criterion Validation of Employee Selection Testing,"" Doctoral Dissertation (UMI Dissertation Services), University of North Texas, 1995.;;Scarborough, ""Tutorial on the Use of Neural Network Models for Personnel Selection,"" Decision Sciences Institute Southwest Region Theory and Applications Proceedings 27th Annual Conference , pp. 151-153, Mar. 6-9, 1996.;;""1999 StoreWorks! Conference and Exhibition,"" Decision Point Data, Inc. (predecessor company of Unicru, Inc.), 13 pages, May 1999.;;""A Technology Case Study for Human Resource Executive,"" Getting the High-Tech Hiring Edge, 2 pages, www.workindex.com/editorial/staff/sta0301.01.asp, Jan. 2003.;;""Aspen Tree Software helps lessen resume overload,"" PC Week, vol. 14, No. 36, p. 84, ZDNet, Aug. 25, 1997.;;""Assess v.2: Technical Manual,"" Bigby Havis & Associates, Inc., 106 pages, Dec. 2003, describing products from 1970-2003.;;""Assess v2-for Selection and Development,"" Bigby Havis & Associates, Inc., 5 pages, http://www.bigby.com/systesms/assessv2/System/main.asp, printed Aug. 5, 2005, showing applicants from 1998.;;""Before You Begin: Welcome to SSA Online Help,"" http://web.archive.org/web/19980118183643/http://www.coopersclub.com/inethlp2.Htm, 6 pages, 1998.;;""Companies: Registration,"" www.epredix.com, 8 pages, archived Jun. 2000.;;""Configuring Your Hardware and Browser,"" Virtual Learning Technologies, http://web.archive.org/web/19980524111629/http://www.proveit.com/browser.html, 2 pages, 1998.;;""Customer Service and Clerical Potential Index(TM),"" candidate test, ePredix, Inc., 17 pages, Copyright 2001.;;""Customer Service and Clerical Potential Index(TM),"" technical manual, ePredix, Inc., 91 pages, Copyright 2001.;;""Example Campus Manager Process,"" Bigby Havis & Associates, Inc., 3 pages, Mar. 18, 1999.;;""Get eCertified as a Java Programmer,"" http://www.tekmetrics.com, 1 page, Nov. 16, 2000.;;""Getting Started: 1-2-3Assess,"" TekMetrics, Inc., www.tekmetrics.com, 3 pages, 1998.;;""Guide to Using Assess Internet,"" Bigby Havis & Associates, Inc., 13 pages, Mar. 1999.;;""Interactive Interview Category Analysis Report,"" DPD Applicant Report, Decision Point Data, Inc. (predecessor company of Unicru, Inc.), 1 page, Apr. 1998.;;""Internet chats on line to replace paper CVS,"" UK: Launch of an Internet CV Package, Retail Week, p. 23 (1 page), Mar. 13, 1998.;;""Invoice, Assess for Internet Units,"" Bigby Havis & Associates, Inc., 1 page, Feb. 16, 1999.;;""Know It All-Staffing Professionals,"" Know It All, Inc., http://web.archive.org/web/19991009154935/www.knowitallinc.com/staffing.html, 1 page, 1999.;;""Know It All-Technical Recruiters,"" Know It All, Inc., http://web.archive.org/web/19981206160646/www.knowitallinc.com/recruiter.html, 1 page, 1998.;;""Know It All-Training Directors,"" Know It All, Inc., http://web.archive.org/web/19991009192333/www.knowitallinc.com/training.html, 1 page, 1999.;;""Know It All, Inc.: About Us,"" Know It All, Inc., http://web.archive.org/web/19991109161725/www.knowitallinc.com/about.html, 1 page, 1999.;;""Know It All, Inc.: Features and Benefits,"" Know It All, Inc., http://web.archive.org/web/19991110092810/www.knowitallinc.com/software.html, 2 pages, 1999.;;""Management Information Packet for Customer Service and Sales Selection,"" Criterion International, Inc., 33 pages, May 12, 2000.;;""More Firms Recruit Via the Internet,"" Boston Globe, 2 pages, Nov. 18, 1997.;;""Process Complete: Assessment Results,"" TekMetrics, Inc., http://www.pvv.org/~kentda/cv/filer/ProgrammerAptitudeTest.html, 3 pages, 1999.;;""Proposal to: [Customer Name Redacted]: for Selection System Development-Production and Operations Job Families,"" Proposal #P0317R00, Development Dimensions International, Inc., 27 pages, Submitted Sep. 30, 1998.;;""Proposal to: Client Name: Web-Screen Proposal,"" Development Dimensions International, Inc., 19 pages, 1999.;;""Prove It! Demonstration Test: Welcome to Prove It!,"" Virtual Learning Technologies, http://web.archive.org/web/19990508182217/www.proveit.com/demo.shtml, 6 pages, 1999.;;""Prove It! Features and Benefits,"" Know It All, Inc., http://web.archive.org/web/19991009032643/www.knowitallinc.com/features.html, 2 pages, 1999.;;""Prove It! Features and Benefits: Internet and Intranet Solutions,"" Know It All, Inc., http://web.archive.org/web/19991110011034/www.knowitallinc.com/network.html, 2 pages, 1999.;;""Prove It! Results Page,"" Know It All, Inc., http://web.archive.org/web/19991009121500/www.knowitallinc.com/results.html, 2 pages, 1999.;;""Prove It!,"" Virtual Learning Technologies, http://web.archive.org/web/19980524111918/http://www.proveit.com/index.html, 2 pages, 1998.;;""proveit.com Features and Advantages,"" Virtual Learning Technologies, http://web.archive.org/web/19990508184214/www.proveit.com/features.html, 1 page, 1998.;;""Psychology Technology Design: Solutions for Selection and Development,"" SHRM Conference flyer, Bigby Havis & Associates, Inc., 2 pages, Jun. 1998.;;""QWIZ-The Standard for Testing and Training,"" QWIZ, Inc., http://web.archive.org/web/19990218064159/www.qwiz.com/main.htm, 1 page, 1999.;;""QWIZtek Remote Demo,"" http://web.archive.org/web/19981205104155/208.147.160.198/welcome.asp , 2 pages, 1998.;;""QWIZtek(TM) Technical Skills Testing Software,"" http://web.archive.org/web/19981205232749/www.qwiz.com/qwiz-tek.cfm, 2 pages, 1998.;;""Spherion, ExxonMobil expand employee-screening agreement,"" Industry News, 2 pages, www.petroretail.net/npn/2001/0201/0201msin.asp, Feb. 2001.;;""TechTests Product Line,"" Virtual Learning Technologies, http://web.archive.org/web/19980524111739/http://www.proveit.com/products.html, 3 pages, 1998.;;""TeckChek-IT Skills Testing-Logistics and Scoring,"" Bookman Testing Services, Inc., http://web.archive.org/web/20000823160658/www.teckchek.com/services/logistics.html, 1 page, 2000.;;""TeckChek Apr. 1999 Newsletter,"" Bookman Testing Services, Inc., http://web.archive.org/web/19991022004537/www.teckchek.com/home/newsletter0499.html, 3 pages, Apr. 1999.;;""TekMetrics E-Certifications(TM) Offered On www.CareerBuilder.com,"" PR Newswire, p. 9882 (2 pages), Mar. 22, 1999.;;""The Assess System: An Assessment Tool for Consulting to Business,"" Professional Users Training Conference brochure, 2 pages, Jul. 22-24, 1999 and Oct. 7-9, 1999.;;""The Candidate Profile Record,"" brochure, Richardson, Bellows, Henry & Co., Inc., 21 pages, Copyright 1982, 1983, 1989.;;""The Candidate Profile Record,"" Richardson, Bellows, Henry & Co., Inc., 95 pages, at least as early as 1995.;;""The Manager Profile Record,"" Richardson, Bellows, Henry & Co., Inc., 48 pages, at least as early as 1992.;;""The Supervisory Profile Record,"" technical report, Richardson, Bellows, Henry & Co., Inc., 192 pages, at least as early as 1992.;;""Unicru-History,"" http://www.unicru.com/about/history.aspx, 3 pages, website visited on Sep. 23, 2005, 3 pages, recounting events from 1987-2005.;;""Welcome to C&L Springboard: Welcome to SSA Online,"" http://web.archive.org/web/19980118183630/www.coopersclub.com/Screen1.htm, 2 pages, 1998.;;""What's New at TeckChek in IT Adaptive Test Assessment,"" Bookman Testing Services, Inc., http://web.archive.org/web/19990422225528/www.teckchek.com/home/whatsnew.html, 1 page, 1999.;;""123Assess Demonstration,"" www.tekmetrics.com website archived Jan. 28, 1999, 2 pages.;;""123Assess(TM)-Qualify Applicants in 10 Minutes!"" TekMetrics, 1998, 1 page.;;""All About ApView"" video (Length 17:13), Aspen Tree Software, Inc., Mar. 7, 1997, video file ""TRAINING.avi"" on CD #1.;;""Are you ready to: Are you Ready!,"" www.brainbench.com website archived Mar. 2, 2000, 1 page.;;""Aspen Tree Software: The Total Solution to Employee Recruiting & Selection,"" Aspen Tree Software, Inc., Oct. 27, 1997, 29 pages.;;""Assess Expert System/Bigby, Havis & Associates, Inc.,"" page archived from www.bigby.com website, 2 pages, May 7, 1999.;;""assesspreview: Assess User Site Instructions,"" page archived from www.bigby.com website, 1 page, Oct. 12, 2000.;;""assesspreview: History of Assess,"" page archived from www.bigby.com website, 1 page, Oct. 11, 1999.;;""assesspreview: Welcome to the Assess Internet Online Preview,"" page archived from www.bigby.com website, 1 page, May 8, 1999.;;""assesspreview: What is Assess?,"" page archived from www.bigby.com website, 1 page, Oct. 11, 1999.;;""Brainbench-The Measure of Achievement: A Skills-Based Employment Market,"" www.brainbench.com website white paper dated Jan. 24, 2000, 9 pages.;;""Brainbench-The Measure of Achievement: Completed Assessment,"" www.brainbench.com website archived May 1, 2003, page.;;""Brainbench-The Measure of Achievement: Javascript Certification,"" www.brainbench.com website archived Apr. 4, 2001, 3 pages.",EXPIRED
576,US,B2,US 8046251 B2,095-790-585-374-708,2011-10-25,2011,US 96219104 A,2004-10-08,US 96219104 A;;US 92199301 A;;US 92219701 A;;US 22328900 P,2000-08-03,Electronic employee selection systems and methods,"An automated employee selection system can use a variety of techniques to provide information for assisting in selection of employees. For example, pre-hire and post-hire information can be collected electronically and used to build an artificial-intelligence based model. The model can then be used to predict a desired job performance criterion (e.g., tenure, number of accidents, sales level, or the like) for new applicants. A wide variety of features can be supported, such as electronic reporting. Pre-hire information identified as ineffective can be removed from a collected pre-hire information. For example, ineffective questions can be identified and removed from a job application. New items can be added and their effectiveness tested. As a result, a system can exhibit adaptive learning and maintain or increase effectiveness even under changing conditions.",KRONOS TALENT MAN INC,SCARBOROUGH DAVID J;;CHAMBLESS BJORN;;BECKER RICHARD W;;CHECK THOMAS F;;CLAINOS DEME M;;ENG MAXWELL W;;LEVY JOEL R;;MERTZ ADAM N;;PAAJANEN GEORGE E;;SMITH DAVID R;;SMITH JOHN R,KRONOS TALENT MANAGEMENT INC (2001-08-03);;CADIENT LLC (2019-04-05),https://lens.org/095-790-585-374-708,Granted Patent,yes,96,26,18,19,0,G06Q10/063;;G06Q10/063118;;G06Q10/0639;;G06Q10/10;;G06Q10/1053;;G06Q30/08;;G09B5/00;;G09B7/00;;G09B7/02;;G06Q10/10;;G06Q10/0639;;G09B7/00;;G06Q10/1053;;G06Q10/063;;G09B5/00;;G06Q10/063118;;G06Q30/08;;G09B7/02,G06E1/00;;G06F17/00;;G06N5/00;;G06Q10/00;;G09B5/00;;G09B7/00;;G09B7/02,705/7.17;;705/321;;706/21,105,3,035-581-170-138-052;;082-827-864-115-463;;015-522-231-004-037,10.1109/annes.1993.323046;;10361841;;10.1037//0021-9010.84.2.177;;10.1037/0021-9010.84.2.177;;10.1109/3477.662769;;18255946,"Ukwendu, Michael Okey Egbosiuba. ""Effects of satisfaction with performance evaluation systems on employee turnover"". Nova Southeastern University, 1998 from Proquest.;;Kaatz, James Bryan. ""City manager tenure stability: A predictive model based on perceived council conflict, leadership effectiveness, and conflict resolution ability"". Northern Illinois University, 1996. from Proquest.;;Bartholomew, D. J. Note on the Measurement and Predication of Labour Turnover. University College of North Staffordshire. www.jstor.org.;;Martin, Scott L. and Boye, Michael W. Using a Conceptually-based Predictor of Tenure to Select Employees. Journal of Business and Psychology, vol. 13, No. 2, Winter 1998.;;Hart, Ann Yeager. Predicting the tenure outcome of teachers based on variables known at the time of application. North Carolina State University, 1997, 84 pages. (proquest).;;Stone, William Steve. Principal Selection: An application of neural network forecasting. North Carolina State University, 1993, 122 pages. (proquest).;;Kemp, ""Knowledge-based Simulation for Teaching,"" Proceedings of the 1st New Zealand International Stream Conference on Artificial Neural Networks and Expert Systems; pp. 192-195, Nov. 1993.;;Kirby et al., ""An Analysis of Applying Artificial Neural Networks for Employee Selection,"" Americas Conference on Information Systems, 4 pages, 1998.;;Somers, M.J., ""Application of two neural network paradigms to the study of voluntary employee turnover"" Journal of Applied Psychology, 84, 177-185 (1999).;;Walczak, ""Neural Network Models for a Resource Allocation Problem,"" IEEE Transactions on Systems, Man, and Cybernetics-Part B: Cybernetics, vol. 28, No. 2, pp. 276-284, Apr. 1998.;;U.S. Appl. No. 60/211,044, filed Jun. 12, 2000, Dewar.;;""123Assess Demonstration,"" www.tekmetrics.com website archived Jan. 28, 1999, 2 pages.;;""123Assess(TM)-Qualify Applicants in 10 Minutes!"" TekMetrics, 1998, 1 page.;;""1999 StoreWorks! Conference and Exhibition,"" Decision Point Data, Inc. (predecessor company of Unicru, Inc.), 13 pages, May 1999.;;""A Technology Case Study for Human Resource Executive,"" Getting the High-Tech Hiring Edge, 2 pages, www.workindex.com/editorial/staff/sta0301.01.asp, Jan. 2003.;;""An Applied Look at Reducing Adverse Impact by Differentially Weighting Selection Measures,"" SIOP 2000, 15th Annual Conference, Hyatt Regency, New Orleans, USA, 3 pages, Apr. 14, 2000.;;""Applying Neural Networking Techniques to Prediction Problems in I-O Psychology,"" SIOP 2000, 15th Annual Conference, Hyatt Regency, New Orleans, USA, 2 pages, Apr. 15, 2000.;;""ApView Main Menu,"" Demo, Aspen Tree Software, Inc., Jun. 13, 1997, 30 pages.;;""Are you ready to: Are you Ready?,"" www.brainbench.com website archived Mar. 2, 2000, 1 page.;;""Aspen Tree Software helps lessen resume overload,"" PC Week, vol. 14, No. 36, p. 84, ZDNet, Aug. 25, 1997.;;""Aspen Tree Software: The Total Solution to Employee Recruiting & Selection,"" Aspen Tree Software, Inc., Oct. 27, 1997, 29 pages.;;""ASSESS Expert System/Bigby, Havis & Associates, Inc.,"" page archived from www.bigby.com website, 2 pages, May 7, 1999.;;""Assess v.2: Technical Manual,"" Bigby Havis & Associates, Inc., 106 pages, Dec. 2003, describing products from 1970-2003.;;""Assess v2-for Selection and Development,"" Bigby Havis & Associates, Inc., 5 pages, http://www.bigby.com/systesms/assessv2/System/main.asp, printed Aug. 5, 2005, showing applicants from 1998.;;""assesspreview: ASSESS User Site Instructions,"" page archived from www.bigby.com website, 1 page, Oct. 12, 2000.;;""assesspreview: History of ASSESS,"" page archived from www.bigby.com website, 1 page, Oct. 11, 1999.;;""assesspreview: Welcome to the ASSESS Internet Online Preview,"" page archived from www.bigby.com website, 1 page, May 8, 1999.;;""assesspreview: What is ASSESS?,"" page archived from www.bigby.com website, 1 page, Oct. 11, 1999.;;""Automated Technologies for Biodata Prediction Systems,"" SIOP 2000, 15th Annual Conference, Hyatt Regency, New Orleans, USA, 2 pages, Apr. 15, 2000.;;""Before You Begin: Welcome to SSA Online Help,"" http://web.archive.org/web/19980118183643/http://www.coopersclub.com/inethlp2.Htm, 6 pages, 1998.;;""Brainbench-The Measure of Achievement: A Skills-Based Employment Market,"" www.brainbench.com website white paper dated Jan. 24, 2000, 9 pages.;;""Brainbench-The Measure of Achievement: Completed Assessment,"" www.brainbench.com website archived May 1, 2003, 1 page.;;""Brainbench-The Measure of Achievement: Javascript Certification,"" www.brainbench.com website archived Apr. 4, 2001, 3 pages.;;""Brainbench-The Measure of Achievement: Mike Russiello,"" www.brainbench.com website archived May 1, 2003, 2 pages.;;""Brainbench-The Measure of Achievement: The Rise of Online Certifications,"" www.brainbench.com website white paper dated Jan. 26, 2000, 8 pages.;;""Brainbench-The Skills Authority: About Our Assessments,"" www.brainbench.com website archived May 10, 2000, 2 pages.;;""Brainbench-The Skills Authority: Account Registration,"" www.brainbench.com website archived May 11, 2000, 2 pages.;;""Brainbench-The Skills Authority: Assessment Center Demonstration,"" www.brainbench.com website archived May 12, 2000, 2 pages.;;""Brainbench-The Skills Authority: Brainbench Certifications(TM),"" www.brainbench.com website archived May 24, 2000, 2 pages.;;""Brainbench-The Skills Authority: Brainbench to Develop/Measure Talent for BTG to Staff Major Department of Education Project,"" www.brainbench.com website press release dated Feb. 11, 2000, 2 pages.;;""Brainbench-The Skills Authority: Brainbench VP to Discuss Rapid Growth of Online Certification Industry,"" www.brainbench.com website press release dated May 2, 2000, 2 pages.;;""Brainbench-The Skills Authority: Certifications Add Efficiency to the Employment Market,"" www.brainbench.com website white paper dated Jun. 7, 2000, 4 pages.;;""Brainbench-The Skills Authority: Data Warehousing Specialist Certification,"" www.brainbench.com website archived May 10, 2000, 2 pages.;;""Brainbench-The Skills Authority: Dear Affiliate,"" www.brainbench.com website archived May 11, 2000, 3 pages.;;""Brainbench-The Skills Authority: EDS Targets Training with Brainbench Test!,"" www.brainbench.com website press release dated Mar. 11, 1999, 2 pages.;;""Brainbench-The Skills Authority: FedSources, Inc. Teams Up with Brainbench for Online Skills Certification Service,"" www.brainbench.com website press release dated Oct. 22, 1999, 2 pages.;;""Brainbench-The Skills Authority: Frequently Asked Questions about Brainbench Certifications(TM),"" www.brainbench.com website archived May 10, 2000, 5 pages.;;""Brainbench -The Skills Authority: Global E-Market Company for Skilled Services Team with World's Largest Online Certification Authority,"" www.brainbench.com website press release dated Feb. 1, 2000, 2 pages.;;""Brainbench-The Skills Authority: Hear What Our Customers Are Saying . . . ,"" www.brainbench.com website archived May 10, 2000, 6 pages.;;""Brainbench-The Skills Authority: Looking for Qualified candidates?,"" www.brainbench.com website archived May 10, 2000, 1 page.;;""Brainbench-The Skills Authority: Microsoft Chooses Brainbench Tests to Prep the Market for Windows 2000,"" www.brainbench.com website press release dated Feb. 17, 2000, 2 pages.;;""Brainbench-The Skills Authority: Online Cert Prep(TM),"" www.brainbench.com website archived Jun. 22, 2000, 2 pages.;;""Brainbench-The Skills Authority: Online Public Transcript for Chastity Sterling,"" www.brainbench.com website archived May 11, 2000, 3 pages.;;""Brainbench-The Skills Authority: Online Skills Assessment Leader Brainbench Forms Partnership With Leading Quality-Rating Services Provider,"" www.brainbench.com website archived Jun. 6, 2000, 2 pages.;;""Brainbench-The Skills Authority: Pricing,"" www.brainbench.com website archived May 10, 2000, 2 pages.;;""Brainbench-The Skills Authority: Privacy Policy,"" www.brainbench.com website archived May 10, 2000, 2 pages.;;""Brainbench-The Skills Authority: Sample Certificate,"" www.brainbench.com website archived May 11, 2000, 2 pages.;;""Brainbench-The Skills Authority: See Where You Stand,"" www.brainbench.com website archived Apr. 19, 2000, 1 page.;;""Brainbench-The Skills Authority: Take the Microsoft Challenge,"" www.brainbench.com website archived Mar. 3, 2000, 2 pages.;;""Brainbench-The Skills Authority: Test Alert,"" www.brainbench.com website archived Jun. 21, 2000, 2 pages.;;""Brainbench-The Skills Authority: Test Developer,"" www.brainbench.com website archived May 10, 2000, 2 pages.;;""Brainbench-The Skills Authority: The Company,"" www.brainbench.com website archived May 11, 2000, 1 page.;;""Brainbench-The Skills Authority: Top Ten Scores List,"" www.brainbench.com website archived May 11, 2000, 1 page.;;""Brainbench-The Skills Authority: Welcome to Brainbench,"" www.brainbench.com website archived May 11, 2000, 2 pages.;;""CAPS-A Total Solution for Off-Site Screening and Scheduling,"" Demo, Aspen Tree Software, Inc., Apr. 24, 1997, 20 pages.;;""Catalog,"" www.tekmetrics.com website archived Dec. 6, 1998, 3 pages.;;""Companies: Registration,"" www.epredix.com, 8 pages, archived Jun. 2000.;;""Configuring Your Hardware and Browser,"" Virtual Learning Technologies, http://web.archive.org/web/19980524111629/http://www.proveit.com/browser.html, 2 pages, 1998.;;""Custom Job Center,"" DecisionPoint Systems Hirelink Network advertisement, 2 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""Customer Service and Clerical Potential Index(TM),"" candidate test, ePredix, Inc., 17 pages, Copyright 2001.;;""Customer Service and Clerical Potential Index(TM),"" technical manual, ePredix, Inc., 91 pages, Copyright 2001.;;""DDI Launches Tech Spin-Off Targeting Small to Mid-Size Businesses,"" AdvantageHiring.com, http://www.advantagehiring.com/about/pr-DDIspinoff.asp, 2 pages, Sep. 17, 1999.;;""DecisionPoint Systems-Hiring Technology That Gives You a Competitive Advantage,"" DecisionPoint Systems HirePro(TM) advertisement, 2 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""DecisionPoint Systems-Imagine Being Able to Incorporate Your Company's Job Application, Skills Test, Background Checks and Tax Credit Paperwork Into One Simple Process."" DecisionPoint Systems advertisement, 4 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""Example Campus Manager Process,"" Bigby Havis & Associates, Inc., 3 pages, Mar. 18, 1999.;;""Facts About DDI: Who We Are, What We Do,"" Development Dimensions International, Inc., http://www.ddiworld.com/about/pr-facts.asp, 3 pages, website visited on Nov. 2, 2004.;;""Get eCertified as a Java Programmer,"" http://www.tekmetrics.com, 1 page, Nov. 16, 2000.;;""Getting Started: 1-2-3Assess,"" TekMetrics, Inc., www.tekmetrics.com, 3 pages, 1998.;;""Guide to Using Assess Internet,"" Bigby Havis & Associates, Inc., 13 pages, Mar. 1999.;;""Highlights, the Bigby, Havis Newsletter: How Our Clients Use ASSESS,"" page archived from www.bigby.com website, 1 page, Oct. 8, 1999.;;""HirePro.com-The Technology to Select the Ideal Employee Is Now Online,"" DecisionPoint Systems HirePro.com advertisement, 2 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""HirePro(TM)-Automated Hiring System,"" DecisionPoint Systems HirePro(TM) advertisement, 2 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""HirePro(TM) Assessments-Application Assessment Tests for HirePro(TM),"" DecisionPoint Systems Assessment Series advertisement, 2 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""HirePro(TM),"" DecisionPoint Systems HirePro(TM) advertisement, 1 page, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""HirePro(TM),"" Retail Direct Mail Piece, 6 pages, provided to potential customers by Decision Point Systems (predecessor company of Unicru, Inc.), before Jan. 2000.;;""How Do You Stack Up Next to Training's New Guard?"" http://web.archive.org/web/19991012021341/ddiworld.com/newguard/index .htm, Development Dimensions International, Inc., 4 pages, website archived Oct. 12, 1999.;;""Industry of Choice,"" Food Service Research Forum, 46 pages, Jan. 1997.;;""Interactive Interview Category Analysis Report,"" DPD Applicant Report, Decision Point Data, Inc. (predecessor company of Unicru, Inc.), 1 page, Apr. 1998.;;""Internet chats on line to replace paper CVS,"" UK: Launch of an Internet CV Package, Retail Week, p. 23 (1 page), Mar. 13, 1998.;;""Interview Guide for Tom Horn,"" Aspen Tree Software, Inc., Jun. 13, 1997, 17 pages.;;""Invoice, Assess for Internet Units,"" Bigby Havis & Associates, Inc., 1 page, Feb. 16, 1999.;;""Know It All-Staffing Professionals,"" Know It All, Inc., http://web.archive.org/web/19991009154935/www.knowitallinc.com/staffing.html, 1 page, 1999.;;""Know It All-Technical Recruiters,"" Know It All, Inc., http://web.archive.org/web/19981206160646/www.knowitallinc.com/recruiter.html, 1 page, 1998.;;""Know It All-Training Directors,"" Know It All, Inc., http://web.archive.org/web/19991009192333/www.knowitallinc.com/training.html, 1 page, 1999.;;""Know It All, Inc.: About Us,"" Know It All, Inc., http://web.archive.org/web/19991109161725/www.knowitallinc.com/about.html, 1 page, 1999.;;""Know It All, Inc.: Features and Benefits,"" Know It All, Inc., http://web.archive.org/web/19991110092810/www.knowitallinc.com/software.html, 2 pages, 1999.;;""Management Information Packet for Customer Service and Sales Selection,"" Criterion International, Inc., 33 pages, May 12, 2000.;;""More Firms Recruit Via the Internet,"" Boston Globe, 2 pages, Nov. 18, 1997.;;""NeuralWorks Professional II/PLUS,"" http://www.neuralware.com/products-pro2.jsp, pp. 1-3, Jul. 28, 2001.;;""New Approaches to Combining Multiple Assessments for Predicting Criterion Outcomes,"" SIOP 2000, 15th Annual Conference, Hyatt Regency, New Orleans, USA, 2 pages, Apr. 14, 2000.;;""Nov. 18, 1997: More Firms Recruit Via the Internet,"" The Boston Globe, 2 pages, Nov. 14, 1997.;;""Online Recruiting Strategist,"" Hunt-Scanlon.com, http://www.hunt-scanlon.com/newsarchives/orsarchives/2000/jan.htm, 8 pages, Jan. 2000.;;""PR Newswire: TekMetrics Help EDS Select Top Sales Talent Online,"" 3 pages, http://www.google.com/search?hl=en&q=cache%3Awww.findarticles.com%2Fcf-dls%2Fm4PRN%2F1999-April-29%2F54502514%2Fpl%2Farticle.jhtml PR Newswire, Apr. 29, 1999.;;""Predicting Sales Success: An Examination of Alternative Predictors,"" SIOP 2000, 15th Annual Conference, Hyatt Regency, New Orleans, USA, 2 pages, Apr. 14, 2000.;;""Process Complete: Assessment Results,"" TekMetrics, Inc., http://www.pvv.org/~kentda/cv/filer/ProgrammerAptitudeTest.html, 3 pages, 1999.",EXPIRED
577,AU,A,AU 2001/081017 A,129-334-555-928-610,2002-02-18,2002,AU 2001/081017 A,2001-08-02,US 22328900 P;;US 0124323 W,2000-08-03,Electronic employee selection systems and methods,,UNICRU INC,SCARBOROUGH DAVID J;;BECKER RICHARD W;;CHAMBLESS BJORN;;CHECK THOMAS F;;CLAINOS DEME M;;ENG MAXWELL W;;LEVY JOEL R;;MERTZ ADAM N;;SMITH DAVID R;;SMITH JOHN R;;PAAJANEN GEORGE E,,https://lens.org/129-334-555-928-610,Patent Application,no,0,0,18,19,0,G06Q10/063;;G06Q10/063118;;G06Q10/0639;;G06Q10/10;;G06Q10/1053;;G06Q30/08;;G09B5/00;;G09B7/00;;G09B7/02;;G06Q10/10;;G06Q10/0639;;G09B7/00;;G06Q10/1053;;G06Q10/063;;G09B5/00;;G06Q10/063118;;G06Q30/08;;G09B7/02,G06E1/00;;G06F17/00;;G06N5/00;;G06Q10/00;;G09B5/00;;G09B7/00;;G09B7/02,,0,0,,,,PENDING
578,BR,A2,BR PI0715872 A2,170-923-208-811-508,2014-08-26,2014,BR PI0715872 A,2007-08-23,US 83956806 P;;US 2007/0076661 W,2006-08-23,COMPOSTO; COMPOSIÇÃO FARMACÊUTICA; MÉTODO DE PREPARAÇÃO DO COMPOSTO; COMPOSTO PREPARADO PELO MÉTODO; E MÉTODO DE TRATAMENTO DE UM TRANSTORNO EM UM MAMÍFERO NECESSITADO,,WYETH CORP,BURSAVICH MATTHEW G;;LOMBARDI SABRINA;;GILBERT ADAM M;;LAAKSO LEIF MARK;;KHAFIZOVA GULNAZ;;HOW DAVID BRIAN;;SABATINI JOSHUA JAMES;;SUM PHAIK-ENG;;CLEMENS JEREMY J,,https://lens.org/170-923-208-811-508,Patent Application,no,0,0,10,10,0,C07D215/26;;C07D215/28;;C07D401/06;;C07D401/12;;C07D405/06;;C07D409/10;;C07D417/10;;A61P9/10;;C07D215/28;;C07D401/06;;C07D405/06;;C07D417/10;;C07D215/26;;C07D409/10;;C07D401/12,A61K31/47;;C07D215/16,,0,0,,,,DISCONTINUED
579,WO,A2,WO 2008/024922 A2,017-171-941-021-393,2008-02-28,2008,US 2007/0076661 W,2007-08-23,US 83956806 P,2006-08-23,8-HYDROXYQUINOLINE COMPOUNDS AND METHODS THEREOF,"The present invention relates to 8-Hydroxyquinoline Compounds; compositions comprising an 8-Hydroxyquinoline Compound; and methods for treating or preventing a metalloproteinase-related disorder, such as, an arthritic disorder, osteoarthritis, malignant neoplasm, rheumatoid arthritis, asthma, chronic obstructive pulmonary disease, atherosclerosis, age-related macular degeneration, myocardial infarction, a corneal ulceration, an ocular surface disease, hepatitis, an aortic aneurysm, tendonitis, a central nervous system disorder, abnormal wound healing, angiogenesis, restenosis, cirrhosis, multiple sclerosis, glomerulonephritis, graft versus host disease, diabetes, an inflammatory bowel disease, shock, invertebral disc degeneration, stroke, osteopenia or a periodontal disease or comprising administering an effective dose of an 8-Hydroxyquinoline Compound to a mammal in need thereof.",WYETH CORP;;BURSAVICH MATTHEW G;;LOMBARDI SABRINA;;GILBERT ADAM M;;LAAKSO LEIF MARK;;KHAFIZOVA GULNAZ;;HOW DAVID BRIAN;;SABATINI JOSHUA JAMES;;SUM PHAIK-ENG;;CLEMENS JEREMY J,BURSAVICH MATTHEW G;;LOMBARDI SABRINA;;GILBERT ADAM M;;LAAKSO LEIF MARK;;KHAFIZOVA GULNAZ;;HOW DAVID BRIAN;;SABATINI JOSHUA JAMES;;SUM PHAIK-ENG;;CLEMENS JEREMY J,,https://lens.org/017-171-941-021-393,Patent Application,yes,0,14,10,10,0,C07D215/26;;C07D215/28;;C07D401/06;;C07D401/12;;C07D405/06;;C07D409/10;;C07D417/10;;A61P9/10;;C07D215/28;;C07D401/06;;C07D405/06;;C07D417/10;;C07D215/26;;C07D409/10;;C07D401/12,A61K31/4709,,0,0,,,,PENDING
580,CA,A1,CA 2659952 A1,105-996-012-664-067,2008-02-28,2008,CA 2659952 A,2007-08-23,US 83956806 P;;US 2007/0076661 W,2006-08-23,8-HYDROXYQUINOLINE COMPOUNDS AND METHODS THEREOF,"The present invention relates to 8-Hydroxyquinoline Compounds; compositio ns comprising an 8-Hydroxyquinoline Compound; and methods for treating or pr eventing a metalloproteinase-related disorder, such as, an arthritic disorde r, osteoarthritis, malignant neoplasm, rheumatoid arthritis, asthma, chronic obstructive pulmonary disease, atherosclerosis, age-related macular degener ation, myocardial infarction, a corneal ulceration, an ocular surface diseas e, hepatitis, an aortic aneurysm, tendonitis, a central nervous system disor der, abnormal wound healing, angiogenesis, restenosis, cirrhosis, multiple s clerosis, glomerulonephritis, graft versus host disease, diabetes, an inflam matory bowel disease, shock, invertebral disc degeneration, stroke, osteopen ia or a periodontal disease or comprising administering an effective dose of an 8-Hydroxyquinoline Compound to a mammal in need thereof.",WYETH CORP,KHAFIZOVA GULNAZ;;BURSAVICH MATTHEW G;;SABATINI JOSHUA JAMES;;HOW DAVID BRIAN;;LAAKSO LEIF MARK;;SUM PHAIK-ENG;;CLEMENS JEREMY J;;GILBERT ADAM M;;LOMBARDI SABRINA,,https://lens.org/105-996-012-664-067,Patent Application,no,0,0,10,10,0,C07D215/26;;C07D215/28;;C07D401/06;;C07D401/12;;C07D405/06;;C07D409/10;;C07D417/10;;A61P9/10;;C07D215/28;;C07D401/06;;C07D405/06;;C07D417/10;;C07D215/26;;C07D409/10;;C07D401/12,A61K31/47;;C07D215/16,,0,0,,,,DISCONTINUED
581,EP,A2,EP 2056823 A2,101-700-315-443-439,2009-05-13,2009,EP 07814400 A,2007-08-23,US 2007/0076661 W;;US 83956806 P,2006-08-23,8-HYDROXYQUINOLINE COMPOUNDS AND METHODS THEREOF,,WYETH CORP,BURSAVICH MATTHEW G;;LOMBARDI SABRINA;;GILBERT ADAM M;;LAAKSO LEIF MARK;;KHAFIZOVA GULNAZ;;HOW DAVID BRIAN;;SABATINI JOSHUA JAMES;;SUM PHAIK-ENG;;CLEMENS JEREMY J,,https://lens.org/101-700-315-443-439,Patent Application,yes,0,0,10,10,0,C07D215/26;;C07D215/28;;C07D401/06;;C07D401/12;;C07D405/06;;C07D409/10;;C07D417/10;;A61P9/10;;C07D215/28;;C07D401/06;;C07D405/06;;C07D417/10;;C07D215/26;;C07D409/10;;C07D401/12,A61K31/47;;C07D215/16,,0,0,,,,DISCONTINUED
582,WO,A3,WO 2008/024922 A3,117-030-204-511-188,2008-10-09,2008,US 2007/0076661 W,2007-08-23,US 83956806 P,2006-08-23,8-HYDROXYQUINOLINE COMPOUNDS AND METHODS THEREOF,"The present invention relates to 8-Hydroxyquinoline Compounds; compositions comprising an 8-Hydroxyquinoline Compound; and methods for treating or preventing a metalloproteinase-related disorder, such as, an arthritic disorder, osteoarthritis, malignant neoplasm, rheumatoid arthritis, asthma, chronic obstructive pulmonary disease, atherosclerosis, age-related macular degeneration, myocardial infarction, a corneal ulceration, an ocular surface disease, hepatitis, an aortic aneurysm, tendonitis, a central nervous system disorder, abnormal wound healing, angiogenesis, restenosis, cirrhosis, multiple sclerosis, glomerulonephritis, graft versus host disease, diabetes, an inflammatory bowel disease, shock, invertebral disc degeneration, stroke, osteopenia or a periodontal disease or comprising administering an effective dose of an 8-Hydroxyquinoline Compound to a mammal in need thereof.",WYETH CORP;;BURSAVICH MATTHEW G;;LOMBARDI SABRINA;;GILBERT ADAM M;;LAAKSO LEIF MARK;;KHAFIZOVA GULNAZ;;HOW DAVID BRIAN;;SABATINI JOSHUA JAMES;;SUM PHAIK-ENG;;CLEMENS JEREMY J,BURSAVICH MATTHEW G;;LOMBARDI SABRINA;;GILBERT ADAM M;;LAAKSO LEIF MARK;;KHAFIZOVA GULNAZ;;HOW DAVID BRIAN;;SABATINI JOSHUA JAMES;;SUM PHAIK-ENG;;CLEMENS JEREMY J,,https://lens.org/117-030-204-511-188,Search Report,yes,2,0,10,10,0,C07D215/26;;C07D215/28;;C07D401/06;;C07D401/12;;C07D405/06;;C07D409/10;;C07D417/10;;A61P9/10;;C07D215/28;;C07D401/06;;C07D405/06;;C07D417/10;;C07D215/26;;C07D409/10;;C07D401/12,A61K31/47;;C07D215/16,,1,1,011-766-933-291-451,10.1002/ijc.20968;;15729694,"BERKSON R.G., INTERNATIONAL JOURNAL OF CANCER, vol. 115, no. 5, 2005, pages 701 - 710, XP008104151",PENDING
583,WO,A2,WO 2005/114565 A2,020-576-825-246-361,2005-12-01,2005,US 2005/0014671 W,2005-04-28,US 84214704 A,2004-05-10,SYSTEM AND METHOD FOR PROVISIONING AUDIOVISUAL WORKS,"A method for provisioning audiovisual works to a client includes maintaining categorization information specifying, for each of multiple audiovisual works, one or more of multiple categories. One or more of the categories are associated with each of multiple delivery slots in response to input from a client. For each of the delivery slots, a first audiovisual work from one of the categories associated with the respective delivery slot is provisioned for delivery to a location associated with the client.",BLOCKBUSTER INC;;WYNN DOMINIC C;;WILLIAMS PHILIP M;;SIMONS MALACHI G;;WILKINS NICHOLAS F;;MACROW ALISTAIR;;DUFTY NIGEL A;;ENG ALVIN;;DOHERTY MICHAEL J;;GROVES DAVID M,WYNN DOMINIC C;;WILLIAMS PHILIP M;;SIMONS MALACHI G;;WILKINS NICHOLAS F;;MACROW ALISTAIR;;DUFTY NIGEL A;;ENG ALVIN;;DOHERTY MICHAEL J;;GROVES DAVID M,,https://lens.org/020-576-825-246-361,Patent Application,yes,0,0,5,5,0,G06Q30/06;;G06Q30/0645;;H04L67/01;;G06Q30/0645;;G06Q30/06;;H04L67/00;;H04L67/01,G06Q30/00;;G06Q99/00,,0,0,,,,PENDING
584,WO,A3,WO 2005/114565 A3,055-559-923-593-354,2008-12-18,2008,US 2005/0014671 W,2005-04-28,US 84214704 A,2004-05-10,SYSTEM AND METHOD FOR PROVISIONING AUDIOVISUAL WORKS,"A method for provisioning audiovisual works to a client includes maintaining categorization information specifying, for each of multiple audiovisual works, one or more of multiple categories. One or more of the categories are associated with each of multiple delivery slots in response to input from a client. For each of the delivery slots, a first audiovisual work from one of the categories associated with the respective delivery slot is provisioned for delivery to a location associated with the client.",BLOCKBUSTER INC;;WYNN DOMINIC C;;WILLIAMS PHILIP M;;SIMONS MALACHI G;;WILKINS NICHOLAS F;;MACROW ALISTAIR;;DUFTY NIGEL A;;ENG ALVIN;;DOHERTY MICHAEL J;;GROVES DAVID M,WYNN DOMINIC C;;WILLIAMS PHILIP M;;SIMONS MALACHI G;;WILKINS NICHOLAS F;;MACROW ALISTAIR;;DUFTY NIGEL A;;ENG ALVIN;;DOHERTY MICHAEL J;;GROVES DAVID M,,https://lens.org/055-559-923-593-354,Search Report,yes,1,0,5,5,0,G06Q30/06;;G06Q30/0645;;H04L67/01;;G06Q30/0645;;G06Q30/06;;H04L67/00;;H04L67/01,G06Q99/00;;G06Q30/00,,0,0,,,,PENDING
585,US,A1,US 2006/0015352 A1,066-301-492-131-537,2006-01-19,2006,US 84214704 A,2004-05-10,US 84214704 A,2004-05-10,System and method for provisioning audiovisual works,"A method for provisioning audiovisual works to a client includes maintaining categorization information specifying, for each of multiple audiovisual works, one or more of multiple categories. One or more of the categories are associated with each of multiple delivery slots in response to input from a client. For each of the delivery slots, a first audiovisual work from one of the categories associated with the respective delivery slot is provisioned for delivery to a location associated with the client.",WYNN DOMINIC C;;WILLIAMS PHILIP M;;SIMONS MALACHI G;;WILKINS NICHOLAS F;;MACROW ALISTAIR;;DUFTY NIGEL A;;ENG ALVIN;;DOHERTY MICHAEL J;;GROVES DAVID M,WYNN DOMINIC C;;WILLIAMS PHILIP M;;SIMONS MALACHI G;;WILKINS NICHOLAS F;;MACROW ALISTAIR;;DUFTY NIGEL A;;ENG ALVIN;;DOHERTY MICHAEL J;;GROVES DAVID M,BLOCKBUSTER L.L.C (2011-05-27);;BLOCKBUSTER INC (2004-07-07),https://lens.org/066-301-492-131-537,Patent Application,yes,42,27,5,5,0,G06Q30/06;;G06Q30/0645;;H04L67/01;;G06Q30/0645;;G06Q30/06;;H04L67/00;;H04L67/01,G06Q99/00;;G06Q30/00,705/1,0,0,,,,ACTIVE
586,MX,A,MX 2009001929 A,087-901-725-886-473,2009-03-06,2009,MX 2009001929 A,2007-08-23,US 83956806 P;;US 2007/0076661 W,2006-08-23,8-HYDROXYQUINOLINE COMPOUNDS AND METHODS THEREOF.,"The present invention relates to 8-Hydroxyquinoline Compounds; compositions comprising an 8-Hydroxyquinoline Compound; and methods for treating or preventing a metalloproteinase-related disorder, such as, an arthritic disorder, osteoarthritis, malignant neoplasm, rheumatoid arthritis, asthma, chronic obstructive pulmonary disease, atherosclerosis, age-related macular degeneration, myocardial infarction, a corneal ulceration, an ocular surface disease, hepatitis, an aortic aneurysm, tendonitis, a central nervous system disorder, abnormal wound healing, angiogenesis, restenosis, cirrhosis, multiple sclerosis, glomerulonephritis, graft versus host disease, diabetes, an inflammatory bowel disease, shock, invertebral disc degeneration, stroke, osteopenia or a periodontal disease or comprising administering an effective dose of an 8-Hydroxyquinoline Compound to a mammal in need thereof.",WYETH CORP,SUM PHAIK-ENG;;KHAFIZOVA GULNAZ;;HOW DAVID BRIAN;;SABATINI JOSHUA JAMES;;BURSAVICH MATTHEW G;;LOMBARDI SABRINA;;GILBERT ADAM M;;LAAKSO LEIF MARK;;CLEMENS JEREMY J,,https://lens.org/087-901-725-886-473,Patent Application,no,0,0,10,10,0,C07D215/26;;C07D215/28;;C07D401/06;;C07D401/12;;C07D405/06;;C07D409/10;;C07D417/10;;A61P9/10;;C07D215/28;;C07D401/06;;C07D405/06;;C07D417/10;;C07D215/26;;C07D409/10;;C07D401/12,A61K31/4709,,0,0,,,,PENDING
587,US,B2,US 8346673 B2,188-714-065-383-149,2013-01-01,2013,US 84214704 A,2004-05-10,US 84214704 A,2004-05-10,System and method for provisioning audiovisual works,"A method for provisioning audiovisual works to a client includes maintaining categorization information specifying, for each of multiple audiovisual works, one or more of multiple categories. One or more of the categories are associated with each of multiple delivery slots in response to input from a client. For each of the delivery slots, a first audiovisual work from one of the categories associated with the respective delivery slot is provisioned for delivery to a location associated with the client.",BLOCKBUSTER L L C;;WYNN DOMINIC C;;WILLIAMS PHILIP M;;SIMONS MALACHI G;;WILKINS NICHOLAS F;;MACROW ALISTAIR;;DUFTY NIGEL A;;ENG ALVIN;;DOHERTY MICHAEL J;;GROVES DAVID M,WYNN DOMINIC C;;WILLIAMS PHILIP M;;SIMONS MALACHI G;;WILKINS NICHOLAS F;;MACROW ALISTAIR;;DUFTY NIGEL A;;ENG ALVIN;;DOHERTY MICHAEL J;;GROVES DAVID M,BLOCKBUSTER L.L.C (2011-05-27);;BLOCKBUSTER INC (2004-07-07),https://lens.org/188-714-065-383-149,Granted Patent,yes,43,3,5,5,0,G06Q30/06;;G06Q30/0645;;H04L67/01;;G06Q30/0645;;G06Q30/06;;H04L67/00;;H04L67/01,G06Q50/00;;G06Q30/00;;G06Q99/00,705/307,75,0,,,"Kenton County Public Library, ""The Talking Book Library,"" http://web.archive.org/web/19980130051137/www.kenton.lib.ky.us/talking.html, 3 pages, Jul. 8, 2003.;;The Library of Congress, ""Procurement and Supply Division,"" Bidder's Conference, The National Library Service for the Blind and Physically Handicapped, 17 pages, Sep. 1, 1987.;;Matsuyama Toshinori, ""Rental Video Tape Order System,"" 1 page, Jun. 7, 2005.;;""The Unabashed Librarian,"" No. 82, p. 3, 1 page, May 5, 2005.;;Brad Dick Editor, ""The Future of Television,"" Intertec Publishing Corporation, a Primedia Co., 1 page, Dec. 1999.;;Netflix.com, Inc. ""About Netflix,"" 1 page, © 1997-2002.;;American Action Fund for Blind Children and Adults, ""Facts About the Library,"" http://web.archive.org/web/20000104114940/www.actionfund.org, 2 pages, undated.;;American Action Fund for Blind Children and Adults, ""Application for Library Services,"" Kenneth Jernigan Library for Blind-Children, http://web.archive.org/web/19991103190509/ww.actionfund.org, 3 pages, Feb. 26, 2004.;;Frank Johnson, ""Audio Diversions: Where Books Talk and People Listen,"" Publishers Weekly, 2 pages, Feb. 26, 2004.;;Frank Johnson, ""Audio Diversions : Literature for Listening Club(TM),"" http://web.archive.org/web/20000309021742/www.audiodiversions.com, 2 pages, Aug. 31, 2003.;;Audiobook Search, http://web.archive.org/web/2000309073728/www.audiodiversions.com, 2 pages, Aug. 31, 2003.;;books on tape.com, http://web.archive.org/web/19990424061355/http://www.booksontape.com, 2 pages, Aug. 31, 2003.;;booksontape.com, ""More About B-O-T® & Frequently Asked Questions,"" http://web.archive.org/web/19990508223402/www.booksontape.com/i/help.htm, 11 pages, Aug. 31, 2003.;;© 1999 DVD Overnight, Inc., America's Online Door to Door Rental Store, DVD Overnight-America's Online Door to Door DVD R . . . , http://web.archive.org/web/19990922160527/http://www.dvdovernight.com, 2 pages, 1999.;;© 1999 DVD Overnight, Inc. ""Getting Started to Rent or Buy DVDs Online At DVD Overnight,"" http://web.archive.org/web/20000304111243/www.dvdovernight.com/started.html, 7 pages, 1999.;;© 1999 DVD Overnight, Inc. ""DVD Overnight Store Policies & Frequently Asked Questions,"" DVD Overnight-Customer Service, http://web.archive.org/web/19991123014901/www.dvdovernight.com/service.html, 8 pages, 1999.;;© 2000 DVD Overnight, Inc., ""Customer Service Questions & Answers,"" DVDOvernight Movies-America's Online Door to Door, http://web.archive.org/web/20001109071400/www.dvdovernight.com/dvd/custservice.html 5 pages, 2000.;;© 2000 DVD Overnight, Inc., ""DVD Cache Frequently Asked Questions,""DVD Cache Customer Service, http://web.archive.org/web/20000512001209/www.dvdcache.com/store/customer-service. html, 5 pages, 2000.;;Libraries, ""R.G. 40: Libraries,"" http://www.archives.mcgill.ca/resources/guide/vol1/rg40.htm, 8 pages, Feb. 26, 2004.;;Fastlane Video & Records-Rental Prices, http://web.archive.org/web/19990506190744/members.aol.com/atfastlane/video/rental. htm, 1 page, 1999.;;""5 Day Rental,"" Fastlane Video & Records, http://web.archive.org/web/19990210101315/members.aol.com/atfastlane/video/index.htm 13 pages, Feb. 27, 2004.;;Fastlane Video & Records, http://web.archive.org/web/19990209181937/members.aol.com/atfastlane, 2 pages, 1999.;;""Make Your Payments Online,"" Fastlane Video & Records-Payment on Account, http://web.archive.org/web/19990504102814/members.aol.com/atfastlane/video/payment. htm, 1 page, 1999.;;""Try Before You Buy Program,"" http://web.archive.org/web/19990922040420/www.gametradersclub.com/gametradersclub/tryb.html, 2 pages, 1999.;;Trade or Sell Your Games!, Todd @ Game Traders Club!, http://web.archive.org/web/19991010012624/www.gametradersclub.com/gametradersclub/tradeorselyou.html, 2 pages, 1999.;;""Try Before You Buy Program,"" http://web.archive.org/web/19991012021059/www.gametradersclub.com/gametradersclub/tryb.html, 2 pages, 1999.;;Peter F. McNally, ""Print Culture and English Speaking Quebec,"" History of the Book in Canada, http://www.hbic.library.utoronto.ca/fconfmcnally-fr.htm, 5 pages, Feb. 26, 2004.;;Roger Ebert, ""Welcome to Home Film,"" Home Film Festival, http://web.archive.org/web/19961106000542/www.homefilmfestival.com/frames/index1. html, 3 pages, 1996.;;""Join Home Film Festival and enjoy these features,"" Home Film Festival, http://web.archive.org/web/19961106001054/www.homefilmfestival.com/membership.html 2 pages, 1996.;;""It's easy! Ordering info,"" Home Film Festival, http://web.archive.org/web/19961106001006/www.homefilmfestival.com/infopack.html, 2 pages, 1996.;;Online Video Rentals, ""Multiple Rental Order Form,"" http://web.archive.org/web/19990420045928/www.home..., 3 pages, Jul. 2, 2003.;;Online Video Rentals, ""Individual Rental Order,"" http://web.archive.org/web/19990127160422/www.home..., 3 pages, Jul. 2, 2003.;;""Welcome to the Internet's 1st DVD rental program,"" Magic Disc Entertainment, http://web.archive.org/web/19981206142316/www.magicdisc.com/rentals/rentalprogram.htm, 2 pages, Feb. 27, 2004.;;""Welcome to the Internet's 1st DVD rental program,"" Magic Disc Entertainment, http://web.archive.org/web/19990503073644/www.magicdisc.com/rentals/rentalprogram.htm, 3 pages, 1999.;;""Featured DVDs for Saturday, Jan. 16, 1999,"" NetFlix.com, http://web.archive.org/web/19990117011532/http://www..., 5 pages, Jul. 3, 2003.;;""DVD Favorites,"" NetFlix.com, http://web.archive.org/web/19991204131346/www.netfli..., 4 pages, Jul. 3, 2003.;;Barbara Cheadle, ""Future Reflections,"" ISSN 0883-3419, National Federation of the Blind, http://www.nfb.org/fr/frl/93win.htm, 5 pages, Aug. 23, 2003.;;""Hear Ye! Hear Ye!,"" National Federation of the Blind, http://web.archive.org/web/19990220032120/www.nfb.org, 7 pages, 1999.;;David Esposito (cooldej@home.com), ""Need Cheep Games,"" alt.games.sony-playstation, http://groups.google.com, 1 page, Feb. 7, 1999.;;Ramon (ramon@theriver.com), ""100's of Games for About a Buck a Day . . . (Incredible Deal),"" alt.games.video.sony-playstation, http://groups.google.com, 1 page, Feb. 6, 1999.;;Ramon (ramon@theriver.com), ""Best Deal Around 100's of games for about a buck a day,"" alt.games.video.sony-playstation, http://groups.google.com, 1 page, Feb. 8, 1999.;;Ramon (ramon@theriver.com), ""Best Deal Ever!! Choose From 100's of Games for About a Buck a Day . . . Plus a Free Playstation,"" alt.games.video.sony-playstation, http://groups.google.com, 1 page, Feb. 9, 1999.;;Ramon (ramon@theriver.com), ""Best Deal I've Ever Seen . . . 100's of Games for About a Buck a Day,"" alt.games.video.nintendo-64, http://groups.google.com, 1 page, Feb. 8, 1999.;;Ramon (ramon@theriver.com), ""Best Deal Ever . . . All the N-64 Games You Want for About a Buck a Day,"" alt.games.video.nintendo-64, http://groups.google.com, 3 pages, Feb. 10, 1999.;;Ramon (ramon@theriver.com), ""All the New Playstation Games Are Yours for About a Buck a Day,"" alt.games.video.sony-playstation, http://groups.google.com, 1 page, Feb. 10, 1999.;;Test (ramon@theriver.com), ""Check Out the New Web Site (Best Deal I've Seen),"" alt.games.video.nintendo-64, http://groups.google.com, 1 page, Jul. 11, 1999.;;Test (ramon@theriver.com), ""How Many Games Can You Beat in a Month?,"" alt.games.video.nintendo-64, http://groups.google.com, 1 page, Jul. 11, 1999.;;David N. Berkwitz, ""A New Way to Avoid Exercise,"" U.S. Edition Newsweek, Cyberscope (R); Web; p. 15, 1 page, Mar. 15, 1999.;;The Unabashed Librarian, No. 82, p. 3, 1 page, no date.;;Kevin Brass, ""Company Town; Rental Control; Video Distributor Takes Industry Down Controversial Path,"" http://faculty-gsb.stanford.edu/oyer-c..., 2 pages, Nov. 28, 1997.;;Mary L. Daniels, ""A Love for Libraries: Whether Large or Small, They are Special Places,"" Orlando Sentinel (Florida), Editorial; p. A19, Copyright 1994 Sentinel Communications Co., 2 pages, Nov. 11, 1994.;;Jennifer deJong, ""Securing Your Site for the Age of E-commerce,"" VAR Business Strategy Guide Supplement, p. 9,10; ISSN: 0894-5802, Copyright 1998 Responsive Database Services, Inc., 3 pages, Nov. 16, 1998.;;""Door-to-Door Service,"" High Points, vol. 6, No. 2; p. 50; ISSN: 1074-293X, Copyright 1999 Responsive Database Services, Inc., 2 pages, Feb. 1999.;;Larry Greenemeier, ""Manna Rises Above Conventional Net Marketing: Manna Network Technologies; Company Business and Marketing,"" Midrange Systems, No. 18, vol. 11; p. 41; ISSN: 1041-8237; Copyright 1998 Information Access Company, 2 pages, Dec. 18, 1998.;;Hilda M. Hamlyn, ""Eighteenth-century Circulating Libraries in England,"" The Bibliographical Society, cover page; pp. 197-222, no date.;;Alan S. Horowitz, ""PC Leasing Gains Ground-Shorter life spans popularize practice,"" Information Week, Copyright 1998 CMP Media, Inc., 3 pages, May 25, 1998.;;Bob Ingram, ""Boston Bears Watching; supermarket industry in Massachusetts,"" Supermarket Business, No. 3, vol. 53; p. 41; ISSN: 0196-5700, Copyright 1999, Information Access Company, 5 pages, Mar. 1, 1999.;;Nancy J. Kim, ""Nordstrom sees Net gains with Streamline,"" Puget Sound Business Journal, vol. 19; No. 25; p. 5, Copyright 1998 UMI Inc., 2 pages, Oct. 30, 1998.;;Alan Dugald McKillop, ""English Circulating Libraries, 1725-50,"" The Bibliographical Society, 10 pages, no date.;;Carol Memmott, ""Web site streamlines your errands,"" USA Today, Bonus; p. 5E, Copyright 1998 Gannett Company, Inc., 2 pages, Nov. 16, 1998.;;""News briefs,"" Video Store, p. 8; 0195-1750; Copyright 1999 Information Access Company, 1 page, Mar. 21, 1999.;;""Nordstrom Announces Partnership With Streamline; Nordstrom Invests $22.8 Million in Streamline, the Pioneer Provider of Consumer Direct Essential and Convenience Services,"" PR Newswire, Financial News Section, Copyright 1998 PR Newswire Association, Inc., 2 pages, Oct. 8, 1998.;;Carolyn Said, ""Chips and Flicks On Your Doorstep,"" The San Francisco Chronicle, Business; p. B1, Copyright 1999 The Chronicle Publishing Co., 4 pages, Oct. 18, 1999.;;Linda Shrieves, ""Now Library Books Just Show Up At Your Door,"" Orlando Sentinel (Florida), Style; p. E1, Copyright 1990 Sentinel Communications Co., Dec. 7, 1990.;;Streamline, DSN Supercenter & Club Business, vol. 6, No. 6; p. 5, Copyright 1999 Responsive Database Services, Inc., 1 page, Mar. 29, 1999.;;Hal R. Varian, ""Buying, Sharing and Renting Information Goods,"" University of California at Berkeley, cover page; pp. 1-19, Dec. 1994 Current Version Aug. 5, 2000.;;Hal R. Varian and Richard Roehl, ""Circulating Libraries and Video Rental Stores,"" Universtiy of California, Berkeley and University of Michigan, Dearborn, pp. 1-14, Dec. 1996.;;Richard Roehl and Hal R. Varian, ""Circulating Libraries and Video Rental Stores,"" University of Michigan, Dearborn and University of California, Berkeley, 13 pages, Dec. 1996 Revised: Mar. 9, 2000.;;Guinevere L. Griest, ""Mudie's Circulating Library and the Victorian Novel,"" Copyright © 1970 by Indiana University Press, Library of Congress catalog card No. 76-126210; ISBN: 253-15480-4, 282 pages, 1970.;;Kathleen Clynes, McLellan Travelling Library of McGill University, pp. 394-395, no date.;;James Lardner, ""Fast Forward, Hollywood, The Japanese, and the Onslaught of the VCR,"" W.W. Norton & Company, 36 pages, © 1987.;;Wayne A. Wiegland and Donald G. Davis, Jr., ""Encyclopedia of Library History,"" Garland Publishing, Inc., New York and London, 5 pages, 1994.;;Glenn Miller, ""Customer Service & Innovation in Libraries,"" The Highsmith Press Handbook Series, 19 pages, 1996.;;Judith Wagner, Joseph W. Haaf and Ruth N. Cuadra, ""Automated Circulation Systems in Libraries Serving the Blind and Physically Handicapped: A Reference Guide for Planning,"" Cuadra Associates, Inc., 136 pages, May 15, 1981.;;""Access Self-Study,"" Texas State Library, Division for the Blind & Physically Handicapped, vol. 7, Functional Requirements, (C.01-C.11), 14 pages, Dec. 15, 1987.",ACTIVE
588,AU,A1,AU 2007/286659 A1,060-532-657-473-149,2008-02-28,2008,AU 2007/286659 A,2007-08-23,US 83956806 P;;US 2007/0076661 W,2006-08-23,8-Hydroxyquinoline Compounds and methods thereof,,WYETH CORP,GILBERT ADAM M;;LOMBARDI SABRINA;;BURSAVICH MATTHEW G;;CLEMENS JEREMY J;;LAAKSO LEIF MARK;;KHAFIZOVA GULNAZ;;SUM PHAIK-ENG;;SABATINI JOSHUA JAMES;;HOW DAVID BRIAN,,https://lens.org/060-532-657-473-149,Patent Application,no,0,0,10,10,0,C07D215/26;;C07D215/28;;C07D401/06;;C07D401/12;;C07D405/06;;C07D409/10;;C07D417/10;;A61P9/10;;C07D215/28;;C07D401/06;;C07D405/06;;C07D417/10;;C07D215/26;;C07D409/10;;C07D401/12,A61K31/4709,,0,0,,,,PENDING
589,EP,A2,EP 1576169 A2,012-125-892-995-781,2005-09-21,2005,EP 03726083 A,2003-03-19,US 0308490 W;;US 36549102 P;;US 41061802 P,2002-03-19,THERAPEUTIC POLYPEPTIDES AND METHODS OF USE,,CURAGEN CORP,LEPLEY DENISE M;;RIEGER DANIEL K;;TSE KAM-FAI;;RASTELLI LUCA;;SMITHSON GLENNDA;;MESRI MEHDI;;OOI CHEAN ENG;;ANDERSON DAVID W;;GUO XIAOJIA;;GIOT LOIC;;STARLING GARY,"CURAGEN CORPORATION (2005-11-16);;CELLDEX THERAPEUTICS, INC. (2014-08-06)",https://lens.org/012-125-892-995-781,Patent Application,yes,0,0,11,775,39,C07K14/47;;G01N33/6893;;G01N2800/042;;A61P29/00;;A61P35/00;;C07K14/47;;G01N33/6893;;G01N2800/042,A61K39/395;;G01N33/50;;A61K38/00;;A61K38/17;;A61P29/00;;A61P35/00;;C07K14/47;;C07K16/18;;C07K19/00;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N15/09;;C12P21/02;;C12P21/08;;C12Q1/02;;C12Q1/68;;G01N33/15;;G01N33/53;;G01N33/567;;G01N33/68,,0,0,,,,EXPIRED
590,CA,A1,CA 2479732 A1,132-833-219-312-74X,2003-10-02,2003,CA 2479732 A,2003-03-19,US 36549102 P;;US 41061802 P;;US 0308490 W,2002-03-19,"THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS ENCODING SAME, AND METHODS OF USE","Disclosed herein are nucleic acid sequences that encode novel polypeptides encoded by these nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, as well as derivatives, variants , mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide. Vectors, host cells, antibodies and recombinant methods for producing the polypeptides and polynucleotides, as well as metho ds for using same are also included. The invention further discloses therapeuti c, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.",CURAGEN CORP,MESRI MEHDI;;TSE KAM-FAI;;GIOT LOIC;;STARLING GARY;;GUO XIAOJIA;;OOI CHEAN ENG;;SMITHSON GLENNDA;;RASTELLI LUCA;;LEPLEY DENISE M;;RIEGER DANIEL K;;ANDERSON DAVID W,,https://lens.org/132-833-219-312-74X,Patent Application,no,0,0,11,775,39,C07K14/47;;G01N33/6893;;G01N2800/042;;A61P29/00;;A61P35/00;;C07K14/47;;G01N33/6893;;G01N2800/042,G01N33/50;;A61K38/00;;A61K38/17;;A61K39/395;;A61P29/00;;A61P35/00;;C07K14/47;;C07K16/18;;C07K19/00;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N15/09;;C12P21/02;;C12P21/08;;C12Q1/02;;C12Q1/68;;G01N33/15;;G01N33/53;;G01N33/567;;G01N33/68,,0,0,,,,DISCONTINUED
591,WO,A2,WO 2003/080856 A2,128-150-397-349-134,2003-10-02,2003,US 0308490 W,2003-03-19,US 36549102 P;;US 41061802 P,2002-03-19,"THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS ENCODING SAME, AND METHODS OF USE","Disclosed herein are nucleic acid sequences that encode novel polypeptides encoded by these nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide. Vectors, host cells, antibodies and recombinant methods for producing the polypeptides and polynucleotides, as well as methods for using same are also included. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.",CURAGEN CORP;;LEPLEY DENISE M;;RIEGER DANIEL K;;TSE KAM-FAI;;RASTELLI LUCA;;SMITHSON GLENNDA;;MESRI MEHDI;;OOI CHEAN ENG;;ANDERSON DAVID W;;GUO XIAOJIA;;GIOT LOIC;;STARLING GARY,LEPLEY DENISE M;;RIEGER DANIEL K;;TSE KAM-FAI;;RASTELLI LUCA;;SMITHSON GLENNDA;;MESRI MEHDI;;OOI CHEAN ENG;;ANDERSON DAVID W;;GUO XIAOJIA;;GIOT LOIC;;STARLING GARY,,https://lens.org/128-150-397-349-134,Patent Application,yes,0,0,11,775,0,C07K14/47;;G01N33/6893;;G01N2800/042;;A61P29/00;;A61P35/00;;C07K14/47;;G01N33/6893;;G01N2800/042,A61K38/00;;A61K38/17;;G01N33/50;;A61K39/395;;A61P29/00;;A61P35/00;;C07K14/47;;C07K16/18;;C07K19/00;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N15/09;;C12P21/02;;C12P21/08;;C12Q1/02;;C12Q1/68;;G01N33/15;;G01N33/53;;G01N33/567;;G01N33/68,,0,0,,,,PENDING
592,AU,A1,AU 2003/228336 A1,057-057-952-532-772,2003-10-08,2003,AU 2003/228336 A,2003-03-19,US 36549102 P;;US 41061802 P;;US 0308490 W,2002-03-19,"THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS ENCODING SAME, AND METHODS OF USE",,CURAGEN CORP,MESRI MEHDI;;OOI CHEAN ENG;;ANDERSON DAVID W;;GUO XIAOJIA;;GIOT LOIC;;STARLING GARY;;LEPLEY DENISE M;;RIEGER DANIEL K;;TSE KAM-FAI;;RASTELLI LUCA;;SMITHSON GLENNDA,,https://lens.org/057-057-952-532-772,Patent Application,no,0,1,11,775,0,C07K14/47;;G01N33/6893;;G01N2800/042;;A61P29/00;;A61P35/00;;C07K14/47;;G01N33/6893;;G01N2800/042,G01N33/50;;A61K38/00;;A61K38/17;;A61K39/395;;A61P29/00;;A61P35/00;;C07K14/47;;C07K16/18;;C07K19/00;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N15/09;;C12P21/02;;C12P21/08;;C12Q1/02;;C12Q1/68;;G01N33/15;;G01N33/53;;G01N33/567;;G01N33/68,,0,0,,,,EXPIRED
593,AU,B2,AU 2013/205381 B2,104-889-220-868-558,2016-04-14,2016,AU 2013/205381 A,2013-04-22,AU 2009/202669 A;;AU 2013/205381 A,2009-07-01,"THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS ENCODING SAME, AND METHODS OF USE","Disclosed herein are nucleic acid sequences that encode novel polypeptides encoded by these nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide. Vectors, host cells, antibodies and recombinant methods for producing the polypeptides and polynucleotides, as well as methods for using same are also included. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins. PATHWAY 2968812:CG57008 HAVCR-1 CG51373-10 PINK1 HAVCR-1 Fig. 1",CURAGEN CORP,LEPLEY DENISE M;;RIEGER DANIEL K;;TSE KAM-FAI;;RASTELLI LUCA;;SMITHSON GLENNDA;;MESRI MEHDI;;ANDERSON DAVID W;;GUO XIAOJIA;;GIOT LOIC;;STARLING GARY;;OOI CHEAN ENG,,https://lens.org/104-889-220-868-558,Granted Patent,no,1,0,2,2,0,,C07K14/00;;A61K38/00;;A61K38/17;;A61K39/395;;A61P29/00;;A61P35/00;;C07H21/02;;C07H21/04;;C07K14/47;;C07K16/00;;C07K16/18;;C07K19/00;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N15/09;;C12N15/63;;C12P21/02;;C12P21/06;;C12P21/08;;C12Q1/02;;C12Q1/68;;G01N33/00;;G01N33/15;;G01N33/50;;G01N33/53;;G01N33/567;;G01N33/68,,0,0,,,,INACTIVE
594,AU,A1,AU 2013/205381 A1,107-307-419-519-60X,2013-05-23,2013,AU 2013/205381 A,2013-04-22,AU 2009/202669 A;;AU 2013/205381 A,2009-07-01,"THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS ENCODING SAME, AND METHODS OF USE","Disclosed herein are nucleic acid sequences that encode novel polypeptides encoded by these nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide. Vectors, host cells, antibodies and recombinant methods for producing the polypeptides and polynucleotides, as well as methods for using same are also included. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins. PATHWAY 2968812:CG57008 HAVCR-1 CG51373-10 PINK1 HAVCR-1 Fig. 1",CURAGEN CORP,LEPLEY DENISE M;;RIEGER DANIEL K;;TSE KAM-FAI;;RASTELLI LUCA;;SMITHSON GLENNDA;;MESRI MEHDI;;ANDERSON DAVID W;;GUO XIAOJIA;;GIOT LOIC;;STARLING GARY;;OOI CHEAN ENG,,https://lens.org/107-307-419-519-60X,Patent Application,no,0,2,2,2,0,,C07K14/00;;A61K38/00;;A61K38/17;;A61K39/395;;A61P29/00;;A61P35/00;;C07H21/02;;C07H21/04;;C07K14/47;;C07K16/00;;C07K16/18;;C07K19/00;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N15/09;;C12N15/63;;C12P21/02;;C12P21/06;;C12P21/08;;C12Q1/02;;C12Q1/68;;G01N33/00;;G01N33/15;;G01N33/50;;G01N33/53;;G01N33/567;;G01N33/68,,0,0,,,,INACTIVE
595,WO,A3,WO 2003/080856 A3,025-172-386-163-37X,2007-08-16,2007,US 0308490 W,2003-03-19,US 36549102 P;;US 41061802 P,2002-03-19,"THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS ENCODING SAME, AND METHODS OF USE","Disclosed herein are nucleic acid sequences that encode novel polypeptides encoded by these nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide. Vectors, host cells, antibodies and recombinant methods for producing the polypeptides and polynucleotides, as well as methods for using same are also included. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.",CURAGEN CORP;;LEPLEY DENISE M;;RIEGER DANIEL K;;TSE KAM-FAI;;RASTELLI LUCA;;SMITHSON GLENNDA;;MESRI MEHDI;;OOI CHEAN ENG;;ANDERSON DAVID W;;GUO XIAOJIA;;GIOT LOIC;;STARLING GARY,LEPLEY DENISE M;;RIEGER DANIEL K;;TSE KAM-FAI;;RASTELLI LUCA;;SMITHSON GLENNDA;;MESRI MEHDI;;OOI CHEAN ENG;;ANDERSON DAVID W;;GUO XIAOJIA;;GIOT LOIC;;STARLING GARY,,https://lens.org/025-172-386-163-37X,Search Report,yes,1,0,11,775,0,C07K14/47;;G01N33/6893;;G01N2800/042;;A61P29/00;;A61P35/00;;C07K14/47;;G01N33/6893;;G01N2800/042,A61K38/17;;A61K38/00;;G01N33/50;;A61K39/395;;A61P29/00;;A61P35/00;;C07H21/02;;C07H21/04;;C07K14/00;;C07K14/47;;C07K16/00;;C07K16/18;;C07K19/00;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N15/09;;C12N15/63;;C12P21/02;;C12P21/06;;C12P21/08;;C12Q1/02;;C12Q1/68;;G01N33/00;;G01N33/15;;G01N33/53;;G01N33/567;;G01N33/68,,0,0,,,,PENDING
596,AU,A1,AU 2009/202669 A1,009-628-172-497-852,2009-07-23,2009,AU 2009/202669 A,2009-07-01,AU 2003/228336 A;;AU 2009/202669 A;;US 36549102 P;;US 41061802 P,2002-03-19,"Therapeutic Polypeptides, Nucleic Acids Encoding Same, and Methods of Use",,CURAGEN CORP,ANDERSON DAVID W;;TSE KAM-FAI;;SMITHSON GLENNDA;;STARLING GARY;;RASTELLI LUCA;;GIOT LOIC;;GUO XIAOJIA;;LEPLEY DENISE M;;OOI CHEAN ENG;;RIEGER DANIEL K;;MESRI MEHDI,,https://lens.org/009-628-172-497-852,Patent Application,no,0,0,11,775,0,C07K14/47;;G01N33/6893;;G01N2800/042;;A61P29/00;;A61P35/00;;C07K14/47;;G01N33/6893;;G01N2800/042,A61K38/17;;G01N33/50;;A61K38/00;;A61K39/395;;A61P29/00;;A61P35/00;;C07H21/02;;C07H21/04;;C07K14/00;;C07K14/47;;C07K16/00;;C07K16/18;;C07K19/00;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N15/09;;C12N15/63;;C12P21/02;;C12P21/06;;C12P21/08;;C12Q1/02;;C12Q1/68;;G01N33/00;;G01N33/15;;G01N33/53;;G01N33/567;;G01N33/68,,0,0,,,,DISCONTINUED
597,AU,B2,AU 2003/228336 B2,166-755-379-275-282,2009-07-30,2009,AU 2003/228336 A,2003-03-19,US 36549102 P;;US 41061802 P;;US 0308490 W,2002-03-19,"Therapeutic polypeptides, nucleic acids encoding same, and methods of use",,CURAGEN CORP,ANDERSON DAVID W;;GUO XIAOJIA;;OOI CHEAN ENG;;SMITHSON GLENNDA;;TSE KAM-FAI;;STARLING GARY;;MESRI MEHDI;;RIEGER DANIEL K;;RASTELLI LUCA;;GIOT LOIC;;LEPLEY DENISE M,,https://lens.org/166-755-379-275-282,Granted Patent,no,2,0,11,775,0,C07K14/47;;G01N33/6893;;G01N2800/042;;A61P29/00;;A61P35/00;;C07K14/47;;G01N33/6893;;G01N2800/042,A61K38/17;;G01N33/50;;A61K38/00;;A61K39/395;;A61P29/00;;A61P35/00;;C07H21/02;;C07H21/04;;C07K14/00;;C07K14/47;;C07K16/00;;C07K16/18;;C07K19/00;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N15/09;;C12N15/63;;C12P21/02;;C12P21/06;;C12P21/08;;C12Q1/02;;C12Q1/68;;G01N33/00;;G01N33/15;;G01N33/53;;G01N33/567;;G01N33/68,,1,1,028-639-183-662-182,10.1128/jvi.72.8.6621-6628.1998;;9658108;;pmc109848,"EIGELSTOCK D et al, J Virol, 1998 Vol 72, p 6621-6628",EXPIRED
598,EP,B1,EP 1576169 B1,042-156-342-874-053,2016-08-10,2016,EP 03726083 A,2003-03-19,US 0308490 W;;US 36549102 P;;US 41061802 P,2002-03-19,THERAPEUTIC POLYPEPTIDES AND METHODS OF USE,,CELLDEX THERAPEUTICS INC,LEPLEY DENISE M;;RIEGER DANIEL K;;TSE KAM-FAI;;RASTELLI LUCA;;SMITHSON GLENNDA;;MESRI MEHDI;;OOI CHEAN ENG;;ANDERSON DAVID W;;GUO XIAOJIA;;GIOT LOIC;;STARLING GARY,"CURAGEN CORPORATION (2005-11-16);;CELLDEX THERAPEUTICS, INC. (2014-08-06)",https://lens.org/042-156-342-874-053,Granted Patent,yes,7,0,11,775,0,C07K14/47;;G01N33/6893;;G01N2800/042;;A61P29/00;;A61P35/00;;C07K14/47;;G01N33/6893;;G01N2800/042,A61K39/395;;G01N33/50;;A61K38/00;;A61K38/17;;A61P29/00;;A61P35/00;;C07K14/47;;C07K16/18;;C07K19/00;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N15/09;;C12P21/02;;C12P21/08;;C12Q1/02;;C12Q1/68;;G01N33/15;;G01N33/53;;G01N33/567;;G01N33/68,,1,0,,,"FEIGELSTOCK D ET AL: ""The human homolog of HAVcr-1 codes for a hepatitis A virus cellular receptor"" JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 72, no. 8, 1 August 1998 (1998-08-01), pages 6621-6628, XP002959127 ISSN: 0022-538X",EXPIRED
599,EP,A4,EP 1576169 A4,153-453-325-072-10X,2008-07-16,2008,EP 03726083 A,2003-03-19,US 0308490 W;;US 36549102 P;;US 41061802 P,2002-03-19,"THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS ENCODING SAME, AND METHODS OF USE",,CURAGEN CORP,LEPLEY DENISE M;;RIEGER DANIEL K;;TSE KAM-FAI;;RASTELLI LUCA;;SMITHSON GLENNDA;;MESRI MEHDI;;OOI CHEAN ENG;;ANDERSON DAVID W;;GUO XIAOJIA;;GIOT LOIC;;STARLING GARY,"CURAGEN CORPORATION (2005-11-16);;CELLDEX THERAPEUTICS, INC. (2014-08-06)",https://lens.org/153-453-325-072-10X,Search Report,no,6,0,11,775,0,C07K14/47;;G01N33/6893;;G01N2800/042;;A61P29/00;;A61P35/00;;C07K14/47;;G01N33/6893;;G01N2800/042,A61K38/00;;A61K38/17;;A61K39/395;;A61P29/00;;A61P35/00;;C07K14/47;;C07K16/18;;C07K19/00;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;G01N33/50;;C12N15/09;;C12P21/02;;C12P21/08;;C12Q1/02;;C12Q1/68;;G01N33/15;;G01N33/53;;G01N33/567;;G01N33/68,,1,1,028-639-183-662-182,10.1128/jvi.72.8.6621-6628.1998;;9658108;;pmc109848,"FEIGELSTOCK D ET AL: ""The human homolog of HAVcr-1 codes for a hepatitis A virus cellular receptor"", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 72, no. 8, 1 August 1998 (1998-08-01), pages 6621 - 6628, XP002959127, ISSN: 0022-538X",EXPIRED
600,US,A1,US 2005/0014687 A1,002-337-816-282-319,2005-01-20,2005,US 39193903 A,2003-03-19,US 39193903 A;;US 36549102 P;;US 41061802 P,2002-03-19,"Therapeutic polypeptides, nucleic acids encoding same, and methods of use","Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide. Vectors, host cells, antibodies and recombinant methods for producing the polypeptides and polynucleotides, as well as methods for using same are also included. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.",ANDERSON DAVID W.;;GIOT LOIC;;GUO XIAOJIA;;LEPLEY DENISE M.;;MESRI MEHDI;;OOI CHEAN ENG;;RASTELLI LUCA;;RIEGER DANIEL K.;;SMITHSON GLENNDA;;STARLING GARY;;TSE KAM-FAI,ANDERSON DAVID W;;GIOT LOIC;;GUO XIAOJIA;;LEPLEY DENISE M;;MESRI MEHDI;;OOI CHEAN ENG;;RASTELLI LUCA;;RIEGER DANIEL K;;SMITHSON GLENNDA;;STARLING GARY;;TSE KAM-FAI,CURAGEN CORPORATION (2003-06-12),https://lens.org/002-337-816-282-319,Patent Application,yes,1,30,11,775,0,C07K14/47;;G01N33/6893;;G01N2800/042;;A61P29/00;;A61P35/00;;C07K14/47;;G01N33/6893;;G01N2800/042,A61K38/00;;A61K38/17;;A61K39/395;;A61P29/00;;G01N33/50;;A61P35/00;;C07K14/47;;C07K16/18;;C07K19/00;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N15/09;;C12P21/02;;C12P21/08;;C12Q1/02;;C12Q1/68;;G01N33/15;;G01N33/53;;G01N33/567;;G01N33/68,514/12;;530/324,0,0,,,,DISCONTINUED
601,US,B2,US 7268135 B2,191-157-973-624-920,2007-09-11,2007,US 71104 A,2004-12-01,US 71104 A;;US 52688303 P,2003-12-04,Biaryl sulfonamides and methods for using same,"The present invention relates to biaryl sulfonamides and their use as, for example, metalloproteinase inhibitors.",WYETH CORP,XIANG JASON SHAOYUN;;TAM STEVE YIKKAI;;HU YONGHAN;;SUM PHAIK-ENG;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES;;RUSH III THOMAS SALTMARSH,WYETH (2005-01-19),https://lens.org/191-157-973-624-920,Granted Patent,yes,4,2,39,39,0,A61K31/4188;;A61K31/424;;A61K31/429;;C07C311/29;;C07C311/46;;C07D213/30;;C07D213/64;;C07D213/643;;C07D215/14;;C07D215/227;;C07D215/233;;C07D217/18;;C07D235/12;;C07D239/34;;C07D239/60;;C07D261/14;;C07D263/22;;C07D263/58;;C07D277/64;;C07D277/68;;C07D295/096;;C07D295/192;;C07D307/79;;C07D307/80;;C07D307/82;;C07D307/84;;C07D319/18;;C07D321/10;;C07D333/20;;C07D333/36;;C07D333/66;;C07C2601/08;;C07C2602/10;;A61P1/00;;A61P1/02;;A61P1/04;;A61P1/16;;A61P11/00;;A61P11/06;;A61P13/12;;A61P17/02;;A61P19/00;;A61P19/02;;A61P19/04;;A61P19/08;;A61P19/10;;A61P21/00;;A61P25/00;;A61P27/02;;A61P29/00;;A61P3/00;;A61P35/00;;A61P35/04;;A61P37/00;;A61P37/06;;A61P43/00;;A61P7/00;;A61P9/00;;A61P9/10;;A61P9/14;;A61P3/10;;C07D213/30;;C07D217/18;;C07D319/18;;C07D215/227;;C07D295/096;;C07D321/10;;C07C311/29;;C07D277/64;;C07D213/643;;A61K31/4188;;A61K31/424;;C07D215/233;;C07D263/22;;C07D307/84;;C07D213/64;;C07C311/46;;A61K31/429;;C07D295/192;;C07D215/14;;C07D307/79;;C07D333/20;;C07D261/14;;C07D239/34;;C07D307/80;;C07D333/66;;C07D239/60;;C07D277/68;;C07D307/82;;C07D263/58;;C07D333/36;;C07D235/12;;C07C2601/08;;C07C2602/10,C07D217/02;;A61K31/50;;C07C311/29;;C07C311/46;;C07D213/30;;C07D213/64;;C07D213/643;;C07D215/14;;C07D215/22;;C07D215/227;;C07D215/233;;C07D217/18;;C07D235/12;;C07D239/34;;C07D239/60;;C07D261/14;;C07D263/22;;C07D263/58;;C07D277/64;;C07D277/68;;C07D295/096;;C07D295/192;;C07D307/79;;C07D307/80;;C07D307/82;;C07D307/84;;C07D319/18;;C07D321/10;;C07D333/20;;C07D333/36;;C07D333/66,514/247;;514/252.1;;514/256;;514/307;;514/310;;514/311;;514/313;;514/352;;514/357;;514/367;;514/370;;514/374;;514/375;;514/406;;514/407;;514/562;;544/224;;544/242;;544/336;;546/147;;546/152;;546/304;;546/341;;548/148;;548/216;;562/430,27,21,017-895-235-087-735;;017-171-751-918-394;;044-818-906-136-295;;069-158-340-991-44X;;045-470-361-571-490;;004-914-835-124-914;;078-419-272-100-703;;105-804-415-869-201;;022-579-586-775-544;;069-766-900-161-081;;183-022-553-352-289;;017-738-995-123-197;;125-230-735-125-063;;036-990-702-277-410;;088-553-913-634-060;;072-065-218-673-515;;003-012-473-323-211;;184-809-052-195-735;;134-286-353-563-577;;146-037-035-826-309;;017-634-281-935-576,10.1021/jm9707582;;9484512;;10.1016/s1357-2725(00)00061-3;;11167130;;10.1074/jbc.274.33.23443;;10438522;;10.1016/s0945-053x(97)90052-4;;10438512;;10.1074/jbc.274.33.23349;;9006920;;10.1074/jbc.272.5.2801;;8995297;;10.1074/jbc.272.1.556;;10.1016/0169-409x(92)90014-h;;10.1002/jps.2600770402;;3379586;;5432063;;10.1038/227680a0;;6161559;;pmc411572;;388439;;10.1073/pnas.76.9.4350;;pmc1136329;;10.1042/bj3050799;;7531436;;10.1021/jm00033a018;;7512142;;10.1039/jr9570003144;;10.1016/s0040-4039(98)00502-4;;10.1016/s0040-4020(01)98751-4;;10.1016/0040-4020(95)00159-6;;10.1021/ja01242a036;;10.1016/s0040-4020(00)00315-x;;10.1016/0014-5793(92)80300-6;;1537400,"U.S. Appl. No. 11/001,589, filed Dec. 1, 2004, Levin et al.;;Tamura, Y. et al., ""Highly Selective and Orally Active Inhibitors of Type IV Collagenase (MMP-9 and MMP-2): N-Sulfonylamino Acid Derivatives,"" J Med Chem, 1998, 41:640-649.;;Tang, B. L., ""ADAMTS: a novel family of extracellular matrix proteases,"", Int J Biochem Cell Biol, 2001, 33:33-44.;;Abbaszade I. et al., ""Cloning and Characterization of ADAMTS11, an Aggrecanase from the ADAMTS family,"" J Biol Chem, Aug. 13, 1999, 274(33): 23443-23450.;;Colige, A. et al., ""cDNA cloning and expression of bovine procollagen I N-proteinase: A new member of the superfamily of zinc-metalloproteinases with binding sites for cells and other matrix components,"" Proc Natl Acad Sci USA, Mar. 1997, 94, 2374-2379.;;Vázquez F. et al., ""METH-1, a Human Orgholog of ADAMTS-1, and METH-2 Are Members of a New Family of Proteins with Angio-inhibitory Activity,"" J Biol Chem, Aug. 13, 1999, 274(33): 23349-23357.;;Masui T., et al., ""An Alu-linked Repetitive Sequence Corresponding to 280 Amino Acids Is Expressed in a Novel Bovine Protein, but Not in Its Human Homologue,"" J Biol Chem, Jan. 31, 1997, 272(5), 2801-2807.;;Kuno, K. et al., ""Molecular Cloning of a Gene Encoding a New Type of Metalloproteinase-disintegrin Family Protein with Thrombospondin Motifs as an Inflammation Associated Gene,"" J Biol Chem, Jan. 3, 1997, 272(1), 556-562.;;Bundgaard, H. (ed.), Design of Prodrugs, Elsevier (1985), Ch. 1 (pp. 1-92), Ch. 4 (pp. 157-176), Ch. 5 (pp. 177-198), and Ch. 6 (pp. 199-241).;;Widder, et al. (ed.), Methods in Enzymology, vol. 112, Academic Press (1985), pp. 309-396.;;Krogsgaard-Larsen, et al., (ed). Design and Application of Prodrugs, Textbook of Drug Design and Development, Chapter 5, 113-191, 1991.;;Bundgaard, H., ""Means to enhance penetration; Prodrugs as a means to improve the delivery of peptide drugs,"" Advanced Drug Deliver Reviews, 1992, 8, 1-38.;;Bundgaard, H. et al., ""Glycolamide Esters as Biolabile Prodrugs of Carboxylic Acid Agents: Synthesis, Stability, Bioconversion, and Physicochemical Properties,"" J. of Pharmaceutical Sciences, Apr. 1988, 77(4):285-298.;;Higuchi and Stella (eds.), Prodrugs as Novel Drug Delivery Systems, American Chemical Society (1975), pp. 1-115 and 196-223.;;Laemmli, U. K., ""Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4,"" Nature, Aug. 15, 1970, 227:680-685.;;Oaklet, B. R. et al., ""A Simplified Ultrasensitive Silver Stain for Detecting Proteins in Polyacrylamide Gels,"" Anal. Biochem, 1980, 105:361-363.;;Towbin, H. et al., ""Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications,"" Proc. Natl. Acad. Sci. USA, Sep. 1979, 76(9), 4350-4354.;;Hughes, C. E. et al., ""Monoclonal antibodies that specifically recognize neoepitope sequences generated by 'aggrecanase' and matrix metalloproteinase cleavage of aggrecan: application to catabolism in situ and in vitro,"" Biochem J, Feb. 1, 1995, 305(3), 799-804.;;Romero, D. L. et al, ""Discovery, Synthesis, and Bioactivity of Bis(heteroaryl)piperazines. 1. A Novel Class of Non-Nucleoside HIV-1 Reverse Tranascriptase Inhibitors,"" J. Med. Chem. 1994, 37, 999-1014.;;Emmott, P. et al., ""Preparation of Some Naphthofurans,"" J. Chem. Soc. (Jul. 1957) pp. 3144-3148.;;Evans, D. A. et al., ""Synthesis of Diaryl Ethers through the Copper-Promoted Arylation of Phenols with Arylboronic Acids. An Expedient Synthesis of Thyroxine,"" Tetrahedron Lett., May 7, 1998, 39(19):2937-2940.;;Bencze, W. L. et. al, ""The Absolute Configuration of a Hypolipidemic 1-Aryl Tetralin, Nafenopin,"" Tetrahedron 1970, 26:5407-5414.;;Werner, A. W. et al., ""Porphyrins with Four Azole Substituents in meso Positions: X-Ray Crystal Structure of Meso-tetrakis-(1-benzylpyrazol-4-yl)-porphyrin at 200 K,"" Tetrahedron, Apr. 17, 1995, 51(16): 4779-4800.;;Burtner, R.R. et al., ""Antispasmodics. I. Basic Esters of Some Arylacetic Acids,"" J. Am. Chem. Soc., 1943, 65:262-267.;;Abramov, M. A. et al., ""Nucleophilic Intramolecular Cyclization Reactions of Alkylnechalcogenolates,"" Tetrahedron, Jun. 9, 2000, 56(24): 3933-3940.;;Knight, C.G. et al., ""A novel-coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases,"" FEBS Lett. (Jan. 1992) 296(3):263-266.;;Remington's Pharmaceutical Sciences, 17<SUP>th </SUP>Ed., Gennaro, A. R. (Ed.), Mack Publishing Company, Easton, PA (1985) pp. 1409-1677.",INACTIVE
602,WO,A1,WO 2010/123702 A1,015-437-443-957-140,2010-10-28,2010,US 2010/0030512 W,2010-04-09,US 38697109 A,2009-04-24,DISTRACTION TOOL FOR DISTRACTING AN INTERSPINOUS SPACE,Distraction tools for distracting an interspinous space formed between spinous processes. The distraction tool may include first and second handles connected together at a pivot between first and second ends. First and second prongs may extend outward from the handles. The handles may move about the pivot between a first orientation with the first and second prongs in proximity to each other and a second orientation with the first and second prongs separated in a first direction. A third member may be connected to the first and second handles and include a third outwardly-extending prong. The third member may be positioned together with the first and second prongs to form a unified prong when the first and second handles are in the first orientation. The unified prong is sized and shaped for insertion into the interspinous space. The third prong may separate from the first and second prongs in a second direction when the first and second handles are in the second orientation. The prongs distract the interspinous space when the handles are in the second orientation.,KYPHON SARL;;DONOVAN BRIAN W;;LEUNG ANDREA Y;;ENG LISANNE;;THOMPSON DAVID P;;HUBLER ROBERT B;;BARNES STEPHANIE A;;ARENDS THOMAS C;;SCHUBERT KEITH;;LEONARD PAUL C;;MULLER PAUL F,DONOVAN BRIAN W;;LEUNG ANDREA Y;;ENG LISANNE;;THOMPSON DAVID P;;HUBLER ROBERT B;;BARNES STEPHANIE A;;ARENDS THOMAS C;;SCHUBERT KEITH;;LEONARD PAUL C;;MULLER PAUL F,,https://lens.org/015-437-443-957-140,Patent Application,yes,4,1,5,5,0,A61B17/8872;;A61B2017/0256;;A61M5/1452;;A61M5/16854;;A61M5/16877;;A61M2205/3317;;A61M2205/3389;;A61M2205/50;;A61M2205/502;;A61B17/8872;;A61M2205/3317;;A61M5/16854;;A61M2205/502;;A61B2017/0256;;A61M5/16877;;A61M2205/50;;A61M2205/3389;;A61M5/1452,A61B17/88,,0,0,,,,PENDING
603,AU,A1,AU 2003/245387 A1,050-397-888-645-436,2003-12-19,2003,AU 2003/245387 A,2003-05-30,US 40240702 P;;US 44306203 P;;US 40367603 A;;US 38479802 P;;US 0317412 W,2002-05-30,SEMAPHORIN-LIKE PROTEINS AND METHODS OF USING SAME,,CURAGEN CORP,ALVAREZ ENRIQUE;;ANDERSON DAVID W;;DHANABAL MOHANRAJ;;KHRAMTSOV NIKOLAI V;;LAROCHELLE WILLIAM J;;LICHENSTEIN HENRI S;;LI LI;;OOI CHEAN ENG;;PADIGARU MURALIDHARA;;SHIMKETS RICHARD A;;ZHONG MEI,,https://lens.org/050-397-888-645-436,Patent Application,no,0,0,7,775,0,A61K38/00;;C07K14/4703;;A61P35/00,C12N15/09;;A61K38/00;;A61P35/00;;C07K14/47;;C07K16/18;;C07K19/00;;C12N5/07;;C12N5/077;;C12N5/078;;C12N5/0793;;C12N5/09;;C12N5/10;;C12Q1/68;;G01N33/53,,0,0,,,,DISCONTINUED
604,US,B2,US 8002748 B2,168-296-127-694-774,2011-08-23,2011,US 38697109 A,2009-04-24,US 38697109 A,2009-04-24,Digital syringe with compensation control,"A syringe for performing a medical procedure includes a pressure sensor, a volume sensor, and a compensation circuit. The volume sensor measures a volume of a flowable material that is dispensed from the syringe, the pressure sensor measures a pressure being applied to the flowable material, and the compensation circuit calculates a delivered volume of the flowable material by accounting for system compliance (expansion) as the pressure is increased. By compensating for system compliance in this manner, a syringe can be used in high pressure procedures while still providing accurately controllable material delivery.",KYPHON SARL,DONOVAN BRIAN W;;LEUNG ANDREA Y;;ENG LISANNE;;THOMPSON DAVID P;;HUBLER ROBERT B;;BARNES STEPHANIE ANN;;ARENDS THOMAS C;;SCHUBERT KEITH;;LEONARD PAUL C;;MULLER PAUL F,KYPHON SARL (2009-04-24),https://lens.org/168-296-127-694-774,Granted Patent,yes,9,6,5,5,0,A61B17/8872;;A61B2017/0256;;A61M5/1452;;A61M5/16854;;A61M5/16877;;A61M2205/3317;;A61M2205/3389;;A61M2205/50;;A61M2205/502;;A61B17/8872;;A61M2205/3317;;A61M5/16854;;A61M2205/502;;A61B2017/0256;;A61M5/16877;;A61M2205/50;;A61M2205/3389;;A61M5/1452,A61M37/00,604/154,0,0,,,,INACTIVE
605,EP,A2,EP 1549951 A2,012-738-892-296-704,2005-07-06,2005,EP 03739026 A,2003-05-30,US 0317412 W;;US 38479802 P;;US 40240702 P;;US 44306203 P;;US 40367603 A,2002-05-30,SEMAPHORIN-LIKE PROTEINS AND METHODS OF USING SAME,,CURAGEN CORP,ALVAREZ ENRIQUE;;ANDERSON DAVID W;;DHANABAL MOHANRAJ;;KHRAMTSOV NIKOLAI V;;LAROCHELLE WILLIAM J;;LICHENSTEIN HENRI S;;LI LI;;OOI CHEAN ENG;;PADIGARU MURALIDHARA;;SHIMKETS RICHARD A;;ZHONG MEI,CURAGEN CORPORATION (2005-11-16),https://lens.org/012-738-892-296-704,Patent Application,yes,0,0,7,775,57,A61K38/00;;C07K14/4703;;A61P35/00,C12N15/09;;C12N15/62;;A61K38/00;;A61K38/16;;A61P35/00;;C07K14/47;;C07K16/18;;C07K19/00;;C12N5/07;;C12N5/077;;C12N5/078;;C12N5/0793;;C12N5/09;;C12N5/10;;C12Q1/68;;G01N33/53,,0,0,,,,DISCONTINUED
606,US,A1,US 2004/0220947 A1,162-425-972-894-984,2004-11-04,2004,US 42889303 A,2003-05-02,US 42889303 A,2003-05-02,Method and apparatus for real-time intelligent workload reporting in a heterogeneous environment,"
   Workload reporting is provided in a distributed transaction processing environment having call trees in which a child application performs a child transaction on behalf of a parent application performing a parent transaction. When a parent application starts a transaction, it makes a call to a reporting agent, passing to it any parent correlator the parent application may have received from a calling application. The reporting agent returns to the parent application a child correlator, which the parent application passes to any child application it calls to perform child transactions. The child correlator contains end-to-end information classifying the parent transaction as well as a hop count indicating the depth of the child application in the call tree. The reporting agent uses the hop count to construct a topology in which commonly classified applications are grouped according to their depth in the call tree for better visualization of performance of individual applications. 
",IBM,AMAN JEFFREY D;;BOSTJANCIC DAVID V;;ENG DILLENBERGER DONNA N;;DRITSCHLER GREGORY M;;HULBER MARK F;;JOHNSON MARK W;;SHAH HIREN R;;WEBB ALAN M;;YOCOM PETER B,INTERNATIONAL BUSINESS MACHINES CORPORATION (2003-07-23),https://lens.org/162-425-972-894-984,Patent Application,yes,9,90,1,1,0,G06F11/3433;;G06F11/3495;;G06F2201/86;;G06F2201/865;;G06F2201/87;;G06F2201/875;;G06F2201/88;;G06F11/3433;;G06F2201/875;;G06F2201/865;;G06F2201/86;;G06F11/3495;;G06F2201/87;;G06F2201/88,G06F7/00,707 100000,0,0,,,,DISCONTINUED
607,EP,A4,EP 1549951 A4,082-102-144-179-735,2006-08-09,2006,EP 03739026 A,2003-05-30,US 0317412 W;;US 38479802 P;;US 40240702 P;;US 44306203 P;;US 40367603 A,2002-05-30,SEMAPHORIN-LIKE PROTEINS AND METHODS OF USING SAME,,CURAGEN CORP,ALVAREZ ENRIQUE;;ANDERSON DAVID W;;DHANABAL MOHANRAJ;;KHRAMTSOV NIKOLAI V;;LAROCHELLE WILLIAM J;;LICHENSTEIN HENRI S;;LI LI;;OOI CHEAN ENG;;PADIGARU MURALIDHARA;;SHIMKETS RICHARD A;;ZHONG MEI,CURAGEN CORPORATION (2005-11-16),https://lens.org/082-102-144-179-735,Search Report,no,4,0,7,775,0,A61K38/00;;C07K14/4703;;A61P35/00,C12N15/09;;A61K38/00;;A61P35/00;;C07K14/47;;C07K16/18;;C07K19/00;;C12N5/07;;C12N5/077;;C12N5/078;;C12N5/0793;;C12N5/09;;C12N5/10;;C12Q1/68;;G01N33/53,,0,0,,,,DISCONTINUED
608,US,A1,US 2010/0274180 A1,163-909-791-412-453,2010-10-28,2010,US 38697109 A,2009-04-24,US 38697109 A,2009-04-24,Digital syringe with compensation control,"A syringe for performing a medical procedure includes a pressure sensor, a volume sensor, and a compensation circuit. The volume sensor measures a volume of a flowable material that is dispensed from the syringe, the pressure sensor measures a pressure being applied to the flowable material, and the compensation circuit calculates a delivered volume of the flowable material by accounting for system compliance (expansion) as the pressure is increased. By compensating for system compliance in this manner, a syringe can be used in high pressure procedures while still providing accurately controllable material delivery.",KYPHON SARL,DONOVAN BRIAN W;;LEUNG ANDREA Y;;ENG LISANNE;;THOMPSON DAVID P;;HUBLER ROBERT B;;BARNES STEPHANIE ANN;;ARENDS THOMAS C;;SCHUBERT KEITH;;LEONARD PAUL C;;MULLER PAUL F,KYPHON SARL (2009-04-24),https://lens.org/163-909-791-412-453,Patent Application,no,9,69,5,5,0,A61B17/8872;;A61B2017/0256;;A61M5/1452;;A61M5/16854;;A61M5/16877;;A61M2205/3317;;A61M2205/3389;;A61M2205/50;;A61M2205/502;;A61B17/8872;;A61M2205/3317;;A61M5/16854;;A61M2205/502;;A61B2017/0256;;A61M5/16877;;A61M2205/50;;A61M2205/3389;;A61M5/1452,A61M5/31;;G05D7/06;;G06F17/10;;G08B21/02,604/65;;604/187;;700/283;;703/2;;340/626,0,0,,,,INACTIVE
609,WO,A3,WO 2003/102584 A3,055-583-351-260-609,2004-02-19,2004,US 0317412 W,2003-05-30,US 40367603 A;;US 44306203 P;;US 40240702 P;;US 38479802 P,2002-05-30,SEMAPHORIN-LIKE PROTEINS AND METHODS OF USING SAME,"The proteins of the invention are a family used to modulate the activity of cells and their ability to attract blood vessels. The proteins are used to inhibit angiogenesis, inhibit cell migration, and inhibit actin filament formation. These proteins are used in this context to diagnose and treat proliferative disorders such as cancer.",CURAGEN CORP;;ALVAREZ ENRIQUE;;ANDERSON DAVID W;;DHANABAL MOHANRAJ;;KHRAMTSOV NIKOLAI V;;LAROCHELLE WILLIAM J;;LICHENSTEIN HENRI S;;LI LI;;OOI CHEAN ENG;;PADIGARU MURALIDHARA;;SHIMKETS RICHARD A;;ZHONG MEI,ALVAREZ ENRIQUE;;ANDERSON DAVID W;;DHANABAL MOHANRAJ;;KHRAMTSOV NIKOLAI V;;LAROCHELLE WILLIAM J;;LICHENSTEIN HENRI S;;LI LI;;OOI CHEAN ENG;;PADIGARU MURALIDHARA;;SHIMKETS RICHARD A;;ZHONG MEI,,https://lens.org/055-583-351-260-609,Search Report,yes,0,0,7,775,0,A61K38/00;;C07K14/4703;;A61P35/00,C12N15/09;;A61K38/00;;A61P35/00;;C07K14/47;;C07K16/18;;C07K19/00;;C12N5/07;;C12N5/077;;C12N5/078;;C12N5/0793;;C12N5/09;;C12N5/10;;C12Q1/68;;G01N33/53,,2,1,007-324-578-813-848,10993894;;10.1074/jbc.m006316200,"DATABASE GENBANK [online] 2 June 2000 (2000-06-02), BEHL ET AL.: ""Human semaphorin 6A-1"", XP002972634, Database accession no. (AAY71460);;KLOSTERMANN ET AL.: ""The orthologous human and murine semaphorin 6A-1 proteins (SEMA ^ A-1/Sema6A-1) bind to the enabled/vasodilator-stimulated phosphoprotein-like protein (EVL) via a novel carboxyl-terminal Zyxin-like domain"", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 275, no. 50, 15 December 2000 (2000-12-15), pages 39647 - 39653, XP002171338",PENDING
610,US,A1,US 2004/0018977 A1,089-257-367-308-216,2004-01-29,2004,US 44954803 A,2003-05-30,US 44954803 A;;US 52078100 A;;US 40367603 A;;US 12366799 P;;US 37100202 P;;US 38479802 P;;US 40240702 P;;US 44306203 P,1999-03-09,Semaphorin-like proteins and methods of using same,"
   The proteins of the invention are a family used to modulate the activity of cells and their ability to attract blood vessels. The proteins are used to inhibit angiogenesis, inhibit cell migration, and inhibit actin filament formation. These proteins are used in this context to diagnose and treat proliferative disorders such as cancer. 
",ALVAREZ ENRIQUE;;ANDERSON DAVID W.;;DHANABAL MOHANRAJ;;KHRAMTSOV NIKOLAI V.;;LAROCHELLE WILLIAM J.;;LICHENSTEIN HENRI S.;;LI LI;;OOI CHEAN ENG;;PADIGARU MURALIDHARA;;SHIMKETS RICHARD A.;;ZHONG MEI,ALVAREZ ENRIQUE;;ANDERSON DAVID W;;DHANABAL MOHANRAJ;;KHRAMTSOV NIKOLAI V;;LAROCHELLE WILLIAM J;;LICHENSTEIN HENRI S;;LI LI;;OOI CHEAN ENG;;PADIGARU MURALIDHARA;;SHIMKETS RICHARD A;;ZHONG MEI,CURAGEN CORPORATION (2003-06-11),https://lens.org/089-257-367-308-216,Patent Application,yes,1,2,1,775,57,A61K48/00;;C07K14/4703;;A61K38/1709;;C07K14/4703;;A61K48/00;;A61K38/1709,A61K38/17;;A61K48/00;;C12N5/08,514/12;;435/366;;435/372;;514/44,0,0,,,,DISCONTINUED
611,WO,A2,WO 2003/102584 A2,074-594-046-335-582,2003-12-11,2003,US 0317412 W,2003-05-30,US 40367603 A;;US 44306203 P;;US 40240702 P;;US 38479802 P,2002-05-30,SEMAPHORIN-LIKE PROTEINS AND METHODS OF USING SAME,"The proteins of the invention are a family used to modulate the activity of cells and their ability to attract blood vessels. The proteins are used to inhibit angiogenesis, inhibit cell migration, and inhibit actin filament formation. These proteins are used in this context to diagnose and treat proliferative disorders such as cancer.",CURAGEN CORP;;ALVAREZ ENRIQUE;;ANDERSON DAVID W;;DHANABAL MOHANRAJ;;KHRAMTSOV NIKOLAI V;;LAROCHELLE WILLIAM J;;LICHENSTEIN HENRI S;;LI LI;;OOI CHEAN ENG;;PADIGARU MURALIDHARA;;SHIMKETS RICHARD A;;ZHONG MEI,ALVAREZ ENRIQUE;;ANDERSON DAVID W;;DHANABAL MOHANRAJ;;KHRAMTSOV NIKOLAI V;;LAROCHELLE WILLIAM J;;LICHENSTEIN HENRI S;;LI LI;;OOI CHEAN ENG;;PADIGARU MURALIDHARA;;SHIMKETS RICHARD A;;ZHONG MEI,,https://lens.org/074-594-046-335-582,Patent Application,yes,0,0,7,775,0,A61K38/00;;C07K14/4703;;A61P35/00,C12N15/09;;A61K38/00;;A61P35/00;;C07K14/47;;C07K16/18;;C07K19/00;;C12N5/07;;C12N5/077;;C12N5/078;;C12N5/0793;;C12N5/09;;C12N5/10;;C12Q1/68;;G01N33/53,,0,0,,,,PENDING
612,CA,A1,CA 2487939 A1,168-363-380-101-490,2003-12-11,2003,CA 2487939 A,2003-05-30,US 38479802 P;;US 40240702 P;;US 44306203 P;;US 40367603 A;;US 0317412 W,2002-05-30,SEMAPHORIN-LIKE PROTEINS AND METHODS OF USING SAME,"The proteins of the invention are a family used to modulate the activity of cells and their ability to attract blood vessels. The proteins are used to inhibit angiogenesis, inhibit cell migration, and inhibit actin filament formation. These proteins are used in this context to diagnose and treat proliferative disorders such as cancer.",CURAGEN CORP,SHIMKETS RICHARD A;;KHRAMTSOV NIKOLAI V;;ANDERSON DAVID W;;DHANABAL MOHANRAJ;;ALVAREZ ENRIQUE;;ZHONG MEI;;LI LI;;OOI CHEAN ENG;;LICHENSTEIN HENRI S;;PADIGARU MURALIDHARA;;LAROCHELLE WILLIAM J,,https://lens.org/168-363-380-101-490,Patent Application,no,0,0,7,775,0,A61K38/00;;C07K14/4703;;A61P35/00,C12N15/09;;A61K38/00;;A61P35/00;;C07K14/47;;C07K16/18;;C07K19/00;;C12N5/07;;C12N5/077;;C12N5/078;;C12N5/0793;;C12N5/09;;C12N5/10;;C12Q1/68;;G01N33/53,,0,0,,,,DISCONTINUED
613,US,A1,US 2011/0288523 A1,095-125-024-756-44X,2011-11-24,2011,US 201113196256 A,2011-08-02,US 201113196256 A;;US 38697109 A,2009-04-24,Digital Syringe With Compensation Control,"A syringe for performing a medical procedure includes a pressure sensor, a volume sensor, and a compensation circuit. The volume sensor measures a volume of a flowable material that is dispensed from the syringe, the pressure sensor measures a pressure being applied to the flowable material, and the compensation circuit calculates a delivered volume of the flowable material by accounting for system compliance (expansion) as the pressure is increased. By compensating for system compliance in this manner, a syringe can be used in high pressure procedures while still providing accurately controllable material delivery.",DONOVAN BRIAN W;;LEUNG ANDREA Y;;ENG LISANNE;;THOMPSON DAVID P;;HUBLER ROBERT B;;BARNES STEPHANIE ANN;;ARENDS THOMAS C;;SCHUBERT KEITH;;LEONARD PAUL C;;MULLER PAUL F;;KYPHON SARL,DONOVAN BRIAN W;;LEUNG ANDREA Y;;ENG LISANNE;;THOMPSON DAVID P;;HUBLER ROBERT B;;BARNES STEPHANIE ANN;;ARENDS THOMAS C;;SCHUBERT KEITH;;LEONARD PAUL C;;MULLER PAUL F,KYPHON SARL (2009-04-24),https://lens.org/095-125-024-756-44X,Patent Application,yes,2,3,5,5,0,A61B17/8872;;A61B2017/0256;;A61M5/1452;;A61M5/16854;;A61M5/16877;;A61M2205/3317;;A61M2205/3389;;A61M2205/50;;A61M2205/502;;A61B17/8872;;A61M2205/3317;;A61M5/16854;;A61M2205/502;;A61B2017/0256;;A61M5/16877;;A61M2205/50;;A61M2205/3389;;A61M5/1452,A61M5/00,604/500,0,0,,,,ACTIVE
614,US,A1,US 2008/0274225 A1,053-568-479-575-716,2008-11-06,2008,US 17465208 A,2008-07-17,US 17465208 A;;US 4730005 A;;US 63410403 A;;US 40075502 P;;US 43819403 P,2002-08-02,PROCESS AND APPARATUS FOR MICROREPLICATION,"A method of embossing a sheet material includes: heating at least a portion of the sheet directly or indirectly with radiant energy from a radiant energy source; pressing a tool against the heated portion of the sheet, thereby patterning a surface of the sheet; and separating the sheet and the tool. The radiant energy may travel through a solid material that is relatively transparent to radiation, on its way to being absorbed by a relatively-absorptive material. The relatively-transparent material may be an unheated portion of the sheet, and the relatively-absorptive material may be either the tool or the heated portion of the sheet. Alternatively, the relatively-transparent material may be the tool, and the relatively-absorptive material may be all or part of the sheet. The method may be performed as one or more roll-to-roll operations.",BHARADWAI RISHIKESH K;;CHANG ENG-PI;;YI ZHI CHU PHILIP;;CHUANQ HSIAO KEN;;EDWARDS DAVID N;;FERMIN ROBERT J;;MEHRABI ALI R;;MEHRABI REZA;;SIELOFF RONALD F;;WANG CHUNHWA,BHARADWAI RISHIKESH K;;CHANG ENG-PI;;YI ZHI CHU PHILIP;;CHUANQ HSIAO KEN;;EDWARDS DAVID N;;FERMIN ROBERT J;;MEHRABI ALI R;;MEHRABI REZA;;SIELOFF RONALD F;;WANG CHUNHWA,,https://lens.org/053-568-479-575-716,Patent Application,yes,41,11,11,19,0,B29C59/02;;B29C59/02;;B29C35/0272;;B29C35/0272;;B29C35/0888;;B29C35/0888;;B29C59/04;;B29C59/04;;B29C2035/0822;;B29C2035/0822;;Y10T156/1023;;Y10T156/1023;;Y10T156/1041;;Y10T156/1041;;Y10T156/1737;;Y10T156/1737,B29C35/08;;B28C1/00;;B29C/;;B29C35/02;;B29C47/06;;B29C55/00;;B29C59/00;;B29C59/02;;B29C59/04;;B29C67/00;;B29C71/00;;H05B6/00,425/174.4,1,0,,,http://missionscience.nasa.gov/ems/07_infraredwaves.html,DISCONTINUED
615,KR,A,KR 20070087196 A,017-073-021-560-459,2007-08-27,2007,KR 20077016827 A,2007-07-20,US 13720005 A;;US 26616705 A;;US 63789704 P,2004-12-21,AN IN-SITU CHAMBER CLEAN PROCESS TO REMOVE BY-PRODUCT DEPOSITS FROM CHEMICAL VAPOR ETCH CHAMBER,"A method and apparatus for cleaning a processing chamber comprising blocking a flow of cooling fluid to a channel within a support member within a processing chamber, elevating the support member to be within about 0.1 inches of a gas distribution plate, heating the gas distribution plate, and introducing a thermally conductive gas through the gas distribution plate into the processing chamber. In one aspect, the chamber comprises a chamber body and a support assembly at least partially disposed within the chamber body adapted to support a substrate thereon. The chamber further comprises a lid assembly disposed on an upper surface of the chamber body. The lid assembly includes a top plate and a gas delivery assembly which define a plasma cavity therebetween, wherein the gas delivery assembly is adapted to heat the substrate. A remote plasma source having a U-shaped plasma region is connected to the gas delivery assembly.",APPLIED MATERIALS INC,KAO CHIEN TEH;;CHOU JING PEI;;UMOTOY SALVADOR P;;CHANG MEI;;YUAN XIAOXIONG JOHN;;CHANG YU;;LU XINLIANG;;PHAN SEE ENG;;KUANG WILLIAM;;TZU GWO CHUAN;;OR DAVID T,,https://lens.org/017-073-021-560-459,Patent Application,no,0,3,4,94,0,B08B7/00;;B08B7/0035;;H01J37/32009;;H01J37/32357;;H01J37/3244;;H01J37/32522;;H01J37/32862;;H01L29/665;;H01L29/6656;;H01L29/6659;;H01L29/7833;;C23C16/50;;H01L21/67207;;C23C16/503;;C23C16/505;;H01J37/3244;;H01J37/32522;;B08B7/0035;;H01L21/0262;;C23C16/511,C23C16/50,,0,0,,,,DISCONTINUED
616,US,B2,US 8257310 B2,076-615-783-725-014,2012-09-04,2012,US 201113196256 A,2011-08-02,US 201113196256 A;;US 38697109 A,2009-04-24,Digital syringe with compensation control,"A syringe for performing a medical procedure includes a pressure sensor, a volume sensor, and a compensation circuit. The volume sensor measures a volume of a flowable material that is dispensed from the syringe, the pressure sensor measures a pressure being applied to the flowable material, and the compensation circuit calculates a delivered volume of the flowable material by accounting for system compliance (expansion) as the pressure is increased. By compensating for system compliance in this manner, a syringe can be used in high pressure procedures while still providing accurately controllable material delivery.",DONOVAN BRIAN W;;LEUNG ANDREA Y;;ENG LISANNE A;;THOMPSON DAVID P;;HUBLER ROBERT B;;BARNES STEPHANIE A;;ARENDS THOMAS C;;SCHUBERT KEITH;;LEONARD PAUL C;;MULLER PAUL F;;KYPHON SARL,DONOVAN BRIAN W;;LEUNG ANDREA Y;;ENG LISANNE A;;THOMPSON DAVID P;;HUBLER ROBERT B;;BARNES STEPHANIE A;;ARENDS THOMAS C;;SCHUBERT KEITH;;LEONARD PAUL C;;MULLER PAUL F,KYPHON SARL (2009-04-24),https://lens.org/076-615-783-725-014,Granted Patent,yes,2,14,5,5,0,A61B17/8872;;A61B2017/0256;;A61M5/1452;;A61M5/16854;;A61M5/16877;;A61M2205/3317;;A61M2205/3389;;A61M2205/50;;A61M2205/502;;A61B17/8872;;A61M2205/3317;;A61M5/16854;;A61M2205/502;;A61B2017/0256;;A61M5/16877;;A61M2205/50;;A61M2205/3389;;A61M5/1452,A61M31/00;;A61M37/00,604/154;;604/500,0,0,,,,ACTIVE
617,US,A1,US 2005/0167863 A1,073-692-842-392-599,2005-08-04,2005,US 4730005 A,2005-01-31,US 4730005 A;;US 63410403 A;;US 40075502 P;;US 43819403 P,2002-08-02,Process and apparatus for microreplication,"A method of embossing a sheet material includes: heating at least a portion of the sheet directly or indirectly with radiant energy from a radiant energy source; pressing a tool against the heated portion of the sheet, thereby patterning a surface of the sheet; and separating the sheet and the tool. The radiant energy may travel through a solid material that is relatively transparent to radiation, on its way to being absorbed by a relatively-absorptive material. The relatively-transparent material may be an unheated portion of the sheet, and the relatively-absorptive material may be either the tool or the heated portion of the sheet. Alternatively, the relatively-transparent material may be the tool, and the relatively-absorptive material may be all or part of the sheet. The method may be performed as one or more roll-to-roll operations.",BHARADWAI RISHIKESH K.;;CHANG ENG-PI;;CHU PHILIP Y.Z.;;CHUANG HSIAO K.;;EDWARDS DAVID N.;;FERMIN ROBERT J.;;MEHRABI ALI R.;;MEHRABI REZA;;SIELOFF RONALD F.;;WANG CHUNHWA,BHARADWAI RISHIKESH K;;CHANG ENG-PI;;CHU PHILIP Y Z;;CHUANG HSIAO K;;EDWARDS DAVID N;;FERMIN ROBERT J;;MEHRABI ALI R;;MEHRABI REZA;;SIELOFF RONALD F;;WANG CHUNHWA,AVERY DENNISON CORPORATION (2005-01-26),https://lens.org/073-692-842-392-599,Patent Application,yes,29,4,11,19,0,B29C59/02;;B29C59/02;;B29C35/0272;;B29C35/0272;;B29C35/0888;;B29C35/0888;;B29C59/04;;B29C59/04;;B29C2035/0822;;B29C2035/0822;;Y10T156/1023;;Y10T156/1023;;Y10T156/1041;;Y10T156/1041;;Y10T156/1737;;Y10T156/1737,B28C1/00;;B29C/;;B29C35/02;;B29C35/08;;B29C47/06;;B29C55/00;;B29C59/00;;B29C59/02;;B29C59/04;;B29C67/00;;B29C71/00;;H05B6/00,264/1.1;;264/171.13;;264/173.16;;264/284;;264/348;;264/481;;425/363;;425/370,0,0,,,,EXPIRED
618,CN,B,CN 101437981 B,025-277-982-071-78X,2012-07-04,2012,CN 200580043491 A,2005-12-20,US 2005/0046226 W;;US 63789704 P;;US 13720005 A;;US 26616705 A,2004-12-21,In-situ chamber clean process to remove by-product deposits from chemical vapor etch chamber,"A method and apparatus for cleaning a processing chamber comprising blocking a flow of cooling fluid to a channel within a support member within a processing chamber, elevating the support member to be within about 0.1 inches of a gas distribution plate, heating the gas distribution plate, and introducing a thermally conductive gas through the gas distribution plate into the processing chamber. In one aspect, the chamber comprises a chamber body and a support assembly at least partially disposed within the chamber body adapted to support a substrate thereon. The chamber further comprises a lid assembly disposed on an upper surface of the chamber body. The lid assembly includes a top plate and a gas delivery assembly which define a plasma cavity therebetween, wherein the gas delivery assembly is adapted to heat the substrate. A remote plasma source having a U-shaped plasma region is connected to the gas delivery assembly.",APPLIED MATERIALS INC,MEI CHANG;;UMOTOY SALVADOR P;;WILLIAM KUANG;;CHUAN TZU GWO;;JOHN YUAN XIAOXIONG;;PEI CHOU JING;;XINLIANG LU;;ENG PHAN SEE;;TEH KAO CHIEN;;YU CHANG;;OR DAVID T,,https://lens.org/025-277-982-071-78X,Granted Patent,no,0,0,3,94,0,H01L21/31116;;H01L21/31116;;H01J37/32082;;H01J37/32082;;H01J37/32357;;H01J37/32357;;H01J37/32541;;H01J37/32541;;H01L21/28247;;H01L21/28247;;H01L21/67069;;H01L21/67069;;H01L29/665;;H01L29/665,H05H1/24;;C23C14/46,,0,0,,,,ACTIVE
619,US,B2,US 7416692 B2,084-867-575-017-524,2008-08-26,2008,US 4730005 A,2005-01-31,US 4730005 A;;US 63410403 A;;US 40075502 P;;US 43819403 P,2002-08-02,Process and apparatus for microreplication,"A method of embossing a sheet material includes: heating at least a portion of the sheet directly or indirectly with radiant energy from a radiant energy source; pressing a tool against the heated portion of the sheet, thereby patterning a surface of the sheet; and separating the sheet and the tool. The radiant energy may travel through a solid material that is relatively transparent to radiation, on its way to being absorbed by a relatively-absorptive material. The relatively-transparent material may be an unheated portion of the sheet, and the relatively-absorptive material may be either the tool or the heated portion of the sheet. Alternatively, the relatively-transparent material may be the tool, and the relatively-absorptive material may be all or part of the sheet. The method may be performed as one or more roll-to-roll operations.",AVERY DENNISON CORP,MEHRABI REZA;;FERMIN ROBERT J;;MEHRABI ALI R;;EDWARDS DAVID N;;WANG CHUNHWA;;BHARADWAJ RISHIKESH K;;SIELOFF RONALD F;;CHU PHILIP YI ZHI;;CHANG ENG-PI;;CHUANG HSIAO KEN,AVERY DENNISON CORPORATION (2005-01-26),https://lens.org/084-867-575-017-524,Granted Patent,yes,40,6,11,19,0,B29C59/02;;B29C59/02;;B29C35/0272;;B29C35/0272;;B29C35/0888;;B29C35/0888;;B29C59/04;;B29C59/04;;B29C2035/0822;;B29C2035/0822;;Y10T156/1023;;Y10T156/1023;;Y10T156/1041;;Y10T156/1041;;Y10T156/1737;;Y10T156/1737,B29C59/02;;B28C1/00;;B29C/;;B29C35/02;;B29C35/08;;B29C47/06;;B29C55/00;;B29C59/00;;B29C59/04;;B29C59/16;;B29C67/00;;B29C71/00;;B29C71/04;;H05B6/00,264/446;;264/210.2;;264/284;;264/293;;264/448;;264/464;;264/476;;264/480;;264/481,5,3,153-164-095-019-811;;114-454-339-320-362;;082-154-439-992-170,10.1889/1.1830169;;10.1038/417802a;;12075333;;12075347;;10.1038/nature00792,"Jagt, et al. 45.3: Micro-structured Polymeric Linearly Polarized Light Emitting Lightguide for LCD Illumination. 1236 SID 02 Digest (2002).;;Pease, Fabian R. ""Imprints offer Moore."" in Nature (2002), vol. 417, pp. 802-803.;;Chou, Stephen Y., et al. ""Ultrafast and direct imprint of nanostructures in silicon."" in Nature (2002), vol. 417, pp. 835-837.;;Claims from U.S. Appl. No. 11/176,435, filed Jul. 7, 2005.;;European Search Report from corresponding Patent Application No. EP 03 79 6292.",EXPIRED
620,WO,A2,WO 2006/069085 A2,009-133-432-606-142,2006-06-29,2006,US 2005/0046226 W,2005-12-20,US 63789704 P;;US 13720005 A;;US 26616705 A,2004-12-21,AN IN-SITU CHAMBER CLEAN PROCESS TO REMOVE BY-PRODUCT DEPOSITS FROM CHEMICAL VAPOR ETCH CHAMBER,"A method and apparatus for cleaning a processing chamber comprising blocking a flow of cooling fluid to a channel within a support member within a processing chamber, elevating the support member to be within about 0.1 inches of a gas distribution plate, heating the gas distribution plate, and introducing a thermally conductive gas through the gas distribution plate into the processing chamber. In one aspect, the chamber comprises a chamber body and a support assembly at least partially disposed within the chamber body adapted to support a substrate thereon. The chamber further comprises a lid assembly disposed on an upper surface of the chamber body. The lid assembly includes a top plate and a gas delivery assembly which define a plasma cavity therebetween, wherein the gas delivery assembly is adapted to heat the substrate. A remote plasma source having a U-shaped plasma region is connected to the gas delivery assembly.",APPLIED MATERIALS INC;;KAO CHIEN-TEH;;CHOU JING-PEI CONNIE;;UMOTOY SALVADOR P;;CHANG MEI;;YUAN XIAOXIONG JOHN;;CHANG YU;;LU XINLIANG;;PHAN SEE-ENG;;KUANG WILLIAM;;TZU GWO-CHUAN;;OR DAVID T,KAO CHIEN-TEH;;CHOU JING-PEI CONNIE;;UMOTOY SALVADOR P;;CHANG MEI;;YUAN XIAOXIONG JOHN;;CHANG YU;;LU XINLIANG;;PHAN SEE-ENG;;KUANG WILLIAM;;TZU GWO-CHUAN;;OR DAVID T,,https://lens.org/009-133-432-606-142,Patent Application,yes,0,20,4,94,0,B08B7/00;;B08B7/0035;;H01J37/32009;;H01J37/32357;;H01J37/3244;;H01J37/32522;;H01J37/32862;;H01L29/665;;H01L29/6656;;H01L29/6659;;H01L29/7833;;C23C16/50;;H01L21/67207;;C23C16/503;;C23C16/505;;H01J37/3244;;H01J37/32522;;B08B7/0035;;H01L21/0262;;C23C16/511,C23F1/00;;H01L21/306,,0,0,,,,PENDING
621,JP,A,JP 2012256942 A,150-465-972-515-332,2012-12-27,2012,JP 2012204729 A,2012-09-18,US 63789704 P;;US 13720005 A;;US 26616705 A,2004-12-21,IN-SITU CHAMBER CLEANING PROCESS FOR REMOVING DEPOSIT OF BY-PRODUCT FROM CHEMICAL VAPOR DEPOSITION ETCHING CHAMBER,"PROBLEM TO BE SOLVED: To provide a method and device for cleaning a processing chamber.SOLUTION: A method and device comprise the steps of: blocking a cooling fluid flow into a channel in a support member in a processing chamber; lifting the support member so as to be within about 0.1 inch from a gas distribution plate; heating the gas distribution plate; and introducing a heat-transfer gas to the processing chamber through the gas distribution plate. In an embodiment, a chamber comprises: a chamber body; and a support assembly at least partially disposed in the chamber body and adapted to support a substrate on it. The chamber further comprises a lid assembly disposed on an upper face of the chamber body. The lid assembly includes a top part plate and a gas distribution assembly defining a plasma cavity between the top part plate and the gas distribution assembly, and is adapted so that the gas distribution assembly heats the substrate. A remote plasma source having a U-type plasma region is connected to the gas distribution assembly.",APPLIED MATERIALS INC,KAO CHIEN-TEH;;CHOU JING PEI(CONNIE);;SALVADOR P UMOTOY;;CHANG MEI;;YUAN XIAOXIONG (JOHN);;CHANG YOO;;LOU SYNLIAN;;PHAN SEE ENG;;QUANG WILLIAM;;TZU GWO CHUAN;;DAVID T OR,,https://lens.org/150-465-972-515-332,Patent Application,no,8,7,6,94,0,H01L21/31116;;H01J37/32082;;H01J37/32357;;H01J37/32541;;H01L21/28247;;H01L21/67069;;H01L29/665,H01L21/31,,0,0,,,,ACTIVE
622,WO,A3,WO 2006/069085 A3,076-064-607-703-643,2009-06-11,2009,US 2005/0046226 W,2005-12-20,US 63789704 P;;US 13720005 A;;US 26616705 A,2004-12-21,AN IN-SITU CHAMBER CLEAN PROCESS TO REMOVE BY-PRODUCT DEPOSITS FROM CHEMICAL VAPOR ETCH CHAMBER,"A method and apparatus for cleaning a processing chamber comprising blocking a flow of cooling fluid to a channel within a support member within a processing chamber, elevating the support member to be within about 0.1 inches of a gas distribution plate, heating the gas distribution plate, and introducing a thermally conductive gas through the gas distribution plate into the processing chamber. In one aspect, the chamber comprises a chamber body and a support assembly at least partially disposed within the chamber body adapted to support a substrate thereon. The chamber further comprises a lid assembly disposed on an upper surface of the chamber body. The lid assembly includes a top plate and a gas delivery assembly which define a plasma cavity therebetween, wherein the gas delivery assembly is adapted to heat the substrate. A remote plasma source having a U-shaped plasma region is connected to the gas delivery assembly.",APPLIED MATERIALS INC;;KAO CHIEN-TEH;;CHOU JING-PEI CONNIE;;UMOTOY SALVADOR P;;CHANG MEI;;YUAN XIAOXIONG JOHN;;CHANG YU;;LU XINLIANG;;PHAN SEE-ENG;;KUANG WILLIAM;;TZU GWO-CHUAN;;OR DAVID T,KAO CHIEN-TEH;;CHOU JING-PEI CONNIE;;UMOTOY SALVADOR P;;CHANG MEI;;YUAN XIAOXIONG JOHN;;CHANG YU;;LU XINLIANG;;PHAN SEE-ENG;;KUANG WILLIAM;;TZU GWO-CHUAN;;OR DAVID T,,https://lens.org/076-064-607-703-643,Search Report,yes,6,0,4,94,0,B08B7/00;;B08B7/0035;;H01J37/32009;;H01J37/32357;;H01J37/3244;;H01J37/32522;;H01J37/32862;;H01L29/665;;H01L29/6656;;H01L29/6659;;H01L29/7833;;C23C16/50;;H01L21/67207;;C23C16/503;;C23C16/505;;H01J37/3244;;H01J37/32522;;B08B7/0035;;H01L21/0262;;C23C16/511,H01L21/00;;C23C14/00;;C23C16/00,,1,1,001-504-067-429-297,10.1143/jjap.41.5349,"HIROKI OGAWA ET AL.: ""Dry cleaning technology for removal of silicon native oxide employing hot NH3/NF3 exposure"", JPN. J. APPL.PHYS., vol. 41, no. 8, August 2002 (2002-08-01), pages 5349 - 5358, XP002491732",PENDING
623,TW,B,TW I387667 B,042-714-318-880-633,2013-03-01,2013,TW 94145341 A,2005-12-20,US 63789704 P;;US 13720005 A;;US 26616705 A,2004-12-21,An in-situ chamber clean process to remove by-product deposits from chemical vapor etch chamber,,APPLIED MATERIALS INC,KAO CHIEN-TEH;;CHOU JING PEI CONNIE;;UMOTOY SALVADOR P;;CHANG MEI;;YUAN XIAOXIONG JOHN;;CHANG YU;;LU XINLIANG;;PHAN SEE-ENG;;KUANG WILLIAM;;TZU GWO-CHUAN;;OR DAVID T,,https://lens.org/042-714-318-880-633,Granted Patent,no,0,0,6,94,0,H01L21/31116;;H01J37/32082;;H01J37/32357;;H01J37/32541;;H01L21/28247;;H01L21/67069;;H01L29/665,,,0,0,,,,ACTIVE
624,EP,A2,EP 1831430 A2,115-160-985-400-490,2007-09-12,2007,EP 05854872 A,2005-12-20,US 2005/0046226 W;;US 63789704 P;;US 13720005 A;;US 26616705 A,2004-12-21,AN IN-SITU CHAMBER CLEAN PROCESS TO REMOVE BY-PRODUCT DEPOSITS FROM CHEMICAL VAPOR ETCH CHAMBER,,APPLIED MATERIALS INC,KAO CHIEN-TEH;;CHOU JING-PEI CONNIE;;UMOTOY SALVADOR P;;CHANG MEI;;YUAN XIAOXIONG JOHN;;CHANG YU;;LU XINLIANG;;PHAN SEE-ENG;;KUANG WILLIAM;;TZU GWO-CHUAN;;OR DAVID T,,https://lens.org/115-160-985-400-490,Patent Application,yes,0,0,4,94,0,B08B7/00;;B08B7/0035;;H01J37/32009;;H01J37/32357;;H01J37/3244;;H01J37/32522;;H01J37/32862;;H01L29/665;;H01L29/6656;;H01L29/6659;;H01L29/7833;;C23C16/50;;H01L21/67207;;C23C16/503;;C23C16/505;;H01J37/3244;;H01J37/32522;;B08B7/0035;;H01L21/0262;;C23C16/511,C23F1/00;;H01L21/306,,0,0,,,,DISCONTINUED
625,TW,A,TW 200628633 A,094-734-216-264-447,2006-08-16,2006,TW 94145341 A,2005-12-20,US 63789704 P;;US 13720005 A;;US 26616705 A,2004-12-21,An in-situ chamber clean process to remove by-product deposits from chemical vapor etch chamber,"A method and apparatus for cleaning a processing chamber comprising blocking a flow of cooling fluid to a channel within a support member within a processing chamber, elevating the support member to be within about 0.1 inches of a gas distribution plate, heating the gas distribution plate, and introducing a thermally conductive gas through the gas distribution plate into the processing chamber. In one aspect, the chamber comprises a chamber body and a support assembly at least partially disposed within the chamber body adapted to support a substrate thereon. The chamber further comprises a lid assembly disposed on an upper surface of the chamber body. The lid assembly includes a top plate and a gas delivery assembly which define a plasma cavity therebetween, wherein the gas delivery assembly is adapted to heat the substrate. A remote plasma source having a U-shaped plasma region is connected to the gas delivery assembly.",APPLIED MATERIALS INC,KAO CHIEN-TEH;;CHOU JING-PEI CONNIE;;UMOTOY SALVADOR P;;CHANG MEI;;YUAN XIAO-XIONG JOHN;;CHANG YU;;LU XINLIANG;;PHAN SEE-ENG;;KUANG WILLIAM;;TZU GWO-CHUAN;;OR DAVID T,,https://lens.org/094-734-216-264-447,Patent of Addition,no,0,6,6,94,0,H01L21/31116;;H01J37/32082;;H01J37/32357;;H01J37/32541;;H01L21/28247;;H01L21/67069;;H01L29/665,,,0,0,,,,ACTIVE
626,BR,A,BR 0318625 A,192-605-579-698-510,2006-10-31,2006,BR 0318625 A,2003-12-22,US 52688303 P;;US 0341173 W,2003-12-04,biaril sulfonamidas e métodos para usar as mesmas,"""BIARIL SULFONAMIDAS E MéTODOS PARA USAR AS MESMAS"". A presente invenção se refere a biaril sulfonamidas de fórmula 1, em que R¬ 1¬ é H ou C~ 1~ - C~ 6~ alquila; R¬ 2¬ é H, C~ 1~ - C~ 6~ alquila, (CH~ 2~)~ n~R¬ 2¬, fenila ou benzila; n é 0 - 6; R¬ 2<39>¬ é arila, heteroarila, cicloalquila ou heterocicloalquila; R¬ 3¬ é, independentemente com relação a cada ocorrência, H, halogênio, OC(halogênio)~ 3~, C(halogênio)~ 3~, alcóxi ou C~ 1~ - C~ 6~ alquila; X é selecionado em CH~ 2~O, OCH~ 2~, C(R¬ 3¬)=(R¬ 3¬)~ 2~-C(R¬ 3¬)~ 2~, CH~ 2~NHC(=O), O(C=O)NH, O, C(=O)CH~ 2~, SO~ 2~CH~ 2~C(=O)NH, SO~ 2~NH, OC(=O), CH~ 2~S(O) e CH~ 2~S(O)~ 2~; e Z é pelo menos uma porção arila ou heteroarila, e seu uso como, por exemplo, inibidores de metaloproteinase.",WYETH CORP,XIANG JASON SHAOYUN;;TAM STEVE YIK-KAI;;HU YONGHAN;;SUM PHAIK-ENG;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES;;RUSH THOMAS SALTMARSH;;MORRIS ELISABETH ANN;;GEORGIADIS KATY EVANGELIA,,https://lens.org/192-605-579-698-510,Patent Application,no,0,0,39,39,0,A61K31/4188;;A61K31/424;;A61K31/429;;C07C311/29;;C07C311/46;;C07D213/30;;C07D213/64;;C07D213/643;;C07D215/14;;C07D215/227;;C07D215/233;;C07D217/18;;C07D235/12;;C07D239/34;;C07D239/60;;C07D261/14;;C07D263/22;;C07D263/58;;C07D277/64;;C07D277/68;;C07D295/096;;C07D295/192;;C07D307/79;;C07D307/80;;C07D307/82;;C07D307/84;;C07D319/18;;C07D321/10;;C07D333/20;;C07D333/36;;C07D333/66;;C07C2601/08;;C07C2602/10;;A61P1/00;;A61P1/02;;A61P1/04;;A61P1/16;;A61P11/00;;A61P11/06;;A61P13/12;;A61P17/02;;A61P19/00;;A61P19/02;;A61P19/04;;A61P19/08;;A61P19/10;;A61P21/00;;A61P25/00;;A61P27/02;;A61P29/00;;A61P3/00;;A61P35/00;;A61P35/04;;A61P37/00;;A61P37/06;;A61P43/00;;A61P7/00;;A61P9/00;;A61P9/10;;A61P9/14;;A61P3/10;;C07D213/30;;C07D217/18;;C07D319/18;;C07D215/227;;C07D295/096;;C07D321/10;;C07C311/29;;C07D277/64;;C07D213/643;;A61K31/4188;;A61K31/424;;C07D215/233;;C07D263/22;;C07D307/84;;C07D213/64;;C07C311/46;;A61K31/429;;C07D295/192;;C07D215/14;;C07D307/79;;C07D333/20;;C07D261/14;;C07D239/34;;C07D307/80;;C07D333/66;;C07D239/60;;C07D277/68;;C07D307/82;;C07D263/58;;C07D333/36;;C07D235/12;;C07C2601/08;;C07C2602/10,C07C311/29;;C07C311/46;;C07D213/30;;C07D213/64;;C07D213/643;;C07D215/14;;C07D215/22;;C07D215/227;;C07D215/233;;C07D217/18;;C07D235/12;;C07D239/34;;C07D239/60;;C07D261/14;;C07D263/22;;C07D263/58;;C07D277/64;;C07D277/68;;C07D295/096;;C07D295/192;;C07D307/79;;C07D307/80;;C07D307/82;;C07D307/84;;C07D319/18;;C07D321/10;;C07D333/20;;C07D333/36;;C07D333/66,,0,0,,,,DISCONTINUED
627,US,A1,US 2005/0130973 A1,138-229-502-130-826,2005-06-16,2005,US 71104 A,2004-12-01,US 71104 A;;US 52688303 P,2003-12-04,Biaryl sulfonamides and methods for using same,"The present invention relates to biaryl sulfonamides and their use as, for example, metalloproteinase inhibitors.",WYETH CORP,XIANG JASON S;;TAM STEVE Y;;HU YONGHAN;;SUM PHAIK-ENG;;HOW DAVID B;;HOPPER DARRIN W;;VERA MATTHEW D;;SABATINI JOSHUA J;;RUSH THOMAS S III;;MORRIS ELISABETH A;;GEORGIADIS KATY E,WYETH (2005-01-19),https://lens.org/138-229-502-130-826,Patent Application,yes,0,26,39,39,0,A61K31/4188;;A61K31/424;;A61K31/429;;C07C311/29;;C07C311/46;;C07D213/30;;C07D213/64;;C07D213/643;;C07D215/14;;C07D215/227;;C07D215/233;;C07D217/18;;C07D235/12;;C07D239/34;;C07D239/60;;C07D261/14;;C07D263/22;;C07D263/58;;C07D277/64;;C07D277/68;;C07D295/096;;C07D295/192;;C07D307/79;;C07D307/80;;C07D307/82;;C07D307/84;;C07D319/18;;C07D321/10;;C07D333/20;;C07D333/36;;C07D333/66;;C07C2601/08;;C07C2602/10;;A61P1/00;;A61P1/02;;A61P1/04;;A61P1/16;;A61P11/00;;A61P11/06;;A61P13/12;;A61P17/02;;A61P19/00;;A61P19/02;;A61P19/04;;A61P19/08;;A61P19/10;;A61P21/00;;A61P25/00;;A61P27/02;;A61P29/00;;A61P3/00;;A61P35/00;;A61P35/04;;A61P37/00;;A61P37/06;;A61P43/00;;A61P7/00;;A61P9/00;;A61P9/10;;A61P9/14;;A61P3/10;;C07D213/30;;C07D217/18;;C07D319/18;;C07D215/227;;C07D295/096;;C07D321/10;;C07C311/29;;C07D277/64;;C07D213/643;;A61K31/4188;;A61K31/424;;C07D215/233;;C07D263/22;;C07D307/84;;C07D213/64;;C07C311/46;;A61K31/429;;C07D295/192;;C07D215/14;;C07D307/79;;C07D333/20;;C07D261/14;;C07D239/34;;C07D307/80;;C07D333/66;;C07D239/60;;C07D277/68;;C07D307/82;;C07D263/58;;C07D333/36;;C07D235/12;;C07C2601/08;;C07C2602/10,C07C311/29;;C07C311/46;;C07D213/30;;C07D213/64;;C07D213/643;;C07D215/14;;C07D215/22;;C07D215/227;;C07D215/233;;C07D217/18;;C07D235/12;;C07D239/34;;C07D239/60;;C07D261/14;;C07D263/22;;C07D263/58;;C07D277/64;;C07D277/68;;C07D295/096;;C07D295/192;;C07D307/79;;C07D307/80;;C07D307/82;;C07D307/84;;C07D319/18;;C07D321/10;;C07D333/20;;C07D333/36;;C07D333/66,514/247;;514/275;;514/255.06;;514/310;;514/313;;514/352;;514/355;;514/367;;514/370;;514/374;;514/375;;514/406;;514/562;;544/239;;544/330;;544/406;;546/159;;546/146;;544/304;;546/304;;546/314;;562/430,0,0,,,,INACTIVE
628,US,B2,US 7923446 B2,148-703-818-319-703,2011-04-12,2011,US 75625307 A,2007-05-31,US 75625307 A;;US 71104 A;;US 52688303 P,2003-12-04,Biaryl sulfonamides and methods for using same,"The present invention relates to biaryl sulfonamides and their use as, for example, metalloproteinase inhibitors.",WYETH LLC,XIANG JASON SHAOYUN;;TAM STEVE YIKKAI;;HU YONGHAN;;SUM PHAIK-ENG;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES;;RUSH III THOMAS SALTMARSH;;MORRIS ELISABETH ANN;;GEORGIADIS KATY EVANGELIA,WYETH LLC (2009-11-09),https://lens.org/148-703-818-319-703,Granted Patent,yes,7,0,39,39,0,A61K31/4188;;A61K31/424;;A61K31/429;;C07C311/29;;C07C311/46;;C07D213/30;;C07D213/64;;C07D213/643;;C07D215/14;;C07D215/227;;C07D215/233;;C07D217/18;;C07D235/12;;C07D239/34;;C07D239/60;;C07D261/14;;C07D263/22;;C07D263/58;;C07D277/64;;C07D277/68;;C07D295/096;;C07D295/192;;C07D307/79;;C07D307/80;;C07D307/82;;C07D307/84;;C07D319/18;;C07D321/10;;C07D333/20;;C07D333/36;;C07D333/66;;C07C2601/08;;C07C2602/10;;A61P1/00;;A61P1/02;;A61P1/04;;A61P1/16;;A61P11/00;;A61P11/06;;A61P13/12;;A61P17/02;;A61P19/00;;A61P19/02;;A61P19/04;;A61P19/08;;A61P19/10;;A61P21/00;;A61P25/00;;A61P27/02;;A61P29/00;;A61P3/00;;A61P35/00;;A61P35/04;;A61P37/00;;A61P37/06;;A61P43/00;;A61P7/00;;A61P9/00;;A61P9/10;;A61P9/14;;A61P3/10;;C07D213/30;;C07D217/18;;C07D319/18;;C07D215/227;;C07D295/096;;C07D321/10;;C07C311/29;;C07D277/64;;C07D213/643;;A61K31/4188;;A61K31/424;;C07D215/233;;C07D263/22;;C07D307/84;;C07D213/64;;C07C311/46;;A61K31/429;;C07D295/192;;C07D215/14;;C07D307/79;;C07D333/20;;C07D261/14;;C07D239/34;;C07D307/80;;C07D333/66;;C07D239/60;;C07D277/68;;C07D307/82;;C07D263/58;;C07D333/36;;C07D235/12;;C07C2601/08;;C07C2602/10,A61K31/47;;C07D217/02;;A61K31/50;;C07C311/29;;C07C311/46;;C07D213/30;;C07D213/64;;C07D213/643;;C07D215/14;;C07D215/22;;C07D215/227;;C07D215/233;;C07D217/18;;C07D235/12;;C07D239/34;;C07D239/60;;C07D261/14;;C07D263/22;;C07D263/58;;C07D277/64;;C07D277/68;;C07D295/096;;C07D295/192;;C07D307/79;;C07D307/80;;C07D307/82;;C07D307/84;;C07D319/18;;C07D321/10;;C07D333/20;;C07D333/36;;C07D333/66,514/247;;514/252.1;;514/256;;514/307;;514/310;;514/311;;514/313;;514/352;;514/357;;514/367;;514/370;;514/374;;514/375;;514/406;;514/407;;514/562;;544/224;;544/242;;544/336;;546/147;;546/152;;546/304;;546/341;;548/148;;548/216;;562/430,26,21,017-895-235-087-735;;017-171-751-918-394;;044-818-906-136-295;;069-158-340-991-44X;;045-470-361-571-490;;004-914-835-124-914;;078-419-272-100-703;;105-804-415-869-201;;022-579-586-775-544;;069-766-900-161-081;;183-022-553-352-289;;017-738-995-123-197;;125-230-735-125-063;;036-990-702-277-410;;088-553-913-634-060;;072-065-218-673-515;;003-012-473-323-211;;184-809-052-195-735;;134-286-353-563-577;;146-037-035-826-309;;017-634-281-935-576,10.1021/jm9707582;;9484512;;10.1016/s1357-2725(00)00061-3;;11167130;;10.1074/jbc.274.33.23443;;10438522;;10.1016/s0945-053x(97)90052-4;;10438512;;10.1074/jbc.274.33.23349;;9006920;;10.1074/jbc.272.5.2801;;8995297;;10.1074/jbc.272.1.556;;10.1016/0169-409x(92)90014-h;;10.1002/jps.2600770402;;3379586;;5432063;;10.1038/227680a0;;6161559;;pmc411572;;388439;;10.1073/pnas.76.9.4350;;pmc1136329;;10.1042/bj3050799;;7531436;;10.1021/jm00033a018;;7512142;;10.1039/jr9570003144;;10.1016/s0040-4039(98)00502-4;;10.1016/s0040-4020(01)98751-4;;10.1016/0040-4020(95)00159-6;;10.1021/ja01242a036;;10.1016/s0040-4020(00)00315-x;;10.1016/0014-5793(92)80300-6;;1537400,"Tamura, Y. et al., ""Highly Selective and Orally Active Inhibitors of Type IV Collagenase (MMP-9 and MMP-2): N-Sulfonylamino Acid Derivatives,"" J Med Chem, 1998, 41:640-649.;;Tang, B. L., ""ADAMTS: a novel family of extracellular matrix proteases,"", Int J Biochem Cell Biol, 2001, 33:33-44.;;Abbaszade I. et al., ""Cloning and Characterization of ADAMTS11, an Aggrecanase from the ADAMTS family,"" J Biol Chem, Aug. 13, 1999, 274(33): 23443-23450.;;Colige, A. et al., ""cDNA cloning and expression of bovine procollagen I N-proteinase: A new member of the superfamily of zinc-metalloproteinases with binding sites for cells and other matrix components,"" Proc Natl Acad Sci USA, Mar. 1997, 94, 2374-2379.;;Vázquez F. et al., ""METH-1, a Human Orgholog of ADAMTS-1, and METH-2 Are Members of a New Family of Proteins with Angio-inhibitory Activiy,"" J Biol Chem, Aug. 13, 1999, 274(33): 23349-23357.;;Masui T., et al., ""An Alu-linked Repetitive Sequence Corresponding to 280 Amino Acids Is Expressed in a Novel Bovine Protein, but Not in Its Human Homologue,"" J Biol Chem, Jan. 31, 1997, 272(5), 2801-2807.;;Kuno, K. et al., ""Molecular Cloning of a Gene Encoding a New Type of Metalloproteinase-disintegrin Family Protein with Thrombospondin Motifs as an Inflammation Associated Gene,"" J Biol Chem, Jan. 3, 1997, 272(1), 556-562.;;Bundgaard, H. (ed.), Design of Prodrugs, Elsevier (1985), Ch. 1 (pp. 1-92), Ch. 4 (pp. 157-176), Ch. 5 (pp. 177-198), and Ch. 6 (pp. 199-241).;;Widder, et al. (ed.), Methods in Enzymology, vol. 112, Academic Press (1985), pp. 309-396.;;Krogsgaard-Larsen, et al., (ed). Design and Application of Prodrugs, Textbook of Drug Design and Development, Chapter 5, 113-191, 1991.;;Bundgaard, H., ""Means to enhance penetration; Prodrugs as a means to improve the delivery of peptide drugs,"" Advanced Drug Deliver Reviews, 1992, 8, 1-38.;;Bundgaard, H. et al., ""Glycolamide Esters as Biolabile Prodrugs of Carboxylic Acid Agents: Synthesis, Stability, Bioconversion, and Physicochemical Properties,"" J. of Pharmaceutical Sciences, Apr. 1988, 77(4):285-298.;;Higuchi and Stella (eds.), Prodrugs as Novel Drug Delivery Systems, American Chemical Society (1975), pp. 1-115 and 196-223.;;Laemmli, U. K., ""Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4,"" Nature, Aug. 15, 1970, 227:680-685.;;Oaklet, B. R. et al., ""A Simplified Ultrasensitive Silver Stain for Detecting Proteins in Polyacrylamide Gels,"" Anal. Biochem, 1980, 105:361-363.;;Towbin, H. et al., ""Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications,"" Proc. Natl. Acad. Sci. USA, Sep. 1979, 76(9), 4350-4354.;;Hughes, C. E. et al., ""Monoclonal antibodies that specifically recognize neoepitope sequences generated by 'aggrecanase' and matrix metalloproteinase cleavage of aggrecan: application to catabolism in situ and in vitro,"" Biochem J, Feb. 1, 1995, 305(3), 799-804.;;Romero, D. L. et al, ""Discovery, Synthesis, and Bioactivity of Bis(heteroaryl)piperazines. 1. A Novel Class of Non-Nucleoside HIV-1 Reverse Tranascriptase Inhibitors,"" J. Med. Chem. 1994, 37, 999-1014.;;Emmott, P. et al., ""Preparation of Some Naphthofurans,"" J. Chem. Soc. (Jul. 1957) pp. 3144-3148.;;Evans, D. A. et al., ""Synthesis of Diaryl Ethers through the Copper-Promoted Arylation of Phenols with Arylboronic Acids. An Expedient Synthesis of Thyroxine,"" Tetrahedron Lett., May 7, 1998, 39(19):2937-2940.;;Bencze, W. L. et. al, ""The Absolute Configuration of a Hypolipidemic 1-Aryl Tetralin, Nafenopin,"" Tetrahedron 1970, 26:5407-5414.;;Werner, A. W. et al., ""Porphyrins with Four Azole Substituents in meso Positions: X-Ray Crystal Structure of Meso-tetrakis-(1-benzylpyrazol-4-y1)-porphyrin at 200 K,"" Tetrahedron, Apr. 17, 1995, 51(16): 4779-4800.;;Burtner, R.R. et al., ""Antispasmodics. I. Basic Esters of Some Arylacetic Acids,"" J. Am. Chem. Soc., 1943, 65:262-267.;;Abramov, M. A. et al., ""Nucleophilic Intramolecular Cyclization Reactions of Alkylnechalcogenolates,"" Tetrahedron, Jun. 9, 2000, 56(24): 3933-3940.;;Knight, C.G. et al., ""A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases,"" FEBS Lett. (Jan. 1992) 296(3):263-266.;;Remington's Pharmaceutical Sciences, 17th Ed., Gennaro, A. R. (Ed.), Mack Publishing Company, Easton, PA (1985) pp. 1409-1677.",INACTIVE
629,US,A1,US 2007/0225327 A1,127-552-480-266-933,2007-09-27,2007,US 75625307 A,2007-05-31,US 75625307 A;;US 71104 A;;US 52688303 P,2003-12-04,Biaryl Sulfonamides and Methods for Using Same,"The present invention relates to biaryl sulfonamides and their use as, for example, metalloproteinase inhibitors.",WYETH CORP,XIANG JASON S;;TAM STEVE Y;;HU YONGHAN;;SUM PHAIK-ENG;;HOW DAVID B;;HOPPER DARRIN W;;VERA MATTHEW D;;SABATINI JOSHUA J;;RUSH THOMAS S III;;MORRIS ELISABETH A;;GEORGIADIS KATY E,WYETH LLC (2009-11-09),https://lens.org/127-552-480-266-933,Patent Application,yes,2,0,39,39,0,A61K31/4188;;A61K31/424;;A61K31/429;;C07C311/29;;C07C311/46;;C07D213/30;;C07D213/64;;C07D213/643;;C07D215/14;;C07D215/227;;C07D215/233;;C07D217/18;;C07D235/12;;C07D239/34;;C07D239/60;;C07D261/14;;C07D263/22;;C07D263/58;;C07D277/64;;C07D277/68;;C07D295/096;;C07D295/192;;C07D307/79;;C07D307/80;;C07D307/82;;C07D307/84;;C07D319/18;;C07D321/10;;C07D333/20;;C07D333/36;;C07D333/66;;C07C2601/08;;C07C2602/10;;A61P1/00;;A61P1/02;;A61P1/04;;A61P1/16;;A61P11/00;;A61P11/06;;A61P13/12;;A61P17/02;;A61P19/00;;A61P19/02;;A61P19/04;;A61P19/08;;A61P19/10;;A61P21/00;;A61P25/00;;A61P27/02;;A61P29/00;;A61P3/00;;A61P35/00;;A61P35/04;;A61P37/00;;A61P37/06;;A61P43/00;;A61P7/00;;A61P9/00;;A61P9/10;;A61P9/14;;A61P3/10;;C07D213/30;;C07D217/18;;C07D319/18;;C07D215/227;;C07D295/096;;C07D321/10;;C07C311/29;;C07D277/64;;C07D213/643;;A61K31/4188;;A61K31/424;;C07D215/233;;C07D263/22;;C07D307/84;;C07D213/64;;C07C311/46;;A61K31/429;;C07D295/192;;C07D215/14;;C07D307/79;;C07D333/20;;C07D261/14;;C07D239/34;;C07D307/80;;C07D333/66;;C07D239/60;;C07D277/68;;C07D307/82;;C07D263/58;;C07D333/36;;C07D235/12;;C07C2601/08;;C07C2602/10,A61K31/47;;A61K31/197;;C07C311/29;;C07C311/46;;C07D213/30;;C07D213/64;;C07D213/643;;C07D215/14;;C07D215/22;;C07D215/227;;C07D215/233;;C07D217/18;;C07D235/12;;C07D239/34;;C07D239/60;;C07D261/14;;C07D263/22;;C07D263/58;;C07D277/64;;C07D277/68;;C07D295/096;;C07D295/192;;C07D307/79;;C07D307/80;;C07D307/82;;C07D307/84;;C07D319/18;;C07D321/10;;C07D333/20;;C07D333/36;;C07D333/66,514/311;;514/562,0,0,,,,INACTIVE
630,AR,A1,AR 046860 A1,065-492-741-382-192,2005-12-28,2005,AR P040104462 A,2004-12-01,US 52688303 P;;US 0341173 W,2003-12-04,BIARIL SULFONAMIDAS CON CAPACIDAD MODULADORA DE ACTIVIDAD DE METALOPROTEASA.,"Estos compuestos presentan actividad como inhibidores de metaloproteinasas. Reivindicación 1: Compuesto de fórmula (1), caracterizado porque: R1 es H o alquilo C1-6; R2 es H, alquilo C1-6, (CH2)nR'2, fenilo o bencilo; n es 0-6; R'2 es arilo, heteroarilo, cicloalquilo, o heterocicloalquilo; R3 es, independientemente en cada una de las ocurrencias, H, halógeno, OC(halógeno)3, C(halógeno)3, alcoxi, o alquilo C1-6; X se escoge entre CH2O, OCH2, C(R3)=C(R3), C(R3)2-C(R3)2, CH2NHC(=O), O(C=O)NH, O, C(=O)CH2, SO2CH2C(=O)NH, SO2NH, OC(=O), CH2S(O), y CH2S(O)2; y Z es al menos un grupo arilo o heteroarilo.",WYETH CORP,XIANG JASON SHAOYUN;;TAM STEVE YIK-KAI;;HU YONGHAN;;SUM PHAIK-ENG;;HOW DAVID BRAIN;;HOPPER DARRIN WILLIAM;;SABATINI JOSHUA JAMES;;RUSH THOMAS SALTMARSH III;;MORRIS ELISABETH ANN;;GEORGIADIS KATY EVANGELIA;;VERA MATTHEW DOUGLAS,,https://lens.org/065-492-741-382-192,Patent Application,no,0,0,39,39,0,A61K31/4188;;A61K31/424;;A61K31/429;;C07C311/29;;C07C311/46;;C07D213/30;;C07D213/64;;C07D213/643;;C07D215/14;;C07D215/227;;C07D215/233;;C07D217/18;;C07D235/12;;C07D239/34;;C07D239/60;;C07D261/14;;C07D263/22;;C07D263/58;;C07D277/64;;C07D277/68;;C07D295/096;;C07D295/192;;C07D307/79;;C07D307/80;;C07D307/82;;C07D307/84;;C07D319/18;;C07D321/10;;C07D333/20;;C07D333/36;;C07D333/66;;C07C2601/08;;C07C2602/10;;A61P1/00;;A61P1/02;;A61P1/04;;A61P1/16;;A61P11/00;;A61P11/06;;A61P13/12;;A61P17/02;;A61P19/00;;A61P19/02;;A61P19/04;;A61P19/08;;A61P19/10;;A61P21/00;;A61P25/00;;A61P27/02;;A61P29/00;;A61P3/00;;A61P35/00;;A61P35/04;;A61P37/00;;A61P37/06;;A61P43/00;;A61P7/00;;A61P9/00;;A61P9/10;;A61P9/14;;A61P3/10;;C07D213/30;;C07D217/18;;C07D319/18;;C07D215/227;;C07D295/096;;C07D321/10;;C07C311/29;;C07D277/64;;C07D213/643;;A61K31/4188;;A61K31/424;;C07D215/233;;C07D263/22;;C07D307/84;;C07D213/64;;C07C311/46;;A61K31/429;;C07D295/192;;C07D215/14;;C07D307/79;;C07D333/20;;C07D261/14;;C07D239/34;;C07D307/80;;C07D333/66;;C07D239/60;;C07D277/68;;C07D307/82;;C07D263/58;;C07D333/36;;C07D235/12;;C07C2601/08;;C07C2602/10,C07C311/29;;C07C311/46;;C07D213/30;;C07D213/64;;C07D213/643;;C07D215/14;;C07D215/22;;C07D215/227;;C07D215/233;;C07D217/18;;C07D235/12;;C07D239/34;;C07D239/60;;C07D261/14;;C07D263/22;;C07D263/58;;C07D277/64;;C07D277/68;;C07D295/096;;C07D295/192;;C07D307/79;;C07D307/80;;C07D307/82;;C07D307/84;;C07D319/18;;C07D321/10;;C07D333/20;;C07D333/36;;C07D333/66,,0,0,,,,PENDING
631,AU,A1,AU 2004/200075 A1,002-418-221-832-822,2005-06-23,2005,AU 2004/200075 A,2004-01-08,US 25688303 P,2003-12-04,Biaryl sulfonamides and methods for using same,,WYETH CORP,MORRIS ELISABETH ANN;;RUSH THOMAS SALTMARSH III;;SABATINI JOSHUA JAMES;;VERA MATTHEW DOUGLAS;;HOPPER DARRIN WILLIAM;;HOW DAVID BRIAN;;SUM PHAIK-ENG;;HU YONGHAN;;TAM STEVE YIK-KAI;;XIANG JASON SHAOYUN;;GEORGIADIS KATY EVANGELIA,,https://lens.org/002-418-221-832-822,Patent Application,no,0,0,1,1,0,,A61K31/198;;A61K31/20;;A61K31/235;;A61K31/341;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;A61K31/42;;A61K31/421;;A61K31/425;;A61K31/428;;A61K31/435;;A61K31/44;;A61K31/4995;;A61K31/505;;A61P1/16;;A61P3/08;;A61P3/10;;A61P5/48;;A61P5/50;;A61P9/00;;A61P9/10;;A61P11/00;;A61P13/12;;A61P17/02;;A61P19/02;;A61P19/08;;A61P25/28;;A61P27/00;;A61P35/00;;A61P37/06,,0,0,,,,DISCONTINUED
632,EP,A1,EP 1689716 A1,078-240-208-911-819,2006-08-16,2006,EP 03819166 A,2003-12-22,US 0341173 W;;US 52688303 P,2003-12-04,BIARYL SULFONAMIDES AND METHODS FOR USING SAME,,WYETH CORP,XIANG JASON SHAOYUN;;TAM STEVE YIK-KAI;;HU YONGHAN;;SUM PHAIK-ENG;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES;;RUSH THOMAS SALTMARSH III;;MORRIS ELISABETH ANN;;GEORGIADIS KATY EVANGELIA,,https://lens.org/078-240-208-911-819,Patent Application,yes,0,0,39,39,0,A61K31/4188;;A61K31/424;;A61K31/429;;C07C311/29;;C07C311/46;;C07D213/30;;C07D213/64;;C07D213/643;;C07D215/14;;C07D215/227;;C07D215/233;;C07D217/18;;C07D235/12;;C07D239/34;;C07D239/60;;C07D261/14;;C07D263/22;;C07D263/58;;C07D277/64;;C07D277/68;;C07D295/096;;C07D295/192;;C07D307/79;;C07D307/80;;C07D307/82;;C07D307/84;;C07D319/18;;C07D321/10;;C07D333/20;;C07D333/36;;C07D333/66;;C07C2601/08;;C07C2602/10;;A61P1/00;;A61P1/02;;A61P1/04;;A61P1/16;;A61P11/00;;A61P11/06;;A61P13/12;;A61P17/02;;A61P19/00;;A61P19/02;;A61P19/04;;A61P19/08;;A61P19/10;;A61P21/00;;A61P25/00;;A61P27/02;;A61P29/00;;A61P3/00;;A61P35/00;;A61P35/04;;A61P37/00;;A61P37/06;;A61P43/00;;A61P7/00;;A61P9/00;;A61P9/10;;A61P9/14;;A61P3/10;;C07D213/30;;C07D217/18;;C07D319/18;;C07D215/227;;C07D295/096;;C07D321/10;;C07C311/29;;C07D277/64;;C07D213/643;;A61K31/4188;;A61K31/424;;C07D215/233;;C07D263/22;;C07D307/84;;C07D213/64;;C07C311/46;;A61K31/429;;C07D295/192;;C07D215/14;;C07D307/79;;C07D333/20;;C07D261/14;;C07D239/34;;C07D307/80;;C07D333/66;;C07D239/60;;C07D277/68;;C07D307/82;;C07D263/58;;C07D333/36;;C07D235/12;;C07C2601/08;;C07C2602/10,C07D215/22;;A61K31/198;;A61K31/33;;C07C311/29;;C07C311/46;;C07D213/30;;C07D213/64;;C07D213/643;;C07D215/14;;C07D215/227;;C07D215/233;;C07D217/18;;C07D235/12;;C07D239/34;;C07D239/60;;C07D261/14;;C07D263/22;;C07D263/58;;C07D277/64;;C07D277/68;;C07D295/08;;C07D295/096;;C07D295/18;;C07D295/192;;C07D307/79;;C07D307/80;;C07D307/82;;C07D307/84;;C07D319/18;;C07D321/10;;C07D333/20;;C07D333/36;;C07D333/66,,0,0,,,,DISCONTINUED
633,CA,A1,CA 2548513 A1,021-611-764-139-892,2005-07-07,2005,CA 2548513 A,2003-12-22,US 52688303 P;;US 0341173 W,2003-12-04,BIARYL SULFONAMIDES AND METHODS FOR USING SAME,"The present invention relates to biaryl sulfonamides of the formula 1: wherein: R1 is H or Cl-.C6 a]kyl; R2 is H, C I -C6 alkyl, (CH2)nR2' , phenyl , or benzyl; n is 0-6; R2'is aryl, heteroaryl, cycloalkyl, or heterocycloalkyl ; R 3 is, independently with respect to each occurrence, H, halogen, OC(halogen)3,C(halogen)3, alkoxy, or C I -C 6 alkyl; X is selected from CH20 , OCH2, C (R3)=(R3)2-C(R3)2, CH2NHC(=O), O(C=O)NH, O, C(=O)CH2, SO2CH2C(=O)NH, SO2NH, OC(=O), CH2S(O), and CH2S(O)2; and Z is at least one aryl or heteroar yl moiety, and their use as for example metalloproteinase inhibitors.",WYETH CORP,XIANG JASON SHAOYUN;;TAM STEVE YIK-KAI;;HU YONGHAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;RUSH THOMAS SALTMARSH III;;MORRIS ELISABETH ANN;;GEORGIADIS KATY EVANGELIA;;HOW DAVID BRIAN;;SABATINI JOSHUA JAMES;;SUM PHAIK-ENG,,https://lens.org/021-611-764-139-892,Patent Application,no,0,0,39,39,0,A61K31/4188;;A61K31/424;;A61K31/429;;C07C311/29;;C07C311/46;;C07D213/30;;C07D213/64;;C07D213/643;;C07D215/14;;C07D215/227;;C07D215/233;;C07D217/18;;C07D235/12;;C07D239/34;;C07D239/60;;C07D261/14;;C07D263/22;;C07D263/58;;C07D277/64;;C07D277/68;;C07D295/096;;C07D295/192;;C07D307/79;;C07D307/80;;C07D307/82;;C07D307/84;;C07D319/18;;C07D321/10;;C07D333/20;;C07D333/36;;C07D333/66;;C07C2601/08;;C07C2602/10;;A61P1/00;;A61P1/02;;A61P1/04;;A61P1/16;;A61P11/00;;A61P11/06;;A61P13/12;;A61P17/02;;A61P19/00;;A61P19/02;;A61P19/04;;A61P19/08;;A61P19/10;;A61P21/00;;A61P25/00;;A61P27/02;;A61P29/00;;A61P3/00;;A61P35/00;;A61P35/04;;A61P37/00;;A61P37/06;;A61P43/00;;A61P7/00;;A61P9/00;;A61P9/10;;A61P9/14;;A61P3/10;;C07D213/30;;C07D217/18;;C07D319/18;;C07D215/227;;C07D295/096;;C07D321/10;;C07C311/29;;C07D277/64;;C07D213/643;;A61K31/4188;;A61K31/424;;C07D215/233;;C07D263/22;;C07D307/84;;C07D213/64;;C07C311/46;;A61K31/429;;C07D295/192;;C07D215/14;;C07D307/79;;C07D333/20;;C07D261/14;;C07D239/34;;C07D307/80;;C07D333/66;;C07D239/60;;C07D277/68;;C07D307/82;;C07D263/58;;C07D333/36;;C07D235/12;;C07C2601/08;;C07C2602/10,C07D215/22;;A61K31/198;;A61K31/33;;C07C311/29;;C07C311/46;;C07D213/30;;C07D213/64;;C07D213/643;;C07D215/14;;C07D215/227;;C07D215/233;;C07D217/18;;C07D235/12;;C07D239/34;;C07D239/60;;C07D261/14;;C07D263/22;;C07D263/58;;C07D277/64;;C07D277/68;;C07D295/08;;C07D295/096;;C07D295/18;;C07D295/192;;C07D307/79;;C07D307/80;;C07D307/82;;C07D307/84;;C07D319/18;;C07D321/10;;C07D333/20;;C07D333/36;;C07D333/66,,0,0,,,,DISCONTINUED
634,WO,A1,WO 2005/061459 A1,152-277-771-440-906,2005-07-07,2005,US 0341173 W,2003-12-22,US 52688303 P,2003-12-04,BIARYL SULFONAMIDES AND METHODS FOR USING SAME,"The present invention relates to biaryl sulfonamides of the formula 1: wherein: R1 is H or Cl-.C6 a&rsqb;kyl; R2 is H, C I -C6 alkyl, (CH2)nR2&apos; , phenyl, or benzyl; n is 0-6; R2&apos;is aryl, heteroaryl, cycloalkyl, or heterocycloalkyl; R 3 is, independently with respect to each occurrence, H, halogen, OC(halogen)3,C(halogen)3, alkoxy, or C I -C 6 alkyl; X is selected from CH20, OCH2, C (R3)=(R3)2-C(R3)2, CH2NHC(=O), O(C=O)NH, O, C(=O)CH2, SO2CH2C(=O)NH, SO2NH, OC(=O), CH2S(O), and CH2S(O)2; and Z is at least one aryl or heteroaryl moiety, and their use as for example metalloproteinase inhibitors.",WYETH CORP;;XIANG JASON SHAOYUN;;TAM STEVE YIK-KAI;;HU YONGHAN;;SUM PHAIK-ENG;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES;;RUSH THOMAS SALTMARSH III;;MORRIS ELISABETH ANN;;GEORGIADIS KATY EVANGELIA,XIANG JASON SHAOYUN;;TAM STEVE YIK-KAI;;HU YONGHAN;;SUM PHAIK-ENG;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES;;RUSH THOMAS SALTMARSH III;;MORRIS ELISABETH ANN;;GEORGIADIS KATY EVANGELIA,,https://lens.org/152-277-771-440-906,Patent Application,yes,2,3,39,39,0,A61K31/4188;;A61K31/424;;A61K31/429;;C07C311/29;;C07C311/46;;C07D213/30;;C07D213/64;;C07D213/643;;C07D215/14;;C07D215/227;;C07D215/233;;C07D217/18;;C07D235/12;;C07D239/34;;C07D239/60;;C07D261/14;;C07D263/22;;C07D263/58;;C07D277/64;;C07D277/68;;C07D295/096;;C07D295/192;;C07D307/79;;C07D307/80;;C07D307/82;;C07D307/84;;C07D319/18;;C07D321/10;;C07D333/20;;C07D333/36;;C07D333/66;;C07C2601/08;;C07C2602/10;;A61P1/00;;A61P1/02;;A61P1/04;;A61P1/16;;A61P11/00;;A61P11/06;;A61P13/12;;A61P17/02;;A61P19/00;;A61P19/02;;A61P19/04;;A61P19/08;;A61P19/10;;A61P21/00;;A61P25/00;;A61P27/02;;A61P29/00;;A61P3/00;;A61P35/00;;A61P35/04;;A61P37/00;;A61P37/06;;A61P43/00;;A61P7/00;;A61P9/00;;A61P9/10;;A61P9/14;;A61P3/10;;C07D213/30;;C07D217/18;;C07D319/18;;C07D215/227;;C07D295/096;;C07D321/10;;C07C311/29;;C07D277/64;;C07D213/643;;A61K31/4188;;A61K31/424;;C07D215/233;;C07D263/22;;C07D307/84;;C07D213/64;;C07C311/46;;A61K31/429;;C07D295/192;;C07D215/14;;C07D307/79;;C07D333/20;;C07D261/14;;C07D239/34;;C07D307/80;;C07D333/66;;C07D239/60;;C07D277/68;;C07D307/82;;C07D263/58;;C07D333/36;;C07D235/12;;C07C2601/08;;C07C2602/10,C07C311/29;;C07C311/46;;C07D213/30;;C07D213/64;;C07D213/643;;C07D215/14;;C07D215/22;;C07D215/227;;C07D215/233;;C07D217/18;;C07D235/12;;C07D239/34;;C07D239/60;;C07D261/14;;C07D263/22;;C07D263/58;;C07D277/64;;C07D277/68;;C07D295/096;;C07D295/192;;C07D307/79;;C07D307/80;;C07D307/82;;C07D307/84;;C07D319/18;;C07D321/10;;C07D333/20;;C07D333/36;;C07D333/66,,0,0,,,,PENDING
635,AU,A1,AU 2003/304638 A1,077-068-426-257-992,2005-07-14,2005,AU 2003/304638 A,2003-12-22,US 52688303 P;;US 0341173 W,2003-12-04,Biaryl sulfonamides and methods for using same,,WYETH CORP,VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES;;RUSH THOMAS SALTMARSH III;;MORRIS ELISABETH ANN;;GEORGIADIS KATY EVANGELIA;;XIANG JASON SHAOYUN;;TAM STEVE YIK-KAI;;HU YONGHAN;;SUM PHAIK-ENG;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM,,https://lens.org/077-068-426-257-992,Patent Application,no,0,0,39,39,0,A61K31/4188;;A61K31/424;;A61K31/429;;C07C311/29;;C07C311/46;;C07D213/30;;C07D213/64;;C07D213/643;;C07D215/14;;C07D215/227;;C07D215/233;;C07D217/18;;C07D235/12;;C07D239/34;;C07D239/60;;C07D261/14;;C07D263/22;;C07D263/58;;C07D277/64;;C07D277/68;;C07D295/096;;C07D295/192;;C07D307/79;;C07D307/80;;C07D307/82;;C07D307/84;;C07D319/18;;C07D321/10;;C07D333/20;;C07D333/36;;C07D333/66;;C07C2601/08;;C07C2602/10;;A61P1/00;;A61P1/02;;A61P1/04;;A61P1/16;;A61P11/00;;A61P11/06;;A61P13/12;;A61P17/02;;A61P19/00;;A61P19/02;;A61P19/04;;A61P19/08;;A61P19/10;;A61P21/00;;A61P25/00;;A61P27/02;;A61P29/00;;A61P3/00;;A61P35/00;;A61P35/04;;A61P37/00;;A61P37/06;;A61P43/00;;A61P7/00;;A61P9/00;;A61P9/10;;A61P9/14;;A61P3/10;;C07D213/30;;C07D217/18;;C07D319/18;;C07D215/227;;C07D295/096;;C07D321/10;;C07C311/29;;C07D277/64;;C07D213/643;;A61K31/4188;;A61K31/424;;C07D215/233;;C07D263/22;;C07D307/84;;C07D213/64;;C07C311/46;;A61K31/429;;C07D295/192;;C07D215/14;;C07D307/79;;C07D333/20;;C07D261/14;;C07D239/34;;C07D307/80;;C07D333/66;;C07D239/60;;C07D277/68;;C07D307/82;;C07D263/58;;C07D333/36;;C07D235/12;;C07C2601/08;;C07C2602/10,C07C311/29;;C07C311/46;;C07D213/30;;C07D213/64;;C07D213/643;;C07D215/14;;C07D215/22;;C07D215/227;;C07D215/233;;C07D217/18;;C07D235/12;;C07D239/34;;C07D239/60;;C07D261/14;;C07D263/22;;C07D263/58;;C07D277/64;;C07D277/68;;C07D295/096;;C07D295/192;;C07D307/79;;C07D307/80;;C07D307/82;;C07D307/84;;C07D319/18;;C07D321/10;;C07D333/20;;C07D333/36;;C07D333/66,,0,0,,,,DISCONTINUED
636,PE,A1,PE 20051004 A1,171-825-103-916-95X,2006-01-12,2006,PE 2004001191 A,2004-12-03,US 52688303 P;;US 0341173 W,2003-12-04,COMPUESTOS DE BIARIL SULFONAMIDAS COMO INHIBIDORES DE METALOPROTEINASAS,"SE REFIERE A COMPUESTO DE FORMULA (I), DONDE R1 ES H, ALQUILO C1-C6; R2 ES H, ALQUILO C1-C6, FENILO, BENCILO, ENTRE OTROS; R3 ES H, HALOGENO, OC(HALOGENO)3, ENTRE OTROS; Z ES ARILO O HETEROARILO; X ES CH2O, OCH2, CH2S(O), ENTRE OTROS; Z ES ARILO O HETROARILO. SON COMPUESTOS PREFERIDOS: ACIDO 3- METIL-2-[4´-(3-METIL-QUINOLIN-2-ILOXIMETIL)-BIFENIL-4-SULFONILAMINO]-BUTIRICO; ACIDO 3-METIL-2-[4´-(5-TRIFLUOROMETIL-PIRIDIN-2-ILOXIMETIL)-BIFENIL-4-SULFONILAMINO]-BUTIRICO; ACIDO 2-[4´-(2,8-BIS-TRIFLUOROMETIL-QUINOLIN-4-ILOXIMETIL)-BIFENIL-4-SULFONILAMINO]-3-METIL-BUTIRICO, ENTRE OTROS. DICHOS COMPUESTOS SON INHIBIDORES DE METALOPROTEINASAS DE MATRIZ (MMPS) UTILES EN EL TRATAMIENTO DE CANCER, OSTEOARTRITIS, ASMA, ATEROSCLEROSIS, ENTRE OTROS",WYETH CORP,XIANG JASON SHAOYUN;;TAM STEVE YIK-KAI;;HU YONGHAN;;SUM PHAIK-ENG;;HOW DAVID BRAIN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES;;RUSH III THOMAS SALTMARSH;;MORRIS ELISABETH ANN;;GEORGIADIS KATY EVANGELIA,,https://lens.org/171-825-103-916-95X,Patent Application,no,0,0,39,39,0,A61K31/4188;;A61K31/424;;A61K31/429;;C07C311/29;;C07C311/46;;C07D213/30;;C07D213/64;;C07D213/643;;C07D215/14;;C07D215/227;;C07D215/233;;C07D217/18;;C07D235/12;;C07D239/34;;C07D239/60;;C07D261/14;;C07D263/22;;C07D263/58;;C07D277/64;;C07D277/68;;C07D295/096;;C07D295/192;;C07D307/79;;C07D307/80;;C07D307/82;;C07D307/84;;C07D319/18;;C07D321/10;;C07D333/20;;C07D333/36;;C07D333/66;;C07C2601/08;;C07C2602/10;;A61P1/00;;A61P1/02;;A61P1/04;;A61P1/16;;A61P11/00;;A61P11/06;;A61P13/12;;A61P17/02;;A61P19/00;;A61P19/02;;A61P19/04;;A61P19/08;;A61P19/10;;A61P21/00;;A61P25/00;;A61P27/02;;A61P29/00;;A61P3/00;;A61P35/00;;A61P35/04;;A61P37/00;;A61P37/06;;A61P43/00;;A61P7/00;;A61P9/00;;A61P9/10;;A61P9/14;;A61P3/10;;C07D213/30;;C07D217/18;;C07D319/18;;C07D215/227;;C07D295/096;;C07D321/10;;C07C311/29;;C07D277/64;;C07D213/643;;A61K31/4188;;A61K31/424;;C07D215/233;;C07D263/22;;C07D307/84;;C07D213/64;;C07C311/46;;A61K31/429;;C07D295/192;;C07D215/14;;C07D307/79;;C07D333/20;;C07D261/14;;C07D239/34;;C07D307/80;;C07D333/66;;C07D239/60;;C07D277/68;;C07D307/82;;C07D263/58;;C07D333/36;;C07D235/12;;C07C2601/08;;C07C2602/10,A61K31/198;;C07C311/29;;C07C311/46;;C07D213/30;;C07D213/64;;C07D213/643;;C07D215/14;;C07D215/22;;C07D215/227;;C07D215/233;;C07D217/18;;C07D235/12;;C07D239/34;;C07D239/60;;C07D261/14;;C07D263/22;;C07D263/58;;C07D277/64;;C07D277/68;;C07D295/08;;C07D295/096;;C07D295/192;;C07D307/79;;C07D307/80;;C07D307/82;;C07D307/84;;C07D319/18;;C07D321/10;;C07D333/20;;C07D333/36;;C07D333/66,,0,0,,,,DISCONTINUED
637,TW,A,TW 200519089 A,157-331-944-249-20X,2005-06-16,2005,TW 93100823 A,2004-01-13,US 52688303 P,2003-12-04,Biaryl sulfonamides and methods for using same,"The present invention relates to biaryl sulfonamides and their use as, for example, metalloproteinase inhibitors.",WYETH CORP,XIANG JASON SHAOYUN;;TAM STEVE YIK-KAI;;HU YONG-HAN;;SUM PHAIK-ENG;;HOW DAVID BRIAN;;HOPPER DARRIN WILLIAM;;VERA MATTHEW DOUGLAS;;SABATINI JOSHUA JAMES;;RUSH III THOMAS SALTMARSH;;MORRIS ELISABETH ANN;;GEORGIADIS KATY EVANGELIA,,https://lens.org/157-331-944-249-20X,Patent of Addition,no,0,0,39,39,0,A61K31/4188;;A61K31/424;;A61K31/429;;C07C311/29;;C07C311/46;;C07D213/30;;C07D213/64;;C07D213/643;;C07D215/14;;C07D215/227;;C07D215/233;;C07D217/18;;C07D235/12;;C07D239/34;;C07D239/60;;C07D261/14;;C07D263/22;;C07D263/58;;C07D277/64;;C07D277/68;;C07D295/096;;C07D295/192;;C07D307/79;;C07D307/80;;C07D307/82;;C07D307/84;;C07D319/18;;C07D321/10;;C07D333/20;;C07D333/36;;C07D333/66;;C07C2601/08;;C07C2602/10;;A61P1/00;;A61P1/02;;A61P1/04;;A61P1/16;;A61P11/00;;A61P11/06;;A61P13/12;;A61P17/02;;A61P19/00;;A61P19/02;;A61P19/04;;A61P19/08;;A61P19/10;;A61P21/00;;A61P25/00;;A61P27/02;;A61P29/00;;A61P3/00;;A61P35/00;;A61P35/04;;A61P37/00;;A61P37/06;;A61P43/00;;A61P7/00;;A61P9/00;;A61P9/10;;A61P9/14;;A61P3/10;;C07D213/30;;C07D217/18;;C07D319/18;;C07D215/227;;C07D295/096;;C07D321/10;;C07C311/29;;C07D277/64;;C07D213/643;;A61K31/4188;;A61K31/424;;C07D215/233;;C07D263/22;;C07D307/84;;C07D213/64;;C07C311/46;;A61K31/429;;C07D295/192;;C07D215/14;;C07D307/79;;C07D333/20;;C07D261/14;;C07D239/34;;C07D307/80;;C07D333/66;;C07D239/60;;C07D277/68;;C07D307/82;;C07D263/58;;C07D333/36;;C07D235/12;;C07C2601/08;;C07C2602/10,C07C311/29;;C07C311/46;;C07D213/30;;C07D213/64;;C07D213/643;;C07D215/14;;C07D215/22;;C07D215/227;;C07D215/233;;C07D217/18;;C07D235/12;;C07D239/34;;C07D239/60;;C07D261/14;;C07D263/22;;C07D263/58;;C07D277/64;;C07D277/68;;C07D295/096;;C07D295/192;;C07D307/79;;C07D307/80;;C07D307/82;;C07D307/84;;C07D319/18;;C07D321/10;;C07D333/20;;C07D333/36;;C07D333/66,,0,0,,,,PENDING
638,US,A1,US 2016/0098540 A1,002-956-133-312-286,2016-04-07,2016,US 201514874334 A,2015-10-02,US 201514874334 A;;US 201514874188 A;;US 201462060351 P,2014-10-06,SYSTEM AND METHOD FOR DATA ANALYTICS AND VISUALIZATION,"Systems and methods are described that provide a dynamic reporting functionality that can identify important information and dynamically present a report about the important information that highlights important findings to the user. The described systems and methods are generally described in the field of diabetes management, but are applicable to other medical reports as well. In one implementation, the dynamic reports are based on available data and devices. For example, useless sections of the report, such as those with no populated data, may be removed, minimized in importance, assigned a lower priority, or the like.",DEXCOM INC,ZAMANAKOS GEORGIOS;;WIEDEBACK DANIEL JUSTIN;;STEWART JEFFREY GRANT;;REIHMAN ELI;;PRICE DAVID;;MILLER LAUREN C;;LEONE KERI;;KRAEMER DAN;;KIRBY KATHERINE ENG;;KIDA GREG;;KAMATH APURV ULLAS;;GREENE ADAM R;;GIMENEZ REBECCA;;ELLI SARAH PAIGE;;DRAEGER RIAN;;DELMORE SHANE PHILIP;;BOWMAN LEIF N,DEXCOM INC (2014-11-10),https://lens.org/002-956-133-312-286,Patent Application,yes,2,5,19,19,0,G16H15/00;;G16H10/40;;G16H40/63;;G16H20/17;;G06T2200/24;;A61B5/7282;;A61B5/0022;;A61B5/14532;;A61B5/742;;G06T11/206;;Y02A90/10;;A61B5/14532;;A61B5/7275;;A61B5/742;;G16H15/00;;G16H10/40;;A61B5/0022;;G16H40/63;;A61B5/7282;;G16H20/17;;G06T2200/24;;Y02A90/10;;G06T11/206;;G16H10/60,G06F19/00,,0,0,,,,ACTIVE
639,US,A1,US 2016/0098539 A1,153-910-969-289-954,2016-04-07,2016,US 201514874188 A,2015-10-02,US 201514874188 A;;US 201462060351 P,2014-10-06,SYSTEM AND METHOD FOR DATA ANALYTICS AND VISUALIZATION,"Systems and methods are described that provide a dynamic reporting functionality that can identify important information and dynamically present a report about the important information that highlights important findings to the user. The described systems and methods are generally described in the field of diabetes management, but are applicable to other medical reports as well. In one implementation, the dynamic reports are based on available data and devices. For example, useless sections of the report, such as those with no populated data, may be removed, minimized in importance, assigned a lower priority, or the like.",DEXCOM INC,ZAMANAKOS GEORGIOS;;WIEDEBACK DANIEL JUSTIN;;STEWART JEFFREY GRANT;;REIHMAN ELI;;PRICE DAVID;;MILLER LAUREN C;;LEONE KERI;;KRAEMER DAN;;KIRBY KATHERINE ENG;;KIDA GREG;;KAMATH APURV ULLAS;;GREENE ADAM R;;GIMENEZ REBECCA;;ELLI SARAH PAIGE;;DRAEGER RIAN;;DELMORE SHANE PHILIP;;BOWMAN LEIF N,DEXCOM INC (2014-11-10),https://lens.org/153-910-969-289-954,Patent Application,yes,3,22,19,19,0,G16H15/00;;G16H10/40;;G16H40/63;;G16H20/17;;G06T2200/24;;A61B5/7282;;A61B5/0022;;A61B5/14532;;A61B5/742;;G06T11/206;;Y02A90/10;;A61B5/14532;;A61B5/7275;;A61B5/742;;G16H15/00;;G16H10/40;;A61B5/0022;;G16H40/63;;A61B5/7282;;G16H20/17;;G06T2200/24;;Y02A90/10;;G06T11/206;;G16H10/60,G06F19/00;;A61B5/00;;A61B5/145,,0,0,,,,ACTIVE
640,WO,A1,WO 2016/057343 A1,040-402-461-406-277,2016-04-14,2016,US 2015/0053854 W,2015-10-02,US 201462060351 P,2014-10-06,SYSTEM AND METHOD FOR DATA ANALYTICS AND VISUALIZATION,"Systems and methods are described that provide a dynamic reporting functionality that can identify important information and dynamically present a report about the important information that highlights important findings to the user. The described systems and methods are generally described in the field of diabetes management, but are applicable to other medical reports as well. In one implementation, the dynamic reports are based on available data and devices. For example, useless sections of the report, such as those with no populated data, may be removed, minimized in importance, assigned a lower priority, or the like.",DEXCOM INC,ZAMANAKOS GEORGIOS;;WIEDEBACK DANIEL JUSTIN;;STEWART JEFFREY GRANT;;REIHMAN ELI;;PRICE DAVID;;MILLER LAUREN C;;LEONE KERI;;KRAEMER DAN;;KIRBY KATHERINE ENG;;KIDA GREG;;KAMATH APURV ULLAS;;GREENE ADAM R;;GIMENEZ REBECCA;;ELLI SARAH PAIGE;;DRAEGER RIAN;;DELMORE SHANE PHILIP;;BOWMAN LEIF N,,https://lens.org/040-402-461-406-277,Patent Application,yes,21,3,19,19,0,G16H15/00;;G16H10/40;;G16H40/63;;G16H20/17;;G06T2200/24;;A61B5/7282;;A61B5/0022;;A61B5/14532;;A61B5/742;;G06T11/206;;Y02A90/10;;A61B5/14532;;A61B5/7275;;A61B5/742;;G16H15/00;;G16H10/40;;A61B5/0022;;G16H40/63;;A61B5/7282;;G16H20/17;;G06T2200/24;;Y02A90/10;;G06T11/206;;G16H10/60,G06F19/00,,0,0,,,,PENDING
641,EP,A1,EP 3204880 A1,041-404-247-191-32X,2017-08-16,2017,EP 15794360 A,2015-10-02,US 201462060351 P;;US 2015/0053854 W,2014-10-06,SYSTEM AND METHOD FOR DATA ANALYTICS AND VISUALIZATION,,DEXCOM INC,ZAMANAKOS GEORGIOS;;WIEDEBACK DANIEL JUSTIN;;STEWART JEFFREY GRANT;;REIHMAN ELI;;PRICE DAVID;;MILLER LAUREN C;;LEONE KERI;;KRAEMER DAN;;KIRBY KATHERINE ENG;;KIDA GREG;;KAMATH APURV ULLAS;;GREENE ADAM R;;GIMENEZ REBECCA;;ELLI SARAH PAIGE;;DRAEGER RIAN;;DELMORE SHANE PHILIP;;BOWMAN LEIF N,,https://lens.org/041-404-247-191-32X,Patent Application,yes,0,0,19,19,0,G16H15/00;;G16H10/40;;G16H40/63;;G16H20/17;;G06T2200/24;;A61B5/7282;;A61B5/0022;;A61B5/14532;;A61B5/742;;G06T11/206;;Y02A90/10;;A61B5/14532;;A61B5/7275;;A61B5/742;;G16H15/00;;G16H10/40;;A61B5/0022;;G16H40/63;;A61B5/7282;;G16H20/17;;G06T2200/24;;Y02A90/10;;G06T11/206;;G16H10/60,G06F19/00,,0,0,,,,PENDING
642,AU,B2,AU 2021/202782 B2,076-188-293-535-222,2023-01-19,2023,AU 2021/202782 A,2021-05-04,AU 2021/202782 A;;AU 2019/202094 A;;AU 2015/328459 A;;US 201462060351 P;;US 2015/0053854 W,2014-10-06,System and method for data analytics and visualization,"Systems and methods are described that provide a dynamic reporting functionality that can identify important information and dynamically present a report about the important information that highlights important findings to the user. The described systems and methods are generally described in the field of diabetes management, but are applicable to other medical reports as well. In one implementation, the dynamic reports are based on available data and devices. For example, useless sections of the report, such as those with no populated data, may be removed, minimized in importance, assigned a lower priority, or the like. WO 2016/057343 PCT/US2015/053854 co C uJ uJ F- LU F- co U)) S co, LU, oi",DEXCOM INC,ZAMANAKOS GEORGIOS;;WIEDEBACK DANIEL JUSTIN;;STEWART JEFFREY GRANT;;REIHMAN ELI;;PRICE DAVID;;MILLER LAUREN C;;LEONE KERI;;KRAEMER DAN;;KIRBY KATHERINE ENG;;KIDA GREG;;KAMATH APURV ULLAS;;GREENE ADAM R;;GIMENEZ REBECCA;;ELLI SARAH PAIGE;;DRAEGER RIAN;;DELMORE SHANE PHILIP;;BOWMAN LEIF N,,https://lens.org/076-188-293-535-222,Granted Patent,no,1,0,19,19,0,G16H15/00;;G16H10/40;;G16H40/63;;G16H20/17;;G06T2200/24;;A61B5/7282;;A61B5/0022;;A61B5/14532;;A61B5/742;;G06T11/206;;Y02A90/10;;A61B5/14532;;A61B5/7275;;A61B5/742;;G16H15/00;;G16H10/40;;A61B5/0022;;G16H40/63;;A61B5/7282;;G16H20/17;;G06T2200/24;;Y02A90/10;;G06T11/206;;G16H10/60,G16H15/00,,0,0,,,,ACTIVE
643,CA,C,CA 2953582 C,169-023-342-467-614,2023-10-24,2023,CA 2953582 A,2015-10-02,US 201462060351 P;;US 2015/0053854 W,2014-10-06,SYSTEM AND METHOD FOR DATA ANALYTICS AND VISUALIZATION,"Systems and methods are described for interfacing a computing device and a user to display data pertaining to user intake of a substance or user glucose concentration values. The described systems and methods are generally described in the field of diabetes management but are applicable to other medical reports as well. In one implementation, a screen for display has a indicator to indicate how the user intake of a substance tends to increase or decrease analyte concentration values or glucose concentration values.",DEXCOM INC,ZAMANAKOS GEORGIOS;;WIEDEBACK DANIEL JUSTIN;;STEWART JEFFREY GRANT;;REIHMAN ELI;;PRICE DAVID;;MILLER LAUREN C;;LEONE KERI;;KRAEMER DAN;;KIRBY KATHERINE ENG;;KIDA GREG;;KAMATH APURV ULLAS;;GREENE ADAM R;;GIMENEZ REBECCA;;ELLI SARAH PAIGE;;DRAEGER RIAN;;DELMORE SHANE PHILIP;;BOWMAN LEIF N,,https://lens.org/169-023-342-467-614,Granted Patent,no,0,0,19,19,0,G16H15/00;;G16H10/40;;G16H40/63;;G16H20/17;;G06T2200/24;;A61B5/7282;;A61B5/0022;;A61B5/14532;;A61B5/742;;G06T11/206;;Y02A90/10;;A61B5/14532;;A61B5/7275;;A61B5/742;;G16H15/00;;G16H10/40;;A61B5/0022;;G16H40/63;;A61B5/7282;;G16H20/17;;G06T2200/24;;Y02A90/10;;G06T11/206;;G16H10/60,G16H15/00;;A61B5/145;;G16H10/00;;G16H10/40;;G16H10/60;;G16H20/10;;G16H20/17;;G16H40/63,,0,0,,,,PENDING
644,AU,A1,AU 2023/202235 A1,170-114-416-967-11X,2023-05-04,2023,AU 2023/202235 A,2023-04-12,AU 2023/202235 A;;AU 2021/202782 A;;AU 2019/202094 A;;AU 2015/328459 A;;US 201462060351 P;;US 2015/0053854 W,2014-10-06,System and method for data analytics and visualization,"Systems and methods are described that provide a dynamic reporting functionality that can identify important information and dynamically present a report about the important information that highlights important findings to the user. The described systems and methods are generally described in the field of diabetes management, but are applicable to other medical reports as well. In one implementation, the dynamic reports are based on available data and devices. For example, useless sections of the report, such as those with no populated data, may be removed, minimized in importance, assigned a lower priority, or the like.",DEXCOM INC,ZAMANAKOS GEORGIOS;;WIEDEBACK DANIEL JUSTIN;;STEWART JEFFREY GRANT;;REIHMAN ELI;;PRICE DAVID;;MILLER LAUREN C;;LEONE KERI;;KRAEMER DAN;;KIRBY KATHERINE ENG;;KIDA GREG;;KAMATH APURV ULLAS;;GREENE ADAM R;;GIMENEZ REBECCA;;ELLI SARAH PAIGE;;DRAEGER RIAN;;DELMORE SHANE PHILIP;;BOWMAN LEIF N,,https://lens.org/170-114-416-967-11X,Patent Application,no,0,0,19,19,0,G16H15/00;;G16H10/40;;G16H40/63;;G16H20/17;;G06T2200/24;;A61B5/7282;;A61B5/0022;;A61B5/14532;;A61B5/742;;G06T11/206;;Y02A90/10;;A61B5/14532;;A61B5/7275;;A61B5/742;;G16H15/00;;G16H10/40;;A61B5/0022;;G16H40/63;;A61B5/7282;;G16H20/17;;G06T2200/24;;Y02A90/10;;G06T11/206;;G16H10/60,G16H15/00,,0,0,,,,PENDING
645,US,A1,US 2020/0074703 A1,018-185-556-886-538,2020-03-05,2020,US 201916673850 A,2019-11-04,US 201916673850 A;;US 201514874188 A;;US 201462060351 P,2014-10-06,SYSTEM AND METHOD FOR DATA ANALYTICS AND VISUALIZATION,"Systems and methods are described that provide a dynamic reporting functionality that can identify important information and dynamically present a report about the important information that highlights important findings to the user. The described systems and methods are generally described in the field of diabetes management, but are applicable to other medical reports as well. In one implementation, the dynamic reports are based on available data and devices. For example, useless sections of the report, such as those with no populated data, may be removed, minimized in importance, assigned a lower priority, or the like.",DEXCOM INC,ZAMANAKOS GEORGIOS;;WIEDEBACK DANIEL JUSTIN;;STEWART JEFFREY GRANT;;REIHMAN ELI;;PRICE DAVID;;MILLER LAUREN C;;LEONE KERI;;KRAEMER DAN;;KIRBY KATHERINE ENG;;KIDA GREG;;KAMATH APURV ULLAS;;GREENE ADAM R;;GIMENEZ REBECCA;;ELLI SARAH PAIGE;;DRAEGER RIAN;;DELMORE SHANE PHILIP;;BOWMAN LEIF N,DEXCOM INC (2014-11-10),https://lens.org/018-185-556-886-538,Patent Application,yes,4,2,19,19,0,G16H15/00;;G16H10/40;;G16H40/63;;G16H20/17;;G06T2200/24;;A61B5/7282;;A61B5/0022;;A61B5/14532;;A61B5/742;;G06T11/206;;Y02A90/10;;A61B5/14532;;A61B5/7275;;A61B5/742;;G16H15/00;;G16H10/40;;A61B5/0022;;G16H40/63;;A61B5/7282;;G16H20/17;;G06T2200/24;;Y02A90/10;;G06T11/206;;G16H10/60,G06T11/20;;A61B5/00;;A61B5/145;;G16H10/40;;G16H10/60;;G16H15/00;;G16H40/63,,0,0,,,,ACTIVE
646,US,B2,US 10467780 B2,172-123-871-927-790,2019-11-05,2019,US 201514874296 A,2015-10-02,US 201514874296 A;;US 201514874188 A;;US 201462060351 P,2014-10-06,System and method for data analytics and visualization,"Systems and methods are described that provide a dynamic reporting functionality that can identify important information and dynamically present a report about the important information that highlights important findings to the user. The described systems and methods are generally described in the field of diabetes management, but are applicable to other medical reports as well. In one implementation, the dynamic reports are based on available data and devices. For example, useless sections of the report, such as those with no populated data, may be removed, minimized in importance, assigned a lower priority, or the like.",DEXCOM INC,ZAMANAKOS GEORGIOS;;WIEDEBACK DANIEL JUSTIN;;STEWART JEFFREY GRANT;;REIHMAN ELI;;PRICE DAVID;;MILLER LAUREN C;;LEONE KERI;;KRAEMER DAN;;KIRBY KATHERINE ENG;;KIDA GREG;;KAMATH APURV ULLAS;;GREENE ADAM R;;GIMENEZ REBECCA;;ELLI SARAH PAIGE;;DRAEGER RIAN;;DELMORE SHANE PHILIP;;BOWMAN LEIF N,DEXCOM INC (2014-11-10),https://lens.org/172-123-871-927-790,Granted Patent,yes,22,3,19,19,0,G16H15/00;;G16H10/40;;G16H40/63;;G16H20/17;;G06T2200/24;;A61B5/7282;;A61B5/0022;;A61B5/14532;;A61B5/742;;G06T11/206;;Y02A90/10;;A61B5/14532;;A61B5/7275;;A61B5/742;;G16H15/00;;G16H10/40;;A61B5/0022;;G16H40/63;;A61B5/7282;;G16H20/17;;G06T2200/24;;Y02A90/10;;G06T11/206;;G16H10/60,G06T11/20;;A61B5/00;;A61B5/145;;G16H10/40;;G16H15/00;;G16H20/17;;G16H40/63,,0,0,,,,ACTIVE
647,CA,A1,CA 2953582 A1,151-629-706-305-580,2016-04-14,2016,CA 2953582 A,2015-10-02,US 201462060351 P;;US 2015/0053854 W,2014-10-06,SYSTEM AND METHOD FOR DATA ANALYTICS AND VISUALIZATION,"Systems and methods are described for interfacing a computing device and a user to display data pertaining to user intake of a substance or user glucose concentration values. The described systems and methods are generally described in the field of diabetes management but are applicable to other medical reports as well. In one implementation, a screen for display has a indicator to indicate how the user intake of a substance tends to increase or decrease analyte concentration values or glucose concentration values.",DEXCOM INC,ZAMANAKOS GEORGIOS;;WIEDEBACK DANIEL JUSTIN;;STEWART JEFFREY GRANT;;REIHMAN ELI;;PRICE DAVID;;MILLER LAUREN C;;LEONE KERI;;KRAEMER DAN;;KIRBY KATHERINE ENG;;KIDA GREG;;KAMATH APURV ULLAS;;GREENE ADAM R;;GIMENEZ REBECCA;;ELLI SARAH PAIGE;;DRAEGER RIAN;;DELMORE SHANE PHILIP;;BOWMAN LEIF N,,https://lens.org/151-629-706-305-580,Patent Application,no,0,0,19,19,0,G16H15/00;;G16H10/40;;G16H40/63;;G16H20/17;;G06T2200/24;;A61B5/7282;;A61B5/0022;;A61B5/14532;;A61B5/742;;G06T11/206;;Y02A90/10;;A61B5/14532;;A61B5/7275;;A61B5/742;;G16H15/00;;G16H10/40;;A61B5/0022;;G16H40/63;;A61B5/7282;;G16H20/17;;G06T2200/24;;Y02A90/10;;G06T11/206;;G16H10/60,G06F19/00,,0,0,,,,PENDING
648,AU,A1,AU 2019/202094 A1,157-902-284-496-577,2019-04-18,2019,AU 2019/202094 A,2019-03-26,AU 2019/202094 A;;AU 2015/328459 A;;US 201462060351 P;;US 2015/0053854 W,2014-10-06,System and method for data analytics and visualization,"Systems and methods are described that provide a dynamic reporting functionality that can identify important information and dynamically present a report about the important information that highlights important findings to the user. The described systems and methods are generally described in the field of diabetes management, but are applicable to other medical reports as well. In one implementation, the dynamic reports are based on available data and devices. For example, useless sections of the report, such as those with no populated data, may be removed, minimized in importance, assigned a lower priority, or the like. C-j 0 ll 2- ll UJI co -O _ 0 , Lu c7o U) 0 Co C=) 0)) S co, < -0 L4. C) C)K",DEXCOM INC,ZAMANAKOS GEORGIOS;;WIEDEBACK DANIEL JUSTIN;;STEWART JEFFREY GRANT;;REIHMAN ELI;;PRICE DAVID;;LEONE KERI;;KRAEMER DAN;;KIRBY KATHERINE ENG;;KIDA GREG;;KAMATH APURV ULLAS;;GREENE ADAM R;;GIMENEZ REBECCA;;ELLI SARAH PAIGE;;DRAEGER RIAN;;DELMORE SHANE PHILIP;;BOWMAN LEIF N;;MILLER LAUREN C,,https://lens.org/157-902-284-496-577,Patent Application,no,0,0,19,19,0,G16H15/00;;G16H10/40;;G16H40/63;;G16H20/17;;G06T2200/24;;A61B5/7282;;A61B5/0022;;A61B5/14532;;A61B5/742;;G06T11/206;;Y02A90/10;;A61B5/14532;;A61B5/7275;;A61B5/742;;G16H15/00;;G16H10/40;;A61B5/0022;;G16H40/63;;A61B5/7282;;G16H20/17;;G06T2200/24;;Y02A90/10;;G06T11/206;;G16H10/60,G16H15/00,,0,0,,,,DISCONTINUED
649,US,A1,US 2023/0146456 A1,025-081-942-462-917,2023-05-11,2023,US 202218055358 A,2022-11-14,US 202218055358 A;;US 201916673850 A;;US 201514874188 A;;US 201462060351 P,2014-10-06,SYSTEM AND METHOD FOR DATA ANALYTICS AND VISUALIZATION,"Systems and methods are described that provide a dynamic reporting functionality that can identify important information and dynamically present a report about the important information that highlights important findings to the user. The described systems and methods are generally described in the field of diabetes management, but are applicable to other medical reports as well. In one implementation, the dynamic reports are based on available data and devices. For example, useless sections of the report, such as those with no populated data, may be removed, minimized in importance, assigned a lower priority, or the like.",DEXCOM INC,ZAMANAKOS GEORGIOS;;WIEDEBACK DANIEL JUSTIN;;STEWART JEFFREY GRANT;;REIHMAN ELI;;PRICE DAVID;;MILLER LAUREN C;;LEONE KERI;;KRAEMER DAN;;KIRBY KATHERINE ENG;;KIDA GREG;;KAMATH APURV ULLAS;;GREENE ADAM R;;GIMENEZ REBECCA;;ELLI SARAH PAIGE;;DRAEGER RIAN;;DELMORE SHANE PHILIP;;BOWMAN LEIF N,DEXCOM INC (2014-11-10),https://lens.org/025-081-942-462-917,Patent Application,yes,0,0,19,19,0,G16H15/00;;G16H10/40;;G16H40/63;;G16H20/17;;G06T2200/24;;A61B5/7282;;A61B5/0022;;A61B5/14532;;A61B5/742;;G06T11/206;;Y02A90/10;;A61B5/14532;;A61B5/7275;;A61B5/742;;G16H15/00;;G16H10/40;;A61B5/0022;;G16H40/63;;A61B5/7282;;G16H20/17;;G06T2200/24;;Y02A90/10;;G06T11/206;;G16H10/60,G06T11/20;;A61B5/00;;A61B5/145;;G16H10/40;;G16H10/60;;G16H15/00;;G16H40/63,,0,0,,,,PENDING
650,US,B2,US 11574426 B2,195-560-444-803-136,2023-02-07,2023,US 201916673850 A,2019-11-04,US 201916673850 A;;US 201514874188 A;;US 201462060351 P,2014-10-06,System and method for data analytics and visualization,"Systems and methods are described that provide a dynamic reporting functionality that can identify important information and dynamically present a report about the important information that highlights important findings to the user. The described systems and methods are generally described in the field of diabetes management, but are applicable to other medical reports as well. In one implementation, the dynamic reports are based on available data and devices. For example, useless sections of the report, such as those with no populated data, may be removed, minimized in importance, assigned a lower priority, or the like.",DEXCOM INC,ZAMANAKOS GEORGIOS;;WIEDEBACK DANIEL JUSTIN;;STEWART JEFFREY GRANT;;REIHMAN ELI;;PRICE DAVID;;MILLER LAUREN C;;LEONE KERI;;KRAEMER DAN;;KIRBY KATHERINE ENG;;KIDA GREG;;KAMATH APURV ULLAS;;GREENE ADAM R;;GIMENEZ REBECCA;;ELLI SARAH PAIGE;;DRAEGER RIAN;;DELMORE SHANE PHILIP;;BOWMAN LEIF N,DEXCOM INC (2014-11-10),https://lens.org/195-560-444-803-136,Granted Patent,yes,57,0,19,19,0,G16H15/00;;G16H10/40;;G16H40/63;;G16H20/17;;G06T2200/24;;A61B5/7282;;A61B5/0022;;A61B5/14532;;A61B5/742;;G06T11/206;;Y02A90/10;;A61B5/14532;;A61B5/7275;;A61B5/742;;G16H15/00;;G16H10/40;;A61B5/0022;;G16H40/63;;A61B5/7282;;G16H20/17;;G06T2200/24;;Y02A90/10;;G06T11/206;;G16H10/60,G16H15/00;;A61B5/00;;A61B5/145;;G06T11/20;;G16H10/40;;G16H10/60;;G16H20/17;;G16H40/63,,2,0,,,"International Search Report and Written Opinion for Application No. PCT/US2015/053854 dated Jan. 15, 2016, 16 pages.;;International Preliminary Report on Patentability for Application No. PCT/US2015/053854 dated Apr. 20, 2017, 11 pages.",ACTIVE
651,AU,A1,AU 2021/202782 A1,045-596-258-086-28X,2021-05-27,2021,AU 2021/202782 A,2021-05-04,AU 2021/202782 A;;AU 2019/202094 A;;AU 2015/328459 A;;US 201462060351 P;;US 2015/0053854 W,2014-10-06,System and method for data analytics and visualization,"Systems and methods are described that provide a dynamic reporting functionality that can identify important information and dynamically present a report about the important information that highlights important findings to the user. The described systems and methods are generally described in the field of diabetes management, but are applicable to other medical reports as well. In one implementation, the dynamic reports are based on available data and devices. For example, useless sections of the report, such as those with no populated data, may be removed, minimized in importance, assigned a lower priority, or the like. WO 2016/057343 PCT/US2015/053854 co C uJ uJ F- LU F- co U)) S co, LU, oi",DEXCOM INC,ZAMANAKOS GEORGIOS;;WIEDEBACK DANIEL JUSTIN;;STEWART JEFFREY GRANT;;REIHMAN ELI;;PRICE DAVID;;MILLER LAUREN C;;LEONE KERI;;KRAEMER DAN;;KIRBY KATHERINE ENG;;KIDA GREG;;KAMATH APURV ULLAS;;GREENE ADAM R;;GIMENEZ REBECCA;;ELLI SARAH PAIGE;;DRAEGER RIAN;;DELMORE SHANE PHILIP;;BOWMAN LEIF N,,https://lens.org/045-596-258-086-28X,Patent Application,no,0,0,19,19,0,G16H15/00;;G16H10/40;;G16H40/63;;G16H20/17;;G06T2200/24;;A61B5/7282;;A61B5/0022;;A61B5/14532;;A61B5/742;;G06T11/206;;Y02A90/10;;A61B5/14532;;A61B5/7275;;A61B5/742;;G16H15/00;;G16H10/40;;A61B5/0022;;G16H40/63;;A61B5/7282;;G16H20/17;;G06T2200/24;;Y02A90/10;;G06T11/206;;G16H10/60,G16H15/00,,0,0,,,,ACTIVE
652,AU,A1,AU 2015/328459 A1,100-844-321-914-272,2017-04-20,2017,AU 2015/328459 A,2015-10-02,US 201462060351 P;;US 2015/0053854 W,2014-10-06,System and method for data analytics and visualization,"Systems and methods are described that provide a dynamic reporting functionality that can identify important information and dynamically present a report about the important information that highlights important findings to the user. The described systems and methods are generally described in the field of diabetes management, but are applicable to other medical reports as well. In one implementation, the dynamic reports are based on available data and devices. For example, useless sections of the report, such as those with no populated data, may be removed, minimized in importance, assigned a lower priority, or the like.",DEXCOM INC,ELLI SARAH PAIGE;;DRAEGER RIAN;;DELMORE SHANE PHILIP;;BOWMAN LEIF N;;ZAMANAKOS GEORGIOS;;WIEDEBACK DANIEL JUSTIN;;STEWART JEFFREY GRANT;;REIHMAN ELI;;PRICE DAVID;;MILLER LAUREN C;;LEONE KERI;;KRAEMER DAN;;KIRBY KATHERINE ENG;;KIDA GREG;;KAMATH APURV ULLAS;;GREENE ADAM R;;GIMENEZ REBECCA,,https://lens.org/100-844-321-914-272,Patent Application,no,0,0,19,19,0,G16H15/00;;G16H10/40;;G16H40/63;;G16H20/17;;G06T2200/24;;A61B5/7282;;A61B5/0022;;A61B5/14532;;A61B5/742;;G06T11/206;;Y02A90/10;;A61B5/14532;;A61B5/7275;;A61B5/742;;G16H15/00;;G16H10/40;;A61B5/0022;;G16H40/63;;A61B5/7282;;G16H20/17;;G06T2200/24;;Y02A90/10;;G06T11/206;;G16H10/60,G06F19/00,,0,0,,,,DISCONTINUED
653,US,A1,US 2016/0098848 A1,148-644-117-369-233,2016-04-07,2016,US 201514874296 A,2015-10-02,US 201514874296 A;;US 201514874188 A;;US 201462060351 P,2014-10-06,SYSTEM AND METHOD FOR DATA ANALYTICS AND VISUALIZATION,"Systems and methods are described that provide a dynamic reporting functionality that can identify important information and dynamically present a report about the important information that highlights important findings to the user. The described systems and methods are generally described in the field of diabetes management, but are applicable to other medical reports as well. In one implementation, the dynamic reports are based on available data and devices. For example, useless sections of the report, such as those with no populated data, may be removed, minimized in importance, assigned a lower priority, or the like.",DEXCOM INC,ZAMANAKOS GEORGIOS;;WIEDEBACK DANIEL JUSTIN;;STEWART JEFFREY GRANT;;REIHMAN ELI;;PRICE DAVID;;MILLER LAUREN C;;LEONE KERI;;KRAEMER DAN;;KIRBY KATHERINE ENG;;KIDA GREG;;KAMATH APURV ULLAS;;GREENE ADAM R;;GIMENEZ REBECCA;;ELLI SARAH PAIGE;;DRAEGER RIAN;;DELMORE SHANE PHILIP;;BOWMAN LEIF N,DEXCOM INC (2014-11-10),https://lens.org/148-644-117-369-233,Patent Application,yes,4,52,19,19,0,G16H15/00;;G16H10/40;;G16H40/63;;G16H20/17;;G06T2200/24;;A61B5/7282;;A61B5/0022;;A61B5/14532;;A61B5/742;;G06T11/206;;Y02A90/10;;A61B5/14532;;A61B5/7275;;A61B5/742;;G16H15/00;;G16H10/40;;A61B5/0022;;G16H40/63;;A61B5/7282;;G16H20/17;;G06T2200/24;;Y02A90/10;;G06T11/206;;G16H10/60,G06F19/00;;G06T11/20,,0,0,,,,ACTIVE
654,US,B2,US 10332286 B2,057-058-622-683-062,2019-06-25,2019,US 201514874334 A,2015-10-02,US 201514874334 A;;US 201514874188 A;;US 201462060351 P,2014-10-06,System and method for data analytics and visualization,"Systems and methods are described that provide a dynamic reporting functionality that can identify important information and dynamically present a report about the important information that highlights important findings to the user. The described systems and methods are generally described in the field of diabetes management, but are applicable to other medical reports as well. In one implementation, the dynamic reports are based on available data and devices. For example, useless sections of the report, such as those with no populated data, may be removed, minimized in importance, assigned a lower priority, or the like.",DEXCOM INC,ZAMANAKOS GEORGIOS;;WIEDEBACK DANIEL JUSTIN;;STEWART JEFFREY GRANT;;REIHMAN ELI;;PRICE DAVID;;MILLER LAUREN C;;LEONE KERI;;KRAEMER DAN;;KIRBY KATHERINE ENG;;KIDA GREG;;KAMATH APURV ULLAS;;GREENE ADAM R;;GIMENEZ REBECCA;;ELLI SARAH PAIGE;;DRAEGER RIAN;;DELMORE SHANE PHILIP;;BOWMAN LEIF N,DEXCOM INC (2014-11-10),https://lens.org/057-058-622-683-062,Granted Patent,yes,21,8,19,19,0,G16H15/00;;G16H10/40;;G16H40/63;;G16H20/17;;G06T2200/24;;A61B5/7282;;A61B5/0022;;A61B5/14532;;A61B5/742;;G06T11/206;;Y02A90/10;;A61B5/14532;;A61B5/7275;;A61B5/742;;G16H15/00;;G16H10/40;;A61B5/0022;;G16H40/63;;A61B5/7282;;G16H20/17;;G06T2200/24;;Y02A90/10;;G06T11/206;;G16H10/60,G06T11/20;;A61B5/00;;A61B5/145;;G16H10/40;;G16H10/60;;G16H15/00,,0,0,,,,ACTIVE
655,US,B2,US 10867420 B2,189-701-870-605-780,2020-12-15,2020,US 201514874188 A,2015-10-02,US 201514874188 A;;US 201462060351 P,2014-10-06,System and method for data analytics and visualization,"Systems and methods are described that provide a dynamic reporting functionality that can identify important information and dynamically present a report about the important information that highlights important findings to the user. The described systems and methods are generally described in the field of diabetes management, but are applicable to other medical reports as well. In one implementation, the dynamic reports are based on available data and devices. For example, useless sections of the report, such as those with no populated data, may be removed, minimized in importance, assigned a lower priority, or the like.",DEXCOM INC,ZAMANAKOS GEORGIOS;;WIEDEBACK DANIEL JUSTIN;;STEWART JEFFREY GRANT;;REIHMAN ELI;;PRICE DAVID;;MILLER LAUREN C;;LEONE KERI;;KRAEMER DAN;;KIRBY KATHERINE ENG;;KIDA GREG;;KAMATH APURV ULLAS;;GREENE ADAM R;;GIMENEZ REBECCA;;ELLI SARAH PAIGE;;DRAEGER RIAN;;DELMORE SHANE PHILIP;;BOWMAN LEIF N,DEXCOM INC (2014-11-10),https://lens.org/189-701-870-605-780,Granted Patent,yes,53,7,19,19,0,G16H15/00;;G16H10/40;;G16H40/63;;G16H20/17;;G06T2200/24;;A61B5/7282;;A61B5/0022;;A61B5/14532;;A61B5/742;;G06T11/206;;Y02A90/10;;A61B5/14532;;A61B5/7275;;A61B5/742;;G16H15/00;;G16H10/40;;A61B5/0022;;G16H40/63;;A61B5/7282;;G16H20/17;;G06T2200/24;;Y02A90/10;;G06T11/206;;G16H10/60,G06T11/20;;A61B5/00;;A61B5/145;;G16H10/40;;G16H10/60;;G16H15/00;;G16H20/17;;G16H40/63,,2,0,,,"International Search Report and Written Opinion for Application No. PCT/US2015/053854 dated Jan. 15, 2016, 16 pages.;;International Preliminary Report on Patentability for Application No. PCT/US2015/053854 dated Apr. 20, 2017, 11 pages.",ACTIVE
656,EP,A2,EP 1532238 A2,017-980-741-865-698,2005-05-25,2005,EP 02778744 A,2002-11-05,US 0235535 W;;US 33862601 P;;US 33391201 P;;US 99601501 A;;US 33430001 P;;US 33819601 P;;US 37380602 P;;US 38104302 P;;US 40159302 P;;US 28719002 A,2001-11-05,"THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS ENCODING SAME, AND METHODS OF USE",,CURAGEN CORP,ALSOBROOK JOHN P II;;ANDERSON DAVID W;;BOLDOG FERENC L;;BURGESS CATHERINE E;;CHANT JOHN S;;CHAPOVAL ANDREI;;CHAUDHURI AMITABHA;;EDINGER SHLOMIT R;;EISEN ANDREW;;GANGOLLI ESHA A;;GERLACH VALERIE L;;GUO XIAOJIA;;JI WEIZHEN;;KHRAMTSOV NIKOLAI V;;LEITE MARIO W;;LI LI;;MEZES PETER S;;MILLET ISABELLE;;OOI CHEAN ENG;;ORT TATIANA,CURAGEN CORPORATION (2005-11-16),https://lens.org/017-980-741-865-698,Patent Application,yes,0,0,7,775,194,A61K38/00;;A61K48/00;;C07K14/47;;C12N9/00;;A61P1/04;;A61P1/14;;A61P11/06;;A61P13/08;;A61P15/08;;A61P17/00;;A61P19/00;;A61P25/00;;A61P25/16;;A61P25/28;;A61P3/04;;A61P31/04;;A61P31/18;;A61P35/00;;A61P3/06;;A61P37/04;;A61P37/06;;A61P5/38;;A61P7/04;;A61P7/06;;A61P9/00;;A61P9/10;;A61P9/12;;A61P3/10;;C12N9/00;;A61K38/00;;C07K14/47;;A61K48/00,A61K38/00;;A61K48/00;;A61P1/04;;A61P1/14;;A61P3/04;;A61P3/06;;A61P3/10;;A61P5/38;;G01N33/50;;A61P7/04;;A61P7/06;;A61P9/00;;A61P9/10;;A61P9/12;;A61P11/06;;A61P13/08;;A61P15/08;;A61P17/00;;A61P19/00;;A61P25/00;;A61P25/16;;A61P25/28;;A61P31/04;;A61P31/18;;A61P35/00;;A61P37/04;;A61P37/06;;C07K14/47;;C07K16/18;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/00;;C12N15/09;;C12P21/02;;C12P21/04;;C12P21/08;;C12Q1/68;;G01N33/15;;G01N33/53,,0,0,,,,DISCONTINUED
657,EP,A4,EP 1532238 A4,146-256-688-434-601,2005-12-28,2005,EP 02778744 A,2002-11-05,US 0235535 W;;US 33862601 P;;US 33391201 P;;US 99601501 A;;US 33430001 P;;US 33819601 P;;US 37380602 P;;US 38104302 P;;US 40159302 P;;US 28719002 A,2001-11-05,"THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS ENCODING SAME, AND METHODS OF USE",,CURAGEN CORP,ALSOBROOK JOHN P II;;ANDERSON DAVID W;;BOLDOG FERENC L;;BURGESS CATHERINE E;;CHANT JOHN S;;CHAPOVAL ANDREI;;CHAUDHURI AMITABHA;;EDINGER SHLOMIT R;;EISEN ANDREW;;GANGOLLI ESHA A;;GERLACH VALERIE L;;GUO XIAOJIA;;JI WEIZHEN;;KHRAMTSOV NIKOLAI V;;LEITE MARIO W;;LI LI;;MEZES PETER S;;MILLET ISABELLE;;OOI CHEAN ENG;;ORT TATIANA,CURAGEN CORPORATION (2005-11-16),https://lens.org/146-256-688-434-601,Search Report,no,3,0,7,775,0,A61K38/00;;A61K48/00;;C07K14/47;;C12N9/00;;A61P1/04;;A61P1/14;;A61P11/06;;A61P13/08;;A61P15/08;;A61P17/00;;A61P19/00;;A61P25/00;;A61P25/16;;A61P25/28;;A61P3/04;;A61P31/04;;A61P31/18;;A61P35/00;;A61P3/06;;A61P37/04;;A61P37/06;;A61P5/38;;A61P7/04;;A61P7/06;;A61P9/00;;A61P9/10;;A61P9/12;;A61P3/10;;C12N9/00;;A61K38/00;;C07K14/47;;A61K48/00,A61K38/00;;A61K48/00;;G01N33/50;;A61P1/04;;A61P1/14;;A61P3/04;;A61P3/06;;A61P3/10;;A61P5/38;;A61P7/04;;A61P7/06;;A61P9/00;;A61P9/10;;A61P9/12;;A61P11/06;;A61P13/08;;A61P15/08;;A61P17/00;;A61P19/00;;A61P25/00;;A61P25/16;;A61P25/28;;A61P31/04;;A61P31/18;;A61P35/00;;A61P37/04;;A61P37/06;;C07K14/47;;C07K16/18;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/00;;C12N15/09;;C12P21/02;;C12P21/04;;C12P21/08;;C12Q1/68;;G01N33/15;;G01N33/53,,3,2,045-503-388-417-010;;108-374-198-615-062,10.1006/geno.2000.6132;;10756099;;10.1016/s0021-9258(17)38830-0;;2997153,"DATABASE EMBL [online] 24 February 1999 (1999-02-24), ""Human DNA sequence from clone RP5-860F19 on chromosome 20p12.3-13 Contains the gene for a novel protein (KIAA1442), the RPL19P1 gene for ribosomal protein L19 pseudogene 1, the CPX-1 gene for metallocarboxypeptidase, the C20orf141 gene, a novel gene and four CpG islands."", XP002350680, retrieved from EBI accession no. EM_PRO:AL035460 Database accession no. AL035460;;COUZENS M ET AL: ""Peptide YY-2 (PYY2) and Pancreatic Polypeptide-2 (PPY2): Species-Specific Evolution of Novel Members of the Neuropeptide Y Gene Family"", GENOMICS, ACADEMIC PRESS, SAN DIEGO, US, vol. 64, no. 3, 15 March 2000 (2000-03-15), pages 318 - 323, XP004439407, ISSN: 0888-7543;;LEITER AB ET AL: ""Exons of the human pancreatic polypeptide gene define functional domains of the precursor"", JOURNAL OF BIOLOGICAL CHEMISTRY. (MICROFILMS), AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 260, no. 24, 25 October 1985 (1985-10-25), pages 13013 - 13017, XP002118761",DISCONTINUED
658,US,A1,US 2022/0212483 A1,130-797-860-904-814,2022-07-07,2022,US 202117646631 A,2021-12-30,US 202117646631 A;;IN 202111046460 A;;US 202163133685 P;;US 202163145865 P;;US 202163201659 P,2021-01-04,PRINTING APPARATUS,"Examples of the present disclosure relate generally to a printing apparatus and, more particularly, to apparatuses, systems, and methods for printing utilizing laser print head and reactive media.",HAND HELD PROD INC,CHING SZE PING;;SAPTU SURAINI BINTE;;LEE PHEK THONG;;NG CHENG KHOON;;DURAIRAJU DEENADAYALAN;;GO FLORANTE SUMALINOG;;DJAYAPUTRA DAVID PRATAMA;;LIM ENG HING;;NARAYANASWAMI RAJAN;;SHU YONG XING;;D'ARMANCOURT SEBASTIEN MICHEL MARIE JOSEPH;;LANSANGAN HARRY NICHOLAS MAKABALI;;CELINDER THOMAS AXEL JONAS;;ZHANG WENWEI;;NELSON BRIAN H;;GOOD TIMOTHY ALLEN;;DAVIES NORMAN;;CHANEY DAVID;;SOH TECK SIONG;;LIM HENG YEW;;OUNG KAR BOON;;WANG ZHIWEI;;LAU FONG YIN;;ZHENG HAO;;ARDIFF HENRY G;;GUNTIPALLI GIRI BABU;;ALLAKA PRAVEEN;;LAI ZYN MING;;CHAO JANG WEI;;SANCHEZ GUTIERREZ JOSE F;;LIM CHIN CHEAN,HAND HELD PRODUCTS INC (2020-12-22),https://lens.org/130-797-860-904-814,Patent Application,yes,0,1,4,8,0,B41J2/435;;B41M5/00;;B41J2/442;;B41J15/046;;B41J11/0095;;B41J11/005;;B41M5/26;;B65H23/038;;B65H2513/51;;B65H2801/12;;B65H2513/52;;B41J11/04;;G06K15/12;;G06K15/16;;G06K15/4055,B41J11/04;;G06K15/00;;G06K15/12;;G06K15/16,,0,0,,,,PENDING
659,CA,A1,CA 2465239 A1,058-352-714-354-93X,2003-05-15,2003,CA 2465239 A,2002-11-05,US 33862601 P;;US 33391201 P;;US 99601501 A;;US 33430001 P;;US 33819601 P;;US 37380602 P;;US 38104302 P;;US 40159302 P;;US 28719002 A;;US 0235535 W,2001-11-05,"THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS ENCODING SAME, AND METHODS OF USE","Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide. The invention furth er discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel huma n nucleic acids and proteins.",CURAGEN CORP,CHAPOVAL ANDREI;;CHAUDHURI AMITABHA;;CHANT JOHN S;;PENA CAROL E A;;EDINGER SHLOMIT R;;EISEN ANDREW;;STONE DAVID J;;BOLDOG FERENC L;;TWOMLOW NANCY;;VOSS EDWARD Z;;VERNET CORINE A M;;BURGESS CATHERINE E;;PATTURAJAN MEERA;;ALSOBROOK JOHN P II;;LI LI;;SPADERNA STEVEN K;;MEZES PETER S;;GANGOLLI ESHA A;;ANDERSON DAVID W;;SPYTEK KIMBERLY A;;ZHONG MEI;;ZERHUSEN BRYAN D;;RASTELLI LUCA;;MILLET ISABELLE;;GUO XIAOJIA;;JI WEIZHEN;;ORT TATIANA;;OOI CHEAN ENG;;KHRAMTSOV NIKOLAI V;;LEITE MARIO W;;QUINN SENGER KERRY E;;PADIGARU MURALIDHARA;;RIEGER DANIEL K;;SMITHSON GLENNDA;;GERLACH VALERIE L,,https://lens.org/058-352-714-354-93X,Patent Application,no,0,0,7,775,194,A61K38/00;;A61K48/00;;C07K14/47;;C12N9/00;;A61P1/04;;A61P1/14;;A61P11/06;;A61P13/08;;A61P15/08;;A61P17/00;;A61P19/00;;A61P25/00;;A61P25/16;;A61P25/28;;A61P3/04;;A61P31/04;;A61P31/18;;A61P35/00;;A61P3/06;;A61P37/04;;A61P37/06;;A61P5/38;;A61P7/04;;A61P7/06;;A61P9/00;;A61P9/10;;A61P9/12;;A61P3/10;;C12N9/00;;A61K38/00;;C07K14/47;;A61K48/00,A61K38/00;;A61K48/00;;A61P1/04;;A61P1/14;;A61P3/04;;A61P3/06;;A61P3/10;;A61P5/38;;G01N33/50;;A61P7/04;;A61P7/06;;A61P9/00;;A61P9/10;;A61P9/12;;A61P11/06;;A61P13/08;;A61P15/08;;A61P17/00;;A61P19/00;;A61P25/00;;A61P25/16;;A61P25/28;;A61P31/04;;A61P31/18;;A61P35/00;;A61P37/04;;A61P37/06;;C07K14/47;;C07K16/18;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/00;;C12N15/09;;C12P21/02;;C12P21/04;;C12P21/08;;C12Q1/68;;G01N33/15;;G01N33/53,,0,0,,,,DISCONTINUED
660,JP,A,JP 2022105494 A,153-787-578-125-118,2022-07-14,2022,JP 2022000252 A,2022-01-04,US 202163133685 P;;US 202163145865 P;;US 202163201659 P;;IN 202111046460 A;;US 202117646631 A,2021-01-04,PRINTER,"To provide a printer, a system, and a method that use a laser printing head and utilize a reaction medium.SOLUTION: A first roller 132 and a second roller 134 are operated by a processor so as to cause the travel of a printing medium in a first direction. The first roller is positioned and operated at the upstream side of the second roller along the first direction, and the first roller's rotation is stopped by the processor during a first moment. The second roller's rotation is stopped by the processor during a second moment. The second moment is later than the first moment in the time sequence.SELECTED DRAWING: Figure 1",HAND HELD PROD INC,CHING SZE PING;;HARRY NICHOLAS MAKABALI LANSANGAN;;LAU FONG YIN;;SURAINI BINTE SAPTU;;THOMAS AXEL JONAS CELINDER;;CHEN HAO;;LEE PHEK THONG;;ZHANG WENWEI;;HENRY G ARDIFF;;NG CHENG KHOON;;BRIAN H NELSON;;GIRI BABU GUNTIPALLI;;DEENADAYALAN DURAIRAJU;;TIMOTHY ALLEN GOOD;;PRAVEEN ALLAKA;;FLORANTE SUMALINOG GO;;NORMAN DAVIES;;LAI ZYN MING;;DAVID PRATAMA DJAYAPUTRA;;DAVID CHANEY;;CHAO JANG WEI;;LIM ENG HING;;SOH TECK SIONG;;JOSE F SANCHEZ GUTIERREZ;;RAJAN NARAYANASWAMI;;LIM HENG YEW;;LIM CHIN CHEAN;;SHU YONG XING;;OUNG KAR BOON;;SEBASTIEN MICHEL MARIE JOSEPH D'ARMANCOURT;;WANG ZHIWEI,,https://lens.org/153-787-578-125-118,Patent Application,no,0,0,4,8,0,B41J2/435;;B41M5/00;;B41J2/442;;B41J15/046;;B41J11/0095;;B41J11/005;;B41M5/26;;B65H23/038;;B65H2513/51;;B65H2801/12;;B65H2513/52;;B41J11/04;;G06K15/12;;G06K15/16;;G06K15/4055,B65H5/06;;B41J2/475;;B41J15/04;;B41M5/26,,0,0,,,,PENDING
661,US,A1,US 2004/0038230 A1,042-463-951-832-369,2004-02-26,2004,US 28719002 A,2002-11-04,US 28719002 A;;US 99601501 A;;US 33862601 P;;US 37380602 P;;US 33819601 P;;US 33391201 P;;US 38104302 P;;US 40159302 P;;US 33430001 P,2001-11-05,"Therapeutic polypeptides, nucleic acids encoding same, and methods of use","
   Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins. 
",ALSOBROOK JOHN P.;;ANDERSON DAVID W.;;BOLDOG FERENC L.;;BURGESS CATHERINE E.;;CHANT JOHN S.;;CHAPOVAL ANDREI;;CHAUDHURI AMITABHA;;EDINGER SHLOMIT R.;;EISEN ANDREW;;GANGOLLI ESHA A.;;GERLACH VALERIE;;GUO XIAOJIA SASHA;;JI WEIZHEN;;KHRAMTSOV NIKOLAI V.;;LEITE MARIO W.;;LI LI;;MEZES PETER S.;;MILLET ISABELLE;;OOI CHEAN ENG;;ORT TATIANA;;PADIGARU MURALIDHARA;;PATTURAJAN MEERA;;PENA CAROL E. A.;;RASTELLI LUCA;;RIEGER DANIEL K.;;SENGER KERRY E. QUINN;;SMITHSON GLENNDA;;SPADERNA STEVEN K.;;SPYTEK KIMBERLY A.;;STONE DAVID J.;;TWOMLOW NANCY;;VERNET CORINE A.M.;;VOSS EDWARD Z.;;ZERHUSEN BRYAN D.;;ZHONG MEI,ALSOBROOK JOHN P;;ANDERSON DAVID W;;BOLDOG FERENC L;;BURGESS CATHERINE E;;CHANT JOHN S;;CHAPOVAL ANDREI;;CHAUDHURI AMITABHA;;EDINGER SHLOMIT R;;EISEN ANDREW;;GANGOLLI ESHA A;;GERLACH VALERIE;;GUO XIAOJIA SASHA;;JI WEIZHEN;;KHRAMTSOV NIKOLAI V;;LEITE MARIO W;;LI LI;;MEZES PETER S;;MILLET ISABELLE;;OOI CHEAN ENG;;ORT TATIANA;;PADIGARU MURALIDHARA;;PATTURAJAN MEERA;;PENA CAROL E A;;RASTELLI LUCA;;RIEGER DANIEL K;;SENGER KERRY E QUINN;;SMITHSON GLENNDA;;SPADERNA STEVEN K;;SPYTEK KIMBERLY A;;STONE DAVID J;;TWOMLOW NANCY;;VERNET CORINE A M;;VOSS EDWARD Z;;ZERHUSEN BRYAN D;;ZHONG MEI,CURAGEN CORPORATION (2002-11-07),https://lens.org/042-463-951-832-369,Patent Application,yes,13,4,7,775,0,A61K38/00;;A61K48/00;;C07K14/47;;C12N9/00;;A61P1/04;;A61P1/14;;A61P11/06;;A61P13/08;;A61P15/08;;A61P17/00;;A61P19/00;;A61P25/00;;A61P25/16;;A61P25/28;;A61P3/04;;A61P31/04;;A61P31/18;;A61P35/00;;A61P3/06;;A61P37/04;;A61P37/06;;A61P5/38;;A61P7/04;;A61P7/06;;A61P9/00;;A61P9/10;;A61P9/12;;A61P3/10;;C12N9/00;;A61K38/00;;C07K14/47;;A61K48/00,A61K38/00;;A61K48/00;;A61P1/04;;A61P1/14;;A61P3/04;;A61P3/06;;G01N33/50;;A61P3/10;;A61P5/38;;A61P7/04;;A61P7/06;;A61P9/00;;A61P9/10;;A61P9/12;;A61P11/06;;A61P13/08;;A61P15/08;;A61P17/00;;A61P19/00;;A61P25/00;;A61P25/16;;A61P25/28;;A61P31/04;;A61P31/18;;A61P35/00;;A61P37/04;;A61P37/06;;C07K14/47;;C07K16/18;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/00;;C12N15/09;;C12P21/02;;C12P21/04;;C12P21/08;;C12Q1/68;;G01N33/15;;G01N33/53,435/6;;435/69.1;;435/183;;435/320.1;;435/325;;514/12;;536/23.2,0,0,,,,DISCONTINUED
662,EP,A1,EP 4026698 A1,121-170-104-551-106,2022-07-13,2022,EP 22150080 A,2022-01-03,US 202117646631 A;;IN 202111046460 A;;US 202163133685 P;;US 202163145865 P;;US 202163201659 P,2021-01-04,A PRINTING APPARATUS,"Examples of the present disclosure relate generally to a printing apparatus (100) and, more particularly, to apparatuses, systems, and methods for printing utilizing laser print head and reactive media.
",HAND HELD PROD INC,CHING SZE PING;;SAPTU SURAINI BINTE;;LEE PHEK THONG;;NG CHENG KHOON;;DURAIRAJU DEENADAYALAN;;GO FLORANTE SUMALINOG;;DJAYAPUTRA DAVID PRATAMA;;LIM ENG HING;;NARAYANASWAMI RAJAN;;SHU YONG XING;;D'ARMANCOURT SEBASTIEN MICHEL MARIE JOSEPH;;LANSANGAN HARRY NICHOLAS MAKABALI;;CELINDER THOMAS AXEL JONAS;;ZHANG WENWEI;;NELSON BRIAN H;;GOOD TIMOTHY ALLEN;;DAVIES NORMAN;;CHANEY DAVID;;SOH TECK SIONG;;LIM HENG YEW;;OUNG KAR BOON;;WANG ZHIWEI;;LAU FONG YIN;;ZHENG HAO;;ARDIFF HENRY G;;GUNTIPALLI GIRI BABU;;ALLAKA PRAVEEN;;LAI ZYN MING;;CHAO JANG WEI;;SANCHEZ GUTIERREZ JOSE F;;LIM CHIN CHEAN,,https://lens.org/121-170-104-551-106,Patent Application,yes,6,0,4,8,0,B41J2/435;;B41M5/00;;B41J2/442;;B41J15/046;;B41J11/0095;;B41J11/005;;B41M5/26;;B65H23/038;;B65H2513/51;;B65H2801/12;;B65H2513/52;;B41J11/04;;G06K15/12;;G06K15/16;;G06K15/4055,B41J2/44;;B41J11/00;;B41J15/04;;B41M5/26;;B65H23/038;;B65H23/188,,0,0,,,,PENDING
663,CA,A1,CA 2449341 A1,053-850-433-832-472,2003-09-18,2003,CA 2449341 A,2002-08-02,US 30950101 P;;US 31029101 P;;US 31095101 P;;US 31129201 P;;US 31197901 P;;US 31220301 P;;US 31315601 P;;US 31320101 P;;US 31370201 P;;US 31403101 P;;US 31446601 P;;US 31540301 P;;US 31585301 P;;US 31650801 P;;US 32393601 P;;US 33807801 P;;US 35465502 P;;US 36176402 P;;US 37382502 P;;US 38098002 P;;US 38097102 P;;US 38103902 P;;US 38376102 P;;US 38388702 P;;US 21013002 A;;US 0224459 W,2001-08-02,NOVEL PROTEINS AND NUCLEIC ACIDS ENCODING SAME,"The present invention provides novel isolated polynucleotides and small molecule target polypeptides encoded by the polynucleotides. Antibodies that immunospecifically bind to a novel small molecule target polypeptide or any derivative, variant, mutant or fragment of that polypeptide, polynucleotide or antibody are disclosed, as are methods in which the small molecule target polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states. More specifically, the present invention discloses methods of using recombinantly expressed and/or endogenously expressed proteins in various screening procedures for the purpose of identifying therapeutic antibodies and therapeutic small molecule s associated with diseases. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.",CURAGEN CORP,DIPIPPO VINCENT A;;SHIMKETS RICHARD A;;PADIGARU MURALIDHARA;;SHENOY SURESH G;;CATTERTON ELINA;;SMITHSON GLENNDA;;AGEE MICHELE L;;CHAUDHURI AMITABHA;;LI LI;;JI WEIZHEN;;BOLDOG FERENC L;;CHANT JOHN S;;EDINGER SHLOMIT R;;TAUPIER RAYMOND J JR;;RIEGER DANIEL K;;GORMAN LINDA;;MILLER CHARLES E;;VERNET CORINE A M;;LEITE MARIO W;;PENA CAROL E A;;HJALT TORD;;BURGESS CATHERINE E;;GERLACH VALERIE L;;SPADERNA STEVEN K;;KHRAMTS V NIKOLAI V;;ZHONG MEI;;BERGHS CONSTANCE;;ELLERMAN KAREN;;OOI CHEAN ENG;;CASMAN STACIE J;;ROTHENBERG MARK E;;ORT TATIANA;;KEKUDA RAMESH;;RASTELLI LUCA;;GIOT LOIC;;GANGOLLI ESHA A;;PATTURAJAN MEERA;;EISEN ANDREW;;VOSS EDWARD Z;;SPYTEK KIMBERLY A;;LIU XIAOHONG;;GUO XIAOJIA;;ZERHUSEN BRYAN D;;ANDERSON DAVID W,,https://lens.org/053-850-433-832-472,Patent Application,no,0,0,7,775,369,A61K38/00;;A61K38/00;;C07K14/705;;C07K14/705;;C07K14/47;;C07K14/47,A61K38/00;;C07K14/47;;C07K14/705;;C12N15/12,,0,0,,,,DISCONTINUED
664,AU,A1,AU 2002/367467 A1,012-542-764-563-981,2003-09-22,2003,AU 2002/367467 A,2002-08-02,US 31403101 P;;US 31446601 P;;US 31540301 P;;US 31585301 P;;US 31650801 P;;US 32393601 P;;US 33807801 P;;US 35465502 P;;US 36176402 P;;US 37382502 P;;US 38098002 P;;US 38097102 P;;US 38103902 P;;US 38376102 P;;US 38388702 P;;US 21013002 A;;US 30950101 P;;US 31029101 P;;US 31095101 P;;US 31129201 P;;US 31197901 P;;US 31220301 P;;US 31315601 P;;US 31320101 P;;US 31370201 P;;US 0224459 W,2001-08-02,NOVEL PROTEINS AND NUCLEIC ACIDS ENCODING SAME,,CURAGEN CORP,ZERHUSEN BRYAN D;;PATTURAJAN MEERA;;KEKUDA RAMESH;;MILLER CHARLES E;;RIEGER DANIEL K;;PENA CAROL E A;;SHIMKETS RICHARD A;;LI LI;;BERGHS CONSTANCE;;ZHONG MEI;;CASMAN STACIE J;;VOSS EDWARD Z;;BOLDOG FERENC L;;PADIGARU MURALIDHARA;;SMITHSON GLENNDA;;SHENOY SURESH G;;JI WEIZHEN;;GORMAN LINDA;;VERNET CORINE A M;;LEITE MARIO W;;GUO XIAOJIA;;ANDERSON DAVID W;;SPYTEK KIMBERLY A;;GERLACH VALERIE L;;BURGESS CATHERINE E;;KHRAMTSOV NIKOLAI V;;ORT TATIANA;;ELLERMAN KAREN;;RASTELLI LUCA;;AGEE MICHELE L;;CHAUDHURI AMITABHA;;CHANT JOHN S;;DIPIPPO VINCENT A;;EDINGER SHLOMIT R;;EISEN ANDREW;;GANGOLLI ESHA A;;GIOT LOIC;;OOI CHEAN ENG;;ROTHENBERG MARK E;;SPADERNA STEVEN K;;HJALT TORD;;LIU XIAOHONG;;TAUPIER RAYMOND J JR;;CATTERTON ELINA,,https://lens.org/012-542-764-563-981,Patent Application,no,0,0,7,775,0,A61K38/00;;A61K38/00;;C07K14/705;;C07K14/705;;C07K14/47;;C07K14/47,A61K38/00;;C07K14/47;;C07K14/705;;C12N15/12,,0,0,,,,DISCONTINUED
665,US,A1,US 2004/0014053 A1,199-448-203-474-939,2004-01-22,2004,US 21013002 A,2002-08-01,US 21013002 A;;US 30950101 P;;US 31650801 P;;US 35465502 P;;US 31029101 P;;US 38388702 P;;US 31095101 P;;US 32393601 P;;US 38103902 P;;US 31129201 P;;US 31197901 P;;US 31220301 P;;US 36176402 P;;US 31320101 P;;US 33807801 P;;US 38097102 P;;US 31315601 P;;US 31370201 P;;US 38098002 P;;US 31364301 P;;US 38376102 P;;US 32271601 P;;US 31403101 P;;US 31446601 P;;US 31540301 P;;US 31585301 P;;US 37382502 P,2001-08-02,Novel proteins and nucleic acids encoding same,"
   The present invention provides novel isolated polynucleotides and small molecule target polypeptides encoded by the polynucleotides. Antibodies that immunospecifically bind to a novel small molecule target polypeptide or any derivative, variant, mutant or fragment of that polypeptide, polynucleotide or antibody are disclosed, as are methods in which the small molecule target polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states. More specifically, the present invention discloses methods of using recombinantly expressed and/or endogenously expressed proteins in various screening procedures for the purpose of identifying therapeutic antibodies and therapeutic small molecules associated with diseases. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins. 
",ZERHUSEN BRYAN D.;;PATTURAJAN MEERA;;KEKUDA RAMESH;;MILLER CHARLES E.;;RIEGER DANIEL K.;;PENA CAROL E.A.;;SHIMKETS RICHARD A.;;LI LI;;BERGHS CONSTANCE;;ZHONG MEI;;CASMAN STACIE J.;;VOSS EDWARD Z.;;BOLDOG FERENC L.;;PADIGARU MURALIDHARA;;SMITHSON GLENNDA;;JI WEIZHEN;;GORMAN LINDA;;VERNET CORINE A.M.;;LEITE MARIO W.;;GUO XIAOJIA SASHA;;ANDERSON DAVID W.;;SPYTEK KIMBERLY A.;;GERLACH VALERIE;;BURGESS CATHERINE E.;;KHRAMTSOV NIKOLAI V.;;ORT TATIANA;;ELLERMAN KAREN;;RASTELLI LUCA;;AGEE MICHELE L.;;CHAUDHURI AMITABHA;;CHANT JOHN S.;;DIPIPPO VINCENT A.;;EDINGER SHLOMIT R.;;EISEN ANDREW J.;;GANGOLLI ESHA A.;;GIOT LOIC;;OOI CHEAN ENG;;ROTHENBERG MARK E.;;SPADERNA STEVEN K.;;HJALT TORD;;LIU XIAOHONG;;TAUPIER RAYMOND J.;;CATTERTON ELINA;;SHENOY SURESH G.,ZERHUSEN BRYAN D;;PATTURAJAN MEERA;;KEKUDA RAMESH;;MILLER CHARLES E;;RIEGER DANIEL K;;PENA CAROL E A;;SHIMKETS RICHARD A;;LI LI;;BERGHS CONSTANCE;;ZHONG MEI;;CASMAN STACIE J;;VOSS EDWARD Z;;BOLDOG FERENC L;;PADIGARU MURALIDHARA;;SMITHSON GLENNDA;;JI WEIZHEN;;GORMAN LINDA;;VERNET CORINE A M;;LEITE MARIO W;;GUO XIAOJIA SASHA;;ANDERSON DAVID W;;SPYTEK KIMBERLY A;;GERLACH VALERIE;;BURGESS CATHERINE E;;KHRAMTSOV NIKOLAI V;;ORT TATIANA;;ELLERMAN KAREN;;RASTELLI LUCA;;AGEE MICHELE L;;CHAUDHURI AMITABHA;;CHANT JOHN S;;DIPIPPO VINCENT A;;EDINGER SHLOMIT R;;EISEN ANDREW J;;GANGOLLI ESHA A;;GIOT LOIC;;OOI CHEAN ENG;;ROTHENBERG MARK E;;SPADERNA STEVEN K;;HJALT TORD;;LIU XIAOHONG;;TAUPIER RAYMOND J;;CATTERTON ELINA;;SHENOY SURESH G,CURAGEN CORPORATION (2002-09-25),https://lens.org/199-448-203-474-939,Patent Application,yes,2,4,1,775,369,A61K38/00;;A61K38/00;;C07K14/705;;C07K14/705;;C07K14/47;;C07K14/47,A61K38/00;;C07K14/47;;C07K14/705,435/6;;435/7.23;;435/69.1;;435/183;;435/320.1;;435/325;;X53035;;536/23.2,0,0,,,,DISCONTINUED
666,CA,A1,CA 2451254 A1,027-844-558-696-095,2003-03-20,2003,CA 2451254 A,2002-09-09,US 31812001 P;;US 31818401 P;;US 31843001 P;;US 32263601 P;;US 32281701 P;;US 32281601 P;;US 32278101 P;;US 32351901 P;;US 32363101 P;;US 32363601 P;;US 32496901 P;;US 32509101 P;;US 32499001 P;;US 34114401 P;;US 35959902 P;;US 36166302 P;;US 37790802 P;;US 38148302 P;;US 38386302 P;;US 39333202 P;;US 39641202 P;;US 40351702 P;;US 23641702 A;;US 0228538 W,2001-09-07,NOVEL PROTEINS AND NUCLEIC ACIDS ENCODING SAME,"The present invention provides novel isolated polynucleotides and small molecule target polypeptides encoded by the polynucleotides. Antibodies that immunospecifically bind to a novel small molecule target polypeptide or any derivative, variant, mutant or fragment of that polypeptide, polynucleotide or antibody are disclosed as are methods in which the small molecule target polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states. More specifically, the present invention discloses methods of using recombinantly expressed and/or endogenously expressed proteins in various screening procedures for the purpose of identifying therapeutic antibodies and therapeutic small molecule s associated with diseases. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.",CURAGEN CORP,ORT TATIANA;;EDINGER SHLOMIT R;;TWOMLOW NANCY;;VERNET CORINE A M;;PATTURAJAN MEERA;;MALYANKAR URIEL M;;VOSS EDWARD Z;;MILLER CHARLES E;;PADIGARU MURALIDHARA;;ZHONG MEI;;CATTERTON ELINA;;KHRAMTSOV NIKOLAI V;;ZERHUSEN BRYAN D;;EISEN ANDREW;;ELLERMAN KAREN;;CASMAN STACIE J;;GUO XIAOJIA;;GUSEV VLADIMIR Y;;GIOT LOIC;;BURGESS CATHERINE E;;GERLACH VALERIE L;;KEKUDA RAMESH;;GANGOLLI ESHA A;;LIU XIAOHONG;;SPYTEK KIMBERLY A;;ALSOBROOK JOHN P II;;ANDERSON DAVID W;;TAUPIER RAYMOND J JR;;LEACH MARTIN D;;AGEE MICHELE L;;BERGHS CONSTANCE;;LI LI;;LEPLEY DENISE M;;GORMAN LINDA;;BOLDOG FERENC L;;SHENOY SURESH G;;SHIMKETS RICHARD A;;CHAUDHURI AMITABHA;;ROTHENBERG MARK E;;SPADERNA STEVEN K;;CHANT JOHN S;;OOI CHEAN ENG;;PENA CAROL E A;;RIEGER DANIEL K;;JI WEIZHEN;;CRABTREE JULIE;;DIPIPPO VINCENT A,,https://lens.org/027-844-558-696-095,Patent Application,no,0,0,6,775,341,A01K2217/05;;A01K2217/05;;A61K38/00;;A61K38/00;;A61K48/00;;A61K48/00;;A61P3/00;;A61P3/04;;A61P3/06;;A61P3/10;;A61P7/00;;A61P25/00;;A61P25/16;;A61P25/28;;A61P31/00;;A61P35/00;;A61P37/00;;C07K14/47;;C07K14/47;;C07K2319/00;;C07K2319/00;;C12N9/00;;C12N9/00,G01N33/53;;A61K38/00;;A61K48/00;;A61P3/00;;A61P3/04;;A61P3/06;;A61P3/10;;A61P7/00;;A61P25/00;;A61P25/16;;A61P25/28;;A61P31/00;;A61P35/00;;A61P37/00;;C07K14/47;;C07K16/18;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/00;;C12N15/09;;C12P21/02;;C12P21/08;;C12Q1/02;;C12Q1/68,,0,0,,,,DISCONTINUED
667,WO,A3,WO 2003/023001 A3,079-664-379-184-287,2007-12-06,2007,US 0228538 W,2002-09-09,US 31812001 P;;US 40351702 P;;US 39333202 P;;US 35959902 P;;US 34114401 P;;US 32499001 P;;US 32509101 P;;US 38386302 P;;US 32496901 P;;US 32363601 P;;US 38148302 P;;US 37790802 P;;US 32363101 P;;US 32351901 P;;US 32281601 P;;US 32281701 P;;US 32263601 P;;US 39641202 P;;US 36166302 P;;US 31818401 P;;US 32278101 P;;US 31843001 P;;US 23641702 A,2001-09-07,NOVEL PROTEINS AND NUCLEIC ACIDS ENCODING SAME,"The present invention provides novel isolated polynucleotides and small molecule target polypeptides encoded by the polynucleotides. Antibodies that immunospecifically bind to a novel small molecule target polypeptide or any derivative, variant, mutant or fragment of that polypeptide, polynucleotide or antibody are disclosed as are methods in which the small molecule target polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states. More specifically, the present invention discloses methods of using recombinantly expressed and/or endogenously expressed proteins in various screening procedures for the purpose of identifying therapeutic antibodies and therapeutic small molecules associated with diseases. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.",CURAGEN CORP;;AGEE MICHELE L;;ALSOBROOK JOHN P II;;ANDERSON DAVID W;;BERGHS CONSTANCE;;BOLDOG FERENC L;;BURGESS CATHERINE E;;CASMAN STACIE J;;CATTERTON ELINA;;CHANT JOHN S;;CHAUDHURI AMITABHA;;CRABTREE JULIE;;DIPIPPO VINCENT A;;EDINGER SHLOMIT R;;EISEN ANDREW;;ELLERMAN KAREN;;GANGOLLI ESHA A;;GERLACH VALERIE L;;GIOT LOIC;;GORMAN LINDA;;GUO XIAOJIA;;GUSEV VLADIMIR Y;;JI WEIZHEN;;KEKUDA RAMESH;;KHRAMTSOV NIKOLAI V;;LEACH MARTIN D;;LEPLEY DENISE M;;LI LI;;LIU XIAOHONG;;MALYANKAR URIEL M;;MILLER CHARLES E;;OOI CHEAN ENG;;ORT TATIANA;;PADIGARU MURALIDHARA;;PATTURAJAN MEERA;;PENA CAROL E A;;RIEGER DANIEL K;;ROTHENBERG MARK E;;SHENOY SURESH G;;SHIMKETS RICHARD A;;SPADERNA STEVEN K;;SPYTEK KIMBERLY A;;TAUPIER RAYMOND J JR;;TWOMLOW NANCY;;VERNET CORINE A M;;VOSS EDWARD Z;;ZERHUSEN BRYAN D;;ZHONG MEI,AGEE MICHELE L;;ALSOBROOK JOHN P II;;ANDERSON DAVID W;;BERGHS CONSTANCE;;BOLDOG FERENC L;;BURGESS CATHERINE E;;CASMAN STACIE J;;CATTERTON ELINA;;CHANT JOHN S;;CHAUDHURI AMITABHA;;CRABTREE JULIE;;DIPIPPO VINCENT A;;EDINGER SHLOMIT R;;EISEN ANDREW;;ELLERMAN KAREN;;GANGOLLI ESHA A;;GERLACH VALERIE L;;GIOT LOIC;;GORMAN LINDA;;GUO XIAOJIA;;GUSEV VLADIMIR Y;;JI WEIZHEN;;KEKUDA RAMESH;;KHRAMTSOV NIKOLAI V;;LEACH MARTIN D;;LEPLEY DENISE M;;LI LI;;LIU XIAOHONG;;MALYANKAR URIEL M;;MILLER CHARLES E;;OOI CHEAN ENG;;ORT TATIANA;;PADIGARU MURALIDHARA;;PATTURAJAN MEERA;;PENA CAROL E A;;RIEGER DANIEL K;;ROTHENBERG MARK E;;SHENOY SURESH G;;SHIMKETS RICHARD A;;SPADERNA STEVEN K;;SPYTEK KIMBERLY A;;TAUPIER RAYMOND J JR;;TWOMLOW NANCY;;VERNET CORINE A M;;VOSS EDWARD Z;;ZERHUSEN BRYAN D;;ZHONG MEI,,https://lens.org/079-664-379-184-287,Search Report,yes,0,0,6,775,0,A01K2217/05;;A01K2217/05;;A61K38/00;;A61K38/00;;A61K48/00;;A61K48/00;;A61P3/00;;A61P3/04;;A61P3/06;;A61P3/10;;A61P7/00;;A61P25/00;;A61P25/16;;A61P25/28;;A61P31/00;;A61P35/00;;A61P37/00;;C07K14/47;;C07K14/47;;C07K2319/00;;C07K2319/00;;C12N9/00;;C12N9/00,A61K38/00;;G01N33/53;;A61K48/00;;A61P3/00;;A61P3/04;;A61P3/06;;A61P3/10;;A61P7/00;;A61P25/00;;A61P25/16;;A61P25/28;;A61P31/00;;A61P35/00;;A61P37/00;;C07K1/00;;C07K14/47;;C07K16/18;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/00;;C12N15/09;;C12P21/02;;C12P21/08;;C12Q1/02;;C12Q1/68,,1,1,043-664-677-063-989,7744246;;10.1101/gad.9.9.1033,"WILLY P.J. ET AL.: ""LXR, a nuclear receptor that defines a distinct retinoid response pathway"", GENES AND DEVELOPMENT, vol. 9, no. 9, May 1995 (1995-05-01), pages 1033 - 1045, XP000972205",PENDING
668,US,A1,US 2004/0048256 A1,063-432-044-930-483,2004-03-11,2004,US 23641702 A,2002-09-06,US 23641702 A;;US 31812001 P;;US 31843001 P;;US 32278101 P;;US 31818401 P;;US 36166302 P;;US 39641202 P;;US 32263601 P;;US 32281701 P;;US 32281601 P;;US 32351901 P;;US 32363101 P;;US 37790802 P;;US 38148302 P;;US 32363601 P;;US 32496901 P;;US 38386302 P;;US 32509101 P;;US 32499001 P;;US 34114401 P;;US 35959902 P;;US 39333202 P;;US 40351702 P,2001-09-07,Novel proteins and nucleic acids encoding same,"
   The present invention provides novel isolated polynucleotides and small molecule target polypeptides encoded by the polynucleotides. Antibodies that immunospecifically bind to a novel small molecule target polypeptide or any derivative, variant, mutant or fragment of that polypeptide, polynucleotide or antibody are disclosed, as are methods in which the small molecule target polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states. More specifically, the present invention discloses methods of using recombinantly expressed and/or endogenously expressed proteins in various screening procedures for the purpose of identifying therapeutic antibodies and therapeutic small molecules associated with diseases. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins. 
",AGEE MICHELE L.;;ALSOBROOK JOHN P.;;ANDERSON DAVID W.;;BERGHS CONSTANCE;;BOLDOG FERENC L.;;BURGESS CATHERINE E.;;CASMAN STACIE J.;;CATTERTON ELINA;;CHANT JOHN S.;;CHAUDHURI AMITABHA;;BOKOR JULIE;;DIPIPPO VINCENT A.;;EDINGER SHLOMIT R.;;EISEN ANDREW;;ELLERMAN KAREN;;GANGOLLI ESHA A.;;GERLACH VALERIE;;GIOT LOIC;;GORMAN LINDA;;GUO XIAOJIA (SASHA);;GUSEV VLADIMIR Y.;;JI WEIZHEN;;KEKUDA RAMESH;;KHRAMTSOV NIKOLAI V.;;LEACH MARTIN D.;;LEPLEY DENISE M.;;LI LI;;LIU XIAOHONG;;MALYANKAR URIEL M.;;MILLER CHARLES E.;;OOI CHEAN ENG;;ORT TATIANA;;PADIGARU MURALIDHARA;;PATTURAJAN MEERA;;PENA CAROL E. A.;;RIEGER DANIEL K.;;ROTHENBERG MARK E.;;SHENOY SURESH G.;;SHIMKETS RICHARD A.;;SPADERNA STEVEN K.;;SPYTEK KIMBERLY A.;;TAUPIER RAYMOND J.;;TWOMLOW NANCY;;VERNET CORINE A.M.;;VOSS EDWARD Z.;;ZERHUSEN BRYAN D.;;ZHONG MEI,AGEE MICHELE L;;ALSOBROOK JOHN P;;ANDERSON DAVID W;;BERGHS CONSTANCE;;BOLDOG FERENC L;;BURGESS CATHERINE E;;CASMAN STACIE J;;CATTERTON ELINA;;CHANT JOHN S;;CHAUDHURI AMITABHA;;BOKOR JULIE;;DIPIPPO VINCENT A;;EDINGER SHLOMIT R;;EISEN ANDREW;;ELLERMAN KAREN;;GANGOLLI ESHA A;;GERLACH VALERIE;;GIOT LOIC;;GORMAN LINDA;;GUO XIAOJIA SASHA;;GUSEV VLADIMIR Y;;JI WEIZHEN;;KEKUDA RAMESH;;KHRAMTSOV NIKOLAI V;;LEACH MARTIN D;;LEPLEY DENISE M;;LI LI;;LIU XIAOHONG;;MALYANKAR URIEL M;;MILLER CHARLES E;;OOI CHEAN ENG;;ORT TATIANA;;PADIGARU MURALIDHARA;;PATTURAJAN MEERA;;PENA CAROL E A;;RIEGER DANIEL K;;ROTHENBERG MARK E;;SHENOY SURESH G;;SHIMKETS RICHARD A;;SPADERNA STEVEN K;;SPYTEK KIMBERLY A;;TAUPIER RAYMOND J;;TWOMLOW NANCY;;VERNET CORINE A M;;VOSS EDWARD Z;;ZERHUSEN BRYAN D;;ZHONG MEI,CURAGEN CORPORATION (2002-10-05),https://lens.org/063-432-044-930-483,Patent Application,yes,7,10,6,775,0,A01K2217/05;;A01K2217/05;;A61K38/00;;A61K38/00;;A61K48/00;;A61K48/00;;A61P3/00;;A61P3/04;;A61P3/06;;A61P3/10;;A61P7/00;;A61P25/00;;A61P25/16;;A61P25/28;;A61P31/00;;A61P35/00;;A61P37/00;;C07K14/47;;C07K14/47;;C07K2319/00;;C07K2319/00;;C12N9/00;;C12N9/00,G01N33/53;;A61K38/00;;A61K48/00;;A61P3/00;;A61P3/04;;A61P3/06;;A61P3/10;;A61P7/00;;A61P25/00;;A61P25/16;;A61P25/28;;A61P31/00;;A61P35/00;;A61P37/00;;C07K14/47;;C07K16/18;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/00;;C12N15/09;;C12P21/02;;C12P21/08;;C12Q1/02;;C12Q1/68,435/6;;435/69.1;;435/183;;435/320.1;;435/325;;X53035;;536/23.2;;514/12,0,0,,,,DISCONTINUED
